182 chronic JJ I-NP O
182 normocytic JJ I-NP O
182 anemia NN I-NP O
183 felt VBD B-VP O
183 likely JJ O O
183 to TO O O
183 be VB O O
183 secondary JJ O O
183 to TO O O
183 her PRP$ O O
183 chronic JJ B-NP O
183 renal JJ I-NP O
183 insufficiency NN I-NP O
184 Her NNP I-NP O
184 iron NN I-NP O
184 studies NNS I-NP O
184 were VBD B-VP O
184 rechecked VBN O O
184 on IN B-VP O
184 this DT B-NP O
184 admission NN I-NP O
184 and CC O O
184 her PRP$ O O
184 iron NN B-NP O
185 studies NNS I-NP O
185 were VBD B-VP O
185 also RB O O
185 normal JJ O O
185 She PRP O O
185 was VBD B-VP O
185 continued VBN O O
185 on IN B-VP O
185 Aranesp NNP B-NP B-m
185 through IN B-VP O
186 this DT B-NP O
186 hospitalization NN I-NP O
186 and CC O O
186 she PRP O O
186 is VBZ O O
186 on IN B-VP O
186 Procrit NNP B-NP B-m
186 as IN B-VP O
186 an DT B-NP O
186 outpatient NN I-NP O
186 and CC O O
187 she PRP O O
187 will MD O O
187 continue VB O O
187 on IN B-VP O
187 that DT O O
187 with IN B-VP O
187 further JJ B-NP O
187 discussion NN I-NP O
187 with IN B-VP O
187 the DT B-NP O
187 GGVH NNP I-NP O
188 Renal NNP I-NP O
188 Clinic NNP I-NP O
188 after IN B-VP O
188 she PRP O O
188 is VBZ O O
188 discharged JJ O O
189 6 CD O O
189 Fluids NNP B-NP O
189 , , O O
189 electrolytes VBZ O O
189 , , O O
189 and CC O O
189 nutrition: VBZ O O
189 The DT B-NP O
189 patient NN I-NP O
189 was VBD B-VP O
189 fluid RB O O
190 restricted VBN O O
190 to TO O O
190 2 CD O O
190 liters NNS B-NP O
190 of IN B-VP O
190 fluid JJ O O
190 per IN B-VP O
190 day NN B-NP O
190 p.o NN I-NP O
190 and CC O O
190 potassium NN B-NP B-m
190 and CC O O
191 magnesium NN B-NP B-m
191 were VBD B-VP O
191 repleted VBN O O
191 as IN B-VP B-f
191 as IN B-VP B-f
191 needed VBN O I-f
191 needed VBN O I-f
191 and CC O O
191 she PRP O O
191 was VBD B-VP O
191 maintained VBN O O
191 on IN B-VP O
191 a DT B-NP O
192 cardiac JJ I-NP O
192 diet NN I-NP O
192 Prophylaxis NNP I-NP B-r
192 Prophylaxis NNP I-NP B-r
192 was VBD B-VP O
192 with IN B-VP O
192 Coumadin NNP B-NP B-m
192 and CC O O
192 Nexium NNP B-NP B-m
193 DISCHARGE NNP I-NP O
193 PLAN: NNP I-NP O
193 The DT B-NP O
193 patient NN I-NP O
193 will MD O O
193 be VB O O
193 discharged VBN O O
193 to TO O O
193 home NN B-NP O
193 with IN B-VP O
193 VNA NNP B-NP O
194 services NNS I-NP O
194 for IN B-VP O
194 some DT B-NP O
194 home NN I-NP O
194 physical JJ B-NP O
194 therapy NN I-NP O
194 She PRP O O
194 will MD O O
194 follow VB O O
194 up RP O O
194 with IN B-VP O
195 her PRP$ O O
195 primary JJ B-NP O
195 care NN I-NP O
195 provider NN I-NP O
195 Dr NNP I-NP O
195 Bublitz NNP I-NP O
195 at IN B-VP O
195 MHS NNP B-NP O
195 and CC O O
195 also RB O O
195 with IN B-VP O
195 the DT B-NP O
196 SRRH NNP I-NP O
196 Cardiology NNP I-NP O
196 Clinic NNP I-NP O
196 and CC O O
196 Renal NNP B-NP O
196 Clinic NNP I-NP O
196 She PRP O O
196 should MD O O
196 have VB O O
196 her PRP$ O O
196 INR NNP B-NP O
197 checked VBD B-VP O
197 within IN B-VP O
197 4-5 JJ B-NP O
197 days NNS I-NP O
197 after IN B-VP O
197 discharge NN B-NP O
197 and CC O O
197 her PRP$ O O
197 Coumadin NNP B-NP B-m
198 restarted VBD B-VP O
198 when WRB O O
198 her PRP$ O O
198 INR NNP B-NP O
198 is VBZ O O
198 less JJR O O
198 than IN B-VP O
198 2.5 CD O O
199 DISCHARGE NNP B-NP O
199 MEDICATIONS: NNP I-NP O
200 1 CD O O
200 Aspirin NNP B-NP B-m
200 81 CD O B-do
200 mg NN B-NP I-do
200 p.o JJ O B-mo
200 daily JJ O B-f
201 2 CD O O
201 Amiodarone $ O B-m
201 200 CD O B-do
201 mg JJ O I-do
201 p.o JJ O B-mo
201 daily JJ O B-f
202 3 CD O O
202 Lipitor NNP B-NP B-m
202 80 CD O B-do
202 mg NN B-NP I-do
202 p.o JJ O B-mo
202 daily JJ O B-f
203 4 CD O O
203 Folate NNP B-NP B-m
203 1 CD O B-do
203 mg NN B-NP I-do
203 p.o JJ O B-mo
203 daily JJ O B-f
204 5 CD O O
204 Lantus NNP B-NP B-m
204 insulin NN I-NP I-m
204 12 CD O B-do
204 units NNS B-NP I-do
204 subcutaneous JJ O B-mo
204 nightly RB O B-f
205 6 CD O O
205 Ativan NNP B-NP B-m
205 0.5 CD O B-do
205 mg NN B-NP I-do
205 p.o NN I-NP B-mo
205 t.i.d VBD B-VP B-f
206 7 CD O O
206 Metolazone NNP B-NP B-m
206 2.5 CD O B-do
206 mg NN B-NP I-do
206 p.o JJ O B-mo
206 daily RB O B-f
206 as IN B-VP I-f
206 needed VBN O I-f
206 for IN B-VP O
206 fluid JJ B-NP B-r
206 retention NN I-NP I-r
206 as IN B-VP O
207 directed VBN O O
207 by IN B-VP O
207 your PRP$ O O
207 physician JJ O O
208 8 CD O O
208 Multivitamin NNP B-NP B-m
208 one CD O B-do
208 tablet NN B-NP I-do
208 p.o VB O B-mo
208 daily JJ O B-f
209 9 CD O O
209 Torsemide NNP B-NP B-m
209 Torsemide NNP I-NP B-m
209 100 CD O B-do
209 mg NN B-NP I-do
209 p.o NN I-NP B-mo
209 q.a.m NN I-NP B-f
209 at IN B-VP O
209 50 CD O B-do
209 mg NN B-NP I-do
209 p.o NN I-NP B-mo
209 q.p.m VBD B-VP B-f
210 10 CD O O
210 Vitamin NNP B-NP B-m
210 B12 NNP I-NP I-m
211 11 CD O O
211 Iron NNP B-NP B-m
212 12 CD O O
212 Procrit NNP B-NP B-m
212 40 CD O B-do
212 , , O I-do
212 000 CD O I-do
212 units NNS B-NP I-do
212 subcutaneously RB O B-mo
212 every DT B-NP B-f
212 other JJ I-NP I-f
212 week NN I-NP I-f
213 eScription NN I-NP O
213 document: VBZ O O
213 6-0072111 JJ B-NP O
213 RFFocus NNP I-NP O
214 Dictated NNP I-NP O
214 By: NNP I-NP O
214 BURROW NNP I-NP O
214 , , O O
214 KENNETH NNP B-NP O
215 Attending: NNP I-NP O
215 NOVAKOVICH NNP I-NP O
215 , , O O
215 CURT NNP B-NP O
216 Dictation NNP I-NP O
216 ID NNP I-NP O
216 1743355 CD O O
217 D: NNP B-NP O
217 1/16/06 CD O O
218 T: NNP B-NP O
218 2/8/06 CD O O
219 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #815287 VBZ O O
2 265642788 CD O O
2 AYMC NNP B-NP O
2 78055007 CD O O
2 5390462 CD O O
2 6/4/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Pneumonia NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/4/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 1/10/2004 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 EANS NNP I-NP O
5 , , O O
5 JUSTIN NNP B-NP O
5 244-78-04-0 JJ B-NP O
6 Chi NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 0/0/04 CD O O
8 AT NNP B-NP O
8 02:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 VANHYNING NNP I-NP O
11 , , O O
11 GLENN NNP B-NP O
11 E NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 TYLENOL NNP I-NP B-m
16 TYLENOL NNP I-NP B-m
16 TYLENOL NNP I-NP B-m
16 ( ( O I-m
16 ( ( O I-m
16 ( ( O I-m
16 ACETAMINOPHEN NNP B-NP I-m
16 ACETAMINOPHEN NNP I-NP I-m
16 ACETAMINOPHEN NNP I-NP I-m
16 ) ) O I-m
16 ) ) O I-m
16 ) ) O I-m
16 500 CD O B-do
16 500 CD O B-do
16 500 CD O B-do
16 MG NNP B-NP I-do
16 MG NNP I-NP I-do
16 MG NNP I-NP I-do
16 PO NNP I-NP B-mo
16 PO NNP I-NP B-mo
16 PO NNP I-NP B-mo
16 Q6H NNP I-NP B-f
16 Q6H NNP I-NP B-f
16 Q6H NNP I-NP B-f
16 PRN NNP I-NP I-f
16 PRN NNP I-NP I-f
16 PRN NNP I-NP I-f
16 Pain NNP I-NP B-r
16 , , O O
16 Headache NNP B-NP B-r
16 Headache NNP I-NP B-r
17 ATENOLOL NNP I-NP B-m
17 100 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 CALCIUM NNP I-NP B-m
18 CITRATE NNP I-NP I-m
18 950 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 BID NNP I-NP B-f
19 COLACE NNP I-NP B-m
19 ( ( O I-m
19 DOCUSATE NNP B-NP I-m
19 SODIUM NNP I-NP I-m
19 ) ) O I-m
19 100 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 GEMFIBROZIL NNP I-NP B-m
20 600 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 BID NNP I-NP B-f
21 HYDROCHLOROTHIAZIDE NNP I-NP B-m
21 25 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 NPH NNP I-NP B-m
22 INSULIN NNP I-NP I-m
22 HUMAN NNP I-NP I-m
22 ( ( O I-m
22 INSULIN NNP B-NP I-m
22 NPH NNP I-NP I-m
22 HUMAN NNP I-NP I-m
22 ) ) O I-m
23 15 CD O B-do
23 UNITS NNP B-NP I-do
23 SC NNP I-NP B-mo
23 At IN B-VP B-f
23 10 CD O I-f
23 p.m NN B-NP I-f
23 ( ( O I-f
23 bedtime NN B-NP I-f
23 ) ) O I-f
24 LISINOPRIL VBZ O B-m
24 40 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QD NNP I-NP B-f
25 Override NNP I-NP O
25 Notice: NNP I-NP O
25 Override NNP I-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 0/28/04 CD O O
25 by IN B-VP O
26 WILBY NNP B-NP O
26 , , O O
26 BRYANT NNP B-NP O
26 BRYON NNP I-NP O
26 , , O O
26 M.D NNP B-NP O
27 on IN B-VP O
27 order NN B-NP O
27 for IN B-VP O
27 POTASSIUM NNP B-NP B-m
27 CHLORIDE NNP I-NP I-m
27 IMMED NNP I-NP I-m
27 REL NNP I-NP I-m
27 PO NNP I-NP B-mo
27 ( ( O O
27 ref JJ O O
27 # # O O
28 93677429 CD O O
28 ) ) O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 LISINOPRIL NNP I-NP B-m
29 &amp; NNP I-NP O
29 POTASSIUM NNP I-NP B-m
30 CHLORIDE NNP I-NP O
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 will MD O O
30 follow VB O O
31 Previous NNP B-NP O
31 override IN B-VP O
31 information: JJ B-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 0/28/04 CD O O
32 by IN B-VP O
32 WASHMUTH NNP B-NP O
32 , , O O
32 SCOTTIE NNP B-NP O
32 CLEO NNP I-NP O
32 , , O O
32 M.D NNP B-NP O
33 on IN B-VP O
33 order NN B-NP O
33 for IN B-VP O
33 POTASSIUM NNP B-NP B-m
33 CHLORIDE NNP I-NP I-m
33 IV NNP I-NP B-mo
33 ( ( O O
33 ref JJ O O
33 # # O O
33 23327775 CD O O
33 ) ) O O
34 POTENTIALLY NNP B-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 LISINOPRIL NNP I-NP B-m
34 &amp; NNP I-NP O
34 POTASSIUM NNP I-NP B-m
35 CHLORIDE NNP I-NP O
35 Reason NNP I-NP O
35 for IN B-VP O
35 override: NN B-NP O
35 will MD O O
35 follow VB O O
36 NIFEREX-150 NNP B-NP B-m
36 150 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 BID NNP I-NP B-f
37 Override NNP I-NP O
37 Notice: NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 3/3/04 CD O O
37 by IN B-VP O
38 BEILER NNP B-NP O
38 , , O O
38 TOMMY NNP B-NP O
38 L NNP I-NP O
39 on IN B-VP O
39 order NN B-NP O
39 for IN B-VP O
39 LEVOFLOXACIN NNP B-NP B-m
39 PO NNP I-NP B-mo
39 ( ( O O
39 ref JJ O O
39 # # O O
39 46869053 CD O O
39 ) ) O O
40 POTENTIALLY NNP B-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 POLYSACCHARIDE NNP I-NP B-m
40 IRON NNP I-NP O
41 COMPLEX NNP I-NP O
41 &amp; NNP I-NP O
41 LEVOFLOXACIN NNP I-NP B-m
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
42 Will NNP I-NP O
42 separate JJ B-NP O
42 doses NNS I-NP O
42 by IN B-VP O
42 2 CD O O
42 hours NNS B-NP O
43 Previous JJ O O
43 override IN B-VP O
43 information: JJ B-NP O
44 Override NNP I-NP O
44 added VBD B-VP O
44 on IN B-VP O
44 0/28/04 CD O O
44 by IN B-VP O
44 UREN NNP B-NP O
44 , , O O
44 FERMIN NNP B-NP O
44 JEWEL NNP I-NP O
44 , , O O
44 M.D NNP B-NP O
45 POTENTIALLY NNP I-NP O
45 SERIOUS NNP I-NP O
45 INTERACTION: NNP I-NP O
45 LEVOFLOXACIN NNP I-NP B-m
45 &amp; NNP I-NP O
46 POLYSACCHARIDE NNP I-NP B-m
46 IRON NNP I-NP I-m
46 COMPLEX NNP I-NP I-m
46 Reason NNP I-NP O
46 for IN B-VP O
46 override: NN B-NP O
46 will MD O O
46 follow VB O O
47 SIMETHICONE NNP B-NP B-m
47 80 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QID NNP I-NP B-f
47 PRN NNP I-NP I-f
47 Upset NNP I-NP B-r
47 Stomach NNP I-NP I-r
48 VITAMIN NNP I-NP B-m
48 E NNP I-NP I-m
48 ( ( O I-m
48 TOCOPHEROL-DL-ALPHA NNP B-NP I-m
48 ) ) O I-m
48 1 CD O B-do
48 , , O I-do
48 200 CD O I-do
48 UNITS NNP B-NP I-do
48 PO NNP I-NP B-mo
48 QD NNP I-NP B-f
49 Starting VBG O O
49 Today NNP B-NP O
49 ( ( O O
49 7/21 CD O O
49 ) ) O O
50 VITAMIN NNP B-NP B-m
50 B NNP I-NP I-m
50 COMPLEX NNP I-NP I-m
50 1 CD O B-do
50 TAB NNP B-NP I-do
50 PO NNP I-NP B-mo
50 QD NNP I-NP B-f
51 TRIAMCINOLONE NNP I-NP B-m
51 TRIAMCINOLONE NNP I-NP B-m
51 ACETONIDE NNP I-NP I-m
51 ACETONIDE NNP I-NP I-m
51 0.5% CD O I-m
51 0.5% CD O I-m
51 ( ( O I-m
51 ( ( O I-m
51 TRIAMCINOLONE NNP B-NP I-m
51 TRIAMCINOLONE NNP I-NP I-m
51 A NNP I-NP I-m
51 A NNP I-NP I-m
51 ) ) O I-m
51 ) ) O I-m
52 TOPICAL NNP B-NP B-mo
52 TOPICAL NNP I-NP B-mo
52 TP NNP I-NP I-mo
52 TP NNP I-NP I-mo
52 QID NNP I-NP B-f
52 QID NNP I-NP B-f
53 Instructions: NNP I-NP O
53 Please NNP I-NP O
53 apply VB O O
53 to TO O O
53 affected JJ B-NP O
53 area NN I-NP O
53 in IN B-VP O
53 right JJ B-NP O
54 axilla NN I-NP O
54 four CD O O
54 times NNS B-NP O
54 per IN B-VP O
54 day NN B-NP O
55 LEVOFLOXACIN NNP I-NP B-m
55 500 CD O B-do
55 MG NNP B-NP I-do
55 PO NNP I-NP B-mo
55 QD NNP I-NP B-f
56 Instructions: NNP I-NP O
56 Please NNP I-NP O
56 give VB O O
56 at IN B-VP O
56 least JJS O O
56 2 CD O O
56 hours NNS B-NP O
56 before IN B-VP O
56 and CC O O
57 after IN B-VP O
57 any DT B-NP O
57 iron NN I-NP B-m
57 supplements NNS I-NP I-m
57 until IN B-VP B-du
57 November NNP B-NP I-du
58 Food/Drug NNP I-NP O
58 Interaction NNP I-NP O
58 Instruction NNP I-NP O
59 Administer NNP I-NP O
59 iron NN I-NP B-m
59 products NNS I-NP I-m
59 a DT B-NP O
59 minimum NN I-NP O
59 of IN B-VP O
59 2 CD O O
59 hours NNS B-NP O
59 before IN B-VP O
59 or CC O O
60 after IN B-VP O
60 a DT B-NP O
60 levofloxacin NN I-NP B-m
60 or CC O O
60 ciprofloxacin NN B-NP B-m
60 dose VBP O O
60 dose JJ O O
61 If IN B-VP O
61 on IN B-VP O
61 tube NN B-NP O
61 feeds NNS I-NP O
61 , , O O
61 please VB O O
61 cycle NN B-NP O
61 ( ( O O
61 hold VB O O
61 1 CD O O
61 hr NN B-NP O
61 before IN B-VP O
61 to TO O O
61 2 CD O O
61 hr NNS B-NP O
62 after IN B-VP O
62 ) ) O O
62 Take VBP O O
62 2 CD O O
62 hours NNS B-NP O
62 before IN B-VP O
62 or CC O O
62 2 CD O O
62 hours NNS B-NP O
62 after IN B-VP O
62 dairy NN B-NP O
62 products NNS I-NP O
63 Alert NNP I-NP O
63 overridden: MD O O
63 Override NNP B-NP O
63 added VBD B-VP O
63 on IN B-VP O
63 3/3/04 CD O O
63 by IN B-VP O
64 GANAWAY NNP B-NP O
64 , , O O
64 BENNETT NNP B-NP O
64 S NNP I-NP O
65 POTENTIALLY NNP I-NP O
65 SERIOUS NNP I-NP O
65 INTERACTION: NNP I-NP O
65 POLYSACCHARIDE NNP I-NP B-m
65 IRON NNP I-NP O
66 COMPLEX NNP I-NP O
66 &amp; NNP I-NP O
66 LEVOFLOXACIN NNP I-NP B-m
66 Reason NNP I-NP O
66 for IN B-VP O
66 override: NN B-NP O
67 Will NNP I-NP O
67 separate JJ B-NP O
67 doses NNS I-NP O
67 by IN B-VP O
67 2 CD O O
67 hours NNS B-NP O
68 MICONAZOLE NNP I-NP B-m
68 NITRATE NNP I-NP I-m
68 2% CD O I-m
68 POWDER NNP B-NP I-m
68 TOPICAL NNP I-NP B-mo
68 TP NNP I-NP I-mo
68 BID NNP I-NP B-f
69 MAALOX-TABLETS NNP I-NP B-m
69 QUICK NNP I-NP I-m
69 DISSOLVE/CHEWABLE NNP I-NP I-m
69 1-2 JJ B-NP B-do
69 TAB NNP I-NP I-do
69 PO NNP I-NP B-mo
69 Q6H NNP I-NP B-f
70 PRN NNP I-NP O
70 Upset NNP I-NP B-r
70 Stomach NNP I-NP I-r
71 METFORMIN NNP I-NP B-m
71 XR NNP I-NP I-m
71 ( ( O I-m
71 METFORMIN NNP B-NP I-m
71 EXTENDED NNP I-NP I-m
71 RELEASE NNP I-NP I-m
71 ) ) O I-m
71 2 CD O B-do
71 , , O I-do
71 000 CD O I-do
71 MG NNP B-NP I-do
71 PO NNP I-NP B-mo
71 QD NNP I-NP B-f
72 INSULIN NNP I-NP B-m
72 INSULIN NNP I-NP B-m
72 INSULIN NNP I-NP B-m
72 INSULIN NNP I-NP B-m
72 INSULIN NNP I-NP B-m
72 INSULIN NNP I-NP B-m
72 INSULIN NNP I-NP B-m
72 REGULAR NNP I-NP I-m
72 REGULAR NNP I-NP I-m
72 REGULAR NNP I-NP I-m
72 REGULAR NNP I-NP I-m
72 REGULAR NNP I-NP I-m
72 REGULAR NNP I-NP I-m
72 REGULAR NNP I-NP I-m
72 HUMAN NNP I-NP I-m
72 HUMAN NNP I-NP I-m
72 HUMAN NNP I-NP I-m
72 HUMAN NNP I-NP I-m
72 HUMAN NNP I-NP I-m
72 HUMAN NNP I-NP I-m
72 HUMAN NNP I-NP I-m
73 Sliding NNP I-NP B-do
73 Scale NNP I-NP I-do
73 ( ( O B-mo
73 subcutaneously RB O I-mo
73 ) ) O I-mo
73 SC NNP B-NP I-mo
73 AC NNP I-NP B-f
74 If IN B-VP O
74 BS NNP B-NP O
74 is VBZ O O
74 less JJR O O
74 than IN B-VP O
74 125 CD O O
74 , , O O
74 then RB O O
74 give VB O O
74 0 CD O O
74 units NNS B-NP O
74 subcutaneously RB O O
75 If IN B-VP O
75 BS NNP B-NP O
75 is VBZ O O
75 125-150 JJ O O
75 , , O O
75 then RB O O
75 give VB O O
75 2 CD O B-do
75 units NNS B-NP I-do
75 subcutaneously RB O B-mo
76 If IN B-VP O
76 BS NNP B-NP O
76 is VBZ O O
76 151-200 CD O O
76 , , O O
76 then RB O O
76 give VB O O
76 3 CD O B-do
76 units NNS B-NP I-do
76 subcutaneously RB O B-mo
77 If IN B-VP O
77 BS NNP B-NP O
77 is VBZ O O
77 201-250 JJ O O
77 , , O O
77 then RB O O
77 give VB O O
77 4 CD O B-do
77 units NNS B-NP I-do
77 subcutaneously RB O B-mo
78 If IN B-VP O
78 BS NNP B-NP O
78 is VBZ O O
78 251-300 JJ O O
78 , , O O
78 then RB O O
78 give VB O O
78 6 CD O B-do
78 units NNS B-NP I-do
78 subcutaneously RB O B-mo
79 If IN B-VP O
79 BS NNP B-NP O
79 is VBZ O O
79 301-350 JJ O O
79 , , O O
79 then RB O O
79 give VB O O
79 8 CD O B-do
79 units NNS B-NP I-do
79 subcutaneously RB O B-mo
80 If IN B-VP O
80 BS NNP B-NP O
80 is VBZ O O
80 351-400 CD O O
80 , , O O
80 then RB O O
80 give VB O O
80 10 CD O B-do
80 units NNS B-NP I-do
80 subcutaneously RB O B-mo
80 and CC O O
81 call VB O O
81 HO NNP B-NP O
81 Call NNP I-NP O
81 HO NNP I-NP O
81 if IN B-VP O
81 BS NNP B-NP O
81 is VBZ O O
81 greater JJR O O
81 than IN B-VP O
81 400 CD O O
82 PROTONIX NNP B-NP B-m
82 ( ( O I-m
82 PANTOPRAZOLE NNP B-NP I-m
82 ) ) O I-m
82 40 CD O B-do
82 MG NNP B-NP I-do
82 PO NNP I-NP B-mo
82 BID NNP I-NP B-f
83 DIET: NNP I-NP O
83 House NNP I-NP O
83 / NNP I-NP O
83 NAS NNP I-NP O
83 / NNP I-NP O
83 ADA NNP I-NP O
83 2100 CD O O
83 cals/day NN B-NP O
83 / VB O O
83 Very RB O O
83 low JJ B-NP O
83 fat NN I-NP O
83 ( ( O O
83 20gms/day CD O O
83 ) ) O O
84 ACTIVITY: NNP B-NP O
84 Walking NNP I-NP O
84 as IN B-VP O
84 tolerated VBN O O
85 FOLLOW NNP B-NP O
85 UP NNP I-NP O
85 APPOINTMENT( NNP I-NP O
85 S NNP I-NP O
85 ): NNP I-NP O
86 Dr NNP I-NP O
86 Devon NNP I-NP O
86 Filgo NNP I-NP O
86 11/10/04 CD O O
86 scheduled VBN O O
86 , , O O
87 Dr NNP B-NP O
87 Marvin NNP I-NP O
87 Brendle NNP I-NP O
87 10/8/04 CD O O
87 scheduled VBN O O
87 , , O O
88 ALLERGY: NNP B-NP O
88 HORSE NNP I-NP O
88 , , O O
88 tricor JJ B-NP O
89 ADMIT NNP I-NP O
89 DIAGNOSIS: NNP I-NP O
90 Shortness NNP I-NP O
90 of IN B-VP O
90 breath NN B-NP O
90 , , O O
90 right JJ B-NP O
90 upper NN I-NP O
90 quadrant NN I-NP O
90 pain NN I-NP O
91 PRINCIPAL NNP I-NP O
91 DISCHARGE NNP I-NP O
91 DIAGNOSIS NNP I-NP O
91 ;Responsible JJ O O
91 After IN B-VP O
91 Study NNP B-NP O
91 for IN B-VP O
91 Causing NNP B-NP O
91 Admission NNP I-NP O
91 ) ) O O
92 Pneumonia NNP B-NP O
93 OTHER NNP I-NP O
93 DIAGNOSIS;Conditions NNP I-NP O
93 , , O O
93 Infections NNP B-NP O
93 , , O O
93 Complications NNP B-NP O
93 , , O O
93 affecting VBG O O
93 Treatment/Stay NNP B-NP O
94 HTN NNP I-NP O
94 ( ( O O
94 hypertension NN B-NP O
94 ) ) O O
94 +H NN B-NP O
94 pylori NN I-NP O
94 , , O O
94 s/p JJ B-NP O
94 rx NN I-NP O
94 ( ( O O
94 Helicobacter NNP B-NP O
94 pylori NN I-NP O
94 ) ) O O
94 guiac NN B-NP O
94 + NN I-NP O
95 stools NNS I-NP O
95 ( ( O O
95 lower JJR B-NP O
95 GI NNP I-NP O
95 bleeding VBG O O
95 ) ) O O
95 diverticulosis NN B-NP O
96 ( ( O O
96 diverticulosis NN B-NP O
96 ) ) O O
96 polyposis NN B-NP O
96 ( ( O O
96 colonic JJ B-NP O
96 polyp NN I-NP O
96 ) ) O O
96 nephrolithiasis NN B-NP O
96 ( ( O O
96 kidney VB O O
97 stone NN B-NP O
97 ) ) O O
97 depression NN B-NP O
97 ( ( O O
97 depression NN B-NP O
97 ) ) O O
97 obesity NN B-NP O
98 ( ( O O
98 obesity NN B-NP O
98 ) ) O O
98 hypertriglyceridemia NN B-NP O
98 ( ( O O
98 elevated JJ B-NP O
98 triglycerides NNS I-NP O
98 ) ) O O
98 OSA NNP B-NP O
98 ( ( O O
98 sleep JJ B-NP O
99 apnea NN I-NP O
99 ) ) O O
99 pneumonia NN B-NP O
99 ( ( O O
99 pneumonia NN B-NP O
99 ) ) O O
99 contact NN B-NP O
99 dermatitis NN I-NP O
99 R NNP I-NP O
99 axilla NN I-NP O
99 ( ( O O
99 contact JJ B-NP O
100 dermatitis NN I-NP O
100 ) ) O O
101 OPERATIONS NNP B-NP O
101 AND NNP I-NP O
101 PROCEDURES: NNP I-NP O
102 Mr NNP I-NP O
102 Schoel NNP I-NP O
102 underwent VBD B-VP O
102 an DT B-NP O
102 upper JJ I-NP O
102 endoscopy NN I-NP O
102 on IN B-VP O
102 6/1 CD O O
103 OTHER NNP B-NP O
103 TREATMENTS/PROCEDURES NNP I-NP O
103 ( ( O O
103 NOT NNP B-NP O
103 IN NNP I-NP O
103 O.R NNP I-NP O
103 ) ) O O
104 None NN B-NP O
105 BRIEF NNP I-NP O
105 RESUME NNP I-NP O
105 OF NNP I-NP O
105 HOSPITAL NNP I-NP O
105 COURSE: NNP I-NP O
106 CC/HPI: NNP I-NP O
106 56 CD O O
106 y.o NN B-NP O
106 man NN I-NP O
106 with IN B-VP O
106 DM NNP B-NP O
106 , , O O
106 HTN NNP B-NP O
106 , , O O
106 hypertryglyceridemia NN B-NP O
106 , , O O
106 depression NN B-NP O
107 comes VBZ O O
107 in IN B-VP O
107 with IN B-VP O
107 2-day JJ B-NP O
107 h/o NN I-NP O
107 increasing VBG O O
108 abdominal JJ B-NP O
108 girth NN I-NP O
108 , , O O
108 1-day JJ B-NP O
108 h/o NN I-NP O
108 shortness NN I-NP O
108 of IN B-VP O
108 breath NN B-NP O
108 , , O O
108 pleuritic JJ B-NP O
108 CP NNP I-NP O
108 7 CD O O
108 days NNS B-NP O
109 PTA NNP I-NP O
109 noticed VBD B-VP O
109 increase NN B-NP O
109 in IN B-VP O
109 nocturia NNS B-NP O
109 from IN B-VP O
109 2x CD O O
109 to TO O O
109 6x CD O O
109 2 CD O O
110 days NNS B-NP O
110 PTA NNP I-NP O
110 became VBD B-VP O
110 uncomfortable JJ O O
110 while IN B-VP O
110 sleeping VBG O O
110 , , O O
110 could MD O O
110 not RB O O
110 take VB O O
110 deep JJ B-NP O
111 breath NN I-NP O
111 without IN B-VP O
111 RUQ NNP B-NP O
111 abdominal JJ B-NP O
111 pain NN I-NP O
111 No NNP I-NP O
111 fever/chills NNS I-NP O
111 , , O O
111 no DT B-NP O
111 cough NN I-NP O
111 , , O O
111 mild JJ B-NP O
112 nausea NN I-NP O
112 , , O O
112 no DT B-NP O
112 vomiting NN I-NP O
112 , , O O
112 no DT B-NP O
112 change NN I-NP O
112 in IN B-VP O
112 bowel NN B-NP O
112 habits NNS I-NP O
112 , , O O
112 no DT B-NP O
113 dysuria NN I-NP O
113 Arrived NNP I-NP O
113 in IN B-VP O
113 ED NNP B-NP O
113 10/21 CD O O
113 , , O O
113 given VBN O O
113 i.v NNS B-NP B-mo
113 Lasix NNP I-NP B-m
113 for IN B-VP O
114 presumed JJ B-NP B-r
114 CHF NNP I-NP I-r
115 PMH: NNP I-NP O
115 Per NNP I-NP O
115 problem NN I-NP O
115 list NN I-NP O
115 MEDS: NNP I-NP O
115 Not RB O O
115 compliant JJ B-NP O
115 Admission NNP I-NP O
115 - : O O
115 Nexium NN B-NP B-m
115 40 CD O B-do
115 mg NN B-NP I-do
116 po NN I-NP B-mo
116 bid NN I-NP B-f
116 , , O O
116 HCTZ NNP B-NP B-m
116 25 CD O B-do
116 mg NN B-NP I-do
116 po NN I-NP B-mo
116 qd NN I-NP B-f
116 , , O O
116 Lisinopril NNP B-NP B-m
116 40 CD O B-do
116 mg NN B-NP I-do
116 po NN I-NP B-mo
117 qd NN I-NP B-f
117 , , O O
117 Tiazac NNP B-NP B-m
117 240 CD O B-do
117 mg NN B-NP I-do
117 po NN I-NP B-mo
117 qd NN I-NP B-f
117 , , O O
117 Metformin NNP B-NP B-m
117 XR NNP I-NP I-m
117 2000 CD O B-do
117 mg NN B-NP I-do
117 po NN I-NP B-mo
117 qd NN I-NP B-f
118 on IN B-VP O
118 admission NN B-NP O
119 Allergies: NNP I-NP O
119 Horse NNP I-NP O
119 ( ( O O
119 unknown JJ O O
119 ) ) O O
119 , , O O
119 TriCort NNP B-NP O
119 ( ( O O
119 rash NN B-NP O
119 ) ) O O
119 PE VBD B-VP O
119 6/6 CD O O
119 T NNP B-NP O
119 97.5 CD O O
119 HR NNP B-NP O
119 108 CD O O
119 BP NNP B-NP O
120 196/112 CD O O
120 RR NNP B-NP O
120 18 CD O O
120 SAT NNP B-NP O
120 96% CD O O
120 RA NNP B-NP O
120 AOX3 NNP I-NP O
120 , , O O
120 no DT B-NP O
120 JVD NNP I-NP O
120 , , O O
120 lungs NNS B-NP O
120 clear VBP O O
120 , , O O
120 RRR NNP B-NP O
120 no DT B-NP O
120 M/R/G NNP I-NP O
120 , , O O
121 abdom RB O O
121 en IN B-VP O
121 obese JJ O O
121 , , O O
121 distended VBD B-VP O
121 , , O O
121 w/o JJ B-NP O
121 peritoneal NN I-NP O
121 signs NNS I-NP O
121 , , O O
121 +bs NNP B-NP O
121 , , O O
122 no DT B-NP O
122 LE NNP I-NP O
123 edema VBZ O O
123 PE NNP B-NP O
123 10/25 CD O O
123 Tm NNP B-NP O
123 99.8 CD O O
123 HR NNP B-NP O
123 80-90 JJ B-NP O
123 BP NNP I-NP O
123 140-170/80-90 CD O O
124 RR NNP B-NP O
124 18 CD O O
124 - : O O
124 22 CD O O
124 SAT NNP B-NP O
124 97% CD O O
124 3L CD O O
124 92-94% JJ B-NP O
125 RA NNP I-NP O
125 AOX3 NNP I-NP O
125 , , O O
125 no DT B-NP O
125 JVD NNP I-NP O
125 , , O O
125 lungs NNS B-NP O
125 and CC O O
125 heart NN B-NP O
125 WNL NNP I-NP O
125 , , O O
125 abd RB O O
125 less JJR B-NP O
126 tender JJ I-NP O
126 HOSPITAL NNP I-NP O
126 COURSE: NNP I-NP O
126 1 CD O O
126 ) ) O O
126 CV NNP B-NP O
126 Ischemia NNP I-NP O
126 Cardiac NNP I-NP O
127 enzymes VBZ O O
127 flat JJ B-NP O
127 x NNP I-NP O
127 3 CD O O
127 No NNP B-NP O
127 significant JJ B-NP O
127 EKG NNP I-NP O
127 changes NNS I-NP O
127 Pump NNP I-NP O
128 10/21 CD O O
128 BNP NNP B-NP O
128 64 CD O O
128 , , O O
128 no DT B-NP O
128 clinical JJ I-NP O
128 CHF NNP I-NP O
128 Hypertension NNP I-NP O
129 poorly RB O O
129 controlled VBD B-VP O
129 in IN B-VP O
129 setting NN B-NP O
129 of IN B-VP O
129 missing VBG O O
129 home NN B-NP O
129 meds NNS I-NP O
130 w/bp VBP O O
130 up RB O O
130 to TO O O
130 170's/90's CD O O
130 Diltiazem NNP B-NP B-m
130 d/c'd NN I-NP O
130 in IN B-VP O
130 favor NN B-NP O
130 of IN B-VP O
130 Metoprolol NNP B-NP B-m
130 and CC O O
131 uptitrated VBD B-VP B-do
131 2 CD O O
131 ) ) O O
131 Pulmonary NNP B-NP O
131 Ruled VBD B-VP O
131 out RP O O
131 PE NNP B-NP O
131 with IN B-VP O
131 D-dimer NNP B-NP O
132 ( ( O O
132 &lt;200 NNP B-NP O
132 ) ) O O
132 OSA NNP B-NP O
132 , , O O
132 likely JJ B-NP O
132 obesity NN I-NP O
132 hypoventilation NN I-NP O
132 Failed VBD B-VP O
132 2 CD O O
132 CPAP NNP B-NP O
132 trials NNS I-NP O
133 Had VBD B-VP O
133 fever VBN O O
133 to TO O O
133 101.5 CD O O
133 , , O O
133 desat NN B-NP O
133 on IN B-VP O
133 RA NNP B-NP O
133 , , O O
133 tachypneic NN B-NP O
133 , , O O
133 pan-cx JJ O O
133 , , O O
133 CXR NNP B-NP O
133 LLL NNP I-NP O
133 PNA NNP I-NP O
133 , , O O
134 Vanco/Levo/Flagyl NNP B-NP B-m
134 Vanco/Levo/Flagyl NNP I-NP B-m
134 begun VBN O O
134 , , O O
134 Vanco NNP B-NP B-m
134 d/c'd NN I-NP O
134 since IN B-VP O
134 unlikely JJ O O
135 nosocomial JJ O O
135 , , O O
135 Levo/Flagyl NNP B-NP B-m
135 changed VBD B-VP O
135 to TO O O
135 p.o VB O B-mo
135 3 CD O O
135 ) ) O O
135 GI NNP B-NP O
135 10/21 CD O O
136 Abd NNP B-NP O
136 CT NNP I-NP O
136 - : O O
136 fatty NN B-NP O
136 liver NN I-NP O
136 , , O O
136 pancreas JJ B-NP O
136 ALT/AST: NNP I-NP O
136 133/98 CD O O
136 , , O O
136 others NNS B-NP O
136 WNL NNP I-NP O
136 , , O O
136 trending VBG O O
137 down RP O O
137 , , O O
137 near IN B-VP O
137 norma JJ B-NP O
137 TG NNP I-NP O
137 - : O O
137 2032 CD O O
137 Serological NNP B-NP O
137 liver NN I-NP O
137 dz NN I-NP O
137 w/u NN I-NP O
137 neg JJ B-NP O
137 Gemfibrozil NNP I-NP B-m
138 begun VBN O O
138 presumed JJ B-NP O
138 dx NN I-NP O
138 NASH NNP I-NP O
138 , , O O
138 EGD NNP B-NP O
138 - : O O
138 antral JJ B-NP O
138 erosions NNS I-NP O
138 , , O O
138 ASA/NSAIDs NNP B-NP B-m
138 ASA/NSAIDs NNP I-NP B-m
138 d/c'd NN I-NP O
138 for IN B-VP B-du
138 for IN B-VP B-du
139 6 CD O O
139 - : O O
139 8 CD O O
139 wks NN B-NP O
139 4 CD O O
139 )END: NN B-NP O
139 Metformin NNP I-NP B-m
139 , , O O
139 ISS NNP B-NP O
139 8/18 CD O O
139 15 CD O B-do
139 units NNS B-NP I-do
139 NPH NNP I-NP B-m
139 added VBD B-VP O
139 at IN B-VP B-f
139 bedtime NN B-NP I-f
139 am VBP O O
140 FSBG NNP B-NP O
140 120 CD O O
140 , , O O
140 will MD O O
140 continue VB O O
140 5 CD O O
140 )RENAL/FEN NNP B-NP O
140 Good NNP I-NP O
141 renal JJ B-NP O
141 function NN I-NP O
141 , , O O
141 pt NN B-NP O
141 on IN B-VP O
141 ACE NNP B-NP B-m
141 inhibitor NN I-NP I-m
141 Urine NNP I-NP O
141 cx NN I-NP O
141 likely RB O O
141 contaminant JJ O O
141 , , O O
142 6 CD O O
142 )NEURO/PSY JJ B-NP O
142 Pt NNP I-NP O
142 self-d/c'd NN I-NP O
142 Wellbutrin NNP I-NP B-m
142 Effexor NNP I-NP I-m
142 7d CD O B-du
142 PTA NNP B-NP O
142 Restart NNP I-NP O
142 as IN B-VP O
143 outpatient JJ B-NP O
144 ADDITIONAL NNP I-NP O
144 COMMENTS: NNP I-NP O
144 Please NNP I-NP O
144 return VB O O
144 to TO O O
144 the DT B-NP O
144 hospital NN I-NP O
144 if IN B-VP O
144 you PRP O O
144 feel VBP O O
144 fever RB O O
144 or CC O O
144 chills NNS B-NP O
144 dizziness NN I-NP O
144 , , O O
145 worsening VBG O O
145 shortness NN B-NP O
145 of IN B-VP O
145 breath NN B-NP O
145 , , O O
145 persistent JJ B-NP O
145 nausea/vomiting NN I-NP O
145 Please NNP I-NP O
145 go VB O O
146 to TO O O
146 all DT O O
146 follow VB O O
146 up RP O O
146 appointments NNS B-NP O
146 , , O O
146 including VBG O O
146 Dr NNP B-NP O
146 Gregorio NNP I-NP O
146 Fernald NNP I-NP O
147 ( ( O O
147 Endocrinology NNP B-NP O
147 ) ) O O
147 9/29 CD O O
147 2 CD O O
147 p.m NN B-NP O
147 in IN B-VP O
147 Stin NNP B-NP O
147 Hi NNP I-NP O
147 Wi NNP I-NP O
147 ( ( O O
147 651 CD O O
147 ) ) O O
147 510-9486 CD O O
147 and CC O O
148 with IN B-VP O
148 Dr NNP B-NP O
148 Antonia NNP I-NP O
148 Swarn NNP I-NP O
148 , , O O
148 your PRP$ O O
148 Primary NNP B-NP O
148 Care NNP I-NP O
148 Doctor NNP I-NP O
148 , , O O
148 on IN B-VP O
148 9/24/04 CD O O
148 at IN B-VP O
148 1:30 CD O O
148 p.m JJ B-NP O
149 Please NNP I-NP O
149 call VB O O
149 her PRP$ O O
149 office NN B-NP O
149 to TO O O
149 confirm VB O O
149 at IN B-VP O
149 ( ( O O
149 190 CD O O
149 ) ) O O
149 786-1186 JJ B-NP O
149 Please NNP I-NP O
149 take VB O O
149 all DT B-NP O
150 medications NNS I-NP O
150 as IN B-VP O
150 prescribed JJ B-NP O
151 DISCHARGE NNP I-NP O
151 CONDITION: NNP I-NP O
151 Satisfactory NNP I-NP O
152 TO NNP I-NP O
152 DO/PLAN: NNP I-NP O
153 1 CD O O
153 ) ) O O
153 Complete JJ B-NP O
153 14-day JJ I-NP O
153 course NN I-NP O
153 of IN B-VP O
153 Levofloxacin NNP B-NP B-m
153 ( ( O O
153 until IN B-VP O
153 4/18/04 CD O O
153 ) ) O O
154 2 CD O O
154 ) ) O O
154 Follow NNP B-NP O
154 up RP O O
154 with IN B-VP O
154 Endocrine NNP B-NP O
154 and CC O O
154 PCP NNP B-NP O
154 re VBP O O
154 diabetes NNS B-NP O
154 and CC O O
154 lipid JJ B-NP O
154 management NN I-NP O
155 3 CD O O
155 ) ) O O
155 Follow NNP B-NP O
155 up RP O O
155 with IN B-VP O
155 PCP NNP B-NP O
155 for IN B-VP O
155 management NN B-NP O
155 of IN B-VP O
155 chronic JJ B-NP O
155 medical JJ I-NP O
156 problems NNS I-NP O
156 , , O O
156 including VBG O O
156 GERD NNP B-NP O
156 , , O O
156 gastric JJ B-NP O
156 erosions NNS I-NP O
156 , , O O
156 hypertension NN B-NP O
156 , , O O
156 obstructive JJ B-NP O
157 sleep NN I-NP O
157 apnea NN I-NP O
158 4 CD O O
158 ) ) O O
158 Follow NNP B-NP O
158 up RP O O
158 with IN B-VP O
158 outpatient JJ B-NP O
158 psychiatrist NN I-NP O
158 regarding VBG O O
158 reinitiation NN B-NP O
158 of IN B-VP O
159 medications NNS B-NP O
160 No NNP I-NP O
160 dictated VBD B-VP O
160 summary JJ B-NP O
161 ENTERED NNP I-NP O
161 BY: NNP I-NP O
161 DEMARIO NNP I-NP O
161 , , O O
161 ROSENDO NNP B-NP O
161 EUSEBIO NNP I-NP O
161 , , O O
161 M.D NNP B-NP O
161 ( ( O O
161 DN49 NNP B-NP O
161 ) ) O O
161 0/0/04 CD O O
161 @ $ O O
161 10 CD O O
162 ****** JJ B-NP O
162 END NN I-NP O
162 OF NNP I-NP O
162 DISCHARGE NNP I-NP O
162 ORDERS NNP I-NP O
162 ****** NNP I-NP O
163 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #815850 VBZ O O
4 437970544 CD O O
4 SAMC NNP B-NP O
4 86695057 CD O O
4 097799 CD O O
4 4/6/1998 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CORONARY NNP I-NP O
4 ARTERY NNP I-NP O
4 DISEASE NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/10/1998 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/24/1998 CD O O
7 ADMISSION NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 CORONARY NNP I-NP O
7 ARTERY NNP I-NP O
7 BYPASS NNP I-NP O
7 GRAFT NNP I-NP O
8 IDENTIFICATION: NNP I-NP O
8 Mr NNP I-NP O
8 Wolfinbarger NNP I-NP O
8 is VBZ O O
8 a DT O O
8 55 CD O O
8 year NN B-NP O
8 old JJ B-NP O
8 male NN I-NP O
8 , , O O
8 who WP O O
8 had VBD B-VP O
9 increased VBN O O
9 symptoms NNS B-NP O
9 of IN B-VP O
9 dyspnea NN B-NP O
9 on IN B-VP O
9 exertion NN B-NP O
9 and CC O O
10 fatigue NN B-NP O
10 and CC O O
10 had VBD B-VP O
10 a DT B-NP O
10 positive JJ I-NP O
10 exercise NN I-NP O
10 tolerance NN I-NP O
10 test NN I-NP O
10 on IN B-VP O
10 7/6/98 CD O O
11 BRIEF NNP B-NP O
11 HISTORY: NNP I-NP O
11 He PRP O O
11 was VBD B-VP O
11 admitted VBN O O
11 to TO O O
11 Enreen VB O O
11 Dallout NNP B-NP O
11 Medical NNP I-NP O
11 Center NNP I-NP O
11 for IN B-VP O
12 cardiac JJ B-NP O
12 catheterization NN I-NP O
12 , , O O
12 which WDT O O
12 demonstrated VBD B-VP O
12 a DT B-NP O
12 right JJ I-NP O
13 dominate NN I-NP O
13 system NN I-NP O
13 with IN B-VP O
13 diffuse NN B-NP O
13 30% CD O O
13 to TO O O
13 40% CD O O
13 lesions NNS B-NP O
13 of IN B-VP O
13 his PRP$ O O
13 left JJ O O
13 main JJ O O
13 , , O O
14 90% CD O O
14 lesion NN B-NP O
14 of IN B-VP O
14 his PRP$ O O
14 left JJ O O
14 anterior JJ O O
14 descending VBG O O
14 coronary JJ B-NP O
14 artery NN I-NP O
14 , , O O
14 100% CD O O
15 lesion NN B-NP O
15 of IN B-VP O
15 his PRP$ O O
15 circumflex NN B-NP O
15 and CC O O
15 OM NNP B-NP O
15 1 CD O O
15 and CC O O
15 a DT O O
15 100% CD O O
15 lesion NN B-NP O
15 past IN B-VP O
15 his PRP$ O O
15 obtuse NN B-NP O
16 marginal JJ B-NP O
16 #2 NNP I-NP O
16 , , O O
16 60% CD O O
16 proximal JJ B-NP O
16 right JJ I-NP O
16 coronary JJ I-NP O
16 artery NN I-NP O
16 lesion NN I-NP O
16 and CC O O
16 a DT O O
16 70% CD O O
17 posterior JJ O O
17 descending VBG O O
17 coronary JJ B-NP O
17 artery NN I-NP O
17 lesion NN I-NP O
17 On IN B-VP O
17 7/6/98 CD O O
17 he PRP O O
17 had VBD B-VP O
17 an DT B-NP O
18 echocardiogram NN I-NP O
18 which WDT O O
18 demonstrated VBD B-VP O
18 good JJ B-NP O
18 LV NNP I-NP O
18 function NN I-NP O
18 He PRP O O
18 is VBZ O O
18 admitted VBN O O
19 for IN B-VP O
19 CABG NNP B-NP O
20 PAST NNP I-NP O
20 MEDICAL NNP I-NP O
20 HISTORY: NNP I-NP O
20 His PRP$ O O
20 Past NNP B-NP O
20 Medical NNP I-NP O
20 History NNP I-NP O
20 includes VBZ O O
21 non-Hodgkin's JJ B-NP O
21 lymphoma NN I-NP O
21 , , O O
21 status NN B-NP O
21 bone NN I-NP O
21 marrow NN I-NP O
22 transplant NN I-NP O
22 and CC O O
22 chemotherapy NN B-NP O
22 in IN B-VP O
22 1992 CD O O
22 and CC O O
22 1993; CD O O
22 history NN B-NP O
22 of IN B-VP O
23 hypercholesterolemia NN B-NP O
23 , , O O
23 hypertension NN B-NP O
23 , , O O
23 insulin NN B-NP O
23 dependent NN I-NP O
23 diabetes NNS I-NP O
23 , , O O
24 gastroesophageal JJ B-NP O
24 reflux NN I-NP O
24 disorder NN I-NP O
24 and CC O O
24 chronic JJ B-NP O
24 renal JJ I-NP O
24 insufficiency NN I-NP O
25 ALLERGIES: NNP I-NP O
25 He PRP O O
25 has VBZ O O
25 an DT B-NP O
25 allergy NN I-NP O
25 to TO O O
25 Benadryl NNP B-NP O
25 , , O O
25 it PRP O O
25 gives VBZ O O
25 him PRP O O
25 the DT B-NP O
26 jitters NNS I-NP O
27 MEDICATIONS NNP I-NP O
27 ON NNP I-NP O
27 ADMISSION: NNP I-NP O
27 His PRP$ O O
27 medications NNS B-NP O
27 on IN B-VP O
27 admission NN B-NP O
27 are VBP O O
28 Toprol NNP B-NP B-m
28 XL NNP I-NP I-m
28 200 CD O B-do
28 mg NN B-NP I-do
28 q.d NN I-NP B-f
28 Procardia NNP I-NP B-m
28 XL NNP I-NP I-m
28 90 CD O B-do
29 mg NN B-NP O
29 q.d NN I-NP B-f
29 , , O O
29 Lipitor NNP B-NP B-m
29 20 CD O B-do
29 mg NN B-NP I-do
29 q.d NN I-NP B-f
29 , , O O
29 aspirin RB O B-m
29 325 CD O B-do
29 mg NN B-NP I-do
29 q.d NN I-NP B-f
29 , , O O
29 Zantac NNP B-NP B-m
29 150 CD O B-do
29 mg NN B-NP I-do
30 b.i.d NN I-NP B-f
30 , , O O
30 NPH NNP B-NP B-m
30 NPH NNP I-NP B-m
30 humulin NNP I-NP I-m
30 humulin NNP I-NP I-m
30 insulin NN I-NP I-m
30 insulin NN I-NP I-m
30 32 CD O B-do
30 units NNS B-NP I-do
30 each DT B-NP B-f
30 morning NN I-NP I-f
30 and CC O O
30 18 CD O B-do
30 units NNS B-NP I-do
30 each DT O B-f
31 evening VBG O O
31 subcutaneously RB O B-mo
31 subcutaneously RB O B-mo
31 , , O O
31 Valium NNP B-NP B-m
31 5 CD O B-do
31 mg NN B-NP I-do
31 q.d NN I-NP B-f
31 , , O O
31 Minipress NNP B-NP B-m
31 1 CD O B-do
31 mg NN B-NP I-do
31 b.i.d NN I-NP B-f
32 PHYSICAL NNP I-NP O
32 EXAMINATION: NNP I-NP O
32 His PRP$ O O
32 physical JJ B-NP O
32 examination NN I-NP O
32 was VBD B-VP O
32 within IN B-VP O
32 normal JJ B-NP O
33 limits NNS I-NP O
33 , , O O
33 no DT B-NP O
33 varicosities NNS I-NP O
34 LABORATORY NNP I-NP O
34 DATA: NNP I-NP O
34 His PRP$ O O
34 laboratories NNS B-NP O
34 on IN B-VP O
34 admission NN B-NP O
34 included VBD B-VP O
34 BUN NNP B-NP O
35 of IN B-VP O
35 40 CD O O
35 , , O O
35 creatinine NN B-NP O
35 of IN B-VP O
35 1.7 CD O O
35 His PRP$ O O
35 white JJ B-NP O
35 count NN I-NP O
35 was VBD B-VP O
36 6.5 CD O O
36 and CC O O
36 hematocrit NN B-NP O
36 was VBD B-VP O
36 35.0 CD O O
36 EKG NNP B-NP O
36 showed VBD B-VP O
36 sinus JJ B-NP O
36 rhythm NN I-NP O
36 with IN B-VP O
36 first JJ B-NP O
37 degree NN I-NP O
37 AV NNP I-NP O
37 block NN I-NP O
37 Chest NNP I-NP O
37 x-ray NN I-NP O
37 , , O O
37 no DT B-NP O
37 active JJ I-NP O
37 disease NN I-NP O
38 PROCEDURE: NNP I-NP O
38 He PRP O O
38 was VBD B-VP O
38 taken VBN O O
38 to TO O O
38 the DT B-NP O
38 Operating NN I-NP O
38 Room NNP I-NP O
38 on IN B-VP O
38 11/11/98 CD O O
38 where WRB O O
38 he PRP O O
39 underwent VBD B-VP O
39 harvesting NN B-NP O
39 of IN B-VP O
39 the DT B-NP O
39 left JJ I-NP O
39 radial JJ I-NP O
39 artery NN I-NP O
39 for IN B-VP O
40 graft NN B-NP O
40 and CC O O
40 he PRP O O
40 underwent VBD B-VP O
40 a DT B-NP O
40 coronary JJ I-NP O
40 artery NN I-NP O
40 bypass NN I-NP O
40 grafting VBG O O
40 x NNP B-NP O
40 three CD O O
41 with IN B-VP O
41 a DT B-NP O
41 left JJ I-NP O
41 internal JJ I-NP O
41 mammary JJ I-NP O
41 artery NN I-NP O
41 to TO O O
41 the DT O O
41 left VBN O O
41 anterior JJ O O
41 descending VBG O O
42 coronary JJ B-NP O
42 artery NN I-NP O
42 , , O O
42 saphenous JJ B-NP O
42 vein NN I-NP O
42 graft NN I-NP O
42 from IN B-VP O
42 the DT B-NP O
42 posterior JJ I-NP O
42 descending NN I-NP O
43 coronary JJ B-NP O
43 artery NN I-NP O
43 to TO O O
43 the DT B-NP O
43 aorta NN I-NP O
43 and CC O O
43 a DT B-NP O
43 radial JJ I-NP O
43 artery NN I-NP O
43 from IN B-VP O
43 the DT B-NP O
43 saphenous JJ I-NP O
44 vein NN I-NP O
44 graft NN I-NP O
44 to TO O O
44 the DT B-NP O
44 obtuse NN I-NP O
44 marginal JJ B-NP O
44 coronary JJ I-NP O
44 artery NN I-NP O
45 HOSPITAL NNP I-NP O
45 COURSE: NNP I-NP O
45 His PRP$ O O
45 postoperative JJ B-NP O
45 course NN I-NP O
45 was VBD B-VP O
45 complicated VBN O O
45 by IN B-VP O
46 fever NN B-NP O
46 to TO O O
46 101 CD O O
46 on IN B-VP O
46 two CD O O
46 occasions NNS B-NP O
46 , , O O
46 his PRP$ O O
46 white JJ B-NP O
46 count NN I-NP O
46 at IN B-VP O
47 that DT B-NP O
47 time NN I-NP O
47 was VBD B-VP O
47 5 CD O O
47 and CC O O
47 6 CD O O
47 respectively RB O O
47 His PRP$ O O
47 cultures NNS B-NP O
47 were VBD B-VP O
47 negative JJ O O
47 , , O O
48 sputum NN B-NP O
48 , , O O
48 blood NN B-NP O
48 , , O O
48 line NN B-NP O
48 tip NN I-NP O
48 and CC O O
48 chest VB O O
48 x-ray NN B-NP O
48 were VBD B-VP O
48 negative JJ O O
48 He PRP O O
48 had VBD B-VP O
48 , , O O
48 on IN B-VP O
49 postoperative JJ B-NP O
49 day NN I-NP O
49 5 CD O O
49 , , O O
49 an DT B-NP O
49 episode NN I-NP O
49 of IN B-VP O
49 rapid JJ B-NP B-r
49 rapid JJ I-NP B-r
49 rapid JJ I-NP B-r
49 atrial JJ I-NP I-r
49 atrial JJ I-NP I-r
49 atrial JJ I-NP I-r
49 flutter NN I-NP I-r
49 flutter NN I-NP I-r
49 flutter NN I-NP I-r
49 and CC O O
49 was VBD B-VP O
50 chemically RB O O
50 converted VBN O O
50 to TO O O
50 sinus VB O O
50 rhythm NN B-NP O
50 with IN B-VP O
50 Corvert NNP B-NP B-m
50 and CC O O
50 has VBZ O O
50 remained VBN O O
51 in IN B-VP O
51 sinus NN B-NP O
51 rhythm NN I-NP O
51 on IN B-VP O
51 Lopressor NNP B-NP B-m
51 and CC O O
51 diltiazem NN B-NP B-m
51 for IN B-VP B-du
51 for IN B-VP B-du
51 24 CD O I-du
51 24 CD O I-du
51 hours NNS B-NP I-du
51 hours NNS I-NP I-du
51 He PRP O O
51 will MD O O
52 be VB O O
52 discharged VBN O O
52 today NN B-NP O
52 , , O O
52 postoperative JJ B-NP O
52 day NN I-NP O
52 6 CD O O
52 , , O O
52 to TO O O
52 the DT B-NP O
52 care NN I-NP O
52 of IN B-VP O
52 Dr NNP B-NP O
52 Carmen NNP I-NP O
52 E NNP I-NP O
52 Okray NNP I-NP O
52 on IN B-VP O
52 the DT B-NP O
52 following JJ I-NP O
52 medications NNS I-NP O
52 Of IN B-VP O
52 note NN B-NP O
52 , , O O
52 his PRP$ O O
52 saphenous JJ B-NP O
52 vein NN I-NP O
53 harvest JJS B-NP O
53 site NN I-NP O
53 showed VBD B-VP O
53 some DT B-NP O
53 slight JJ I-NP O
53 erythema NN I-NP B-r
53 to TO O O
53 be VB O O
53 treated VBN O O
53 with IN B-VP O
54 antibiotics NNS B-NP B-m
54 by IN B-VP B-mo
54 mouth NN B-NP I-mo
55 DISCHARGE NNP I-NP O
55 MEDICATIONS: NNP I-NP O
55 He PRP O O
55 is VBZ O O
55 discharged VBN O O
55 on IN B-VP O
55 the DT B-NP O
55 following JJ I-NP O
56 medications: NN I-NP O
56 Axid NNP I-NP B-m
56 150 CD O B-do
56 mg NN B-NP I-do
56 b.i.d NN I-NP B-f
56 , , O O
56 Lipitor NNP B-NP B-m
56 20 CD O B-do
57 mg NN B-NP O
57 once RB O B-f
57 a DT B-NP I-f
57 day NN I-NP I-f
57 , , O O
57 NPH NNP B-NP B-m
57 NPH NNP I-NP B-m
57 Humulin NNP I-NP I-m
57 Humulin NNP I-NP I-m
57 insulin NN I-NP I-m
57 insulin NN I-NP I-m
57 32 CD O B-do
57 Units NNS B-NP I-do
57 every DT B-NP B-f
57 morning NN I-NP I-f
57 , , O O
57 18 CD O B-do
57 Units NNS B-NP I-do
58 every DT B-NP B-f
58 evening; NN I-NP I-f
58 Diltiazem NNP I-NP B-m
58 60 CD O B-do
58 mg NN B-NP I-do
58 t.i.d NN I-NP B-f
58 , , O O
58 Lopressor NNP B-NP B-m
58 150 CD O B-do
58 mg NN B-NP I-do
58 b.i.d NN I-NP B-f
58 , , O O
59 enteric RB O B-m
59 coated VBD B-VP I-m
59 aspirin JJ O I-m
59 125 CD O B-do
59 mg NN B-NP I-do
59 once RB O B-f
59 a DT B-NP I-f
59 day NN I-NP I-f
59 , , O O
59 Valium NNP B-NP B-m
59 5 CD O B-do
59 mg NN B-NP I-do
59 once RB O B-f
59 a DT B-NP I-f
59 day NN I-NP I-f
59 , , O O
60 Keflex NNP B-NP B-m
60 500 CD O B-do
60 mg NN B-NP I-do
60 four CD O B-f
60 times NNS B-NP I-f
60 a DT B-NP I-f
60 day NN I-NP I-f
60 for IN B-VP B-du
60 7 CD O I-du
60 days NNS B-NP I-du
60 , , O O
60 Percocet NNP B-NP B-m
60 1 CD O B-do
60 to TO O I-do
60 2 CD O I-do
60 tablets NNS B-NP I-do
61 every DT O B-f
61 four CD O I-f
61 hours NNS B-NP I-f
61 as IN B-VP I-f
61 needed VBN O I-f
61 for IN B-VP O
61 pain NN B-NP B-r
62 Dictated NNP I-NP O
62 By: NNP I-NP O
62 MARCEL NNP I-NP O
62 MAZZILLO NNP I-NP O
62 , , O O
62 P.A NNP B-NP O
63 Attending: NNP I-NP O
63 FLORENCIO NNP I-NP O
63 J NNP I-NP O
63 WETZEL NNP I-NP O
63 , , O O
63 M.D NNP B-NP O
63 YX4 NNP I-NP O
63 HA126/7839 NNP I-NP O
64 Batch: NNP I-NP O
64 10482 CD O O
64 Index NNP B-NP O
64 No NNP I-NP O
64 BJBOUO06I3 NNP I-NP O
64 D: NNP I-NP O
64 5/18/98 CD O O
65 T: NNP B-NP O
65 8/21/98 CD O O
66 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #817866 VBZ O O
4 546608017 CD O O
4 OWH NNP B-NP O
4 85716261 CD O O
4 046188 CD O O
4 7/12/1994 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/16/1994 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/7/1994 CD O O
7 PRINCIPLE NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 1 CD O O
7 BRADYARRHYTHMIA NNP B-NP O
8 SECONDARY NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
8 1 CD O O
8 SYNCOPE NNP B-NP O
9 PROCEDURES: NNP I-NP O
9 Pacemaker NNP I-NP O
9 insertion NN I-NP O
9 , , O O
9 4 CD O O
9 of IN B-VP O
9 October NNP B-NP O
10 IDENTIFICATION: NNP I-NP O
10 Sixty NNP I-NP O
10 year NN I-NP O
10 old JJ B-NP O
10 black JJ I-NP O
10 female NN I-NP O
10 who WP O O
10 has VBZ O O
10 a DT B-NP O
10 chief JJ I-NP O
11 complaint NN I-NP O
11 of IN B-VP O
11 dizziness NN B-NP O
11 and CC O O
11 syncope VB O O
11 The DT B-NP O
11 source NN I-NP O
11 of IN B-VP O
12 history NN B-NP O
12 was VBD B-VP O
12 the DT B-NP O
12 patient NN I-NP O
12 , , O O
12 who WP O O
12 was VBD B-VP O
12 a DT B-NP O
12 moderate JJ I-NP O
12 historian NN I-NP O
12 and CC O O
12 the DT B-NP O
12 old JJ I-NP O
13 chart JJ I-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 According VBG O O
13 to TO O O
13 the DT B-NP O
13 patient NN I-NP O
13 , , O O
13 she PRP O O
14 first RB O O
14 presented VBD B-VP O
14 to TO O O
14 the DT B-NP O
14 medical JJ I-NP O
14 system NN I-NP O
14 in IN B-VP O
14 1989 CD O O
14 At IN B-VP O
14 that DT B-NP O
14 time NN I-NP O
14 she PRP O O
15 was VBD B-VP O
15 walking VBG O O
15 at IN B-VP O
15 home NN B-NP O
15 and CC O O
15 became VBD B-VP O
15 dizzy JJ O O
15 She PRP O O
15 was VBD B-VP O
15 taken VBN O O
15 to TO O O
15 Meeville NNP B-NP O
15 Valley NNP I-NP O
15 Health NNP I-NP O
15 in IN B-VP O
15 Rhode NNP B-NP O
15 Island NNP I-NP O
15 She PRP O O
15 was VBD B-VP O
15 told VBN O O
15 that IN B-VP O
15 she PRP O O
15 had VBD B-VP O
15 a DT B-NP O
15 heart NN I-NP O
16 attack NN I-NP O
16 and CC O O
16 was VBD B-VP O
16 placed VBN O O
16 on IN B-VP O
16 a DT B-NP O
16 monitor NN I-NP O
16 when WRB O O
16 she PRP O O
16 was VBD B-VP O
16 noted VBN O O
16 to TO O O
16 have VB O O
16 an DT B-NP O
17 episode NN I-NP O
17 of IN B-VP O
17 asystole NN B-NP O
17 on IN B-VP O
17 the DT B-NP O
17 monitor NN I-NP O
17 This DT O O
17 led VBD B-VP O
17 to TO O O
17 emergent VB O O
17 pacer NN B-NP O
18 insertion NN I-NP O
18 After IN B-VP O
18 pacer NN B-NP O
18 placement NN I-NP O
18 , , O O
18 the DT B-NP O
18 dizziness NN I-NP O
18 never RB O O
18 recurred VBN O O
19 until IN B-VP O
19 a DT B-NP O
19 few JJ I-NP O
19 months NNS I-NP O
19 ago IN B-VP O
19 This DT O O
19 led VBN O O
19 to TO O O
19 hospitalization NN B-NP O
19 on IN B-VP O
19 March NNP B-NP O
19 , , O O
19 1994 CD O O
20 at IN B-VP O
20 Xas*tu NNP B-NP O
20 Hospital NNP I-NP O
20 Medical NNP I-NP O
20 Center NNP I-NP O
20 She PRP O O
20 was VBD B-VP O
20 seen VBN O O
20 by IN B-VP O
20 the DT B-NP O
20 pacer NN I-NP O
20 service NN I-NP O
21 who WP O O
21 interrogated VBD B-VP O
21 her PRP$ O O
21 pacer NN B-NP O
21 and CC O O
21 found VBD B-VP O
21 it PRP O O
21 functioning VBG O O
21 normally RB O O
22 However RB O O
22 , , O O
22 the DT B-NP O
22 pacer NN I-NP O
22 lead NN I-NP O
22 type NN I-NP O
22 ( ( O O
22 MECHRONIC NNP B-NP O
22 4012 CD O O
22 ) ) O O
22 is VBZ O O
22 felt VBN O O
22 to TO O O
22 have VB O O
22 a DT B-NP O
23 high JJ I-NP O
23 failure NN I-NP O
23 rate NN I-NP O
23 , , O O
23 necessitating VBG O O
23 a DT B-NP O
23 new JJ I-NP O
23 pacer NN I-NP O
23 insertion NN I-NP O
24 Unfortunately RB O O
24 , , O O
24 the DT B-NP O
24 patient NN I-NP O
24 left VBD B-VP O
24 AMA NNP B-NP O
24 before IN B-VP O
24 the DT B-NP O
24 procedure NN I-NP O
24 could MD O O
24 be VB O O
25 performed VBN O O
26 Today NNP B-NP O
26 , , O O
26 the DT B-NP O
26 patient NN I-NP O
26 got VBD B-VP O
26 out IN B-VP O
26 of IN B-VP O
26 bed NN B-NP O
26 and CC O O
26 preceded VBD B-VP O
26 to TO O O
26 the DT B-NP O
26 bathroom NN I-NP O
26 , , O O
27 where WRB O O
27 she PRP O O
27 had VBD B-VP O
27 a DT B-NP O
27 normal JJ I-NP O
27 bowel NN I-NP O
27 movement NN I-NP O
27 without IN B-VP O
27 any DT B-NP O
27 symptoms NNS I-NP O
27 She PRP O O
28 got VBD B-VP O
28 up RB O O
28 from IN B-VP O
28 the DT B-NP O
28 toilet NN I-NP O
28 and CC O O
28 while IN B-VP O
28 walking VBG O O
28 back RB O O
28 to TO O O
28 bed NN B-NP O
28 became VBD B-VP O
28 dizzy RB O O
29 again RB O O
29 She PRP O O
29 subsequently RB O O
29 passed VBD B-VP O
29 out RP O O
29 for IN B-VP O
29 an DT B-NP O
29 undetermined JJ I-NP O
29 time NN I-NP O
30 After IN B-VP O
30 waking VBG O O
30 up RP O O
30 she PRP O O
30 knew VBD B-VP O
30 exactly RB O O
30 where WRB O O
30 she PRP O O
30 was VBD B-VP O
30 and CC O O
30 had VBD B-VP O
30 no DT B-NP O
31 post-ictal JJ I-NP O
31 symptoms NNS I-NP O
31 She PRP O O
31 fell VBD B-VP O
31 to TO O O
31 the DT B-NP O
31 floor NN I-NP O
31 , , O O
31 but CC O O
31 denies VBZ O O
31 any DT B-NP O
31 trauma NN I-NP O
32 She PRP O O
32 also RB O O
32 denied VBD B-VP O
32 urinary/fecal JJ B-NP O
32 incontinence NN I-NP O
32 during IN B-VP O
32 this DT B-NP O
32 episode NN I-NP O
33 She PRP O O
33 adamantly RB O O
33 denies VBZ O O
33 chest JJS B-NP O
33 pain NN I-NP O
33 , , O O
33 shortness NN B-NP O
33 of IN B-VP O
33 breath NN B-NP O
33 or CC O O
33 significant JJ B-NP O
34 palpitations NNS I-NP O
34 She PRP O O
34 presented VBD B-VP O
34 today NN B-NP O
34 to TO O O
34 the DT B-NP O
34 ER NNP I-NP O
34 for IN B-VP O
34 evaluation NN B-NP O
35 Medications NNS I-NP O
35 on IN B-VP O
35 admission NN B-NP O
35 - : O O
35 None NN B-NP O
35 No DT O O
35 known VBN O O
35 drug NN B-NP O
35 allergies NNS I-NP O
35 PAST NNP I-NP O
36 MEDICAL NNP I-NP O
36 HISTORY: NNP I-NP O
36 None NNP I-NP O
36 HABITS: NNP I-NP O
36 No NNP I-NP O
36 tobacco NN I-NP O
36 , , O O
36 no DT B-NP O
36 alcohol NN I-NP O
36 SOCIAL NNP I-NP O
37 HISTORY: NNP I-NP O
37 Unemployed NNP I-NP O
37 , , O O
37 divorced VBD B-VP O
37 , , O O
37 mother NN B-NP O
37 of IN B-VP O
37 six CD O O
37 children NNS B-NP O
37 FAMILY NNP I-NP O
38 HISTORY: NNP I-NP O
38 Positive NNP I-NP O
38 for IN B-VP O
38 hypertension NN B-NP O
38 No NNP I-NP O
38 seizure NN I-NP O
38 disorder NN I-NP O
38 in IN B-VP O
38 the DT B-NP O
39 family NN I-NP O
39 and CC O O
39 her PRP$ O O
39 mother NN B-NP O
39 and CC O O
39 two CD O O
39 aunts NNS B-NP O
39 have VBP O O
39 pacemakers NNS B-NP O
39 inserted VBN O O
40 PHYSICAL NNP B-NP O
40 EXAMINATION: NNP I-NP O
40 Admission NNP I-NP O
40 - : O O
40 Morbidly RB O O
40 obese JJ B-NP O
40 black JJ I-NP O
40 female NN I-NP O
40 in IN B-VP O
41 no DT B-NP O
41 acute NN I-NP O
41 distress NN I-NP O
41 without IN B-VP O
41 complaints NNS B-NP O
42 presently RB O O
42 T NNP B-NP O
42 98.3 CD O O
42 , , O O
42 blood NN B-NP O
42 pressure NN I-NP O
42 lying VBG O O
42 down RB O O
42 120/80 CD O O
42 , , O O
42 sitting VBG O O
42 up RP O O
43 133/82 CD O O
43 , , O O
43 heart NN B-NP O
43 rate NN I-NP O
43 lying VBG O O
43 down RP O O
43 72 CD O O
43 , , O O
43 heart NN B-NP O
43 rate NN I-NP O
43 sitting VBG O O
43 up RP O O
43 80 CD O O
43 , , O O
44 respiratory NN B-NP O
44 rate NN I-NP O
44 is VBZ O O
44 16 CD O O
44 , , O O
44 O2 NNP B-NP O
44 sat VBD B-VP O
44 is VBZ O O
44 98% CD O O
44 on IN B-VP O
44 room NN B-NP O
44 air NN I-NP O
44 HEENT NNP I-NP O
44 - : O O
45 Anicteric JJ B-NP O
45 Clear JJ I-NP O
45 oropharynx NN I-NP O
45 Neck NNP I-NP O
45 is VBZ O O
45 supple JJ B-NP O
45 Lungs NNS I-NP O
45 are VBP O O
45 clear JJ B-NP O
46 Back NNP I-NP O
46 - : O O
46 Without IN B-VP O
46 spinal JJ O O
46 or CC O O
46 cvat JJ B-NP O
46 Cardiovascular NNP I-NP O
46 - : O O
46 Regular JJ B-NP O
46 rate NN I-NP O
46 and CC O O
47 rhythm NN B-NP O
47 No NNP I-NP O
47 jugular NN I-NP O
47 venous JJ B-NP O
47 distention NN I-NP O
47 Normal NNP I-NP O
47 S1 NNP I-NP O
47 and CC O O
47 S2 NNP B-NP O
47 , , O O
47 no DT B-NP O
47 S3 NNP I-NP O
47 or CC O O
48 S4 NNP B-NP O
48 , , O O
48 no DT B-NP O
48 murmurs NNS I-NP O
48 Carotids NNP I-NP O
48 with IN B-VP O
48 normal JJ B-NP O
48 upstrokes NNS I-NP O
48 and CC O O
48 no DT B-NP O
48 bruits NNS I-NP O
49 Abdomen NNP I-NP O
49 - : O O
49 Positive JJ B-NP O
49 bowel NN I-NP O
49 sounds NNS I-NP O
49 , , O O
49 obese JJ O O
49 , , O O
49 soft JJ O O
49 , , O O
49 nontender NN B-NP O
49 , , O O
49 no DT B-NP O
50 organomegaly NN I-NP O
50 Extremities NNP I-NP O
50 - : O O
50 No DT O O
50 pitting VBG O O
50 edema RB O O
50 2+ CD O O
50 radial JJ O O
50 and CC O O
50 DP NNP B-NP O
51 pulses VBZ O O
51 bilaterally RB O O
51 Neuro NNP B-NP O
51 - : O O
51 Alert NN B-NP O
51 and CC O O
51 oriented VBN O O
51 times NNS B-NP O
51 three CD O O
52 Cranial JJ B-NP O
52 nerves NNS I-NP O
52 III-XII NNP I-NP O
52 are VBP O O
52 tested VBN O O
52 and CC O O
52 are VBP O O
52 intact JJ B-NP O
52 Sensation NNP I-NP O
52 is VBZ O O
53 grossly RB O O
53 intact JJ B-NP O
53 Motor NNP I-NP O
53 strength NN I-NP O
53 - : O O
53 Normal JJ B-NP O
53 gait NN I-NP O
53 , , O O
53 not RB O O
53 tested VBN O O
54 Reflexes NNP B-NP O
54 are VBP O O
54 1-2+ JJ B-NP O
54 patella NN I-NP O
54 and CC O O
54 biceps NN B-NP O
54 reflexes NNS I-NP O
54 , , O O
54 symmetrically RB O O
55 LABORATORY NNP B-NP O
55 DATA: NNP I-NP O
55 K NNP I-NP O
55 3.9 CD O O
55 , , O O
55 mag FW O O
55 2.1 CD O O
55 , , O O
55 Hematocrit NNP B-NP O
55 38.9 CD O O
55 Chest NNP B-NP O
55 x-ray NN I-NP O
56 is VBZ O O
56 negative JJ B-NP O
56 Costophrenic JJ I-NP O
56 angles NNS I-NP O
56 were VBD B-VP O
56 not RB O O
57 visualized VBN O O
57 well RB O O
57 secondary JJ O O
57 to TO O O
57 her PRP$ O O
57 large JJ B-NP O
57 habitus NN I-NP O
57 EKG NNP I-NP O
57 showed VBD B-VP O
57 normal JJ B-NP O
58 sinus NN I-NP O
58 rhythm NN I-NP O
58 at IN B-VP O
58 72 CD O O
58 , , O O
58 first RB O O
58 degree JJ B-NP O
58 AV NNP I-NP O
58 block NN I-NP O
58 , , O O
58 PR NNP B-NP O
58 interval NN I-NP O
58 of IN B-VP O
58 0.30 CD O O
58 , , O O
59 left VBD B-VP O
59 ventricular JJ B-NP O
59 hypertrophy NN I-NP O
60 HOSPITAL NNP I-NP O
60 COURSE: NNP I-NP O
60 The DT B-NP O
60 patient NN I-NP O
60 was VBD B-VP O
60 admitted VBN O O
60 to TO O O
60 the DT B-NP O
60 unit NN I-NP O
60 Her NNP I-NP O
60 story NN I-NP O
61 was VBD B-VP O
61 most RBS O O
61 consistent JJ O O
61 with IN B-VP O
61 an DT B-NP O
61 arrhythmia NN I-NP O
61 induced VBD B-VP O
62 syncope NN B-NP O
62 Considering VBG O O
62 her PRP$ O O
62 history NN B-NP O
62 , , O O
62 it PRP O O
62 was VBD B-VP O
62 felt VBN O O
62 that IN B-VP O
62 she PRP O O
62 certainly RB O O
63 had VBD B-VP O
63 a DT B-NP O
63 symptomatic JJ I-NP O
63 bradycardic NN I-NP O
63 episode NN I-NP O
63 Because IN B-VP O
63 her PRP$ O O
63 current JJ B-NP O
64 pacemaker NN I-NP O
64 had VBD B-VP O
64 a DT O O
64 very RB O O
64 high JJ B-NP O
64 failure NN I-NP O
64 rate NN I-NP O
64 , , O O
64 we PRP O O
64 recommended VBD B-VP O
64 changing VBG O O
64 the DT B-NP O
65 pacemaker NN I-NP O
65 and CC O O
65 the DT B-NP O
65 patient NN I-NP O
65 agreed VBD B-VP O
65 She PRP O O
65 was VBD B-VP O
65 placed VBN O O
65 on IN B-VP O
65 the DT B-NP O
65 cardiac JJ I-NP O
66 monitor NN I-NP O
66 without IN B-VP O
66 any DT B-NP O
66 event NN I-NP O
66 over IN B-VP O
66 her PRP$ O O
66 hospital JJ B-NP O
66 stay NN I-NP O
67 As IN B-VP O
67 part NN B-NP O
67 of IN B-VP O
67 her PRP$ O O
67 prepacer NN B-NP O
67 work-up NN I-NP O
67 , , O O
67 she PRP O O
67 had VBD B-VP O
67 a DT B-NP O
67 right JJ I-NP O
67 upper JJ I-NP O
67 extremity NN I-NP O
68 venogram NN I-NP O
68 which WDT O O
68 showed VBD B-VP O
68 patent NN B-NP O
68 vessels NNS I-NP O
68 on IN B-VP O
68 that DT B-NP O
68 side NN I-NP O
68 The DT B-NP O
68 patient NN I-NP O
68 had VBD B-VP O
69 a DT B-NP O
69 pacemaker NN I-NP O
69 insertedon VBZ O O
69 4 CD O O
69 of IN B-VP O
69 October NNP B-NP O
69 in IN B-VP O
69 the DT B-NP O
69 OR NNP I-NP O
69 without IN B-VP O
69 any DT B-NP O
69 complications NNS I-NP O
70 The DT B-NP O
70 reason NN I-NP O
70 it PRP O O
70 was VBD B-VP O
70 done VBN O O
70 in IN B-VP O
70 the DT B-NP O
70 OR NNP I-NP O
70 was VBD B-VP O
70 because IN B-VP O
70 of IN B-VP O
70 her PRP$ O O
70 large JJ B-NP O
70 size NN I-NP O
70 and CC O O
71 the DT B-NP O
71 strength NN I-NP O
71 of IN B-VP O
71 the DT B-NP O
71 table NN I-NP O
71 After IN B-VP O
71 pacer NN B-NP O
71 insertion NN I-NP O
71 , , O O
71 the DT B-NP O
71 patient NN I-NP O
71 did VBD B-VP O
72 very RB O O
72 well RB O O
72 without IN B-VP O
72 any DT B-NP O
72 further JJ I-NP O
72 symptoms NNS I-NP O
72 of IN B-VP O
72 dizziness NN B-NP O
72 or CC O O
72 syncope NN B-NP O
72 She PRP O O
73 was VBD B-VP O
73 discharged VBN O O
73 to TO O O
73 home VB O O
73 the DT B-NP O
73 following JJ I-NP O
73 day NN I-NP O
73 in IN B-VP O
73 good JJ B-NP O
73 condition NN I-NP O
74 DISPOSITION: NNP I-NP O
74 Discharge NNP I-NP O
74 medications NNS I-NP O
74 - : O O
74 Keflex NNP B-NP B-m
74 500 CD O B-do
74 mg NN B-NP I-do
74 q8h NN I-NP B-f
74 for IN B-VP B-du
74 nine CD O O
75 doses NNS B-NP O
75 , , O O
75 Percocet NNP B-NP B-m
75 1-2 CD O B-do
75 p.o NN B-NP B-mo
75 q6h NN I-NP B-f
75 p.r.n NN I-NP I-f
75 pain NN I-NP B-r
75 Follow-up NNP I-NP O
76 will MD O O
76 be VB O O
76 in IN B-VP O
76 the DT B-NP O
76 Pacemaker NNP I-NP O
76 Clinic NNP I-NP O
77 Dictated NNP I-NP O
77 By: NNP I-NP O
77 KASEY NNP I-NP O
77 NAVEED NNP I-NP O
77 , , O O
77 M.D NNP B-NP O
77 HE93 NNP I-NP O
78 Attending: NNP I-NP O
78 WELDON NNP I-NP O
78 S NNP I-NP O
78 HERSHFIELD NNP I-NP O
78 , , O O
78 M.D NNP B-NP O
78 VT22 NNP I-NP O
78 CY954/3795 NNP I-NP O
79 Batch: NNP I-NP O
79 014 CD O O
79 Index NNP B-NP O
79 No NNP I-NP O
79 EQSO6P28BC NNP I-NP O
79 D: NNP I-NP O
79 6/26/94 CD O O
80 T: NNP B-NP O
80 6/26/94 CD O O
81 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #818404 VBZ O O
2 514414960 CD O O
2 OCMH NNP B-NP O
2 44300452 CD O O
2 439016 CD O O
2 7/26/2002 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CHRONIC NNP I-NP O
2 HEART NNP I-NP O
2 FAILURE NNP I-NP O
2 , , O O
2 HIP NNP B-NP O
2 FRACTURE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/5/2002 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/14/2002 CD O O
4 ADMISSION NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 LEFT NNP I-NP O
4 HIP NNP I-NP O
4 FRACTURE NNP I-NP O
5 SECONDARY NNP I-NP O
5 DIAGNOSES: NNP I-NP O
5 1 CD O O
5 FAT NNP B-NP O
5 EMBOLI NNP I-NP O
5 SYNDROME NNP I-NP O
6 2 CD O O
6 CONGESTIVE NNP B-NP O
6 HEART NNP I-NP O
6 FAILURE NNP I-NP O
7 3 CD O O
7 DECUBITUS NNP B-NP O
7 ULCERS NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 Mr NNP I-NP O
8 Lumadue NNP I-NP O
8 is VBZ O O
8 a DT B-NP O
8 68-year-old JJ I-NP O
8 man NN I-NP O
8 who WP O O
9 came VBD B-VP O
9 in IN B-VP O
9 with IN B-VP O
9 a DT B-NP O
9 chief JJ I-NP O
9 complaint NN I-NP O
9 of IN B-VP O
9 hip NN B-NP O
10 pain NN I-NP O
10 after IN B-VP O
10 a DT B-NP O
10 mechanical JJ I-NP O
10 fall NN I-NP O
10 The DT B-NP O
10 patient NN I-NP O
10 had VBD B-VP O
10 been VBN O O
10 hospitalized VBN O O
10 in IN B-VP O
11 3/0 CD O O
11 for IN B-VP O
11 ischemic JJ B-NP O
11 right NN I-NP O
11 toes NNS I-NP O
11 requiring VBG O O
11 debridement NN B-NP O
11 and CC O O
11 amputation NN B-NP O
12 At IN B-VP O
12 that DT B-NP O
12 time NN I-NP O
12 , , O O
12 his PRP$ O O
12 hospital JJ B-NP O
12 course NN I-NP O
12 was VBD B-VP O
12 complicated VBN O O
12 by IN B-VP O
12 a DT B-NP O
12 non-Q JJ I-NP B-r
12 wave NN I-NP O
13 MI NNP I-NP O
13 Cardiology NNP I-NP O
13 have VBP O O
13 recommended VBN O O
13 medical JJ B-NP O
13 management NN I-NP O
13 with IN B-VP O
13 Lopressor NNP B-NP B-m
14 at IN B-VP O
14 that DT B-NP O
14 time NN I-NP O
14 and CC O O
14 an DT B-NP O
14 echocardiogram NN I-NP O
14 revealed VBD B-VP O
14 an DT B-NP O
14 ejection NN I-NP O
14 fraction NN I-NP O
14 of IN B-VP O
15 45% CD O O
15 Dobutamine NNP B-NP B-m
15 MIBI NNP I-NP O
15 revealed VBD B-VP O
15 a DT O O
15 severe JJ O O
15 fixed VBN O O
15 perfusion NN B-NP O
15 defect NN I-NP O
15 in IN B-VP O
16 the DT B-NP O
16 inferoposterior NN I-NP O
16 and CC O O
16 inferoseptal JJ O O
16 left VBD B-VP O
16 ventricle NN B-NP O
16 without IN B-VP O
16 any DT B-NP O
17 peri-infarct JJ I-NP O
17 ischemia NN I-NP O
17 Ejection NNP I-NP O
17 fraction NN I-NP O
17 by IN B-VP O
17 MIBI NNP B-NP O
17 imaging NN I-NP O
17 was VBD B-VP O
17 26% CD O O
18 in IN B-VP O
18 contrast NN B-NP O
18 to TO O O
18 the DT B-NP O
18 echo JJ I-NP O
18 results NNS I-NP O
18 The DT B-NP O
18 patient NN I-NP O
18 was VBD B-VP O
18 ultimately RB O O
19 discharged VBN O O
19 on IN B-VP O
19 Lopressor NNP B-NP B-m
19 , , O O
19 however RB O O
19 , , O O
19 she PRP O O
19 stopped VBD B-VP O
19 taking VBG O O
19 the DT B-NP O
19 Lopressor NNP I-NP B-m
20 for IN B-VP O
20 unclear JJ B-NP O
20 reasons NNS I-NP O
20 For IN B-VP O
20 the DT B-NP O
20 few JJ I-NP O
20 months NNS I-NP O
20 prior RB O O
20 to TO O O
20 admission NN B-NP O
20 , , O O
20 he PRP O O
21 developed VBD B-VP O
21 increasing VBG O O
21 dyspnea NN B-NP O
21 on IN B-VP O
21 exertion NN B-NP O
21 with IN B-VP O
21 paroxysmal JJ B-NP O
21 nocturnal JJ I-NP O
22 dyspnea NN I-NP O
22 and CC O O
22 increasing VBG O O
22 pedal JJ B-NP O
22 edema NN I-NP O
22 , , O O
22 as RB O O
22 well RB O O
22 as IN B-VP O
22 nocturia NNS B-NP O
22 , , O O
22 however RB O O
22 , , O O
23 denied VBD B-VP O
23 any DT B-NP O
23 orthopnea NN I-NP O
23 , , O O
23 any DT B-NP O
23 chest JJS I-NP O
23 pain NN I-NP O
23 , , O O
23 fevers NNS B-NP O
23 , , O O
23 melena NN B-NP O
23 , , O O
23 bright JJ B-NP O
23 red JJ I-NP O
24 blood NN I-NP O
24 per IN B-VP O
24 rectum NN B-NP O
24 or CC O O
24 palpitations NNS B-NP O
24 A NNP I-NP O
24 few JJ B-NP O
24 days NNS I-NP O
24 prior RB O O
24 to TO O O
24 admission NN B-NP O
24 , , O O
25 the DT B-NP O
25 patient NN I-NP O
25 developed VBD B-VP O
25 a DT B-NP O
25 dry JJ I-NP O
25 cough NN I-NP O
25 and CC O O
25 some DT B-NP O
25 rhinorrhea NN I-NP O
26 On IN B-VP O
26 the DT B-NP O
26 morning NN I-NP O
26 of IN B-VP O
26 admission NN B-NP O
26 , , O O
26 the DT B-NP O
26 patient NN I-NP O
26 sustained VBD B-VP O
26 a DT B-NP O
26 mechanical JJ I-NP O
27 fall NN I-NP O
27 while IN B-VP O
27 trying VBG O O
27 to TO O O
27 retrieve VB O O
27 a DT B-NP O
27 newspaper NN I-NP O
27 He PRP O O
27 had VBD B-VP O
27 no DT O O
28 light-headedness JJ O O
28 , , O O
28 palpitations NNS B-NP O
28 , , O O
28 pain NN B-NP O
28 in IN B-VP O
28 his PRP$ O O
28 chest NN B-NP O
28 , , O O
28 nausea NN B-NP O
28 or CC O O
29 vomiting NN B-NP O
29 , , O O
29 sweating VBG O O
29 or CC O O
29 change NN B-NP O
29 in IN B-VP O
29 vision NN B-NP O
29 or CC O O
29 sensory NN B-NP O
29 symptoms NNS I-NP O
29 prior RB O O
29 to TO O O
30 or CC O O
30 after IN B-VP O
30 the DT B-NP O
30 fall NN I-NP O
30 The DT B-NP O
30 patient NN I-NP O
30 fell VBD B-VP O
30 onto IN B-VP O
30 his PRP$ O O
30 left JJ B-NP O
30 side NN I-NP O
30 and CC O O
31 immediately RB O O
31 developed VBD B-VP O
31 left-sided JJ B-NP O
31 leg NN I-NP O
31 and CC O O
31 hip NN B-NP O
31 pain NN I-NP O
31 for IN B-VP O
31 which WDT O O
31 she PRP O O
32 presented VBD B-VP O
32 to TO O O
32 the DT B-NP O
32 emergency NN I-NP O
32 room NN I-NP O
32 at IN B-VP O
32 Fentstraub NNP B-NP O
32 Neycian's NNP I-NP O
32 Medical NNP I-NP O
32 Center NNP I-NP O
33 PAST NNP I-NP O
33 MEDICAL NNP I-NP O
33 HISTORY: NNP I-NP O
33 Coronary NNP I-NP O
33 artery NN I-NP O
33 disease NN I-NP O
33 , , O O
33 cardiomyopathy NN B-NP O
34 ( ( O O
34 ischemic JJ O O
34 ) ) O O
34 , , O O
34 peripheral JJ B-NP O
34 vascular JJ I-NP O
34 disease NN I-NP O
34 , , O O
35 status NN B-NP O
35 post NN I-NP O
35 amputation NN I-NP O
35 of IN B-VP O
35 right-sided JJ B-NP O
35 toes NNS I-NP O
35 , , O O
35 status NN B-NP O
35 post NN I-NP O
35 right RB O O
36 femoral JJ O O
36 to TO O O
36 PT NNP B-NP O
36 avascularization NN I-NP O
36 , , O O
36 diabetes VBZ O O
36 type JJ B-NP O
36 II NNP I-NP O
36 , , O O
36 status NN B-NP O
36 post NN I-NP O
36 CVA NNP I-NP O
36 , , O O
37 hypertension NN B-NP O
38 MEDICATIONS: NNP I-NP O
38 HCTZ NNP I-NP B-m
38 50 CD O B-do
38 mg NN B-NP I-do
38 p.o NN I-NP B-mo
38 q.d NN I-NP B-f
38 , , O O
38 enteric-coated JJ B-NP B-m
38 aspirin NN I-NP I-m
38 325 CD O B-do
38 mg NN B-NP I-do
39 p.o NN I-NP B-mo
39 q.d NN I-NP B-f
39 , , O O
39 Zestril NNP B-NP B-m
39 20 CD O B-do
39 mg NN B-NP I-do
39 p.o NN I-NP B-mo
39 q.d NN I-NP B-f
39 , , O O
39 glyburide RB O B-m
39 5 CD O B-do
39 mg NNS B-NP I-do
40 p.o JJ B-NP B-mo
40 q.d NN I-NP B-f
40 , , O O
40 multivitamins NNS B-NP B-m
40 , , O O
40 cough JJ B-NP B-m
40 medicine NN I-NP I-m
40 p.r.n NN I-NP B-f
41 ALLERGIES: NNP I-NP O
41 Aminoglycosides NNP I-NP O
41 , , O O
41 unknown JJ B-NP O
41 reaction NN I-NP O
42 SOCIAL NNP I-NP O
42 HISTORY: NNP I-NP O
42 The DT B-NP O
42 patient NN I-NP O
42 has VBZ O O
42 a DT B-NP O
42 history NN I-NP O
42 of IN B-VP O
42 smoking VBG O O
42 one CD O O
42 pack NN B-NP O
42 per IN B-VP O
43 day NN B-NP O
43 x40 CD O O
43 years NNS B-NP O
43 , , O O
43 quit RB O O
43 five CD O O
43 years NNS B-NP O
43 prior RB O O
43 to TO O O
43 admission NN B-NP O
44 He PRP O O
44 has VBZ O O
44 one CD O O
44 drink NN B-NP O
44 of IN B-VP O
44 liquor NN B-NP O
44 per IN B-VP O
44 day NN B-NP O
44 , , O O
44 lives VBZ O O
44 at IN B-VP O
44 home NN B-NP O
44 alone RB O O
44 in IN B-VP O
44 Targtine NNP B-NP O
44 Highway NNP I-NP O
44 , , O O
44 Birm NNP B-NP O
44 , , O O
44 Vermont NNP B-NP O
44 21711 CD O O
44 , , O O
44 and CC O O
44 is VBZ O O
44 in IN B-VP O
44 the DT B-NP O
44 insurance NN I-NP O
44 business NN I-NP O
45 FAMILY NNP I-NP O
45 HISTORY: NNP I-NP O
45 Notable NNP I-NP O
45 for IN B-VP O
45 mother NN B-NP O
45 died VBD B-VP O
45 of IN B-VP O
45 cancer NN B-NP O
45 at IN B-VP O
45 74 CD O O
45 Father NNP B-NP O
46 died VBD B-VP O
46 at IN B-VP O
46 55 CD O O
46 of IN B-VP O
46 heart NN B-NP O
46 disease NN I-NP O
46 Mother NNP I-NP O
46 died VBD B-VP O
46 at IN B-VP O
46 50 CD O O
46 of IN B-VP O
47 a DT B-NP O
47 heart NN I-NP O
47 attack NN I-NP O
48 PHYSICAL NNP I-NP O
48 EXAMINATION: NNP I-NP O
48 VITAL NNP I-NP O
48 SIGNS: NNP I-NP O
48 Afebrile NNP I-NP O
48 , , O O
48 temperature NN B-NP O
48 97.3 CD O O
48 , , O O
49 heart NN B-NP O
49 rate NN I-NP O
49 106 CD O O
49 , , O O
49 blood NN B-NP O
49 pressure NN I-NP O
49 162/77 CD O O
49 , , O O
50 oxygenation NN B-NP O
50 94% CD O O
50 on IN B-VP O
50 room NN B-NP O
50 air NN I-NP O
50 GENERAL: NNP I-NP O
50 He PRP O O
50 was VBD B-VP O
50 alert JJ O O
50 and CC O O
50 oriented JJ B-NP O
51 LUNGS: NNP I-NP O
51 Clear NNP I-NP O
51 HEART: NNP I-NP O
51 Regular NNP I-NP O
51 rate NN I-NP O
51 and CC O O
51 rhythm NN B-NP O
51 PELVIS: NNP I-NP O
51 Stable NNP I-NP O
52 His PRP$ O O
52 left VBD B-VP O
52 lower JJR B-NP O
52 extremity NN I-NP O
52 had VBD B-VP O
52 well-healed JJ B-NP O
52 scars NNS I-NP O
52 from IN B-VP O
52 donor JJ B-NP O
52 site NN I-NP O
52 for IN B-VP O
53 bypass NN B-NP O
53 grafting NN I-NP O
53 , , O O
53 strong JJ B-NP O
53 dopplerable JJ I-NP O
53 PT NNP I-NP O
53 and CC O O
53 DP NNP B-NP O
53 pulses VBZ O O
53 His PRP$ O O
53 left JJ B-NP O
53 leg NN I-NP O
54 was VBD B-VP O
54 externally RB O O
54 rotated JJ B-NP O
54 Sensation NNP I-NP O
54 was VBD B-VP O
54 intact JJ O O
54 to TO O O
54 light JJ B-NP O
54 touch JJ I-NP O
55 LABORATORY NNP I-NP O
55 DATA: NNP I-NP O
55 Sodium NNP I-NP O
55 135 CD O O
55 , , O O
55 potassium NN B-NP O
55 4.4 CD O O
55 , , O O
55 chloride RB O O
55 102 CD O O
55 , , O O
55 bicarb NN B-NP O
56 19 CD O O
56 , , O O
56 BUN NNP B-NP O
56 56 CD O O
56 , , O O
56 creatinine NN B-NP O
56 2.5 CD O O
56 White NNP B-NP O
56 count NN I-NP O
56 12 CD O O
56 , , O O
57 hematocrit NN B-NP O
57 33 CD O O
57 , , O O
57 platelets NNS B-NP O
57 388 CD O O
57 PTT NNP B-NP O
57 40.5 CD O O
57 , , O O
57 INR NNP B-NP O
57 1.2 CD O O
57 EKG NNP B-NP O
57 showed VBD B-VP O
57 sinus JJ B-NP O
58 tach NN I-NP O
58 at IN B-VP O
58 102 CD O O
58 , , O O
58 with IN B-VP O
58 occasional JJ B-NP O
58 PVCs NNP I-NP O
58 , , O O
58 normal JJ B-NP O
58 axis NN I-NP O
58 , , O O
58 normal JJ B-NP O
58 intervals NNS I-NP O
58 , , O O
59 no DT B-NP O
59 evidence NN I-NP O
59 of IN B-VP O
59 ischemia JJ B-NP O
59 Chest NNP I-NP O
59 x-ray NN I-NP O
59 showed VBD B-VP O
59 bilateral JJ B-NP O
59 pulmonary JJ I-NP O
60 edema NN I-NP O
60 X-rays NNS I-NP O
60 of IN B-VP O
60 his PRP$ O O
60 left JJ B-NP O
60 pelvis NN I-NP O
60 and CC O O
60 femur NN B-NP O
60 revealed VBD B-VP O
60 fracture NN B-NP O
60 of IN B-VP O
61 the DT B-NP O
61 left JJ I-NP O
61 intertrochanter NN I-NP O
61 and CC O O
61 subtrochanteric JJ B-NP O
61 fracture NN I-NP O
61 with IN B-VP O
61 lesser JJR B-NP O
62 trochanteric JJ I-NP O
62 fracture NN I-NP O
62 intact JJ O O
62 by IN B-VP O
62 3 CD O O
62 cm NNS B-NP O
62 , , O O
62 less JJR O O
62 than IN B-VP O
62 five CD O O
62 degrees NNS B-NP O
63 angulation NN I-NP O
63 His PRP$ O O
63 femoral JJ B-NP O
63 head NN I-NP O
63 was VBD B-VP O
63 reduced VBN O O
64 IMPRESSION: NNP B-NP O
64 A NNP I-NP O
64 68-year-old JJ B-NP O
64 man NN I-NP O
64 with IN B-VP O
64 significant JJ B-NP O
64 cardiac JJ I-NP O
64 history NN I-NP O
65 and CC O O
65 vascular JJ B-NP O
65 disease NN I-NP O
65 , , O O
65 status NN B-NP O
65 post NN I-NP O
65 left VBD B-VP O
65 hip JJ B-NP O
65 fracture NN I-NP O
66 with IN B-VP O
66 mechanical JJ B-NP O
66 fall NN I-NP O
66 , , O O
66 with IN B-VP O
66 pulmonary JJ B-NP O
66 edema NN I-NP O
66 noted VBD B-VP O
66 on IN B-VP O
66 chest JJS B-NP O
66 x-ray JJ I-NP O
67 HOSPITAL NNP I-NP O
67 COURSE: NNP I-NP O
67 1 CD O O
67 Cardiovascular NNP B-NP O
67 - : O O
67 Initially RB O O
67 , , O O
67 the DT B-NP O
67 patient NN I-NP O
67 was VBD B-VP O
68 to TO O O
68 be VB O O
68 admitted VBN O O
68 to TO O O
68 the DT B-NP O
68 orthopedic JJ I-NP O
68 service NN I-NP O
68 with IN B-VP O
69 medicine NN B-NP O
69 consult NN I-NP O
69 for IN B-VP O
69 wrist NN B-NP O
69 stratification NN I-NP O
69 However RB O O
69 , , O O
69 the DT B-NP O
69 patient NN I-NP O
70 was VBD B-VP O
70 transferred VBN O O
70 to TO O O
70 the DT B-NP O
70 medicine NN I-NP O
70 service NN I-NP O
70 for IN B-VP O
70 further JJ B-NP O
70 evaluation NN I-NP O
70 and CC O O
71 management NN B-NP O
71 The DT B-NP O
71 patient NN I-NP O
71 was VBD B-VP O
71 noted VBN O O
71 to TO O O
71 have VB O O
71 a DT B-NP O
71 troponin NN I-NP O
71 leak NN I-NP O
71 although IN B-VP O
72 CK NNP B-NP O
72 enzymes NNS I-NP O
72 remained VBD B-VP O
72 negative JJ O O
72 for IN B-VP O
72 ischemia NN B-NP O
72 He PRP O O
72 had VBD B-VP O
72 a DT B-NP O
72 MIBI NNP I-NP O
72 performed VBD B-VP O
73 which WDT O O
73 revealed VBD B-VP O
73 an DT B-NP O
73 unchanged JJ I-NP O
73 fixed JJ I-NP O
73 defect NN I-NP O
73 He PRP O O
73 remained VBD B-VP O
73 in IN B-VP O
73 sinus JJ B-NP O
74 tach NN I-NP O
74 with IN B-VP O
74 occasional JJ B-NP O
74 PVCs NNP I-NP O
74 and CC O O
74 runs NNS B-NP O
74 of IN B-VP O
74 nonsustained JJ B-NP O
74 ventricular JJ I-NP O
75 tachycardia NN I-NP O
75 lasting VBG O O
75 3-4 JJ B-NP O
75 beats NNS I-NP O
75 at IN B-VP O
75 a DT B-NP O
75 time NN I-NP O
75 throughout IN B-VP O
75 his PRP$ O O
75 admission NN B-NP O
76 Sinus NNP I-NP O
76 tach NN I-NP O
76 was VBD B-VP O
76 attributed VBN O O
76 pain NN B-NP O
76 and CC O O
76 discomfort NN B-NP O
76 , , O O
76 possibly RB O O
76 with IN B-VP O
77 element NN B-NP O
77 of IN B-VP O
77 hypoxia NN B-NP O
77 contributing NN I-NP O
77 as RB O O
77 well RB O O
77 A NNP B-NP O
77 troponin NN I-NP O
77 leak NN I-NP O
77 was VBD B-VP O
78 attributed VBN O O
78 to TO O O
78 strain VB O O
78 particularly RB O O
78 in IN B-VP O
78 the DT B-NP O
78 setting NN I-NP O
78 of IN B-VP O
78 his PRP$ O O
79 tachycardia JJ B-NP B-r
79 tachycardia NN I-NP B-r
79 tachycardia NN I-NP B-r
79 He PRP O O
79 was VBD B-VP O
79 started VBN O O
79 on IN B-VP O
79 beta NN B-NP B-m
79 blocker NN I-NP I-m
79 , , O O
79 Ace NNP B-NP B-m
79 inhibitor NN I-NP I-m
79 and CC O O
80 continued VBD B-VP O
80 on IN B-VP O
80 an DT B-NP O
80 aspirin NN I-NP B-m
80 He PRP O O
80 was VBD B-VP O
80 aggressively RB O O
80 diuresed VBN O O
80 with IN B-VP O
81 afterload NN B-NP O
81 reduction NN I-NP O
81 He PRP O O
81 was VBD B-VP O
81 titrated VBN O O
81 upward RB O O
81 as IN B-VP O
81 noted JJ O O
82 2 CD O O
82 Pulmonary NNP B-NP O
82 - : O O
82 The DT B-NP O
82 patient's NN I-NP O
82 crackles NNS I-NP O
82 persisted VBN O O
82 on IN B-VP O
82 lung NN B-NP O
82 exam NN I-NP O
82 after IN B-VP O
83 aggressive JJ B-NP O
83 diuresis NN I-NP O
83 , , O O
83 prompting VBG O O
83 performance NN B-NP O
83 of IN B-VP O
83 a DT B-NP O
83 chest NN I-NP O
83 CT NNP I-NP O
83 which WDT O O
84 revealed VBD B-VP O
84 an DT B-NP O
84 interstitial JJ I-NP O
84 pattern NN I-NP O
84 with IN B-VP O
84 peripheral JJ B-NP O
84 nodularity NN I-NP O
85 consistent NN I-NP O
85 with IN B-VP O
85 fat JJ B-NP O
85 emboli JJ I-NP O
85 syndrome NN I-NP O
85 , , O O
85 positive JJ B-NP O
85 component NN I-NP O
85 of IN B-VP O
86 congestive JJ B-NP O
86 heart NN I-NP O
86 failure NN I-NP O
86 and CC O O
86 aspiration NN B-NP O
86 pneumonia NN I-NP O
86 as RB O O
86 well RB O O
86 The DT B-NP O
87 patient NN I-NP O
87 was VBD B-VP O
87 continued VBN O O
87 on IN B-VP O
87 a DT B-NP O
87 regimen NN I-NP O
87 of IN B-VP O
87 Lasix NNP B-NP B-m
87 for IN B-VP O
87 diuresis NN B-NP O
87 and CC O O
87 was VBD B-VP O
88 treated VBN O O
88 for IN B-VP O
88 aspiration NN B-NP B-r
88 pneumonia NN I-NP I-r
88 as IN B-VP O
88 noted VBN O O
88 below IN B-VP O
88 His PRP$ O O
88 oxygen NN B-NP O
89 requirement NN I-NP O
89 diminished VBD B-VP O
89 over IN B-VP O
89 a DT B-NP O
89 few JJ I-NP O
89 days NNS I-NP O
89 and CC O O
89 he PRP O O
89 was VBD B-VP O
89 maintained VBN O O
89 on IN B-VP O
89 two CD O B-do
90 liters NNS B-NP O
90 of IN B-VP O
90 nasal JJ B-NP B-mo
90 cannula NN I-NP I-mo
90 oxygen NN I-NP B-m
90 at IN B-VP O
90 the DT B-NP O
90 time NN I-NP O
90 of IN B-VP O
90 transfer NN B-NP O
90 to TO O O
90 rehab VB O O
91 3 CD O O
91 Renal NNP B-NP O
91 - : O O
91 The DT B-NP O
91 patient NN I-NP O
91 developed VBD B-VP O
91 some DT B-NP O
91 renal JJ I-NP O
91 failure NN I-NP O
91 in IN B-VP O
91 the DT B-NP O
91 setting NN I-NP O
92 of IN B-VP O
92 diuresis NN B-NP O
92 , , O O
92 which WDT O O
92 improved VBD B-VP O
92 with IN B-VP O
92 hydration NN B-NP O
92 The DT B-NP O
92 patient NN I-NP O
93 subsequently RB O O
93 tolerated VBD B-VP O
93 further JJ B-NP O
93 diuresis NN I-NP O
93 with IN B-VP O
93 improvement NN B-NP O
93 in IN B-VP O
93 his PRP$ O O
94 creatinine NN B-NP O
94 and CC O O
94 it PRP O O
94 is VBZ O O
94 possible JJ O O
94 that IN B-VP O
94 renal JJ B-NP O
94 failure NN I-NP O
94 is VBZ O O
94 due JJ O O
94 to TO O O
94 fat VB O O
95 emboli JJ B-NP O
95 syndrome NN I-NP O
95 as IN B-VP O
95 well RB O O
95 and CC O O
95 should MD O O
95 improve VB O O
95 slowly RB O O
96 4 CD O O
96 ID NNP B-NP O
96 - : O O
96 The DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 treated VBN O O
96 with IN B-VP O
96 vancomycin NN B-NP B-m
96 , , O O
96 Flagyl NNP B-NP B-m
96 and CC O O
97 levofloxacin NN B-NP B-m
97 for IN B-VP O
97 presumed VBN O B-r
97 presumed JJ B-NP B-r
97 presumed JJ I-NP B-r
97 aspiration NN I-NP I-r
97 aspiration NN I-NP I-r
97 aspiration NN I-NP I-r
97 pneumonia NN I-NP I-r
97 pneumonia NN I-NP I-r
97 pneumonia NN I-NP I-r
97 , , O O
97 course NN B-NP O
97 completed VBD B-VP O
98 5/6/02 CD O O
98 The DT B-NP O
98 patient NN I-NP O
98 remained VBD B-VP O
98 afebrile IN B-VP O
98 His PRP$ O O
98 white JJ B-NP O
98 blood NN I-NP O
98 count NN I-NP O
98 on IN B-VP O
99 admission NN B-NP O
99 and CC O O
99 discharge NN B-NP O
99 was VBD B-VP O
99 12 CD O O
100 5 CD O O
100 Neurologically RB O O
100 - : O O
100 The DT B-NP O
100 patient NN I-NP O
100 apparently RB O O
100 had VBD B-VP O
100 baseline JJ B-NP O
100 mild JJ I-NP O
101 perfusion NN I-NP O
101 The DT O O
101 possibly RB O O
101 worsened VBN O O
101 due JJ O O
101 to TO O O
101 the DT B-NP O
101 fat JJ I-NP O
101 embolic JJ I-NP O
101 syndrome NN I-NP O
102 and CC O O
102 was VBD B-VP O
102 at IN B-VP O
102 baseline JJ B-NP O
102 prior NN I-NP O
102 to TO O O
102 discharge VB O O
102 per IN B-VP O
102 the DT B-NP O
102 patient's NN I-NP O
102 daughter NN I-NP O
103 6 CD O O
103 Heme NNP B-NP O
103 - : O O
103 The DT B-NP O
103 patient NN I-NP O
103 was VBD B-VP O
103 continued VBN O O
103 on IN B-VP O
103 Lovenox NNP B-NP B-m
103 60 CD O B-do
103 mg NN B-NP I-do
103 subcu NN I-NP B-mo
103 b.i.d NN I-NP B-f
104 for IN B-VP O
104 prophylaxis NN B-NP B-r
104 against IN B-VP I-r
104 DVT NNP B-NP I-r
104 post-hip NN I-NP I-r
104 surgery NN I-NP I-r
104 to TO O O
104 continue VB O O
104 for IN B-VP B-du
104 six CD O O
105 months NNS B-NP O
105 minimal JJ O O
105 followed VBN O O
105 by IN B-VP O
105 orthopedic JJ B-NP O
105 surgery NN I-NP O
106 7 CD O O
106 GI NNP B-NP O
106 - : O O
106 The DT B-NP O
106 patient NN I-NP O
106 developed VBD B-VP O
106 some DT B-NP O
106 diarrhea NNS I-NP O
106 C NNP I-NP O
106 diff NN I-NP O
106 cultures NNS I-NP O
107 were VBD B-VP O
107 negative JJ O O
107 to TO O O
107 date NN B-NP O
107 at IN B-VP O
107 the DT B-NP O
107 time NN I-NP O
107 of IN B-VP O
107 discharge NN B-NP O
107 The DT B-NP O
107 patient NN I-NP O
107 was VBD B-VP O
108 maintained VBN O O
108 on IN B-VP O
108 Nexium NNP B-NP B-m
108 prophylaxis NN I-NP O
108 in IN B-VP O
108 the DT B-NP O
108 setting NN I-NP O
108 of IN B-VP O
108 his PRP$ O O
109 anticoagulation NN B-NP O
110 8 CD O O
110 Endocrine NNP B-NP O
110 - : O O
110 The DT B-NP O
110 patient NN I-NP O
110 was VBD B-VP O
110 restarted VBN O O
110 on IN B-VP O
110 oral JJ B-NP B-mo
110 hypoglycemics NNS I-NP B-m
111 prior RB O O
111 to TO O O
111 discharge VB O O
111 in IN B-VP O
111 addition NN B-NP O
111 to TO O O
111 sliding VBG O B-do
111 scale JJ B-NP I-do
111 insulin NN I-NP B-m
111 The DT B-NP O
112 patient NN I-NP O
112 had VBD B-VP O
112 a DT B-NP O
112 Foley NNP I-NP O
112 and CC O O
112 a DT B-NP O
112 triple JJ I-NP O
112 lumen NNS I-NP O
112 catheter NN I-NP O
112 , , O O
112 both DT O O
112 of IN B-VP O
112 which WDT O O
112 were VBD B-VP O
113 removed VBN O O
113 on IN B-VP O
113 5/6/02 CD O O
113 The DT B-NP O
113 patient NN I-NP O
113 was VBD B-VP O
113 evaluated VBN O O
113 by IN B-VP O
113 plastic NN B-NP O
113 surgery NN I-NP O
114 for IN B-VP O
114 his PRP$ O O
114 peripheral JJ B-NP O
114 vascular JJ I-NP O
114 disease NN I-NP O
114 with IN B-VP O
114 ulcers NNS B-NP O
114 Recommended NNP I-NP O
114 dry NN I-NP O
115 sterile NN I-NP O
115 dressings NNS I-NP O
115 to TO O O
115 the DT B-NP O
115 right NN I-NP O
115 and CC O O
115 left VBD B-VP O
115 foot NN B-NP O
115 wound NN I-NP O
115 changed VBD B-VP O
115 q.d NN B-NP O
116 with IN B-VP O
116 DuoDerm NNP B-NP O
116 to TO O O
116 the DT B-NP O
116 left NN I-NP O
116 lower JJR B-NP O
116 leg NN I-NP O
116 wound NN I-NP O
116 to TO O O
116 be VB O O
116 changed VBN O O
116 q.3 JJ B-NP O
116 days NNS I-NP O
116 , , O O
117 with IN B-VP O
117 pressure NN B-NP O
117 sore NN I-NP O
117 prevention NN I-NP O
118 9 CD O O
118 FEN NNP B-NP O
118 - : O O
118 The DT B-NP O
118 patient NN I-NP O
118 was VBD B-VP O
118 discharged VBN O O
118 on IN B-VP O
118 standing VBG O O
118 20 CD O B-do
118 mEq NN B-NP I-do
118 of IN B-VP O
118 K-Dur NNP B-NP B-m
119 q.d NN I-NP B-f
119 It PRP O O
119 is VBZ O O
119 likely JJ O O
119 to TO O O
119 be VB O O
119 checked VBN O O
119 q.o.d JJ O O
119 to TO O O
119 monitor VB O O
119 for IN B-VP O
119 any DT B-NP O
119 further JJ I-NP O
120 requirements NNS I-NP O
120 particularly RB O O
120 in IN B-VP O
120 the DT B-NP O
120 setting NN I-NP O
120 of IN B-VP O
120 his PRP$ O O
120 runs NNS B-NP O
120 of IN B-VP O
121 nonsustained JJ B-NP O
121 V-tach NNP I-NP O
121 as IN B-VP O
121 noted VBN O O
121 above IN B-VP O
122 10 CD O O
122 Ortho NNP B-NP O
122 - : O O
122 The DT B-NP O
122 patient NN I-NP O
122 is VBZ O O
122 followed VBN O O
122 daily JJ O O
122 by IN B-VP O
122 orthopedic JJ B-NP O
122 surgery NN I-NP O
123 and CC O O
123 was VBD B-VP O
123 discharged VBN O O
123 with IN B-VP O
123 staples NNS B-NP O
123 on IN B-VP O
123 his PRP$ O O
123 left JJ B-NP O
123 lower JJR I-NP O
123 extremities NNS I-NP O
123 to TO O O
123 be VB O O
124 discontinued VBN O O
124 per IN B-VP O
124 orthopedic NN B-NP O
124 surgery NN I-NP O
124 recommendations NNS I-NP O
124 in IN B-VP O
124 the DT B-NP O
124 future NN I-NP O
125 11 CD O O
125 Disposition NNP B-NP O
125 - : O O
125 The DT B-NP O
125 patient NN I-NP O
125 was VBD B-VP O
125 stable JJ O O
125 for IN B-VP O
125 discharge NN B-NP O
125 to TO O O
125 rehab VB O O
125 on IN B-VP O
126 8/18/02 CD O O
126 He PRP O O
126 was VBD B-VP O
126 to TO O O
126 follow VB O O
126 up RP O O
126 with IN B-VP O
126 his PRP$ O O
126 primary JJ B-NP O
126 care NN I-NP O
126 physician NN I-NP O
126 , , O O
127 orthopedic JJ B-NP O
127 surgery NN I-NP O
127 , , O O
127 cardiology NN B-NP O
127 , , O O
127 and CC O O
127 pulmonary JJ B-NP O
127 medicine NN I-NP O
127 within IN B-VP O
127 the DT O O
128 next JJ O O
128 two CD O O
128 weeks NNS B-NP O
128 His PRP$ O O
128 labs NNS B-NP O
128 are VBP O O
128 to TO O O
128 be VB O O
128 drawn VBN O O
128 for IN B-VP O
128 a DT B-NP O
128 metabolic JJ I-NP O
128 panel NN I-NP O
128 , , O O
129 magnesium NN B-NP O
129 and CC O O
129 calcium NN B-NP O
129 q.o.d NN I-NP O
129 for IN B-VP O
129 as RB O O
129 long RB O O
129 as IN B-VP O
129 the DT B-NP O
129 primary JJ I-NP O
129 care NN I-NP O
130 physician JJ B-NP O
130 feels NNS I-NP O
130 it PRP O O
130 is VBZ O O
130 necessary JJ O O
130 with IN B-VP O
130 repletion NN B-NP O
130 of IN B-VP O
130 his PRP$ O O
130 electrolytes NNS B-NP O
131 as IN B-VP O
131 needed VBN O O
131 He PRP O O
131 is VBZ O O
131 to TO O O
131 have VB O O
131 physical JJ B-NP O
131 therapy NN I-NP O
131 performed VBD B-VP O
131 as IN B-VP O
131 needed VBN O O
132 His PRP$ O O
132 weightbearing NN B-NP O
132 status NN I-NP O
132 is VBZ O O
132 non-weightbearing VBG O O
132 on IN B-VP O
132 the DT B-NP O
132 left NN I-NP O
132 lower JJR B-NP O
133 extremity NN I-NP O
133 and CC O O
133 weightbearing NN B-NP O
133 as RB O O
133 tolerated VBN O O
133 on IN B-VP O
133 his PRP$ O O
133 right NN B-NP O
133 lower JJR B-NP O
134 extremity NN I-NP O
134 per IN B-VP O
134 orthopedic JJ B-NP O
134 surgery NN I-NP O
134 at IN B-VP O
134 the DT B-NP O
134 time NN I-NP O
134 of IN B-VP O
134 discharge NN B-NP O
135 DISCHARGE NNP I-NP O
135 DIET: NNP I-NP O
135 ADA NNP I-NP O
135 diet JJ O O
135 , , O O
135 low JJ B-NP O
135 fat NN I-NP O
135 , , O O
135 low JJ B-NP O
135 cholesterol NN I-NP O
135 , , O O
135 low JJ B-NP O
135 salt NN I-NP O
136 DISCHARGE NNP I-NP O
136 MEDICATIONS: NNP I-NP O
136 Enteric-coated NNP I-NP B-m
136 aspirin VBZ O I-m
136 325 CD O B-do
136 mg NN B-NP I-do
136 p.o NN I-NP B-mo
136 q.d NN I-NP B-f
136 , , O O
137 Lopressor NNP B-NP B-m
137 12.5 CD O B-do
137 mg NN B-NP I-do
137 p.o NN I-NP B-mo
137 t.i.d NN I-NP B-f
137 , , O O
137 hold NN B-NP O
137 for IN B-VP O
138 systolic JJ B-NP O
138 blood NN I-NP O
138 pressure NN I-NP O
138 less JJR O O
138 than IN B-VP O
138 100 CD O O
138 or CC O O
138 heart NN B-NP O
138 rate NN I-NP O
138 less JJR O O
138 than IN B-VP O
138 55 CD O O
138 , , O O
139 lisinopril VBD B-VP B-m
139 5 CD O B-do
139 mg NN B-NP I-do
139 p.o NN I-NP B-mo
139 q.d NN I-NP B-f
139 , , O O
139 hold NN B-NP O
139 for IN B-VP O
139 systolic JJ B-NP O
139 blood NN I-NP O
139 pressure NN I-NP O
139 less JJR O O
140 than IN B-VP O
140 100 CD O O
140 , , O O
140 Lasix NNP B-NP B-m
140 100 CD O B-do
140 mg NN B-NP I-do
140 p.o NN I-NP B-mo
140 q.d NN I-NP B-f
140 , , O O
140 Lovenox NNP B-NP B-m
140 60 CD O B-do
140 mg NN B-NP I-do
140 subcu NN I-NP B-mo
140 b.i.d NN I-NP B-f
140 x6 NNP I-NP B-du
141 months NNS I-NP O
141 , , O O
141 glipizide RB O B-m
141 2.5 CD O B-do
141 mg NNS B-NP I-do
141 p.o JJ B-NP B-mo
141 q.d NN I-NP B-f
141 , , O O
141 sliding VBG O B-do
141 scale JJ B-NP I-do
141 insulin NN I-NP B-m
141 , , O O
141 Nexium NNP B-NP B-m
142 20 CD O B-do
142 mg NN B-NP I-do
142 p.o NN I-NP B-mo
142 q.d NN I-NP B-f
142 , , O O
142 Silvadene NNP B-NP B-m
142 wet-to-dry JJ B-NP O
142 dressing NN I-NP O
142 , , O O
142 please VB O O
142 appy JJ B-NP O
142 dry JJ I-NP O
143 sterile NN I-NP O
143 dressing VBG O O
143 to TO O O
143 right VB O O
143 and CC O O
143 left JJ B-NP O
143 foot NN I-NP B-r
143 wound NN I-NP I-r
143 to TO O O
143 change VB O O
143 q.d RB O B-f
143 Apply NNP B-NP O
144 DuoDerm NNP I-NP B-m
144 to TO O O
144 left VB O O
144 lower JJR B-NP O
144 leg NN I-NP B-r
144 wound NN I-NP I-r
144 and CC O O
144 change NN B-NP O
144 q.3 NN I-NP B-f
144 days NNS I-NP I-f
144 , , O O
144 continue VBP O O
145 pressure NN B-NP O
145 care NN I-NP O
145 precautions NNS I-NP O
146 Dictated VBD B-VP O
146 By: NNP B-NP O
146 EVAN NNP I-NP O
146 HOBLIT NNP I-NP O
146 , , O O
146 M.D NNP B-NP O
146 XJ782 NNP I-NP O
147 Attending: NNP I-NP O
147 ENOCH NNP I-NP O
147 HADDAWAY NNP I-NP O
147 , , O O
147 M.D NNP B-NP O
147 FV88 NNP I-NP O
148 SJ564/025538 NNP I-NP O
149 Batch: NNP I-NP O
149 3727 CD O O
149 Index NNP B-NP O
149 No NNP I-NP O
149 WICEEC84U0 NNP I-NP O
149 D: NNP I-NP O
149 6/12/02 CD O O
150 T: NNP B-NP O
150 6/12/02 CD O O
151 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #818884 VBZ O O
2 571742072 CD O O
2 MMC NNP B-NP O
2 97450845 CD O O
2 891607 CD O O
2 1/7/2001 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CHF NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 4/30/2001 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 7/10/2001 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 UMBAUGH NNP I-NP O
5 , , O O
5 ARRON NNP B-NP O
5 327-41-37-5 CD O O
6 none NN B-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 11/23/01 CD O O
8 AT NNP B-NP O
8 05:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 MCQUILLEN NNP I-NP O
11 , , O O
11 GIOVANNI NNP B-NP O
11 ARCHIE NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ASA NNP I-NP B-m
16 ( ( O I-m
16 ACETYLSALICYLIC NNP B-NP I-m
16 ACID NNP I-NP I-m
16 ) ) O I-m
16 325 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 Override NNP I-NP O
17 Notice: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 11/23/01 CD O O
17 by IN B-VP O
18 DELAGOL NNP B-NP O
18 , , O O
18 WILTON NNP B-NP O
18 HUGO NNP I-NP O
18 , , O O
18 M.D NNP B-NP O
19 on IN B-VP O
19 order NN B-NP O
19 for IN B-VP O
19 COUMADIN NNP B-NP B-m
19 PO NNP I-NP B-mo
19 ( ( O O
19 ref JJ O O
19 # # O O
19 29560859 CD O O
19 ) ) O O
20 POTENTIALLY NNP B-NP O
20 SERIOUS NNP I-NP O
20 INTERACTION: NNP I-NP O
20 ASPIRIN NNP I-NP B-m
20 &amp; NNP I-NP O
20 WARFARIN NNP I-NP B-m
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: NN B-NP O
21 will MD O O
21 follow VB O O
22 Previous NNP B-NP O
22 override IN B-VP O
22 information: JJ B-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 0/26/01 CD O O
23 by IN B-VP O
23 MIRAMON NNP B-NP O
23 , , O O
23 LOREN NNP B-NP O
23 , , O O
23 M.D NNP B-NP O
24 on IN B-VP O
24 order NN B-NP O
24 for IN B-VP O
24 COUMADIN NNP B-NP B-m
24 PO NNP I-NP B-mo
24 ( ( O O
24 ref JJ O O
24 # # O O
24 13666204 CD O O
24 ) ) O O
25 POTENTIALLY NNP B-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 ASPIRIN NNP I-NP B-m
25 &amp; NNP I-NP O
25 WARFARIN NNP I-NP B-m
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 will MD O O
26 follow VB O O
27 ATENOLOL NNP B-NP B-m
27 25 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
27 Starting VBG O O
27 Today NNP B-NP O
27 ( ( O O
27 1/24 CD O O
27 ) ) O O
27 HOLD NNP B-NP O
27 IF: NNP I-NP O
28 Food/Drug NNP I-NP O
28 Interaction NNP I-NP O
28 Instruction NNP I-NP O
29 Take NNP I-NP O
29 consistently RB O O
29 with IN B-VP O
29 meals NNS B-NP O
29 or CC O O
29 on IN B-VP O
29 empty JJ B-NP O
29 stomach NN I-NP O
30 COLACE NNP I-NP B-m
30 ( ( O I-m
30 DOCUSATE NNP B-NP I-m
30 SODIUM NNP I-NP I-m
30 ) ) O I-m
30 100 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 BID NNP I-NP B-f
31 LASIX NNP I-NP B-m
31 ( ( O I-m
31 FUROSEMIDE NNP B-NP I-m
31 ) ) O I-m
31 60 CD O O
31 MG NNP B-NP O
31 PO NNP I-NP B-mo
31 QD NNP I-NP O
31 Starting VBG O O
31 Today NNP B-NP O
31 ( ( O O
31 1/24 CD O O
31 ) ) O O
32 Instructions: NNP B-NP O
32 Take NNP I-NP O
32 60mg CD O B-do
32 per IN B-VP O
32 day NN B-NP O
32 for IN B-VP B-du
32 3 CD O I-du
32 days NNS B-NP I-du
32 and CC O O
32 then RB O O
32 change NN B-NP O
33 dose NN I-NP O
33 as IN B-VP O
33 per IN B-VP O
33 Dr NNP B-NP O
33 Paul NNP I-NP O
33 Ciesiolka NNP I-NP O
33 instructions NNS I-NP O
34 ZESTRIL NNP I-NP B-m
34 ( ( O I-m
34 LISINOPRIL NNP B-NP I-m
34 ) ) O I-m
34 7.5 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QD NNP I-NP B-f
35 Starting VBG O O
35 Today NNP B-NP O
35 ( ( O O
35 1/24 CD O O
35 ) ) O O
35 HOLD NNP B-NP O
35 IF: NNP I-NP O
36 Override NNP I-NP O
36 Notice: NNP I-NP O
36 Override NNP I-NP O
36 added VBD B-VP O
36 on IN B-VP O
36 0/26/01 CD O O
36 by IN B-VP O
37 ANGERER NNP B-NP O
37 , , O O
37 KENNITH NNP B-NP O
37 , , O O
37 M.D NNP B-NP O
38 on IN B-VP O
38 order NN B-NP O
38 for IN B-VP O
38 KCL NNP B-NP B-m
38 IMMEDIATE NNP I-NP I-m
38 REL NNP I-NP I-m
38 PO NNP I-NP B-mo
38 ( ( O O
38 ref JJ O O
38 # # O O
38 85723815 CD O O
38 ) ) O O
39 POTENTIALLY NNP B-NP O
39 SERIOUS NNP I-NP O
39 INTERACTION: NNP I-NP O
39 LISINOPRIL NNP I-NP B-m
39 &amp; NNP I-NP O
39 POTASSIUM NNP I-NP B-m
40 CHLORIDE NNP I-NP O
40 Reason NNP I-NP O
40 for IN B-VP O
40 override: NN B-NP O
40 will MD O O
40 follow VB O O
41 Previous NNP B-NP O
41 override IN B-VP O
41 information: JJ B-NP O
42 Override NNP I-NP O
42 added VBD B-VP O
42 on IN B-VP O
42 0/26/01 CD O O
42 by IN B-VP O
42 SHALA NNP B-NP O
42 , , O O
42 LEONARDO NNP B-NP O
42 , , O O
42 M.D NNP B-NP O
43 on IN B-VP O
43 order NN B-NP O
43 for IN B-VP O
43 KCL NNP B-NP B-m
43 SLOW NNP I-NP I-m
43 REL NNP I-NP I-m
43 PO NNP I-NP B-mo
43 ( ( O O
43 ref JJ O O
43 # # O O
43 68279429 CD O O
43 ) ) O O
44 POTENTIALLY NNP B-NP O
44 SERIOUS NNP I-NP O
44 INTERACTION: NNP I-NP O
44 LISINOPRIL NNP I-NP B-m
44 &amp; NNP I-NP O
44 POTASSIUM NNP I-NP B-m
45 CHLORIDE NNP I-NP O
45 Reason NNP I-NP O
45 for IN B-VP O
45 override: NN B-NP O
45 will MD O O
45 follow VB O O
46 COUMADIN NNP B-NP B-m
46 ( ( O I-m
46 WARFARIN NNP B-NP I-m
46 SODIUM NNP I-NP I-m
46 ) ) O I-m
46 6 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 QD NNP I-NP B-f
47 Food/Drug NNP I-NP O
47 Interaction NNP I-NP O
47 Instruction NNP I-NP O
48 No NNP I-NP O
48 high JJ B-NP O
48 Vitamin-K NNP I-NP O
48 containing VBG O O
48 foods NNS B-NP O
49 Override NNP I-NP O
49 Notice: NNP I-NP O
49 Override NNP I-NP O
49 added VBD B-VP O
49 on IN B-VP O
49 11/23/01 CD O O
49 by IN B-VP O
50 CAPAS NNP B-NP O
50 , , O O
50 FREDERIC NNP B-NP O
50 NEVILLE NNP I-NP O
50 , , O O
50 M.D NNP B-NP O
51 on IN B-VP O
51 order NN B-NP O
51 for IN B-VP O
51 ZOCOR NNP B-NP B-m
51 PO NNP I-NP B-mo
51 ( ( O O
51 ref JJ O O
51 # # O O
51 88249805 CD O O
51 ) ) O O
52 POTENTIALLY NNP B-NP O
52 SERIOUS NNP I-NP O
52 INTERACTION: NNP I-NP O
52 WARFARIN NNP I-NP B-m
52 &amp; NNP I-NP O
52 SIMVASTATIN NNP I-NP B-m
53 Reason NNP I-NP O
53 for IN B-VP O
53 override: NN B-NP O
53 will MD O O
53 follow VB O O
54 Previous NNP B-NP O
54 override IN B-VP O
54 information: JJ B-NP O
55 Override NNP I-NP O
55 added VBD B-VP O
55 on IN B-VP O
55 0/26/01 CD O O
55 by IN B-VP O
55 SERUM NNP B-NP O
55 , , O O
55 ALAN NNP B-NP O
55 , , O O
55 M.D NNP B-NP O
56 on IN B-VP O
56 order NN B-NP O
56 for IN B-VP O
56 ZOCOR NNP B-NP B-m
56 PO NNP I-NP B-mo
56 ( ( O O
56 ref JJ O O
56 # # O O
56 58803531 CD O O
56 ) ) O O
57 POTENTIALLY NNP B-NP O
57 SERIOUS NNP I-NP O
57 INTERACTION: NNP I-NP O
57 WARFARIN NNP I-NP B-m
57 &amp; NNP I-NP O
57 SIMVASTATIN NNP I-NP B-m
58 Reason NNP I-NP O
58 for IN B-VP O
58 override: NN B-NP O
58 will MD O O
58 follow VB O O
59 Previous NNP B-NP O
59 override IN B-VP O
59 information: JJ B-NP O
60 Override NNP I-NP O
60 added VBD B-VP O
60 on IN B-VP O
60 0/26/01 CD O O
60 by IN B-VP O
60 AGAN NNP B-NP O
60 , , O O
60 FRANCIS NNP B-NP O
60 , , O O
60 M.D NNP B-NP O
61 POTENTIALLY NNP I-NP O
61 SERIOUS NNP I-NP O
61 INTERACTION: NNP I-NP O
61 ASPIRIN NNP I-NP B-m
61 &amp; NNP I-NP O
61 WARFARIN NNP I-NP B-m
62 Reason NNP I-NP O
62 for IN B-VP O
62 override: NN B-NP O
62 will MD O O
62 follow VB O O
63 ZOCOR NNP B-NP B-m
63 ( ( O I-m
63 SIMVASTATIN NNP B-NP I-m
63 ) ) O I-m
63 20 CD O B-do
63 MG NNP B-NP I-do
63 PO NNP I-NP B-mo
63 QHS NNP I-NP B-f
64 Food/Drug NNP I-NP O
64 Interaction NNP I-NP O
64 Instruction NNP I-NP O
65 Avoid NNP I-NP O
65 grapefruit NN I-NP O
65 unless IN B-VP O
65 MD NNP B-NP O
65 instructs NNS I-NP O
65 otherwise RB O O
66 Override NNP B-NP O
66 Notice: NNP I-NP O
66 Override NNP I-NP O
66 added VBD B-VP O
66 on IN B-VP O
66 11/23/01 CD O O
66 by IN B-VP O
67 SLEIGH NNP B-NP O
67 , , O O
67 ROMEO NNP B-NP O
67 FABIAN NNP I-NP O
67 , , O O
67 M.D NNP B-NP O
68 on IN B-VP O
68 order NN B-NP O
68 for IN B-VP O
68 ERYTHROMYCIN NNP B-NP B-m
68 TP NNP I-NP B-mo
68 ( ( O O
68 ref JJ O O
68 # # O O
68 53201344 CD O O
68 ) ) O O
69 POTENTIALLY NNP B-NP O
69 SERIOUS NNP I-NP O
69 INTERACTION: NNP I-NP O
69 SIMVASTATIN NNP I-NP B-m
69 &amp; NNP I-NP O
70 ERYTHROMYCIN NNP I-NP B-m
70 ERYTHROMYCIN NNP I-NP B-m
70 , , O O
70 TOPICAL NNP B-NP B-mo
70 OR NNP I-NP O
70 OPHTHALMIC NNP I-NP B-mo
70 Reason NNP I-NP O
70 for IN B-VP O
70 override: NN B-NP O
71 will MD O O
71 follow VB O O
71 Previous NNP B-NP O
71 override IN B-VP O
71 information: JJ B-NP O
72 Override NNP I-NP O
72 added VBD B-VP O
72 on IN B-VP O
72 11/23/01 CD O O
72 by IN B-VP O
72 LOFGREN NNP B-NP O
72 , , O O
72 RONNIE NNP B-NP O
72 ALEC NNP I-NP O
72 , , O O
72 M.D NNP B-NP O
73 on IN B-VP O
73 order NN B-NP O
73 for IN B-VP O
73 COUMADIN NNP B-NP B-m
73 PO NNP I-NP B-mo
73 ( ( O O
73 ref JJ O O
73 # # O O
73 29560859 CD O O
73 ) ) O O
74 POTENTIALLY NNP B-NP O
74 SERIOUS NNP I-NP O
74 INTERACTION: NNP I-NP O
74 SIMVASTATIN NNP I-NP B-m
74 &amp; NNP I-NP O
74 WARFARIN NNP I-NP B-m
75 Reason NNP I-NP O
75 for IN B-VP O
75 override: NN B-NP O
75 will MD O O
75 follow VB O O
76 Previous NNP B-NP O
76 override IN B-VP O
76 information: JJ B-NP O
77 Override NNP I-NP O
77 added VBD B-VP O
77 on IN B-VP O
77 0/26/01 CD O O
77 by IN B-VP O
77 DAGNONE NNP B-NP O
77 , , O O
77 ROBIN NNP B-NP O
77 , , O O
77 M.D NNP B-NP O
78 POTENTIALLY NNP I-NP O
78 SERIOUS NNP I-NP O
78 INTERACTION: NNP I-NP O
78 WARFARIN NNP I-NP B-m
78 &amp; NNP I-NP O
78 SIMVASTATIN NNP I-NP B-m
79 Reason NNP I-NP O
79 for IN B-VP O
79 override: NN B-NP O
79 will MD O O
79 follow VB O O
80 METFORMIN NNP B-NP B-m
80 1 CD O B-do
80 , , O I-do
80 000 CD O I-do
80 MG NNP B-NP I-do
80 PO NNP I-NP B-mo
80 BID NNP I-NP B-f
80 Starting VBG O O
80 Today NNP B-NP O
80 ( ( O O
80 1/24 CD O O
80 ) ) O O
81 PRILOSEC NNP B-NP B-m
81 ( ( O I-m
81 OMEPRAZOLE NNP B-NP I-m
81 ) ) O I-m
81 20 CD O B-do
81 MG NNP B-NP I-do
81 PO NNP I-NP B-mo
81 QD NNP I-NP B-f
82 Alert NNP I-NP O
82 overridden: NNP I-NP O
82 Override NNP I-NP O
82 added VBD B-VP O
82 on IN B-VP O
82 6/3/01 CD O O
82 by IN B-VP O
82 : : O O
83 POTENTIALLY NNP B-NP O
83 SERIOUS NNP I-NP O
83 INTERACTION: NNP I-NP O
83 FUROSEMIDE NNP I-NP B-m
83 &amp; NNP I-NP O
83 OMEPRAZOLE NNP I-NP B-m
84 Reason NNP I-NP O
84 for IN B-VP O
84 override: NN B-NP O
84 indicated VBD B-VP O
85 VALACYCLOVIR NNP B-NP B-m
85 1 CD O B-do
85 , , O I-do
85 000 CD O I-do
85 MG NNP B-NP I-do
85 PO NNP I-NP B-mo
85 Q8H NNP I-NP B-f
85 X NNP I-NP B-du
85 7 CD O I-du
85 Days NNP B-NP I-du
86 DIET: NNP I-NP O
86 House NNP I-NP O
86 / NNP I-NP O
86 ADA NNP I-NP O
86 1800 CD O O
86 cals/dy NN B-NP O
87 FOLLOW NNP I-NP O
87 UP NNP I-NP O
87 APPOINTMENT( NNP I-NP O
87 S NNP I-NP O
87 ): NNP I-NP O
88 Dr NNP I-NP O
88 Drzewiecki NNP I-NP O
88 on IN B-VP O
88 wenesday NN B-NP O
88 at IN B-VP O
88 HAMH NNP B-NP O
88 10/24/01 CD O O
88 scheduled VBN O O
88 , , O O
89 ALLERGY: NNP B-NP O
89 Penicillins NNP I-NP O
90 ADMIT NNP I-NP O
90 DIAGNOSIS: NNP I-NP O
91 CHF NNP I-NP O
92 PRINCIPAL NNP I-NP O
92 DISCHARGE NNP I-NP O
92 DIAGNOSIS NNP I-NP O
92 ;Responsible JJ O O
92 After IN B-VP O
92 Study NNP B-NP O
92 for IN B-VP O
92 Causing NNP B-NP O
92 Admission NNP I-NP O
92 ) ) O O
93 CHF NNP B-NP O
94 OTHER NNP I-NP O
94 DIAGNOSIS;Conditions NNP I-NP O
94 , , O O
94 Infections NNP B-NP O
94 , , O O
94 Complications NNP B-NP O
94 , , O O
94 affecting VBG O O
94 Treatment/Stay NNP B-NP O
95 chronic JJ B-NP O
95 Afib NNP I-NP O
95 G-E NNP I-NP O
95 Reflux NNP I-NP O
95 HTN NNP I-NP O
96 NIDDM NNP I-NP O
96 , , O O
96 DIET NNP B-NP O
96 CTRL NNP I-NP O
96 CHF NNP I-NP O
96 ( ( O O
96 EF NNP B-NP O
96 65% CD O O
96 ) ) O O
96 ( ( O O
96 congestive JJ B-NP O
96 heart NN I-NP O
96 failure NN I-NP O
96 ) ) O O
96 s/p NN B-NP O
97 colectomy NN I-NP O
97 for IN B-VP O
97 diverticulitis NN B-NP O
97 ( ( O O
97 S/P NNP B-NP O
97 colectomy NN I-NP O
97 ) ) O O
97 s/p VBZ O O
97 ventral JJ B-NP O
97 hernia NN I-NP O
98 repair NN I-NP O
98 ( ( O O
98 S/P NNP B-NP O
98 hernia NNP I-NP O
98 repair NN I-NP O
98 ) ) O O
98 s/p NN B-NP O
98 carpal JJ B-NP O
98 tunnel NN I-NP O
98 release NN I-NP O
98 ( ( O O
98 S/P NNP B-NP O
98 carpal VBZ O O
99 tunnel RB O O
99 repair NN B-NP O
99 ) ) O O
100 OPERATIONS NNP B-NP O
100 AND NNP I-NP O
100 PROCEDURES: NNP I-NP O
101 none NN I-NP O
102 OTHER NNP I-NP O
102 TREATMENTS/PROCEDURES NNP I-NP O
102 ( ( O O
102 NOT NNP B-NP O
102 IN NNP I-NP O
102 O.R NNP I-NP O
102 ) ) O O
103 none NN B-NP O
104 BRIEF NNP I-NP O
104 RESUME NNP I-NP O
104 OF NNP I-NP O
104 HOSPITAL NNP I-NP O
104 COURSE: NNP I-NP O
105 75 CD O O
105 y.o NN B-NP O
105 admitted VBN O O
105 for IN B-VP O
105 cHF JJ B-NP O
105 exacerbation NN I-NP O
105 , , O O
105 incr JJ B-NP O
105 SOB NNP I-NP O
106 over IN B-VP O
106 past JJ B-NP O
106 few JJ I-NP O
106 days NNS I-NP O
106 , , O O
106 orthopnea NN B-NP O
106 and CC O O
106 PND NNP B-NP O
106 JVP NNP I-NP O
106 7 CD O O
106 cm NN B-NP O
106 , , O O
106 minimal JJ B-NP O
106 pedal NN I-NP O
106 edema NN I-NP O
106 , , O O
107 L NNP B-NP O
107 sided VBD B-VP O
107 failure NN B-NP O
107 with IN B-VP O
107 diastolic JJ B-NP O
107 dysfunction NN I-NP O
107 IV NNP I-NP B-mo
107 lasix VBZ O B-m
107 40 CD O B-do
107 in IN B-VP O
107 ED NNP B-NP O
107 , , O O
108 pt NN B-NP O
108 diruesed VBN O O
108 well RB O O
108 and CC O O
108 decreased VBD B-VP O
108 SOB NNP B-NP B-r
108 Pt NNP I-NP O
108 also RB O O
108 with IN B-VP O
109 L NNP B-NP O
109 subcostal NN I-NP O
109 pain NN I-NP O
109 likely JJ B-NP O
109 musculoskeltal NN I-NP O
109 in IN B-VP O
110 orgin NN B-NP O
110 , , O O
110 chronic JJ B-NP O
110 No NNP I-NP O
110 ekg NN I-NP O
110 changes NNS I-NP O
110 , , O O
110 enzymes RB O O
110 flat JJ B-NP O
111 CXR NNP I-NP O
111 enlarged VBD B-VP O
111 heart NN B-NP O
111 with IN B-VP O
111 minimal JJ B-NP O
111 pulm NN I-NP O
111 engorgement NN I-NP O
111 , , O O
112 no DT B-NP O
112 pulm NN I-NP O
112 edema VBZ O O
112 Comparison NNP B-NP O
112 with IN B-VP O
112 old JJ B-NP O
112 CXR NNP I-NP O
113 shows VBZ O O
113 increase NN B-NP O
113 in IN B-VP O
113 size NN B-NP O
113 of IN B-VP O
113 heart--echo JJ O O
113 done VBN O O
113 and CC O O
113 shows VBZ O O
113 EF NNP B-NP O
113 55% CD O O
113 mod NN B-NP O
113 MR NNP I-NP O
113 and CC O O
114 severe JJ B-NP O
114 TR NNP I-NP O
114 , , O O
114 slight VBD B-VP O
114 worsening NN B-NP O
114 of IN B-VP O
114 MR/TR NNP B-NP O
114 from IN B-VP O
114 old JJ B-NP O
114 echo NN I-NP O
114 , , O O
114 still RB O O
114 increased VBD B-VP O
115 right RB O O
115 sided JJ B-NP O
115 pressures NNS I-NP O
115 as IN B-VP O
115 well RB O O
115 Plan NNP B-NP O
115 is VBZ O O
115 for IN B-VP O
115 pt NN B-NP O
115 to TO O O
115 go VB O O
115 home NN B-NP O
115 on IN B-VP O
115 60 CD O B-do
115 mg NNS B-NP I-do
116 lasix JJ B-NP B-m
116 qd NN I-NP B-f
116 and CC O O
116 see VB O O
116 Dr NNP B-NP O
116 boeshore VB O O
116 on IN B-VP O
116 wed NN B-NP O
116 as RB O O
116 well RB O O
116 as IN B-VP O
116 daily JJ B-NP O
116 weights NNS I-NP O
116 Back RP O O
117 lesions NNS B-NP O
117 vesicular NN I-NP O
117 and CC O O
117 c/w NN B-NP O
117 herpes NNS I-NP O
117 zoster RBR O O
118 ADDITIONAL NNP B-NP O
118 COMMENTS: NNP I-NP O
118 please NN I-NP O
118 weigh VBD B-VP O
118 yourself PRP O O
118 every DT B-NP O
118 day NN I-NP O
118 If IN B-VP O
118 you PRP O O
118 gain VBP O O
118 more JJR O O
118 than IN B-VP O
118 2 CD O O
118 lbs NN B-NP O
118 , , O O
118 please VB O O
119 call VB O O
119 Dr NNP B-NP O
119 Mitchel NNP I-NP O
119 Your NNP I-NP O
119 baseline NN I-NP O
119 "dry" NN I-NP O
119 weight NN I-NP O
119 is VBZ O O
119 185 CD O O
119 Please NNP B-NP O
119 weigh JJ O O
120 yourself PRP O O
120 on IN B-VP O
120 scale NN B-NP O
120 as RB O O
120 soon RB O O
120 as IN B-VP O
120 you PRP O O
120 get VBP O O
120 home VBN O O
120 to TO O O
120 have VB O O
120 accurate JJ B-NP O
120 baseline NN I-NP O
120 wei NN I-NP O
121 gt NN I-NP O
121 and CC O O
121 compare VB O O
121 all DT B-NP O
121 values NNS I-NP O
121 to TO O O
121 first VB O O
121 weight NN B-NP O
121 at IN B-VP O
121 home NN B-NP O
121 You PRP O O
121 have VBP O O
121 herpes NNS B-NP O
122 zoster RBR O O
122 on IN B-VP O
122 your PRP$ O O
122 back NN B-NP O
122 Call NN I-NP O
122 Dr NNP I-NP O
122 Pradel NNP I-NP O
122 if IN B-VP O
122 you PRP O O
122 can't VBP O O
122 control VB O O
122 your PRP$ O O
122 pain NN B-NP B-r
123 with IN B-VP O
123 Tylenol NNP B-NP B-m
123 Please NNP I-NP O
123 page VB O O
123 Dr NNP B-NP O
123 Blouir NNP I-NP O
123 about IN B-VP O
123 your PRP$ O O
123 eye NN B-NP O
123 pain NN I-NP O
123 and CC O O
123 come NN B-NP O
123 to TO O O
123 the DT B-NP O
123 ED NNP I-NP O
124 if IN B-VP O
124 pain JJ B-NP O
124 worse JJR I-NP O
124 VNA:page NNP I-NP O
124 Dr NNP I-NP O
124 Cudd NNP I-NP O
124 when WRB O O
124 he/she NN B-NP O
124 sees VBZ O O
124 ms JJ B-NP O
124 Krzak NNP I-NP O
124 ( ( O O
124 193 CD O O
124 ) ) O O
124 484-0206 CD O O
124 DB NNP B-NP O
124 26096 CD O O
124 and CC O O
124 leave VB O O
124 call NN B-NP O
124 back RB O O
124 number NN B-NP O
125 DISCHARGE NNP I-NP O
125 CONDITION: NNP I-NP O
125 Stable NNP I-NP O
126 TO NNP I-NP O
126 DO/PLAN: NNP I-NP O
127 No NNP I-NP O
127 dictated VBD B-VP O
127 summary JJ B-NP O
128 ENTERED NNP I-NP O
128 BY: NNP I-NP O
128 ZEUNER NNP I-NP O
128 , , O O
128 PASQUALE NNP B-NP O
128 DEVIN NNP I-NP O
128 , , O O
128 M.D NNP B-NP O
128 ( ( O O
128 QK37 NNP B-NP O
128 ) ) O O
128 6/3/01 CD O O
128 @ $ O O
128 01 CD O O
129 ****** JJ B-NP O
129 END NN I-NP O
129 OF NNP I-NP O
129 DISCHARGE NNP I-NP O
129 ORDERS NNP I-NP O
129 ****** NNP I-NP O
130 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #824987 VBZ O O
2 184716522 CD O O
2 GH NNP B-NP O
2 05684560 CD O O
2 8163103 CD O O
2 5/2/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ABDOMINAL NNP I-NP O
2 PAIN NNP I-NP O
2 Unsigned VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 7/0/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/16/2006 CD O O
4 ATTENDING: NNP B-NP O
4 DRISCOLL NNP I-NP O
4 , , O O
4 ELDEN NNP B-NP O
4 MD NNP I-NP O
5 SERVICE: NNP I-NP O
6 GMS NNP I-NP O
6 Katena NNP I-NP O
6 Highway NNP I-NP O
7 PRIMARY NNP I-NP O
7 CARE NNP I-NP O
7 PHYSICIAN: NNP I-NP O
8 Chet NNP I-NP O
8 Nerpio NNP I-NP O
8 , , O O
8 M.D NNP B-NP O
9 PRINCIPAL NNP I-NP O
9 DIAGNOSES: NNP I-NP O
10 End-stage NNP I-NP O
10 renal JJ B-NP O
10 disease NN I-NP O
10 and CC O O
10 osteomyelitis JJ B-NP O
11 LIST NNP I-NP O
11 OF IN B-VP O
11 OTHER NNP B-NP O
11 PROBLEMS NNP I-NP O
11 AND NNP I-NP O
11 DIAGNOSES: NNP I-NP O
12 Insulin-dependent NNP I-NP O
12 diabetes VBZ O O
12 mellitus NN B-NP O
12 , , O O
12 peripheral JJ B-NP O
12 neuropathy NN I-NP O
12 , , O O
12 left VBD B-VP O
13 Charcot NNP B-NP O
13 foot NN I-NP O
13 complicated VBN O O
13 by IN B-VP O
13 ulceration NN B-NP O
13 requiring VBG O O
13 partial JJ B-NP O
14 thickness NN I-NP O
14 debridement NN I-NP O
14 on IN B-VP O
14 7/28/06 CD O O
14 in IN B-VP O
14 the DT B-NP O
14 setting NN I-NP O
14 of IN B-VP O
14 new JJ B-NP O
14 Aircast NNP I-NP O
15 started VBD B-VP O
15 on IN B-VP O
15 6/23/06 CD O O
15 now RB O O
15 with IN B-VP O
15 a DT B-NP O
15 cast NN I-NP O
15 applied VBN O O
15 to TO O O
15 the DT B-NP O
15 left JJ I-NP O
15 foot NN I-NP O
15 , , O O
16 hypertension NN B-NP O
16 , , O O
16 chronic JJ B-NP O
16 renal JJ I-NP O
16 insufficiency NN I-NP O
16 , , O O
16 hyperlipidemia NN B-NP O
16 , , O O
16 spinal JJ B-NP O
17 stenosis NN I-NP O
17 , , O O
17 anemia NN B-NP O
17 of IN B-VP O
17 chronic JJ B-NP O
17 disease NN I-NP O
17 , , O O
17 thrombocytopenia NN B-NP O
17 , , O O
17 and CC O O
17 ascus VB O O
18 1/5 CD O O
18 and CC O O
18 4/27 CD O O
19 BRIEF NNP B-NP O
19 HISTORY NNP I-NP O
19 OF NNP I-NP O
19 PRESENT NNP I-NP O
19 ILLNESS: NNP I-NP O
20 The DT B-NP O
20 patient NN I-NP O
20 is VBZ O O
20 a DT B-NP O
20 58-year-old JJ I-NP O
20 female NN I-NP O
20 with IN B-VP O
20 chronic JJ B-NP O
20 renal JJ I-NP O
21 insufficiency NN I-NP O
21 , , O O
21 baseline JJ B-NP O
21 creatinine NN I-NP O
21 3.8 CD O O
21 , , O O
21 diabetes VBZ O O
21 mellitus NN B-NP O
21 , , O O
22 hypertension NN B-NP O
22 , , O O
22 and CC O O
22 anemia NN B-NP O
22 , , O O
22 who WP O O
22 present VBP O O
22 with IN B-VP O
22 two CD O O
22 weeks NNS B-NP O
22 of IN B-VP O
22 diffuse NN B-NP O
23 abdominal JJ B-NP O
23 pain NN I-NP O
23 that WDT O O
23 acutely RB O O
23 worsened VBD B-VP O
23 one CD O O
23 day NN B-NP O
23 prior RB O O
23 to TO O O
23 admission NN B-NP O
24 with IN B-VP O
24 associated JJ B-NP O
24 nausea NN I-NP O
24 , , O O
24 nonbloody NN B-NP O
24 emesis NN I-NP O
24 , , O O
24 and CC O O
24 chills VBZ O O
24 The DT B-NP O
25 patient NN I-NP O
25 was VBD B-VP O
25 found VBN O O
25 to TO O O
25 be VB O O
25 febrile JJ O O
25 with IN B-VP O
25 leukocytosis NN B-NP O
25 in IN B-VP O
25 the DT B-NP O
25 ED NNP I-NP O
25 The DT B-NP O
26 patient NN I-NP O
26 had VBD B-VP O
26 been VBN O O
26 seen VBN O O
26 previously RB O O
26 in IN B-VP O
26 the DT B-NP O
26 ED NNP I-NP O
26 on IN B-VP O
26 3/30/06 CD O O
26 at IN B-VP O
26 which WDT O O
27 time NN B-NP O
27 she PRP O O
27 was VBD B-VP O
27 treated VBN O O
27 with IN B-VP O
27 a DT B-NP O
27 UTI NNP I-NP O
27 She PRP O O
27 was VBD B-VP O
27 sent VBN O O
27 home NN B-NP O
27 with IN B-VP O
27 a DT B-NP O
28 seven-day JJ I-NP B-du
28 course NN I-NP I-du
28 of IN B-VP O
28 ciprofloxacin NN B-NP B-m
28 and CC O O
28 oxycodone NN B-NP B-m
28 for IN B-VP O
28 pain NN B-NP B-r
28 pain VBP O B-r
28 The DT B-NP O
29 ciprofloxacin NN I-NP B-m
29 was VBD B-VP O
29 renally RB O O
29 dosed VBN O O
29 The DT B-NP O
29 patient NN I-NP O
29 reports NNS I-NP O
29 that IN B-VP O
29 she PRP O O
30 stopped VBD B-VP O
30 taking VBG O O
30 oxycodone NN B-NP B-m
30 and CC O O
30 ciprofloxacin NN B-NP B-m
30 After IN B-VP O
30 developing VBG O O
31 constipation NN B-NP O
31 , , O O
31 it PRP O O
31 is VBZ O O
31 unclear JJ O O
31 if IN B-VP O
31 she PRP O O
31 completed VBD B-VP O
31 her PRP O O
31 full JJ B-NP O
31 course NN I-NP O
31 of IN B-VP O
32 antibiotics NNS B-NP B-m
32 She PRP O O
32 currently RB O O
32 present VBP O O
32 with IN B-VP O
32 complaints NNS B-NP O
32 of IN B-VP O
32 diarrhea NN B-NP O
33 in IN B-VP O
33 the DT B-NP O
33 setting NN I-NP O
33 of IN B-VP O
33 having VBG O O
33 taken VBN O O
33 laxative JJ O O
33 at IN B-VP O
33 home NN B-NP O
33 No NNP I-NP O
33 melena NN I-NP O
33 or CC O O
34 hematochezia VB O O
34 The DT B-NP O
34 pain NN I-NP O
34 is VBZ O O
34 not RB O O
34 related VBN O O
34 to TO O O
34 food NN B-NP O
34 , , O O
34 urination NN B-NP O
34 , , O O
34 or CC O O
35 defecation NN B-NP O
35 She PRP O O
35 has VBZ O O
35 poor JJ B-NP O
35 p.o NNS I-NP O
35 intake VBP O O
35 , , O O
35 denies VBZ O O
35 any DT B-NP O
35 sick JJ I-NP O
35 contacts NNS I-NP O
36 at IN B-VP O
36 home NN B-NP O
36 No NNP I-NP O
36 recent JJ B-NP O
36 travel NN I-NP O
37 REVIEW NNP I-NP O
37 OF NNP I-NP O
37 SYSTEMS: NNP I-NP O
38 Positive NNP I-NP O
38 for IN B-VP O
38 blood NN B-NP O
38 sugars NNS I-NP O
38 ranging VBG O O
38 from IN B-VP O
38 180-190 CD O O
38 , , O O
38 although IN B-VP O
38 she PRP O O
38 had VBD B-VP O
39 a DT B-NP O
39 blood NN I-NP O
39 sugar NN I-NP O
39 of IN B-VP O
39 499 CD O O
39 on IN B-VP O
39 the DT B-NP O
39 morning NN I-NP O
39 of IN B-VP O
39 admission NN B-NP O
39 She PRP O O
39 has VBZ O O
40 fatigue VBN O O
40 but CC O O
40 no DT B-NP O
40 myalgias NN I-NP O
40 , , O O
40 no DT B-NP O
40 cough NN I-NP O
40 , , O O
40 chest NN B-NP O
40 pain NN I-NP O
40 , , O O
40 shortness NN B-NP O
40 of IN B-VP O
41 breath NN B-NP O
41 , , O O
41 no DT B-NP O
41 dysuria NN I-NP O
41 In IN B-VP O
41 the DT B-NP O
41 ED NNP I-NP O
41 , , O O
41 she PRP O O
41 was VBD B-VP O
41 given VBN O O
41 ampicillin RB O B-m
41 2 CD O B-do
41 g NN B-NP I-do
41 IV NNP I-NP B-mo
41 , , O O
42 gentamicin VBD B-VP B-m
42 80 CD O B-do
42 mg NN B-NP I-do
42 IV NNP I-NP B-mo
42 , , O O
42 Flagyl NNP B-NP B-m
42 500 CD O B-do
42 mg NN B-NP I-do
42 IV NNP I-NP B-mo
42 and CC O O
42 8 CD O B-do
42 units NNS B-NP I-do
42 of IN B-VP O
42 insulin NN B-NP B-m
43 ALLERGIES: NNP I-NP O
44 Medication NNP I-NP O
44 reaction NN I-NP O
44 , , O O
44 she PRP O O
44 has VBZ O O
44 an DT B-NP O
44 allergy NN I-NP O
44 to TO O O
44 lisinopril VB O O
44 with IN B-VP O
45 reaction NN B-NP O
45 of IN B-VP O
45 elevated JJ B-NP O
45 creatinine NN I-NP O
45 at IN B-VP O
45 a DT B-NP O
45 low JJ I-NP O
45 dose NN I-NP O
45 To TO O O
45 levofloxacin VB O O
45 , , O O
46 she PRP O O
46 has VBZ O O
46 reflux NN B-NP O
46 and CC O O
46 celecoxib NN B-NP O
46 gives VBZ O O
46 her PRP$ O O
46 dizziness NN B-NP O
46 and CC O O
46 elevated JJ B-NP O
47 creatinine NN I-NP O
48 BRIEF NNP I-NP O
48 ADMISSION NNP I-NP O
48 PHYSICAL NNP I-NP O
48 EXAMINATION: NNP I-NP O
49 She PRP O O
49 had VBD B-VP O
49 a DT B-NP O
49 temperature NN I-NP O
49 of IN B-VP O
49 101 CD O O
49 , , O O
49 pulse NN B-NP O
49 of IN B-VP O
49 106 CD O O
49 , , O O
49 blood NN B-NP O
49 pressure NN I-NP O
50 172/71 CD O O
50 , , O O
50 oxygen JJR B-NP O
50 saturation NN I-NP O
50 of IN B-VP O
50 100% CD O O
50 on IN B-VP O
50 room NN B-NP O
50 air NN I-NP O
50 She PRP O O
50 was VBD B-VP O
50 alert JJ O O
50 and CC O O
51 oriented JJ B-NP O
51 x3 NN I-NP O
51 , , O O
51 in IN B-VP O
51 mild JJ B-NP O
51 distress NN I-NP O
51 Her PRP$ O O
51 lungs NNS B-NP O
51 were VBD B-VP O
51 clear JJ O O
51 to TO O O
52 auscultation VB O O
52 bilaterally RB O O
52 Her NNP B-NP O
52 heart NN I-NP O
52 had VBD B-VP O
52 a DT B-NP O
52 regular JJ I-NP O
52 rate NN I-NP O
52 and CC O O
53 rhythm NN B-NP O
53 with IN B-VP O
53 a DT O O
53 2/6 CD O O
53 early JJ B-NP O
53 systolic JJ I-NP O
53 murmur NN I-NP O
53 at IN B-VP O
53 the DT B-NP O
53 left NN I-NP O
53 lower RBR O O
53 sternal JJ B-NP O
54 border NN I-NP O
54 She PRP O O
54 was VBD B-VP O
54 obese JJ O O
54 , , O O
54 but CC O O
54 had VBD B-VP O
54 a DT B-NP O
54 nontender NN I-NP O
54 , , O O
54 nondistended VBD B-VP O
54 abdomen NNS B-NP O
55 with IN B-VP O
55 normal JJ B-NP O
55 abdominal JJ I-NP O
55 bowel NN I-NP O
55 sounds VBZ O O
55 She PRP O O
55 was VBD B-VP O
55 guaiac JJ O O
55 negative JJ O O
55 , , O O
55 and CC O O
56 her PRP$ O O
56 left JJ B-NP O
56 foot NN I-NP O
56 was VBD B-VP O
56 in IN B-VP O
56 a DT B-NP O
56 cast NN I-NP O
57 PERTINENT NNP I-NP O
57 LABORATORY NNP I-NP O
57 TESTS NNP I-NP O
57 AND NNP I-NP O
57 RESULTS: NNP I-NP O
58 She PRP O O
58 had VBD B-VP O
58 a DT B-NP O
58 sodium NN I-NP O
58 of IN B-VP O
58 127 CD O O
58 , , O O
58 corrected VBN O O
58 to TO O O
58 131 CD O O
58 with IN B-VP O
58 her PRP$ O O
58 glucose NN B-NP O
58 , , O O
59 potassium NN B-NP O
59 of IN B-VP O
59 4.9 CD O O
59 , , O O
59 bicarbonate NN B-NP O
59 of IN B-VP O
59 27 CD O O
59 , , O O
59 BUN NNP B-NP O
59 95 CD O O
59 , , O O
59 creatinine NN B-NP O
59 4.5 CD O O
59 , , O O
60 glucose VBD B-VP O
60 329 CD O O
60 LFTs NNP B-NP O
60 were VBD B-VP O
60 normal JJ O O
60 , , O O
60 amylase JJ O O
60 19 CD O O
60 , , O O
60 lipase NN B-NP O
60 8 CD O O
60 , , O O
60 negative JJ B-NP O
61 keto NN I-NP O
61 acids NNS I-NP O
61 in IN B-VP O
61 the DT B-NP O
61 serum NN I-NP O
61 and CC O O
61 urine JJ B-NP O
61 Her NNP I-NP O
61 white JJ B-NP O
61 blood NN I-NP O
61 count NN I-NP O
61 was VBD B-VP O
62 26.8 CD O O
62 , , O O
62 INR NNP B-NP O
62 was VBD B-VP O
62 1.4 CD O O
62 , , O O
62 PTT NNP B-NP O
62 was VBD B-VP O
62 36.6 CD O O
62 She PRP O O
62 had VBD B-VP O
62 a DT B-NP O
62 dirty JJ I-NP O
62 urinalysis NN I-NP O
63 She PRP O O
63 had VBD B-VP O
63 an DT B-NP O
63 abdominal JJ I-NP O
63 CT NN I-NP O
63 that WDT O O
63 showed VBD B-VP O
63 a DT B-NP O
63 non-incarcerated JJ I-NP O
63 hernia NN I-NP O
63 , , O O
63 no DT B-NP O
64 evidence NN I-NP O
64 of IN B-VP O
64 colitis NN B-NP O
65 OPERATIONS NNP I-NP O
65 AND NNP I-NP O
65 PROCEDURES: NNP I-NP O
66 The DT B-NP O
66 patient NN I-NP O
66 had VBD B-VP O
66 a DT B-NP O
66 debridement NN I-NP O
66 of IN B-VP O
66 her PRP$ O O
66 left JJ B-NP O
66 foot NN I-NP O
66 on IN B-VP O
66 3/11/06 CD O O
66 She PRP O O
67 also RB O O
67 had VBD B-VP O
67 hemodialysis NN B-NP O
67 initiated VBN O O
67 on IN B-VP O
67 1/10/06 CD O O
68 HOSPITAL NNP B-NP O
68 COURSE NNP I-NP O
68 BY NNP I-NP O
68 SYSTEMS: NNP I-NP O
69 1 CD O O
69 Infectious NNP B-NP O
69 disease: VBD B-VP O
69 The DT B-NP O
69 patient's NN I-NP O
69 left VBD B-VP O
69 foot NN B-NP O
69 was VBD B-VP O
69 encasted VBN O O
69 by IN B-VP O
70 orthopedics NNS B-NP O
70 surgery NN I-NP O
70 on IN B-VP O
70 6/1/06 CD O O
70 with IN B-VP O
70 evidence NN B-NP O
70 of IN B-VP O
70 underlying JJ B-NP O
71 infection NN I-NP O
71 Her NNP I-NP O
71 wound NN I-NP O
71 cultures VBZ O O
71 grew VBD B-VP O
71 MRSA NNP B-NP O
71 with IN B-VP O
71 probes NNS B-NP O
71 to TO O O
71 the DT B-NP O
71 bone NN I-NP O
72 X-rays NNS I-NP O
72 were VBD B-VP O
72 unrevealing JJ O O
72 and CC O O
72 MRI NNP B-NP O
72 showed VBD B-VP O
72 severe JJ B-NP O
72 osteomyelitis NN I-NP O
72 In IN B-VP O
73 addition NN B-NP O
73 , , O O
73 the DT B-NP O
73 patient NN I-NP O
73 had VBD B-VP O
73 an DT B-NP O
73 ESR NNP I-NP O
73 of IN B-VP O
73 109 CD O O
73 The DT B-NP O
73 patient NN I-NP O
73 was VBD B-VP O
73 thus RB O O
74 put VBN O O
74 on IN B-VP O
74 levofloxacin NN B-NP B-m
74 , , O O
74 vancomycin NN B-NP B-m
74 , , O O
74 and CC O O
74 Flagyl NNP B-NP B-m
74 Blood NNP I-NP O
74 cultures NNS I-NP O
74 from IN B-VP O
75 7/14/06 CD O O
75 additionally RB O O
75 grew VBD B-VP O
75 gram-positive JJ B-NP O
75 cocci NN I-NP O
75 in IN B-VP O
75 clusters NNS B-NP O
75 which WDT O O
76 eventually RB O O
76 yielded VBD B-VP O
76 MRSA NNP B-NP O
76 However RB O O
76 , , O O
76 surveillance NN B-NP O
76 cultures NNS I-NP O
76 with IN B-VP O
77 treatment NN B-NP O
77 on IN B-VP O
77 levofloxacin NN B-NP B-m
77 , , O O
77 vancomycin NN B-NP B-m
77 , , O O
77 and CC O O
77 Flagyl NNP B-NP B-m
77 were VBD B-VP O
77 negative JJ O O
78 The DT B-NP O
78 patient NN I-NP O
78 received VBD B-VP O
78 debridement NN B-NP O
78 of IN B-VP O
78 her PRP$ O O
78 left JJ B-NP O
78 foot NN I-NP O
78 on IN B-VP O
78 3/11/06 CD O O
79 In IN B-VP O
79 the DT B-NP O
79 OR NNP I-NP O
79 , , O O
79 the DT B-NP O
79 bone NN I-NP O
79 looked VBD B-VP O
79 necrotic JJ O O
79 and CC O O
79 infected VBD B-VP O
79 The DT B-NP O
79 bone NN I-NP O
79 was VBD B-VP O
80 sent VBN O O
80 to TO O O
80 pathology NN B-NP O
80 and CC O O
80 microbiology NN B-NP O
80 , , O O
80 the DT B-NP O
80 results NNS I-NP O
80 of IN B-VP O
80 which WDT O O
80 are VBP O O
81 pending VBG O O
81 Given NNP B-NP O
81 the DT B-NP O
81 appearance NN I-NP O
81 of IN B-VP O
81 her PRP$ O O
81 bone NN B-NP O
81 during IN B-VP O
81 debridement NN B-NP O
81 , , O O
81 it PRP O O
82 is VBZ O O
82 presumed VBN O O
82 that IN B-VP O
82 the DT B-NP O
82 patient NN I-NP O
82 will MD O O
82 need VB O O
82 eight CD O B-du
82 weeks NNS B-NP I-du
82 of IN B-VP O
82 vancomycin NN B-NP B-m
83 Because IN B-VP O
83 she PRP O O
83 did VBD B-VP O
83 have VB O O
83 a DT B-NP O
83 clear JJ I-NP O
83 source NN I-NP O
83 of IN B-VP O
83 fevers NNS B-NP O
83 after IN B-VP O
83 it PRP O O
83 was VBD B-VP O
83 found VBN O O
84 that IN B-VP O
84 she PRP O O
84 had VBD B-VP O
84 osteomyelitis NN B-NP O
84 , , O O
84 the DT B-NP O
84 patient NN I-NP O
84 was VBD B-VP O
84 discontinued VBN O O
84 off RP O O
85 Flagyl NNP B-NP B-m
85 and CC O O
85 levofloxacin VB O B-m
85 on IN B-VP O
85 5/22/06 CD O O
86 2 CD O O
86 GI: NNP B-NP O
86 The DT B-NP O
86 patient NN I-NP O
86 has VBZ O O
86 abdominal JJ B-NP O
86 pain NN I-NP O
86 with IN B-VP O
86 gastric JJ O O
86 emptying VBG O O
87 study NN B-NP O
87 on IN B-VP O
87 7/14/06 CD O O
87 showing VBG O O
87 0% CD O O
87 clearance NN B-NP O
87 at IN B-VP O
87 90 CD O O
87 minutes NNS B-NP O
87 consistent JJ O O
88 with IN B-VP O
88 severe JJ B-NP O
88 gastroparesis NN I-NP O
88 versus NN I-NP O
88 obstruction NN I-NP O
88 Radiology NNP I-NP O
88 did VBD B-VP O
88 not RB O O
89 feel VB O O
89 that IN B-VP O
89 an DT B-NP O
89 upper JJ I-NP O
89 GI NNP I-NP O
89 series NN I-NP O
89 would MD O O
89 give VB O O
89 further JJ B-NP O
89 information NN I-NP O
90 regarding VBG O O
90 obstruction NN B-NP O
90 and CC O O
90 it PRP O O
90 was VBD B-VP O
90 judged VBN O O
90 to TO O O
90 be VB O O
90 unlikely JJ O O
90 given VBN O O
90 that IN B-VP O
91 the DT B-NP O
91 patient NN I-NP O
91 has VBZ O O
91 bowel VBN O O
91 movements NNS B-NP O
91 and CC O O
91 rare JJ B-NP O
91 emesis NN I-NP O
91 Later NNP I-NP O
91 on IN B-VP O
91 in IN B-VP O
91 the DT B-NP O
92 hospital NN I-NP O
92 course NN I-NP O
92 , , O O
92 the DT B-NP O
92 patient NN I-NP O
92 was VBD B-VP O
92 put VBN O O
92 on IN B-VP O
92 erythromycin NN B-NP B-m
92 with IN B-VP O
92 a DT B-NP O
93 decrease NN I-NP O
93 in IN B-VP O
93 her PRP$ O O
93 symptoms NNS B-NP O
93 of IN B-VP O
93 abdominal JJ B-NP O
93 pain NN I-NP O
93 , , O O
93 nausea NN B-NP O
93 , , O O
93 and CC O O
93 vomiting VBG O O
94 The DT B-NP O
94 patient NN I-NP O
94 did VBD B-VP O
94 have VB O O
94 any DT B-NP O
94 evidence NN I-NP O
94 of IN B-VP O
94 bowel NN B-NP O
94 ischemia NN I-NP O
94 on IN B-VP O
94 MRA NNP B-NP O
95 Later NNP I-NP O
95 , , O O
95 erythromycin NN B-NP B-m
95 was VBD B-VP O
95 changed VBN O O
95 to TO O O
95 Reglan VB O B-m
95 on IN B-VP O
95 8/6/06 CD O O
95 per IN B-VP O
95 renal JJ B-NP O
96 request NN I-NP O
96 during IN B-VP O
96 hemodialysis NN B-NP O
96 There EX O O
96 is VBZ O O
96 no DT B-NP O
96 evidence NN I-NP O
96 of IN B-VP O
96 pancreatis NN B-NP O
97 or CC O O
97 liver NN B-NP O
97 disease NN I-NP O
97 and CC O O
97 the DT B-NP O
97 patient NN I-NP O
97 was VBD B-VP O
97 also RB O O
97 kept VBN O O
97 on IN B-VP O
97 Compazine NNP B-NP B-m
97 for IN B-VP O
98 nausea NN B-NP B-r
99 3 CD O O
99 Renal: NNP B-NP O
99 The DT B-NP O
99 patient NN I-NP O
99 had VBD B-VP O
99 , , O O
99 on IN B-VP O
99 admission NN B-NP O
99 , , O O
99 acute NN B-NP O
99 on IN B-VP O
99 chronic JJ B-NP O
99 renal JJ I-NP O
100 failure NN I-NP O
100 There EX O O
100 was VBD B-VP O
100 a DT B-NP O
100 concern NN I-NP O
100 for IN B-VP O
100 prerenal JJ B-NP O
100 azotemia NN I-NP O
100 in IN B-VP O
100 the DT B-NP O
101 setting NN I-NP O
101 of IN B-VP O
101 nausea NN B-NP O
101 and CC O O
101 vomiting NN B-NP O
101 and CC O O
101 diarrhea VB O O
101 She PRP O O
101 had VBD B-VP O
101 a DT B-NP O
102 fractional JJ I-NP O
102 excretion NN I-NP O
102 of IN B-VP O
102 sodium NN B-NP O
102 which WDT O O
102 was VBD B-VP O
102 0.3% CD O O
102 , , O O
102 but CC O O
102 it PRP O O
102 was VBD B-VP O
103 difficult JJ O O
103 to TO O O
103 interpret VB O O
103 in IN B-VP O
103 the DT B-NP O
103 setting NN I-NP O
103 of IN B-VP O
103 end-stage JJ B-NP O
103 renal JJ I-NP O
103 disease NN I-NP O
104 Lasix NNP I-NP B-m
104 and CC O O
104 Cozaar NNP B-NP B-m
104 were VBD B-VP O
104 held VBN O O
104 However RB O O
104 , , O O
104 the DT B-NP O
104 creatinine NN I-NP O
104 continued VBD B-VP O
105 to TO O O
105 worsen VB O O
105 reaching VBG O O
105 6.1 CD O O
105 on IN B-VP O
105 10/14/06 CD O O
105 Renal NNP B-NP O
105 was VBD B-VP O
105 consulted VBN O O
106 regarding VBG O O
106 the DT B-NP O
106 need NN I-NP O
106 for IN B-VP O
106 dialysis NN B-NP O
106 On IN B-VP O
106 admission NN B-NP O
106 , , O O
106 the DT B-NP O
106 patient NN I-NP O
106 did VBD B-VP O
107 have VB O O
107 matured VBN O O
107 AV NNP B-NP O
107 fistula NN I-NP O
107 graft NN I-NP O
107 and CC O O
107 she PRP O O
107 was VBD B-VP O
107 thus RB O O
107 started VBN O O
107 on IN B-VP O
108 hemodialysis NN B-NP O
108 on IN B-VP O
108 1/10/06 CD O O
109 4 CD O O
109 Hematology: NNP B-NP O
109 The DT B-NP O
109 patient NN I-NP O
109 had VBD B-VP O
109 an DT B-NP O
109 INR NNP I-NP O
109 which WDT O O
109 was VBD B-VP O
109 elevated VBN O O
110 Hematocrit NNP B-NP O
110 was VBD B-VP O
110 also RB O O
110 decreased VBN O O
110 to TO O O
110 25.5 CD O O
110 from IN B-VP O
110 34 CD O O
110 She PRP O O
110 was VBD B-VP O
110 guaiac JJ O O
111 negative JJ O O
111 and CC O O
111 did VBD B-VP O
111 have VB O O
111 any DT B-NP O
111 schistocyte NN I-NP O
111 Her NNP I-NP O
111 LDH NNP I-NP O
111 was VBD B-VP O
111 also RB O O
111 normal JJ O O
112 with IN B-VP O
112 her PRP$ O O
112 haptoglobin NN B-NP O
112 high JJ O O
112 It PRP O O
112 was VBD B-VP O
112 judged VBN O O
112 from IN B-VP O
112 her PRP$ O O
112 iron NN B-NP O
112 studies NNS I-NP O
113 that IN B-VP O
113 the DT B-NP O
113 patient NN I-NP O
113 was VBD B-VP O
113 iron JJ B-NP B-r
113 deficient NN I-NP I-r
113 She PRP O O
113 was VBD B-VP O
113 put VBN O O
113 on IN B-VP O
113 iron NN B-NP B-m
114 supplementation NN I-NP O
114 She PRP O O
114 also RB O O
114 was VBD B-VP O
114 felt VBN O O
114 to TO O O
114 have VB O O
114 renal JJ B-NP O
114 component NN I-NP O
114 to TO O O
115 her PRP$ O B-r
115 her PRP$ O B-r
115 anemia NN B-NP I-r
115 anemia NN I-NP I-r
115 and CC O O
115 she PRP O O
115 was VBD B-VP O
115 started VBN O O
115 on IN B-VP O
115 darbepoetin NN B-NP B-m
115 initially RB O O
115 and CC O O
116 changed VBD B-VP O
116 to TO O O
116 erythropoietin VB O B-m
116 later RB O O
116 during IN B-VP O
116 dialysis NN B-NP O
116 by IN B-VP O
116 renal JJ O O
117 5 CD O O
117 Cardiovascular: NNP B-NP O
117 The DT B-NP O
117 patient NN I-NP O
117 was VBD B-VP O
117 maintained VBN O O
117 on IN B-VP O
117 aspirin NN B-NP B-m
117 , , O O
117 a DT B-NP O
118 statin NN I-NP B-m
118 , , O O
118 and CC O O
118 calcium NN B-NP B-m
118 channel NN I-NP I-m
118 blocker NN I-NP I-m
118 She PRP O O
118 started VBD B-VP O
118 prophylactic JJ B-NP O
119 beta-blocker NN I-NP B-m
119 during IN B-VP B-du
119 her PRP$ O I-du
119 hospital JJ B-NP I-du
119 course NN I-NP I-du
119 as RB O O
119 well RB O O
120 6 CD O O
120 Endocrine: NNP B-NP O
120 The DT B-NP O
120 patient NN I-NP O
120 had VBD B-VP O
120 hemoglobin VBN O O
120 A1c NNP B-NP O
120 of IN B-VP O
120 7.8 CD O O
120 She PRP O O
120 was VBD B-VP O
121 transitioned VBN O O
121 to TO O O
121 NPH NNP B-NP B-m
121 and CC O O
121 Aspart NNP B-NP B-m
121 during IN B-VP B-du
121 her PRP$ O I-du
121 hospital NN B-NP I-du
121 stay NN I-NP I-du
121 She PRP O O
121 had VBD B-VP O
122 intermittent JJ B-NP O
122 problems NNS I-NP O
122 with IN B-VP O
122 hypoglycemia NN B-NP O
122 in IN B-VP O
122 the DT B-NP O
122 setting NN I-NP O
122 of IN B-VP O
122 being VBG O O
123 NPO NNP B-NP O
123 pending VBG O O
123 operations NNS B-NP O
123 and CC O O
123 procedures; NN B-NP O
123 however RB O O
123 , , O O
123 her PRP O O
123 insulin VBP O B-m
124 regimen NNS B-NP O
124 was VBD B-VP O
124 titrated VBN O O
124 to TO O O
124 good JJ B-NP O
124 glycemic JJ I-NP O
124 response NN I-NP O
125 7 CD O O
125 Prophylaxis: NNP B-NP O
125 The DT B-NP O
125 patient NN I-NP O
125 was VBD B-VP O
125 kept VBN O O
125 on IN B-VP O
125 heparin NN B-NP B-m
125 and CC O O
125 Nexium NNP B-NP B-m
126 8 CD O O
126 Fluids NNP B-NP O
126 , , O O
126 electrolytes VBZ O O
126 , , O O
126 and CC O O
126 nutrition: IN B-VP O
126 Her NNP B-NP O
126 IV NNP I-NP O
126 fluids NNS I-NP O
126 were VBD B-VP O
127 stopped VBN O O
127 as IN B-VP O
127 the DT B-NP O
127 patient NN I-NP O
127 was VBD B-VP O
127 oliguric JJ O O
127 and CC O O
127 anuric JJ O O
127 initially RB O O
127 before IN B-VP O
128 hemodialysis NN B-NP O
128 Later NNP I-NP O
128 on IN B-VP O
128 , , O O
128 she PRP O O
128 was VBD B-VP O
128 also RB O O
128 put VBN O O
128 on IN B-VP O
128 1500 CD O O
128 mL NN B-NP O
128 fluid NN I-NP O
129 restriction NN I-NP O
129 Later NNP I-NP O
129 on IN B-VP O
129 during IN B-VP O
129 dialysis NN B-NP O
129 , , O O
129 her PRP O O
129 volume NN B-NP O
129 status NN I-NP O
130 resolved VBD B-VP O
130 euvolemia RB O O
130 She PRP O O
130 was VBD B-VP O
130 kept VBN O O
130 on IN B-VP O
130 a DT B-NP O
130 low JJ I-NP O
130 fat NN I-NP O
130 and CC O O
130 low JJ B-NP O
131 cholesterol NN I-NP O
131 diabetic JJ O O
131 diet VBZ O O
131 The DT B-NP O
131 patient NN I-NP O
131 is VBZ O O
131 full JJ B-NP O
131 code NN I-NP O
132 DISCHARGE NNP I-NP O
132 MEDICATIONS: NNP I-NP O
133 1 CD O O
133 Tylenol NNP B-NP B-m
133 650 CD O B-do
133 mg NN B-NP I-do
133 p.o NN I-NP B-mo
133 q.4 NN I-NP B-f
133 p.r.n NN I-NP I-f
133 headache NN I-NP B-r
134 2 CD O O
134 Aspirin NNP B-NP B-m
134 81 CD O B-do
134 mg NN B-NP I-do
134 p.o JJ O B-mo
134 daily JJ O B-f
135 3 CD O O
135 Colace NNP B-NP B-m
135 100 CD O B-do
135 mg NN B-NP I-do
135 p.o NN I-NP B-mo
135 b.i.d VBD B-VP B-f
136 4 CD O O
136 Heparin NNP B-NP B-m
136 5000 CD O B-do
136 units NNS B-NP I-do
136 subq VBD B-VP B-mo
136 t.i.d JJ O B-f
137 5 CD O O
137 Dilaudid NNP B-NP B-m
137 0.4-0.8 JJ B-NP B-do
137 mg NN I-NP I-do
137 p.o NN I-NP B-mo
137 q.4 NN I-NP B-f
137 p.r.n NN I-NP I-f
137 pain VBP O B-r
138 6 CD O O
138 Insulin NNP B-NP B-m
138 NPH NNP I-NP I-m
138 human JJ O I-m
138 20 CD O B-do
138 units NNS B-NP I-do
138 subq VBD B-VP B-mo
138 b.i.d RB O B-f
139 7 CD O O
139 Lactulose JJ O B-m
139 30 CD O B-do
139 mL NN B-NP I-do
139 p.o NN I-NP B-mo
139 q.i.d NN I-NP B-f
139 p.r.n NN I-NP I-f
139 constipation NN I-NP B-r
140 8 CD O O
140 Reglan NNP B-NP B-m
140 5 CD O B-do
140 mg NN B-NP I-do
140 p.o NN I-NP B-mo
140 q.a.c VBD B-VP B-f
141 9 CD O O
141 Reglan NNP B-NP B-m
141 5 CD O B-do
141 mg NN B-NP I-do
141 p.o NN I-NP B-mo
141 q.h.s VBD B-VP B-f
142 10 CD O O
142 Lopressor NNP B-NP B-m
142 50 CD O B-do
142 mg NN B-NP I-do
142 p.o NN I-NP B-mo
142 q.i.d VBD B-VP B-f
143 11 CD O O
143 Senna NNP B-NP B-m
143 tablets NNS I-NP I-m
143 two CD O B-do
143 tabs NNS B-NP I-do
143 p.o VBP O B-mo
143 b.i.d RB O B-f
144 12 CD O O
144 Norvasc NNP B-NP B-m
144 10 CD O B-do
144 mg NN B-NP I-do
144 p.o JJ O B-mo
144 daily JJ O B-f
145 13 CD O O
145 Compazine NNP B-NP B-m
145 5-10 JJ B-NP B-do
145 mg NN I-NP I-do
145 p.o NN I-NP B-mo
145 q.6h NN I-NP B-f
145 p.r.n NN I-NP I-f
145 nausea NN I-NP B-r
146 14 CD O O
146 Nephrocaps NNP B-NP B-m
146 one CD O B-do
146 tab NN B-NP I-do
146 p.o VBD B-VP B-mo
146 daily RB O B-f
147 15 CD O O
147 Insulin NNP B-NP B-m
147 Aspart NNP I-NP I-m
147 sliding VBG O B-do
147 scale JJ B-NP I-do
147 subq NN I-NP B-mo
147 a.c VBZ O B-f
148 16 CD O O
148 Insulin NNP B-NP B-m
148 Aspart NNP I-NP I-m
148 4 CD O B-do
148 units NNS B-NP I-do
148 subq VBD B-VP B-mo
148 q.a.c RB O B-f
149 17 CD O O
149 Lipitor NNP B-NP B-m
149 80 CD O B-do
149 mg NN B-NP I-do
149 p.o JJ O B-mo
149 daily JJ O B-f
150 18 CD O O
150 Protonix NNP B-NP B-m
150 40 CD O B-do
150 mg NN B-NP I-do
150 p.o JJ O B-mo
150 daily JJ O B-f
151 19 CD O O
151 Vancomycin NNP B-NP B-m
151 1 CD O B-do
151 g NN B-NP I-do
151 IV NNP I-NP B-mo
151 three CD O B-f
151 times NNS B-NP I-f
151 a DT B-NP I-f
151 week NN I-NP I-f
151 These DT B-NP O
151 doses NNS I-NP O
151 are VBP O O
151 all DT O O
152 to TO O O
152 be VB O O
152 given VBN O O
152 during IN B-VP O
152 hemodialysis NN B-NP O
153 20 CD O O
153 Ergocalciferol NNP B-NP B-m
153 50 CD O B-do
153 , , O I-do
153 000 CD O I-do
153 units NNS B-NP I-do
153 p.o RB O B-mo
153 q VBP O B-f
153 week NN B-NP I-f
153 for IN B-VP B-du
153 six CD O I-du
153 weeks NNS B-NP I-du
154 eScription NN I-NP O
154 document: IN B-VP O
154 3-9828070 JJ B-NP O
154 EMSSten NNP I-NP O
154 Tel NNP I-NP O
155 Dictated NNP I-NP O
155 By: NNP I-NP O
155 NADOLNY NNP I-NP O
155 , , O O
155 SANG NNP B-NP O
156 Attending: NNP I-NP O
156 UNSWORTH NNP I-NP O
156 , , O O
156 OTTO NNP B-NP O
157 Dictation NNP I-NP O
157 ID NNP I-NP O
157 6989547 CD O O
158 D: NNP B-NP O
158 2/5/06 CD O O
159 T: NNP B-NP O
159 2/5/06 CD O O
160 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #827931 VBZ O O
4 757633121 CD O O
4 SHR NNP B-NP O
4 39434670 CD O O
4 081816 CD O O
4 0/5/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 UROSEPSIS NNP I-NP O
4 , , O O
4 MYOCARDIAL NNP B-NP O
4 INFARCTION NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/5/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 0/29/2001 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 1 CD O O
7 BKA NNP B-NP O
8 2 CD O O
8 E NNP B-NP O
8 COLI NNP I-NP O
8 UROSEPSIS NNP I-NP O
9 3 CD O O
9 NON-Q-WAVE NNP B-NP O
9 MI NNP I-NP O
10 SIGNIFICANT NNP I-NP O
10 PROBLEMS: NNP I-NP O
10 1 CD O O
10 MORBID NNP B-NP O
10 OBESITY NNP I-NP O
11 2 CD O O
11 PULMONARY NNP B-NP O
11 EDEMA NNP I-NP O
12 3 CD O O
12 PULMONARY NNP B-NP O
12 HYPERTENSION NNP I-NP O
13 4 CD O O
13 RULE NNP B-NP O
13 OUT NNP I-NP O
13 PE NNP I-NP O
14 5 CD O O
14 OBSTRUCTIVE NNP B-NP O
14 SLEEP NNP I-NP O
14 APNEA NNP I-NP O
15 6 CD O O
15 ACUTE NNP B-NP O
15 RENAL NNP I-NP O
15 FAILURE NNP I-NP O
16 This DT O O
16 is VBZ O O
16 the DT B-NP O
16 third JJ I-NP O
16 Daughters NNP I-NP O
16 Wyckwe NNP I-NP O
16 Hospital NNP I-NP O
16 hospitalization NN I-NP O
16 for IN B-VP O
17 this DT O O
17 46-year-old JJ O O
17 morbidly RB O O
17 obese JJ B-NP O
17 female NN I-NP O
17 with IN B-VP O
17 a DT B-NP O
17 history NN I-NP O
17 of IN B-VP O
18 insulin-dependent JJ B-NP O
18 diabetes NNS I-NP O
18 mellitus RB O O
18 complicated VBN O O
18 by IN B-VP O
18 BKA NNP B-NP O
18 on IN B-VP O
18 two CD O O
18 prior JJ B-NP O
19 occasions NNS I-NP O
19 , , O O
19 admitted VBN O O
19 to TO O O
19 the DT B-NP O
19 MICU NNP I-NP O
19 with IN B-VP O
19 BKA NNP B-NP O
19 , , O O
19 urosepsis NN B-NP O
19 , , O O
19 and CC O O
19 a DT B-NP O
20 non-Q-wave JJ I-NP O
20 MI NNP I-NP O
20 On IN B-VP O
20 presentation NN B-NP O
20 to TO O O
20 the DT B-NP O
20 Emergency NNP I-NP O
20 Department NNP I-NP O
20 , , O O
20 the DT B-NP O
21 patient NN I-NP O
21 was VBD B-VP O
21 confused VBN O O
21 and CC O O
21 therefore RB O O
21 proved VBD B-VP O
21 to TO O O
21 be VB O O
21 a DT O O
21 difficult JJ O O
22 historian JJ O O
22 , , O O
22 but CC O O
22 she PRP O O
22 complained VBD B-VP O
22 of IN B-VP O
22 four CD O O
22 days NNS B-NP O
22 of IN B-VP O
22 epigastric JJ B-NP O
22 pain NN I-NP O
22 with IN B-VP O
23 radiation NN B-NP O
23 under IN B-VP O
23 her PRP$ O O
23 right JJ B-NP O
23 breast NN I-NP O
23 She PRP O O
23 also RB O O
23 complained VBD B-VP O
23 of IN B-VP O
23 abdominal JJ B-NP O
24 pain NN I-NP O
24 for IN B-VP O
24 4-5 JJ B-NP O
24 days NNS I-NP O
24 associated VBN O O
24 with IN B-VP O
24 nausea NN B-NP O
24 , , O O
24 but CC O O
24 denied VBD B-VP O
24 vomiting NN B-NP O
24 , , O O
25 diarrhea NN B-NP O
25 , , O O
25 constipation NN B-NP O
25 , , O O
25 hematochezia NN B-NP O
25 , , O O
25 or CC O O
25 melena NN B-NP O
25 In IN B-VP O
25 addition NN B-NP O
25 , , O O
25 she PRP O O
26 complained VBD B-VP O
26 of IN B-VP O
26 some DT B-NP O
26 dysuria NN I-NP O
26 for IN B-VP O
26 the DT B-NP O
26 same JJ I-NP O
26 time NN I-NP O
26 period NN I-NP O
26 , , O O
26 as RB O O
26 well RB O O
26 as IN B-VP O
27 subjective JJ B-NP O
27 fevers NNS I-NP O
27 , , O O
27 but CC O O
27 denied VBD B-VP O
27 cough NN B-NP O
27 , , O O
27 shortness NN B-NP O
27 of IN B-VP O
27 breath NN B-NP O
27 , , O O
27 or CC O O
27 any DT B-NP O
28 prior JJ I-NP O
28 history NN I-NP O
28 of IN B-VP O
28 heart NN B-NP O
28 disease NN I-NP O
28 or CC O O
28 chest JJS B-NP O
28 pain NN I-NP O
29 On IN B-VP O
29 presentation NN B-NP O
29 to TO O O
29 the DT B-NP O
29 Emergency NNP I-NP O
29 Department NNP I-NP O
29 , , O O
29 her PRP$ O O
29 vital JJ B-NP O
29 signs NNS I-NP O
29 were VBD B-VP O
30 notable JJ O O
30 for IN B-VP O
30 a DT B-NP O
30 blood NN I-NP O
30 pressure NN I-NP O
30 of IN B-VP O
30 189/92 CD O O
30 , , O O
30 pulse JJ B-NP O
30 rate NN I-NP O
30 of IN B-VP O
30 120 CD O O
30 , , O O
31 respiratory JJ B-NP O
31 rate NN I-NP O
31 of IN B-VP O
31 20 CD O O
31 , , O O
31 and CC O O
31 an DT B-NP O
31 O2 NNP I-NP O
31 sat NN I-NP O
31 of IN B-VP O
31 90% CD O O
31 She PRP O O
31 was VBD B-VP O
31 found VBN O O
31 to TO O O
32 have VB O O
32 a DT B-NP O
32 finger NN I-NP O
32 stick JJ B-NP O
32 blood NN I-NP O
32 glucose NN I-NP O
32 of IN B-VP O
32 354 CD O O
32 , , O O
32 a DT B-NP O
32 positive JJ I-NP O
32 urinalysis NN I-NP O
32 , , O O
33 and CC O O
33 an DT B-NP O
33 EKG NNP I-NP O
33 that WDT O O
33 was VBD B-VP O
33 concerning VBG O O
33 for IN B-VP O
33 ischemia NN B-NP O
33 She PRP O O
33 was VBD B-VP O
33 started VBN O O
33 on IN B-VP O
33 IV NNP B-NP B-mo
34 insulin NN I-NP B-m
34 , , O O
34 given VBN O O
34 sublingual JJ B-NP B-mo
34 nitroglycerin NN I-NP B-m
34 x NNP I-NP B-du
34 three CD O I-du
34 , , O O
34 4 CD O B-do
34 mg NN B-NP I-do
34 of IN B-VP O
34 morphine NN B-NP B-m
34 , , O O
35 5 CD O B-do
35 mg NN B-NP I-do
35 of IN B-VP O
35 Lopressor NNP B-NP B-m
35 , , O O
35 and CC O O
35 started VBD B-VP O
35 on IN B-VP O
35 a DT B-NP O
35 heparin NN I-NP B-m
35 drip NN I-NP I-m
35 and CC O O
35 IV NNP B-NP B-mo
36 antibiotics NNS I-NP B-m
36 , , O O
36 and CC O O
36 admitted VBD B-VP O
36 to TO O O
36 the DT B-NP O
36 MICU NNP I-NP O
36 for IN B-VP O
36 further JJ B-NP O
36 management NN I-NP O
37 PAST NNP I-NP O
37 MEDICAL NNP I-NP O
37 HISTORY: NNP I-NP O
37 1 CD O O
37 Insulin-dependent JJ B-NP B-r
37 diabetes NNS I-NP I-r
37 mellitus NNS I-NP I-r
37 , , O O
38 with IN B-VP O
38 a DT B-NP O
38 history NN I-NP O
38 of IN B-VP O
38 BKA NNP B-NP O
38 in IN B-VP O
38 March NNP B-NP O
38 1992 CD O O
38 in IN B-VP O
38 the DT B-NP O
39 setting NN I-NP O
39 of IN B-VP O
39 E NNP B-NP O
39 coli JJ B-NP O
39 sepsis NN I-NP O
39 of IN B-VP O
39 unclear JJ B-NP O
39 source NN I-NP O
39 , , O O
39 history NN B-NP O
39 of IN B-VP O
39 BKA NNP B-NP O
39 in IN B-VP O
40 March NNP B-NP O
40 2001 CD O O
40 in IN B-VP O
40 the DT B-NP O
40 setting NN I-NP O
40 of IN B-VP O
40 MS NNP B-NP B-m
40 Contin NNP I-NP I-m
40 withdrawal VBD B-VP O
40 2 CD O O
41 Hypertension NNP B-NP O
41 3 CD O O
41 Iron NNP B-NP O
41 deficiency NN I-NP O
41 anemia RB O O
41 4 CD O O
41 Fibroids NNS B-NP O
41 5 CD O O
42 Status NNP B-NP O
42 post NN I-NP O
42 C-section NNP I-NP O
42 complicated VBN O O
42 by IN B-VP O
42 wound JJ B-NP O
42 infection NN I-NP O
42 and CC O O
43 dehiscence NN B-NP O
43 6 CD O O
43 Sciatica NNP B-NP O
43 and CC O O
43 low JJ O O
43 back RB O O
43 pain NN B-NP O
43 secondary JJ O O
43 to TO O O
43 disc VB O O
44 herniation NN B-NP O
45 MEDICATIONS: NNP I-NP O
45 The DT B-NP O
45 patient NN I-NP O
45 was VBD B-VP O
45 unable JJ O O
45 to TO O O
45 provide VB O O
45 the DT B-NP O
45 dose NN I-NP O
45 of IN B-VP O
45 her PRP$ O O
46 medications NNS B-NP O
46 , , O O
46 but CC O O
46 her PRP$ O O
46 medication NN B-NP O
46 list NN I-NP O
46 on IN B-VP O
46 admission NN B-NP O
47 included VBD B-VP O
47 insulin NN B-NP B-m
47 , , O O
47 amitriptyline NN B-NP B-m
47 , , O O
47 Flexeril NNP B-NP B-m
47 , , O O
47 Valium NNP B-NP B-m
47 , , O O
47 Prozac NNP B-NP B-m
47 , , O O
47 and CC O O
48 albuterol NN B-NP B-m
48 and CC O O
48 Atrovent NNP B-NP B-m
48 inhalers NNS I-NP I-m
49 ALLERGIES: NNP I-NP O
49 No NNP I-NP O
49 known VBN O O
49 drug NN B-NP O
49 allergies NNS I-NP O
50 FAMILY NNP I-NP O
50 HISTORY: NNP I-NP O
50 Patient NNP I-NP O
50 was VBD B-VP O
50 unable JJ O O
50 to TO O O
50 provide VB O O
50 significant JJ B-NP O
50 details NNS I-NP O
51 of IN B-VP O
51 her PRP$ O O
51 family NN B-NP O
51 history NN I-NP O
52 SOCIAL NNP I-NP O
52 HISTORY: NNP I-NP O
52 Notable NNP I-NP O
52 for IN B-VP O
52 positive JJ B-NP O
52 tobacco NN I-NP O
52 use NN I-NP O
52 , , O O
52 approximately RB O O
53 one CD O O
53 cigarette NN B-NP O
53 per IN B-VP O
53 day NN B-NP O
53 She PRP O O
53 was VBD B-VP O
53 unable JJ O O
53 to TO O O
53 say VB O O
53 for IN B-VP O
54 how WRB O O
54 many JJ B-NP O
54 years NNS I-NP O
54 Positive NNP I-NP O
54 ethanol NN I-NP B-m
54 use NN I-NP O
54 , , O O
54 approximately RB O O
54 one CD O B-f
54 drink NN B-NP O
54 per IN B-VP O
55 week NN B-NP O
55 She PRP O O
55 denied VBD B-VP O
55 IV NNP B-NP O
55 drug NN I-NP O
55 use NN I-NP O
55 or CC O O
55 other JJ B-NP O
55 illicit JJ I-NP O
55 drug NN I-NP O
55 use NN I-NP O
55 She PRP O O
55 is VBZ O O
56 married JJ O O
56 and CC O O
56 has VBZ O O
56 three CD O O
56 children NNS B-NP O
57 REVIEW NNP I-NP O
57 OF NNP I-NP O
57 SYSTEMS: NNP I-NP O
57 As IN B-VP O
57 noted VBN O O
57 in IN B-VP O
57 the DT B-NP O
57 HPI NNP I-NP O
58 PHYSICAL NNP I-NP O
58 EXAMINATION: NNP I-NP O
58 Vital NNP I-NP O
58 signs NNS I-NP O
58 on IN B-VP O
58 admission NN B-NP O
58 to TO O O
58 the DT B-NP O
58 MICU: NNP I-NP O
59 Temperature NNP I-NP O
59 103.7 CD O O
59 , , O O
59 pulse RB O O
59 110 CD O O
59 , , O O
59 blood NN B-NP O
59 pressure NN I-NP O
60 125/55 CD O O
60 , , O O
60 respiratory NN B-NP O
60 rate NN I-NP O
60 34 CD O O
60 , , O O
60 O2 NNP B-NP O
60 sat VBD B-VP O
60 95% CD O O
60 on IN B-VP O
60 2 CD O O
60 L NNP B-NP O
60 In IN B-VP O
60 general JJ O O
60 , , O O
60 she PRP O O
61 was VBD B-VP O
61 an DT B-NP O
61 obese JJ I-NP O
61 African JJ I-NP O
61 American JJ I-NP O
61 female NN I-NP O
61 who WP O O
61 was VBD B-VP O
61 confused VBN O O
61 , , O O
61 but CC O O
61 alert JJ O O
62 and CC O O
62 oriented JJ B-NP O
62 x NN I-NP O
62 two CD O O
62 HEENT: NNP B-NP O
62 Pupils NNPS I-NP O
62 were VBD B-VP O
62 equal JJ O O
62 , , O O
62 round NN B-NP O
62 , , O O
62 and CC O O
62 reactive JJ O O
63 to TO O O
63 light JJ B-NP O
63 Extraocular JJ I-NP O
63 movements NNS I-NP O
63 were VBD B-VP O
63 intact JJ B-NP O
63 Oropharynx NNP I-NP O
63 was VBD B-VP O
63 dry JJ O O
64 and CC O O
64 was VBD B-VP O
64 notable JJ O O
64 for IN B-VP O
64 a DT B-NP O
64 fruity NN I-NP O
64 odor NN I-NP O
64 LUNGS: NNP I-NP O
64 Clear NNP I-NP O
64 to TO O O
64 auscultation VB O O
65 bilaterally RB O O
65 NECK: NNP B-NP O
65 Supple NNP I-NP O
65 CARDIOVASCULAR: NNP I-NP O
65 Regular NNP I-NP O
65 rate NN I-NP O
65 and CC O O
66 rhythm NN B-NP O
66 , , O O
66 no DT B-NP O
66 murmurs NN I-NP O
66 , , O O
66 rubs NN B-NP O
66 , , O O
66 or CC O O
66 gallops NNS B-NP O
66 , , O O
66 with IN B-VP O
66 normal JJ B-NP O
66 S1 NNP I-NP O
66 and CC O O
66 S2 NNP B-NP O
67 ABDOMEN: NNP I-NP O
67 Obese NNP I-NP O
67 , , O O
67 positive JJ B-NP O
67 bowel NN I-NP O
67 sounds NNS I-NP O
67 , , O O
67 soft JJ O O
67 , , O O
67 nondistended VBD B-VP O
67 , , O O
68 positive JJ B-NP O
68 tenderness NN I-NP O
68 in IN B-VP O
68 the DT B-NP O
68 left NN I-NP O
68 lower RBR O O
68 quadrant NN B-NP O
68 , , O O
68 with IN B-VP O
68 no DT B-NP O
68 guarding NN I-NP O
68 or CC O O
69 rebound VB O O
69 EXTREMITIES: NNP B-NP O
69 2+ CD O O
69 distal NN B-NP O
69 pulses NNS I-NP O
69 , , O O
69 1+ CD O O
69 edema NN B-NP O
69 RECTAL NNP I-NP O
69 EXAM: NNP I-NP O
70 Guaiac NNP I-NP O
70 negative JJ O O
70 , , O O
70 with IN B-VP O
70 normal JJ B-NP O
70 tone NN I-NP O
70 per IN B-VP O
70 ED NNP B-NP O
70 physician NN I-NP O
71 LABS: NNP I-NP O
71 Sodium NNP I-NP O
71 139 CD O O
71 , , O O
71 potassium NN B-NP O
71 3.9 CD O O
71 , , O O
71 chloride RB O O
71 105 CD O O
71 , , O O
71 bicarb NN B-NP O
71 19 CD O O
71 , , O O
71 BUN NNP B-NP O
71 37 CD O O
71 , , O O
72 creatinine NN B-NP O
72 2.1 CD O O
72 ( ( O O
72 increased VBN O O
72 from IN B-VP O
72 her PRP$ O O
72 baseline NN B-NP O
72 of IN B-VP O
72 1.4 CD O O
72 ) ) O O
72 , , O O
72 glucose JJ O O
73 379 CD O O
73 , , O O
73 calcium NN B-NP O
73 8.1 CD O O
73 , , O O
73 magnesium NN B-NP O
73 2.1 CD O O
73 , , O O
73 phosphorus NN B-NP O
73 3 CD O O
73 , , O O
73 ALT NNP B-NP O
73 33 CD O O
73 , , O O
73 AST NNP B-NP O
73 56 CD O O
73 , , O O
73 alk VBP O O
74 phos JJ O O
74 119 CD O O
74 , , O O
74 T NNP B-NP O
74 bili VBD B-VP O
74 1.0 CD O O
74 , , O O
74 amylase NN B-NP O
74 13 CD O O
74 , , O O
74 lipase NN B-NP O
74 3 CD O O
74 , , O O
74 white JJ B-NP O
74 blood NN I-NP O
74 cell NN I-NP O
74 count NN I-NP O
75 14.7 CD O O
75 , , O O
75 with IN B-VP O
75 85% CD O O
75 polys NNS B-NP O
75 , , O O
75 9 CD O O
75 bands NNS B-NP O
75 , , O O
75 and CC O O
75 4 CD O O
75 lymphocytes NNS B-NP O
75 , , O O
75 hematocrit NN B-NP O
75 34.1 CD O O
75 , , O O
76 platelets NNS B-NP O
76 122 CD O O
76 , , O O
76 PT NNP B-NP O
76 14.2 CD O O
76 , , O O
76 PTT NNP B-NP O
76 29.1 CD O O
76 , , O O
76 INR NNP B-NP O
76 1.3 CD O O
76 , , O O
76 ABG NNP B-NP O
76 T NNP I-NP O
76 at IN B-VP O
76 7.4 CD O O
76 , , O O
76 PCO2 NNP B-NP O
76 32 CD O O
76 , , O O
77 PO2 NNP B-NP O
77 82 CD O O
77 , , O O
77 O2 NNP B-NP O
77 saturation NN I-NP O
77 96% CD O O
77 , , O O
77 CK NNP B-NP O
77 12-35 CD O O
77 , , O O
77 MB NNP B-NP O
77 1.5 CD O O
77 , , O O
77 troponin NN B-NP O
77 1.52 CD O O
77 , , O O
77 beta NN B-NP O
78 hydroxybutyrate NN I-NP O
78 .7 NNP I-NP O
78 Positive NNP I-NP O
78 ACE NNP I-NP O
78 test NN I-NP O
78 Urine NN I-NP O
78 and CC O O
78 serum NN B-NP O
78 toxicology NN I-NP O
79 screens NNS I-NP O
79 negative JJ B-NP O
79 Urinalysis NNP I-NP O
79 was VBD B-VP O
79 notable JJ O O
79 for IN B-VP O
79 a DT B-NP O
79 pH NN I-NP O
79 of IN B-VP O
79 5.5 CD O O
79 , , O O
79 specific JJ B-NP O
80 gravity NN I-NP O
80 of IN B-VP O
80 1.02 CD O O
80 , , O O
80 3+ CD O O
80 protein NN B-NP O
80 , , O O
80 3+ CD O O
80 glucose NN B-NP O
80 , , O O
80 1+ CD O O
80 ketones NNS B-NP O
80 , , O O
80 3+ CD O O
80 bloods NNS B-NP O
80 , , O O
81 positive JJ B-NP O
81 leuk NN I-NP O
81 esterase NN I-NP O
81 and CC O O
81 nitrites NNS B-NP O
81 , , O O
81 45-50 JJ B-NP O
81 white JJ I-NP O
81 blood NN I-NP O
81 cells NNS I-NP O
81 , , O O
81 3-4 JJ B-NP O
82 red JJ I-NP O
82 blood NN I-NP O
82 cells NNS I-NP O
82 , , O O
82 3+ CD O O
82 bacteria NNS B-NP O
82 , , O O
82 and CC O O
82 1+ CD O O
82 squamous JJ B-NP O
82 epithelium NN I-NP O
82 Urine NNP I-NP O
83 beta-hCG NN I-NP O
83 was VBD B-VP O
83 negative JJ O O
83 The DT B-NP O
83 chest JJS I-NP O
83 x-ray JJ I-NP O
83 showed JJ I-NP O
83 cephalization NN I-NP O
83 and CC O O
84 interstitial JJ B-NP O
84 edema NN I-NP O
84 Her NNP I-NP O
84 initial JJ B-NP O
84 EKG NNP I-NP O
84 showed VBD B-VP O
84 .5-1 JJ B-NP O
84 mm NN I-NP O
84 ST NNP I-NP O
84 depressions NNS I-NP O
85 in IN B-VP O
85 leads NNS B-NP O
85 1 CD O O
85 and CC O O
85 aVL RB O O
85 , , O O
85 1 CD O O
85 mm NN B-NP O
85 ST NNP I-NP O
85 elevations NNS I-NP O
85 in IN B-VP O
85 leads NNS B-NP O
85 V1 NNP I-NP O
85 and CC O O
85 V2 NNP B-NP O
85 , , O O
86 flattened VBD B-VP O
86 T NNP B-NP O
86 waves NNS I-NP O
86 in IN B-VP O
86 leads NNS B-NP O
86 1 CD O O
86 , , O O
86 aVL NN B-NP O
86 , , O O
86 V2 NNP B-NP O
86 , , O O
86 and CC O O
86 V3 NNP B-NP O
87 SUMMARY: NNP I-NP O
87 This DT O O
87 is VBZ O O
87 a DT O O
87 42-year-old JJ O O
87 morbidly RB O O
87 obese JJ B-NP O
87 female NN I-NP O
87 with IN B-VP O
87 a DT B-NP O
88 history NN I-NP O
88 of IN B-VP O
88 insulin-dependent JJ B-NP O
88 diabetes NNS I-NP O
88 mellitus RB O O
89 complicated VBN O O
89 by IN B-VP O
89 BKA NNP B-NP O
89 on IN B-VP O
89 two CD O O
89 prior JJ B-NP O
89 occasions NNS I-NP O
89 , , O O
89 who WP O O
89 was VBD B-VP O
89 admitted VBN O O
89 to TO O O
89 the DT B-NP O
90 MICU NNP I-NP O
90 with IN B-VP O
90 a DT B-NP O
90 BKA NNP I-NP O
90 in IN B-VP O
90 the DT B-NP O
90 setting NN I-NP O
90 of IN B-VP O
90 urosepsis NN B-NP O
90 and CC O O
90 a DT B-NP O
90 non-Q-wave JJ I-NP O
90 MI NNP I-NP O
91 HOSPITAL NNP I-NP O
91 COURSE: NNP I-NP O
91 Her NNP I-NP O
91 hospital NN I-NP O
91 course NN I-NP O
91 by IN B-VP O
91 systems NNS B-NP O
91 is VBZ O O
91 as IN B-VP O
91 follows: JJ O O
92 1 CD O O
92 ENDOCRINE: NNP B-NP O
92 As IN B-VP O
92 noted VBN O O
92 above IN B-VP O
92 , , O O
92 the DT B-NP O
92 patient NN I-NP O
93 presented VBN O O
93 with IN B-VP O
93 BKA NNP B-NP O
93 in IN B-VP O
93 the DT B-NP O
93 setting NN I-NP O
93 of IN B-VP O
93 urosepsis NN B-NP O
93 and CC O O
93 a DT B-NP O
93 non-Q-wave JJ I-NP B-r
93 MI NNP I-NP I-r
94 She PRP O O
94 was VBD B-VP O
94 placed VBN O O
94 on IN B-VP O
94 an DT B-NP O
94 insulin NN I-NP B-m
94 drip NN I-NP I-m
94 and CC O O
94 hydrated VBN O O
94 with IN B-VP O
94 intravenous JJ B-NP B-mo
95 fluids NNS I-NP O
95 , , O O
95 with IN B-VP O
95 improvement NN B-NP O
95 She PRP O O
95 was VBD B-VP O
95 eventually RB O O
95 transitioned VBN O O
95 to TO O O
95 NPH NNP B-NP B-m
96 with IN B-VP O
96 insulin NN B-NP O
96 sliding VBG O B-do
96 scale JJ B-NP I-do
96 coverage NN I-NP O
96 Despite IN B-VP O
96 escalating VBG O O
96 her PRP$ O O
96 dose NN B-NP O
97 of IN B-VP O
97 NPH NNP B-NP B-m
97 up RB O O
97 to TO O O
97 65 CD O B-do
97 U NNP B-NP I-do
97 subcu NN I-NP B-mo
97 b.i.d NN I-NP B-f
97 on IN B-VP O
97 the DT B-NP O
97 day NN I-NP O
97 of IN B-VP O
97 discharge NN B-NP O
97 , , O O
97 she PRP O O
98 continued VBD B-VP O
98 to TO O O
98 have VB O O
98 elevated VBN O B-r
98 elevated JJ B-NP B-r
98 blood NN I-NP I-r
98 blood NN I-NP I-r
98 sugars NNS I-NP I-r
98 sugars VBZ O I-r
98 &gt;200 JJ O O
98 and CC O O
98 required JJ B-NP O
98 coverage NN I-NP O
99 with IN B-VP O
99 insulin NN B-NP B-m
99 sliding VBG O B-do
99 scale NN B-NP I-do
99 This DT B-NP O
99 issue NN I-NP O
99 will MD O O
99 need VB O O
99 to TO O O
99 be VB O O
99 addressed VBN O O
100 as IN B-VP O
100 an DT O O
100 outpatient JJ O O
101 2 CD O O
101 PULMONARY: NNP B-NP O
101 Posthydration NNP I-NP O
101 , , O O
101 the DT B-NP O
101 patient NN I-NP O
101 was VBD B-VP O
101 noted VBN O O
101 to TO O O
101 have VB O O
102 increasing VBG O O
102 respiratory JJ B-NP O
102 rates NNS I-NP O
102 and CC O O
102 O2 NNP B-NP O
102 requirements NNS I-NP O
102 and CC O O
102 rales NNS B-NP O
102 on IN B-VP O
102 exam NN B-NP O
103 As IN B-VP O
103 her PRP$ O O
103 creatinine NN B-NP O
103 had VBD B-VP O
103 improved VBN O O
103 concurrent NN B-NP O
103 with IN B-VP O
103 hydration NN B-NP O
103 , , O O
103 she PRP O O
103 was VBD B-VP O
104 gently RB O O
104 diuresed VBN O O
104 An DT B-NP O
104 echocardiogram NN I-NP O
104 was VBD B-VP O
104 obtained VBN O O
104 to TO O O
104 assess VB O O
104 her PRP$ O O
104 left JJ B-NP O
105 ventricular JJ I-NP O
105 function NN I-NP O
105 in IN B-VP O
105 the DT B-NP O
105 context NN I-NP O
105 of IN B-VP O
105 her PRP$ O O
105 non-Q-wave JJ B-NP O
105 MI NNP I-NP O
105 , , O O
105 which WDT O O
105 was VBD B-VP O
106 notable JJ O O
106 for IN B-VP O
106 normal JJ O O
106 left VBD B-VP O
106 ventricular JJ B-NP O
106 function NN I-NP O
106 , , O O
106 with IN B-VP O
106 an DT B-NP O
106 EF NNP I-NP O
106 of IN B-VP O
106 50% CD O O
106 , , O O
107 hypokinesis NN B-NP O
107 of IN B-VP O
107 the DT B-NP O
107 inferior JJ I-NP O
107 septum NN I-NP O
107 , , O O
107 a DT B-NP O
107 right JJ I-NP O
107 ventricle NN I-NP O
107 that WDT O O
107 was VBD B-VP O
108 mildly RB O O
108 enlarged VBN O O
108 , , O O
108 with IN B-VP O
108 mildly RB O O
108 decreased VBN O O
108 systolic JJ B-NP O
108 function NN I-NP O
108 , , O O
108 normal JJ B-NP O
109 aortic JJ I-NP O
109 valve NN I-NP O
109 , , O O
109 mild JJ B-NP O
109 TR NNP I-NP O
109 , , O O
109 and CC O O
109 mild JJ B-NP O
109 MR NNP I-NP O
109 , , O O
109 and CC O O
109 a DT B-NP O
109 pulmonary JJ I-NP O
109 artery NN I-NP O
109 pressure NN I-NP O
110 of IN B-VP O
110 39 CD O O
110 mm NN B-NP O
110 of IN B-VP O
110 mercury NN B-NP O
110 plus CC O O
110 right JJ B-NP O
110 atrial JJ I-NP O
110 pressure NN I-NP O
110 consistent JJ O O
110 with IN B-VP O
111 pulmonary JJ B-NP O
111 hypertension NN I-NP O
111 and CC O O
111 no DT B-NP O
111 pericardial JJ I-NP O
111 effusion NN I-NP O
111 With IN B-VP O
111 her PRP$ O O
111 body NN B-NP O
112 habitus NN I-NP O
112 putting VBG O O
112 her PRP$ O O
112 at IN B-VP O
112 risk NN B-NP O
112 for IN B-VP O
112 DVT NNP B-NP O
112 and CC O O
112 PE NNP B-NP O
112 , , O O
112 an DT B-NP O
112 echocardiogram NN I-NP O
112 which WDT O O
113 showed VBD B-VP O
113 evidence NN B-NP O
113 of IN B-VP O
113 pulmonary JJ B-NP O
113 hypertension NN I-NP O
113 raised VBD B-VP O
113 the DT B-NP O
113 concern NN I-NP O
113 for IN B-VP O
113 PE NNP B-NP O
114 being VBG O O
114 responsible JJ O O
114 for IN B-VP O
114 her PRP$ O O
114 symptoms NNS B-NP O
114 of IN B-VP O
114 tachypnea NN B-NP O
114 and CC O O
114 tachycardia VB O O
114 A NNP B-NP O
115 spiral JJ B-NP O
115 CT NNP I-NP O
115 was VBD B-VP O
115 obtained VBN O O
115 that IN B-VP O
115 was VBD B-VP O
115 nondiagnostic JJ O O
115 secondary JJ O O
115 to TO O O
115 her PRP$ O O
115 body NN B-NP O
116 habitus VBZ O O
116 A NNP B-NP O
116 VQ NNP I-NP O
116 scan NN I-NP O
116 was VBD B-VP O
116 obtained VBN O O
116 , , O O
116 which WDT O O
116 was VBD B-VP O
116 read VBN O O
116 as IN B-VP O
116 low JJ B-NP O
116 probability NN I-NP O
117 for IN B-VP O
117 PE NNP B-NP O
117 In IN B-VP O
117 addition NN B-NP O
117 , , O O
117 she PRP O O
117 also RB O O
117 had VBD B-VP O
117 negative JJ B-NP O
117 LENIs NNP I-NP O
117 These DT B-NP O
117 studies NNS I-NP O
118 taken VBN O O
118 together RB O O
118 alleviated VBD B-VP O
118 the DT B-NP O
118 concern NN I-NP O
118 of IN B-VP O
118 PE NNP B-NP O
118 or CC O O
118 DVT NNP B-NP O
118 in IN B-VP O
118 her PRP$ O O
118 It PRP O O
118 was VBD B-VP O
119 felt VBN O O
119 that IN B-VP O
119 the DT B-NP O
119 patient NN I-NP O
119 likely RB O O
119 had VBD B-VP O
119 obstructive JJ B-NP O
119 sleep JJ I-NP O
119 apnea NN I-NP O
119 secondary JJ O O
120 to TO O O
120 her PRP$ O O
120 body NN B-NP O
120 habitus NN I-NP O
120 She PRP O O
120 was VBD B-VP O
120 maintained VBN O O
120 on IN B-VP O
120 CPAP NNP B-NP O
120 during IN B-VP O
120 her PRP$ O O
121 hospitalization NN B-NP O
121 stay; NN I-NP O
121 however RB O O
121 , , O O
121 the DT B-NP O
121 patient NN I-NP O
121 informed VBD B-VP O
121 the DT B-NP O
121 treating NN I-NP O
122 team NN I-NP O
122 that IN B-VP O
122 she PRP O O
122 would MD O O
122 not RB O O
122 be VB O O
122 using VBG O O
122 a DT B-NP O
122 CPAP NNP I-NP O
122 machine NN I-NP O
122 once RB O O
122 she PRP O O
122 returned VBD B-VP O
123 home RB O O
123 secondary JJ O O
123 to TO O O
123 the DT B-NP O
123 inconvenience NN I-NP O
123 and CC O O
123 discomfort NN B-NP O
124 3 CD O O
124 ID: NNP B-NP O
124 On IN B-VP O
124 admission NN B-NP O
124 to TO O O
124 MICU NNP B-NP O
124 , , O O
124 given VBN O O
124 her PRP$ O O
124 positive JJ B-NP O
124 urinalysis NN I-NP O
124 , , O O
124 she PRP O O
125 was VBD B-VP O
125 placed VBN O O
125 on IN B-VP O
125 cefotaxime NN B-NP B-m
125 for IN B-VP O
125 gram JJ B-NP B-r
125 negative JJ I-NP I-r
125 coverage NN I-NP I-r
125 Both DT O O
125 her PRP$ O O
126 blood NN B-NP O
126 cultures NNS I-NP O
126 and CC O O
126 urine JJ B-NP O
126 cultures NNS I-NP O
126 grew VBD B-VP O
126 out RP O O
126 E NNP B-NP O
126 coli NNS I-NP O
126 which WDT O O
126 were VBD B-VP O
127 sensitive JJ O O
127 to TO O O
127 cefotaxime VB O B-m
127 and CC O O
127 gentamycin VB O B-m
127 As IN B-VP O
127 she PRP O O
127 initially RB O O
127 continued VBD B-VP O
128 to TO O O
128 be VB O O
128 febrile JJ O O
128 and CC O O
128 continued VBN O O
128 to TO O O
128 have VB O O
128 positive JJ B-NP O
128 blood NN I-NP O
128 cultures NNS I-NP O
128 , , O O
128 one CD O B-do
129 dose NN B-NP O
129 of IN B-VP O
129 gentamycin NN B-NP B-m
129 was VBD B-VP O
129 given VBN O O
129 for IN B-VP O
129 synergy NN B-NP B-r
129 Subsequently NNP I-NP O
129 , , O O
129 she PRP O O
130 improved VBD B-VP O
130 She PRP O O
130 remains VBZ O O
130 on IN B-VP O
130 IV NNP B-NP B-mo
130 cefotaxime NN I-NP B-m
130 for IN B-VP B-du
130 the DT B-NP I-du
130 7-day JJ I-NP I-du
130 period NN I-NP I-du
130 that IN B-VP O
131 she PRP O O
131 was VBD B-VP O
131 in IN B-VP O
131 the DT B-NP O
131 MICU NNP I-NP O
131 On IN B-VP O
131 transfer NN B-NP O
131 to TO O O
131 the DT B-NP O
131 floor NN I-NP O
131 , , O O
131 she PRP O O
131 was VBD B-VP O
131 switched VBN O O
131 to TO O O
132 p.o VB O B-mo
132 levofloxacin NN B-NP B-m
132 and CC O O
132 will MD O O
132 take VB O O
132 7 CD O B-du
132 7 CD O B-du
132 days NNS B-NP I-du
132 days NNS I-NP I-du
132 of IN B-VP O
132 p.o JJ B-NP B-mo
132 levofloxacin NN I-NP B-m
132 to TO O O
133 complete VB O O
133 a DT B-NP O
133 total JJ I-NP O
133 14-day JJ I-NP B-du
133 course NN I-NP O
133 of IN B-VP O
133 antibiotics NNS B-NP B-m
133 for IN B-VP O
133 urosepsis JJ B-NP B-r
133 urosepsis NN I-NP B-r
134 4 CD O O
134 CARDIOVASCULAR: NNP B-NP O
134 Patient NNP I-NP O
134 ruled VBD B-VP O
134 in IN B-VP O
134 for IN B-VP O
134 a DT B-NP O
134 non-Q-wave JJ I-NP O
134 MI NNP I-NP O
134 by IN B-VP O
134 EKG NNP B-NP O
135 and CC O O
135 enzymes VBZ O O
135 Her NNP B-NP O
135 peak NN I-NP O
135 CK NNP I-NP O
135 was VBD B-VP O
135 1200 CD O O
135 , , O O
135 with IN B-VP O
135 a DT B-NP O
135 troponin NN I-NP O
135 of IN B-VP O
135 1.52 CD O O
135 She PRP O O
136 was VBD B-VP O
136 initially RB O O
136 placed VBN O O
136 on IN B-VP O
136 aspirin NN B-NP B-m
136 , , O O
136 heparin NN B-NP B-m
136 , , O O
136 and CC O O
136 a DT B-NP O
136 beta NN I-NP B-m
136 blocker NN I-NP I-m
136 Once IN B-VP O
137 her PRP$ O O
137 creatinine NN B-NP O
137 normalized VBN O O
137 , , O O
137 an DT B-NP O
137 ACE NNP I-NP B-m
137 inhibitor NN I-NP I-m
137 was VBD B-VP O
137 also RB O O
137 added JJ B-NP O
138 Heparin NNP I-NP B-m
138 was VBD B-VP O
138 discontinued VBN O O
138 once RB O O
138 the DT B-NP O
138 concern NN I-NP O
138 for IN B-VP O
138 PE NNP B-NP B-r
138 was VBD B-VP O
138 alleviated VBN O O
139 Her NNP B-NP O
139 beta NN I-NP B-m
139 blocker NN I-NP I-m
139 and CC O O
139 ACE NNP B-NP B-m
139 inhibitor NN I-NP I-m
139 were VBD B-VP O
139 titrated VBN O B-do
139 titrated VBN O B-do
139 up RP O I-do
139 up RB O I-do
139 for IN B-VP O
139 a DT B-NP O
139 goal NN I-NP O
140 systolic JJ B-NP O
140 blood NN I-NP O
140 pressure NN I-NP O
140 of IN B-VP O
140 &lt;140 NN B-NP O
140 and CC O O
140 a DT B-NP O
140 pulse NN I-NP O
140 of IN B-VP O
140 &lt;70 NNP B-NP O
140 She PRP O O
140 was VBD B-VP O
141 transferred VBN O O
141 to TO O O
141 the DT B-NP O
141 floor NN I-NP O
141 on IN B-VP O
141 hospital JJ B-NP O
141 day NN I-NP O
141 7 CD O O
141 , , O O
141 where WRB O O
141 she PRP O O
141 remained VBD B-VP O
142 stable JJ O O
142 Another DT B-NP O
142 guanosine NN I-NP O
142 MIBI NNP I-NP O
142 was VBD B-VP O
142 obtained VBN O O
142 , , O O
142 as IN B-VP O
142 the DT B-NP O
142 patient NN I-NP O
143 reported VBD B-VP O
143 that IN B-VP O
143 she PRP O O
143 would MD O O
143 be VB O O
143 unable JJ O O
143 to TO O O
143 exercise VB O O
143 , , O O
143 given VBN O O
143 her PRP$ O O
143 chronic JJ O O
144 low JJ O O
144 back RB O O
144 pain NN B-NP O
144 and CC O O
144 sciatica VB O O
144 A NNP B-NP O
144 planar NN I-NP O
144 study NN I-NP O
144 was VBD B-VP O
144 done VBN O O
144 secondary JJ O O
144 to TO O O
145 her PRP$ O O
145 body NN B-NP O
145 habitus NN I-NP O
145 , , O O
145 which WDT O O
145 revealed VBD B-VP O
145 a DT B-NP O
145 moderate JJ I-NP O
145 sized JJ I-NP O
145 area NN I-NP O
145 of IN B-VP O
145 prior JJ B-NP O
146 myocardial JJ I-NP O
146 infarction NN I-NP O
146 throughout IN B-VP O
146 the DT B-NP O
146 mid NN I-NP O
146 LAD NNP I-NP O
146 coronary JJ B-NP O
146 territory NN I-NP O
146 , , O O
147 with IN B-VP O
147 moderate JJ B-NP O
147 residual JJ I-NP O
147 peri-infarct NN I-NP O
147 ischemia NN I-NP O
147 The DT B-NP O
147 Cardiology NNP I-NP O
148 Service NNP I-NP O
148 did VBD B-VP O
148 not RB O O
148 feel VB O O
148 that IN B-VP O
148 the DT B-NP O
148 degree NN I-NP O
148 of IN B-VP O
148 this DT B-NP O
148 lesion NN I-NP O
148 warranted VBD B-VP O
149 catheterization NN B-NP O
149 , , O O
149 given VBN O O
149 the DT B-NP O
149 sizable JJ I-NP O
149 risk NN I-NP O
149 of IN B-VP O
149 catheterization NN B-NP O
149 in IN B-VP O
149 her PRP$ O O
150 5 CD O O
150 RENAL: NNP B-NP O
150 On IN B-VP O
150 presentation NN B-NP O
150 , , O O
150 the DT B-NP O
150 patient NN I-NP O
150 had VBD B-VP O
150 a DT B-NP O
150 creatinine NN I-NP O
150 of IN B-VP O
150 2.1 CD O O
150 , , O O
151 up RB O O
151 from IN B-VP O
151 her PRP$ O O
151 baseline NN B-NP O
151 of IN B-VP O
151 1.4 CD O O
151 She PRP O O
151 was VBD B-VP O
151 felt VBN O O
151 to TO O O
151 have VB O O
151 acute JJ B-NP O
151 renal JJ I-NP O
152 failure NN I-NP O
152 , , O O
152 secondary JJ B-NP O
152 dehydration NN I-NP O
152 , , O O
152 in IN B-VP O
152 the DT B-NP O
152 setting NN I-NP O
152 of IN B-VP O
152 diabetic JJ B-NP O
153 ketoacidosis NN I-NP O
153 She PRP O O
153 was VBD B-VP O
153 rehydrated VBN O O
153 and CC O O
153 concurrent JJ O O
153 with IN B-VP O
153 this DT O O
153 her PRP$ O O
154 creatinine NN B-NP O
154 returned VBD B-VP O
154 to TO O O
154 her PRP$ O O
154 baseline NN B-NP O
154 and CC O O
154 remained VBD B-VP O
154 stable JJ O O
154 thereafter RB O O
155 6 CD O O
155 GI: NNP B-NP O
155 On IN B-VP O
155 admission NN B-NP O
155 to TO O O
155 the DT B-NP O
155 MICU NNP I-NP O
155 , , O O
155 the DT B-NP O
155 patient NN I-NP O
155 was VBD B-VP O
155 placed VBN O O
155 on IN B-VP O
155 GI NNP B-NP B-r
156 prophylaxis NN I-NP O
156 with IN B-VP O
156 Carafate NNP B-NP B-m
156 Carafate NNP I-NP B-m
156 Once NNP I-NP O
156 she PRP O O
156 was VBD B-VP O
156 tolerating VBG O O
156 p.o.'s NN B-NP O
156 , , O O
156 she PRP O O
156 was VBD B-VP O
157 placed VBN O O
157 on IN B-VP O
157 an DT B-NP O
157 ADA NNP I-NP O
157 diet NN I-NP O
157 and CC O O
157 her PRP$ O O
157 Carafate NNP B-NP O
157 was VBD B-VP O
157 discontinued VBN O O
157 prior RB O O
157 to TO O O
158 discharge VB O O
158 Once RB O O
158 transferred VBN O O
158 to TO O O
158 the DT B-NP O
158 floor NN I-NP O
158 , , O O
158 the DT B-NP O
158 patient NN I-NP O
158 complained VBD B-VP O
159 of IN B-VP O
159 diarrhea; NN B-NP O
159 however RB O O
159 , , O O
159 the DT B-NP O
159 nurses NNS I-NP O
159 did VBD B-VP O
159 not RB O O
159 witness JJ O O
159 and CC O O
159 were VBD B-VP O
159 unable JJ O O
159 to TO O O
160 obtain VB O O
160 a DT B-NP O
160 stool NN I-NP O
160 sample NN I-NP O
160 to TO O O
160 check VB O O
160 for IN B-VP O
160 C NNP B-NP O
160 diff NN I-NP O
160 toxin NN I-NP O
160 Patient NNP I-NP O
160 was VBD B-VP O
161 treated VBN O O
161 symptomatically RB O O
161 with IN B-VP O
161 Imodium NNP B-NP B-m
161 p.r.n NN I-NP B-f
161 diarrhea NN I-NP B-r
161 Prior NNP I-NP O
161 to TO O O
162 discharge VB O O
162 , , O O
162 the DT B-NP O
162 patient NN I-NP O
162 was VBD B-VP O
162 counseled VBN O O
162 by IN B-VP O
162 the DT B-NP O
162 Nutrition NNP I-NP O
162 Service NNP I-NP O
163 regarding VBG O O
163 an DT B-NP O
163 appropriate JJ I-NP O
163 diabetic NN I-NP O
163 and CC O O
163 coronary JJ B-NP O
163 artery NN I-NP O
163 disease NN I-NP O
163 diet JJ O O
164 7 CD O O
164 PAIN: NNP B-NP O
164 On IN B-VP O
164 admission NN B-NP O
164 , , O O
164 the DT B-NP O
164 patient NN I-NP O
164 was VBD B-VP O
164 on IN B-VP O
164 several JJ B-NP O
164 pain NN I-NP B-m
164 medicines NNS I-NP I-m
164 , , O O
165 including VBG O O
165 amitriptyline JJ B-NP B-m
165 amitriptyline NN I-NP B-m
165 , , O O
165 Flexeril NNP B-NP B-m
165 Flexeril NNP I-NP B-m
165 , , O O
165 and CC O O
165 Valium NNP B-NP B-m
165 Valium NNP I-NP B-m
165 for IN B-VP O
165 reported VBD B-VP O
165 history NN B-NP O
166 of IN B-VP O
166 sciatica NN B-NP B-r
166 sciatica NN I-NP B-r
166 sciatica NN I-NP B-r
166 and CC O O
166 low JJ B-NP B-r
166 low JJ I-NP B-r
166 low NN I-NP B-r
166 back RB O I-r
166 back RB O I-r
166 back RB O I-r
166 pain NN B-NP I-r
166 pain NN I-NP I-r
166 pain NN I-NP I-r
166 On IN B-VP O
166 this DT B-NP O
166 hospitalization NN I-NP O
166 , , O O
166 these DT B-NP B-m
167 medications NNS I-NP O
167 were VBD B-VP O
167 discontinued VBN O O
167 and CC O O
167 she PRP O O
167 was VBD B-VP O
167 placed VBN O O
167 on IN B-VP O
167 Neurontin NNP B-NP B-m
167 for IN B-VP O
168 likely JJ B-NP B-r
168 diabetic JJ I-NP I-r
168 neuropathy JJ I-NP I-r
169 DISCHARGE NNP I-NP O
169 MEDICATIONS: NNP I-NP O
169 Enteric NNP I-NP B-m
169 coated VBD B-VP I-m
169 aspirin RB O I-m
169 325 CD O B-do
169 mg NNS B-NP I-do
169 p.o JJ B-NP B-mo
169 q.d NN I-NP B-f
169 , , O O
170 NPH NNP B-NP B-m
170 Humulin NNP I-NP I-m
170 insulin NN I-NP I-m
170 65 CD O B-do
170 U NNP B-NP I-do
170 subcu NN I-NP B-mo
170 b.i.d NN I-NP B-f
170 , , O O
171 human JJ B-NP B-m
171 human JJ I-NP B-m
171 human JJ I-NP B-m
171 human JJ I-NP B-m
171 human JJ I-NP B-m
171 insulin NN I-NP I-m
171 insulin NN I-NP I-m
171 insulin NN I-NP I-m
171 insulin NN I-NP I-m
171 insulin NN I-NP I-m
171 sliding VBG O B-do
171 scale: NN B-NP I-do
171 for IN B-VP O
171 blood NN B-NP B-r
171 sugars NNS I-NP I-r
171 151-200 JJ O O
171 give JJ O O
171 4 CD O B-do
171 U NNP B-NP I-do
171 , , O O
172 for IN B-VP O
172 blood NN B-NP B-r
172 sugars NNS I-NP I-r
172 201-250 JJ O O
172 give JJ O O
172 6 CD O B-do
172 U NNP B-NP I-do
172 , , O O
172 for IN B-VP O
172 blood NN B-NP B-r
172 sugars NNS I-NP I-r
172 251-300 JJ O O
172 give JJ O O
172 8 CD O B-do
173 U NNP B-NP O
173 , , O O
173 for IN B-VP O
173 blood NN B-NP B-r
173 sugars NNS I-NP I-r
173 301-350 JJ O O
173 give JJ O O
173 10 CD O B-do
173 U NNP B-NP I-do
173 , , O O
173 Imodium NNP B-NP B-m
173 2 CD O B-do
173 mg NN B-NP I-do
173 p.o NN I-NP B-mo
173 q VBD B-VP B-f
173 6 CD O I-f
173 hrs NN B-NP I-f
174 p.r.n NN I-NP O
174 diarrhea NN I-NP B-r
174 , , O O
174 Niferex NNP B-NP B-m
174 150 CD O B-do
174 mg NN B-NP I-do
174 p.o NN I-NP B-mo
174 b.i.d NN I-NP B-f
174 , , O O
174 nitroglycerin RB O B-m
174 1/150 CD O I-m
175 one CD O B-do
175 tab NN B-NP I-do
175 sublingual JJ B-NP B-mo
175 q NN I-NP B-f
175 5 CD O I-f
175 min NN B-NP I-f
175 x VBD B-VP I-f
175 3 CD O I-f
175 p.r.n JJ B-NP I-f
175 chest NN I-NP B-r
175 pain NN I-NP I-r
175 , , O O
175 multivitamin VB O B-m
176 one CD O B-do
176 tab NN B-NP I-do
176 p.o NN I-NP B-mo
176 q.d NN I-NP B-f
176 , , O O
176 simvastatin VBD B-VP B-m
176 10 CD O B-do
176 mg NN B-NP I-do
176 p.o NN I-NP B-mo
176 q.h.s NN I-NP B-f
176 , , O O
176 Neurontin NNP B-NP B-m
176 600 CD O B-do
176 mg NN B-NP I-do
177 p.o NN I-NP B-mo
177 t.i.d NN I-NP B-f
177 , , O O
177 levofloxacin VBZ O B-m
177 500 CD O B-do
177 mg NN B-NP I-do
177 p.o NN I-NP B-mo
177 q.d NN I-NP B-f
177 x $ O B-du
177 5 CD O I-du
177 days NNS B-NP I-du
177 , , O O
177 Toprol NNP B-NP B-m
177 XL NNP I-NP I-m
177 400 CD O B-do
178 mg NN B-NP O
178 p.o NN I-NP B-mo
178 q.d NN I-NP B-f
178 , , O O
178 lisinopril VBZ O B-m
178 40 CD O B-do
178 mg NN B-NP I-do
178 p.o NN I-NP B-mo
178 q.d JJ B-NP B-f
179 CONDITION NNP I-NP O
179 UPON NNP I-NP O
179 DISCHARGE: NNP I-NP O
179 Stable NNP I-NP O
180 DISPOSITION: NNP I-NP O
180 Prior NNP I-NP O
180 to TO O O
180 discharge VB O O
180 , , O O
180 the DT B-NP O
180 patient NN I-NP O
180 was VBD B-VP O
180 evaluated VBN O O
180 by IN B-VP O
180 the DT B-NP O
181 physical JJ I-NP O
181 therapist NN I-NP O
181 , , O O
181 who WP O O
181 noted VBD B-VP O
181 her PRP O O
181 to TO O O
181 walk VB O O
181 around IN B-VP O
181 the DT B-NP O
182 hospital NN I-NP O
182 Eldsche NNP I-NP O
182 St NNP I-NP O
182 , , O O
182 Lake NNP B-NP O
182 Corp NNP I-NP O
182 Ver NNP I-NP O
182 , , O O
182 Alaska NNP B-NP O
182 29176 CD O O
182 without IN B-VP O
182 significant JJ B-NP O
182 problems NNS I-NP O
182 They PRP O O
182 felt VBD B-VP O
182 that IN B-VP O
182 she PRP O O
183 would MD O O
183 be VB O O
183 safe JJ O O
183 to TO O O
183 discharge VB O O
183 to TO O O
183 home NN B-NP O
183 and CC O O
183 did VBD B-VP O
183 not RB O O
183 need VB O O
183 home NN B-NP O
183 PT NNP I-NP O
183 , , O O
183 but CC O O
184 agreed VBD B-VP O
184 that IN B-VP O
184 she PRP O O
184 would MD O O
184 benefit VB O O
184 from IN B-VP O
184 cardiac JJ B-NP O
184 rehab NN I-NP O
184 , , O O
184 for IN B-VP O
184 which WDT O O
184 she PRP O O
184 was VBD B-VP O
185 referred VBN O O
185 Patient NNP B-NP O
185 was VBD B-VP O
185 discharged VBN O O
185 to TO O O
185 home NN B-NP O
185 on IN B-VP O
185 hospital JJ B-NP O
185 day NN I-NP O
185 9 CD O O
185 , , O O
185 with IN B-VP O
186 VNA NNP B-NP O
186 , , O O
186 who WP O O
186 will MD O O
186 monitor VB O O
186 her PRP$ O O
186 blood NN B-NP O
186 pressure NN I-NP O
186 , , O O
186 pulse NN B-NP O
186 , , O O
186 and CC O O
186 blood NN B-NP O
186 sugar NN I-NP O
186 , , O O
187 and CC O O
187 contact VB O O
187 her PRP$ O O
187 PCP NNP B-NP O
187 with IN B-VP O
187 any DT B-NP O
187 concerns NNS I-NP O
187 or CC O O
187 questions NNS B-NP O
187 She PRP O O
187 will MD O O
188 follow VB O O
188 up RP O O
188 with IN B-VP O
188 her PRP$ O O
188 PCP NNP B-NP O
188 , , O O
188 Dr NNP B-NP O
188 Carmine NNP I-NP O
188 Guillebeau NNP I-NP O
188 , , O O
188 at IN B-VP O
188 WNDH NNP B-NP O
188 in IN B-VP O
188 one CD O O
188 week's NN B-NP O
189 time NN I-NP O
189 , , O O
189 and CC O O
189 she PRP O O
189 will MD O O
189 follow VB O O
189 up RP O O
189 with IN B-VP O
189 Dr NNP B-NP O
189 Sammie NNP I-NP O
189 Derobertis NNP I-NP O
189 of IN B-VP O
189 cardiology NN B-NP O
190 at IN B-VP O
190 Gons NNP B-NP O
190 Landgilesnyton NNP I-NP O
190 Dralvail NNP I-NP O
190 in IN B-VP O
190 May NNP B-NP O
191 Dictated NNP I-NP O
191 By: NNP I-NP O
191 DAMIAN NNP I-NP O
191 TABISOLA NNP I-NP O
191 , , O O
191 M.D NNP B-NP O
191 D NNP I-NP O
192 Attending: NNP I-NP O
192 BRODERICK NNP I-NP O
192 TURPEN NNP I-NP O
192 , , O O
192 M.D NNP B-NP O
192 IJ11 NNP I-NP O
192 WE511/247457 NNP I-NP O
193 Batch: NNP I-NP O
193 33669 CD O O
193 Index NNP B-NP O
193 No NNP I-NP O
193 MKYNKN6RWB NNP I-NP O
193 D: NNP I-NP O
193 10/9/01 CD O O
194 T: NNP B-NP O
194 10/9/01 CD O O
195 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #828964 VBZ O O
4 037061753 CD O O
4 NCPUMC NNP B-NP O
4 63134887 CD O O
4 477589 CD O O
4 0/24/1995 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/16/1995 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/19/1995 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 MYOCARDIAL NNP I-NP O
7 INFARCTION NNP I-NP O
8 SECONDARY NNP I-NP O
8 DIAGNOSES: NNP I-NP O
8 HYPERLIPIDEMIA NNP I-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 Mr NNP I-NP O
9 Legions NNP I-NP O
9 is VBZ O O
9 a DT O O
9 54 CD O O
9 year NN B-NP O
9 old JJ B-NP O
9 professor NN I-NP O
10 at IN B-VP O
10 A NNP B-NP O
10 No NNP I-NP O
10 Sa NNP I-NP O
10 , , O O
10 status NN B-NP O
11 post NN I-NP O
11 coronary JJ B-NP O
11 artery NN I-NP O
11 bypass NN I-NP O
11 graft NN I-NP O
11 ( ( O O
11 5 CD O O
11 vessel NN B-NP O
11 bypass NN I-NP O
11 ) ) O O
11 8 CD O O
11 years NNS B-NP O
11 ago RB O O
11 who WP O O
12 presents VBZ O O
12 with IN B-VP O
12 recurrent JJ B-NP O
12 substernal JJ I-NP O
12 chest NN I-NP O
12 pain NN I-NP O
12 times NNS I-NP O
12 one CD O O
12 day NN B-NP O
12 The DT B-NP O
13 patient NN I-NP O
13 was VBD B-VP O
13 transferred VBN O O
13 from IN B-VP O
13 Phlukester NNP B-NP O
13 Hospital NNP I-NP O
13 after IN B-VP O
13 developing VBG O O
13 the DT B-NP O
14 acute NN I-NP O
14 onset NN I-NP O
14 of IN B-VP O
14 substernal JJ B-NP O
14 chest NN I-NP O
14 pain NN I-NP O
14 while IN B-VP O
14 driving VBG O O
14 his PRP$ O O
14 automobile NN B-NP O
15 The DT B-NP O
15 patient NN I-NP O
15 was VBD B-VP O
15 under IN B-VP O
15 no DT B-NP O
15 extraordinary JJ I-NP O
15 circumstances NNS I-NP O
15 ( ( O O
15 e.g JJ B-NP O
16 emotional JJ I-NP O
16 stress NN I-NP O
16 , , O O
16 exertional JJ B-NP O
16 stress NN I-NP O
16 ) ) O O
16 at IN B-VP O
16 the DT B-NP O
16 time NN I-NP O
16 he PRP O O
16 developed VBD B-VP O
16 chest JJS B-NP O
17 pain NN I-NP O
17 Since IN B-VP O
17 the DT B-NP O
17 time NN I-NP O
17 of IN B-VP O
17 his PRP$ O O
17 five CD O O
17 vessel NN B-NP O
17 CABG NNP I-NP O
17 in IN B-VP O
17 1987 CD O O
17 , , O O
17 the DT B-NP O
17 patient NN I-NP O
18 had VBD B-VP O
18 experienced VBN O O
18 no DT O O
18 intercurrent JJ O O
18 angina VBZ O O
19 The DT B-NP O
19 patient's NN I-NP O
19 coronary JJ B-NP O
19 risk NN I-NP O
19 factors NNS I-NP O
19 include VBP O O
19 a DT B-NP O
19 positive JJ I-NP O
19 family NN I-NP O
20 history NN I-NP O
20 and CC O O
20 a DT B-NP O
20 previous JJ I-NP O
20 diagnosis NN I-NP O
20 of IN B-VP O
20 hyperlipidemia NN B-NP O
20 However RB O O
20 the DT B-NP O
21 patient NN I-NP O
21 does VBZ O O
21 not RB O O
21 have VB O O
21 hypertension NN B-NP O
21 , , O O
21 diabetes NNS B-NP O
21 and CC O O
21 he PRP O O
21 is VBZ O O
21 not RB O O
21 a DT B-NP O
22 tobacco NN I-NP O
22 smoker NN I-NP O
23 As IN B-VP O
23 mentioned VBN O O
23 , , O O
23 the DT B-NP O
23 patient's NN I-NP O
23 chest NN I-NP O
23 pain NN I-NP O
23 was VBD B-VP O
23 substernal JJ O O
23 and CC O O
23 radiated VBD B-VP O
24 to TO O O
24 the DT B-NP O
24 upper JJ I-NP O
24 epigastrium NN I-NP O
24 He PRP O O
24 experienced VBD B-VP O
24 an DT B-NP O
24 element NN I-NP O
24 of IN B-VP O
24 burning VBG O O
25 with IN B-VP O
25 exertion NN B-NP O
25 Prior NNP I-NP O
25 to TO O O
25 this DT B-NP O
25 episode NN I-NP O
25 of IN B-VP O
25 recurrent NN B-NP O
25 chest NN I-NP O
25 pain NN I-NP O
25 , , O O
25 the DT B-NP O
26 patient NN I-NP O
26 had VBD B-VP O
26 had VBN O O
26 multiple JJ B-NP O
26 exercise NN I-NP O
26 tolerance NN I-NP O
26 tests NNS I-NP O
26 which WDT O O
26 were VBD B-VP O
26 read VBN O O
27 as IN B-VP O
27 normal JJ O O
27 He PRP O O
27 graded VBD B-VP O
27 the DT B-NP O
27 chest JJS I-NP O
27 pain NN I-NP O
27 at IN B-VP O
27 8/10 CD O O
28 The DT B-NP O
28 patient NN I-NP O
28 presented VBD B-VP O
28 to TO O O
28 G NNP B-NP O
28 urgent NN I-NP O
28 care NN I-NP O
28 where WRB O O
28 his PRP$ O B-r
28 pain NN B-NP I-r
28 was VBD B-VP O
28 not RB O O
29 relieved VBN O O
29 with IN B-VP O
29 four CD O B-do
29 sublingual JJ O B-mo
29 nitroglycerin RB O B-m
29 An DT B-NP O
29 EKG NNP I-NP O
29 demonstrated VBD B-VP O
30 lateral JJ B-NP O
30 ST NNP I-NP O
30 wave NN I-NP O
30 depressions NNS I-NP O
30 The DT B-NP O
30 patient NN I-NP O
30 was VBD B-VP O
30 transferred VBN O O
30 to TO O O
31 Skaggssin NNP B-NP O
31 Hospital NNP I-NP O
31 where WRB O O
31 IV NNP B-NP B-mo
31 TNG NNP I-NP B-m
31 , , O O
31 morphine NN B-NP B-m
31 and CC O O
31 Nifedipine NNP B-NP B-m
31 were VBD B-VP O
31 given VBN O O
32 The DT B-NP O
32 patient's NN I-NP O
32 pain NN I-NP O
32 decreased VBD B-VP O
32 to TO O O
32 a DT B-NP O
32 level NN I-NP O
32 of IN B-VP O
32 4/10 CD O O
32 Despite IN B-VP O
32 these DT B-NP O
33 maneuvers NNS I-NP O
33 , , O O
33 the DT B-NP B-r
33 patient's NN I-NP I-r
33 pain NN I-NP I-r
33 continued VBD B-VP O
33 through IN B-VP O
33 the DT B-NP O
33 night NN I-NP O
33 and CC O O
33 in IN B-VP O
34 the DT B-NP O
34 morning NN I-NP O
34 In IN B-VP O
34 the DT B-NP O
34 morning NN I-NP O
34 , , O O
34 he PRP O O
34 received VBD B-VP O
34 additional JJ B-NP O
34 morphine NN I-NP B-m
34 and CC O O
35 IV NNP B-NP B-mo
35 Heparin NNP I-NP B-m
35 was VBD B-VP O
35 begun VBN O O
35 Subsequently RB O O
35 the DT B-NP O
35 patient NN I-NP O
35 became VBD B-VP O
35 pain-free JJ O O
36 The DT B-NP O
36 patient NN I-NP O
36 was VBD B-VP O
36 transferred VBN O O
36 to TO O O
36 Ck NNP B-NP O
36 Health NNP I-NP O
36 Of IN B-VP O
36 for IN B-VP O
37 further JJ B-NP O
37 management NN I-NP O
38 PAST NNP I-NP O
38 MEDICAL NNP I-NP O
38 HISTORY: NNP I-NP O
38 Hyperlipidemia NNP I-NP O
38 Bilateral NNP I-NP O
38 anterior NN I-NP O
38 and CC O O
39 lateral JJ B-NP O
39 thigh JJ I-NP O
39 achiness NN I-NP O
39 with IN B-VP O
39 exertion NN B-NP O
40 times NNS I-NP O
40 six CD O O
40 months NNS B-NP O
40 ( ( O O
40 workup NN B-NP O
40 in IN B-VP O
40 progress NN B-NP O
40 ) ) O O
41 MEDICATIONS: NN B-NP O
41 On IN B-VP O
41 presentation NN B-NP O
41 to TO O O
41 Menjack NNP B-NP O
41 Hospital NNP I-NP O
41 Medical NNP I-NP O
41 Center NNP I-NP O
41 , , O O
42 Lovastatin NNP B-NP B-m
42 Lovastatin NNP I-NP B-m
42 40 CD O B-do
42 mg NN B-NP I-do
42 q NN I-NP B-f
42 q.m NN I-NP I-f
42 , , O O
42 20 CD O B-do
42 mg NN B-NP I-do
42 q NN I-NP B-f
42 p.m NN I-NP I-f
42 and CC O O
43 enteric-coated JJ B-NP B-m
43 aspirin NN I-NP I-m
43 one CD O B-do
43 tablet NN B-NP I-do
43 q NN I-NP B-f
43 day NN I-NP I-f
44 MEDICATIONS NNP I-NP O
44 ON NNP I-NP O
44 TRANSFER NNP I-NP O
44 FROM NNP I-NP O
44 A,XO NNP I-NP O
44 COMMUNITY NNP I-NP O
44 HOSPITAL NNP I-NP O
44 IV NNP I-NP B-mo
44 nitroglycerin NN I-NP B-m
44 , , O O
44 IV NNP B-NP B-mo
44 heparin NN I-NP B-m
44 , , O O
44 Nifedipine NNP B-NP B-m
44 SL NNP I-NP B-mo
44 , , O O
44 morphine NN B-NP B-m
44 as RB O O
45 well RB O O
45 as IN B-VP O
45 aspirin NN B-NP B-m
45 and CC O O
45 Lovastatin NNP B-NP B-m
46 The DT B-NP O
46 patient NN I-NP O
46 has VBZ O O
46 no DT O O
46 known VBN O O
46 drug NN B-NP O
46 allergies NNS I-NP O
47 FAMILY NNP I-NP O
47 HISTORY: NNP I-NP O
47 The DT B-NP O
47 patient's NN I-NP O
47 father NN I-NP O
47 developed VBD B-VP O
47 angina RB O O
47 secondary JJ O O
48 to TO O O
48 coronary JJ B-NP O
48 artery NN I-NP O
48 disease NN I-NP O
48 at IN B-VP O
48 age NN B-NP O
48 54 CD O O
48 and CC O O
48 died VBD B-VP O
49 at IN B-VP O
49 age NN B-NP O
49 75 CD O O
49 from IN B-VP O
49 an DT B-NP O
49 MI NNP I-NP O
50 SOCIAL NNP I-NP O
50 HISTORY: NNP I-NP O
50 The DT B-NP O
50 patient NN I-NP O
50 is VBZ O O
50 married JJ O O
50 and CC O O
50 lives VBZ O O
50 at IN B-VP O
50 home NN B-NP O
50 with IN B-VP O
51 his PRP$ O O
51 wife NN B-NP O
51 He PRP O O
51 works VBZ O O
51 as IN B-VP O
51 a DT B-NP O
51 professor NN I-NP O
51 at IN B-VP O
52 Rieglemoinesro NNP B-NP O
52 A NNP I-NP O
52 Shing NNP I-NP O
52 and CC O O
52 restores VBZ O O
52 buildings NNS B-NP O
52 in IN B-VP O
52 his PRP$ O O
52 free JJ B-NP O
52 time NN I-NP O
53 HABITS: NNP I-NP O
53 The DT B-NP O
53 patient NN I-NP O
53 denies VBZ O O
53 tobacco NN B-NP O
53 use NN I-NP O
53 He PRP O O
53 is VBZ O O
53 an DT B-NP O
54 occasional JJ I-NP O
54 alcohol NN I-NP O
54 drinker NN I-NP O
55 PHYSICAL NNP I-NP O
55 EXAMINATION: NNP I-NP O
55 On IN B-VP O
55 physical JJ B-NP O
55 examination NN I-NP O
55 , , O O
55 Mr NNP B-NP O
55 Latimer NNP I-NP O
55 is VBZ O O
56 a DT B-NP O
56 pleasant JJ I-NP O
56 middle-aged JJ I-NP O
56 man NN I-NP O
56 , , O O
56 mildly RB O O
57 anxious JJ O O
57 but CC O O
57 in IN B-VP O
57 no DT B-NP O
57 acute NN I-NP O
57 distress NN I-NP O
57 Vital NNP I-NP O
57 signs NNS I-NP O
57 on IN B-VP O
57 transfer: JJ B-NP O
58 temperature NN I-NP O
58 98.6 CD O O
58 , , O O
58 heart NN B-NP O
58 rate NN I-NP O
58 78 CD O O
58 , , O O
58 blood NN B-NP O
58 pressure NN I-NP O
58 110/78 CD O O
58 , , O O
58 respiratory NN B-NP O
59 rate NN I-NP O
59 22 CD O O
59 with IN B-VP O
59 oxygen JJ B-NP O
59 saturation NN I-NP O
59 of IN B-VP O
59 99% CD O O
59 on IN B-VP O
59 4 CD O B-do
59 liters NNS B-NP I-do
59 of IN B-VP O
59 oxygen NN B-NP B-m
60 HEENT: NNP I-NP O
60 unremarkable JJ B-NP O
60 Neck: NNP I-NP O
60 no DT B-NP O
60 jugular JJ I-NP O
60 venous JJ I-NP O
60 distention NN I-NP O
60 ( ( O O
60 JVP NNP B-NP O
61 less JJR O O
61 than IN B-VP O
61 6 CD O O
61 cm NN B-NP O
61 ) ) O O
61 , , O O
61 carotids NNS B-NP O
61 were VBD B-VP O
61 2+ CD O O
61 bilaterally RB O O
61 with IN B-VP O
61 no DT B-NP O
61 bruits NNS I-NP O
61 or CC O O
62 delayed VBN O O
62 upstroke JJ B-NP O
62 Lungs: NNP I-NP O
62 clear JJ O O
62 with IN B-VP O
62 good JJ B-NP O
62 breath NN I-NP O
62 sounds NNS I-NP O
63 bilaterally RB O O
63 Coronary: NNP B-NP O
63 regular JJ B-NP O
63 rate NN I-NP O
63 and CC O O
63 rhythm NN B-NP O
63 with IN B-VP O
63 good JJ B-NP O
63 heart NN I-NP O
64 sounds NNS I-NP O
64 and CC O O
64 a DT B-NP O
64 clear JJ I-NP O
64 Sl NNP I-NP O
64 and CC O O
64 S2 NNP B-NP O
64 There EX O O
64 were VBD B-VP O
64 no DT B-NP O
64 rubs NN I-NP O
64 , , O O
64 murmurs NNS B-NP O
64 or CC O O
65 gallops NNS B-NP O
65 appreciated VBD B-VP O
65 There EX O O
65 was VBD B-VP O
65 no DT B-NP O
65 S3 NNP I-NP O
65 or CC O O
65 S4 NNP B-NP O
65 The DT B-NP O
65 point NN I-NP O
65 of IN B-VP O
65 maximum JJ B-NP O
66 impulse NN I-NP O
66 was VBD B-VP O
66 not RB O O
66 displaced VBN O O
66 The DT B-NP O
66 patient's NN I-NP O
66 spine NN I-NP O
66 was VBD B-VP O
66 not RB O O
66 tender NN B-NP O
66 and CC O O
67 there EX O O
67 was VBD B-VP O
67 no DT B-NP O
67 evidence NN I-NP O
67 of IN B-VP O
67 costovertebral JJ B-NP O
67 angle NN I-NP O
67 tenderness NN I-NP O
67 Abdomen NNP I-NP O
68 had VBD B-VP O
68 good JJ B-NP O
68 bowel NN I-NP O
68 sounds NNS I-NP O
68 and CC O O
68 was VBD B-VP O
68 soft JJ O O
68 and CC O O
68 nontender NN B-NP O
68 to TO O O
68 palpation VB O O
68 No DT B-NP O
69 masses NNS I-NP O
69 were VBD B-VP O
69 palpated VBN O O
69 Groin NNP B-NP O
69 demonstrated VBD B-VP O
69 decreased JJ B-NP O
69 femoral JJ I-NP O
69 pulses NNS I-NP O
70 bilaterally RB O O
70 with IN B-VP O
70 a DT B-NP O
70 faint NN I-NP O
70 left VBD B-VP O
70 femoral JJ B-NP O
70 bruit NN I-NP O
70 Rectal: NNP I-NP O
70 normal JJ B-NP O
71 rectal JJ I-NP O
71 tone NN I-NP O
71 with IN B-VP O
71 an DT B-NP O
71 anodular JJ I-NP O
71 prostate NN I-NP O
71 Stool NNP I-NP O
71 was VBD B-VP O
71 soft JJ O O
71 , , O O
71 brown JJ O O
71 and CC O O
72 guaiac JJ B-NP O
72 negative JJ I-NP O
72 Extremities NNS I-NP O
72 demonstrated VBD B-VP O
72 no DT B-NP O
72 clubbing NN I-NP O
72 , , O O
72 cyanosis NN B-NP O
72 or CC O O
73 edema VB O O
73 The DT B-NP O
73 patient's NN I-NP O
73 pulses VBZ O O
73 at IN B-VP O
73 the DT B-NP O
73 dorsalis NN I-NP O
73 pedis NN I-NP O
73 and CC O O
73 posterior JJ B-NP O
74 tibialis NNS I-NP O
74 were VBD B-VP O
74 2+ CD O O
74 bilaterally RB O O
74 Neurologic NNP B-NP O
74 examination NN I-NP O
74 was VBD B-VP O
74 nonfocal JJ B-NP O
75 Electrolytes NNS I-NP O
75 on IN B-VP O
75 presentation NN B-NP O
75 were VBD B-VP O
75 within IN B-VP O
75 normal JJ B-NP O
75 limits NNS I-NP O
75 His PRP$ O O
75 LFTs NNP B-NP O
76 were VBD B-VP O
76 notable JJ O O
76 for IN B-VP O
76 a DT B-NP O
76 slight JJ I-NP O
76 increase NN I-NP O
76 in IN B-VP O
76 his PRP$ O O
76 LDH NNP B-NP O
76 to TO O O
76 252 CD O O
76 The DT B-NP O
77 patient's NN I-NP O
77 first RB O O
77 CK NNP B-NP O
77 on IN B-VP O
77 presentation NN B-NP O
77 was VBD B-VP O
77 2300 CD O O
77 with IN B-VP O
77 a DT B-NP O
77 quantitative JJ I-NP O
77 MB NNP I-NP O
78 of IN B-VP O
78 10.2 CD O O
78 ng/ml NNS B-NP O
78 Cholesterol NNP I-NP O
78 was VBD B-VP O
78 79 CD O O
78 Albumin NNP B-NP O
78 2.8 CD O O
78 Protime NNP B-NP O
78 12.4 CD O O
78 , , O O
79 INR NNP B-NP O
79 1.1 CD O O
79 PTT NNP B-NP O
79 40.7 CD O O
79 , , O O
79 consistent NN B-NP O
79 with IN B-VP O
79 heparin JJ B-NP B-m
79 therapy NN I-NP O
79 CBC NNP I-NP O
79 was VBD B-VP O
80 notable JJ O O
80 for IN B-VP O
80 a DT B-NP O
80 normal JJ I-NP O
80 white JJ I-NP O
80 count NN I-NP O
80 , , O O
80 hematocrit NN B-NP O
80 and CC O O
80 platelet NN B-NP O
80 count NN I-NP O
81 Urine NNP I-NP O
81 had VBD B-VP O
81 a DT B-NP O
81 specific JJ I-NP O
81 gravity NN I-NP O
81 of IN B-VP O
81 1.021 CD O O
81 , , O O
81 pH NN B-NP O
81 5 CD O O
81 , , O O
81 negative JJ B-NP O
81 dipstick NN I-NP O
82 evaluation NN I-NP O
83 Chest NNP I-NP O
83 x-ray NN I-NP O
83 demonstrated VBD B-VP O
83 clear JJ B-NP O
83 lung NN I-NP O
83 parenchyma NN I-NP O
83 and CC O O
83 no DT B-NP O
83 bony NN I-NP O
84 abnormalities VBZ O O
84 EKG NNP B-NP O
84 on IN B-VP O
84 admission NN B-NP O
84 to TO O O
84 Raldmance NNP B-NP O
84 Mountbay NNP I-NP O
85 showed VBD B-VP O
85 normal JJ B-NP O
85 sinus NN I-NP O
85 rhythm NN I-NP O
85 at IN B-VP O
85 a DT B-NP O
85 rate NN I-NP O
85 of IN B-VP O
85 73 CD O O
85 with IN B-VP O
85 normal JJ B-NP O
85 intervals NNS I-NP O
86 and CC O O
86 an DT B-NP O
86 axis NN I-NP O
86 of IN B-VP O
86 0 CD O O
86 The DT B-NP O
86 patient NN I-NP O
86 had VBD B-VP O
86 Q NNP B-NP O
86 waves NNS I-NP O
86 in IN B-VP O
86 leads NNS B-NP O
86 3 CD O O
86 and CC O O
86 F NNP B-NP O
86 and CC O O
87 biphasic JJ B-NP O
87 T NNP I-NP O
87 waves NNS I-NP O
87 in IN B-VP O
87 leads NNS B-NP O
87 V4 NNP I-NP O
87 through IN B-VP O
87 V6 NNP B-NP O
87 There EX O O
87 was VBD B-VP O
87 minimal JJ B-NP O
87 change NN I-NP O
88 in IN B-VP O
88 these DT B-NP O
88 abnormalities NNS I-NP O
88 with IN B-VP O
88 resolution NN B-NP O
88 of IN B-VP O
88 the DT B-NP O
88 patient's NN I-NP O
88 pain NN I-NP O
88 Of IN B-VP O
89 note NN B-NP O
89 , , O O
89 EKGs NNP B-NP O
89 taken VBN O O
89 at IN B-VP O
89 Townileahli NNP B-NP O
89 Medical NNP I-NP O
89 Center NNP I-NP O
89 during IN B-VP O
89 the DT B-NP O
89 patient's JJ I-NP O
89 initial JJ I-NP O
90 admission NN I-NP O
90 were VBD B-VP O
90 notable JJ O O
90 for IN B-VP O
90 T NNP B-NP O
90 wave VBP O O
90 depressions NNS B-NP O
90 in IN B-VP O
90 leads NNS B-NP O
90 V4 NNP I-NP O
90 through IN B-VP O
91 V6 NNP B-NP O
92 HOSPITAL NNP I-NP O
92 COURSE: NNP I-NP O
92 The DT B-NP O
92 patient NN I-NP O
92 was VBD B-VP O
92 admitted VBN O O
92 to TO O O
92 the DT B-NP O
92 Cardiac NNP I-NP O
93 Intensive NNP I-NP O
93 Care NNP I-NP O
93 Unit NNP I-NP O
93 on IN B-VP O
93 IV NNP B-NP B-mo
93 heparin NN I-NP B-m
93 and CC O O
94 nitroglycerine NN B-NP B-m
94 as RB O O
94 well RB O O
94 as IN B-VP O
94 continuation NN B-NP O
94 of IN B-VP O
94 his PRP$ O O
94 aspirin NN B-NP B-m
94 and CC O O
95 Lovastatin NNP B-NP B-m
95 The DT B-NP B-r
95 patient's NN I-NP I-r
95 pain NN I-NP I-r
95 was VBD B-VP O
95 treated VBN O O
95 with IN B-VP O
95 morphine NN B-NP B-m
95 sulfate NN I-NP I-m
96 His PRP$ O O
96 CKs NNP B-NP O
96 were VBD B-VP O
96 followed VBN O O
96 serially RB O O
96 every DT O O
96 8 CD O O
96 hours NNS B-NP O
96 and CC O O
96 achieved VBD B-VP O
96 a DT B-NP O
96 peak JJ I-NP O
96 CK NNP I-NP O
97 of IN B-VP O
97 2790 CD O O
97 on IN B-VP O
97 2/15/95 CD O O
97 at IN B-VP O
97 12 CD O O
97 a.m NN B-NP O
97 with IN B-VP O
97 an DT B-NP O
97 MB NNP I-NP O
97 fraction NN I-NP O
97 of IN B-VP O
97 188.8 CD O O
97 ng/ml JJ B-NP O
98 Thereafter NNP I-NP O
98 the DT B-NP O
98 patient's NN I-NP O
98 CKs NNP I-NP O
98 rapidly RB O O
98 declined VBD B-VP O
98 On IN B-VP O
98 3/26/94 CD O O
98 , , O O
98 the DT B-NP O
99 patient's NN I-NP O
99 CK NNP I-NP O
99 was VBD B-VP O
99 317 CD O O
99 with IN B-VP O
99 an DT B-NP O
99 MB NNP I-NP O
99 fraction NN I-NP O
99 of IN B-VP O
99 3.5 CD O O
99 ng/ml NNS B-NP O
100 After IN B-VP O
100 24 CD O O
100 hours NNS B-NP O
100 pain-free JJ O O
100 in IN B-VP O
100 the DT B-NP O
100 Cardiac NNP I-NP O
100 Intensive NNP I-NP O
100 Care NNP I-NP O
100 Unit NNP I-NP O
100 , , O O
100 the DT B-NP O
101 patient NN I-NP O
101 was VBD B-VP O
101 transferred VBN O O
101 to TO O O
101 the DT B-NP O
101 Cardiac NNP I-NP O
101 Step-Down NNP I-NP O
101 floor NN I-NP O
101 His PRP$ O O
101 IV NNP B-NP B-mo
102 nitroglycerin NN I-NP B-m
102 and CC O O
102 IV NNP B-NP B-mo
102 heparin NN I-NP B-m
102 were VBD B-VP O
102 discontinued VBN O O
102 and CC O O
102 the DT B-NP O
102 patient NN I-NP O
103 remained VBD B-VP O
103 pain-free JJ B-NP O
103 Echocardiogram NNP I-NP O
103 performed VBD B-VP O
103 on IN B-VP O
103 2/15/95 CD O O
104 demonstrated JJ B-NP O
104 inferior NN I-NP O
104 and CC O O
104 posterior JJ B-NP O
104 hypokinesis NN I-NP O
104 with IN B-VP O
104 an DT B-NP O
104 ejection NN I-NP O
105 fraction NN I-NP O
105 of IN B-VP O
105 approximately RB O O
105 46% CD O O
106 On IN B-VP O
106 3/21/95 CD O O
106 , , O O
106 the DT B-NP O
106 patient JJ I-NP O
106 underwent JJ I-NP O
106 exercise NN I-NP O
106 tolerance NN I-NP O
106 testing VBG O O
106 with IN B-VP O
106 a DT B-NP O
107 submax NN I-NP O
107 modified VBN O O
107 Bruce NNP B-NP O
107 protocol VBZ O O
107 The DT B-NP O
107 patient NN I-NP O
107 exercised VBD B-VP O
107 9 CD O O
107 minutes NNS B-NP O
108 and CC O O
108 was VBD B-VP O
108 able JJ O O
108 to TO O O
108 complete VB O O
108 the DT B-NP O
108 study NN I-NP O
108 without IN B-VP O
108 dyspnea NN B-NP O
108 on IN B-VP O
108 exertion NN B-NP O
108 or CC O O
109 chest NN B-NP O
109 pain NN I-NP O
109 He PRP O O
109 achieved VBD B-VP O
109 a DT B-NP O
109 maximum JJ I-NP O
109 heart NN I-NP O
109 rate NN I-NP O
109 of IN B-VP O
109 108 CD O O
109 and CC O O
109 a DT B-NP O
110 maximum JJ I-NP O
110 blood NN I-NP O
110 pressure NN I-NP O
110 of IN B-VP O
110 160/80 CD O O
110 EKG NNP B-NP O
110 was VBD B-VP O
110 notable JJ O O
110 for IN B-VP O
110 unifocal JJ B-NP O
111 PVCs NNP I-NP O
111 and CC O O
111 up RB O O
111 to TO O O
111 2 CD O O
111 mm NNS B-NP O
111 ST NNP I-NP B-r
111 depression NN I-NP I-r
111 in IN B-VP O
111 leads NNS B-NP O
111 V2 NNP I-NP O
111 through IN B-VP O
111 V4 NNP B-NP O
111 which WDT O O
112 persisted VBD B-VP O
112 up RB O O
112 to TO O O
112 15 CD O O
112 minutes NNS B-NP O
112 into IN B-VP O
112 recovery NN B-NP O
112 The DT B-NP O
112 patient NN I-NP O
112 was VBD B-VP O
112 given VBN O O
113 one CD O B-do
113 sublingual JJ B-NP B-mo
113 nitroglycerin NN I-NP B-m
113 and CC O O
113 these DT B-NP O
113 EKG NNP I-NP O
113 changes NNS I-NP O
113 resolved VBD B-VP O
114 The DT B-NP O
114 exercise NN I-NP O
114 tolerance NN I-NP O
114 test NN I-NP O
114 was VBD B-VP O
114 interpreted VBN O O
114 as IN B-VP O
114 strongly RB O O
114 positive JJ O O
115 for IN B-VP O
115 ischemic JJ B-NP O
115 coronary JJ I-NP O
115 artery NN I-NP O
115 disease NN I-NP O
116 On IN B-VP O
116 3/28/95 CD O O
116 , , O O
116 the DT B-NP O
116 patient NN I-NP O
116 underwent NN I-NP O
116 a DT B-NP O
116 submax NN I-NP O
116 MIBI NNP I-NP O
116 to TO O O
116 assess VB O O
116 coronary JJ B-NP O
117 perfusion NN I-NP O
117 of IN B-VP O
117 the DT B-NP O
117 heart NN I-NP O
117 Similarly NNP I-NP O
117 , , O O
117 the DT B-NP O
117 exercise NN I-NP O
117 component NN I-NP O
117 of IN B-VP O
117 this DT B-NP O
118 examination NN I-NP O
118 demonstrated VBD B-VP O
118 EKG NNP B-NP O
118 changes NNS I-NP O
118 consistent VBP O O
118 with IN B-VP O
118 ischemic JJ B-NP O
119 coronary JJ I-NP O
119 flow NN I-NP O
119 Nuclear NNP I-NP O
119 imaging NN I-NP O
119 demonstrated VBD B-VP O
119 a DT B-NP O
119 fixed JJ I-NP O
119 apical JJ I-NP O
119 lateral JJ I-NP O
120 defect NN I-NP O
120 in IN B-VP O
120 the DT B-NP O
120 patient's JJ I-NP O
120 heart NN I-NP O
120 consistent NN I-NP O
120 with IN B-VP O
120 a DT O O
120 healed VBN O O
120 or CC O O
120 healing VBG O O
121 transmural JJ B-NP O
121 infarct NN I-NP O
121 There EX O O
121 was VBD B-VP O
121 no DT B-NP O
121 evidence NN I-NP O
121 of IN B-VP O
121 ischemic JJ B-NP O
121 reperfusion NN I-NP O
122 defects VBZ O O
123 The DT B-NP O
123 results NNS I-NP O
123 of IN B-VP O
123 these DT B-NP O
123 tests NNS I-NP O
123 were VBD B-VP O
123 discussed VBN O O
123 with IN B-VP O
123 the DT B-NP O
123 patient NN I-NP O
123 and CC O O
123 his PRP$ O O
124 wife NN B-NP O
124 in IN B-VP O
124 conjunction NN B-NP O
124 with IN B-VP O
124 the DT O O
124 treating VBG O O
124 medical JJ B-NP O
124 team NN I-NP O
124 of IN B-VP O
124 Dr NNP B-NP O
124 Settecase NNP I-NP O
125 The DT B-NP O
125 patient NN I-NP O
125 was VBD B-VP O
125 offered VBN O O
125 the DT B-NP O
125 opportunity NN I-NP O
125 for IN B-VP O
125 coronary JJ B-NP O
126 catheterization NN I-NP O
126 to TO O O
126 evaluate VB O O
126 his PRP$ O O
126 anatomy NN B-NP O
126 , , O O
126 but CC O O
126 he PRP O O
126 declined VBD B-VP O
126 at IN B-VP O
126 the DT B-NP O
127 present JJ I-NP O
127 time NN I-NP O
127 It PRP O O
127 was VBD B-VP O
127 decided VBN O O
127 that IN B-VP O
127 the DT B-NP O
127 patient NN I-NP O
127 would MD O O
127 be VB O O
127 maximally RB O O
128 medically RB O O
128 managed VBN O O
128 and CC O O
128 discharged VBN O O
128 to TO O O
128 home NN B-NP O
128 with IN B-VP O
128 close JJ B-NP O
128 followup NNS I-NP O
128 under IN B-VP O
129 Dr NNP B-NP O
129 Cockburn NNP I-NP O
129 and CC O O
129 Dr NNP B-NP O
129 Stenkamp NNP I-NP O
129 The DT B-NP O
129 patient's NN I-NP O
129 cardiac JJ B-NP B-m
129 medications NNS I-NP I-m
129 were VBD B-VP O
130 appropriately RB O O
130 adjusted VBN O O
130 while IN B-VP O
130 an DT B-NP O
130 inpatient NN I-NP O
130 to TO O O
130 achieve VB O O
130 maximum JJ B-NP O
131 cardiac JJ I-NP O
131 benefit NN I-NP O
132 On IN B-VP O
132 presentation NN B-NP O
132 , , O O
132 the DT B-NP O
132 patient NN I-NP O
132 also RB O O
132 complained VBD B-VP O
132 of IN B-VP O
132 progressive JJ B-NP O
133 anterior NN I-NP O
133 and CC O O
133 lateral JJ B-NP O
133 thigh NN I-NP O
133 pain NN I-NP O
133 This DT B-NP O
133 pain NN I-NP O
133 was VBD B-VP O
133 brought VBN O O
133 on IN B-VP O
133 by IN B-VP O
134 exertion NN B-NP O
134 and CC O O
134 had VBD B-VP O
134 increasingly RB O O
134 limited VBN O O
134 his PRP$ O O
134 ability NN B-NP O
134 to TO O O
134 walk VB O O
134 over IN B-VP O
134 the DT O O
135 last JJ O O
135 six CD O O
135 months NNS B-NP O
135 whereas IN B-VP O
135 he PRP O O
135 had VBD B-VP O
135 been VBN O O
135 able JJ O O
135 to TO O O
135 walk VB O O
135 four CD O O
135 to TO O O
135 five CD O O
135 miles NNS B-NP O
136 a DT B-NP O
136 day NN I-NP O
136 in IN B-VP O
136 recent JJ B-NP O
136 months NNS I-NP O
136 He PRP O O
136 had VBD B-VP O
136 been VBN O O
136 able JJ O O
136 to TO O O
136 walk VB O O
136 only RB O O
137 approximately RB O O
137 one-quarter JJ B-NP O
137 mile NN I-NP O
137 before IN B-VP O
137 developing VBG O O
137 pain NN B-NP O
137 in IN B-VP O
137 his PRP$ O O
138 anterior JJ B-NP O
138 thighs NNS I-NP O
138 as RB O O
138 well RB O O
138 whereas IN B-VP O
138 he PRP O O
138 had VBD B-VP O
138 been VBN O O
138 able JJ O O
138 to TO O O
138 climb VB O O
138 several JJ B-NP O
139 flights NNS I-NP O
139 of IN B-VP O
139 stairs NNS B-NP O
139 a DT B-NP O
139 few JJ I-NP O
139 months NNS I-NP O
139 ago IN B-VP O
139 He PRP O O
139 now RB O O
139 was VBD B-VP O
139 able JJ O O
139 to TO O O
139 walk VB O O
139 only RB O O
140 half PDT O O
140 a DT B-NP O
140 flight NN I-NP O
140 to TO O O
140 a DT B-NP O
140 flight NN I-NP O
140 of IN B-VP O
140 stairs NNS B-NP O
140 at IN B-VP O
140 a DT B-NP O
140 time NN I-NP O
140 before IN B-VP O
140 having VBG O O
140 to TO O O
141 rest VB O O
141 Six CD O O
141 months NNS B-NP O
141 ago RB O O
141 , , O O
141 the DT B-NP O
141 patient NN I-NP O
141 had VBD B-VP O
141 achieved VBN O O
141 a DT O O
141 25 CD O O
141 pound NN B-NP O
141 weight VBD B-VP O
142 loss NN B-NP O
142 but CC O O
142 , , O O
142 by IN B-VP O
142 his PRP$ O O
142 report NN B-NP O
142 , , O O
142 because IN B-VP O
142 of IN B-VP O
142 his PRP$ O O
142 inability NN B-NP O
142 to TO O O
142 exercise VB O O
143 effectively RB O O
143 , , O O
143 he PRP O O
143 had VBD B-VP O
143 regained VBN O O
143 15 CD O O
143 pounds NNS B-NP O
143 The DT B-NP O
143 patient NN I-NP O
143 did VBD B-VP O
143 not RB O O
144 experience VB O O
144 this DT B-NP O
144 same JJ I-NP O
144 anterior JJ I-NP O
144 thigh NN I-NP O
144 pain NN I-NP O
144 while IN B-VP O
144 riding VBG O O
144 a DT B-NP O
144 bicycle NN I-NP O
144 or CC O O
145 swimming NN B-NP O
145 As IN B-VP O
145 an DT B-NP O
145 inpatient NN I-NP O
145 , , O O
145 Mr NNP B-NP O
145 Woollen NNP I-NP O
145 underwent VBD B-VP O
145 a DT B-NP O
145 non-invasive JJ I-NP O
146 vascular NN I-NP O
146 study NN I-NP O
146 of IN B-VP O
146 the DT O O
146 femoral JJ O O
146 and CC O O
146 popliteal JJ B-NP O
146 arteries NNS I-NP O
146 These DT O O
147 demonstrated VBD B-VP O
147 no DT B-NP O
147 significant JJ I-NP O
147 arterial JJ I-NP O
147 occlusions NNS I-NP O
147 as IN B-VP O
147 assessed VBN O O
147 by IN B-VP O
148 pressure NN B-NP O
148 manometry NN I-NP O
148 The DT B-NP O
148 possibility NN I-NP O
148 of IN B-VP O
148 myositis NN B-NP O
148 or CC O O
148 neuromuscular JJ B-NP O
149 compromise NN I-NP O
149 was VBD B-VP O
149 entertained VBN O O
149 and CC O O
149 these DT O O
149 are VBP O O
149 to TO O O
149 be VB O O
149 followed VBN O O
149 up RP O O
149 as IN B-VP O
149 an DT B-NP O
150 outpatient NN I-NP O
151 The DT B-NP O
151 patient NN I-NP O
151 also RB O O
151 complained VBD B-VP O
151 of IN B-VP O
151 symptoms NNS B-NP O
151 consistent JJ O O
151 with IN B-VP O
151 an DT B-NP O
151 upper JJ I-NP O
152 respiratory NN I-NP O
152 viral JJ B-NP O
152 infection NN I-NP O
152 which WDT O O
152 he PRP O O
152 had VBD B-VP O
152 been VBN O O
152 experiencing VBG O O
152 over IN B-VP O
152 the DT O O
153 past JJ O O
153 two CD O O
153 weeks NNS B-NP O
153 While IN B-VP O
153 an DT B-NP O
153 inpatient NN I-NP O
153 , , O O
153 he PRP O O
153 had VBD B-VP O
153 a DT B-NP O
153 number NN I-NP O
153 of IN B-VP O
153 febrile JJ B-NP O
154 episodes NNS I-NP O
154 , , O O
154 achieving VBG O O
154 a DT B-NP O
154 maximum JJ I-NP O
154 temperature NN I-NP B-r
154 temperature NN I-NP B-r
154 of IN B-VP O
154 101.4 CD O O
154 The DT B-NP O
154 patient NN I-NP O
155 was VBD B-VP O
155 treated VBN O O
155 symptomatically RB O O
155 with IN B-VP O
155 Tylenol NNP B-NP B-m
155 and CC O O
155 started VBD B-VP O
155 on IN B-VP O
155 Biaxin NNP B-NP B-m
155 500 CD O B-do
156 mg NN B-NP O
156 po NN I-NP B-mo
156 bid NN I-NP B-f
156 He PRP O O
156 received VBD B-VP O
156 a DT O O
156 five CD O B-du
156 day NN B-NP I-du
156 course NN I-NP I-du
156 of IN B-VP O
156 oral JJ B-NP B-mo
156 Biaxin NNP I-NP B-m
156 with IN B-VP O
157 resolution NN B-NP O
157 of IN B-VP O
157 his PRP$ O O
157 fever NN B-NP B-r
157 and CC O O
157 decrease NN B-NP O
157 in IN B-VP O
157 his PRP$ O O
157 symptomatology NN B-NP O
158 The DT B-NP O
158 patient NN I-NP O
158 never RB O O
158 complained VBD B-VP O
158 of IN B-VP O
158 shortness NN B-NP O
158 of IN B-VP O
158 breath NN B-NP O
158 , , O O
158 palpitations NNS B-NP O
158 , , O O
159 diaphoresis NN B-NP O
159 , , O O
159 nausea NN B-NP O
159 , , O O
159 vomiting VBG O O
159 or CC O O
159 recurrent JJ B-NP O
159 chest NN I-NP O
159 pain NN I-NP O
159 as IN B-VP O
159 an DT B-NP O
160 inpatient NN I-NP O
160 However RB O O
160 physical JJ B-NP O
160 examination NN I-NP O
160 demonstrated VBD B-VP O
160 rales NNS B-NP O
160 4 CD O O
160 to TO O O
160 5 CD O O
161 cm NNS B-NP O
161 above IN B-VP O
161 the DT B-NP O
161 bases NNS I-NP O
161 bilaterally RB O O
161 The DT B-NP O
161 extremities NNS I-NP O
161 remained VBD B-VP O
161 free JJ O O
161 of IN B-VP O
162 edema NN B-NP O
162 and CC O O
162 the DT B-NP O
162 patient's NN I-NP O
162 jugular NN I-NP O
162 venous JJ B-NP O
162 pressure NN I-NP O
162 never RB O O
162 exceeded VBD B-VP O
162 6 CD O O
163 cm NN B-NP O
163 A DT B-NP O
163 chest JJ I-NP O
163 x-ray NN I-NP O
163 on IN B-VP O
163 0/26/95 CD O O
163 demonstrated JJ B-NP O
163 evidence NN I-NP O
163 of IN B-VP O
163 early JJ B-NP B-r
164 congestive JJ I-NP O
164 heart NN I-NP O
164 failure NN I-NP O
164 The DT B-NP O
164 patient NN I-NP O
164 was VBD B-VP O
164 treated VBN O O
164 with IN B-VP O
164 daily JJ B-NP B-f
164 doses NNS I-NP O
165 of IN B-VP O
165 IV NNP B-NP B-mo
165 Lasix NNP I-NP B-m
165 with IN B-VP O
165 resolution NN B-NP O
165 of IN B-VP O
165 his PRP$ O O
165 rales NNS B-NP O
165 By IN B-VP O
165 the DT B-NP O
165 time NN I-NP O
165 of IN B-VP O
166 discharge NN B-NP O
166 , , O O
166 there EX O O
166 was VBD B-VP O
166 no DT B-NP O
166 evidence NN I-NP O
166 of IN B-VP O
166 continued JJ B-NP O
166 heart NN I-NP O
166 failure NN I-NP O
166 and CC O O
166 the DT B-NP O
167 patient's NN I-NP O
167 Lasix NNP I-NP B-m
167 was VBD B-VP O
167 discontinued VBN O O
168 DISCHARGE NNP B-NP O
168 MEDICATIONS: NNP I-NP O
169 1 CD O O
169 Enteric-coated JJ B-NP B-m
169 aspirin NN I-NP I-m
169 325 CD O B-do
169 mg NN B-NP I-do
169 po NN I-NP B-mo
169 q JJ B-NP B-f
169 day NN I-NP I-f
170 2 CD O O
170 Cholestyramine NNP B-NP B-m
170 one CD O B-do
170 packet NN B-NP I-do
170 po NN I-NP B-mo
170 q NN I-NP B-f
170 hs VBD B-VP I-f
171 3 CD O O
171 Lovastatin NNP B-NP B-m
171 20 CD O B-do
171 mg NN B-NP I-do
171 po NN I-NP B-mo
171 q NN I-NP B-f
171 hs VBD B-VP I-f
172 4 CD O O
172 Lopressor NNP B-NP B-m
172 50 CD O B-do
172 mg NN B-NP I-do
172 po NN I-NP B-mo
172 tid VBD B-VP B-f
173 5 CD O O
173 Sublingual NNP B-NP B-mo
173 nitroglycerin RB O B-m
173 1/150 CD O I-m
173 tablets NNS B-NP I-m
173 to TO O O
173 be VB O O
173 taken VBN O O
173 prn NN B-NP B-f
174 with IN B-VP O
174 chest NN B-NP B-r
174 pain NN I-NP I-r
175 DISPOSITION: NNP I-NP O
175 The DT B-NP O
175 patient NN I-NP O
175 is VBZ O O
175 being VBG O O
175 discharged VBN O O
175 to TO O O
175 home NN B-NP O
175 with IN B-VP O
176 followup NN B-NP O
176 in IN B-VP O
176 MERH NNP B-NP O
176 under IN B-VP O
176 Drs NNP B-NP O
176 Dwayne NNP I-NP O
176 Ariel NNP I-NP O
176 Bremme NNP I-NP O
177 The DT B-NP O
177 patient NN I-NP O
177 was VBD B-VP O
177 instructed VBN O O
177 to TO O O
177 call VB O O
177 CMH NNP B-NP O
177 Urgent NNP I-NP O
177 Care NNP I-NP O
177 if IN B-VP O
177 his PRP$ O O
177 chest NN B-NP B-r
178 pain NN I-NP O
178 recurs NNS I-NP O
178 and CC O O
178 does VBZ O O
178 not RB O O
178 resolve VB O O
178 with IN B-VP O
178 sublingual JJ B-NP B-mo
178 nitroglycerin NN I-NP B-m
179 Dictated NNP I-NP O
179 By: NNP I-NP O
179 ROLANDO NNP I-NP O
179 YAFAI NNP I-NP O
179 , , O O
179 M.D NNP B-NP O
179 BE79 NNP I-NP O
180 Attending: NNP I-NP O
180 HOMER NNP I-NP O
180 PRESTWICH NNP I-NP O
180 , , O O
180 M.D NNP B-NP O
180 VN7 NNP I-NP O
180 XP500/6846 NNP I-NP O
181 Batch: NNP I-NP O
181 173 CD O O
181 Index NNP B-NP O
181 No NNP I-NP O
181 JEAJT21F84 NNP I-NP O
181 D: NNP I-NP O
181 3/16/95 CD O O
182 T: NNP B-NP O
182 3/16/95 CD O O
183 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #831462 VBZ O O
4 305748131 CD O O
4 STRH NNP B-NP O
4 02609711 CD O O
4 3036987 CD O O
4 4/16/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 abdominal JJ B-NP O
4 aortic JJ I-NP O
4 aneurysm NN I-NP O
4 , , O O
4 6cm CD O O
4 suprarenal JJ B-NP O
4 abdominal JJ I-NP O
4 aortic JJ I-NP O
4 aneurysm NN I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/24/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/12/2005 CD O O
7 ATTENDING: NNP B-NP O
7 LUIGI NNP I-NP O
7 ILLAS NNP I-NP O
7 MD NNP I-NP O
8 SERVICE: NNP I-NP O
8 This DT B-NP O
8 patient NN I-NP O
8 received VBD B-VP O
8 care NN B-NP O
8 at IN B-VP O
8 the DT B-NP O
8 Vascular NNP I-NP O
8 Surgery NNP I-NP O
9 Service NNP I-NP O
10 ADMISSION NNP I-NP O
10 DIAGNOSIS: NNP I-NP O
10 Abdominal NNP I-NP O
10 aortic JJ B-NP O
10 aneurysm NN I-NP O
11 DISCHARGE NNP I-NP O
11 DIAGNOSIS: NNP I-NP O
11 Status NNP I-NP O
11 post NN I-NP O
11 open JJ B-NP O
11 abdominal JJ I-NP O
11 aortic JJ I-NP O
11 aneurysm NN I-NP O
12 ( ( O O
12 AAA NNP B-NP O
12 ) ) O O
12 repair NN B-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 is VBZ O O
13 a DT B-NP O
13 71-year-old JJ I-NP O
13 male NN I-NP O
14 with IN B-VP O
14 a DT B-NP O
14 history NN I-NP O
14 of IN B-VP O
14 morbid NN B-NP O
14 obesity NN I-NP O
14 , , O O
14 sleep JJ B-NP O
14 apnea NN I-NP O
14 , , O O
14 CAD NNP B-NP O
14 status NN I-NP O
14 post NN I-NP O
15 CABG NNP I-NP O
15 x VBZ O O
15 4 CD O O
15 in IN B-VP O
15 2001 CD O O
15 , , O O
15 who WP O O
15 presented VBD B-VP O
15 with IN B-VP O
15 vague JJ B-NP O
15 abdominal JJ I-NP O
15 pain NN I-NP O
15 and CC O O
15 was VBD B-VP O
16 found VBN O O
16 by IN B-VP O
16 CT NNP B-NP O
16 scan JJ O O
16 to TO O O
16 have VB O O
16 a DT B-NP O
16 6-cm JJ I-NP O
16 infrarenal JJ I-NP O
16 AAA NNP I-NP O
16 The DT B-NP O
16 patient NN I-NP O
16 was VBD B-VP O
17 initially RB O O
17 prepared JJ O O
17 for IN B-VP O
17 a DT B-NP O
17 repair NN I-NP O
17 in IN B-VP O
17 outside JJ B-NP O
17 hospital NN I-NP O
17 that IN B-VP O
17 upon IN B-VP O
18 review NN B-NP O
18 of IN B-VP O
18 the DT B-NP O
18 aneurysm NN I-NP O
18 extended VBD B-VP O
18 up RB O O
18 to TO O O
18 include VB O O
18 of IN B-VP O
18 the DT B-NP O
18 origin NN I-NP O
18 of IN B-VP O
18 at IN B-VP O
19 least JJS O O
19 to TO O O
19 the DT B-NP O
19 left JJ I-NP O
19 renal JJ I-NP O
19 artery NN I-NP O
19 and CC O O
19 this DT O O
19 was VBD B-VP O
19 felt VBN O O
19 to TO O O
19 be VB O O
19 a DT B-NP O
20 suprarenal JJ I-NP O
20 abdominal JJ I-NP O
20 aortic JJ I-NP O
20 aneurysm NN I-NP O
20 requiring VBG O O
20 a DT B-NP O
20 retroperitoneal NN I-NP O
21 approach NN I-NP O
21 He PRP O O
21 presents VBZ O O
21 now RB O O
21 for IN B-VP O
21 surgery NN B-NP O
22 ALLERGIES: NNP I-NP O
22 Penicillin NNP I-NP O
22 leading VBG O O
22 to TO O O
22 a DT B-NP O
22 rash NN I-NP O
23 PAST NNP I-NP O
23 MEDICAL NNP I-NP O
23 HISTORY: NNP I-NP O
23 CAD NNP I-NP O
23 status NN I-NP O
23 post NN I-NP O
23 CABG NNP I-NP O
23 x VBZ O O
23 4 CD O O
23 in IN B-VP O
23 2001 CD O O
23 , , O O
24 hypertension NN B-NP O
24 , , O O
24 hypercholesterolemia NN B-NP O
24 , , O O
24 gout NN B-NP O
24 , , O O
24 GERD NNP B-NP O
24 , , O O
24 morbid NN B-NP O
24 obesity NN I-NP O
24 , , O O
25 status NN B-NP O
25 post NN I-NP O
25 silent NN I-NP O
25 MI NNP I-NP O
25 in IN B-VP O
25 1980 CD O O
25 and CC O O
25 1985 CD O O
25 , , O O
25 Meniere's NNP B-NP O
25 syndrome NN I-NP O
25 in IN B-VP O
26 left JJ B-NP O
26 ear NN I-NP O
26 , , O O
26 sleep JJ B-NP O
26 apnea NN I-NP O
26 leading VBG O O
26 to TO O O
26 BiPAP NNP B-NP O
26 use NN I-NP O
27 PAST NNP I-NP O
27 SURGICAL NNP I-NP O
27 HISTORY: NNP I-NP O
27 Status NNP I-NP O
27 post NN I-NP O
27 CABG NNP I-NP O
27 x VBZ O O
27 4 CD O O
27 in IN B-VP O
27 2001 CD O O
27 , , O O
27 status NN B-NP O
27 post NN I-NP O
28 laparoscopic NN I-NP O
28 cholecystectomy NN I-NP O
28 , , O O
28 2004 CD O O
28 , , O O
28 and CC O O
28 status NN B-NP O
28 post NN I-NP O
28 left VBD B-VP O
28 knee NN B-NP O
29 arthroscopy RB O O
30 PREVIOUS NNP B-NP O
30 STUDIES: NNP I-NP O
30 PFTs NNP I-NP O
30 showing VBG O O
30 an DT B-NP O
30 FVC NNP I-NP O
30 of IN B-VP O
30 3.44 CD O O
30 ( ( O O
30 80% CD O O
30 predicted VBN O O
30 ) ) O O
30 , , O O
31 FEV1 NNP B-NP O
31 of IN B-VP O
31 2.40 CD O O
31 ( ( O O
31 83% CD O O
31 predicted VBN O O
31 ) ) O O
31 , , O O
31 and CC O O
31 an DT B-NP O
31 FEV1/FVC NNP I-NP O
31 of IN B-VP O
31 70 CD O O
31 ( ( O O
31 104% CD O O
32 predicted VBN O O
32 ) ) O O
32 The DT B-NP O
32 patient NN I-NP O
32 had VBD B-VP O
32 an DT B-NP O
32 negative JJ I-NP O
32 stress NN I-NP O
32 test NN I-NP O
32 on IN B-VP O
32 9/6/01 CD O O
33 and CC O O
33 9/12/01 CD O O
33 and CC O O
33 a DT B-NP O
33 MIBI NNP I-NP O
33 , , O O
33 9/12/01 CD O O
33 showing VBG O O
33 concentric JJ B-NP O
33 LVH NNP I-NP O
33 with IN B-VP O
33 an DT B-NP O
34 EF NNP I-NP O
34 of IN B-VP O
34 approximately RB O O
34 48% CD O O
34 , , O O
34 wall NN B-NP O
34 motion NN I-NP O
34 abnormalities NNS I-NP O
34 of IN B-VP O
34 the DT B-NP O
34 septum NN I-NP O
35 consistent NN I-NP O
35 with IN B-VP O
35 cardiac JJ B-NP O
35 surgery NN I-NP O
35 , , O O
35 no DT B-NP O
35 perfusion NN I-NP O
35 abnormalities NNS I-NP O
35 and CC O O
36 minimal JJ B-NP O
36 reversible JJ I-NP O
36 ischemia NN I-NP O
36 at IN B-VP O
36 the DT B-NP O
36 base NN I-NP O
36 of IN B-VP O
36 the DT B-NP O
36 lateral JJ I-NP O
36 wall NN I-NP O
36 with IN B-VP O
37 the DT B-NP O
37 volume NN I-NP O
37 affected VBD B-VP O
37 being VBG O O
37 small JJ B-NP O
38 HOSPITAL NNP I-NP O
38 COURSE: NNP I-NP O
38 The DT B-NP O
38 patient NN I-NP O
38 is VBZ O O
38 a DT B-NP O
38 71-year-old JJ I-NP O
38 male NN I-NP O
38 with IN B-VP O
38 a DT B-NP O
39 history NN I-NP O
39 of IN B-VP O
39 morbid NN B-NP O
39 obesity NN I-NP O
39 , , O O
39 sleep JJ B-NP O
39 apnea NN I-NP O
39 , , O O
39 CAD NNP B-NP O
39 status NN I-NP O
39 post NN I-NP O
39 CABG NNP I-NP O
39 x NNP I-NP O
39 4 CD O O
39 , , O O
40 presenting VBG O O
40 with IN B-VP O
40 abdominal JJ B-NP O
40 pain NN I-NP O
40 and CC O O
40 found VBN O O
40 by IN B-VP O
40 CT NNP B-NP O
40 scan JJ O O
40 to TO O O
40 have VB O O
40 6-cm JJ B-NP O
41 infrarenal JJ I-NP O
41 abdominal JJ I-NP O
41 aortic JJ I-NP O
41 aneurysm NN I-NP O
41 He PRP O O
41 was VBD B-VP O
41 taken VBN O O
41 to TO O O
41 the DT B-NP O
42 operating NN I-NP O
42 room NN I-NP O
42 on IN B-VP O
42 6/28/05 CD O O
42 where WRB O O
42 he PRP O O
42 underwent VBD B-VP O
42 an DT B-NP O
42 uncomplicated JJ I-NP O
43 open JJ I-NP O
43 repair NN I-NP O
43 of IN B-VP O
43 his PRP$ O O
43 abdominal JJ B-NP O
43 aortic JJ I-NP O
43 aneurysm NN I-NP O
43 through IN B-VP O
43 a DT B-NP O
44 retroperitoneal NN I-NP O
44 flank NN I-NP O
44 approach VBP O O
44 The DT B-NP O
44 patient NN I-NP O
44 tolerated VBD B-VP O
44 the DT B-NP O
45 procedure NN I-NP O
45 well RB O O
45 He PRP O O
45 left VBD B-VP O
45 the DT B-NP O
45 operating NN I-NP O
45 room NN I-NP O
45 with IN B-VP O
45 an DT O O
45 epidural JJ O O
45 , , O O
46 Foley NNP B-NP O
46 , , O O
46 and CC O O
46 nasogastric JJ B-NP O
46 tube NN I-NP O
46 to TO O O
46 low VB O O
46 wall DT B-NP O
46 suction NN I-NP O
46 He PRP O O
46 was VBD B-VP O
46 admitted VBN O O
47 overnight RB O O
47 to TO O O
47 the DT B-NP O
47 intensive JJ I-NP O
47 care NN I-NP O
47 unit NN I-NP O
47 for IN B-VP O
47 a DT B-NP O
47 close JJ I-NP O
47 monitoring NN I-NP O
47 of IN B-VP O
48 blood NN B-NP O
48 pressure NN I-NP O
48 His PRP$ O O
48 blood NN B-NP O
48 pressure NN I-NP O
48 overnight VBD B-VP O
48 remained VBN O O
48 good JJ O O
48 and CC O O
49 the DT B-NP O
49 patient NN I-NP O
49 had VBD B-VP O
49 a DT B-NP O
49 negative JJ I-NP O
49 set NN I-NP O
49 of IN B-VP O
49 enzymes NNS B-NP O
49 on IN B-VP O
49 postop JJ B-NP O
49 #0 NN I-NP O
49 with IN B-VP O
49 a DT B-NP O
49 CK NNP I-NP O
50 of IN B-VP O
50 146 CD O O
50 , , O O
50 MB NNP B-NP O
50 of IN B-VP O
50 1.7 CD O O
50 , , O O
50 and CC O O
50 troponin RB O O
50 less JJR O O
50 than IN B-VP O
50 assay VB O O
50 The DT B-NP O
50 patient NN I-NP O
50 was VBD B-VP O
51 taken VBN O O
51 up RP O O
51 to TO O O
51 the DT B-NP O
51 surgical JJ I-NP O
51 intensive JJ I-NP O
51 care NN I-NP O
51 unit NN I-NP O
51 intubated VBD B-VP O
51 He PRP O O
52 received VBD B-VP O
52 7800 CD O B-do
52 units NNS B-NP I-do
52 of IN B-VP O
52 crystalloid NN B-NP B-m
52 , , O O
52 6 CD O B-do
52 units NNS B-NP I-do
52 of IN B-VP O
52 cell NN B-NP B-m
52 saver NN I-NP I-m
52 , , O O
52 and CC O O
52 2 CD O B-do
53 units NNS B-NP O
53 of IN B-VP O
53 packed JJ B-NP B-m
53 red JJ I-NP I-m
53 blood NN I-NP I-m
53 cells NNS I-NP I-m
53 intraoperatively RB O O
53 , , O O
53 put VBD B-VP O
53 out RP O O
53 1200 CD O O
53 cc NN B-NP O
54 of IN B-VP O
54 urine NN B-NP O
54 , , O O
54 175 CD O O
54 cc NN B-NP O
54 out IN B-VP O
54 of IN B-VP O
54 the DT B-NP O
54 nasogastric JJ I-NP O
54 tube NN I-NP O
54 , , O O
54 with IN B-VP O
54 an DT B-NP O
54 EBL NNP I-NP O
54 of IN B-VP O
54 2400 CD O O
55 cc NN B-NP O
55 He PRP O O
55 was VBD B-VP O
55 weaned VBN O O
55 from IN B-VP O
55 the DT B-NP O
55 ventilator NN I-NP O
55 without IN B-VP O
55 difficulty NN B-NP O
55 on IN B-VP O
56 postop JJ B-NP O
56 day NN I-NP O
56 #1 NNP I-NP O
56 and CC O O
56 was VBD B-VP O
56 extubated VBN O O
56 by IN B-VP O
56 the DT B-NP O
56 evening NN I-NP O
56 on IN B-VP O
56 postop JJ B-NP O
56 day NN I-NP O
56 #1 VBD B-VP O
57 The DT B-NP O
57 patient NN I-NP O
57 was VBD B-VP O
57 transferred VBN O O
57 to TO O O
57 the DT B-NP O
57 floor NN I-NP O
57 He PRP O O
57 was VBD B-VP O
57 out IN B-VP O
57 of IN B-VP O
57 bed NN B-NP O
57 and CC O O
58 to TO O O
58 chair VB O O
58 on IN B-VP O
58 postop JJ B-NP O
58 day NN I-NP O
58 #2 IN B-VP O
58 with IN B-VP O
58 nursing NN B-NP O
58 assistance NN I-NP O
58 Diet NNP I-NP O
58 was VBD B-VP O
59 advanced VBN O O
59 as IN B-VP O
59 tolerated VBN O O
59 to TO O O
59 a DT B-NP O
59 low JJ I-NP O
59 fat NN I-NP O
59 , , O O
59 low JJ B-NP O
59 cholesterol NN I-NP O
59 diet VBZ O O
59 The DT B-NP O
60 patient NN I-NP O
60 initially RB O O
60 started VBD B-VP O
60 on IN B-VP O
60 his PRP$ O O
60 home NN B-NP O
60 Celebrex NNP I-NP B-m
60 and CC O O
60 other JJ B-NP B-m
61 medications NNS I-NP O
61 The DT B-NP O
61 epidural NN I-NP O
61 was VBD B-VP O
61 capped VBN O O
61 on IN B-VP O
61 postop JJ B-NP O
61 day NN I-NP O
61 #2 NNP I-NP O
61 , , O O
61 1/29/05 CD O O
62 It PRP O O
62 was VBD B-VP O
62 removed VBN O O
62 on IN B-VP O
62 7/3/05 CD O O
62 and CC O O
62 this DT O O
62 is VBZ O O
62 fully RB O O
62 discontinued VBN O O
62 as RB O O
63 well RB O O
63 on IN B-VP O
63 postop JJ B-NP O
63 day NN I-NP O
63 #3 NNP I-NP O
63 , , O O
63 7/3/05 CD O O
63 The DT B-NP O
63 patient's NN I-NP O
63 nasogastric JJ B-NP O
63 tube NN I-NP O
64 had VBD B-VP O
64 been VBN O O
64 removed VBN O O
64 on IN B-VP O
64 the DT B-NP O
64 morning NN I-NP O
64 of IN B-VP O
64 postop JJ B-NP O
64 day NN I-NP O
64 #1 NNP I-NP O
64 as RB O O
64 well RB O O
65 The DT B-NP O
65 patient NN I-NP O
65 continued VBD B-VP O
65 to TO O O
65 do VB O O
65 well RB O O
65 on IN B-VP O
65 the DT B-NP O
65 floor NN I-NP O
65 He PRP O O
65 was VBD B-VP O
65 placed VBN O O
65 on IN B-VP O
66 aspirin NN B-NP B-m
66 and CC O O
66 subcutaneous JJ B-NP B-mo
66 heparin NN I-NP B-m
66 for IN B-VP O
66 anticoagulation NN B-NP B-r
66 anticoagulation NN I-NP B-r
66 He PRP O O
66 was VBD B-VP O
67 Hep-Lock'd NNP B-NP B-m
67 on IN B-VP O
67 postop JJ B-NP O
67 day NN I-NP O
67 #3 VBD B-VP O
67 as IN B-VP O
67 he PRP O O
67 was VBD B-VP O
67 taking VBG O O
67 good JJ B-NP O
67 p.o NN I-NP O
67 orally RB O O
68 He PRP O O
68 was VBD B-VP O
68 out IN B-VP O
68 of IN B-VP O
68 bed NN B-NP O
68 to TO O O
68 chair VB O O
68 multiple JJ B-NP O
68 times NNS I-NP O
68 during IN B-VP O
68 the DT B-NP O
68 day NN I-NP O
69 Physical NNP I-NP O
69 Therapy NNP I-NP O
69 saw VBD B-VP O
69 the DT B-NP O
69 patient NN I-NP O
69 on IN B-VP O
69 postop JJ B-NP O
69 days NNS I-NP O
69 # # O O
69 4 CD O O
69 to TO O O
69 #5 VB O O
69 and CC O O
70 worked VB O O
70 with IN B-VP O
70 some DT O O
70 on IN B-VP O
70 his PRP$ O O
70 mobility NN B-NP O
70 He PRP O O
70 , , O O
70 at IN B-VP O
70 home NN B-NP O
70 , , O O
70 gets VBZ O O
70 out IN B-VP O
70 of IN B-VP O
70 bed NN B-NP O
71 to TO O O
71 a DT B-NP O
71 wheelchair NN I-NP O
71 and CC O O
71 he PRP O O
71 was VBD B-VP O
71 back RB O O
71 to TO O O
71 his PRP$ O O
71 preoperative JJ B-NP O
71 functional JJ I-NP O
72 status NN I-NP O
72 with IN B-VP O
72 a DT B-NP O
72 small JJ I-NP O
72 amount NN I-NP O
72 of IN B-VP O
72 fatigue NN B-NP O
72 on IN B-VP O
72 postop JJ B-NP O
72 day NN I-NP O
72 #7 NNP I-NP O
72 and CC O O
72 #8 VB O O
73 The DT B-NP O
73 patient NN I-NP O
73 continues VBZ O O
73 to TO O O
73 work VB O O
73 with IN B-VP O
73 Physical JJ B-NP O
73 Therapy NN I-NP O
73 and CC O O
73 to TO O O
73 get VB O O
74 out IN B-VP O
74 of IN B-VP O
74 bed NN B-NP O
74 with IN B-VP O
74 nursing JJ B-NP O
74 staff NN I-NP O
74 on IN B-VP O
74 a DT B-NP O
74 regular JJ I-NP O
74 basis NN I-NP O
74 multiple NN I-NP O
74 times NNS I-NP O
75 per IN B-VP O
75 day NN B-NP O
76 Incision NNP I-NP O
76 site NN I-NP O
76 remained VBD B-VP O
76 clean JJ O O
76 , , O O
76 dry JJ O O
76 , , O O
76 and CC O O
76 intact JJ O O
76 On IN B-VP O
76 postop JJ B-NP O
76 days NNS I-NP O
76 #1 VBP O O
77 to TO O O
77 #2 VB O O
77 secondary JJ O O
77 to TO O O
77 his PRP$ O O
77 large JJ B-NP O
77 amount NN I-NP O
77 of IN B-VP O
77 edema NN B-NP O
77 , , O O
77 the DT B-NP O
77 patient NN I-NP O
77 has VBZ O O
78 large JJ B-NP O
78 amount NN I-NP O
78 of IN B-VP O
78 drainage NN B-NP O
78 from IN B-VP O
78 his PRP$ O O
78 incision NN B-NP O
78 site NN I-NP O
78 on IN B-VP O
78 the DT B-NP O
78 flank NN I-NP O
79 However RB O O
79 , , O O
79 this DT O O
79 slowed VBD B-VP O
79 down RB O O
79 and CC O O
79 the DT B-NP O
79 incision NN I-NP O
79 site NN I-NP O
79 remained VBD B-VP O
79 clean JJ O O
79 , , O O
80 dry JJ O O
80 , , O O
80 and CC O O
80 intact JJ O O
80 with IN B-VP O
80 the DT B-NP O
80 erythema NN I-NP O
80 The DT B-NP O
80 patient NN I-NP O
80 continues VBZ O O
80 to TO O O
80 do VB O O
81 well RB O O
81 By IN B-VP O
81 postop JJ B-NP O
81 days NNS I-NP O
81 #7 VBP O O
81 to TO O O
81 #8 VB O O
81 , , O O
81 the DT B-NP O
81 patient NN I-NP O
81 was VBD B-VP O
81 deemed VBN O O
81 stable JJ O O
81 for IN B-VP O
82 discharge NN B-NP O
82 to TO O O
82 rehabilitation NN B-NP O
82 He PRP O O
82 will MD O O
82 follow VB O O
82 up RP O O
82 with IN B-VP O
82 Dr NNP B-NP O
82 Mevers NNP I-NP O
83 in IN B-VP O
83 clinic NN B-NP O
83 for IN B-VP O
83 staple JJ B-NP O
83 removal NN I-NP O
83 in IN B-VP O
83 seven CD O O
83 days NNS B-NP O
84 DISCHARGE NNP I-NP O
84 DISPOSITION: NNP I-NP O
84 Home NNP I-NP O
84 with IN B-VP O
84 Services NNP B-NP O
85 eScription NN I-NP O
85 document: VBZ O O
85 4-3465349 JJ B-NP O
85 ISSten NNP I-NP O
85 Tel NNP I-NP O
86 Dictated NNP I-NP O
86 By: NNP I-NP O
86 MARCONE NNP I-NP O
86 , , O O
86 BRYCE NNP B-NP O
87 Attending: NNP I-NP O
87 KRIESER NNP I-NP O
87 , , O O
87 ODIS NNP B-NP O
88 Dictation NNP I-NP O
88 ID NNP I-NP O
88 2526615 CD O O
89 D: NNP B-NP O
89 8/23/05 CD O O
90 T: NNP B-NP O
90 8/23/05 CD O O
91 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #832352 VBZ O O
4 521245034 CD O O
4 NTMC NNP B-NP O
4 23821513 CD O O
4 387709 CD O O
4 5/28/1992 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/20/1992 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/6/1992 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 Chief NNP I-NP O
7 complaint NN I-NP O
7 is VBZ O O
7 coronary JJ B-NP O
7 artery JJ I-NP O
8 disease NN I-NP O
8 Patient NNP I-NP O
8 is VBZ O O
8 a DT O O
8 71 CD O O
8 year NN B-NP O
8 old JJ B-NP O
9 white JJ I-NP O
9 male NN I-NP O
9 with IN B-VP O
9 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 coronary JJ B-NP O
9 artery NN I-NP O
9 disease NN I-NP O
9 , , O O
9 angina NN B-NP O
9 , , O O
9 and CC O O
10 dyspnea NN B-NP O
10 on IN B-VP O
10 exertion NN B-NP O
10 who WP O O
10 presents VBZ O O
10 for IN B-VP O
10 coronary JJ B-NP O
10 artery NN I-NP O
10 bypass NN I-NP O
11 grafting VBG O O
11 Patient NNP B-NP O
11 reports NNS I-NP O
11 angina VBD B-VP O
11 since IN B-VP O
11 9/29 CD O O
11 described NNS B-NP O
11 as IN B-VP O
11 chest JJ B-NP O
12 fullness NN I-NP O
12 Patient NNP I-NP O
12 denies VBZ O O
12 shortness NN B-NP O
12 of IN B-VP O
12 breath NN B-NP O
12 , , O O
12 chest JJ B-NP O
12 pressure NN I-NP O
12 , , O O
12 or CC O O
13 syncope VB O O
13 Patient JJ B-NP O
13 notes NNS I-NP O
13 dyspnea VBP O O
13 on IN B-VP O
13 exertion NN B-NP O
13 while IN B-VP O
13 in IN B-VP O
13 Hills NNP B-NP O
13 Sagtyre NNP I-NP O
13 Gillflat NNP I-NP O
13 Drive NNP I-NP O
13 , , O O
13 Field NNP B-NP O
13 Ville NNP I-NP O
13 , , O O
13 Pennsylvania NNP B-NP O
13 63310 CD O O
13 nine CD O O
14 months NNS B-NP O
14 ago RB O O
14 Exercise NNP B-NP O
14 tolerance NN I-NP O
14 tests NNS I-NP O
14 were VBD B-VP O
14 performed VBN O O
14 which WDT O O
14 revealed VBD B-VP O
15 five CD O O
15 minutes NNS B-NP O
15 of IN B-VP O
15 exertion NN B-NP O
15 , , O O
15 however RB O O
15 , , O O
15 was VBD B-VP O
15 stopped VBN O O
15 prior RB O O
15 to TO O O
15 ST NNP B-NP O
15 segment NN I-NP O
16 changes NNS I-NP O
16 Cardiac NNP I-NP O
16 catheterization NN I-NP O
16 in IN B-VP O
16 9/29 CD O O
16 revealed VBD B-VP O
16 a DT O O
16 30% CD O O
16 left NN B-NP O
17 main JJ O O
17 , , O O
17 40% CD O O
17 left VBD B-VP O
17 anterior JJ B-NP O
17 descending NN I-NP O
17 , , O O
17 50% CD O O
17 circumflex NN B-NP O
17 , , O O
17 100% CD O O
17 mid NN B-NP O
17 right JJ B-NP O
18 coronary JJ I-NP O
18 artery NN I-NP O
18 , , O O
18 and CC O O
18 a DT O O
18 90% CD O O
18 right JJ B-NP O
18 coronary JJ I-NP O
18 artery NN I-NP O
18 lesion NN I-NP O
19 Angioplasty NNP I-NP O
19 was VBD B-VP O
19 attempted VBN O O
19 of IN B-VP O
19 the DT B-NP O
19 proximal JJ I-NP O
19 right JJ I-NP O
19 coronary JJ I-NP O
19 artery NN I-NP O
20 lesion NN I-NP O
20 A DT B-NP O
20 dissection NN I-NP O
20 resulted VBD B-VP O
20 and CC O O
20 total JJ B-NP O
20 occlusion NN I-NP O
20 of IN B-VP O
20 the DT B-NP O
20 proximal JJ I-NP O
21 right JJ I-NP O
21 coronary JJ I-NP O
21 artery NN I-NP O
21 without IN B-VP O
21 EKG NNP B-NP O
21 changes NNS I-NP O
21 or CC O O
21 chest JJS B-NP O
21 pain NN I-NP O
21 Cardiac NNP I-NP O
22 risk NN I-NP O
22 factors NNS I-NP O
22 include VBP O O
22 a DT B-NP O
22 family NN I-NP O
22 history NN I-NP O
22 , , O O
22 no DT B-NP O
22 tobacco NN I-NP O
22 , , O O
22 hypertension NN B-NP O
22 , , O O
23 diabetes VBZ O O
23 , , O O
23 and CC O O
23 hypercholesterolemia NN B-NP O
23 PAST NNP I-NP O
23 MEDICAL NNP I-NP O
23 HISTORY: NNP I-NP O
24 Significant NNP I-NP O
24 for IN B-VP O
24 adult NN B-NP O
24 onset NN I-NP O
24 diabetes NNS I-NP O
24 , , O O
24 diet JJ O O
24 controlled VBN O O
24 , , O O
24 and CC O O
24 a DT B-NP O
25 question NN I-NP O
25 of IN B-VP O
25 a DT B-NP O
25 gout NN I-NP O
25 with IN B-VP O
25 no DT B-NP O
25 history NN I-NP O
25 in IN B-VP O
25 the DT B-NP O
25 past JJ I-NP O
25 PAST NNP I-NP O
25 SURGICAL NNP I-NP O
26 HISTORY: NNP I-NP O
26 Significant NNP I-NP O
26 for IN B-VP O
26 tonsillectomy NN B-NP O
26 and CC O O
26 adenoidectomy NN B-NP O
26 and CC O O
27 appendectomy NN B-NP O
27 as IN B-VP O
27 a DT B-NP O
27 child NN I-NP O
27 CURRENT NNP I-NP O
27 MEDICATIONS: NNP I-NP O
27 Levatol NNP I-NP B-m
27 30 CD O B-do
27 mg NN B-NP I-do
27 p.o NN I-NP B-mo
28 q.d NN I-NP B-f
28 , , O O
28 Procardia NNP B-NP B-m
28 XL NNP I-NP I-m
28 30 CD O B-do
28 mg NN B-NP I-do
28 p.o NN I-NP B-mo
28 q.d NN I-NP B-f
28 , , O O
28 Colchicine NNP B-NP B-m
28 0.6 CD O B-do
28 mg NN B-NP I-do
28 p.o NN I-NP B-mo
28 q.d NN I-NP B-f
28 , , O O
29 Pepcid NNP B-NP B-m
29 40 CD O B-do
29 mg NN B-NP I-do
29 p.o NN I-NP B-mo
29 q.6h NN I-NP B-f
29 , , O O
29 and CC O O
29 Aspirin NNP B-NP B-m
29 one CD O B-do
29 tablet NN B-NP I-do
29 p.o NN I-NP B-mo
29 q.d NN I-NP B-f
30 ALLERGIES: NNP I-NP O
30 Patient NNP I-NP O
30 has VBZ O O
30 an DT B-NP O
30 allergy NN I-NP O
30 to TO O O
30 Penicillin NNP B-NP O
31 PHYSICAL NNP I-NP O
31 EXAMINATION: NNP I-NP O
31 Grossly NNP I-NP O
31 within IN B-VP O
31 normal JJ B-NP O
31 limits NNS I-NP O
32 HOSPITAL NNP I-NP O
32 COURSE: NNP I-NP O
32 Patient NNP I-NP O
32 was VBD B-VP O
32 admitted VBN O O
32 to TO O O
32 the DT B-NP O
32 Cardiac NNP I-NP O
32 Surgical NNP I-NP O
33 Service NNP I-NP O
33 and CC O O
33 was VBD B-VP O
33 taken VBN O O
33 to TO O O
33 the DT B-NP O
33 Operating NN I-NP O
33 Room NNP I-NP O
33 on IN B-VP O
34 6/13/92 CD O O
34 where WRB O O
34 he PRP O O
34 underwent VBD B-VP O
34 a DT B-NP O
34 three-vessel JJ I-NP O
34 coronary JJ I-NP O
34 artery NN I-NP O
34 bypass NN I-NP O
35 grafting VBG O O
35 Patient NNP B-NP O
35 tolerated VBD B-VP O
35 the DT B-NP O
35 procedure NN I-NP O
35 well RB O O
35 and CC O O
35 was VBD B-VP O
35 taken VBN O O
35 to TO O O
36 the DT B-NP O
36 Cardiac NNP I-NP O
36 Surgical NNP I-NP O
36 Intensive NNP I-NP O
36 Care NNP I-NP O
36 Unit NNP I-NP O
36 post-operatively JJ B-NP O
37 Patient's NNP I-NP O
37 post-operative JJ B-NP O
37 course NN I-NP O
37 from IN B-VP O
37 this DT B-NP O
37 point NN I-NP O
37 on IN B-VP O
37 was VBD B-VP O
38 uncomplicated JJ B-NP O
38 Patient NNP I-NP O
38 was VBD B-VP O
38 successfully RB O O
38 extubated VBN O O
38 on IN B-VP O
39 post-operative JJ B-NP O
39 day NN I-NP O
39 number NN I-NP O
39 one CD O O
39 and CC O O
39 was VBD B-VP O
39 diuresed VBN O O
39 back RB O O
39 to TO O O
40 pre-operative JJ B-NP O
40 weight NN I-NP O
40 through IN B-VP O
40 the DT B-NP O
40 subsequent JJ I-NP O
40 post-operative JJ I-NP O
40 days NNS I-NP O
41 Patient NNP I-NP O
41 ruled VBD B-VP O
41 out RP O O
41 for IN B-VP O
41 a DT B-NP O
41 myocardial JJ I-NP O
41 infarction NN I-NP O
41 perioperatively RB O O
42 Patient NNP B-NP O
42 continues VBZ O O
42 to TO O O
42 do VB O O
42 very RB O O
42 well RB O O
42 and CC O O
42 plan NN B-NP O
42 is VBZ O O
42 to TO O O
42 discharge VB O O
42 the DT B-NP O
43 patient NN I-NP O
43 home NN I-NP O
43 on IN B-VP O
43 post-operative JJ B-NP O
43 day NN I-NP O
43 number NN I-NP O
43 seven CD O O
43 from IN B-VP O
43 coronary JJ B-NP O
44 artery NN I-NP O
44 bypass NN I-NP O
44 grafting VBG O O
45 DISPOSITION: NNP B-NP O
45 DISCHARGE NNP I-NP O
45 MEDICATIONS: NNP I-NP O
45 Pepcid NNP I-NP B-m
45 20 CD O B-do
45 mg NN B-NP I-do
45 p.o NN I-NP B-mo
45 b.i.d NN I-NP B-f
45 , , O O
46 Procardia NNP B-NP B-m
46 XL NNP I-NP I-m
46 30 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 q.d NN I-NP B-f
46 , , O O
46 Levatol NNP B-NP B-m
46 10 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
47 q.d NN I-NP B-f
47 , , O O
47 Colchicine NNP B-NP B-m
47 , , O O
47 and CC O O
47 Ciprofloxacin NNP B-NP B-m
47 Patient NNP I-NP O
47 is VBZ O O
47 instructed VBN O O
47 to TO O O
48 follow-up JJ O O
48 with IN B-VP O
48 Dr NNP B-NP O
48 Citrin NNP I-NP O
48 in IN B-VP O
48 the DT B-NP O
48 Cardiac NNP I-NP O
48 Surgical NNP I-NP O
48 Clinic NNP I-NP O
48 CONDITION NNP I-NP O
49 ON NNP I-NP O
49 DISCHARGE: NNP I-NP O
49 Good NNP I-NP O
50 DB165/7998 NNP I-NP O
51 CARLOS NNP I-NP O
51 E NNP I-NP O
51 GOLDING NNP I-NP O
51 , , O O
51 M.D NNP B-NP O
51 DF5 NNP I-NP O
51 D: NNP I-NP O
51 1/8/92 CD O O
52 Batch: NNP B-NP O
52 5828 CD O O
52 Report: NNP B-NP O
52 L1905D3 NNP I-NP O
52 T: NNP I-NP O
52 7/19/92 CD O O
53 Dictated NNP B-NP O
53 By: NNP I-NP O
53 ARCHIE NNP I-NP O
53 SIROKA NNP I-NP O
53 , , O O
53 M.D NNP B-NP O
53 QG06 NNP I-NP O
54 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #844334 VBZ O O
4 410601949 CD O O
4 TH NNP B-NP O
4 39177106 CD O O
4 275150 CD O O
4 8/22/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 8/22/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/1/2001 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 Mr NNP I-NP O
7 Raffo NNP I-NP O
7 is VBZ O O
7 a DT B-NP O
7 59-year-old JJ I-NP O
7 male NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
8 history NN I-NP O
8 of IN B-VP O
8 coronary JJ B-NP O
8 artery NN I-NP O
9 disease NN I-NP O
9 status NN I-NP O
9 post NN I-NP O
9 small JJ B-NP O
9 non-ST JJ I-NP O
9 elevation NN I-NP O
9 myocardial JJ B-NP O
9 infarction NN I-NP O
9 in IN B-VP O
10 March NNP B-NP O
10 of IN B-VP O
10 2000 CD O O
10 and CC O O
10 also RB O O
10 status NN B-NP O
10 post NN I-NP O
10 cardiac JJ B-NP O
10 catheterization NN I-NP O
10 with IN B-VP O
10 2 CD O O
11 vessel NN B-NP O
11 disease NN I-NP O
11 , , O O
11 small JJ O O
11 left VBD B-VP O
11 PICA NNP B-NP O
11 cerebrovascular JJ B-NP O
11 accident NN I-NP O
11 , , O O
12 congestive JJ B-NP O
12 heart NN I-NP O
12 failure NN I-NP O
12 with IN B-VP O
12 an DT B-NP O
12 echocardiogram NN I-NP O
12 in IN B-VP O
12 March NNP B-NP O
13 revealing VBG O O
13 an DT B-NP O
13 ejection NN I-NP O
13 fraction NN I-NP O
13 of IN B-VP O
13 30% CD O O
13 Also RB O O
13 diabetes VBZ O O
13 mellitus NNS B-NP O
13 type JJ B-NP O
14 II NNP I-NP O
14 complicated VBN O O
14 by IN B-VP O
14 retinopathy NN B-NP O
14 , , O O
14 nephropathy JJ O O
14 and CC O O
14 question NN B-NP O
14 neuropathy JJ B-NP O
15 History NNP I-NP O
15 of IN B-VP O
15 hypertension NN B-NP O
15 , , O O
15 hypercholesterolemia NN B-NP O
15 as RB O O
15 well RB O O
15 who WP O O
16 presented VBD B-VP O
16 to TO O O
16 Dr NNP B-NP O
16 Bouie NNP I-NP O
16 clinic NN I-NP O
16 on IN B-VP O
16 March NNP B-NP O
16 , , O O
16 2001 CD O O
16 with IN B-VP O
17 progressive JJ O O
17 increasing VBG O O
17 dyspnea NN B-NP O
17 , , O O
17 increasing VBG O O
17 abdominal JJ B-NP O
17 girth NN I-NP O
17 and CC O O
18 weight JJ B-NP O
18 gain NN I-NP O
18 over IN B-VP O
18 the DT B-NP O
18 past JJ I-NP O
18 few JJ I-NP O
18 months NNS I-NP O
19 PAST NNP I-NP O
19 MEDICAL NNP I-NP O
19 HISTORY: NNP I-NP O
19 Diabetes NNP I-NP O
19 mellitus VBD B-VP O
19 x JJ O O
19 20 CD O O
19 years NNS B-NP O
19 , , O O
19 chronic JJ B-NP O
19 renal JJ I-NP O
20 insufficiency NN I-NP O
20 with IN B-VP O
20 the DT B-NP O
20 last JJ I-NP O
20 creatinine NN I-NP O
20 in IN B-VP O
21 March NNP B-NP O
21 of IN B-VP O
21 3.5 CD O O
21 , , O O
21 congestive JJ B-NP O
21 heart NN I-NP O
21 failure NN I-NP O
21 with IN B-VP O
21 an DT B-NP O
21 ejection NN I-NP O
21 fraction NN I-NP O
21 of IN B-VP O
22 30% CD O O
22 in IN B-VP O
22 March NNP B-NP O
22 of IN B-VP O
22 2000 CD O O
22 , , O O
22 coronary JJ B-NP O
22 artery NN I-NP O
22 disease NN I-NP O
22 status NN I-NP O
22 post NN I-NP O
23 myocardial JJ B-NP O
23 infarction NN I-NP O
23 , , O O
23 March NNP B-NP O
23 2000 CD O O
23 question NN B-NP O
23 f FW O O
23 silent JJ B-NP O
23 myocardial JJ I-NP O
24 infarction NN I-NP O
24 x VBD B-VP O
24 2 CD O O
24 , , O O
24 history NN B-NP O
24 of IN B-VP O
24 hyperlipidemia NN B-NP O
25 MEDICATIONS NNP I-NP O
25 ON NNP I-NP O
25 ADMISSION: NNP I-NP O
25 Aspirin NNP I-NP B-m
25 daily RB O B-f
25 , , O O
25 Lasix NNP B-NP B-m
25 80 CD O B-do
25 mg NN B-NP I-do
25 p.o NN I-NP B-mo
25 q JJ B-NP B-f
25 day NN I-NP I-f
25 , , O O
26 Zaroxolyn NNP B-NP B-m
26 2.5 CD O B-do
26 mg NN B-NP I-do
26 p.o NN I-NP B-mo
26 q JJ B-NP B-f
26 day NN I-NP I-f
26 , , O O
26 toprol NN B-NP B-m
26 XL NNP I-NP I-m
27 50 CD O B-do
27 mg NN B-NP I-do
27 p.o NN I-NP B-mo
27 q JJ B-NP B-f
27 day NN I-NP I-f
27 , , O O
27 insulin NN B-NP B-m
27 insulin NN I-NP B-m
27 70/30 CD O B-do
27 70/30 CD O I-m
27 65/45 CD O B-do
27 , , O O
27 Actos NNP B-NP B-m
27 45 CD O B-do
27 q NN B-NP B-f
27 p.m NN I-NP I-f
27 , , O O
27 Avapro NNP B-NP B-m
27 300 CD O B-do
28 mg NN B-NP O
28 p.o NN I-NP B-mo
28 q JJ B-NP B-f
28 day NN I-NP I-f
28 , , O O
28 Lipitor NNP B-NP B-m
28 10 CD O B-do
28 mg NN B-NP I-do
28 p.o NN I-NP B-mo
28 q.h.s NN I-NP B-f
28 , , O O
28 sublingual JJ B-NP B-mo
28 nitroglycerin NN I-NP B-m
29 p.r.n NN I-NP B-f
30 PHYSICAL NNP I-NP O
30 EXAM: NNP I-NP O
30 Temperature NNP I-NP O
30 98.1 CD O O
30 , , O O
30 blood NN B-NP O
30 pressure NN I-NP O
30 116/70 CD O O
30 , , O O
30 pulse RB O O
30 88 CD O O
30 , , O O
31 primary JJ B-NP O
31 care NN I-NP O
31 physician NN I-NP O
31 of IN B-VP O
31 18 CD O O
31 The DT B-NP O
31 patient NN I-NP O
31 appeared VBD B-VP O
32 to TO O O
32 be VB O O
32 in IN B-VP O
32 no DT B-NP O
32 acute NN I-NP O
32 distress NN I-NP O
32 Jugular NNP I-NP O
32 venous JJ B-NP O
32 pressure NN I-NP O
32 approximately RB O O
33 13 CD O O
33 cm JJ B-NP O
33 water NN I-NP O
33 LUNGS: NNP I-NP O
33 Faint NNP I-NP O
33 bibasilar JJ B-NP O
33 rales NNS I-NP O
33 CARDIAC: NNP I-NP O
34 Tachycardia NNP I-NP O
34 , , O O
34 regular JJ B-NP O
34 rhythm NN I-NP O
34 without IN B-VP O
34 murmurs NNS B-NP O
34 ABDOMEN: NNP I-NP O
34 Positive NNP I-NP O
34 , , O O
35 normal JJ B-NP O
35 active JJ I-NP O
35 bowel NN I-NP O
35 sounds VBZ O O
35 Obese JJ O O
35 , , O O
35 distended VBD B-VP O
35 and CC O O
35 nontender JJ B-NP O
36 EXTREMITIES: NNP I-NP O
36 2 CD O O
36 plus CC O O
36 dorsalis JJ B-NP O
36 pedis NN I-NP O
36 pulse NN I-NP O
36 , , O O
36 2-3 JJ O O
36 plus CC O O
36 edema JJ O O
37 bilaterally RB O O
37 to TO O O
37 the DT B-NP O
37 knees NNS I-NP O
38 HOSPITAL NNP I-NP O
38 COURSE: NNP I-NP O
38 1 CD O O
38 Cardiovascular: NNP B-NP O
38 It PRP O O
38 was VBD B-VP O
38 felt VBN O O
38 that IN B-VP O
38 given VBN O O
38 notes NNS B-NP O
39 of IN B-VP O
39 thyroid JJ B-NP O
39 dysfunction NN I-NP O
39 , , O O
39 his PRP$ O O
39 history NN B-NP O
39 was VBD B-VP O
40 consistent JJ O O
40 with IN B-VP O
40 fluid NN B-NP O
40 overload NN I-NP O
40 His PRP$ O O
40 jugular JJ B-NP O
40 venous JJ I-NP O
40 pressure NN I-NP O
40 was VBD B-VP O
41 elevated VBN O O
41 and CC O O
41 he PRP O O
41 had VBD B-VP O
41 3plus CD O O
41 pitting VBG O O
41 edema NN B-NP O
41 to TO O O
41 the DT B-NP O
41 knees NNS I-NP O
41 without IN B-VP O
42 significant JJ B-NP O
42 rales NNS I-NP O
42 on IN B-VP O
42 chest NN B-NP O
42 exam NN I-NP O
42 He PRP O O
42 was VBD B-VP O
42 aggressively RB O O
42 diuresed VBN O O
42 with IN B-VP O
43 doses NNS B-NP O
43 of IN B-VP O
43 Lasix NNP B-NP B-m
43 200 CD O B-do
43 mg NN B-NP I-do
43 b.i.d NN I-NP B-f
43 IV NNP I-NP B-mo
43 as RB O O
43 well RB O O
43 as IN B-VP O
43 Zaroxolyn NNP B-NP B-m
43 Weight NNP I-NP O
43 on IN B-VP O
44 admission NN B-NP O
44 was VBD B-VP O
44 135 CD O O
44 kilograms NNS B-NP O
44 and CC O O
44 on IN B-VP O
44 discharge NN B-NP O
44 he PRP O O
44 was VBD B-VP O
44 down RB O O
44 to TO O O
44 132 CD O O
45 kilograms NNS B-NP O
45 A NNP I-NP O
45 repeat NN I-NP O
45 echocardiogram NN I-NP O
45 at IN B-VP O
45 Ethool NNP B-NP O
45 Hospital NNP I-NP O
46 showed VBD B-VP O
46 an DT B-NP O
46 ejection NN I-NP O
46 fraction NN I-NP O
46 of IN B-VP O
46 30-35 JJ O O
46 , , O O
46 left VBD B-VP O
46 ventricular JJ B-NP O
46 dimensions NNS I-NP O
47 of IN B-VP O
47 47 CD O O
47 mm NNS B-NP O
47 , , O O
47 1 CD O O
47 plus CC O O
47 mitral JJ B-NP O
47 regurgitation NN I-NP O
47 and CC O O
47 global JJ B-NP O
47 hypokinesis NN I-NP O
47 as RB O O
48 well RB O O
48 as IN B-VP O
48 moderate JJ B-NP O
48 right NN I-NP O
48 ventricular NN I-NP O
48 dysfunction NN I-NP O
48 Abdominal NNP I-NP O
49 ultrasound NN I-NP O
49 showed VBD B-VP O
49 no DT B-NP O
49 ascites NNS I-NP O
49 despite IN B-VP O
49 extremely RB O O
49 distended VBN O O
49 abdomen NNS B-NP O
50 and CC O O
50 right JJ B-NP O
50 renal JJ I-NP O
50 cyst NN I-NP O
50 x VBD B-VP O
50 2 CD O O
50 Follow NNP B-NP O
50 up RB O O
50 abdominal JJ B-NP O
50 CT NNP I-NP O
50 also RB O O
50 showed VBD B-VP O
50 there EX O O
51 was VBD B-VP O
51 no DT B-NP O
51 mass NN I-NP O
51 or CC O O
51 ascites NNS B-NP O
51 and CC O O
51 his PRP$ O O
51 distended JJ B-NP O
51 abdomen NN I-NP O
51 was VBD B-VP O
51 likely JJ O O
51 due JJ O O
51 to TO O O
52 adipose VB O O
52 tissue NN B-NP O
52 Diuresis NNP I-NP O
52 was VBD B-VP O
52 limited VBN O O
52 by IN B-VP O
52 acute NN B-NP O
52 and CC O O
52 chronic JJ B-NP O
52 renal JJ I-NP O
53 failure NN I-NP O
53 and CC O O
53 oliguria JJ B-NP O
53 Diuresis NNP I-NP O
53 was VBD B-VP O
53 held VBN O O
53 from IN B-VP O
53 March NNP B-NP O
53 , , O O
53 2001 CD O O
54 Right NNP B-NP O
54 heart NN I-NP O
54 catheterization NN I-NP O
54 on IN B-VP O
54 February NNP B-NP O
54 , , O O
54 2001 CD O O
54 showed VBD B-VP O
54 mildly RB O O
55 elevated VBN O O
55 pulmonary JJ B-NP O
55 capillary JJ I-NP O
55 wedge NN I-NP O
55 pressure NN I-NP O
55 and CC O O
55 moderately RB O O
55 elevated VBD B-VP O
56 right JJ B-NP O
56 ventricular NN I-NP O
56 pressures NNS I-NP O
56 Dopamine NNP I-NP B-m
56 Dopamine NNP I-NP B-m
56 was VBD B-VP O
56 started VBN O O
56 on IN B-VP O
56 November NNP B-NP O
56 , , O O
57 2001 CD O O
57 to TO O O
57 aid VB O O
57 with IN B-VP O
57 renal JJ B-NP B-r
57 perfusion NN I-NP I-r
57 and CC O O
57 diuresis NN B-NP O
57 and CC O O
57 he PRP O O
57 was VBD B-VP O
57 then RB O O
58 weaned VBN O O
58 off IN B-VP O
58 of IN B-VP O
58 that DT O O
58 on IN B-VP O
58 August NNP B-NP O
58 , , O O
58 2001 CD O O
58 His PRP$ O O
58 Lasix NNP B-NP B-m
58 was VBD B-VP O
58 stopped VBN O O
58 on IN B-VP O
59 August NNP B-NP O
59 , , O O
59 2001 CD O O
59 and CC O O
59 he PRP O O
59 auto-diuresed VBD B-VP O
59 until IN B-VP O
59 the DT B-NP O
59 time NN I-NP O
59 of IN B-VP O
59 discharge NN B-NP O
60 with IN B-VP O
60 stable JJ B-NP O
60 blood NN I-NP O
60 pressure NN I-NP O
60 He PRP O O
60 remained VBD B-VP O
60 stable JJ O O
60 with IN B-VP O
60 no DT B-NP O
60 dyspnea NN I-NP O
60 at IN B-VP O
61 rest NN B-NP O
61 and CC O O
61 is VBZ O O
61 symptom JJ O O
61 free JJ O O
61 at IN B-VP O
61 the DT B-NP O
61 time NN I-NP O
61 of IN B-VP O
61 discharge NN B-NP O
62 2 CD O O
62 Renal: NNP B-NP O
62 His PRP$ O O
62 basic JJ B-NP O
62 chronic JJ I-NP O
62 renal JJ I-NP O
62 insufficiency NN I-NP O
62 is VBZ O O
62 likely JJ O O
63 secondary JJ O O
63 to TO O O
63 poor JJ B-NP O
63 diabetic JJ I-NP O
63 control NN I-NP O
63 with IN B-VP O
63 a DT B-NP O
63 creatinine NN I-NP O
63 of IN B-VP O
63 2.5 CD O O
63 on IN B-VP O
63 March NNP B-NP O
63 , , O O
63 2001 CD O O
63 , , O O
63 3.3 CD O O
63 at IN B-VP O
63 the DT B-NP O
63 time NN I-NP O
63 of IN B-VP O
63 admission NN B-NP O
63 Acute NNP I-NP O
63 renal JJ B-NP O
63 failure NN I-NP O
63 with IN B-VP O
64 increasing VBG O O
64 creatinine NN B-NP O
64 of IN B-VP O
64 6 CD O O
64 after IN B-VP O
64 aggressive JJ B-NP O
64 diuresis NN I-NP O
64 with IN B-VP O
64 a DT B-NP O
64 mean NN I-NP O
64 of IN B-VP O
65 0.8 CD O O
65 percent JJ B-NP O
65 Renal NNP I-NP O
65 function NN I-NP O
65 improved VBD B-VP O
65 with IN B-VP O
65 creatinine NN B-NP O
65 of IN B-VP O
65 4.1 CD O O
65 on IN B-VP O
66 August NNP B-NP O
66 , , O O
66 2001 CD O O
66 with IN B-VP O
66 autodiuresis NN B-NP O
66 The DT B-NP O
66 renal JJ I-NP O
66 service NN I-NP O
66 was VBD B-VP O
67 consulted VBN O O
67 to TO O O
67 comment VB O O
67 on IN B-VP O
67 the DT B-NP O
67 nature NN I-NP O
67 of IN B-VP O
67 the DT B-NP O
67 patient's JJ I-NP O
67 renal JJ I-NP O
68 insufficiency NN I-NP O
68 and CC O O
68 acute JJ B-NP O
68 renal JJ I-NP O
68 failure NN I-NP O
68 as RB O O
68 well RB O O
68 as IN B-VP O
68 to TO O O
68 assist VB O O
68 in IN B-VP O
68 the DT B-NP O
69 use NN I-NP O
69 of IN B-VP O
69 vasodilators NNS B-NP O
70 3 CD O O
70 Endocrine: NNP B-NP O
70 He PRP O O
70 has VBZ O O
70 a DT O O
70 long JJ O O
70 standing VBG O O
70 history NN B-NP O
70 of IN B-VP O
70 type NN B-NP O
70 II NNP I-NP O
70 diabetes VBZ O O
71 complicated VBN O O
71 by IN B-VP O
71 retinopathy NN B-NP O
71 and CC O O
71 neuropathy JJ O O
71 and CC O O
71 nephropathy JJ O O
71 He PRP O O
71 was VBD B-VP O
72 maintained VBN O O
72 on IN B-VP O
72 his PRP$ O O
72 outpatient JJ B-NP O
72 endocrine JJ I-NP O
72 regimen NNS I-NP O
72 during IN B-VP O
72 his PRP$ O O
72 stay NN B-NP O
73 The DT B-NP O
73 patient NN I-NP O
73 was VBD B-VP O
73 discharged VBN O O
73 home NN B-NP O
73 with IN B-VP O
73 services NNS B-NP O
73 He PRP O O
73 is VBZ O O
73 to TO O O
73 follow VB O O
73 up RP O O
74 with IN B-VP O
74 Dr NNP B-NP O
74 Marro NNP I-NP O
74 on IN B-VP O
74 June NNP B-NP O
74 , , O O
74 2001 CD O O
74 at IN B-VP O
74 3:30 CD O O
74 p.m NN B-NP O
74 , , O O
74 with IN B-VP O
74 Dr NNP B-NP O
74 Loatman NNP I-NP O
74 on IN B-VP O
75 November NNP B-NP O
75 , , O O
75 2002 CD O O
75 at IN B-VP O
75 3:30 CD O O
75 p.m NN B-NP O
75 , , O O
75 Dr NNP B-NP O
75 Carcano NNP I-NP O
75 March NNP I-NP O
75 , , O O
75 2001 CD O O
75 at IN B-VP O
75 10:00 CD O O
76 a.m JJ B-NP O
77 MEDICATIONS NNP I-NP O
77 ON NNP I-NP O
77 DISCHARGE: NNP I-NP O
77 Aspirin NNP I-NP B-m
77 325 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
77 q JJ B-NP B-f
77 day NN I-NP I-f
77 , , O O
77 Lasix NNP B-NP B-m
77 80 CD O B-do
77 mg NN B-NP I-do
78 p.o NN I-NP B-mo
78 q JJ B-NP B-f
78 day NN I-NP I-f
78 , , O O
78 Zocor NNP B-NP B-m
78 20 CD O B-do
78 mg NN B-NP I-do
78 p.o NN I-NP B-mo
78 q.h.s NN I-NP B-f
78 , , O O
79 insulin NN B-NP B-m
79 70/30 CD O I-m
79 65 CD O B-do
79 units NNS B-NP I-do
79 q RB O B-f
79 a.m RB O I-f
79 , , O O
79 insulin VBZ O B-m
79 70/30 CD O I-m
79 45 CD O B-do
79 units NNS B-NP I-do
79 q RB O B-f
79 p.m RB O I-f
79 , , O O
80 Toprol NNP B-NP B-m
80 XL NNP I-NP I-m
80 50 CD O B-do
80 mg NN B-NP I-do
80 p.o NN I-NP B-mo
80 q JJ B-NP B-f
80 day NN I-NP I-f
80 , , O O
80 Levaquin NNP B-NP B-m
80 250 CD O B-do
80 mg NN B-NP I-do
80 p.o NN I-NP B-mo
80 q JJ B-NP B-f
80 day NN I-NP I-f
80 for IN B-VP O
80 a DT B-NP O
81 duration NN I-NP O
81 of IN B-VP O
81 7 CD O B-du
81 days NNS B-NP I-du
81 , , O O
81 Actos NNP B-NP B-m
81 45 CD O B-do
81 mg NN B-NP I-do
81 p.o NN I-NP B-mo
81 q NN I-NP B-f
81 p.m JJ B-NP I-f
82 CONDITION NNP I-NP O
82 ON NNP I-NP O
82 DISCHARGE: NNP I-NP O
82 Stable NNP I-NP O
83 Dictated NNP I-NP O
83 By: NNP I-NP O
83 BENJAMIN NNP I-NP O
83 DOUYON NNP I-NP O
83 , , O O
83 M.D NNP B-NP O
83 RB65 NNP I-NP O
84 Attending: NNP I-NP O
84 RUDOLF NNP I-NP O
84 D NNP I-NP O
84 FEDERKEIL NNP I-NP O
84 , , O O
84 M.D NNP B-NP O
84 ZS91 NNP I-NP O
84 SY386/598343 NNP I-NP O
85 Batch: NNP I-NP O
85 63384 CD O O
85 Index NNP B-NP O
85 No NNP I-NP O
85 E1SALZWZJ5 NNP I-NP O
85 D: NNP I-NP O
85 0/12/02 CD O O
86 T: NNP B-NP O
86 0/12/02 CD O O
87 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #852130 VBZ O O
2 844726908 CD O O
2 IHC NNP B-NP O
2 54526162 CD O O
2 6224708 CD O O
2 2/15/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ATRIAL NNP I-NP O
2 FIBRILLATION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/3/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/26/2006 CD O O
4 ATTENDING: NNP B-NP O
4 PAWELEK NNP I-NP O
4 , , O O
4 BENTON NNP B-NP O
4 FREDERIC NNP I-NP O
4 MD NNP I-NP O
5 CHIEF NNP I-NP O
5 COMPLAINT: NNP I-NP O
5 Shortness NNP I-NP O
5 of IN B-VP O
5 breath JJ B-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 The DT B-NP O
6 patient NN I-NP O
6 is VBZ O O
6 a DT B-NP O
6 64-year-old JJ I-NP O
6 male NN I-NP O
7 with IN B-VP O
7 a DT B-NP O
7 history NN I-NP O
7 of IN B-VP O
7 coronary JJ B-NP O
7 artery NN I-NP O
7 disease NN I-NP O
7 , , O O
7 CHF NNP B-NP O
7 , , O O
7 EF NNP B-NP O
7 of IN B-VP O
7 15% CD O O
7 status NN B-NP O
8 post NN I-NP O
8 AVR NNP I-NP O
8 , , O O
8 history NN B-NP O
8 of IN B-VP O
8 NSTEMI NNP B-NP O
8 initially RB O O
8 presenting VBG O O
8 to TO O O
8 outside JJ B-NP O
9 hospital NN I-NP O
9 on IN B-VP O
9 0/9/06 CD O O
9 with IN B-VP O
9 chief JJ B-NP O
9 complaint NN I-NP O
9 of IN B-VP O
9 shortness NN B-NP O
9 of IN B-VP O
9 breath NN B-NP O
9 , , O O
10 found VBN O O
10 to TO O O
10 be VB O O
10 volume NN B-NP O
10 overloaded VBN O O
10 with IN B-VP O
10 a DT B-NP O
10 clinical JJ I-NP O
10 exam NN I-NP O
10 and CC O O
10 laboratory NN B-NP O
11 findings NNS I-NP O
11 consistent JJ O O
11 with IN B-VP O
11 heart NN B-NP O
11 failure NN I-NP O
11 The DT B-NP O
11 patient NN I-NP O
11 was VBD B-VP O
11 found VBN O O
11 to TO O O
12 have VB O O
12 a DT B-NP O
12 BNP NNP I-NP O
12 of IN B-VP O
12 747 CD O O
12 as RB O O
12 well RB O O
12 as IN B-VP O
12 a DT B-NP O
12 troponin NN I-NP O
12 I PRP O O
12 of IN B-VP O
12 0.43 CD O O
12 A NNP B-NP O
12 repeat NN I-NP O
12 echo NN I-NP O
13 at IN B-VP O
13 that DT B-NP O
13 time NN I-NP O
13 revealed VBD B-VP O
13 an DT B-NP O
13 EF NNP I-NP O
13 of IN B-VP O
13 15% CD O O
13 , , O O
13 down RB O O
13 from IN B-VP O
13 a DT B-NP O
13 previous JJ I-NP O
13 EF NNP I-NP O
13 of IN B-VP O
13 25 CD O O
14 to TO O O
14 35% CD O O
14 with IN B-VP O
14 a DT B-NP O
14 functional JJ I-NP O
14 aortic JJ I-NP O
14 valve NN I-NP O
14 , , O O
14 moderate-to-severe JJ B-NP O
14 mitral JJ I-NP O
15 insufficiency NN I-NP O
15 A NNP I-NP O
15 persantine NN I-NP O
15 MIBI NNP I-NP O
15 demonstrated VBD B-VP O
15 left VBD B-VP O
15 ventricular JJ B-NP O
16 enlargement NN I-NP O
16 and CC O O
16 three-vessel JJ B-NP O
16 disease NN I-NP O
16 with IN B-VP O
16 ischemia NN B-NP O
16 in IN B-VP O
16 the DT B-NP O
16 mid JJ I-NP O
17 distal JJ I-NP O
17 LAD NNP I-NP O
17 and CC O O
17 left VBD B-VP O
17 circ JJ B-NP O
17 territory NN I-NP O
17 as RB O O
17 well RB O O
17 as IN B-VP O
17 a DT B-NP O
17 fixed JJ I-NP O
17 inferior JJ I-NP O
18 wall NN I-NP O
18 defect NN I-NP O
18 consistent NN I-NP O
18 with IN B-VP O
18 a DT B-NP O
18 right JJ I-NP B-r
18 coronary JJ I-NP I-r
18 artery NN I-NP I-r
18 infarct IN B-VP I-r
18 The DT B-NP O
19 patient NN I-NP O
19 was VBD B-VP O
19 diuresed VBN O O
19 , , O O
19 started VBN O O
19 on IN B-VP O
19 Carvedilol NNP B-NP B-m
19 and CC O O
19 improved VBN O O
20 Troponins NNP B-NP O
20 trended VBD B-VP O
20 down RP O O
20 The DT B-NP O
20 patient NN I-NP O
20 continued VBD B-VP O
20 to TO O O
20 have VB O O
20 frequent JJ B-NP O
21 runs NNS I-NP O
21 of IN B-VP O
21 ectopy NN B-NP O
21 and CC O O
21 SVT NNP B-NP O
21 The DT B-NP O
21 patient NN I-NP O
21 was VBD B-VP O
21 placed VBN O O
21 on IN B-VP O
21 a DT B-NP O
21 heparin NN I-NP B-m
21 drip NN I-NP B-mo
22 and CC O O
22 transferred VBD B-VP O
22 to TO O O
22 the DT B-NP O
22 Acbroadl NNP I-NP O
22 Hospital NNP I-NP O
22 for IN B-VP O
23 catheterization NN B-NP O
23 and CC O O
23 possible JJ B-NP O
23 percutaneous JJ I-NP O
23 intervention NN I-NP O
23 On IN B-VP O
24 admission NN B-NP O
24 , , O O
24 the DT B-NP O
24 patient NN I-NP O
24 reported VBD B-VP O
24 to TO O O
24 be VB O O
24 feeling VBG O O
24 much JJ O O
24 better JJR O O
24 , , O O
24 denied VBD B-VP O
25 shortness NN B-NP O
25 of IN B-VP O
25 breath NN B-NP O
25 or CC O O
25 chest JJS O O
25 pain VBP O O
25 The DT B-NP O
25 patient NN I-NP O
25 reports NNS I-NP O
26 progressive JJ B-NP O
26 dyspnea NN I-NP O
26 on IN B-VP O
26 exertion NN B-NP O
26 over IN B-VP O
26 the DT B-NP O
26 past JJ I-NP O
26 several JJ I-NP O
26 months NNS I-NP O
26 , , O O
27 inability NN B-NP O
27 to TO O O
27 lay VB O O
27 flat JJ O O
27 , , O O
27 positive JJ B-NP O
27 orthopnea NN I-NP O
27 and CC O O
27 PND NNP B-NP O
27 , , O O
27 reports VBZ O O
28 ability NN B-NP O
28 to TO O O
28 climb VB O O
28 two CD O O
28 flights NNS B-NP O
28 of IN B-VP O
28 stairs NNS B-NP O
28 , , O O
28 also RB O O
28 reports VBZ O O
28 occasional JJ B-NP O
29 palpitations NNS I-NP O
29 No DT B-NP O
29 fevers NNS I-NP O
29 , , O O
29 chills NNS B-NP O
29 , , O O
29 nausea NN B-NP O
29 , , O O
29 vomiting VBG O O
29 , , O O
29 constipation NN B-NP O
29 , , O O
30 diarrhea NN B-NP O
30 , , O O
30 bright JJ B-NP O
30 red JJ I-NP O
30 blood NN I-NP O
30 per IN B-VP O
30 rectum NN B-NP O
30 or CC O O
30 pedal NN B-NP O
30 edema VBP O O
30 The DT B-NP O
31 patient NN I-NP O
31 reports NNS I-NP O
31 poor JJ B-NP O
31 compliance NN I-NP O
31 with IN B-VP O
31 diabetes NNS B-NP O
31 management NN I-NP O
31 , , O O
31 denies VBZ O O
32 dietary JJ B-NP O
32 indiscretion NN I-NP O
32 , , O O
32 reports VBZ O O
32 medical JJ B-NP O
32 compliance NN I-NP O
33 PAST NNP I-NP O
33 MEDICAL NNP I-NP O
33 HISTORY: NNP I-NP O
33 Includes NNP I-NP O
33 coronary JJ B-NP O
33 artery NN I-NP O
33 disease NN I-NP O
33 status NN I-NP O
34 post NN I-NP O
34 CABG NNP I-NP O
34 in IN B-VP O
34 1994 CD O O
34 , , O O
34 coronary JJ B-NP O
34 artery NN I-NP O
34 disease NN I-NP O
34 , , O O
34 CHF NNP B-NP O
34 , , O O
34 cardiomyopathy NN B-NP O
34 , , O O
35 non-ST-wave JJ B-NP O
35 MI NNP I-NP O
35 , , O O
35 status NN B-NP O
35 post NN I-NP O
35 aortic JJ B-NP O
35 valve NN I-NP O
35 replacement NN I-NP O
35 with IN B-VP O
35 St NNP B-NP O
36 Jude's NNP I-NP O
36 valve NN I-NP O
36 , , O O
36 hyperlipidemia NN B-NP O
36 , , O O
36 diabetes VBZ O O
36 , , O O
36 anxiety NN B-NP O
37 ALLERGIES: NNP I-NP O
37 The DT B-NP O
37 patient NN I-NP O
37 has VBZ O O
37 no DT O O
37 known VBN O O
37 drug NN B-NP O
37 allergies NNS I-NP O
38 MEDICATIONS NNP I-NP O
38 ON NNP I-NP O
38 ADMISSION: NNP I-NP O
38 Include NNP I-NP O
38 aspirin VBZ O B-m
38 81 CD O B-do
38 , , O O
38 lisinopril VBD B-VP B-m
38 20 CD O B-do
38 , , O O
39 Plavix NNP B-NP B-m
39 75 CD O B-do
39 , , O O
39 verapamil FW O B-m
39 240 CD O B-do
39 sustained JJ B-NP O
39 release NN I-NP O
39 , , O O
39 gemfibrozil VBP O B-m
39 600 CD O B-do
40 b.i.d NN B-NP B-f
40 , , O O
40 nystatin RB O B-m
40 500 CD O B-do
40 b.i.d NN B-NP B-f
40 , , O O
40 Paxil NNP B-NP B-m
40 20 CD O B-do
40 daily RB O B-f
40 , , O O
40 glipizide JJ O B-m
40 10 CD O B-do
40 daily RB O B-f
40 , , O O
41 Coumadin NNP B-NP B-m
41 4 CD O B-do
41 prior RB O B-du
41 to TO O I-du
41 admission NN B-NP I-du
41 to TO O I-du
41 outside JJ B-NP I-du
41 hospital NN I-NP I-du
41 , , O O
41 Carvedilol NNP B-NP B-m
42 6.25 CD O B-do
42 daily RB O B-f
42 , , O O
42 heparin JJ B-NP B-m
42 drip NN I-NP B-mo
42 and CC O O
42 spironolactone NN B-NP B-m
43 SOCIAL NNP I-NP O
43 HISTORY: NNP I-NP O
43 The DT B-NP O
43 patient NN I-NP O
43 currently RB O O
43 uses VBZ O O
43 tobacco NN B-NP O
43 No NNP I-NP O
43 alcohol NN I-NP O
44 use VB O O
44 The DT B-NP O
44 patient NN I-NP O
44 is VBZ O O
44 retired VBN O O
44 , , O O
44 lives VBZ O O
44 with IN B-VP O
44 wife NN B-NP O
44 in IN B-VP O
44 Lin NNP B-NP O
44 Con NNP I-NP O
44 , , O O
44 teaches VBZ O O
45 graduate NN B-NP O
45 courses NNS I-NP O
46 FAMILY NNP I-NP O
46 HISTORY: NNP I-NP O
46 The DT B-NP O
46 patient NN I-NP O
46 denies VBZ O O
46 a DT B-NP O
46 family NN I-NP O
46 history NN I-NP O
46 of IN B-VP O
46 coronary JJ B-NP O
47 artery NN I-NP O
47 disease NN I-NP O
47 , , O O
47 however RB O O
47 , , O O
47 there EX O O
47 is VBZ O O
47 hypertension NN B-NP O
47 and CC O O
48 cerebrovascular JJ B-NP O
48 disease NN I-NP O
48 in IN B-VP O
48 his PRP$ O O
48 family NN B-NP O
49 PHYSICAL NNP I-NP O
49 EXAMINATION: NNP I-NP O
49 On IN B-VP O
49 admission NN B-NP O
49 , , O O
49 the DT B-NP O
49 patient NN I-NP O
49 was VBD B-VP O
49 afebrile RB O O
49 , , O O
50 heart NN B-NP O
50 rate NN I-NP O
50 58 CD O O
50 , , O O
50 BP NNP B-NP O
50 124/60 CD O O
50 , , O O
50 respiratory JJ B-NP O
50 rate NN I-NP O
50 of IN B-VP O
50 20 CD O O
50 , , O O
50 saturating VBG O O
50 98% CD O O
51 on IN B-VP O
51 2 CD O O
51 L NNP B-NP O
51 The DT B-NP O
51 patient NN I-NP O
51 was VBD B-VP O
51 in IN B-VP O
51 no DT B-NP O
51 acute NN I-NP O
51 distress NN I-NP O
51 , , O O
51 lying VBG O O
51 flat JJ O O
51 , , O O
52 speaking VBG O O
52 in IN B-VP O
52 full JJ B-NP O
52 sentences NNS I-NP O
52 Mucous JJ B-NP O
52 membranes NNS I-NP O
52 moist NN I-NP O
52 , , O O
52 oropharynx JJ B-NP O
53 clear JJ I-NP O
53 JVP NNP I-NP O
53 12 CD O O
53 with IN B-VP O
53 bibasilar JJ B-NP O
53 crackles NNS I-NP O
53 , , O O
53 left VBD B-VP O
53 greater JJR O O
53 than IN B-VP O
53 right NN B-NP O
54 and CC O O
54 expiratory NN B-NP O
54 wheeze NN I-NP O
54 with IN B-VP O
54 long JJ O O
54 , , O O
54 pronounced JJ B-NP O
54 expiratory NN I-NP O
54 phase NN I-NP O
55 Heart NNP I-NP O
55 , , O O
55 S1 NNP B-NP O
55 , , O O
55 S2 NNP B-NP O
55 , , O O
55 prosthetic JJ B-NP O
55 S2 NNP I-NP O
55 No NNP I-NP O
55 murmurs NN I-NP O
55 , , O O
55 gallops NNS B-NP O
55 or CC O O
55 rubs NNS B-NP O
56 appreciated VBN O O
56 Abdomen NNP B-NP O
56 soft JJ O O
56 , , O O
56 nontender NN B-NP O
56 and CC O O
56 nondistended VBD B-VP O
56 with IN B-VP O
57 positive JJ B-NP O
57 bowel NN I-NP O
57 sounds VBZ O O
57 Extremities NNS B-NP O
57 are VBP O O
57 without IN B-VP O
57 edema JJ B-NP O
57 DP NNP I-NP O
58 intact JJ B-NP O
58 Feet NNP I-NP O
58 are VBP O O
58 cool JJ O O
58 but CC O O
58 well RB O O
58 perfused JJ B-NP O
58 Skin NNP I-NP O
58 warm NN I-NP O
58 , , O O
58 dry JJ O O
58 and CC O O
59 intact JJ O O
59 , , O O
59 no DT B-NP O
59 rashes NNS I-NP O
59 The DT B-NP O
59 patient NN I-NP O
59 is VBZ O O
59 alert JJ O O
59 and CC O O
59 oriented JJ B-NP O
59 x3 NNP I-NP O
60 LABORATORY NNP I-NP O
60 DATA: NNP I-NP O
60 Labs NNP I-NP O
60 notable JJ O O
60 for IN B-VP O
60 creatinine NN B-NP O
60 of IN B-VP O
60 1 CD O O
60 , , O O
60 hematocrit NN B-NP O
60 of IN B-VP O
61 39.5 CD O O
61 , , O O
61 platelets NNS B-NP O
61 of IN B-VP O
61 113 CD O O
61 , , O O
61 cholesterol NN B-NP O
61 157 CD O O
61 , , O O
61 triglycerides NNS B-NP O
61 76 CD O O
61 , , O O
61 HDL NNP B-NP O
62 32 CD O O
62 , , O O
62 LDL NNP B-NP O
62 110 CD O O
62 , , O O
62 hemoglobin NN B-NP O
62 A1c NNP I-NP O
62 6.3 CD O O
62 , , O O
62 TSH NNP B-NP O
62 1.9 CD O O
62 EKG NNP B-NP O
62 , , O O
62 sinus NN B-NP O
62 rhythm NN I-NP O
62 , , O O
63 left VBD B-VP O
63 bundle JJ B-NP O
63 branch NN I-NP O
63 block NN I-NP O
63 with IN B-VP O
63 multiple JJ B-NP O
63 PVCs NNP I-NP O
63 , , O O
63 a DT B-NP O
63 widened JJ I-NP O
63 QRS NNP I-NP O
63 of IN B-VP O
64 duration NN B-NP O
64 of IN B-VP O
64 190 CD O O
64 milliseconds NNS B-NP O
64 Chest NNP I-NP O
64 x-ray NN I-NP O
64 , , O O
64 cardiomegaly JJ B-NP O
65 consistent NN I-NP O
65 with IN B-VP O
65 mild JJ B-NP O
65 interstitial JJ I-NP O
65 edema NN I-NP O
66 HOSPITAL NNP I-NP O
66 COURSE: NNP I-NP O
66 In IN B-VP O
66 summary JJ O O
66 , , O O
66 this DT O O
66 is VBZ O O
66 a DT B-NP O
66 64-year-old JJ I-NP O
66 male NN I-NP O
66 with IN B-VP O
66 a DT B-NP O
67 history NN I-NP O
67 of IN B-VP O
67 coronary JJ B-NP O
67 artery NN I-NP O
67 disease NN I-NP O
67 status NN I-NP O
67 post NN I-NP O
67 CABG NNP I-NP O
67 and CC O O
67 NSTEMI NNP B-NP O
67 , , O O
68 CHF NNP B-NP O
68 with IN B-VP O
68 a DT B-NP O
68 known JJ I-NP O
68 EF NNP I-NP O
68 of IN B-VP O
68 15% CD O O
68 , , O O
68 status NN B-NP O
68 post NN I-NP O
68 aortic JJ B-NP O
68 valve NN I-NP O
68 replacement NN I-NP O
68 , , O O
69 presenting VBG O O
69 through IN B-VP O
69 an DT B-NP O
69 outside JJ I-NP O
69 hospital NN I-NP O
69 with IN B-VP O
69 CHF NNP B-NP O
69 exacerbation NN I-NP O
70 likely RB O O
70 secondary JJ O O
70 to TO O O
70 ischemia VB O O
71 1 CD O O
71 Cardiovascular: NNP B-NP O
72 Ischemia: NNP I-NP O
72 No NNP I-NP O
72 evidence NN I-NP O
72 of IN B-VP O
72 ongoing VBG O O
72 ischemia NN B-NP O
72 on IN B-VP O
72 admission NN B-NP O
73 Elevated VBN O O
73 troponin NN B-NP O
73 at IN B-VP O
73 outside JJ B-NP O
73 hospital NN I-NP O
73 trended VBD B-VP O
73 down RB O O
73 possibly RB O O
74 secondary JJ O O
74 to TO O O
74 NSTEMI NNP B-NP O
74 prior RB O O
74 to TO O O
74 admission VB O O
74 versus JJ B-NP O
74 demand NN I-NP O
74 The DT B-NP O
75 patient NN I-NP O
75 was VBD B-VP O
75 continued VBN O O
75 on IN B-VP O
75 aspirin NN B-NP B-m
75 , , O O
75 Plavix NNP B-NP B-m
75 , , O O
75 beta-blocker NN B-NP B-m
75 and CC O O
75 ACE NNP B-NP B-m
76 inhibitor NN I-NP O
76 , , O O
76 which WDT O O
76 were VBD B-VP O
76 titrated VBN O O
76 to TO O O
76 effect NN B-NP O
76 The DT B-NP O
76 patient NN I-NP O
76 was VBD B-VP O
77 started VBN O O
77 on IN B-VP O
77 a DT B-NP O
77 statin NN I-NP B-m
77 and CC O O
77 continued VBN O O
77 on IN B-VP O
77 Niaspan NNP B-NP B-m
77 , , O O
77 left VBD B-VP O
77 heart NN B-NP O
77 cath NN I-NP O
78 revealed VBD B-VP O
78 occluded VBN O O
78 graft NN B-NP O
78 and CC O O
78 2+ CD O O
78 aortic JJ B-NP O
78 insufficiency NN I-NP O
78 with IN B-VP O
78 100% CD O O
78 LAD NNP B-NP O
79 stenosis NN I-NP O
79 , , O O
79 70% CD O O
79 diagonal JJ O O
79 1 CD O O
79 , , O O
79 90% CD O O
79 circumflex NN B-NP O
79 , , O O
79 45% CD O O
79 RCA NNP B-NP O
79 and CC O O
79 100% CD O O
80 effused VBD B-VP O
80 LIMA NNP B-NP O
80 graft NN I-NP O
80 to TO O O
80 circumflex VB O O
80 and CC O O
80 a DT O O
80 100% CD O O
80 effused JJ B-NP O
80 SVG NNP I-NP O
80 graft NN I-NP O
80 to TO O O
81 LAD VB O O
81 The DT B-NP O
81 patient NN I-NP O
81 is VBZ O O
81 now RB O O
81 status NN B-NP O
81 post NN I-NP O
81 stenting VBG O O
81 the DT B-NP O
81 OM NNP I-NP O
81 V1 NNP I-NP O
81 and CC O O
81 LAD NNP B-NP O
82 The DT B-NP O
82 patient NN I-NP O
82 has VBZ O O
82 remained VBN O O
82 asymptomatic JJ O O
82 and CC O O
82 shortness NN B-NP O
82 of IN B-VP O
82 breath NN B-NP O
82 has VBZ O O
83 improved VBN O O
84 Pump: NNP B-NP O
84 EF NNP I-NP O
84 15% CD O O
84 on IN B-VP O
84 repeat NN B-NP O
84 echo NN I-NP O
84 with IN B-VP O
84 severe JJ B-NP B-r
84 MR NNP I-NP I-r
84 The DT B-NP O
84 patient NN I-NP O
84 was VBD B-VP O
85 continued VBN O O
85 on IN B-VP O
85 spironolactone NN B-NP B-m
85 The DT B-NP O
85 patient NN I-NP O
85 continued VBD B-VP O
85 to TO O O
85 be VB O O
86 diuresed VBN O O
86 initially RB O O
86 and CC O O
86 is VBZ O O
86 now RB O O
86 euvolemic JJ O O
86 He PRP O O
86 will MD O O
86 need VB O O
86 a DT B-NP O
86 repeat NN I-NP O
87 echo NN I-NP O
87 in IN B-VP O
87 three CD O O
87 months NNS B-NP O
87 to TO O O
87 evaluate VB O O
87 his PRP$ O O
87 ejection NN B-NP O
87 fraction NN I-NP O
87 and CC O O
88 determine VB O O
88 the DT B-NP O
88 utility NN I-NP O
88 of IN B-VP O
88 an DT B-NP O
88 AICD NNP I-NP O
88 placement NN I-NP O
89 Rhythm: NNP I-NP O
89 We PRP O O
89 held VBD B-VP O
89 verapamil RB O B-m
89 secondary JJ O O
89 to TO O O
89 double VB O O
89 AV NNP B-NP O
89 nodal FW O O
89 blockade NN B-NP O
90 However RB O O
90 , , O O
90 with IN B-VP O
90 the DT B-NP O
90 patient's JJ I-NP O
90 history NN I-NP O
90 of IN B-VP O
90 widened JJ B-NP O
90 QRS NNP I-NP O
90 and CC O O
90 multiple JJ B-NP O
91 PVCs NNP I-NP O
91 and CC O O
91 SVT NNP B-NP O
91 , , O O
91 the DT B-NP O
91 patient NN I-NP O
91 will MD O O
91 follow VB O O
91 up RP O O
91 with IN B-VP O
91 EP NNP B-NP O
91 to TO O O
91 assess VB O O
91 the DT B-NP O
92 utility NN I-NP O
92 of IN B-VP O
92 AICD NNP B-NP O
93 2 CD O O
93 Respiratory: NNP B-NP O
93 The DT B-NP O
93 patient NN I-NP O
93 has VBZ O O
93 no DT B-NP O
93 acute JJ I-NP O
93 issues NNS I-NP O
93 Shortness NNP I-NP O
93 of IN B-VP O
94 breath NN B-NP O
94 has VBZ O O
94 improved VBN O O
94 Continues NNS B-NP O
94 to TO O O
94 complain VB O O
94 of IN B-VP O
94 residual JJ B-NP O
94 shortness NN I-NP O
95 of IN B-VP O
95 breath NN B-NP O
95 while IN B-VP O
95 lying VBG O O
95 flat JJ O O
95 on IN B-VP O
95 his PRP$ O O
95 left JJ B-NP O
95 side NN I-NP O
96 3 CD O O
96 Renal: NNP B-NP O
96 Creatinine NNP I-NP O
96 has VBZ O O
96 been VBN O O
96 stable JJ O O
96 at IN B-VP O
96 baseline NN B-NP O
96 We PRP O O
96 will MD O O
97 closely RB O O
97 follow VB O O
97 status NN B-NP O
97 post NN I-NP O
97 chat WP O O
97 The DT B-NP O
97 patient NN I-NP O
97 was VBD B-VP O
97 pretreated VBN O O
97 with IN B-VP O
98 bicarbonate NN B-NP B-m
98 and CC O O
98 Mucomyst NNP B-NP B-m
98 Creatinine NNP I-NP O
98 remained VBD B-VP O
98 stable JJ O O
99 4 CD O O
99 GI: NNP B-NP O
99 LFTs NNP I-NP O
99 are VBP O O
99 mildly RB O O
99 increased VBN O O
99 likely RB O O
99 secondary JJ O O
99 to TO O O
99 right JJ B-NP O
100 heart NN I-NP O
100 failure NN I-NP O
101 5 CD O O
101 Heme: NNP B-NP O
101 The DT B-NP O
101 patient's NN I-NP O
101 hematocrit NN I-NP O
101 was VBD B-VP O
101 39 CD O O
101 on IN B-VP O
101 admission NN B-NP O
101 It PRP O O
102 trended VBD B-VP O
102 down RB O O
102 status NN B-NP O
102 post NN I-NP O
102 cath NN I-NP O
102 likely RB O O
102 secondary JJ O O
102 to TO O O
102 blood VB O O
102 loss NN B-NP O
103 given VBN O O
103 the DT B-NP O
103 long JJ I-NP O
103 case NN I-NP O
103 and CC O O
103 hemodilution; NN B-NP O
103 however RB O O
103 , , O O
103 hematocrit NN B-NP O
103 fell VBD B-VP O
103 to TO O O
104 38 CD O O
104 concerning VBG O O
104 for IN B-VP O
104 retroperitoneal NN B-NP O
104 bleed VBN O O
104 Despite IN B-VP O
104 patient JJ O O
105 remaining VBG O O
105 hemodynamically RB O O
105 stable JJ O O
105 and CC O O
105 groin VB O O
105 without IN B-VP O
105 evidence NN B-NP O
105 of IN B-VP O
106 hematoma NN B-NP O
106 , , O O
106 the DT B-NP O
106 patient NN I-NP O
106 underwent NN I-NP O
106 a DT B-NP O
106 CT NNP I-NP O
106 scan NN I-NP O
106 , , O O
106 which WDT O O
106 was VBD B-VP O
106 negative JJ O O
107 His PRP$ O O
107 hematocrit NN B-NP O
107 was VBD B-VP O
107 stabilized VBN O O
107 He PRP O O
107 was VBD B-VP O
107 not RB O O
107 transfused VBN O O
107 , , O O
107 as IN B-VP O
107 he PRP O O
107 was VBD B-VP O
108 asymptomatic JJ O O
108 and CC O O
108 recently RB O O
108 revascularized VBD B-VP O
108 The DT B-NP O
108 patient NN I-NP O
108 was VBD B-VP O
108 noted VBN O O
109 to TO O O
109 be VB O O
109 guaiac JJ O O
109 positive JJ O O
109 without IN B-VP O
109 evidence NN B-NP O
109 of IN B-VP O
109 gross JJ B-NP O
109 bleeding NN I-NP O
109 , , O O
109 thus RB O O
110 will MD O O
110 need VB O O
110 outpatient JJ O O
110 follow-up JJ O O
110 and CC O O
110 colonoscopy VBZ O O
110 The DT B-NP O
110 patient NN I-NP O
111 continues VBZ O O
111 his PRP$ O O
111 heparin-bridged JJ B-NP B-m
111 Coumadin NNP I-NP I-m
111 with IN B-VP O
111 a DT B-NP O
111 goal NN I-NP O
111 of IN B-VP O
111 INR NNP B-NP O
111 2 CD O O
111 to TO O O
111 3 CD O O
112 In IN B-VP O
112 addition NN B-NP O
112 , , O O
112 the DT B-NP O
112 patient NN I-NP O
112 suffers NNS I-NP O
112 from IN B-VP O
112 long-term JJ B-NP O
113 thrombocytopenia NN I-NP O
113 His PRP$ O O
113 platelet NN B-NP O
113 count NN I-NP O
113 was VBD B-VP O
113 113 CD O O
113 on IN B-VP O
113 admission NN B-NP O
114 Review NNP I-NP O
114 of IN B-VP O
114 records NNS B-NP O
114 revealed VBN O O
114 thrombocytopenia NN B-NP O
114 on IN B-VP O
114 previous JJ B-NP O
114 admission NN I-NP O
115 to TO O O
115 Norpid NNP B-NP O
115 Memorial NNP I-NP O
115 Hospital NNP I-NP O
115 as RB O O
115 well RB O O
115 as IN B-VP O
115 on IN B-VP O
115 presentation NN B-NP O
115 to TO O O
115 outside VB O O
115 hospital NN B-NP O
115 prior RB O O
116 to TO O O
116 heparinization NN B-NP O
116 , , O O
116 thus RB O O
116 low JJ B-NP O
116 suspicion NN I-NP O
116 for IN B-VP O
116 HIT NNP B-NP O
116 The DT B-NP O
116 patient's JJ I-NP O
117 platelet NN I-NP O
117 level NN I-NP O
117 remained VBD B-VP O
117 stable JJ O O
117 He PRP O O
117 should MD O O
117 consider VB O O
117 outpatient JJ B-NP O
118 evaluation NN I-NP O
118 by IN B-VP O
118 Hematology NNP B-NP O
119 6 CD O O
119 Endocrine: NNP B-NP O
119 The DT B-NP O
119 patient NN I-NP O
119 has VBZ O O
119 a DT B-NP O
119 history NN I-NP O
119 of IN B-VP O
119 diabetes NNS B-NP B-r
119 on IN B-VP O
119 oral JJ B-NP B-mo
120 hypoglycemics NNS I-NP B-m
120 , , O O
120 which WDT O O
120 were VBD B-VP O
120 discontinued VBN O O
120 on IN B-VP O
120 admission NN B-NP O
120 The DT B-NP O
120 patient NN I-NP O
121 was VBD B-VP O
121 controlled VBN O O
121 with IN B-VP O
121 regular JJ B-NP B-m
121 insulin NN I-NP I-m
121 and CC O O
121 placed VBD B-VP O
121 back RP O O
121 on IN B-VP O
121 his PRP$ O O
121 oral JJ B-NP B-mo
122 hypoglycemics NNS I-NP B-m
122 prior RB O O
122 to TO O O
122 discontinuing VBG O O
122 A1c NNP B-NP O
122 was VBD B-VP O
122 within IN B-VP O
122 normal JJ B-NP O
123 limits NNS I-NP O
124 7 CD O O
124 ID: NNP B-NP O
124 No NNP I-NP O
124 acute NN I-NP O
124 issues NNS I-NP O
125 8 CD O O
125 Psych: NNP B-NP O
125 History NNP I-NP O
125 of IN B-VP O
125 anxiety NN B-NP B-r
125 anxiety NN I-NP B-r
125 , , O O
125 on IN B-VP O
125 Paxil NNP B-NP B-m
125 and CC O O
125 Ativan NNP B-NP B-m
126 9 CD O O
126 FEN: NNP B-NP O
126 The DT B-NP O
126 patient NN I-NP O
126 was VBD B-VP O
126 maintained VBN O O
126 on IN B-VP O
126 a DT B-NP O
126 cardiac JJ I-NP O
126 diet NN I-NP O
127 10 CD O O
127 Prophylaxis: NNP B-NP O
127 The DT B-NP O
127 patient NN I-NP O
127 was VBD B-VP O
127 encouraged VBN O O
127 to TO O O
127 stop VB O O
127 smoking NN B-NP B-r
128 He PRP O O
128 was VBD B-VP O
128 maintained VBN O O
128 on IN B-VP O
128 a DT B-NP O
128 nicotine JJ I-NP B-m
128 patch NN I-NP I-m
128 during IN B-VP B-du
128 his PRP$ O I-du
128 hospital NN B-NP I-du
128 stay NN I-NP I-du
128 , , O O
129 which WDT O O
129 he PRP O O
129 tolerated VBD B-VP O
129 well RB O O
129 He PRP O O
129 will MD O O
129 be VB O O
129 discharged VBN O O
129 with IN B-VP O
129 a DT B-NP O
130 prescription NN I-NP O
130 for IN B-VP O
130 the DT B-NP O
130 nicotine JJ I-NP B-m
130 patch NN I-NP I-m
130 as IN B-VP O
130 well RB O O
131 DISCHARGE NNP B-NP O
131 CONDITION: NNP I-NP O
131 Stable NNP I-NP O
132 DISCHARGE NNP I-NP O
132 INSTRUCTIONS: NNP I-NP O
132 The DT B-NP O
132 patient NN I-NP O
132 is VBZ O O
132 to TO O O
132 follow VB O O
132 up RP O O
132 with IN B-VP O
132 PCP NNP B-NP O
132 and CC O O
133 Cardiology NNP B-NP O
133 as RB O O
133 well RB O O
133 as IN B-VP O
133 EP NNP B-NP O
133 Patient NNP I-NP O
133 encouraged VBD B-VP O
133 to TO O O
133 check VB O O
133 his PRP$ O O
133 daily JJ B-NP O
134 weights NNS I-NP O
134 and CC O O
134 report VB O O
134 a DT B-NP O
134 weight JJ I-NP O
134 increase NN I-NP O
134 of IN B-VP O
134 more JJR O O
134 than IN B-VP O
134 2 CD O O
134 pounds NNS B-NP O
134 daily JJ O O
135 or CC O O
135 3 CD O O
135 pounds NNS B-NP O
135 a DT B-NP O
135 week NN I-NP O
135 to TO O O
135 his PRP$ O O
135 PCP NNP B-NP O
135 The DT B-NP O
135 patient NN I-NP O
135 will MD O O
135 also RB O O
135 follow VB O O
135 up RP O O
136 with IN B-VP O
136 INR NNP B-NP O
136 checks NNS I-NP O
136 as IN B-VP O
136 an DT B-NP O
136 outpatient JJ I-NP O
137 DISCHARGE NNP I-NP O
137 APPOINTMENTS: NNP I-NP O
137 With IN B-VP O
137 his PRP$ O O
137 PCP NNP B-NP O
137 , , O O
137 Dr NNP B-NP O
137 Qin NNP I-NP O
137 , , O O
137 telephone NN B-NP O
138 044-133-1576 CD O O
138 , , O O
138 on IN B-VP O
138 0/16/06 CD O O
138 at IN B-VP O
138 1:45 CD O O
138 , , O O
138 Cardiology NNP B-NP O
138 with IN B-VP O
138 Dr NNP B-NP O
139 Mccoyle NNP I-NP O
139 at IN B-VP O
139 372-301-7202 NNP B-NP O
139 on IN B-VP O
139 11/21/06 CD O O
139 at IN B-VP O
139 3:15 CD O O
139 and CC O O
139 with IN B-VP O
140 Electrophysiology NNP B-NP O
140 , , O O
140 Dr NNP B-NP O
140 Kunich NNP I-NP O
140 on IN B-VP O
140 11/10/06 CD O O
140 at IN B-VP O
140 10:20 CD O O
140 The DT B-NP O
140 patient NN I-NP O
141 should MD O O
141 arrange VB O O
141 to TO O O
141 have VB O O
141 his PRP$ O O
141 INR NNP B-NP O
141 drawn NN I-NP O
141 on IN B-VP O
141 6/21/06 CD O O
141 and CC O O
141 follow-up JJ B-NP O
142 INRs NNP I-NP O
142 to TO O O
142 be VB O O
142 drawn VBN O O
142 every DT O O
142 seven CD O O
142 days NNS B-NP O
142 INRs NNP I-NP O
142 will MD O O
142 be VB O O
142 followed VBN O O
142 by IN B-VP O
142 his PRP$ O O
143 PCP NNP B-NP O
144 DISCHARGE NNP I-NP O
144 MEDICATIONS: NNP I-NP O
145 1 CD O O
145 Aspirin NNP B-NP B-m
145 325 CD O B-do
145 p.o JJ O B-mo
145 daily RB O B-f
146 2 CD O O
146 Lisinopril NNP B-NP B-m
146 4 CD O B-do
146 mg NN B-NP I-do
146 p.o JJ O B-mo
146 daily JJ O B-f
147 3 CD O O
147 Nicotine NNP B-NP B-m
147 patch NN I-NP I-m
147 14 CD O B-do
147 mg NN B-NP I-do
147 per IN B-VP B-f
147 day NN B-NP I-f
147 topical JJ O B-mo
148 4 CD O O
148 Spironolactone NNP B-NP B-m
148 25 CD O B-do
148 mg NN B-NP I-do
148 p.o JJ O B-mo
148 daily JJ O B-f
149 5 CD O O
149 Paxil NNP B-NP B-m
149 25 CD O B-do
149 mg NN B-NP I-do
149 p.o JJ O B-mo
149 daily JJ O B-f
150 6 CD O O
150 Atorvastatin NNP B-NP B-m
150 80 CD O B-do
150 mg VBD B-VP I-do
150 daily RB O B-f
151 7 CD O O
151 Niaspan NNP B-NP B-m
151 0.5 CD O B-do
151 gm NN B-NP I-do
151 p.o NN I-NP B-mo
151 twice RB O B-f
151 daily RB O I-f
152 8 CD O O
152 Carvedilol NNP B-NP B-m
152 12.5 CD O B-do
152 mg NN B-NP I-do
152 p.o NN I-NP B-mo
152 twice RB O B-f
152 daily RB O I-f
153 9 CD O O
153 Plavix NNP B-NP B-m
153 75 CD O B-do
153 mg VBD B-VP I-do
153 daily RB O B-f
154 10 CD O O
154 Gemfibrozil NNP B-NP B-m
154 900 CD O B-do
154 mg NN B-NP I-do
154 p.o NN I-NP B-mo
154 twice RB O B-f
154 daily RB O I-f
155 11 CD O O
155 Coumadin NNP B-NP B-m
155 5 CD O B-do
155 mg NN B-NP I-do
155 p.o NN I-NP B-mo
155 at IN B-VP B-f
155 night NN B-NP I-f
156 eScription NN I-NP O
156 document: VBD B-VP O
156 1-7905999 CD O O
156 CSSten NNP B-NP O
156 Tel NNP I-NP O
157 Dictated NNP I-NP O
157 By: NNP I-NP O
157 SPELMAN NNP I-NP O
157 , , O O
157 TERENCE NNP B-NP O
158 Attending: NNP I-NP O
158 MELVILLE NNP I-NP O
158 , , O O
158 GARRETT NNP B-NP O
158 WALLY NNP I-NP O
159 Dictation NNP I-NP O
159 ID NNP I-NP O
159 7214166 CD O O
160 D: NNP B-NP O
160 7/0/06 CD O O
161 T: NNP B-NP O
161 7/0/06 CD O O
162 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #854980 VBZ O O
2 466605453 CD O O
2 FLMC NNP B-NP O
2 88455449 CD O O
2 4128807 CD O O
2 8/14/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 WEAKNESS NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 2/2/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/14/2006 CD O O
4 ATTENDING: NNP B-NP O
4 HAJDUK NNP I-NP O
4 , , O O
4 COLUMBUS NNP B-NP O
4 MD NNP I-NP O
5 DATE NNP I-NP O
5 AND NNP I-NP O
5 TIME NNP I-NP O
5 OF NNP I-NP O
5 DEATH: NNP I-NP O
5 10/18/06 CD O O
5 at IN B-VP O
5 2:20 CD O O
5 p.m NN B-NP O
6 CHIEF NNP I-NP O
6 COMPLAINT: NNP I-NP O
6 The DT B-NP O
6 patient NN I-NP O
6 was VBD B-VP O
6 admitted VBN O O
6 on IN B-VP O
6 0/5/06 CD O O
6 with IN B-VP O
6 a DT B-NP O
7 chief JJ I-NP O
7 complaint NN I-NP O
7 of IN B-VP O
7 weakness NN B-NP O
7 and CC O O
7 confusion NN B-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 This DT O O
8 was VBD B-VP O
8 a DT B-NP O
8 70-year-old JJ I-NP O
8 female NN I-NP O
8 with IN B-VP O
9 CHF NNP B-NP O
9 , , O O
9 coronary JJ B-NP O
9 artery NN I-NP O
9 disease NN I-NP O
9 , , O O
9 diabetes VBZ O O
9 , , O O
9 peripheral JJ B-NP O
9 vascular JJ I-NP O
10 disease NN I-NP O
10 , , O O
10 and CC O O
10 chronic JJ B-NP O
10 renal JJ I-NP O
10 insufficiency NN I-NP O
10 that WDT O O
10 was VBD B-VP O
10 admitted VBN O O
10 on IN B-VP O
11 0/5/06 CD O O
11 for IN B-VP O
11 weakness NN B-NP O
11 and CC O O
11 confusion NN B-NP O
11 She PRP O O
11 had VBD B-VP O
11 been VBN O O
11 recently RB O O
12 hospitalized VBN O O
12 on IN B-VP O
12 8/1/06 CD O O
12 through IN B-VP O
12 9/11/06 CD O O
12 and CC O O
12 5/6/06 CD O O
12 through IN B-VP O
13 5/24/06 CD O O
13 for IN B-VP O
13 CHF NNP B-NP O
13 exacerbation NN I-NP O
13 requiring VBG O O
13 aggressive JJ B-NP O
13 diuresis NN I-NP O
14 Her NNP I-NP O
14 weight NN I-NP O
14 on IN B-VP O
14 discharge NN B-NP O
14 on IN B-VP O
14 5/24/06 CD O O
14 was VBD B-VP O
14 85 CD O O
14 kg NN B-NP O
14 She PRP O O
14 did VBD B-VP O
14 well RB O O
15 initially RB O O
15 at IN B-VP O
15 home NN B-NP O
15 after IN B-VP O
15 discharge NN B-NP O
15 , , O O
15 but CC O O
15 two CD O O
15 days NNS B-NP O
15 prior RB O O
15 to TO O O
16 admission NN B-NP O
16 , , O O
16 had VBD B-VP O
16 increasing VBG O O
16 somnolence NN B-NP O
16 and CC O O
16 confusion NN B-NP O
16 with IN B-VP O
16 global JJ B-NP O
17 weakness NN I-NP O
17 causing VBG O O
17 the DT B-NP O
17 patient NN I-NP O
17 to TO O O
17 fall VB O O
17 without IN B-VP O
17 head NN B-NP O
17 trauma NN I-NP O
17 or CC O O
17 loss NN B-NP O
18 of IN B-VP O
18 consciousness NN B-NP O
18 The DT B-NP O
18 patient NN I-NP O
18 had VBD B-VP O
18 decreased VBN O O
18 p.o NNS B-NP O
18 intake NN I-NP O
18 and CC O O
18 was VBD B-VP O
19 febrile VBN O O
19 to TO O O
19 99.5 CD O O
19 On IN B-VP O
19 admission NN B-NP O
19 , , O O
19 her PRP$ O O
19 weight NN B-NP O
19 was VBD B-VP O
19 83.9 CD O O
19 kg NN B-NP O
19 She PRP O O
19 was VBD B-VP O
20 hypotensive JJ O O
20 with IN B-VP O
20 blood NN B-NP O
20 pressures NNS I-NP O
20 of IN B-VP O
20 100/50 CD O O
20 Her NNP B-NP O
20 JVP NNP I-NP O
20 was VBD B-VP O
20 elevated VBN O O
20 to TO O O
21 15 CD O O
21 and CC O O
21 3+ CD O O
21 pitting NN B-NP O
21 edema NN I-NP O
21 She PRP O O
21 had VBD B-VP O
21 a DT B-NP O
21 BNP NNP I-NP O
21 of IN B-VP O
21 2321 CD O O
21 and CC O O
21 a DT B-NP O
21 white JJ I-NP O
21 cell NN I-NP O
22 count NN I-NP O
22 of IN B-VP O
22 18.9 CD O O
23 Assessment: NNP B-NP O
23 An DT B-NP O
23 assessment NN I-NP O
23 on IN B-VP O
23 admission NN B-NP O
23 suggested VBD B-VP O
23 that IN B-VP O
23 the DT B-NP O
24 patient NN I-NP O
24 possibly RB O O
24 had VBD B-VP O
24 hypoperfusion NN B-NP O
24 secondary JJ O O
24 to TO O O
24 over IN B-VP O
24 diuresis NN B-NP O
24 or CC O O
25 worsening VBG O O
25 heart NN B-NP O
25 failure NN I-NP O
25 secondary JJ O O
25 to TO O O
25 a DT B-NP O
25 cardiac JJ I-NP O
25 event NN I-NP O
25 with IN B-VP O
25 a DT B-NP O
25 note NN I-NP O
26 of IN B-VP O
26 having VBG O O
26 a DT B-NP O
26 troponin NN I-NP O
26 of IN B-VP O
26 2.61 CD O O
27 Hospital NNP B-NP O
27 Course: NNP I-NP O
27 Her NNP I-NP O
27 hospital NN I-NP O
27 course NN I-NP O
27 after IN B-VP O
27 admission NN B-NP O
27 on IN B-VP O
27 0/5/06 CD O O
27 was VBD B-VP O
28 complicated VBN O O
28 by IN B-VP O
28 worsening VBG O B-r
28 cardiac JJ B-NP I-r
28 function NN I-NP I-r
28 with IN B-VP O
28 minimal JJ B-NP O
28 improvement NN I-NP O
28 on IN B-VP O
28 milrinone NN B-NP B-m
29 and CC O O
29 decreasing VBG O O
29 urine JJ B-NP O
29 output NN I-NP O
29 despite IN B-VP O
29 diuretics NNS B-NP B-m
29 and CC O O
29 also RB O O
29 gross JJ B-NP O
29 gastrointestinal JJ I-NP O
30 bleeding NN I-NP O
30 with IN B-VP O
30 melanotic JJ B-NP O
30 stool NN I-NP O
30 while IN B-VP O
30 she PRP O O
30 was VBD B-VP O
30 on IN B-VP O
30 Coumadin NNP B-NP B-m
30 for IN B-VP O
30 atrial JJ B-NP B-r
31 fibrillation NN I-NP O
31 In IN B-VP O
31 addition NN B-NP O
31 , , O O
31 there EX O O
31 was VBD B-VP O
31 concern NN B-NP O
31 for IN B-VP O
31 sepsis NN B-NP B-r
31 sepsis NN I-NP B-r
31 sepsis NN I-NP B-r
31 sepsis VBD B-VP B-r
31 The DT B-NP O
31 patient NN I-NP O
31 was VBD B-VP O
31 on IN B-VP O
32 antibiotics NNS B-NP B-m
32 with IN B-VP O
32 levofloxacin NN B-NP B-m
32 , , O O
32 Flagyl NNP B-NP B-m
32 , , O O
32 and CC O O
32 vancomycin IN B-VP B-m
32 She PRP O O
32 required VBD B-VP O
32 a DT B-NP O
32 transfer NN I-NP O
33 to TO O O
33 the DT B-NP O
33 Cardiac NNP I-NP O
33 Care NNP I-NP O
33 Unit NNP I-NP O
33 on IN B-VP O
33 9/15/06 CD O O
33 for IN B-VP O
33 further JJ B-NP O
33 medical JJ I-NP O
33 therapy NN I-NP O
33 for IN B-VP O
33 poor JJ B-NP O
34 cardiac JJ I-NP O
34 output NN I-NP O
34 , , O O
34 a DT B-NP O
35 possible JJ I-NP O
35 need NN I-NP O
35 for IN B-VP O
35 CVVH NNP B-NP O
35 , , O O
35 given VBN O O
35 volume NN B-NP O
35 overload NN I-NP O
35 in IN B-VP O
35 the DT B-NP O
35 setting NN I-NP O
35 of IN B-VP O
35 renal JJ B-NP O
35 failure NN I-NP O
35 , , O O
36 and CC O O
36 work-up NN B-NP O
36 of IN B-VP O
36 GIB NNP B-NP O
36 Her NNP I-NP O
36 code NN I-NP O
36 status NN I-NP O
36 was VBD B-VP O
36 DNR/DNI NNP B-NP O
36 during IN B-VP O
36 her PRP$ O O
36 admission NN B-NP O
36 into IN B-VP O
36 the DT B-NP O
37 CCU NNP I-NP O
37 on IN B-VP O
37 9/23/06 CD O O
37 The DT B-NP O
37 patient NN I-NP O
37 reversed VBD B-VP O
37 her PRP$ O O
37 status NN B-NP O
37 to TO O O
37 DNR NNP B-NP O
37 , , O O
37 but CC O O
37 allowed VBD B-VP O
37 for IN B-VP O
38 elective JJ B-NP O
38 intubation NN I-NP O
38 on IN B-VP O
38 9/15/06 CD O O
38 , , O O
38 given VBN O O
38 her PRP$ O O
38 increasing VBG O O
38 GI NNP B-NP O
38 bleed NN I-NP O
38 and CC O O
38 the DT O O
39 worsening VBG O O
39 renal JJ B-NP O
39 failure NN I-NP O
39 The DT B-NP O
39 patient NN I-NP O
39 was VBD B-VP O
39 electively RB O O
39 intubated VBN O O
39 on IN B-VP O
39 5/27/06 CD O O
40 without IN B-VP O
40 any DT B-NP O
40 complications NNS I-NP O
40 For IN B-VP O
40 her PRP$ O O
40 GI NNP B-NP O
40 bleed NN I-NP O
40 , , O O
40 she PRP O O
40 had VBD B-VP O
40 an DT B-NP O
40 EGD NNP I-NP O
40 and CC O O
40 colonoscopy NN B-NP O
40 , , O O
41 which WDT O O
41 found VBD B-VP O
41 a DT O O
42 gross JJ O O
42 large JJ O O
42 ascending VBG O O
42 colorectal JJ B-NP O
42 mass NN I-NP O
42 with IN B-VP O
42 ulcerations NNS B-NP O
42 , , O O
42 which WDT O O
42 likely RB O O
43 contributed VBD B-VP O
43 to TO O O
43 her PRP$ O O
43 gross JJ B-NP O
43 GI NNP I-NP O
43 bleed VBD B-VP O
43 Given NNP B-NP O
43 the DT B-NP O
43 patient's NN I-NP O
43 wishes VBZ O O
43 to TO O O
44 be VB O O
44 DNR/DNI NNP B-NP O
44 and CC O O
44 given VBN O O
44 her PRP$ O O
44 new JJ B-NP O
44 finding NN I-NP O
44 for IN B-VP O
44 a DT B-NP O
44 large JJ I-NP O
44 mass NN I-NP O
44 in IN B-VP O
44 the DT B-NP O
45 ascending NN I-NP O
45 colon NN I-NP O
45 , , O O
45 the DT B-NP O
45 patient's NN I-NP O
45 code NN I-NP O
45 status NN I-NP O
45 was VBD B-VP O
45 changed VBN O O
45 to TO O O
45 comfort VB O O
46 measures NNS B-NP O
46 only RB O O
46 on IN B-VP O
46 1/17/06 CD O O
46 In IN B-VP O
46 addition NN B-NP O
46 , , O O
46 her PRP$ O O
46 colorectal JJ B-NP O
46 mass NN I-NP O
46 pathology NN I-NP O
46 returned VBD B-VP O
47 showing VBG O O
47 poorly RB O O
47 differentiated VBN O O
47 tumor NN B-NP O
47 with IN B-VP O
47 lymphoma JJ B-NP O
47 versus NN I-NP O
47 adenocarcinoma NN I-NP O
47 being VBG O O
48 most RBS O O
48 likely RB O O
48 as IN B-VP O
48 the DT B-NP O
48 diagnosis NN I-NP O
48 For IN B-VP O
48 the DT B-NP O
48 above JJ I-NP O
48 reason NN I-NP O
48 , , O O
48 the DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 also RB O O
48 made VBN O O
49 CMO NNP B-NP O
50 Being NNP I-NP O
50 CMO NNP I-NP O
50 status NN I-NP O
50 , , O O
50 she PRP O O
50 was VBD B-VP O
50 removed VBN O O
50 of IN B-VP O
50 all DT B-NP O
50 pressors NNS I-NP B-m
50 and CC O O
51 antibiotics NNS B-NP B-m
51 in IN B-VP O
51 the DT B-NP O
51 morning NN I-NP O
51 of IN B-VP O
51 1/17/06 CD O O
51 She PRP O O
51 was VBD B-VP O
51 made VBN O O
51 comfortable JJ O O
51 sedated VBN O O
51 on IN B-VP O
52 fentanyl NN B-NP B-m
52 and CC O O
52 Versed VBD B-VP B-m
52 She PRP O O
52 was VBD B-VP O
52 then RB O O
52 extubated VBN O O
52 for IN B-VP O
52 comfort NN B-NP O
52 with IN B-VP O
52 family NN B-NP O
52 present NN I-NP O
53 She PRP O O
53 had VBD B-VP O
53 agonal JJ B-NP O
53 breathing NN I-NP O
53 with IN B-VP O
53 episodes NNS B-NP O
53 of IN B-VP O
53 apnea NN B-NP O
53 and CC O O
53 was VBD B-VP O
53 given VBN O O
53 additional JJ B-NP O
54 sedation NN I-NP B-m
54 for IN B-VP O
54 comfort NN B-NP B-r
54 The DT B-NP O
54 patient NN I-NP O
54 drew VBD B-VP O
54 her PRP$ O O
54 last JJ B-NP O
54 breath NN I-NP O
54 at IN B-VP O
54 2:20 CD O O
54 p.m NN B-NP O
54 Her NNP I-NP O
55 family NN I-NP O
55 was VBD B-VP O
55 present JJ O O
55 at IN B-VP O
55 bedside IN B-VP O
55 The DT B-NP O
55 attending NN I-NP O
55 was VBD B-VP O
55 aware JJ O O
56 On IN B-VP O
56 assessment NN B-NP O
56 , , O O
56 the DT B-NP O
56 patient NN I-NP O
56 had VBD B-VP O
56 no DT B-NP O
56 spontaneous JJ I-NP O
56 breathing NN I-NP O
56 , , O O
56 no DT B-NP O
56 corneal NN I-NP O
56 reflex NN I-NP O
56 , , O O
57 and CC O O
57 no DT O O
57 peripheral JJ O O
57 pulses VBZ O O
57 The DT B-NP O
57 patient's JJ I-NP O
57 eyes NNS I-NP O
57 were VBD B-VP O
57 dilated VBN O O
57 and CC O O
57 no DT B-NP O
57 heart NN I-NP O
58 sounds VBZ O O
58 or CC O O
58 breath VB O O
58 sounds NNS B-NP O
58 were VBD B-VP O
58 appreciated VBN O O
58 Given NNP B-NP O
58 the DT B-NP O
58 CMO NNP I-NP O
58 status NN I-NP O
58 , , O O
59 no DT B-NP O
59 CPR NNP I-NP O
59 was VBD B-VP O
59 undertaken VBN O O
59 The DT B-NP O
59 patient NN I-NP O
59 was VBD B-VP O
59 pronounced VBN O O
59 dead JJ O O
59 at IN B-VP O
59 2:20 CD O O
60 p.m NN B-NP O
60 on IN B-VP O
60 1/17/06 CD O O
60 Family NNP B-NP O
60 declined VBD B-VP O
60 autopsy JJ B-NP O
61 eScription NN I-NP O
61 document: VBZ O O
61 3-8774785 JJ B-NP O
61 CSSten NNP I-NP O
61 Tel NNP I-NP O
62 Dictated NNP I-NP O
62 By: NNP I-NP O
62 BOYDSTUN NNP I-NP O
62 , , O O
62 JOHNNY NNP B-NP O
63 Attending: NNP I-NP O
63 PETITJEAN NNP I-NP O
63 , , O O
63 SIMON NNP B-NP O
64 Dictation NNP I-NP O
64 ID NNP I-NP O
64 3563977 CD O O
65 D: NNP B-NP O
65 10/18/06 CD O O
66 T: NNP B-NP O
66 10/18/06 CD O O
67 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #858069 VBZ O O
4 094697245 CD O O
4 CLH NNP B-NP O
4 57134396 CD O O
4 4156892 CD O O
4 5/9/2007 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 chf NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 8/12/2007 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/17/2007 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 SHAULL NNP I-NP O
8 , , O O
8 DARIN NNP B-NP O
8 086-88-68-2 CD O O
9 Ton- NNP B-NP O
9 Ph NNP I-NP O
9 Aga NNP I-NP O
9 Van NNP I-NP O
9 Ux NNP I-NP O
9 Ny NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 3/22/07 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 HEINIGER NNP I-NP O
14 , , O O
14 DARRON NNP B-NP O
14 J NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 Override NNP I-NP O
20 Notice: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 10/30/07 CD O O
20 by IN B-VP O
20 LAUB NNP B-NP O
20 , , O O
20 STERLING NN B-NP O
20 B NNP I-NP O
20 M NNP I-NP O
20 , , O O
20 M.D NNP B-NP O
20 on IN B-VP O
20 order NN B-NP O
20 for IN B-VP O
20 COUMADIN NNP B-NP B-m
20 PO NNP I-NP B-mo
20 ( ( O O
20 ref JJ O O
20 # # O O
20 853955570 CD O O
20 ) ) O O
21 POTENTIALLY NNP B-NP O
21 SERIOUS NNP I-NP O
21 INTERACTION: NNP I-NP O
21 ASPIRIN NNP I-NP B-m
21 &amp; NNP I-NP O
21 WARFARIN NNP I-NP B-m
22 POTENTIALLY NNP I-NP O
22 SERIOUS NNP I-NP O
22 INTERACTION: NNP I-NP O
22 ASPIRIN NNP I-NP B-m
22 &amp; NNP I-NP O
22 WARFARIN NNP I-NP B-m
23 POTENTIALLY NNP I-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 ASPIRIN NNP I-NP B-m
23 &amp; NNP I-NP O
23 WARFARIN NNP I-NP B-m
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 aware JJ B-NP O
24 Previous NNP I-NP O
24 override NN I-NP O
24 information: NN I-NP O
25 Override NNP I-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 6/10/07 CD O O
25 by IN B-VP O
25 KRABBE NNP B-NP O
25 , , O O
25 TERRY NNP B-NP O
25 J NNP I-NP O
25 , , O O
25 M.D NNP B-NP O
26 on IN B-VP O
26 order NN B-NP O
26 for IN B-VP O
26 COUMADIN NNP B-NP B-m
26 PO NNP I-NP B-mo
26 ( ( O O
26 ref JJ O O
26 # # O O
26 808894579 CD O O
26 ) ) O O
27 POTENTIALLY NNP B-NP O
27 SERIOUS NNP I-NP O
27 INTERACTION: NNP I-NP O
27 ASPIRIN NNP I-NP B-m
27 &amp; NNP I-NP O
27 WARFARIN NNP I-NP B-m
28 POTENTIALLY NNP I-NP O
28 SERIOUS NNP I-NP O
28 INTERACTION: NNP I-NP O
28 ASPIRIN NNP I-NP B-m
28 &amp; NNP I-NP O
28 WARFARIN NNP I-NP B-m
29 POTENTIALLY NNP I-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 ASPIRIN NNP I-NP B-m
29 &amp; NNP I-NP O
29 WARFARIN NNP I-NP B-m
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 aware JJ B-NP O
31 ATENOLOL NNP I-NP B-m
31 37.5 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 DAILY NNP I-NP B-f
32 CAPTOPRIL NNP I-NP B-m
32 12.5 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
33 Food/Drug NNP I-NP O
33 Interaction NNP I-NP O
33 Instruction NNP I-NP O
34 Give NNP I-NP O
34 on IN B-VP O
34 an DT B-NP O
34 empty JJ I-NP O
34 stomach NN I-NP O
34 ( ( O O
34 give JJ O O
34 1hr CD O O
34 before IN B-VP O
34 or CC O O
34 2hr CD O O
34 after IN B-VP O
35 food NN B-NP O
35 ) ) O O
36 Override NNP B-NP O
36 Notice: NNP I-NP O
36 Override NNP I-NP O
36 added VBD B-VP O
36 on IN B-VP O
36 6/12/07 CD O O
36 by IN B-VP O
36 CUCCHIARA NNP B-NP O
36 , , O O
36 JERROLD NNP B-NP O
36 T NNP I-NP O
36 CURTIS NNP I-NP O
36 REYNALDO NNP I-NP O
36 , , O O
36 M.D NNP B-NP O
37 on IN B-VP O
37 order NN B-NP O
37 for IN B-VP O
37 KCL NNP B-NP B-m
37 IMMEDIATE NNP I-NP I-m
37 RELEASE NNP I-NP I-m
37 PO NNP I-NP B-mo
37 ( ( O O
37 ref JJ O O
37 # # O O
38 545368405 CD O O
38 ) ) O O
39 POTENTIALLY NNP B-NP O
39 SERIOUS NNP I-NP O
39 INTERACTION: NNP I-NP O
39 CAPTOPRIL NNP I-NP B-m
39 &amp; NNP I-NP O
39 POTASSIUM NNP I-NP B-m
40 CHLORIDE NNP I-NP O
41 POTENTIALLY NNP I-NP O
41 SERIOUS NNP I-NP O
41 INTERACTION: NNP I-NP O
41 CAPTOPRIL NNP I-NP B-m
41 &amp; NNP I-NP O
41 POTASSIUM NNP I-NP B-m
42 CHLORIDE NNP I-NP O
42 Reason NNP I-NP O
42 for IN B-VP O
42 override: NN B-NP O
42 aware JJ B-NP O
43 CELEXA NNP I-NP B-m
43 ( ( O I-m
43 CITALOPRAM NNP B-NP I-m
43 ) ) O I-m
43 40 CD O B-do
43 MG NNP B-NP I-do
43 PO NNP I-NP B-mo
43 DAILY NNP I-NP B-f
44 PLAVIX NNP I-NP B-m
44 ( ( O I-m
44 CLOPIDOGREL NNP B-NP I-m
44 ) ) O I-m
44 75 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 DAILY NNP I-NP B-f
45 DIGOXIN NNP I-NP B-m
45 0.125 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 DAILY NNP I-NP B-f
46 EPLERENONE NNP I-NP B-m
46 25 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 DAILY NNP I-NP B-f
47 Override NNP I-NP O
47 Notice: NNP I-NP O
47 Override NNP I-NP O
47 added VBD B-VP O
47 on IN B-VP O
47 6/12/07 CD O O
47 by IN B-VP O
47 HOEGERL NNP B-NP O
47 , , O O
47 ISAAC NNP B-NP O
47 E NNP I-NP O
47 EDGAR NNP I-NP O
47 CHESTER NNP I-NP O
47 , , O O
47 M.D NNP B-NP O
48 on IN B-VP O
48 order NN B-NP O
48 for IN B-VP O
48 KCL NNP B-NP B-m
48 IMMEDIATE NNP I-NP I-m
48 RELEASE NNP I-NP I-m
48 PO NNP I-NP B-mo
48 ( ( O O
48 ref JJ O O
48 # # O O
49 545368405 CD O O
49 ) ) O O
50 SERIOUS NNP B-NP O
50 INTERACTION: NNP I-NP O
50 EPLERENONE NNP I-NP B-m
50 &amp; NNP I-NP O
50 POTASSIUM NNP I-NP B-m
50 CHLORIDE NNP I-NP I-m
51 Reason NNP I-NP O
51 for IN B-VP O
51 override: NN B-NP O
51 aware JJ B-NP O
52 FOLATE NNP I-NP B-m
52 ( ( O I-m
52 FOLIC NNP B-NP I-m
52 ACID NNP I-NP I-m
52 ) ) O I-m
52 1 CD O B-do
52 MG NNP B-NP I-do
52 PO NNP I-NP B-mo
52 DAILY NNP I-NP B-f
53 LASIX NNP I-NP B-m
53 ( ( O I-m
53 FUROSEMIDE NNP B-NP I-m
53 ) ) O I-m
53 60 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 BID NNP I-NP B-f
54 Starting NNP I-NP O
54 AT NNP I-NP O
54 5:00 CD O O
54 PM NNP B-NP O
54 ( ( O O
54 0/19 CD O O
54 ) ) O O
55 Alert NNP B-NP O
55 overridden: NNP I-NP O
55 Override NNP I-NP O
55 added VBD B-VP O
55 on IN B-VP O
55 10/30/07 CD O O
55 by IN B-VP O
55 GOODWINE NNP B-NP O
55 , , O O
55 BUFORD NNP B-NP O
55 H NNP I-NP O
55 B NNP I-NP O
55 , , O O
55 M.D NNP B-NP O
55 on IN B-VP O
55 order NN B-NP O
55 for IN B-VP O
55 LASIX NNP B-NP B-m
55 PO NNP I-NP B-mo
55 ( ( O O
55 ref JJ O O
55 # # O O
55 145213873 CD O O
55 ) ) O O
56 Pt NNP B-NP O
56 has VBZ O O
56 a DT B-NP O
56 POSSIBLE NNP I-NP O
56 allergy NN I-NP O
56 to TO O O
56 TAMSULOSIN; NNP B-NP O
56 reaction NN I-NP O
56 is VBZ O O
57 Genital JJ B-NP O
57 ache NN I-NP O
57 Reason NNP I-NP O
57 for IN B-VP O
57 override: NN B-NP O
57 aware JJ B-NP O
58 NEURONTIN NNP I-NP B-m
58 ( ( O I-m
58 GABAPENTIN NNP B-NP I-m
58 ) ) O I-m
58 100 CD O B-do
58 MG NNP B-NP I-do
58 PO NNP I-NP B-mo
58 TID NNP I-NP B-f
59 LORAZEPAM NNP I-NP B-m
59 0.5 CD O B-do
59 MG NNP B-NP I-do
59 PO NNP I-NP B-mo
59 DAILY NNP I-NP B-f
59 PRN NNP I-NP I-f
59 Anxiety NNP I-NP B-r
60 LOVASTATIN NNP I-NP B-m
60 40 CD O B-do
60 MG NNP B-NP I-do
60 PO NNP I-NP B-mo
60 DAILY NNP I-NP B-f
61 Food/Drug NNP I-NP O
61 Interaction NNP I-NP O
61 Instruction NNP I-NP O
62 Avoid NNP I-NP O
62 grapefruit NN I-NP O
62 unless IN B-VP O
62 MD NNP B-NP O
62 instructs NNS I-NP O
62 otherwise RB O O
63 Give VBP O O
63 with IN B-VP O
63 meals NNS B-NP O
64 Override NNP I-NP O
64 Notice: NNP I-NP O
64 Override NNP I-NP O
64 added VBD B-VP O
64 on IN B-VP O
64 10/30/07 CD O O
64 by IN B-VP O
64 PERAULT NNP B-NP O
64 , , O O
64 SHELBY NNP B-NP O
64 H NNP I-NP O
64 M NNP I-NP O
64 , , O O
64 M.D NNP B-NP O
64 on IN B-VP O
64 order NN B-NP O
64 for IN B-VP O
64 COUMADIN NNP B-NP B-m
64 PO NNP I-NP B-mo
64 ( ( O O
64 ref JJ O O
64 # # O O
64 853955570 CD O O
64 ) ) O O
65 POTENTIALLY NNP B-NP O
65 SERIOUS NNP I-NP O
65 INTERACTION: NNP I-NP O
65 LOVASTATIN NNP I-NP B-m
65 &amp; NNP I-NP O
65 WARFARIN NNP I-NP B-m
66 Reason NNP I-NP O
66 for IN B-VP O
66 override: NN B-NP O
66 aware JJ B-NP O
66 Previous NNP I-NP O
66 override NN I-NP O
66 information: NN I-NP O
67 Override NNP I-NP O
67 added VBD B-VP O
67 on IN B-VP O
67 6/10/07 CD O O
67 by IN B-VP O
67 KATSUDA NNP B-NP O
67 , , O O
67 CLINTON NNP B-NP O
67 R NNP I-NP O
67 , , O O
67 M.D NNP B-NP O
68 on IN B-VP O
68 order NN B-NP O
68 for IN B-VP O
68 COUMADIN NNP B-NP B-m
68 PO NNP I-NP B-mo
68 ( ( O O
68 ref JJ O O
68 # # O O
68 808894579 CD O O
68 ) ) O O
69 POTENTIALLY NNP B-NP O
69 SERIOUS NNP I-NP O
69 INTERACTION: NNP I-NP O
69 LOVASTATIN NNP I-NP B-m
69 &amp; NNP I-NP O
69 WARFARIN NNP I-NP B-m
70 Reason NNP I-NP O
70 for IN B-VP O
70 override: NN B-NP O
70 aware JJ B-NP O
70 Previous NNP I-NP O
70 override NN I-NP O
70 information: NN I-NP O
71 Override NNP I-NP O
71 added VBD B-VP O
71 on IN B-VP O
71 11/14/07 CD O O
71 by IN B-VP O
71 OGIAMIEN NNP B-NP O
71 , , O O
71 JACINTO NNP B-NP O
71 D NNP I-NP O
71 , , O O
71 M.D NNP B-NP O
72 on IN B-VP O
72 order NN B-NP O
72 for IN B-VP O
72 LOVASTATIN NNP B-NP B-m
72 PO NNP I-NP B-mo
72 ( ( O O
72 ref JJ O O
72 # # O O
72 657865834 CD O O
72 ) ) O O
73 Pt NNP B-NP O
73 has VBZ O O
73 a DT B-NP O
73 PROBABLE NNP I-NP O
73 allergy NN I-NP O
73 to TO O O
73 SIMVASTATIN; NNP B-NP O
73 reaction NN I-NP O
73 is VBZ O O
73 leg JJ B-NP O
74 pain NN I-NP O
74 Reason NNP I-NP O
74 for IN B-VP O
74 override: NN B-NP O
74 home NN I-NP O
74 med VBD B-VP O
75 Previous NNP B-NP O
75 Alert NNP I-NP O
75 overridden NNP I-NP O
76 Override NNP I-NP O
76 added VBD B-VP O
76 on IN B-VP O
76 11/14/07 CD O O
76 by IN B-VP O
76 TUROMSHA NNP B-NP O
76 , , O O
76 IRA NNP B-NP O
76 C NNP I-NP O
76 , , O O
76 M.D NNP B-NP O
77 POTENTIALLY NNP I-NP O
77 SERIOUS NNP I-NP O
77 INTERACTION: NNP I-NP O
77 NIACIN NNP I-NP B-m
77 , , O O
77 VIT NNP B-NP B-m
77 B-3 NNP I-NP I-m
77 &amp; NNP I-NP O
78 LOVASTATIN NNP I-NP B-m
78 Reason NNP I-NP O
78 for IN B-VP O
78 override: NN B-NP O
78 aware JJ B-NP O
79 Number NNP I-NP B-du
79 Number NNP I-NP B-du
79 of IN B-VP I-du
79 of IN B-VP I-du
79 Doses NNP B-NP I-du
79 Doses NNP I-NP I-du
79 Required NNP I-NP I-du
79 Required NNP I-NP I-du
79 ( ( O I-du
79 ( ( O I-du
79 approximate VB O I-du
79 approximate NN B-NP I-du
79 ): NNP I-NP I-du
79 ): VBD B-VP I-du
79 7 CD O I-du
79 7 CD O I-du
80 OMEPRAZOLE NNP B-NP B-m
80 20 CD O B-do
80 MG NNP B-NP I-do
80 PO NNP I-NP B-mo
80 DAILY NNP I-NP B-f
81 TEMAZEPAM NNP I-NP B-m
81 15-30 JJ B-NP B-do
81 MG NNP I-NP I-do
81 PO NNP I-NP B-mo
81 BEDTIME NNP I-NP B-f
81 PRN NNP I-NP I-f
81 Insomnia NNP I-NP B-r
82 MULTIVITAMIN NNP I-NP B-m
82 THERAPEUTIC NNP I-NP I-m
82 ( ( O I-m
82 THERAPEUTIC NNP B-NP I-m
82 MULTIVI NNP I-NP I-m
82 ) ) O I-m
83 1 CD O B-do
83 TAB NNP B-NP I-do
83 PO NNP I-NP B-mo
83 DAILY NNP I-NP B-f
84 Override NNP I-NP O
84 Notice: NNP I-NP O
84 Override NNP I-NP O
84 added VBD B-VP O
84 on IN B-VP O
84 11/14/07 CD O O
84 by IN B-VP O
84 VANSTEENBURG NNP B-NP O
84 , , O O
84 TREVOR NNP B-NP O
84 B NNP I-NP O
84 R NNP I-NP O
84 , , O O
84 M.D NNP B-NP O
84 on IN B-VP O
84 order NN B-NP O
84 for IN B-VP O
84 LOVASTATIN NNP B-NP B-m
84 PO NNP I-NP B-mo
84 ( ( O O
84 ref JJ O O
84 # # O O
84 657865834 CD O O
84 ) ) O O
85 POTENTIALLY NNP B-NP O
85 SERIOUS NNP I-NP O
85 INTERACTION: NNP I-NP O
85 NIACIN NNP I-NP B-m
85 , , O O
85 VIT NNP B-NP B-m
85 B-3 NNP I-NP I-m
85 &amp; NNP I-NP O
86 LOVASTATIN NNP I-NP B-m
86 Reason NNP I-NP O
86 for IN B-VP O
86 override: NN B-NP O
86 aware JJ B-NP O
87 COSOPT NNP I-NP B-m
87 ( ( O I-m
87 TIMOLOL/DORZOLAMIDE NNP B-NP I-m
87 ) ) O I-m
87 1 CD O B-do
87 DROP NNP B-NP I-do
87 OU NNP I-NP B-mo
87 BID NNP I-NP B-f
88 Alert NNP I-NP O
88 overridden: NNP I-NP O
88 Override NNP I-NP O
88 added VBD B-VP O
88 on IN B-VP O
88 11/14/07 CD O O
88 by IN B-VP O
88 LUTHY NNP B-NP O
88 , , O O
88 LANNY NNP B-NP O
88 D NNP I-NP O
88 E NNP I-NP O
88 , , O O
88 M.D NNP B-NP O
88 on IN B-VP O
88 order NN B-NP O
88 for IN B-VP O
88 COSOPT NNP B-NP B-m
88 OU NNP I-NP B-mo
88 ( ( O O
88 ref JJ O O
88 # # O O
88 517414331 CD O O
88 ) ) O O
89 Pt NNP B-NP O
89 has VBZ O O
89 a DT B-NP O
89 POSSIBLE NNP I-NP O
89 allergy NN I-NP O
89 to TO O O
89 TAMSULOSIN; NNP B-NP O
89 reaction NN I-NP O
89 is VBZ O O
90 Genital JJ B-NP O
90 ache NN I-NP O
90 Reason NNP I-NP O
90 for IN B-VP O
90 override: NN B-NP O
90 aware JJ O O
90 , , O O
90 home NN B-NP O
90 med VBD B-VP O
91 COUMADIN NNP B-NP B-m
91 COUMADIN NNP I-NP B-m
91 ( ( O I-m
91 ( ( O I-m
91 WARFARIN NNP B-NP I-m
91 WARFARIN NNP I-NP I-m
91 SODIUM NNP I-NP I-m
91 SODIUM NNP I-NP I-m
91 ) ) O I-m
91 ) ) O I-m
91 1 CD O B-do
91 MG NNP B-NP I-do
91 PO NNP I-NP B-mo
91 QPM NNP I-NP B-f
92 Starting NNP I-NP O
92 ROUTINE NNP I-NP O
92 , , O O
92 20:00 CD O O
92 ( ( O O
92 Standard NNP B-NP O
92 Admin NNP I-NP O
92 Time NNP I-NP O
92 ) ) O O
93 Instructions: NNP B-NP O
93 Please NNP I-NP O
93 take VB O O
93 1mg CD O B-do
93 every DT B-NP B-f
93 day NN I-NP I-f
93 except IN B-VP I-f
93 for IN B-VP I-f
93 monday NN B-NP I-f
94 when WRB O O
94 you PRP O O
94 take VBP O O
95 2mg CD O O
95 , , O O
95 unless IN B-VP O
95 your PRP$ O O
95 coumadin NN B-NP O
95 clinic NN I-NP O
95 at IN B-VP O
95 the DT B-NP O
95 AWMH NNP I-NP O
95 tells VBZ O O
95 you PRP O O
96 otherwise RB O O
96 Food/Drug NNP B-NP O
96 Interaction NNP I-NP O
96 Instruction NNP I-NP O
97 No NNP I-NP O
97 high JJ B-NP O
97 Vitamin-K NNP I-NP O
97 containing VBG O O
97 foods NNS B-NP O
98 Alert NNP I-NP O
98 overridden: VBD B-VP O
98 Override NNP B-NP O
98 added VBD B-VP O
98 on IN B-VP O
98 10/30/07 CD O O
98 by IN B-VP O
98 ANGELILLO NNP B-NP O
98 , , O O
98 ORVILLE NNP B-NP O
98 R NNP I-NP O
98 S NNP I-NP O
98 , , O O
98 M.D NNP B-NP O
98 POTENTIALLY NNP I-NP O
98 SERIOUS NNP I-NP O
98 INTERACTION: NNP I-NP O
98 ASPIRIN NNP I-NP B-m
98 &amp; NNP I-NP O
98 WARFARIN NNP I-NP B-m
99 POTENTIALLY NNP I-NP O
99 SERIOUS NNP I-NP O
99 INTERACTION: NNP I-NP O
99 ASPIRIN NNP I-NP B-m
99 &amp; NNP I-NP O
99 WARFARIN NNP I-NP B-m
100 POTENTIALLY NNP I-NP O
100 SERIOUS NNP I-NP O
100 INTERACTION: NNP I-NP O
100 ASPIRIN NNP I-NP B-m
100 &amp; NNP I-NP O
100 WARFARIN NNP I-NP B-m
101 POTENTIALLY NNP I-NP O
101 SERIOUS NNP I-NP O
101 INTERACTION: NNP I-NP O
101 LOVASTATIN NNP I-NP B-m
101 &amp; NNP I-NP O
101 WARFARIN NNP I-NP B-m
102 Reason NNP I-NP O
102 for IN B-VP O
102 override: NN B-NP O
102 aware JJ B-NP O
103 TRAVATAN NNP I-NP B-m
103 1 CD O B-do
103 DROP NNP B-NP I-do
103 OU NNP I-NP B-mo
103 BEDTIME NNP I-NP B-f
103 Instructions: NNP I-NP O
103 OU NNP I-NP O
103 thanks NNS I-NP O
104 DIET: NNP I-NP O
104 Patient NNP I-NP O
104 should MD O O
104 measure VB O O
104 weight JJ B-NP O
104 daily JJ I-NP O
105 DIET: NNP I-NP O
105 Fluid NNP I-NP O
105 restriction NN I-NP O
106 DIET: NNP I-NP O
106 House NNP I-NP O
106 / VBD B-VP O
106 Low NNP B-NP O
106 chol/low NN I-NP O
106 sat VBD B-VP O
106 fat JJ B-NP O
107 ACTIVITY: NNP I-NP O
107 Resume NNP I-NP O
107 regular JJ B-NP O
107 exercise NN I-NP O
108 FOLLOW NNP I-NP O
108 UP NNP I-NP O
108 APPOINTMENT( NNP I-NP O
108 S NNP I-NP O
108 ): NNP I-NP O
109 Dr NNP I-NP O
109 Vonfelden NNP I-NP O
109 8/21 CD O O
109 @ NNP B-NP O
109 10 CD O O
109 , , O O
110 Dr NNP B-NP O
110 Odien NNP I-NP O
110 , , O O
110 please VB O O
110 call VB O O
110 724-105-6354 JJ O O
110 for IN B-VP O
110 earlier RBR O O
110 appointment NN B-NP O
110 if IN B-VP O
110 able JJ O O
110 4/23 CD O O
110 @ JJ O O
110 3:40 CD O O
110 , , O O
111 Arrange NNP B-NP O
111 INR NNP I-NP O
111 to TO O O
111 be VB O O
111 drawn VBN O O
111 on IN B-VP O
111 2/21/07 CD O O
111 with IN B-VP O
111 f/u JJ B-NP O
111 INR's NNP I-NP O
111 to TO O O
111 be VB O O
111 drawn VBN O O
111 every DT O O
112 7 CD O O
112 days NNS B-NP O
112 INR's NNP I-NP O
112 will MD O O
112 be VB O O
112 followed VBN O O
112 by IN B-VP O
112 SUH NNP B-NP O
112 coumadin NN I-NP O
112 clinic NN I-NP O
113 ALLERGY: NNP I-NP O
113 PREDNISONE NNP I-NP O
113 , , O O
113 Penicillins NNP B-NP O
113 , , O O
113 TAMSULOSIN NNP B-NP O
113 , , O O
113 SIMVASTATIN NNP B-NP O
113 , , O O
114 SPIRONOLACTONE NNP B-NP O
114 , , O O
114 Fam NNP B-NP O
114 Hx NNP I-NP O
114 malignant JJ B-NP O
114 hyperthermia NN I-NP O
115 ADMIT NNP I-NP O
115 DIAGNOSIS: NNP I-NP O
116 chf NN I-NP O
117 PRINCIPAL NNP I-NP O
117 DISCHARGE NNP I-NP O
117 DIAGNOSIS NNP I-NP O
117 ;Responsible JJ O O
117 After IN B-VP O
117 Study NNP B-NP O
117 for IN B-VP O
117 Causing NNP B-NP O
117 Admission NNP I-NP O
117 ) ) O O
118 chf VBZ O O
119 OTHER NNP B-NP O
119 DIAGNOSIS;Conditions NNP I-NP O
119 , , O O
119 Infections NNP B-NP O
119 , , O O
119 Complications NNP B-NP O
119 , , O O
119 affecting VBG O O
119 Treatment/Stay NNP B-NP O
120 kidney NNP I-NP O
120 stone NN I-NP O
120 cardiomyopathy-ef25% JJ B-NP O
121 degenerative JJ I-NP O
121 arthritis NN I-NP O
121 blurred VBD B-VP O
121 vision NN B-NP O
121 sleep NN I-NP O
121 apnea NN I-NP O
121 arrhythmias IN B-VP O
122 prior JJ B-NP O
122 MI NNP I-NP O
122 spinal JJ B-NP O
122 stenosis NN I-NP O
122 ( ( O O
122 spinal JJ B-NP O
122 stenosis NN I-NP O
122 ) ) O O
122 barrett's NN B-NP O
122 esophagus NN I-NP O
123 ( ( O O
123 barrett's JJ B-NP O
123 esophagus NN I-NP O
123 ) ) O O
123 peripheral NN B-NP O
123 neuropathy NN I-NP O
123 ( ( O O
123 peripheral JJ B-NP O
124 neuropathy NN I-NP O
124 ) ) O O
124 glaucoma NN B-NP O
124 ( ( O O
124 glaucoma NN B-NP O
124 ) ) O O
125 OPERATIONS NNP B-NP O
125 AND NNP I-NP O
125 PROCEDURES: NNP I-NP O
126 OTHER NNP I-NP O
126 TREATMENTS/PROCEDURES NNP I-NP O
126 ( ( O O
126 NOT NNP B-NP O
126 IN NNP I-NP O
126 O.R NNP I-NP O
126 ) ) O O
127 RHC/LHC NNP B-NP O
128 BRIEF NNP I-NP O
128 RESUME NNP I-NP O
128 OF NNP I-NP O
128 HOSPITAL NNP I-NP O
128 COURSE: NNP I-NP O
129 PCP: NNP I-NP O
129 Wickell NNP I-NP O
129 , , O O
129 Hyman NNP B-NP O
130 CARDS: NNP I-NP O
130 Shannon NNP I-NP O
130 Marlon NNP I-NP O
130 Sefcik NNP I-NP O
130 CC:SOB NNP I-NP O
131 HPI:78M NNP I-NP O
131 w/ VBD B-VP O
131 CAD NNP B-NP O
131 S/ NNP I-NP O
131 P NNP I-NP O
131 stents NNS I-NP O
131 ( ( O O
131 Cypher NNP B-NP O
131 to TO O O
131 LM NNP B-NP O
131 and CC O O
131 LAD NNP B-NP O
131 in IN B-VP O
131 8/15 CD O O
131 ) ) O O
131 , , O O
131 ischemic JJ B-NP O
132 CM NNP I-NP O
132 with IN B-VP O
132 EF NNP B-NP O
132 15-20% JJ O O
132 , , O O
132 S/P NNP B-NP O
132 AV NNP I-NP O
132 node POS O O
132 ablation NN B-NP O
132 1/29 CD O O
132 w/ NN B-NP O
132 BiV NNP I-NP O
132 pacer NN I-NP O
132 , , O O
132 DM NNP B-NP O
132 , , O O
132 HTN NNP B-NP O
132 , , O O
133 MGUS NNP B-NP O
133 , , O O
133 hx NN B-NP O
133 of IN B-VP O
133 syncope NN B-NP O
133 due JJ O O
133 to TO O O
133 orthostasis/dehydration VB O O
133 presenting VBG O O
133 w JJ B-NP O
134 SOB NNP I-NP O
134 Usually NNP I-NP O
134 does VBZ O O
134 30 CD O O
134 mins NNS B-NP O
134 on IN B-VP O
134 bike NN B-NP O
134 , , O O
134 now RB O O
134 having VBG O O
134 dyspnea NN B-NP O
134 with IN B-VP O
134 20 CD O O
134 mins NNS B-NP O
134 , , O O
135 stopping VBG O O
135 after IN B-VP O
135 1 CD O O
135 flight NN B-NP O
135 of IN B-VP O
135 stairs NNS B-NP O
135 , , O O
135 used VBD B-VP O
135 to TO O O
135 do VB O O
135 2 CD O O
135 flights NNS B-NP O
135 Sx NNP I-NP O
136 progressively RB O O
136 worsening VBG O O
136 over IN B-VP O
136 past JJ B-NP O
136 1-2 JJ I-NP O
136 mos NN I-NP O
136 Weight NNP I-NP O
136 195 CD O O
136 lbs NN B-NP O
136 , , O O
136 got VBD B-VP O
137 extra JJ B-NP O
137 lasix NN I-NP B-m
137 , , O O
137 now RB O O
137 190 CD O O
137 lb NN B-NP O
137 ( ( O O
137 he PRP O O
137 says VBZ O O
137 baseline NN B-NP O
137 ) ) O O
137 , , O O
137 but CC O O
137 has VBZ O O
137 not RB O O
137 noticed VBN O O
138 difference NN B-NP O
138 in IN B-VP O
138 sx JJ B-NP O
138 +CP NN I-NP O
138 1 CD O O
138 week NN B-NP O
138 ago RB O O
138 while IN B-VP O
138 on IN B-VP O
138 treadmill NN B-NP O
138 , , O O
138 stopped VBD B-VP O
138 with IN B-VP O
139 resting VBG O O
139 +dizzy NN B-NP O
139 and CC O O
139 lightheadedness NN B-NP O
139 ( ( O O
139 chronic JJ O O
139 ) ) O O
139 , , O O
139 no DT B-NP O
139 orthopena NN I-NP O
139 , , O O
139 PND NNP B-NP O
139 , , O O
139 no DT B-NP O
140 edema.No JJ I-NP O
140 change NN I-NP O
140 in IN B-VP O
140 diet JJ B-NP O
140 Taking NNP I-NP O
140 meds NNS I-NP O
141 *** VBP O O
142 PMHx:ischemic NNP B-NP O
142 CM NNP I-NP O
142 , , O O
142 EF NNP B-NP O
142 15%-20% CD O O
142 ( ( O O
142 dry JJ B-NP O
142 wt NN I-NP O
142 per IN B-VP O
142 D/C NNP B-NP O
142 summary JJ O O
142 185.2 CD O O
142 lb NN B-NP O
142 ) ) O O
142 , , O O
142 hx JJ B-NP O
143 Afib NNP I-NP O
143 and CC O O
143 VT NNP B-NP O
143 , , O O
143 S/P NNP B-NP O
143 ICD NNP I-NP O
143 4/12 CD O O
143 , , O O
143 BiV NNP B-NP O
143 3/22 CD O O
143 , , O O
143 AV NNP B-NP O
143 node POS O O
143 ablation NN B-NP O
143 7/26 CD O O
143 , , O O
143 CAD NNP B-NP O
144 S/P NNP I-NP O
144 IMI NNP I-NP O
144 1982 CD O O
144 stents NNS B-NP O
144 to TO O O
144 LM NNP B-NP O
144 and CC O O
144 LAD NNP B-NP O
144 8/15 CD O O
144 as IN B-VP O
144 not RB O O
144 candidate VB O O
144 for IN B-VP O
144 CABG NNP B-NP O
144 , , O O
145 high JJ B-NP O
145 cholesterol NN I-NP O
145 , , O O
145 sleep JJ B-NP O
145 apnea NN I-NP O
145 , , O O
145 DJD NNP B-NP O
145 , , O O
145 Barrett's NNP B-NP O
145 esophagus NN I-NP O
145 , , O O
145 Glaucoma NNP B-NP O
145 , , O O
146 Graves NNP B-NP O
146 disease NN I-NP O
146 , , O O
146 Diverticulitis NNP B-NP O
146 , , O O
146 Hypothyroidism NNP B-NP O
146 , , O O
146 secondary JJ O O
146 to TO O O
147 amiodarone VB O B-m
147 toxicity NN B-NP O
147 , , O O
147 Peripheral NNP B-NP O
147 neuropathy NN I-NP O
147 , , O O
147 restless NN B-NP O
147 legs NNS I-NP O
147 , , O O
147 Spinal JJ B-NP O
148 stenosis NN I-NP O
149 ALL:Prednisone-&gt;soreness NNP I-NP O
149 , , O O
149 PCN-&gt;flushing NNP B-NP O
149 , , O O
150 Tamsulosin-&gt;genital NNP B-NP O
150 ache NN I-NP O
150 , , O O
150 zocor-&gt;leg JJ B-NP O
150 pain NN I-NP O
150 , , O O
150 spironolactone-&gt;gynecomastia JJ B-NP O
151 Exam: NNP I-NP O
151 95.7 CD O O
151 85 CD O O
151 98/70 CD O O
151 absent JJ B-NP O
151 overshoot NN I-NP O
151 on IN B-VP O
151 valsalva NN B-NP O
152 GEN: NNP I-NP O
152 well-appearing NN I-NP O
152 CV: NNP I-NP O
152 distant NN I-NP O
152 HS NNP I-NP O
152 , , O O
152 non-palpable JJ B-NP O
152 PMI NNP I-NP O
152 , , O O
152 diminished VBD B-VP O
152 carotid NN B-NP O
153 pulses VBZ O O
153 no DT B-NP O
153 bruits NNS I-NP O
153 , , O O
153 JVP NNP B-NP O
153 8 CD O O
153 cm NN B-NP O
153 LUNGS: NNP I-NP O
153 CTAB NNP I-NP O
153 Abd: NNP I-NP O
153 benign NN I-NP O
153 , , O O
153 non-pulsatile JJ B-NP O
154 liver NN I-NP O
154 Ext: NNP I-NP O
154 cool NN I-NP O
154 , , O O
154 2+PT CD O O
154 B/L NNP B-NP O
154 , , O O
154 no DT B-NP O
154 edema NN I-NP O
154 Neuro: NNP I-NP O
154 no DT B-NP O
154 facial JJ I-NP O
154 droop NN I-NP O
154 , , O O
155 non-focal JJ B-NP O
156 *** NNP I-NP O
157 EKG: NNP I-NP O
157 CXR:neg NNP I-NP O
158 Stress NNP I-NP O
158 Echo NNP I-NP O
158 9/24/06: CD O O
158 66% CD O O
158 MPHR NNP B-NP O
158 , , O O
158 RPP NNP B-NP O
158 12000 CD O O
158 BPM NNP B-NP O
158 , , O O
158 stopped VBD B-VP O
158 for IN B-VP O
158 fatigue NN B-NP O
158 , , O O
159 dyspnea NN B-NP O
159 LV NNP I-NP O
159 enlarged VBD B-VP O
159 EF NNP B-NP O
159 15-20% JJ B-NP O
159 +RWMA NNP I-NP O
159 , , O O
159 mid NN B-NP O
159 and CC O O
159 distal JJ B-NP O
159 ant NN I-NP O
159 wall NN I-NP O
159 , , O O
159 mid NN B-NP O
160 and CC O O
160 distal JJ B-NP O
160 ant NN I-NP O
160 septum NN I-NP O
160 , , O O
160 inf JJ B-NP O
160 septum NN I-NP O
160 , , O O
160 entire JJ B-NP O
160 apex NN I-NP O
160 , , O O
160 and CC O O
161 post NN B-NP O
161 wall NN I-NP O
161 AK NNP I-NP O
161 All NNP I-NP O
161 other JJ B-NP O
161 walls NNS I-NP O
161 HK VBP O O
161 At IN B-VP O
161 stress: NN B-NP O
161 LV NNP I-NP O
161 not RB O O
161 dilated VBD B-VP O
161 akinetic JJ B-NP O
162 segments NNS I-NP O
162 remained VBD B-VP O
162 so RB O O
162 EF NNP B-NP O
162 up RB O O
162 to TO O O
162 25% CD O O
163 ETT NNP B-NP O
163 9/24/06: CD O O
163 STANDARD NNP B-NP O
163 BRUCE NNP I-NP O
163 , , O O
163 stopped VBD B-VP O
163 for IN B-VP O
163 DYSPNEA NNP B-NP O
163 &amp; NNP I-NP O
163 FATIGUE NNP I-NP O
163 , , O O
163 3'16" CD O O
163 , , O O
164 57.74% CD O O
164 MPHR NNP B-NP O
164 , , O O
164 RPP NNP B-NP O
164 8200 CD O O
164 , , O O
164 no DT B-NP O
164 ectopy NN I-NP O
164 Cath NNP I-NP O
164 3/29 CD O O
164 Right NNP B-NP O
164 Dominant NNP I-NP O
164 , , O O
164 LM NNP B-NP O
164 ostial JJ O O
165 70% CD O O
165 lesion NN B-NP O
165 , , O O
165 prox VBP O O
165 LAD NNP B-NP O
165 70% CD O O
165 lesion NN B-NP O
165 ( ( O O
165 both DT O O
165 got VBD B-VP O
165 Cyphers NNP B-NP O
165 ) ) O O
165 , , O O
165 no DT B-NP O
165 RAS NNP I-NP O
165 RCA NNP I-NP O
166 not RB O O
166 evaluated VBD B-VP O
166 Cath NNP B-NP O
166 10/16 CD O O
166 RCA NNP B-NP O
166 evaluated VBD B-VP O
166 ( ( O O
166 Mid NNP B-NP O
166 ) ) O O
166 , , O O
166 80% CD O O
167 lesion NN B-NP O
167 RCA NNP I-NP O
167 ( ( O O
167 Proximal NNP B-NP O
167 ) ) O O
167 , , O O
167 60% CD O O
167 lesion NN B-NP O
167 Elevated NNP I-NP O
167 RH NNP I-NP O
168 pressures VBZ O O
169 PFTs NNP B-NP O
169 0/30/92: CD O O
169 FEV1 NNP B-NP O
169 101% CD O O
170 ADENOSINE NNP B-NP O
170 MIBI NNP I-NP O
170 1/11/07: CD O O
170 1 CD O O
170 Abnormal NNP B-NP O
170 and CC O O
170 consistent JJ O O
170 with IN B-VP O
170 a DT B-NP O
170 large JJ I-NP O
170 region NN I-NP O
170 of IN B-VP O
171 myocardial JJ B-NP O
171 scar NN I-NP O
171 in IN B-VP O
171 the DT B-NP O
171 distribution NN I-NP O
171 of IN B-VP O
171 the DT B-NP O
172 right JJ I-NP O
172 coronary JJ I-NP O
172 artery NN I-NP O
172 and CC O O
172 a DT B-NP O
172 posterolateral/OM JJ I-NP O
172 coronary JJ I-NP O
172 artery NN I-NP O
173 without IN B-VP O
173 residual JJ B-NP O
173 adenosine NN I-NP O
173 induced VBN O O
173 perfusion NN B-NP O
173 defect JJ B-NP O
173 Test NNP I-NP O
174 sensitivity NN I-NP O
174 for IN B-VP O
174 detecting VBG O O
174 ischemia NN B-NP O
174 is VBZ O O
174 reduced VBN O O
174 in IN B-VP O
174 this DT B-NP O
174 patient NN I-NP O
174 due JJ O O
175 to TO O O
175 lack VB O O
175 of IN B-VP O
175 a DT O O
175 separate JJ O O
175 normally RB O O
175 perfused JJ B-NP O
175 myocardium NN I-NP O
175 to TO O O
175 compare VB O O
175 to TO O O
176 2 CD O O
176 Severe NNP B-NP O
176 global JJ B-NP O
176 LV NNP I-NP O
176 systolic JJ B-NP O
176 dysfunction NN I-NP O
176 3 CD O O
176 Results NNP B-NP O
177 essentially RB O O
177 unchanged JJ O O
177 from IN B-VP O
177 March NNP B-NP O
177 , , O O
177 2005 CD O O
178 CATH NNP B-NP O
178 10/26/07: CD O O
178 LHC: NNP B-NP O
178 R NNP I-NP O
178 dom NN I-NP O
178 , , O O
178 No NNP B-NP O
178 LM NNP I-NP O
178 or CC O O
178 LAD NNP B-NP O
178 lesions NNS I-NP O
178 Cx NNP I-NP O
178 with IN B-VP O
178 discrete JJ O O
179 calcified VBD B-VP O
179 80% CD O O
179 lesion NN B-NP O
179 , , O O
179 RCA NNP B-NP O
179 with IN B-VP O
179 porx NN B-NP O
179 diffuse NN I-NP O
179 calcified VBD B-VP O
179 80%lesion CD O O
179 , , O O
179 RT NNP B-NP O
179 LV-BR NNP I-NP O
180 prox NN I-NP O
180 tubular NN I-NP O
180 70% CD O O
180 lesion NN B-NP O
180 , , O O
180 no DT B-NP O
180 change NN I-NP O
180 since IN B-VP O
180 2005 CD O O
181 RHC: NNP B-NP O
181 RA NNP I-NP O
181 7/8 CD O O
181 , , O O
181 6 CD O O
181 RV NNP B-NP O
181 27/5 CD O O
181 , , O O
181 6 CD O O
181 PA NNP B-NP O
181 26/13 CD O O
181 , , O O
181 19 CD O O
181 PCWP NNP B-NP O
181 16 CD O O
181 , , O O
181 CO/CI NNP B-NP O
181 3.6/1.8 CD O O
182 TTE: NNP B-NP O
182 5/16/07: CD O O
182 EF NNP B-NP O
182 15-20% JJ O O
182 with IN B-VP O
182 global JJ B-NP O
182 HK NNP I-NP O
182 and CC O O
182 ant/apical/inf/post/mid JJ B-NP O
183 sept NN I-NP O
183 AK NNP I-NP O
183 Severe NNP I-NP O
183 decr NN I-NP O
183 RV NNP I-NP O
183 fxn NN I-NP O
183 , , O O
183 severe JJ B-NP O
183 LAE NNP I-NP O
183 , , O O
183 Mild NNP B-NP O
183 AR NNP I-NP O
183 , , O O
183 Tr NNP B-NP O
183 TR/PR NNP I-NP O
183 , , O O
183 Mod NNP B-NP O
183 MR NNP I-NP O
183 , , O O
184 no DT B-NP O
184 change NN I-NP O
184 from IN B-VP O
184 prior JJ B-NP O
185 *** NNP I-NP O
186 Hospital NNP I-NP O
186 Course:78M NNP I-NP O
186 with IN B-VP O
186 significant JJ B-NP O
186 CAD NNP I-NP O
186 , , O O
186 iCM JJ B-NP O
186 EF NNP I-NP O
186 15-20% CD O O
186 , , O O
186 presenting VBG O O
186 with IN B-VP O
187 SOB NNP B-NP O
187 Suspected NNP I-NP O
187 CHF NNP I-NP O
187 exacerbation NN I-NP O
188 1 CD O O
188 CV: NNP B-NP O
189 Ischemia- NNP I-NP O
189 Checked NNP I-NP O
189 troponin NN I-NP O
189 ( ( O O
189 neg JJ O O
189 ) ) O O
189 for IN B-VP O
189 hx NN B-NP O
189 of IN B-VP O
189 CP NNP B-NP O
189 1 CD O O
189 week NN B-NP O
189 ago RB O O
189 Cont NNP B-NP O
190 ASA/Plavix NNP I-NP B-m
190 , , O O
190 BB NNP B-NP B-m
190 Some DT B-NP O
190 concern NN I-NP O
190 for IN B-VP O
190 ischemia NN B-NP O
190 causing VBG O O
190 his PRP$ O O
191 worsening NN B-NP O
191 symptoms NNS I-NP O
191 so RB O O
191 Adenosine NNP B-NP O
191 MIBI NNP I-NP O
191 on IN B-VP O
191 1/8 CD O O
191 w/o JJ B-NP O
191 focal JJ I-NP O
191 defects NNS I-NP O
191 , , O O
191 but CC O O
192 no DT B-NP O
192 good JJ I-NP O
192 area NN I-NP O
192 to TO O O
192 compare VB O O
192 it PRP O O
192 to TO O O
192 LHC NNP B-NP O
192 w/o VB O O
192 new JJ B-NP O
192 disease NN I-NP O
192 , , O O
192 no DT B-NP O
193 interventions NNS I-NP O
193 TSH NNP I-NP O
193 nl RB O O
194 Pump: NNP B-NP O
194 Possibly NNP I-NP O
194 slightly RB O O
194 volume NN B-NP O
194 up RP O O
194 RHC NNP B-NP O
194 with IN B-VP O
194 wedge NN B-NP O
194 of IN B-VP O
194 16 CD O O
194 Changed NNP B-NP O
194 Lasix NNP I-NP B-m
195 to TO O O
195 60 CD O B-do
195 bid NN B-NP B-f
195 Cont NNP I-NP O
195 Dig/nitrate/BB NNP I-NP B-m
195 , , O O
195 ACEi NNP B-NP B-m
195 Checked NNP I-NP O
195 echo NN I-NP O
195 , , O O
195 no DT B-NP O
195 change NN I-NP O
196 Rhythym: NNP I-NP O
196 Tele NNP I-NP O
196 Lyte NNP I-NP B-m
196 replete VB O O
196 prn RB O B-f
197 2 CD O O
197 PULM: NNP B-NP O
197 no DT B-NP O
197 COPD NNP I-NP O
197 by IN B-VP O
197 PFTs NNP B-NP O
197 1992.No CD O O
197 asthma NN B-NP O
197 or CC O O
197 PNA NNP B-NP O
198 3 CD O O
198 Renal: NNP B-NP O
198 CRI NNP I-NP O
198 ( ( O O
198 1.4-1.8 JJ O O
198 ) ) O O
198 1.6 CD O O
198 on IN B-VP O
198 admit NN B-NP O
198 , , O O
198 follow VBP O O
198 Stable JJ O O
198 , , O O
198 got VBD B-VP O
198 mucomyst JJ B-NP B-m
198 pre NN I-NP O
199 cath NN I-NP O
199 , , O O
199 no DT B-NP O
199 bump NN I-NP O
199 in IN B-VP O
199 Cr NNP B-NP O
199 1.4 CD O O
199 on IN B-VP O
199 discharge NN B-NP O
200 4 CD O O
200 GI: NNP B-NP O
200 Barrett's NNP I-NP B-r
200 , , O O
200 on IN B-VP O
200 a DT B-NP O
200 PPI NNP I-NP B-m
201 5 CD O O
201 NEURO: NNP B-NP O
201 neuropathy JJ B-NP B-r
201 neuropathy NN I-NP B-r
201 , , O O
201 neurontin NN B-NP B-m
201 , , O O
201 celexa VBP O B-m
202 6 CD O O
202 Optho: NNP B-NP O
202 glaucoma NN I-NP O
202 , , O O
202 on IN B-VP O
202 eye NN B-NP B-m
202 drops NNS I-NP I-m
203 7 CD O O
203 FEN: NNP B-NP O
203 CV NNP I-NP O
203 , , O O
203 NAS NNP B-NP O
203 , , O O
203 2L CD O O
203 fluid NN B-NP O
203 restrict NN I-NP O
203 diet JJ O O
204 8 CD O O
204 HEME: NNP B-NP O
204 Held NNP I-NP O
204 coumadin NN I-NP B-m
204 for IN B-VP O
204 cath NN B-NP O
204 , , O O
204 then RB O O
204 restarted VBD B-VP O
204 it PRP O O
204 with IN B-VP O
204 2mg CD O B-do
204 on IN B-VP O
204 8/1 CD O O
204 , , O O
204 1mg CD O O
205 on IN B-VP O
205 6/10 CD O O
205 , , O O
205 INR NNP B-NP O
205 of IN B-VP O
205 1.7 CD O O
205 on IN B-VP O
205 d/c JJ B-NP O
206 ADDITIONAL NNP I-NP O
206 COMMENTS: NNP I-NP O
206 Please NNP I-NP O
206 stop VB O O
206 taking VBG O O
206 your PRP$ O O
206 Imdur NNP B-NP B-m
206 Please NNP I-NP O
206 measure NN I-NP O
206 daily JJ B-NP O
206 weights NNS I-NP O
206 and CC O O
206 call VB O O
207 your PRP$ O O
207 MD NNP B-NP O
207 if IN B-VP O
207 your PRP$ O O
207 weight NN B-NP O
207 increases NNS I-NP O
207 by IN B-VP O
207 more JJR O O
207 than IN B-VP O
207 5lbs CD O O
207 in IN B-VP O
207 one CD O O
207 week NN B-NP O
207 or CC O O
207 by IN B-VP O
207 more JJR O O
208 than IN B-VP O
208 2-3 CD O O
208 lbs NN B-NP O
208 in IN B-VP O
208 one CD O O
208 day NN B-NP O
209 Please NNP I-NP O
209 continue VB O O
209 your PRP$ O O
209 coumadin NN B-NP B-m
209 and CC O O
209 take VB O O
209 it PRP O O
209 as IN B-VP O
209 previously RB O O
209 Check NNP B-NP O
209 your PRP$ O O
209 INR NNP B-NP O
210 on IN B-VP O
210 monday JJ B-NP O
211 Please NNP I-NP O
211 take VB O O
211 Lasix NNP B-NP B-m
211 60 CD O B-do
211 twice RB O B-f
211 a DT B-NP I-f
211 day NN I-NP I-f
212 Otherwise NNP I-NP O
212 resume VBZ O O
212 all DT O O
212 of IN B-VP O
212 your PRP$ O O
212 home NN B-NP O
212 medications NNS I-NP O
213 DISCHARGE NNP I-NP O
213 CONDITION: NNP I-NP O
213 Stable NNP I-NP O
214 TO NNP I-NP O
214 DO/PLAN: NNP I-NP O
215 Please NNP I-NP O
215 follow VB O O
215 up RP O O
215 volume NN B-NP O
215 status NN I-NP O
215 INR NNP I-NP O
215 was VBD B-VP O
215 1.7 CD O O
215 on IN B-VP O
215 d/c NN B-NP O
215 Will NNP I-NP O
215 check VB O O
215 INR NNP B-NP O
215 on IN B-VP O
216 2/21/07 CD O O
217 No NNP B-NP O
217 dictated VBD B-VP O
217 summary JJ B-NP O
218 ENTERED NNP I-NP O
218 BY: NNP I-NP O
218 GIPSON NNP I-NP O
218 , , O O
218 KOREY NNP B-NP O
218 I PRP O O
218 , , O O
218 M.D NNP B-NP O
218 ( ( O O
218 DH589 NNP B-NP O
218 ) ) O O
218 3/22/07 CD O O
218 @ $ O O
218 11:28 CD O O
218 AM NNP B-NP O
219 ****** JJ B-NP O
219 END NN I-NP O
219 OF NNP I-NP O
219 DISCHARGE NNP I-NP O
219 ORDERS NNP I-NP O
219 ****** NNP I-NP O
220 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #868962 VBZ O O
4 417047334 CD O O
4 BH NNP B-NP O
4 46210361 CD O O
4 1866712 CD O O
4 1/20/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Hypertensive NNP I-NP O
4 urgency NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/7/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 9/22/2005 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 HU NNP I-NP O
8 , , O O
8 BRADLY NNP B-NP O
8 340-67-65-6 CD O O
9 Na NNP B-NP O
9 Lu NNP I-NP O
9 Sno NNP I-NP O
9 , , O O
9 Colorado NNP B-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 7/7/05 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Attending NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 CANUPP NNP I-NP O
14 , , O O
14 WILFORD NNP B-NP O
14 STANTON NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 LASIX NNP I-NP B-m
20 LASIX NNP I-NP B-m
20 LASIX NNP I-NP B-m
20 LASIX NNP I-NP B-m
20 ( ( O I-m
20 ( ( O I-m
20 ( ( O I-m
20 ( ( O I-m
20 FUROSEMIDE NNP B-NP I-m
20 FUROSEMIDE NNP I-NP I-m
20 FUROSEMIDE NNP I-NP I-m
20 FUROSEMIDE NNP I-NP I-m
20 ) ) O I-m
20 ) ) O I-m
20 ) ) O I-m
20 ) ) O I-m
20 160 CD O B-do
20 MG NNP B-NP I-do
20 QAM; NNP I-NP B-f
20 120 CD O B-do
20 MG NNP B-NP I-do
20 QPM NNP I-NP B-f
20 PO NNP I-NP B-mo
20 PO NNP I-NP B-mo
20 160 CD O B-do
20 MG NNP B-NP I-do
20 QAM NNP I-NP B-f
21 120 CD O B-do
21 MG NNP B-NP I-do
21 QPM NNP I-NP B-f
22 LISINOPRIL NNP I-NP B-m
22 80 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 Override NNP I-NP O
23 Notice: NNP I-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 7/7/05 CD O O
23 by IN B-VP O
24 KULOW NNP B-NP O
24 , , O O
24 LUPE NNP B-NP O
24 D NNP I-NP O
24 , , O O
24 M.D NNP B-NP O
25 on IN B-VP O
25 order NN B-NP O
25 for IN B-VP O
25 KCL NNP B-NP B-m
25 SLOW NNP I-NP I-m
25 RELEASE NNP I-NP I-m
25 PO NNP I-NP B-mo
25 ( ( O O
25 ref JJ O O
25 # # O O
25 49689673 CD O O
25 ) ) O O
26 POTENTIALLY NNP B-NP O
26 SERIOUS NNP I-NP O
26 INTERACTION: NNP I-NP O
26 LISINOPRIL NNP I-NP B-m
26 &amp; NNP I-NP O
26 POTASSIUM NNP I-NP B-m
27 CHLORIDE NNP I-NP O
27 Reason NNP I-NP O
27 for IN B-VP O
27 override: NN B-NP O
27 aware JJ B-NP O
28 MVI NNP I-NP B-m
28 THERAPEUTIC NNP I-NP I-m
28 ( ( O I-m
28 THERAPEUTIC NNP B-NP I-m
28 MULTIVITAMINS NNP I-NP I-m
28 ) ) O I-m
28 1 CD O B-do
28 TAB NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 NORVASC NNP I-NP B-m
29 ( ( O I-m
29 AMLODIPINE NNP B-NP I-m
29 ) ) O I-m
29 10 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QD NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 Avoid NNP I-NP O
31 grapefruit NN I-NP O
31 unless IN B-VP O
31 MD NNP B-NP O
31 instructs NNS I-NP O
31 otherwise RB O O
32 TOPROL NNP B-NP B-m
32 XL NNP I-NP I-m
32 ( ( O I-m
32 METOPROLOL NNP B-NP I-m
32 ( ( O I-m
32 SUST NNP B-NP I-m
32 REL NNP I-NP I-m
32 ) ) O I-m
32 ) ) O I-m
32 200 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 Food/Drug NNP I-NP O
33 Interaction NNP I-NP O
33 Instruction NNP I-NP O
34 Take NNP I-NP O
34 consistently RB O O
34 with IN B-VP O
34 meals NNS B-NP O
34 or CC O O
34 on IN B-VP O
34 empty JJ B-NP O
34 stomach NN I-NP O
35 Number NNP I-NP B-du
35 of IN B-VP I-du
35 Doses NNP B-NP I-du
35 Required NNP I-NP I-du
35 ( ( O I-du
35 approximate JJ B-NP I-du
35 ): NN I-NP I-du
35 5 CD O I-du
36 AMBIEN NNP B-NP B-m
36 ( ( O I-m
36 ZOLPIDEM NNP B-NP I-m
36 TARTRATE NNP I-NP I-m
36 ) ) O I-m
36 5 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 QHS NNP I-NP B-f
37 Food/Drug NNP I-NP O
37 Interaction NNP I-NP O
37 Instruction NNP I-NP O
38 Give NNP I-NP O
38 on IN B-VP O
38 an DT B-NP O
38 empty JJ I-NP O
38 stomach NN I-NP O
38 ( ( O O
38 give JJ O O
38 1hr CD O O
38 before IN B-VP O
38 or CC O O
38 2hr CD O O
38 after IN B-VP O
39 food NN B-NP O
39 ) ) O O
40 DEPAKOTE NNP B-NP B-m
40 ER NNP I-NP I-m
40 ( ( O I-m
40 DIVALPROEX NNP B-NP I-m
40 SODIUM NNP I-NP I-m
40 ER NNP I-NP I-m
40 ) ) O I-m
40 1 CD O B-do
40 , , O I-do
40 000 CD O I-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 Starting NNP I-NP O
41 IN NNP I-NP O
41 AM NNP I-NP O
41 ( ( O O
41 5/13 CD O O
41 ) ) O O
42 DIET: NNP B-NP O
42 House NNP I-NP O
42 / VBD B-VP O
42 Low NNP B-NP O
42 chol/low NN I-NP O
42 sat VBD B-VP O
42 fat JJ B-NP O
43 DIET: NNP I-NP O
43 2 CD O O
43 gram NN B-NP O
43 Sodium NNP I-NP O
44 ACTIVITY: NNP I-NP O
44 Resume NNP I-NP O
44 regular JJ B-NP O
44 exercise NN I-NP O
45 FOLLOW NNP I-NP O
45 UP NNP I-NP O
45 APPOINTMENT( NNP I-NP O
45 S NNP I-NP O
45 ): NNP I-NP O
46 Primary NNP I-NP O
46 cardiologist NN I-NP O
46 Please NNP I-NP O
46 make VB O O
46 an DT B-NP O
46 appt NN I-NP O
46 for IN B-VP O
46 the DT B-NP O
46 next JJ I-NP O
46 1-2 JJ I-NP O
46 weeks NNS I-NP O
46 , , O O
47 Primary NNP B-NP O
47 care NN I-NP O
47 doctor NN I-NP O
47 , , O O
48 ALLERGY: NNP B-NP O
48 NKA NNP I-NP O
49 ADMIT NNP I-NP O
49 DIAGNOSIS: NNP I-NP O
50 CAD NNP I-NP O
51 PRINCIPAL NNP I-NP O
51 DISCHARGE NNP I-NP O
51 DIAGNOSIS NNP I-NP O
51 ;Responsible JJ O O
51 After IN B-VP O
51 Study NNP B-NP O
51 for IN B-VP O
51 Causing NNP B-NP O
51 Admission NNP I-NP O
51 ) ) O O
52 Hypertensive NNP B-NP O
52 urgency NN I-NP O
53 OTHER NNP I-NP O
53 DIAGNOSIS;Conditions NNP I-NP O
53 , , O O
53 Infections NNP B-NP O
53 , , O O
53 Complications NNP B-NP O
53 , , O O
53 affecting VBG O O
53 Treatment/Stay NNP B-NP O
54 obesity NN I-NP O
54 tobacco NN I-NP O
55 OSA NNP I-NP O
55 ( ( O O
55 sleep JJ B-NP O
55 apnea NN I-NP O
55 ) ) O O
55 h/o NN B-NP O
55 asthma/bronchitis NN I-NP O
55 ( ( O O
55 H/O NNP B-NP O
55 asthmatic JJ B-NP O
55 bronchitis NN I-NP O
55 ) ) O O
56 OPERATIONS NNP B-NP O
56 AND NNP I-NP O
56 PROCEDURES: NNP I-NP O
57 OTHER NNP I-NP O
57 TREATMENTS/PROCEDURES NNP I-NP O
57 ( ( O O
57 NOT NNP B-NP O
57 IN NNP I-NP O
57 O.R NNP I-NP O
57 ) ) O O
58 Cardiac NNP B-NP O
58 catherization NN I-NP O
59 BRIEF NNP I-NP O
59 RESUME NNP I-NP O
59 OF NNP I-NP O
59 HOSPITAL NNP I-NP O
59 COURSE: NNP I-NP O
60 CC: NNP I-NP O
60 Chest NNP I-NP O
60 pain NN I-NP O
61 HPI: NNP I-NP O
61 54M CD O O
61 w/ NN B-NP O
61 hx NN I-NP O
61 chf NN I-NP O
61 ef NN I-NP O
61 45% CD O O
61 , , O O
61 dm NN B-NP O
61 , , O O
61 htn NN B-NP O
61 , , O O
61 osa NN B-NP O
61 , , O O
61 was VBD B-VP O
61 admitted VBN O O
61 to TO O O
61 FH NNP B-NP O
61 w/ NN I-NP O
61 c/o NN I-NP O
62 cp NN I-NP O
62 Found NNP I-NP O
62 to TO O O
62 have VB O O
62 BP NNP B-NP O
62 190-200 JJ B-NP O
62 w/ NN I-NP O
62 troponin NN I-NP O
62 elevated VBD B-VP O
62 to TO O O
62 6.o CD O O
62 No NNP B-NP O
62 ekg NN I-NP O
63 changes NNS I-NP O
63 Pt NNP I-NP O
63 sent VBD B-VP O
63 to TO O O
63 SR NNP B-NP O
63 for IN B-VP O
63 cath NN B-NP O
63 Cath NNP I-NP O
63 revealed VBD B-VP O
63 100% CD O O
63 RCA NNP B-NP O
63 lesion NN I-NP O
64 but CC O O
64 well RB O O
64 collateralized JJ O O
64 and CC O O
64 no DT B-NP O
64 other JJ I-NP O
64 CAD--&gt;no NNP I-NP O
64 intervention NN I-NP O
64 R NNP I-NP O
64 heart NN I-NP O
65 cath NN I-NP O
65 w/ NN I-NP O
65 elev NN I-NP O
65 filling NN I-NP O
65 pressures NNS I-NP O
65 Pt NNP I-NP O
65 chest JJS B-NP O
65 pain NN I-NP O
65 free JJ O O
65 since IN B-VP O
65 ECH NNP B-NP O
66 admission NN I-NP O
66 PMH: NNP I-NP O
66 as IN B-VP O
67 above IN B-VP O
67 meds: NN B-NP O
67 toprol NN I-NP B-m
67 lisinopril NN I-NP I-m
67 , , O O
67 norvasc RB O B-m
67 , , O O
67 asa NN B-NP B-m
67 , , O O
67 statin NN B-NP B-m
67 , , O O
68 depakote VB O B-m
68 PE: NNP B-NP O
68 BP NNP I-NP O
68 145/90 CD O O
68 , , O O
68 HR NNP B-NP O
68 68 CD O O
68 JVP NNP B-NP O
68 9 CD O O
68 , , O O
68 lungs NNS B-NP O
68 clear VBP O O
68 , , O O
68 heart NN B-NP O
69 normal JJ B-NP O
69 labs: JJ I-NP O
69 cr NN I-NP O
69 1.5 CD O O
69 ( ( O O
69 baseline NN B-NP O
69 ) ) O O
69 , , O O
69 hct $ O O
69 55 CD O O
69 , , O O
69 k VBD B-VP O
70 3.3 CD O O
70 EKG: NNP B-NP O
70 nsr NN I-NP O
70 at IN B-VP O
70 68 CD O O
70 w/ NNS B-NP O
70 old JJ B-NP O
70 ST NNP I-NP O
70 depressions NNS I-NP O
70 in IN B-VP O
70 inf JJ B-NP O
70 leads NNS I-NP O
71 and CC O O
71 TWIs NNP B-NP O
71 in IN B-VP O
71 v3-v6 JJ B-NP O
71 CXR: NNP I-NP O
72 nl NN I-NP O
73 ************************************************** NNP I-NP O
74 A/P: NNP I-NP O
74 54M CD O O
74 w/ NN B-NP O
74 hx NN I-NP O
74 chf NN I-NP O
74 admitted VBD B-VP O
74 w/ JJ B-NP O
74 chest NN I-NP O
74 pain NN I-NP O
74 , , O O
74 elev JJ B-NP O
74 troponin NN I-NP O
74 in IN B-VP O
74 setting VBG O O
75 of IN B-VP O
75 elev NN B-NP O
75 BP NNP I-NP O
75 likely JJ B-NP O
75 demand NN I-NP O
75 2/2 CD O O
75 hypertensive JJ B-NP O
75 emergency NN I-NP O
76 1 CD O O
76 )CV: NN B-NP O
76 Presented NNP I-NP O
76 w/ NN I-NP O
76 chest NN I-NP O
76 pain NN I-NP O
76 and CC O O
76 troponin JJ B-NP O
76 elevation NN I-NP O
76 Non-sig NNP I-NP O
76 CAD NNP I-NP O
77 discovered VBD B-VP O
77 at IN B-VP O
77 cath NN B-NP O
77 However RB O O
77 , , O O
77 elev VBP O O
77 filling VBG O O
77 pressures NNS B-NP O
77 on IN B-VP O
77 right JJ B-NP O
77 heart NN I-NP O
77 cath NN I-NP O
78 Keys NNP I-NP O
78 to TO O O
78 management NN B-NP O
78 are VBP O O
78 aggressive JJ B-NP O
78 BP NNP I-NP O
78 control NN I-NP O
78 with IN B-VP O
78 meds NNS B-NP O
78 , , O O
78 low JJ B-NP O
78 salt NN I-NP O
78 diet NN I-NP O
78 , , O O
79 weight JJ B-NP O
79 loss NN I-NP O
79 cont NN I-NP O
79 asa NN I-NP B-m
79 , , O O
79 statin JJ B-NP B-m
79 Cont NNP I-NP O
79 lasix NN I-NP B-m
79 lasix VBD B-VP B-m
79 160 CD O B-do
79 in IN B-VP O
79 AM NNP B-NP B-f
79 , , O O
79 120 CD O B-do
79 in IN B-VP O
79 PM NNP B-NP B-f
79 for IN B-VP O
80 volume NN B-NP B-r
80 volume NN I-NP B-r
80 control NN I-NP I-r
80 control NN I-NP I-r
80 Troponin NNP I-NP O
80 trended VBD B-VP O
80 down RB O O
80 and CC O O
80 pt JJ O O
80 remained VBD B-VP O
80 asymptomatic JJ O O
80 in IN B-VP O
81 house NN B-NP O
81 Monitored VBD B-VP O
81 on IN B-VP O
81 tele--&gt;no JJ B-NP O
81 events NNS I-NP O
82 2 CD O O
82 )Renal: NNP B-NP O
82 Cr NNP I-NP O
82 1.5 CD O O
82 , , O O
82 remained VBD B-VP O
82 stable JJ O O
82 at IN B-VP O
82 baseline NN B-NP O
82 Gave NNP I-NP O
82 mucomyst NN I-NP B-m
83 3 CD O O
83 )Endo: NNP B-NP O
83 DM NNP I-NP O
83 on IN B-VP O
83 diet JJ B-NP O
83 control NN I-NP O
83 Hba1c NNP I-NP O
83 pending VBG O O
83 RISS NNP B-NP B-m
83 in IN B-VP O
83 house NN B-NP O
84 4 CD O O
84 )pulm: NN B-NP O
84 hx NN I-NP O
84 osa NN I-NP O
84 on IN B-VP O
84 cpap NN B-NP B-m
84 Likely JJ O O
84 contributing VBG O O
84 to TO O O
84 pulm VB O O
84 htn VB O O
84 given VBN O O
84 hct PRP O O
84 55 CD O O
85 Cont NNP B-NP O
85 cpap NN I-NP B-m
85 and CC O O
85 encourage VB O O
85 weight JJ B-NP O
85 loss NN I-NP O
85 No NNP I-NP O
85 SOB NNP I-NP O
86 ADDITIONAL NNP I-NP O
86 COMMENTS: NNP I-NP O
86 Please NNP I-NP O
86 be VB O O
86 sure JJ O O
86 to TO O O
86 continue VB O O
86 your PRP$ O B-m
86 medications NNS B-NP I-m
86 as IN B-VP O
86 prescribed JJ B-NP O
87 Continue NNP I-NP O
87 to TO O O
87 monitor VB O O
87 your PRP$ O O
87 BP NNP B-NP O
87 Cutting VBG O O
87 out RP O O
87 salt NN B-NP O
87 , , O O
87 losing VBG O O
87 weight NN B-NP O
87 , , O O
87 and CC O O
87 taking VBG O O
88 your PRP$ O O
88 meds NNS B-NP O
88 will MD O O
88 help VB O O
88 lower VB O O
88 your PRP$ O O
88 BP NNP B-NP O
89 If IN B-VP O
89 you PRP O O
89 re-experience VBP O O
89 chest JJ B-NP O
89 pain NN I-NP O
89 or CC O O
89 shortness NN B-NP O
89 of IN B-VP O
89 breath NN B-NP O
89 , , O O
89 call VB O O
89 your PRP$ O O
89 doctor NN B-NP O
90 or CC O O
90 return NN B-NP O
90 to TO O O
90 the DT B-NP O
90 hospital NN I-NP O
91 DISCHARGE NNP I-NP O
91 CONDITION: NNP I-NP O
91 Stable NNP I-NP O
92 TO NNP I-NP O
92 DO/PLAN: NNP I-NP O
93 No NNP I-NP O
93 dictated VBD B-VP O
93 summary JJ B-NP O
94 ENTERED NNP I-NP O
94 BY: NNP I-NP O
94 SEDER NNP I-NP O
94 , , O O
94 FIDEL NNP B-NP O
94 J NNP I-NP O
94 , , O O
94 M.D NNP B-NP O
94 ( ( O O
94 XR068 NNP B-NP O
94 ) ) O O
94 7/7/05 CD O O
94 @ $ O O
94 10:24 CD O O
94 AM NNP B-NP O
95 ****** JJ B-NP O
95 END NN I-NP O
95 OF NNP I-NP O
95 DISCHARGE NNP I-NP O
95 ORDERS NNP I-NP O
95 ****** NNP I-NP O
96 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #869853 VBZ O O
2 194458735 CD O O
2 RMC NNP B-NP O
2 86089618 CD O O
2 904118 CD O O
2 3/19/1997 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ?MYOCARDIAL NNP I-NP O
2 INFARCTION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/19/1997 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/16/1997 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 1 CD O O
4 ACUTE NNP B-NP O
4 MYOCARDIAL NNP I-NP O
4 INFARCTION NNP I-NP O
5 HISTORY NNP I-NP O
5 OF NNP I-NP O
5 PRESENT NNP I-NP O
5 ILLNESS: NNP I-NP O
5 Mrs NNP I-NP O
5 Trudell NNP I-NP O
5 is VBZ O O
5 a DT O O
5 69 CD O O
5 year NN B-NP O
5 old JJ B-NP O
5 woman NN I-NP O
6 with IN B-VP O
6 a DT B-NP O
6 history NN I-NP O
6 of IN B-VP O
6 coronary JJ B-NP O
6 artery NN I-NP O
7 disease NN I-NP O
7 , , O O
7 status NN B-NP O
7 post NN I-NP O
7 an DT B-NP O
7 inferoposterior JJ I-NP O
7 myocardial JJ I-NP O
7 infarction NN I-NP O
7 in IN B-VP O
8 March NNP B-NP O
8 1996 CD O O
8 She PRP O O
8 had VBD B-VP O
8 a DT B-NP O
8 cardiac JJ I-NP O
8 catheterization NN I-NP O
8 at IN B-VP O
8 the DT B-NP O
8 time NN I-NP O
8 , , O O
8 which WDT O O
9 showed VBD B-VP O
9 an DT O O
9 80% CD O O
9 mid NN B-NP O
9 left VBD B-VP O
9 anterior JJ O O
9 descending VBG O O
9 artery NN B-NP O
9 lesion NN I-NP O
9 , , O O
9 and CC O O
9 80% CD O O
10 left VBD B-VP O
10 circumflex JJ B-NP O
10 lesion NN I-NP O
10 before IN B-VP O
10 OM1 NNP B-NP O
10 , , O O
10 50% CD O O
10 proximal JJ B-NP O
10 right JJ I-NP O
10 coronary JJ I-NP O
11 artery NN I-NP O
11 lesion NN I-NP O
11 , , O O
11 and CC O O
11 an DT O O
11 80% CD O O
11 posterior NN B-NP O
11 left VBD B-VP O
11 ventricular JJ B-NP O
11 branch NN I-NP O
11 lesion NN I-NP O
12 She PRP O O
12 was VBD B-VP O
12 also RB O O
12 noted VBN O O
12 to TO O O
12 have VB O O
12 inferior JJ O O
12 and CC O O
12 anterolateral JJ B-NP O
12 HK NNP I-NP O
12 with IN B-VP O
12 an DT B-NP O
13 ejection NN I-NP O
13 fraction NN I-NP O
13 of IN B-VP O
13 52% CD O O
13 The DT B-NP O
13 patient NN I-NP O
13 expressed VBD B-VP O
13 her PRP$ O O
13 desire NN B-NP O
13 to TO O O
13 be VB O O
14 managed VBN O O
14 conservatively RB O O
14 , , O O
14 and CC O O
14 was VBD B-VP O
14 medically RB O O
14 managed VBN O O
14 for IN B-VP O
14 the DT B-NP O
14 following JJ I-NP O
15 year NN I-NP O
15 She PRP O O
15 had VBD B-VP O
15 a DT B-NP O
15 sub-max JJ I-NP O
15 exercise NN I-NP O
15 tolerance NN I-NP O
15 test NN I-NP O
15 prior RB O O
15 to TO O O
15 discharge VB O O
16 and CC O O
16 one CD O O
16 month NN B-NP O
16 later RB O O
16 had VBD B-VP O
16 a DT B-NP O
16 full JJ I-NP O
16 BRUCE NNP I-NP O
16 protocol NN I-NP O
16 going VBG O O
16 six CD O O
16 minutes NNS B-NP O
17 with IN B-VP O
17 less JJR O O
17 than IN B-VP O
17 1 CD O O
17 mm JJ B-NP O
17 ST NNP I-NP O
17 segment NN I-NP O
17 depressions NNS I-NP O
17 in IN B-VP O
17 several JJ O O
17 leads VBZ O O
17 The DT B-NP O
18 patient NN I-NP O
18 did VBD B-VP O
18 well RB O O
18 for IN B-VP O
18 the DT B-NP O
18 past JJ I-NP O
18 year NN I-NP O
18 without IN B-VP O
18 symptoms NNS B-NP O
18 until IN B-VP O
18 1:00 CD O O
18 a.m NNS B-NP O
19 on IN B-VP O
19 the DT B-NP O
19 morning NN I-NP O
19 of IN B-VP O
19 admission NN B-NP O
19 when WRB O O
19 she PRP O O
19 woke VBD B-VP O
19 from IN B-VP O
19 sleep NN B-NP O
19 with IN B-VP O
20 substernal JJ B-NP B-r
20 chest NN I-NP I-r
20 pain NN I-NP I-r
20 She PRP O O
20 took VBD B-VP O
20 sublingual JJ B-NP B-mo
20 nitroglycerin NN I-NP B-m
20 with IN B-VP O
21 relief NN B-NP O
21 after IN B-VP O
21 half NN B-NP O
21 and CC O O
21 hour NN B-NP O
21 but CC O O
21 at IN B-VP O
21 3:00 CD O O
21 a.m IN B-VP O
21 the DT B-NP O
21 pain NN I-NP O
21 recurred VBD B-VP O
21 with IN B-VP O
22 nausea NN B-NP O
22 The DT B-NP O
22 patient NN I-NP O
22 took VBD B-VP O
22 two CD O B-do
22 sublingual JJ B-NP B-mo
22 nitroglycerin NN I-NP B-m
22 with IN B-VP O
23 resolution NN B-NP O
23 of IN B-VP O
23 the DT B-NP O
23 pain NN I-NP B-r
23 by IN B-VP O
23 4:00 CD O O
23 a.m NN B-NP O
23 She PRP O O
23 presented VBD B-VP O
23 to TO O O
23 the DT B-NP O
23 emergency NN I-NP O
24 department NN I-NP O
24 free JJ O O
24 of IN B-VP O
24 pain NN B-NP O
24 and CC O O
24 electrocardiogram NN B-NP O
24 at IN B-VP O
24 the DT B-NP O
24 time NN I-NP O
24 showed VBD B-VP O
25 changes NNS B-NP O
25 consistent JJ O O
25 with IN B-VP O
25 anterior JJ O O
25 ischemia VBP O O
25 The DT B-NP O
25 patient NN I-NP O
25 was VBD B-VP O
26 admitted VBN O O
26 with IN B-VP O
26 unstable JJ B-NP O
26 angina NN I-NP O
26 for IN B-VP O
26 evaluation NN B-NP O
27 PAST NNP I-NP O
27 MEDICAL NNP I-NP O
27 HISTORY: NNP I-NP O
27 Remarkable NNP I-NP O
27 for IN B-VP O
27 coronary JJ B-NP O
27 artery NN I-NP O
27 disease NN I-NP O
27 , , O O
28 hypertension NN B-NP O
28 , , O O
28 status NN B-NP O
28 post NN I-NP O
28 cholecystectomy NN I-NP O
29 MEDICATIONS NNP I-NP O
29 ON NNP I-NP O
29 ADMISSION: NNP I-NP O
29 Include NNP I-NP O
29 simvastatin VBD B-VP B-m
29 10 CD O B-do
29 mg NN B-NP I-do
29 q.h.s NN I-NP B-f
29 , , O O
30 sublingual JJ B-NP B-mo
30 nitroglycerin NN I-NP B-m
30 , , O O
30 enalapril VBZ O B-m
31 5 CD O B-do
31 mg NN B-NP I-do
31 b.i.d NN I-NP B-f
31 , , O O
31 aspirin RB O B-m
31 325 CD O B-do
31 mg NN B-NP I-do
31 q.d NN I-NP B-f
31 , , O O
31 Atenolol NNP B-NP B-m
31 50 CD O B-do
31 mg NN B-NP I-do
31 b.i.d NN I-NP B-f
32 ALLERGIES: NNP I-NP O
32 She PRP O O
32 had VBD B-VP O
32 no DT O O
32 known VBN O O
32 drug NN B-NP O
32 allergies NNS I-NP O
33 PHYSICAL NNP I-NP O
33 EXAMINATION: NNP I-NP O
33 Revealed VBD B-VP O
33 a DT B-NP O
33 pulse NN I-NP O
33 of IN B-VP O
33 62 CD O O
33 , , O O
33 regular JJ O O
33 and CC O O
33 blood NN B-NP O
34 pressure NN I-NP O
34 160/80 CD O O
34 , , O O
34 respiratory NN B-NP O
34 rate NN I-NP O
34 12 CD O O
34 , , O O
34 oxygen JJR B-NP O
35 saturation NN I-NP O
35 of IN B-VP O
35 99% CD O O
35 on IN B-VP O
35 three CD O O
35 liters NNS B-NP O
35 nasal VBP O O
35 cannula NN B-NP O
35 There EX O O
35 was VBD B-VP O
35 no DT B-NP O
36 evidence NN I-NP O
36 of IN B-VP O
36 jugular JJ B-NP O
36 venous JJ I-NP O
36 distention NN I-NP O
36 , , O O
36 carotids NNS B-NP O
36 2+ CD O O
36 bilaterally RB O O
36 , , O O
36 no DT B-NP O
37 bruits NNS I-NP O
37 Chest NNP I-NP O
37 is VBZ O O
37 clear JJ O O
37 to TO O O
37 auscultation VB O O
37 bilaterally RB O O
37 Heart NNP B-NP O
38 examination NN I-NP O
38 revealed VBD B-VP O
38 a DT B-NP O
38 regular JJ I-NP O
38 rate NN I-NP O
38 and CC O O
38 rhythm NN B-NP O
38 and CC O O
38 an DT B-NP O
38 S4 NNP I-NP O
38 was VBD B-VP O
39 present JJ B-NP O
39 Abdomen NNP I-NP O
39 was VBD B-VP O
39 obese JJ O O
39 , , O O
39 soft JJ O O
39 , , O O
39 nontender NN B-NP O
39 and CC O O
39 nondistended VBN O O
39 with IN B-VP O
40 normal JJ B-NP O
40 bowel NN I-NP O
40 sounds VBZ O O
40 present JJ B-NP O
40 Extremities NNS I-NP O
40 were VBD B-VP O
40 without IN B-VP O
40 edema JJ B-NP O
41 LABORATORY NNP I-NP O
41 DATA: NNP I-NP O
41 On IN B-VP O
41 admission NN B-NP O
41 the DT B-NP O
41 patient's JJ I-NP O
41 initial JJ I-NP O
41 CK NNP I-NP O
41 was VBD B-VP O
41 111 CD O O
42 Her NNP B-NP O
42 second JJ B-NP O
42 CK NNP I-NP O
42 was VBD B-VP O
42 452 CD O O
42 , , O O
42 with IN B-VP O
42 an DT B-NP O
42 MB NNP I-NP O
42 fraction NN I-NP O
42 of IN B-VP O
43 45.1 CD O O
43 , , O O
43 third JJ B-NP O
43 CK NNP I-NP O
43 was VBD B-VP O
43 550 CD O O
43 with IN B-VP O
43 an DT B-NP O
43 MB NNP I-NP O
43 fraction NN I-NP O
43 of IN B-VP O
43 47.9 CD O O
43 , , O O
43 and CC O O
43 a DT B-NP O
43 fourth JJ I-NP O
43 CK NNP I-NP O
44 of IN B-VP O
44 439 CD O O
44 with IN B-VP O
44 MB NNP B-NP O
44 fraction NN I-NP O
44 of IN B-VP O
44 33.5 CD O O
44 , , O O
44 fifth JJ B-NP O
44 CK NNP I-NP O
44 of IN B-VP O
44 261 CD O O
44 , , O O
44 with IN B-VP O
44 MB NNP B-NP O
44 fraction NN I-NP O
45 of IN B-VP O
45 14.9 CD O O
45 , , O O
45 and CC O O
45 a DT B-NP O
45 sixth JJ I-NP O
45 CK NNP I-NP O
45 of IN B-VP O
45 156 CD O O
45 SMA NNP B-NP O
45 seven CD O O
45 was VBD B-VP O
45 normal JJ B-NP O
46 Troponin NNP I-NP O
46 I PRP O O
46 was VBD B-VP O
46 0.0 CD O O
46 on IN B-VP O
46 admission NN B-NP O
46 White NNP I-NP O
46 blood NN I-NP O
46 count NN I-NP O
46 of IN B-VP O
46 11 CD O O
46 , , O O
47 hematocrit NN B-NP O
47 39.7 CD O O
47 Chest NNP B-NP O
47 x-ray NN I-NP O
47 was VBD B-VP O
47 unremarkable JJ O O
47 for IN B-VP O
47 any DT B-NP O
47 infiltrate NN I-NP O
48 or CC O O
48 any DT B-NP O
48 congestive JJ I-NP O
48 heart NN I-NP O
48 failure NN I-NP O
48 evidence NN I-NP O
48 Electrocardiogram NNP I-NP O
49 revealed VBD B-VP O
49 normal JJ B-NP O
49 sinus NN I-NP O
49 rhythm NN I-NP O
49 at IN B-VP O
49 75 CD O O
49 , , O O
49 axis RB O O
49 0 CD O O
49 , , O O
49 2 CD O O
49 to TO O O
49 3 CD O O
49 ST NNP B-NP O
49 segment NN I-NP O
50 elevation NN I-NP O
50 in IN B-VP O
50 V1 NNP B-NP O
50 through IN B-VP O
50 V3 NNP B-NP O
50 , , O O
50 1 CD O O
50 mm NN B-NP O
50 elevation NN I-NP O
50 in IN B-VP O
50 V4 NNP B-NP O
50 , , O O
50 less JJR O O
50 than IN B-VP O
50 1 CD O O
50 mm JJ B-NP O
50 ST NNP I-NP O
51 segment NN I-NP O
51 depressions NNS I-NP O
51 in IN B-VP O
51 1 CD O O
51 , , O O
51 AVL NNP B-NP O
51 , , O O
51 and CC O O
51 V5 NNP B-NP O
51 , , O O
51 V6 NNP B-NP O
51 These DT B-NP O
51 changes NNS I-NP O
51 were VBD B-VP O
51 new JJ O O
52 compared VBN O O
52 to TO O O
52 a DT B-NP O
52 previous JJ I-NP O
52 electrocardiogram NN I-NP O
52 from IN B-VP O
52 March NNP B-NP O
52 1996 CD O O
53 HOSPITAL NNP B-NP O
53 COURSE: NNP I-NP O
53 The DT B-NP O
53 patient NN I-NP O
53 was VBD B-VP O
53 admitted VBN O O
53 to TO O O
53 CCU NNP B-NP O
53 , , O O
53 at IN B-VP O
53 which WDT O O
53 time NN B-NP O
54 she PRP O O
54 was VBD B-VP O
54 pain JJ O O
54 free JJ O O
54 and CC O O
54 her PRP$ O O
54 electrocardiogram NN B-NP O
55 abnormalities NNS I-NP O
55 had VBD B-VP O
55 resolved VBN O O
55 Her NNP B-NP O
55 heart NN I-NP O
55 rate NN I-NP O
55 and CC O O
55 blood NN B-NP O
55 pressure NN I-NP O
55 were VBD B-VP O
56 controlled VBN O O
56 with IN B-VP O
56 intravenous JJ B-NP B-mo
56 medications NNS I-NP B-m
56 and CC O O
56 she PRP O O
56 was VBD B-VP O
56 managed VBN O O
57 medically RB O O
57 until IN B-VP B-du
57 hospital JJ B-NP I-du
57 day NN I-NP I-du
57 three CD O I-du
57 when WRB O O
57 she PRP O O
57 was VBD B-VP O
57 taken VBN O O
57 of IN B-VP O
57 the DT B-NP O
58 cardiac JJ I-NP O
58 catheterization NN I-NP O
58 laboratory NN I-NP O
58 Cardiac NNP I-NP O
58 catheterization NN I-NP O
59 revealed VBD B-VP O
59 a DT O O
59 90% CD O O
59 plus CC O O
59 left VBD B-VP O
59 anterior JJ O O
59 descending VBG O O
59 artery JJ B-NP O
59 lesion NN I-NP O
59 distal NN I-NP O
60 to TO O O
60 D1 NNP B-NP O
60 with IN B-VP O
60 evidence NN B-NP O
60 of IN B-VP O
60 thrombus NN B-NP O
60 , , O O
60 60% CD O O
60 proximal NN B-NP O
60 left VBD B-VP O
60 circumflex JJ B-NP O
61 lesion NN I-NP O
61 with IN B-VP O
61 diffuse NN B-NP O
61 disease NN I-NP O
61 in IN B-VP O
61 the DT B-NP O
61 OM1 NNP I-NP O
61 , , O O
61 a DT O O
61 40% CD O O
61 right JJ B-NP O
61 coronary JJ I-NP O
61 artery NN I-NP O
62 lesion NN I-NP O
62 , , O O
62 left VBD B-VP O
62 ventriculogram NN B-NP O
62 revealed VBN O O
62 anterior JJ O O
62 lateral JJ O O
62 apical JJ O O
62 and CC O O
63 septal JJ B-NP O
63 HK NNP I-NP O
63 and CC O O
63 AK NNP B-NP O
63 The DT B-NP O
63 patient NN I-NP O
63 returned VBD B-VP O
63 to TO O O
63 the DT B-NP O
63 cardiac JJ I-NP O
64 catheterization NN I-NP O
64 laboratory NN I-NP O
64 the DT B-NP O
64 following JJ I-NP O
64 day NN I-NP O
64 for IN B-VP O
64 PTCA NNP B-NP O
64 and CC O O
64 stenting NN B-NP O
65 of IN B-VP O
65 her PRP$ O O
65 left JJ O O
65 anterior JJ O O
65 descending VBG O O
65 artery NN B-NP B-r
65 lesion NN I-NP I-r
65 followed VBN O O
65 by IN B-VP O
65 ReoPro NNP B-NP B-m
66 infusion NN I-NP B-mo
66 From IN B-VP O
66 the DT B-NP O
66 time NN I-NP O
66 of IN B-VP O
66 her PRP$ O O
66 admission NN B-NP O
66 to TO O O
66 the DT B-NP O
66 Cardiac NNP I-NP O
66 Care NNP I-NP O
66 Unit NNP I-NP O
67 throughout IN B-VP O
67 her PRP$ O O
67 hospital NN B-NP O
67 stay VB O O
67 the DT B-NP O
67 patient NN I-NP O
67 did VBD B-VP O
67 not RB O O
67 have VB O O
67 recurrence NN B-NP O
67 of IN B-VP O
68 her PRP$ O O
68 chest JJS B-NP O
68 pain NN I-NP O
68 Cardiac NNP I-NP O
68 enzymes RB O O
68 returned VBD B-VP O
68 to TO O O
68 baseline VB O O
69 Electrocardiogram NNP B-NP O
69 revealed VBD B-VP O
69 ST NNP B-NP O
69 segments NNS I-NP O
69 also RB O O
69 returned VBD B-VP O
69 to TO O O
69 baseline VB O O
70 MEDICATIONS NNP B-NP O
70 ON NNP I-NP O
70 DISCHARGE: NNP I-NP O
70 Include NNP I-NP O
70 aspirin VBZ O B-m
70 325 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 q.d NN I-NP B-f
70 , , O O
71 simvastatin VBD B-VP B-m
71 10 CD O B-do
71 mg NN B-NP I-do
71 p.o NN I-NP B-mo
71 q.h.s NN I-NP B-f
71 , , O O
71 Ticlid NNP B-NP B-m
71 250 CD O B-do
72 mg NN B-NP O
72 p.o NN I-NP B-mo
72 b.i.d NN I-NP B-f
72 for IN B-VP B-du
72 11 CD O I-du
72 days NNS B-NP I-du
72 , , O O
72 Atenolol NNP B-NP B-m
72 25 CD O B-do
72 mg NN B-NP I-do
72 p.o NN I-NP B-mo
72 b.i.d NN I-NP B-f
72 , , O O
72 enalapril VBZ O B-m
73 20 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 q.d VBD B-VP B-f
73 The DT B-NP O
73 patient NN I-NP O
73 is VBZ O O
73 instructed VBN O O
73 to TO O O
73 resume VB O O
73 a DT B-NP O
73 low JJ I-NP O
73 fat NN I-NP O
73 , , O O
73 low JJ B-NP O
74 cholesterol NN I-NP O
74 diet JJ B-NP O
74 Activity NNP I-NP O
74 as IN B-VP O
74 tolerated VBN O O
75 FOLLOW-UP: NNP B-NP O
75 With IN B-VP O
75 Dr NNP B-NP O
75 Kroell NNP I-NP O
75 on IN B-VP O
75 10/10/97 CD O O
75 at IN B-VP O
75 3:50 CD O O
75 p.m NN B-NP O
75 and CC O O
75 will MD O O
76 also RB O O
76 follow-up VB O O
76 with IN B-VP O
76 Dr NNP B-NP O
76 Brendlinger NNP I-NP O
76 in IN B-VP O
76 the DT B-NP O
76 end NN I-NP O
76 of IN B-VP O
76 November NNP B-NP O
76 or CC O O
77 beginning NN B-NP O
77 of IN B-VP O
77 May NNP B-NP O
77 , , O O
77 to TO O O
77 be VB O O
77 arranged VBN O O
78 Dictated NNP B-NP O
78 By: NNP I-NP O
78 ABE NNP I-NP O
78 HENSLER NNP I-NP O
78 , , O O
78 M.D NNP B-NP O
78 MM88 NNP I-NP O
79 Attending: NNP I-NP O
79 RUSTY NNP I-NP O
79 D NNP I-NP O
79 SUELLENTROP NNP I-NP O
79 , , O O
79 M.D NNP B-NP O
79 NY6 NNP I-NP O
80 WD474/8780 NNP I-NP O
81 Batch: NNP I-NP O
81 89907 CD O O
81 Index NNP B-NP O
81 No NNP I-NP O
81 WOCER31071 NNP I-NP O
81 D: NNP I-NP O
81 11/4/97 CD O O
82 T: NNP B-NP O
82 0/29/97 CD O O
83 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #874479 VBZ O O
4 792982757 CD O O
4 LPH NNP B-NP O
4 16192386 CD O O
4 268126 CD O O
4 7/0/1992 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/6/1992 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/21/1992 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 The DT B-NP O
7 patient NN I-NP O
7 was VBD B-VP O
7 a DT O O
7 46 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 woman NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
8 history NN I-NP O
8 of IN B-VP O
8 asthma NN B-NP O
8 , , O O
8 who WP O O
8 was VBD B-VP O
9 admitted VBN O O
9 with IN B-VP O
9 an DT B-NP O
9 asthma NN I-NP O
9 exacerbation NN I-NP O
9 She PRP O O
9 had VBD B-VP O
9 asthma VBN O O
9 since IN B-VP O
10 childhood NN B-NP O
10 , , O O
10 never RB O O
10 intubated VBN O O
10 , , O O
10 never RB O O
10 previously RB O O
10 treated VBN O O
10 with IN B-VP O
10 steroids NNS B-NP O
11 She PRP O O
11 felt VBD B-VP O
11 upper JJ B-NP O
11 respiratory NN I-NP O
11 symptoms NNS I-NP O
11 5 CD O O
11 days NNS B-NP O
11 before IN B-VP O
11 admission NN B-NP O
11 She PRP O O
12 had VBD B-VP O
12 dyspnea NN B-NP O
12 2 CD O O
12 days NNS B-NP O
12 before IN B-VP O
12 admission NN B-NP O
12 In IN B-VP O
12 the DT B-NP O
12 emergency NN I-NP O
12 room NN I-NP O
12 , , O O
12 the DT B-NP O
13 patient NN I-NP O
13 had VBD B-VP O
13 a DT B-NP O
13 peak JJ I-NP O
13 flow NN I-NP O
13 of IN B-VP O
13 300 CD O O
13 , , O O
13 oxygen NN B-NP O
13 saturation NN I-NP O
13 92% CD O O
13 on IN B-VP O
13 room NN B-NP O
13 air NN I-NP O
14 She PRP O O
14 was VBD B-VP O
14 treated VBN O O
14 with IN B-VP O
14 steroids NNS B-NP B-m
14 , , O O
14 Solu-Medrol NNP B-NP B-m
14 and CC O O
14 then RB O O
14 prednisone VB O B-m
14 60 CD O B-do
15 milligrams NNS B-NP O
15 orally RB O B-mo
15 , , O O
15 beta JJ B-NP B-m
15 agonist NN I-NP I-m
15 , , O O
15 nebulizer NN B-NP B-m
15 and CC O O
15 ampicillin NN B-NP B-m
15 She PRP O O
15 had VBD B-VP O
16 continuation NN B-NP O
16 of IN B-VP O
16 oral JJ B-NP B-mo
16 theophylline NN I-NP B-m
16 as IN B-VP O
16 she PRP O O
16 had VBD B-VP O
16 been VBN O O
16 using VBG O O
16 as IN B-VP O
16 an DT B-NP O
17 outpatient NN I-NP O
17 Her NNP I-NP O
17 lung NN I-NP O
17 examination NN I-NP O
17 showed VBD B-VP O
17 wheezes NNS B-NP O
17 bilaterally RB O O
17 in IN B-VP O
17 the DT B-NP O
18 emergency NN I-NP O
18 room NN I-NP O
18 PAST NNP I-NP O
18 MEDICAL NNP I-NP O
18 HISTORY NNP I-NP O
18 was VBD B-VP O
18 significant JJ O O
18 for IN B-VP O
18 asthma NN B-NP O
18 , , O O
19 degenerative JJ B-NP O
19 joint NN I-NP O
19 disease NN I-NP O
19 , , O O
19 lower JJR O O
19 back RB O O
19 pain NN B-NP O
19 , , O O
19 status NN B-NP O
19 post NN I-NP O
19 burn VBP O O
20 injury NN B-NP O
20 MEDICATIONS NNP I-NP O
20 ON NNP I-NP O
20 ADMISSION NNP I-NP O
20 were VBD B-VP O
20 Theo-Dur NNP B-NP B-m
20 200 CD O B-do
20 milligrams NNS B-NP I-do
20 by IN B-VP B-mo
21 mouth NN B-NP O
21 3 CD O B-f
21 times NNS B-NP I-f
21 a DT B-NP I-f
21 day NN I-NP I-f
21 , , O O
21 prednisone NN B-NP B-m
21 60 CD O B-do
21 milligrams NNS B-NP I-do
21 by IN B-VP B-mo
21 mouth JJ O I-mo
21 each DT B-NP B-f
21 day NN I-NP I-f
21 , , O O
22 Albuterol NNP B-NP B-m
22 nebulizer NN I-NP I-m
22 , , O O
22 ampicillin VBZ O B-m
22 500 CD O B-do
22 milligrams NNS B-NP I-do
22 by IN B-VP B-mo
22 mouth NN B-NP I-mo
22 3 CD O B-f
22 times NNS B-NP O
22 a DT B-NP O
23 day NN I-NP O
23 and CC O O
23 Bronkosol NNP B-NP B-m
23 ALLERGIES NNP I-NP O
23 included VBD B-VP O
23 sulfa JJ B-NP O
23 drugs NNS I-NP O
24 PHYSICAL NNP I-NP O
24 EXAMINATION: NNP I-NP O
24 The DT B-NP O
24 patient NN I-NP O
24 was VBD B-VP O
24 an DT B-NP O
24 obese JJ I-NP O
24 woman NN I-NP O
24 in IN B-VP O
24 no DT B-NP O
24 acute NN I-NP O
25 distress NN I-NP O
25 Temperature NNP I-NP O
25 was VBD B-VP O
25 97.8 CD O O
25 , , O O
25 heart NN B-NP O
25 rate NN I-NP O
26 84 CD O O
26 to TO O O
26 90 CD O O
26 , , O O
26 blood NN B-NP O
26 pressure NN I-NP O
26 110 CD O O
26 to TO O O
26 132/70 CD O O
26 to TO O O
26 84 CD O O
26 Of IN B-VP O
26 note NN B-NP O
26 on IN B-VP O
26 the DT B-NP O
27 physical JJ I-NP O
27 examination NN I-NP O
27 her PRP$ O O
27 lungs NNS B-NP O
27 had VBD B-VP O
27 bilateral JJ B-NP O
27 wheezes NNS I-NP O
28 LABORATORY NNP I-NP O
28 EXAMINATION: NNP I-NP O
28 On IN B-VP O
28 admission NN B-NP O
28 , , O O
28 hematocrit NN B-NP O
28 was VBD B-VP O
28 41.6 CD O O
28 , , O O
28 white JJ B-NP O
29 count NN I-NP O
29 9.66 CD O O
29 , , O O
29 platelets NNS B-NP O
29 199 CD O O
29 , , O O
29 000 CD O O
29 SMA-7 NN B-NP O
29 was VBD B-VP O
30 within IN B-VP O
30 normal JJ B-NP O
30 limits NNS I-NP O
30 , , O O
30 theophylline JJ B-NP B-m
30 level NN I-NP O
30 was VBD B-VP O
30 subtherapeutic JJ B-NP O
30 Sputum NNP I-NP O
31 gram NN I-NP O
31 stain NN I-NP O
31 showed VBD B-VP O
31 many JJ O O
31 gram RB O O
31 positive JJ B-NP O
31 cocci NN I-NP O
31 in IN B-VP O
31 clusters NNS B-NP O
31 and CC O O
31 pairs NNS B-NP O
32 with IN B-VP O
32 a DT B-NP O
32 few JJ I-NP O
32 polys NN I-NP O
32 , , O O
32 and CC O O
32 grew VBD B-VP O
32 Hemophilus NNP B-NP O
32 and CC O O
32 a DT B-NP O
32 peri-influenza NN I-NP O
32 that WDT O O
32 was VBD B-VP O
33 sensitive JJ O O
33 to TO O O
33 ciprofloxacin VB O O
33 and CC O O
33 Keflex NNP B-NP O
33 , , O O
33 but CC O O
33 resistant VBP O O
33 to TO O O
33 ampicillin VB O O
34 Chest NNP B-NP O
34 x-ray NN I-NP O
34 was VBD B-VP O
34 negative JJ B-NP O
35 HOSPITAL NNP I-NP O
35 COURSE: NNP I-NP O
35 The DT B-NP O
35 patient NN I-NP O
35 slowly RB O O
35 improved VBN O O
35 with IN B-VP O
35 decreased JJ B-NP O
36 wheezing NN I-NP O
36 in IN B-VP O
36 her PRP$ O O
36 breath NN B-NP O
36 sounds VBZ O O
36 , , O O
36 increased VBD B-VP O
36 peak NN B-NP O
37 flow NN I-NP O
37 from IN B-VP O
37 300 CD O O
37 , , O O
37 went VBD B-VP O
37 down RB O O
37 to TO O O
37 270 CD O O
37 , , O O
37 back RB O O
37 up IN B-VP O
37 to TO O O
37 300 CD O O
37 with IN B-VP O
37 less JJR B-NP O
37 dyspnea NN I-NP O
38 at IN B-VP O
38 the DT B-NP O
38 time NN I-NP O
38 of IN B-VP O
38 discharge NN B-NP O
38 and CC O O
38 she PRP O O
38 was VBD B-VP O
38 given VBN O O
38 an DT B-NP O
38 echocardiogram NN I-NP O
38 to TO O O
39 look VB O O
39 for IN B-VP O
39 a DT B-NP O
39 cardiac JJ I-NP O
39 etiology NN I-NP O
39 of IN B-VP O
39 bilateral JJ B-NP O
39 pedal NN I-NP O
39 edema NN I-NP O
39 that IN B-VP O
39 she PRP O O
39 was VBD B-VP O
40 having VBG O O
40 The DT B-NP O
40 patient NN I-NP O
40 was VBD B-VP O
40 discharged VBN O O
40 on IN B-VP O
40 3 CD O O
40 of IN B-VP O
40 May NNP B-NP O
41 DISPOSITION: NNP I-NP O
41 The DT B-NP O
41 patient NN I-NP O
41 was VBD B-VP O
41 discharged VBN O O
41 to TO O O
41 home NN B-NP O
41 MEDICATIONS NNP I-NP O
41 ON NNP I-NP O
42 DISCHARGE NNP I-NP O
42 were VBD B-VP O
42 all DT O O
42 her PRP$ O O
42 usual JJ B-NP O
42 medications NNS I-NP O
42 , , O O
42 plus CC O O
42 Keflex NNP B-NP B-m
43 500 CD O B-do
43 milligrams NNS B-NP I-do
43 by IN B-VP B-mo
43 mouth NN B-NP I-mo
43 4 CD O B-f
43 times NNS B-NP I-f
43 a DT B-NP I-f
43 day NN I-NP I-f
43 , , O O
43 prednisone NN B-NP B-m
43 50 CD O B-do
43 milligrams NNS B-NP I-do
43 by IN B-VP B-mo
44 mouth JJ O O
44 each DT B-NP B-f
44 day NN I-NP I-f
44 The DT B-NP O
44 patient NN I-NP O
44 was VBD B-VP O
44 to TO O O
44 FOLLOW-UP NNP B-NP O
44 with IN B-VP O
44 Dr NNP B-NP O
44 Joaquin NNP I-NP O
44 A NNP I-NP O
44 Reginal NNP I-NP O
44 at IN B-VP O
44 Ren NNP B-NP O
44 Bern NNP I-NP O
44 A NNP I-NP O
44 , , O O
44 Maryland NNP B-NP O
44 51916 CD O O
44 , , O O
44 S NNP B-NP O
44 , , O O
44 who WP O O
44 can MD O O
44 follow VB O O
44 her PRP$ O O
44 pulmonary JJ B-NP O
45 status NN I-NP O
46 FK608/6405 NNP I-NP O
47 RUSTY NNP I-NP O
47 H NNP I-NP O
47 HUGGARD NNP I-NP O
47 , , O O
47 M.D NNP B-NP O
47 TM1 NNP I-NP O
47 D: NNP I-NP O
47 9/29/92 CD O O
48 Batch: NNP B-NP O
48 1843 CD O O
48 Report: NNP B-NP O
48 L0931O73 NNP I-NP O
48 T: NNP I-NP O
48 1/0/92 CD O O
49 Dictated NNP B-NP O
49 By: NNP I-NP O
49 ANTWAN NNP I-NP O
49 S NNP I-NP O
49 MCKEAGUE NNP I-NP O
49 , , O O
49 M.D NNP B-NP O
50 cc: VBZ O O
50 1 CD O O
50 DWAIN NNP B-NP O
50 YANDELL NNP I-NP O
50 , , O O
50 M.D NNP B-NP O
51 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #881168 VBZ O O
4 147798665 CD O O
4 SPCMC NNP B-NP O
4 89807948 CD O O
4 3321390 CD O O
4 7/6/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHF NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/10/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/10/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 MAZINGO NNP I-NP O
8 , , O O
8 THOMAS NNP B-NP O
8 281-40-01-4 CD O O
9 Awood NNP B-NP O
9 Raburg NNP I-NP O
9 West NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 7/14/04 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 COWDEN NNP I-NP O
14 , , O O
14 PRESTON NNP B-NP O
14 CRISTOBAL NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 No NNP I-NP O
16 defib NN I-NP O
16 / VBZ O O
16 No DT B-NP O
16 intubation NN I-NP O
16 / VBZ O O
17 DISPOSITION: NNP B-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 TYLENOL NNP I-NP B-m
19 ( ( O I-m
19 ACETAMINOPHEN NNP B-NP I-m
19 ) ) O I-m
19 650 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 Q4H NNP I-NP B-f
19 PRN NNP I-NP I-f
19 Headache NNP I-NP B-r
20 ALBUTEROL NNP I-NP B-m
20 NEBULIZER NNP I-NP I-m
20 2.5 CD O B-do
20 MG NNP B-NP I-do
20 NEB NNP I-NP B-mo
20 Q2H NNP I-NP B-f
21 PRN NNP I-NP O
21 Shortness NNP I-NP B-r
21 of IN B-VP I-r
21 Breath NNP B-NP I-r
22 ECASA NNP I-NP B-m
22 ( ( O I-m
22 ASPIRIN NNP B-NP I-m
22 ENTERIC NNP I-NP I-m
22 COATED NNP I-NP I-m
22 ) ) O I-m
22 325 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 COLACE NNP I-NP B-m
23 ( ( O I-m
23 DOCUSATE NNP B-NP I-m
23 SODIUM NNP I-NP I-m
23 ) ) O I-m
23 100 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 LASIX NNP I-NP B-m
24 ( ( O I-m
24 FUROSEMIDE NNP B-NP I-m
24 ) ) O I-m
24 80 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 BID NNP I-NP B-f
24 Starting VBG O O
24 Today NNP B-NP O
24 ( ( O O
24 0/29 CD O O
24 ) ) O O
25 Instructions: NNP B-NP O
25 Please NNP I-NP O
25 take VB O O
25 twice RB O O
25 a DT B-NP O
25 day NN I-NP O
25 until IN B-VP O
25 you PRP O O
25 see VBP O O
25 Dr NNP B-NP O
26 Dimino NNP I-NP O
26 in IN B-VP O
26 clinic JJ B-NP O
27 INSULIN NNP I-NP B-m
27 NPH NNP I-NP I-m
27 HUMAN NNP I-NP I-m
27 110 CD O B-do
27 UNITS NNP B-NP I-do
27 SC NNP I-NP B-mo
27 QAM NNP I-NP B-f
28 INSULIN NNP I-NP B-m
28 NPH NNP I-NP I-m
28 HUMAN NNP I-NP I-m
28 30 CD O B-do
28 UNITS NNP B-NP I-do
28 SC NNP I-NP B-mo
28 QPM NNP I-NP B-f
29 NTG NNP I-NP B-m
29 1/150 CD O I-m
29 ( ( O I-m
29 NITROGLYCERIN NNP B-NP I-m
29 1/150 CD O I-m
29 ( ( O I-m
29 0.4 CD O I-m
29 MG NNP B-NP I-m
29 ) ) O I-m
29 ) ) O I-m
30 1 CD O B-do
30 TAB NNP B-NP I-do
30 SL NNP I-NP B-mo
30 Q5MIN NNP I-NP B-f
30 X NNP I-NP I-f
30 3 CD O I-f
30 PRN NNP B-NP I-f
30 Chest NNP I-NP B-r
30 Pain NNP I-NP I-r
31 VERAPAMIL NNP I-NP B-m
31 SUSTAINED NNP I-NP I-m
31 RELEAS NNP I-NP I-m
31 240 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 BID NNP I-NP B-f
32 Food/Drug NNP I-NP O
32 Interaction NNP I-NP O
32 Instruction NNP I-NP O
33 Avoid NNP I-NP O
33 grapefruit NN I-NP O
33 unless IN B-VP O
33 MD NNP B-NP O
33 instructs NNS I-NP O
33 otherwise RB O O
34 FLOVENT NNP B-NP B-m
34 ( ( O I-m
34 FLUTICASONE NNP B-NP I-m
34 PROPIONATE NNP I-NP I-m
34 ) ) O I-m
34 220 CD O B-do
34 MCG NNP B-NP I-do
34 INH NNP I-NP B-mo
34 BID NNP I-NP B-f
35 DIOVAN NNP I-NP B-m
35 ( ( O I-m
35 VALSARTAN NNP B-NP I-m
35 ) ) O I-m
35 160 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 QD NNP I-NP B-f
36 Number NNP I-NP B-du
36 of IN B-VP I-du
36 Doses NNP B-NP I-du
36 Required NNP I-NP I-du
36 ( ( O I-du
36 approximate JJ B-NP I-du
36 ): NN I-NP I-du
36 5 CD O I-du
37 VIOXX NNP B-NP B-m
37 ( ( O I-m
37 ROFECOXIB NNP B-NP I-m
37 ) ) O I-m
37 12.5 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 Food/Drug NNP I-NP O
38 Interaction NNP I-NP O
38 Instruction NNP I-NP O
38 Take NNP I-NP O
38 with IN B-VP O
38 food NN B-NP O
39 DUONEB NNP I-NP B-m
39 ( ( O I-m
39 ALBUTEROL NNP B-NP I-m
39 AND NNP I-NP I-m
39 IPRATROPIUM NNP I-NP I-m
39 NEBULIZER NNP I-NP I-m
39 ) ) O I-m
40 3/0.5 CD O B-do
40 MG NNP B-NP I-do
40 INH NNP I-NP B-mo
40 Q6H NNP I-NP O
41 LIPITOR NNP I-NP B-m
41 ( ( O I-m
41 ATORVASTATIN NNP B-NP I-m
41 ) ) O I-m
41 10 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 QD NNP I-NP B-f
42 PRILOSEC NNP I-NP B-m
42 ( ( O I-m
42 OMEPRAZOLE NNP B-NP I-m
42 ) ) O I-m
42 20 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 QD NNP I-NP B-f
43 DIET: NNP I-NP O
43 House NNP I-NP O
43 / NNP I-NP O
43 NAS NNP I-NP O
43 / NNP I-NP O
43 ADA NNP I-NP O
43 1800 CD O O
43 cals/day NN B-NP O
43 / NNP I-NP O
43 Low NNP I-NP O
43 saturated VBD B-VP O
43 fat JJ B-NP O
44 low JJ I-NP O
44 cholesterol NN I-NP O
45 ACTIVITY: NNP I-NP O
45 Resume NNP I-NP O
45 regular JJ B-NP O
45 exercise NN I-NP O
46 FOLLOW NNP I-NP O
46 UP NNP I-NP O
46 APPOINTMENT( NNP I-NP O
46 S NNP I-NP O
46 ): NNP I-NP O
47 Dr NNP I-NP O
47 Robby NNP I-NP O
47 Stancey NNP I-NP O
47 7/3/04 CD O O
47 , , O O
48 ALLERGY: NNP B-NP O
48 Ace NNP I-NP O
48 inhibitors NNS I-NP O
49 ADMIT NNP I-NP O
49 DIAGNOSIS: NNP I-NP O
50 CHF NNP I-NP O
51 PRINCIPAL NNP I-NP O
51 DISCHARGE NNP I-NP O
51 DIAGNOSIS NNP I-NP O
51 ;Responsible JJ O O
51 After IN B-VP O
51 Study NNP B-NP O
51 for IN B-VP O
51 Causing NNP B-NP O
51 Admission NNP I-NP O
51 ) ) O O
52 CHF NNP B-NP O
53 OTHER NNP I-NP O
53 DIAGNOSIS;Conditions NNP I-NP O
53 , , O O
53 Infections NNP B-NP O
53 , , O O
53 Complications NNP B-NP O
53 , , O O
53 affecting VBG O O
53 Treatment/Stay NNP B-NP O
54 CAD NNP I-NP O
54 DM NNP I-NP O
54 HTN NNP I-NP O
54 OBESITY NNP I-NP O
55 CHF NNP I-NP O
55 ( ( O O
55 congestive JJ B-NP O
55 heart NN I-NP O
55 failure NN I-NP O
55 ) ) O O
55 restrictive NN B-NP O
55 lung NN I-NP O
55 disease NN I-NP O
55 ( ( O O
55 restrictive JJ B-NP O
56 pulmonary JJ I-NP O
56 disease NN I-NP O
56 ) ) O O
56 asthma NN B-NP O
56 ( ( O O
56 asthma NN B-NP O
56 ) ) O O
56 retinopathy NN B-NP O
57 ( ( O O
57 retinopathy JJ O O
57 ) ) O O
57 s/p NN B-NP O
57 cataract NN I-NP O
57 surgery NN I-NP O
57 ( ( O O
57 S/P NNP B-NP O
57 cataract VB O O
57 extraction NN B-NP O
57 ) ) O O
58 OPERATIONS NNP B-NP O
58 AND NNP I-NP O
58 PROCEDURES: NNP I-NP O
59 OTHER NNP I-NP O
59 TREATMENTS/PROCEDURES NNP I-NP O
59 ( ( O O
59 NOT NNP B-NP O
59 IN NNP I-NP O
59 O.R NNP I-NP O
59 ) ) O O
60 none NN B-NP O
61 BRIEF NNP I-NP O
61 RESUME NNP I-NP O
61 OF NNP I-NP O
61 HOSPITAL NNP I-NP O
61 COURSE: NNP I-NP O
62 CC: NNP I-NP O
62 SOB NNP I-NP O
62 x VBD B-VP O
62 1 CD O O
62 week NN B-NP O
63 HPI: NNP I-NP O
63 63 CD O O
63 yoF NN B-NP O
63 w/ NN I-NP O
63 hx NN I-NP O
63 of IN B-VP O
63 resistant JJ B-NP O
63 DM NNP I-NP O
63 ( ( O O
63 familial JJ B-NP O
63 syndrome NN I-NP O
63 assoc NN I-NP O
63 w/ JJ B-NP O
64 acanthosis NN I-NP O
64 nigricans NNS I-NP O
64 ) ) O O
64 , , O O
64 morbid JJ B-NP O
64 obesity NN I-NP O
64 , , O O
64 CAD NNP B-NP O
64 s/p VBD B-VP O
64 NSTEMI NNP B-NP O
64 in IN B-VP O
64 1/10 CD O O
64 followed VBN O O
65 by IN B-VP O
65 CAGB NNP B-NP O
65 x NNP I-NP O
65 4 CD O O
65 in IN B-VP O
65 1997 CD O O
65 , , O O
65 HTN NNP B-NP O
65 , , O O
65 who WP O O
65 presents VBZ O O
65 w/ VBP O O
65 1 CD O O
65 wk NN B-NP O
65 of IN B-VP O
65 SOB NNP B-NP O
66 Multiple NNP I-NP O
66 admissions NNS I-NP O
66 over IN B-VP O
66 the DT B-NP O
66 past JJ I-NP O
66 year NN I-NP O
66 for IN B-VP O
66 breathing VBG O O
66 issues NNS B-NP O
66 usually RB O O
67 2/2 CD O O
67 either CC O O
67 asthma NN B-NP O
67 or CC O O
67 CHF NNP B-NP O
67 Now RB O O
67 has VBZ O O
67 had VBN O O
67 increasing VBG O O
67 dyspnea NN B-NP O
67 over IN B-VP O
67 one CD O O
68 week NN B-NP O
68 She PRP O O
68 does VBZ O O
68 not RB O O
68 feel VB O O
68 her PRP$ O O
68 usual JJ B-NP O
68 wheezing NN I-NP O
68 Denies NNP I-NP O
69 dietary JJ B-NP O
69 indiscretion NN I-NP O
69 or CC O O
69 med VBN O O
69 non-compliance JJ B-NP O
69 Appears NNP I-NP O
69 to TO O O
70 hav VB O O
70 e JJ B-NP O
70 fluid NN I-NP B-r
70 overload NN I-NP I-r
70 on IN B-VP O
70 CXR NNP B-NP O
70 and CC O O
70 clinical JJ B-NP O
70 exam NN I-NP O
70 Got VBD B-VP O
71 80 CD O B-do
71 IV NNP B-NP B-mo
71 lasix NN I-NP B-m
71 in IN B-VP O
71 ED NNP B-NP O
71 --&gt; NNP I-NP O
71 put VBD B-VP O
71 out RP O O
71 1200 CD O O
71 cc NN B-NP O
72 PE NNP I-NP O
72 notable JJ O O
72 for IN B-VP O
72 RR NNP B-NP O
72 22 CD O O
72 , , O O
72 O2 NNP B-NP O
72 sat VBD B-VP O
72 98% CD O O
72 on IN B-VP O
72 2L CD O O
72 , , O O
73 bibasilar JJ B-NP O
73 crackles NNS I-NP O
73 , , O O
73 decreased VBD B-VP O
73 bs NN B-NP O
73 throughout IN B-VP O
73 , , O O
74 scattered VBD B-VP O
74 wheezes NNS B-NP O
74 , , O O
74 JVP NNP B-NP O
74 ? . B-VP O
74 8 CD O O
74 , , O O
74 nl JJ B-NP O
74 heart NN I-NP O
75 exam NN I-NP O
76 LABS/STUDIES NNP I-NP O
76 notable JJ O O
76 for IN B-VP O
76 cardiac JJ B-NP O
76 enzymes NNS I-NP O
77 negative JJ B-NP O
77 x3 NNP I-NP O
77 , , O O
77 BNP NNP B-NP O
77 marginally RB O O
77 elev VBZ O O
77 at IN B-VP O
77 191 CD O O
77 , , O O
77 glucose RB O O
77 286 CD O O
77 , , O O
77 otherwise RB O O
77 cbc NN B-NP O
77 and CC O O
78 chem NN B-NP O
78 7 CD O O
78 wnl NN B-NP O
78 , , O O
78 A1c NNP B-NP O
78 elev VBP O O
78 at IN B-VP O
78 10.3 CD O O
78 , , O O
78 TSH NNP B-NP O
78 3.847 CD O O
78 , , O O
78 elev FW O O
78 PTT NNP B-NP O
78 at IN B-VP O
78 64.9 CD O O
78 of IN B-VP O
78 uncertain JJ B-NP O
79 significance NN I-NP O
80 ************HOSPITAL NNP I-NP O
80 COURSE*************** NNP I-NP O
81 *CV: NNP I-NP O
81 Ischemia- NNP I-NP O
81 ruled VBD B-VP O
81 out RP O O
81 for IN B-VP O
81 MI NNP B-NP O
81 , , O O
81 cont NN B-NP O
81 ASA NNP I-NP B-m
81 , , O O
81 statin NN B-NP B-m
81 , , O O
81 ccb NN B-NP B-m
81 , , O O
81 no DT B-NP O
81 b-block NN I-NP O
81 as IN B-VP O
82 has VBZ O O
83 asthma VBN O O
83 and CC O O
83 low-prob JJ O O
83 for IN B-VP O
83 ischemia JJ B-NP O
83 Pump- NNP I-NP O
83 appears VBZ O O
83 to TO O O
83 be VB O O
83 overloaded VBN O O
84 BNP NNP B-NP O
84 somewhat RB O O
84 elev VBZ O O
84 at IN B-VP O
84 191 CD O O
84 , , O O
84 diuresed VBD B-VP O
84 2L CD O O
84 w/ NN B-NP O
84 significant JJ B-NP O
84 subjective JJ I-NP O
85 improvement NN I-NP O
85 R&amp;R- NNP I-NP O
85 on IN B-VP O
85 tele NN B-NP O
85 while IN B-VP O
85 being VBG O O
85 ruled VBN O O
85 out RP O O
85 , , O O
85 no DT B-NP O
85 events NNS I-NP O
86 *PULM: VBP O O
86 Sx NNP B-NP O
86 could MD O O
86 also RB O O
86 be VB O O
86 2/2 CD O O
86 asthma JJ B-NP B-r
86 Put NNP I-NP O
87 on IN B-VP O
87 duonebs NN B-NP B-m
88 qid NN I-NP B-f
88 w/ NN I-NP O
88 q2hr NN I-NP B-f
88 albuterol NN I-NP B-m
88 o/n NN I-NP O
88 As IN B-VP O
88 better JJR B-NP O
88 w/ NN I-NP O
88 diuresis NN I-NP O
88 , , O O
88 will MD O O
88 not RB O O
88 give VB O O
89 prednisone NN B-NP O
89 ( ( O O
89 trying VBG O O
89 to TO O O
89 avoid VB O O
89 as IN B-VP O
89 BS NNP B-NP O
89 are VBP O O
89 very RB O O
89 difficult JJ O O
90 to TO O O
90 control VB O O
90 on IN B-VP O
91 steroids NNS B-NP O
91 ) ) O O
92 *ENDO: VBP O O
92 hx NN B-NP O
92 of IN B-VP O
92 very RB O O
93 resistant JJ B-NP O
93 DM NNP I-NP O
93 Will NNP I-NP O
93 put VBD B-VP O
93 on IN B-VP O
93 home NN B-NP O
93 insulin NN I-NP B-m
93 regimen NNS I-NP I-m
93 and CC O O
93 RISS NNP B-NP B-m
94 Will NNP I-NP O
94 check VB O O
94 TSH NNP B-NP O
94 in IN B-VP O
94 case NN B-NP O
94 this DT O O
94 is VBZ O O
94 contributing VBG O O
94 to TO O O
94 tiredness VB O O
94 and CC O O
94 weight VB O O
94 -- : O O
95 nl NN B-NP O
95 at IN B-VP O
95 3.847 CD O O
95 Will NNP B-NP O
95 check VB O O
95 A1c NNP B-NP O
95 to TO O O
95 see VB O O
95 how WRB O O
95 BS NNP B-NP O
95 control NN I-NP O
95 has VBZ O O
96 been VBN O O
96 -- : O O
96 elev NN B-NP O
96 at IN B-VP O
96 10.3 CD O O
97 *FEN: NN B-NP O
97 On IN B-VP O
97 cardiac JJ O O
97 , , O O
98 low-salt JJ O O
98 , , O O
98 ADA NNP B-NP O
98 1800 CD O O
98 diet JJ O O
98 Checking VBG O O
98 lytes NNS B-NP O
98 and CC O O
99 repleting VBG O O
99 prn NN B-NP O
100 *HEME: NN I-NP O
100 had VBD B-VP O
100 newly RB O O
100 elev VBN O O
100 PTT NNP B-NP O
100 x $ O O
100 3 CD O O
100 readings NNS B-NP O
100 here RB O O
100 ( ( O O
100 all DT O O
100 in IN B-VP O
100 low JJ O O
100 60's CD O O
100 ) ) O O
100 , , O O
100 new JJ O O
101 since IN B-VP O
101 last JJ B-NP O
101 admission NN I-NP O
101 Uncertain NNP I-NP O
101 significance NN I-NP O
101 After IN B-VP O
101 discussion NN B-NP O
101 w/ NN I-NP O
102 PCP/attending NNP I-NP O
102 , , O O
102 given VBN O O
102 pt's VBP O O
102 overall JJ B-NP O
102 feelings NNS I-NP O
102 about IN B-VP O
102 aggressiveness NN B-NP O
102 of IN B-VP O
102 care NN B-NP O
103 will MD O O
103 not RB O O
103 work VB O O
103 up RP O O
103 for IN B-VP O
103 now RB O O
104 *PPX: NNP B-NP O
104 Put NNP I-NP O
104 on IN B-VP O
104 heparin NN B-NP B-m
104 5000 CD O B-do
104 sc NN B-NP B-mo
104 tid NN I-NP B-f
104 for IN B-VP O
104 DVT NNP B-NP B-r
104 ppx NN I-NP I-r
104 Put VBD B-VP O
104 on IN B-VP O
104 PPI NNP B-NP B-m
104 as IN B-VP O
104 has VBZ O O
104 hx NN B-NP O
104 of IN B-VP O
105 ? . B-VP O
105 GERD NNP B-NP O
106 *CODE: NNP I-NP O
106 DNR/DNI NNP I-NP O
107 ADDITIONAL NNP I-NP O
107 COMMENTS: NNP I-NP O
107 Please NNP I-NP O
107 call VB O O
107 your PRP$ O O
107 doctor NN B-NP O
107 if IN B-VP O
107 you PRP O O
107 have VBP O O
107 fever VBN O O
107 , , O O
107 chills NNS B-NP O
107 , , O O
107 shortness NN B-NP O
107 of IN B-VP O
107 breath NN B-NP O
107 , , O O
108 or CC O O
108 chest JJS B-NP O
108 pain NN I-NP O
108 If IN B-VP O
108 you PRP O O
108 cannot VBP O O
108 reach VB O O
108 your PRP$ O O
108 doctor NN B-NP O
108 , , O O
108 go VB O O
108 to TO O O
108 the DT B-NP O
108 emergency NN I-NP O
109 room NN I-NP O
109 You PRP O O
109 will MD O O
109 need VB O O
109 to TO O O
109 call VB O O
109 Dr NNP B-NP O
109 Shim NNP I-NP O
109 office NN I-NP O
109 to TO O O
109 make VB O O
109 an DT B-NP O
110 appointment NN I-NP O
110 for IN B-VP O
110 Friday NNP B-NP O
110 6/8/04 CD O O
110 Until IN B-VP I-du
110 you PRP O I-du
110 see VBP O I-du
110 Dr NNP B-NP I-du
110 Nicoll NNP I-NP O
110 , , O O
110 please VB O O
110 take VB O O
111 your PRP$ O O
111 lasix NN B-NP B-m
111 pills NNS I-NP O
111 twice RB O B-f
111 a DT B-NP I-f
111 day NN I-NP I-f
111 ( ( O I-f
111 in IN B-VP I-f
111 the DT B-NP I-f
111 morning NN I-NP I-f
111 and CC O I-f
111 at IN B-VP I-f
111 night NN B-NP I-f
111 ) ) O I-f
111 Dr NNP B-NP O
112 Kuchto NNP I-NP O
112 will MD O O
112 decide VB O O
112 on IN B-VP O
112 Friday NNP B-NP O
112 whether IN B-VP O
112 to TO O O
112 continue VB O O
112 you PRP O O
112 on IN B-VP O
112 twice RB O O
112 a DT B-NP O
112 day NN I-NP O
113 pills VBZ O O
113 or CC O O
113 only RB O O
113 once RB O O
113 a DT B-NP O
113 day NN I-NP O
114 DISCHARGE NNP I-NP O
114 CONDITION: NNP I-NP O
114 Stable NNP I-NP O
115 TO NNP I-NP O
115 DO/PLAN: NNP I-NP O
116 Pt NNP I-NP O
116 is VBZ O O
116 f/u VBN O O
116 with IN B-VP O
116 Dr NNP B-NP O
116 Ross NNP I-NP O
116 Ogston NNP I-NP O
116 on IN B-VP O
116 Friday NNP B-NP O
116 6/8/04 CD O O
116 He PRP O O
116 will MD O O
116 decide VB O O
116 at IN B-VP O
117 that DT B-NP O
117 time NN I-NP O
117 whether IN B-VP O
117 pt NN B-NP O
117 is VBZ O O
117 to TO O O
117 continue VB O O
117 to TO O O
117 take VB O O
117 lasix JJ B-NP B-m
117 lasix JJ I-NP B-m
117 bid NN I-NP B-f
117 or CC O O
117 on IN B-VP O
117 her PRP$ O O
117 usual JJ O O
118 80 CD O O
118 qd NN B-NP B-f
118 schedule NN I-NP O
119 No NNP I-NP O
119 dictated VBD B-VP O
119 summary JJ B-NP O
120 ENTERED NNP I-NP O
120 BY: NNP I-NP O
120 MUFFETT NNP I-NP O
120 , , O O
120 JULIO NNP B-NP O
120 FLORENCIO NNP I-NP O
120 , , O O
120 M.D NNP B-NP O
120 ( ( O O
120 BA76 NNP B-NP O
120 ) ) O O
120 7/14/04 CD O O
120 @ $ O O
120 01:53 CD O O
120 PM NNP B-NP O
121 ****** JJ B-NP O
121 END NNP I-NP O
121 OF NNP I-NP O
121 DISCHARGE NNP I-NP O
121 ORDERS NNP I-NP O
121 ****** NNP I-NP O
122 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #882171 VBZ O O
4 924386513 CD O O
4 OH NNP B-NP O
4 76816742 CD O O
4 262594 CD O O
4 6/27/1995 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 6/27/1995 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/0/1995 CD O O
7 DISCHARGE NNP B-NP O
7 DIAGNOSES: NNP I-NP O
7 ( ( O O
7 1 CD O O
7 ) ) O O
7 GASTRIC NNP B-NP O
7 REFLUX NNP I-NP O
7 DISEASE NNP I-NP O
8 ( ( O O
8 2 CD O O
8 ) ) O O
8 HYPERTENSION NNP B-NP O
8 , , O O
8 15 CD O O
8 YEARS NNP B-NP O
9 ( ( O O
9 3 CD O O
9 ) ) O O
9 ADULT NNP B-NP O
9 ONSET NNP I-NP O
9 DIABETES NNP I-NP O
9 MELLITUS NNP I-NP O
9 , , O O
10 NON-INSULIN NNP B-NP O
10 DEPENDENT NNP I-NP O
10 , , O O
10 1 CD O O
10 - : O O
10 2 CD O O
10 YEARS NNS B-NP O
11 ( ( O O
11 4 CD O O
11 ) ) O O
11 HYPERCHOLESTEROLEMIA NNP B-NP O
11 , , O O
11 TREATED NNP B-NP O
11 FOR NNP I-NP O
12 4 CD O O
12 YEARS NNP B-NP O
13 ( ( O O
13 5 CD O O
13 ) ) O O
13 HISTORY NN B-NP O
13 OF NNP I-NP O
13 MYOCARDITIS NNP I-NP O
14 ( ( O O
14 6 CD O O
14 ) ) O O
14 STATUS NNP B-NP O
14 POST NNP I-NP O
14 TOTAL NNP I-NP O
14 ABDOMINAL NNP I-NP O
15 HYSTERECTOMY/BILATERAL NNP I-NP O
16 SALPINGO-OOPHORECTOMY NNP I-NP O
16 IN NNP I-NP O
16 1975 CD O O
17 WITHOUT NNP B-NP O
17 ESTROGEN NNP I-NP O
17 REPLACEMENT NNP I-NP O
18 ( ( O O
18 7 CD O O
18 ) ) O O
18 HISTORY NN B-NP O
18 OF NNP I-NP O
18 DEPRESSION NNP I-NP O
19 ( ( O O
19 8 CD O O
19 ) ) O O
19 MULTIPLE NNP B-NP O
19 FOOD NNP I-NP O
19 AND NNP I-NP O
19 ENVIRONMENTAL NNP I-NP O
20 ALLERGIES NNP I-NP O
21 HISTORY NNP I-NP O
21 OF NNP I-NP O
21 PRESENT NNP I-NP O
21 ILLNESS: NNP I-NP O
21 This DT O O
21 is VBZ O O
21 a DT O O
21 57 CD O O
21 year NN B-NP O
21 old JJ B-NP O
21 woman NN I-NP O
21 with IN B-VP O
22 cardiac JJ B-NP O
22 risk NN I-NP O
22 factors NNS I-NP O
22 with IN B-VP O
22 complaint NN B-NP O
22 of IN B-VP O
23 substernal JJ B-NP B-r
23 chest NN I-NP I-r
23 pain NN I-NP I-r
23 relieved VBN O O
23 by IN B-VP O
23 two CD O B-do
23 sublingual JJ B-NP B-mo
23 nitroglycerins NNS I-NP B-m
24 Cardiac NNP I-NP O
24 risk NN I-NP O
24 factors NNS I-NP O
24 are VBP O O
24 hypertension NN B-NP O
24 , , O O
24 diabetes VBZ O O
24 mellitus NNS B-NP O
24 , , O O
24 tobacco NN B-NP O
25 use NN I-NP O
25 in IN B-VP O
25 the DT B-NP O
25 past NN I-NP O
25 , , O O
25 hypercholesterolemia NN B-NP O
25 , , O O
25 and CC O O
25 early RB O O
25 menopause NN B-NP O
25 with IN B-VP O
25 no DT B-NP O
26 estrogen NN I-NP O
26 replacement NN I-NP O
26 She PRP O O
26 was VBD B-VP O
26 admitted VBN O O
26 on IN B-VP O
26 0/24/95 CD O O
26 with IN B-VP O
26 complaint NN B-NP O
27 of IN B-VP O
27 chest NN B-NP O
27 pain NN I-NP O
27 at IN B-VP O
27 rest NN B-NP O
27 without IN B-VP O
27 associated VBN O O
27 symptoms NNS B-NP O
27 There EX O O
27 was VBD B-VP O
27 no DT B-NP O
28 complaint NN I-NP O
28 of IN B-VP O
28 decreased JJ B-NP O
28 exercise NN I-NP O
28 tolerance NN I-NP O
28 , , O O
28 exertional JJ B-NP O
28 symptoms NNS I-NP O
28 No DT B-NP O
29 PND NNP I-NP O
29 , , O O
29 edema NN B-NP O
29 , , O O
29 nausea NN B-NP O
29 , , O O
29 vomiting VBG O O
29 , , O O
29 or CC O O
29 diaphoresis NN B-NP O
29 at IN B-VP O
29 this DT B-NP O
29 time NN I-NP O
29 The DT B-NP O
30 complaint NN I-NP O
30 at IN B-VP O
30 that DT B-NP O
30 time NN I-NP O
30 was VBD B-VP O
30 3 CD O O
30 out IN B-VP O
30 of IN B-VP O
30 10 CD O O
30 chest JJS B-NP O
30 pressure NN I-NP O
30 which WDT O O
31 spontaneously RB O O
31 resolved VBD B-VP O
31 It PRP O O
31 recurred VBD B-VP O
31 intermittently RB O O
31 without IN B-VP O
32 associated VBN O O
32 symptoms NNS B-NP O
32 , , O O
32 no DT B-NP O
32 EKG NNP I-NP O
32 changes NNS I-NP O
32 She PRP O O
32 was VBD B-VP O
32 ruled VBN O O
32 out RP O O
32 for IN B-VP O
33 myocardial JJ B-NP O
33 infarction NN I-NP O
33 by IN B-VP O
33 enzymes NNS B-NP O
33 and CC O O
33 EKG NNP B-NP O
33 CKs NNP I-NP O
33 were VBD B-VP O
33 156 CD O O
33 , , O O
33 135 CD O O
33 , , O O
33 and CC O O
34 108 CD O O
34 She PRP O O
34 was VBD B-VP O
34 treated VBN O O
34 with IN B-VP O
34 aspirin NN B-NP B-m
34 , , O O
34 beta NN B-NP B-m
34 blockers NNS I-NP I-m
34 , , O O
34 and CC O O
35 nitroglycerin RB O B-m
35 The DT B-NP O
35 concern NN I-NP O
35 was VBD B-VP O
35 for IN B-VP O
35 a DT B-NP O
35 question NN I-NP O
35 of IN B-VP O
35 unequal JJ B-NP O
35 blood NN I-NP O
36 pressures NNS I-NP O
36 in IN B-VP O
36 the DT B-NP O
36 patient NN I-NP O
36 and CC O O
36 complaint NN B-NP O
36 of IN B-VP O
36 back RB O O
36 pain NN B-NP O
36 A NNP I-NP O
36 GEE NNP I-NP O
36 was VBD B-VP O
37 done VBN O O
37 to TO O O
37 rule VB O O
37 out RP O O
37 aortic JJ B-NP O
37 dissection NN I-NP O
37 On IN B-VP O
37 GEE NNP B-NP O
37 there EX O O
37 were VBD B-VP O
37 no DT B-NP O
37 valvular JJ I-NP O
38 abnormalities NNS I-NP O
38 or CC O O
38 evidence NN B-NP O
38 for IN B-VP O
38 dissection NN B-NP O
38 and CC O O
38 no DT B-NP O
38 regional JJ I-NP O
38 wall NN I-NP O
39 motion NN I-NP O
39 abnormalities NNS I-NP O
39 ETT NNP I-NP O
39 was VBD B-VP O
39 done VBN O O
39 on IN B-VP O
39 3/26/95 CD O O
39 The DT B-NP O
39 patient NN I-NP O
40 exercised VBD B-VP O
40 for IN B-VP O
40 4 CD O O
40 minutes NNS B-NP O
40 13 CD O O
40 seconds NNS B-NP O
40 on IN B-VP O
40 a DT B-NP O
40 standard JJ I-NP O
40 Bruce NNP I-NP O
40 protocol NN I-NP O
41 She PRP O O
41 was VBD B-VP O
41 stopped VBN O O
41 secondary JJ O O
41 to TO O O
41 leg VB O O
41 fatigue NN B-NP O
41 and CC O O
41 dyspnea NN B-NP O
41 with IN B-VP O
41 a DT B-NP O
41 heart NN I-NP O
42 rate NN I-NP O
42 of IN B-VP O
42 84 CD O O
42 - : O O
42 113 CD O O
42 with IN B-VP O
42 a DT B-NP O
42 target NN I-NP O
42 of IN B-VP O
42 138 CD O O
42 Blood NNP B-NP O
42 pressure NN I-NP O
42 was VBD B-VP O
42 136/80 CD O O
43 and CC O O
43 elevated VBD B-VP O
43 to TO O O
43 164/90 CD O O
43 There EX O O
43 were VBD B-VP O
43 no DT B-NP O
43 EKG NNP I-NP O
43 changes NNS I-NP O
43 and CC O O
43 no DT B-NP O
43 evidence NN I-NP O
44 for IN B-VP O
44 ischemia NN B-NP O
44 on IN B-VP O
44 this DT B-NP O
44 study NN I-NP O
44 despite IN B-VP O
44 limited JJ B-NP O
44 effort NN I-NP O
45 On IN B-VP O
45 the DT B-NP O
45 evening NN I-NP O
45 of IN B-VP O
45 admission NN B-NP O
45 on IN B-VP O
45 11/8/95 CD O O
45 she PRP O O
45 again RB O O
45 had VBD B-VP O
45 the DT B-NP O
45 acute JJ I-NP O
46 onset NN I-NP O
46 of IN B-VP O
46 sharp JJ O O
46 , , O O
46 burning NN B-NP O
46 , , O O
46 mid-epigastric JJ B-NP O
46 versus NN I-NP O
46 sternal JJ B-NP O
46 pain NN I-NP O
46 without IN B-VP O
47 radiation NN B-NP O
47 and CC O O
47 with IN B-VP O
47 associated JJ B-NP O
47 shortness NN I-NP O
47 of IN B-VP O
47 breath NN B-NP O
47 , , O O
47 diaphoresis NN B-NP O
47 , , O O
48 nausea NN B-NP O
48 , , O O
48 and CC O O
48 an DT B-NP O
48 acid JJ I-NP O
48 taste NN I-NP O
48 She PRP O O
48 took VBD B-VP O
48 two CD O B-do
48 sublingual JJ B-NP B-mo
48 nitroglycerins NNS I-NP B-m
49 with IN B-VP O
49 relief NN B-NP O
49 of IN B-VP O
49 symptoms NNS B-NP B-r
49 The DT B-NP O
49 pain NN I-NP O
49 lasted VBD B-VP O
49 a DT B-NP O
49 total NN I-NP O
49 of IN B-VP O
49 15 CD O O
49 minutes NNS B-NP O
50 She PRP O O
50 has VBZ O O
50 been VBN O O
50 pain-free JJ O O
50 since IN B-VP O
50 arrival NN B-NP O
50 to TO O O
50 the DT B-NP O
50 hospital NN I-NP O
51 MEDICATIONS: NNP I-NP O
51 Glucotrol NNP I-NP B-m
51 20 CD O B-do
51 mg NN B-NP I-do
51 q.d NN I-NP B-f
51 , , O O
51 Cardizem NNP B-NP B-m
51 CD NNP I-NP I-m
51 , , O O
51 Benadryl NNP B-NP B-m
51 50 CD O B-do
51 mg NN B-NP I-do
52 t.i.d NN I-NP B-f
52 , , O O
52 Provastatin NNP B-NP B-m
52 20 CD O B-do
52 mg NN B-NP I-do
52 q.d NN I-NP B-f
52 , , O O
52 Hydrochlorothiazide NNP B-NP B-m
53 12.5 CD O B-do
53 mg NN B-NP I-do
53 q.d NN I-NP B-f
53 , , O O
53 Trazadone NNP B-NP B-m
53 50 CD O B-do
53 mg NN B-NP I-do
53 q.h.s NN I-NP B-f
53 , , O O
53 aspirin RB O B-m
53 1 CD O B-do
53 q.d NN B-NP B-f
53 , , O O
53 Lopressor NNP B-NP B-m
53 75 CD O B-do
54 mg NN B-NP O
54 q.d NN I-NP B-f
54 , , O O
54 nitroglycerin JJ B-NP B-m
54 sublingual JJ I-NP B-mo
54 p.r.n NN I-NP B-f
54 , , O O
54 Ambien NNP B-NP B-m
54 5 CD O B-do
54 mg NN B-NP I-do
54 q.h.s NN I-NP B-f
55 ALLERGIES: NNP I-NP O
55 No NNP I-NP O
55 known VBN O O
55 drug NN B-NP O
55 allergies NNS I-NP O
56 SOCIAL NNP I-NP O
56 HISTORY: NNP I-NP O
56 She PRP O O
56 is VBZ O O
56 a DT B-NP O
56 receptionist NN I-NP O
56 She PRP O O
56 has VBZ O O
56 three CD O O
56 children NNS B-NP O
57 She PRP O O
57 has VBZ O O
57 never RB O O
57 married VBN O O
57 She PRP O O
57 lives VBZ O O
57 alone RB O O
58 PHYSICAL NNP B-NP O
58 EXAMINATION: NNP I-NP O
58 She PRP O O
58 was VBD B-VP O
58 afebrile JJ O O
58 with IN B-VP O
58 blood NN B-NP O
58 pressure NN I-NP O
58 of IN B-VP O
59 132/96 CD O O
59 , , O O
59 pulse RB O O
59 95 CD O O
59 She PRP O O
59 was VBD B-VP O
59 on IN B-VP O
59 one CD O B-do
59 liter NN B-NP I-do
59 of IN B-VP O
60 oxygen NN B-NP B-m
60 , , O O
60 saturation NN B-NP O
60 of IN B-VP O
60 97% CD O O
60 Respiratory NNP B-NP O
60 rate NN I-NP O
60 was VBD B-VP O
60 20 CD O O
60 HEENT: NNP B-NP O
61 Normal NNP I-NP O
61 No NNP I-NP O
61 JVD NNP I-NP O
61 Lungs NNP I-NP O
61 were VBD B-VP O
61 clear JJ B-NP O
61 Heart: NNP I-NP O
61 PMI NNP I-NP O
61 was VBD B-VP O
61 nondisplaced VBN O O
62 Normal NNP B-NP O
62 S1 NNP I-NP O
62 and CC O O
62 S2 NNP B-NP O
62 No NNP I-NP O
62 S3 NNP I-NP O
62 or CC O O
62 S4 NNP B-NP O
62 No NNP I-NP O
62 murmurs NN I-NP O
62 , , O O
62 gallops NNS B-NP O
62 , , O O
62 or CC O O
62 rubs VB O O
63 Abdomen: NNP B-NP O
63 Soft NNP I-NP O
63 but CC O O
63 obese JJ B-NP O
63 Nontender NNP I-NP O
63 , , O O
63 nondistended VBD B-VP O
63 No DT B-NP O
64 hepatojugular JJ I-NP O
64 reflux NN I-NP O
64 No NNP I-NP O
64 abdominal JJ O O
64 bruits VBZ O O
64 No DT B-NP O
64 pulsatile NN I-NP O
64 masses VBZ O O
65 Extremities: NNP B-NP O
65 Without NNP I-NP O
65 edema NN I-NP O
65 , , O O
65 cords NNS B-NP O
65 , , O O
65 or CC O O
65 femoral JJ B-NP O
65 bruits NNS I-NP O
66 LABORATORY NNP I-NP O
66 EXAMINATION: NNP I-NP O
66 Notable NNP I-NP O
66 for IN B-VP O
66 potassium NN B-NP O
66 of IN B-VP O
66 3.7 CD O O
66 , , O O
66 magnesium NN B-NP O
67 1.9 CD O O
67 Hematocrit NNP B-NP O
67 36 CD O O
67 , , O O
67 WBC NNP B-NP O
67 11.5 CD O O
67 CK NNP B-NP O
67 first RB O O
68 set VBD B-VP O
68 was VBD B-VP O
68 118 CD O O
68 Triponin NNP B-NP O
68 was VBD B-VP O
68 0.0 CD O O
68 EKG NNP B-NP O
68 was VBD B-VP O
68 notable JJ O O
68 for IN B-VP O
68 normal JJ B-NP O
68 sinus NNS I-NP O
69 rhythm VBP O O
69 with IN B-VP O
69 occasional JJ B-NP O
69 PVCs NNP I-NP O
69 Intervals NNP I-NP O
69 and CC O O
69 axis NN B-NP O
69 were VBD B-VP O
69 within IN B-VP O
69 normal JJ B-NP O
70 limits NNS I-NP O
70 There EX O O
70 was VBD B-VP O
70 a DT B-NP O
70 slight JJ I-NP O
70 upper JJ I-NP O
70 concavity NN I-NP O
70 and CC O O
70 ST-T NNP B-NP O
70 segment NN I-NP O
70 in IN B-VP O
70 V2 NNP B-NP O
71 and CC O O
71 V3 NNP B-NP O
71 when WRB O O
71 compared VBN O O
71 to TO O O
71 old JJ O O
71 although IN B-VP O
71 this DT O O
71 could MD O O
71 be VB O O
71 consistent JJ O O
71 with IN B-VP O
72 J NNP B-NP O
72 point NN I-NP O
72 elevation NN I-NP O
72 and CC O O
72 a DT B-NP O
72 question NN I-NP O
72 of IN B-VP O
72 a DT O O
72 0.5 CD O O
72 mm NN B-NP O
72 segment NN I-NP O
72 elevation NN I-NP O
72 in IN B-VP O
73 V2 NNP B-NP O
73 The DT B-NP O
73 EKG NNP I-NP O
73 was VBD B-VP O
73 without IN B-VP O
73 change NN B-NP O
73 from IN B-VP O
73 previous JJ B-NP O
73 admission NN I-NP O
74 IMPRESSION: NNP I-NP O
74 This DT O O
74 is VBZ O O
74 a DT O O
74 57 CD O O
74 year NN B-NP O
74 old JJ B-NP O
74 woman NN I-NP O
74 with IN B-VP O
74 multiple JJ B-NP O
74 cardiac JJ I-NP O
74 risk NN I-NP O
75 factors NNS I-NP O
75 presenting VBG O O
75 with IN B-VP O
75 complaint NN B-NP O
75 of IN B-VP O
75 substernal JJ O O
75 , , O O
76 midepigastric JJ B-NP O
76 pain NN I-NP O
76 , , O O
76 burning VBG O O
76 Although IN B-VP O
76 she PRP O O
76 had VBD B-VP O
76 multiple JJ B-NP O
76 cardiac JJ I-NP O
77 risk NN I-NP O
77 factors NNS I-NP O
77 , , O O
77 her PRP$ O O
77 pain NN B-NP O
77 is VBZ O O
77 of IN B-VP O
77 an DT B-NP O
77 atypical JJ I-NP O
77 quality NN I-NP O
77 and CC O O
77 sounds VBZ O O
77 more RBR O O
78 consistent JJ O O
78 with IN B-VP O
78 a DT B-NP O
78 gastrointestinal JJ I-NP O
78 source NN I-NP O
78 The DT B-NP O
78 GEE NNP I-NP O
78 was VBD B-VP O
78 a DT B-NP O
79 suboptimal JJ I-NP O
79 study NN I-NP O
79 and CC O O
79 it PRP O O
79 was VBD B-VP O
79 deemed VBN O O
79 more RBR O O
79 appropriate JJ O O
79 on IN B-VP O
79 admission NN B-NP O
79 to TO O O
80 both DT O O
80 rule VB O O
80 the DT B-NP O
80 patient NN I-NP O
80 out RP O O
80 but CC O O
80 consider VB O O
80 a DT B-NP O
80 pharmacologic NN I-NP O
80 stress NN I-NP O
80 test NN I-NP O
81 before IN B-VP O
81 cathing VBG O O
81 this DT B-NP O
81 patient JJ I-NP O
82 HOSPITAL NNP I-NP O
82 COURSE: NNP I-NP O
82 Since IN B-VP O
82 the DT B-NP O
82 patient's NN I-NP O
82 symptoms NNS I-NP O
82 did VBD B-VP O
82 sound VB O O
82 more RBR O O
83 gastrointestinal JJ O O
83 , , O O
83 she PRP O O
83 was VBD B-VP O
83 started VBN O O
83 on IN B-VP O
83 Axid NNP B-NP B-m
83 for IN B-VP O
84 possibility NN B-NP O
84 of IN B-VP O
84 gastroesophageal JJ B-NP B-r
84 gastroesophageal JJ I-NP B-r
84 reflux NN I-NP I-r
84 reflux NN I-NP I-r
84 disease NN I-NP I-r
84 disease NN I-NP I-r
84 , , O O
84 as RB O O
84 well RB O O
84 as IN B-VP O
84 provided VBN O O
85 with IN B-VP O
85 Maalox NNP B-NP B-m
85 and CC O O
85 told VBD B-VP O
85 to TO O O
85 keep VB O O
85 the DT B-NP O
85 head NN I-NP O
85 of IN B-VP O
85 the DT B-NP O
85 bed NN I-NP O
85 elevated VBD B-VP O
85 She PRP O O
85 was VBD B-VP O
86 continued VBN O O
86 on IN B-VP O
86 Glucotrol NNP B-NP B-m
86 for IN B-VP O
86 diabetes NNS B-NP B-r
86 mellitus NNS I-NP I-r
86 and CC O O
86 was VBD B-VP O
86 instructed VBN O O
86 on IN B-VP O
87 risk NN B-NP O
87 factor NN I-NP O
87 modifications NNS I-NP O
87 , , O O
87 including VBG O O
87 diabetes NNS B-NP O
87 mellitus RBR O O
87 control NN B-NP O
87 , , O O
88 controlling VBG O O
88 cholesterol NN B-NP O
88 and CC O O
88 hypertension NN B-NP O
88 She PRP O O
88 is VBZ O O
88 currently RB O O
88 a DT B-NP O
89 non-smoker NN I-NP O
90 On IN B-VP O
90 the DT B-NP O
90 day NN I-NP O
90 following VBG O O
90 admission NN B-NP O
90 the DT B-NP O
90 patient NN I-NP O
90 was VBD B-VP O
90 ruled VBN O O
90 out RP O O
90 for IN B-VP O
91 myocardial JJ B-NP O
91 infarction NN I-NP O
91 by IN B-VP O
91 enzyme JJ B-NP O
91 sets NNS I-NP O
91 respectively RB O O
91 A DT B-NP O
91 set NN I-NP O
91 was VBD B-VP O
91 118; CD O O
92 B NNP B-NP O
92 set NN I-NP O
92 was VBD B-VP O
92 105; CD O O
92 C NNP B-NP O
92 set NN I-NP O
92 was VBD B-VP O
92 105; CD O O
92 D NNP B-NP O
92 set NN I-NP O
92 was VBD B-VP O
92 100 CD O O
92 EKGs NNP B-NP O
92 were VBD B-VP O
92 without IN B-VP O
93 change NN B-NP O
93 As NNP I-NP O
93 well RB O O
93 , , O O
93 the DT B-NP O
93 patient NN I-NP O
93 had VBD B-VP O
93 remained VBN O O
93 symptom-free JJ O O
93 during IN B-VP O
93 the DT B-NP O
94 hospital JJ I-NP O
94 course NN I-NP O
94 and CC O O
94 was VBD B-VP O
94 scheduled VBN O O
94 for IN B-VP O
94 a DT B-NP O
94 Dobutamine NNP I-NP B-m
94 MIBI NNP I-NP O
94 for IN B-VP O
95 8/10/95 CD O O
95 The DT B-NP O
95 patient NN I-NP O
95 on IN B-VP B-m
95 Dobutamine NNP B-NP O
95 MIBI NNP I-NP O
95 study NN I-NP O
95 showed VBD B-VP O
95 heart NN B-NP O
95 rate NN I-NP O
96 going VBG O O
96 up IN B-VP O
96 from IN B-VP O
96 70 CD O O
96 to TO O O
96 101 CD O O
96 , , O O
96 blood NN B-NP O
96 pressure NN I-NP O
96 170/80 CD O O
96 went VBD B-VP O
96 up RB O O
96 to TO O O
96 230/90 CD O O
97 There EX O O
97 were VBD B-VP O
97 no DT B-NP O
97 EKG NNP I-NP O
97 changes NNS I-NP O
97 and CC O O
97 no DT B-NP O
97 chest JJ I-NP O
97 pressure NN I-NP O
97 MIBI NNP I-NP O
97 images NNS I-NP O
97 were VBD B-VP O
98 notable JJ O O
98 for IN B-VP O
98 a DT B-NP O
98 fixed JJ I-NP O
98 mild NN I-NP O
98 reduced VBD B-VP O
98 uptake JJ O O
98 in IN B-VP O
98 the DT B-NP O
98 inferior JJ I-NP O
98 wall NN I-NP O
99 consistent NN I-NP O
99 with IN B-VP O
99 but CC O O
99 not RB O O
99 diagnostic JJ O O
99 for IN B-VP O
99 myocardial JJ B-NP O
99 injury NN I-NP O
99 There EX O O
100 were VBD B-VP O
100 no DT B-NP O
100 reversible JJ I-NP O
100 perfusion NN I-NP O
100 abnormalities NNS I-NP O
100 detected VBN O O
100 As IN B-VP O
100 such JJ O O
100 the DT B-NP O
101 patient NN I-NP O
101 was VBD B-VP O
101 discharged VBN O O
101 home NN B-NP O
101 with IN B-VP O
101 a DT B-NP O
101 change NN I-NP O
101 in IN B-VP O
101 her PRP$ O O
101 medication NN B-NP O
102 regimen NNS I-NP O
103 DISPOSITION: NNP I-NP O
103 DISCHARGE NNP I-NP O
103 MEDICATIONS: NNP I-NP O
103 Atenolol NNP I-NP B-m
103 100 CD O B-do
103 mg NN B-NP I-do
103 p.o NN I-NP B-mo
103 q.d NN I-NP B-f
103 , , O O
104 Ecasa NNP B-NP B-m
104 325 CD O B-do
104 mg NN B-NP I-do
104 q.d NN I-NP B-f
104 , , O O
104 Glucotrol NNP B-NP B-m
104 20 CD O B-do
104 mg NN B-NP I-do
104 b.i.d NN I-NP B-f
104 , , O O
105 Hydrochlorothiazide NNP B-NP B-m
105 12.5 CD O B-do
105 mg NN B-NP I-do
105 p.o NN I-NP B-mo
105 q.d NN I-NP B-f
105 , , O O
105 Trazadone NNP B-NP B-m
105 50 CD O B-do
105 mg NN B-NP I-do
105 p.o NN I-NP B-mo
105 q.h.s NN I-NP B-f
105 , , O O
106 Axid NNP B-NP B-m
106 150 CD O B-do
106 mg NN B-NP I-do
106 p.o NN I-NP B-mo
106 q.d NN I-NP B-f
106 , , O O
106 Provastatin NNP B-NP B-m
106 20 CD O B-do
106 mg NN B-NP I-do
106 p.o NN I-NP B-mo
106 q.d VBD B-VP B-f
106 FOLLOW-UP: NNP B-NP O
106 The DT B-NP O
107 patient NN I-NP O
107 is VBZ O O
107 to TO O O
107 follow-up JJ O O
107 with IN B-VP O
107 Dr NNP B-NP O
107 Jonker NNP I-NP O
107 as IN B-VP O
107 an DT B-NP O
107 outpatient NN I-NP O
107 for IN B-VP O
108 further JJ B-NP O
108 workup NN I-NP O
108 and CC O O
108 management NN B-NP O
108 of IN B-VP O
108 gastroesophageal NN B-NP O
108 reflux NN I-NP O
108 disease NN I-NP O
108 , , O O
109 as RB O O
109 well RB O O
109 as IN B-VP O
109 following VBG O O
109 her PRP$ O O
109 for IN B-VP O
109 her PRP$ O O
109 cardiac JJ B-NP O
109 disease NN I-NP O
109 via IN B-VP O
109 the DT B-NP O
109 risk NN I-NP O
110 factor NN I-NP O
110 modification NN I-NP O
111 Dictated NNP I-NP O
111 By: NNP I-NP O
111 MAC NNP I-NP O
111 MCKAMIE NNP I-NP O
111 , , O O
111 M.D NNP B-NP O
111 PD90 NNP I-NP O
112 Attending: NNP I-NP O
112 RAY NNP I-NP O
112 B NNP I-NP O
112 DUNWOODY NNP I-NP O
112 , , O O
112 M.D NNP B-NP O
112 BR50 NNP I-NP O
112 AO808/6489 NNP I-NP O
113 Batch: NNP I-NP O
113 61330 CD O O
113 Index NNP B-NP O
113 No NNP I-NP O
113 LEUDJZ88U9 NNP I-NP O
113 D: NNP I-NP O
113 3/7/96 CD O O
114 T: NNP B-NP O
114 2/18/96 CD O O
115 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #883682 VBZ O O
2 454737049 CD O O
2 VDMH NNP B-NP O
2 87336835 CD O O
2 8702431 CD O O
2 4/29/2007 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 PREGNANCY NNP I-NP O
2 , , O O
2 6 CD O O
2 WEEKS NNP B-NP O
2 DIABETIC NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/0/2007 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/28/2007 CD O O
4 ATTENDING: NNP B-NP O
4 OBEY NNP I-NP O
4 , , O O
4 LAWRENCE NNP B-NP O
4 MD NNP I-NP O
5 SERVICE: NNP I-NP O
5 Obstetrics/Maternal NNP I-NP O
5 Fetal NNP I-NP O
5 Medicine NNP I-NP O
6 PRINCIPAL NNP I-NP O
6 DIAGNOSIS: NNP I-NP O
7 1 CD O O
7 Pre-gestational NNP B-NP O
7 diabetes NNS I-NP O
8 2 CD O O
8 History NNP B-NP O
8 of IN B-VP O
8 coronary JJ B-NP O
8 artery NN I-NP O
8 disease NN I-NP O
9 3 CD O O
9 Recurrent NNP B-NP O
9 SABs NNP I-NP O
10 4 CD O O
10 Hepatitis NNP B-NP O
10 B NNP I-NP O
11 HISTORY NNP I-NP O
11 OF NNP I-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
11 The DT B-NP O
11 patient NN I-NP O
11 is VBZ O O
11 a DT B-NP O
11 36-year-old JJ I-NP O
11 G16 NNP I-NP O
11 , , O O
12 P0-0-15-0 NNP B-NP O
12 , , O O
12 who WP O O
12 presented VBD B-VP O
12 at IN B-VP O
12 6 CD O O
12 and CC O O
12 4/7 CD O O
12 weeks NNS B-NP O
12 by IN B-VP O
12 LMP NNP B-NP O
13 consistent NN I-NP O
13 with IN B-VP O
13 ultrasound NN B-NP O
13 of IN B-VP O
13 the DT B-NP O
13 day NN I-NP O
13 of IN B-VP O
13 admission NN B-NP O
13 , , O O
13 as IN B-VP O
13 a DT B-NP O
13 transfer NN I-NP O
14 from IN B-VP O
14 the DT B-NP O
14 High-Risk NNP I-NP O
14 Obstetric NNP I-NP O
14 Clinic NNP I-NP O
14 , , O O
14 admitted VBD B-VP O
14 to TO O O
14 the DT B-NP O
14 Fuller NNP I-NP O
15 Antepartum NNP I-NP O
15 Service NNP I-NP O
15 for IN B-VP O
15 diabetic JJ B-NP O
15 control NN I-NP O
15 The DT B-NP O
15 patient NN I-NP O
15 had VBD B-VP O
16 presented VBN O O
16 to TO O O
16 the DT B-NP O
16 Special JJ I-NP O
16 OB NNP I-NP O
16 Clinic NNP I-NP O
16 as IN B-VP O
16 a DT B-NP O
16 new JJ I-NP O
16 patient NN I-NP O
16 for IN B-VP O
16 prenatal JJ B-NP O
17 care NN I-NP O
17 Review NNP I-NP O
17 of IN B-VP O
17 her PRP$ O O
17 medical JJ B-NP O
17 problems NNS I-NP O
17 revealed VBD B-VP O
17 that IN B-VP O
17 the DT B-NP O
17 recent JJ I-NP O
18 glucose NN I-NP O
18 control NN I-NP O
18 had VBD B-VP O
18 been VBN O O
18 suboptimal JJ O O
18 In IN B-VP O
18 view NN B-NP O
18 of IN B-VP O
18 this DT O O
18 and CC O O
18 in IN B-VP O
18 view NN B-NP O
19 of IN B-VP O
19 the DT B-NP O
19 fact NN I-NP O
19 that IN B-VP O
19 the DT B-NP O
19 patient NN I-NP O
19 had VBD B-VP O
19 multiple JJ B-NP O
19 other JJ I-NP O
19 issues NNS I-NP O
19 , , O O
19 the DT B-NP O
20 patient NN I-NP O
20 was VBD B-VP O
20 admitted VBN O O
20 for IN B-VP O
20 diabetic JJ B-NP B-r
20 control NN I-NP I-r
20 , , O O
20 adjustment NN B-NP O
20 of IN B-VP O
20 her PRP$ O O
21 insulin NN B-NP B-m
21 regimen NNS I-NP I-m
21 and CC O O
21 evaluation NN B-NP O
21 regarding VBG O O
21 the DT B-NP O
21 other JJ I-NP O
21 medical JJ I-NP O
22 problems NNS I-NP O
23 History NNP I-NP O
23 of IN B-VP O
23 present JJ O O
23 pregnancy: IN B-VP O
23 the DT B-NP O
23 patient NN I-NP O
23 had VBD B-VP O
23 a DT B-NP O
23 last JJ I-NP O
24 menstrual JJ I-NP O
24 period NN I-NP O
24 in IN B-VP O
24 the DT B-NP O
24 second JJ I-NP O
24 week NN I-NP O
24 of IN B-VP O
24 March NNP B-NP O
24 Ultrasound NNP I-NP O
24 on IN B-VP O
24 the DT B-NP O
25 day NN I-NP O
25 of IN B-VP O
25 admission NN B-NP O
25 , , O O
25 11/2/07 CD O O
25 , , O O
25 revealed VBD B-VP O
25 a DT B-NP O
25 6.6-week JJ I-NP O
25 intrauterine JJ I-NP O
26 pregnancy NN I-NP O
26 with IN B-VP O
26 a DT B-NP O
26 fetal JJ I-NP O
26 heart NN I-NP O
26 rate NN I-NP O
26 of IN B-VP O
26 110 CD O O
26 The DT O O
26 estimated VBN O O
26 date NN B-NP O
26 of IN B-VP O
27 confinement NN B-NP O
27 is VBZ O O
27 4/22/07 CD O O
27 Prenatal JJ O O
27 screening VBG O O
27 labs NNS B-NP O
27 were VBD B-VP O
27 pending VBG O O
27 at IN B-VP O
28 the DT B-NP O
28 time NN I-NP O
28 of IN B-VP O
28 admission NN B-NP O
28 The DT B-NP O
28 patient NN I-NP O
28 has VBZ O O
28 blood VBN O O
28 group NN B-NP O
28 O NNP I-NP O
28 +ve NNP I-NP O
29 PAST NNP I-NP O
29 MEDICAL NNP I-NP O
29 HISTORY: NNP I-NP O
29 The DT B-NP O
29 patient NN I-NP O
29 has VBZ O O
29 a DT B-NP O
29 history NN I-NP O
29 of IN B-VP O
29 ST NNP B-NP O
29 elevation NN I-NP O
30 myocardial JJ B-NP O
30 infarction NN I-NP O
30 in IN B-VP O
30 2000 CD O O
30 The DT B-NP O
30 infarct NN I-NP O
30 was VBD B-VP O
30 a DT B-NP O
30 presumed JJ I-NP O
31 embolism NN I-NP O
31 to TO O O
31 the DT O O
31 left VBN O O
31 anterior JJ B-NP O
31 descending NN I-NP O
31 and CC O O
31 the DT B-NP O
31 left NN I-NP O
31 circumflex JJ B-NP O
31 coronary JJ I-NP O
32 artery NN I-NP O
32 The DT B-NP O
32 complete JJ I-NP O
32 occlusion NN I-NP O
32 of IN B-VP O
32 the DT B-NP O
32 mid-to-distal JJ I-NP O
32 left NN I-NP O
33 anterior JJ O O
33 descending VBG O O
33 artery NN B-NP O
33 , , O O
33 which WDT O O
33 was VBD B-VP O
33 thought VBN O O
33 to TO O O
33 be VB O O
33 due JJ O O
33 to TO O O
34 thrombosis VB O B-r
34 , , O O
34 was VBD B-VP O
34 treated VBN O O
34 with IN B-VP O
34 TPA NNP B-NP B-m
34 and CC O O
34 angioplasty VB O O
34 The DT B-NP O
34 patient NN I-NP O
34 had VBD B-VP O
35 a DT B-NP O
35 normal JJ I-NP O
35 catheterization NN I-NP O
35 in IN B-VP O
35 March NNP B-NP O
35 2000 CD O O
35 The DT B-NP O
35 last JJ I-NP O
35 echocardiogram NN I-NP O
36 revealed VBD B-VP O
36 an DT B-NP O
36 ejection NN I-NP O
36 fraction NN I-NP O
36 of IN B-VP O
36 45% CD O O
36 in IN B-VP O
36 2002; CD O O
36 however RB O O
36 , , O O
36 the DT B-NP O
37 patient NN I-NP O
37 never RB O O
37 had VBD B-VP O
37 a DT B-NP O
37 repeat NN I-NP O
37 echo NN I-NP O
37 since IN B-VP O
37 that DT B-NP O
37 time NN I-NP O
37 On IN B-VP O
37 the DT B-NP O
37 day NN I-NP O
37 of IN B-VP O
38 admission NN B-NP O
38 , , O O
38 the DT B-NP O
38 patient NN I-NP O
38 reported VBD B-VP O
38 that IN B-VP O
38 she PRP O O
38 was VBD B-VP O
38 able JJ O O
38 to TO O O
38 climb VB O O
38 four CD O O
39 flights NNS B-NP O
39 of IN B-VP O
39 stairs NNS B-NP O
39 to TO O O
39 her PRP$ O O
39 apartment NN B-NP O
39 , , O O
39 haveing VBG O O
39 to TO O O
39 pause VB O O
39 after IN B-VP O
39 two CD O O
39 flights NNS B-NP O
39 of IN B-VP O
40 stairs NNS B-NP O
40 to TO O O
40 catch VB O O
40 her PRP$ O O
40 breath NN B-NP O
41 In IN B-VP O
41 addition NN B-NP O
41 , , O O
41 the DT B-NP O
41 patient NN I-NP O
41 has VBZ O O
41 a DT B-NP O
41 history NN I-NP O
41 of IN B-VP O
41 diabetes NNS B-NP O
41 mellitus NNS I-NP O
41 , , O O
41 diagnosed VBN O O
41 in IN B-VP O
41 2000 CD O O
42 The DT B-NP O
42 patient NN I-NP O
42 had VBD B-VP O
42 a DT B-NP O
42 medical JJ I-NP O
42 admission NN I-NP O
42 in IN B-VP O
42 2006 CD O O
42 for IN B-VP O
42 hypoglycemia NN B-NP O
42 when WRB O O
42 she PRP O O
43 incidentally RB O O
43 injected VBD B-VP O
43 Humalog NNP B-NP B-m
43 instead RB O O
43 of IN B-VP O
43 Lantus NNP B-NP B-m
43 On IN B-VP O
43 the DT B-NP O
43 day NN I-NP O
43 of IN B-VP O
43 admission NN B-NP O
43 , , O O
43 the DT B-NP O
44 patient NN I-NP O
44 was VBD B-VP O
44 on IN B-VP O
44 a DT B-NP O
44 Humalog NNP I-NP B-m
44 7 CD O B-do
44 units NNS B-NP I-do
44 b.i.d NN I-NP B-f
44 and CC O O
44 Lantus NNP B-NP B-m
44 12 CD O B-do
44 units NNS B-NP I-do
44 in IN B-VP B-f
45 the DT B-NP O
45 evening NN I-NP O
45 Her NNP I-NP O
45 fasting NN I-NP O
45 sugars NNS I-NP O
45 were VBD B-VP O
45 in IN B-VP O
45 the DT O O
45 150s CD O O
45 before IN B-VP O
45 admission NN B-NP O
45 and CC O O
45 her PRP$ O O
46 blood NN B-NP O
46 sugar NN I-NP O
46 measurements NNS I-NP O
46 were VBD B-VP O
46 over RB O O
46 200 CD O O
46 in IN B-VP O
46 the DT B-NP O
46 evening NN I-NP O
46 On IN B-VP O
46 the DT B-NP O
46 day NN I-NP O
46 of IN B-VP O
47 admission NN B-NP O
47 , , O O
47 the DT B-NP O
47 fasting NN I-NP O
47 sugar NN I-NP O
47 was VBD B-VP O
47 123 CD O O
48 In IN B-VP O
48 addition NN B-NP O
48 , , O O
48 the DT B-NP O
48 patient NN I-NP O
48 has VBZ O O
48 a DT B-NP O
48 history NN I-NP O
48 of IN B-VP O
48 hepatitis NN B-NP O
48 B NNP I-NP O
48 , , O O
49 diagnosed VBN O O
49 in IN B-VP O
49 2005 CD O O
49 The DT B-NP O
49 patient NN I-NP O
49 had VBD B-VP O
49 a DT B-NP B-r
49 positive JJ I-NP I-r
49 E NN I-NP I-r
49 antigen NN I-NP I-r
49 in IN B-VP O
49 2005 CD O O
50 She PRP O O
50 had VBD B-VP O
50 previously RB O O
50 been VBN O O
50 on IN B-VP O
50 Epivir NNP B-NP B-m
50 150 CD O B-do
50 mg NN B-NP I-do
50 p.o JJ O B-mo
50 daily JJ O B-f
50 , , O O
50 but CC O O
50 this DT O O
51 was VBD B-VP O
51 stopped VBN O O
51 prior RB O O
51 to TO O O
51 the DT B-NP O
51 current JJ I-NP O
51 pregnancy NN I-NP O
52 PAST NNP I-NP O
52 OB/GYN NNP I-NP O
52 HISTORY: NNP I-NP O
52 The DT B-NP O
52 patient NN I-NP O
52 has VBZ O O
52 a DT B-NP O
52 history NN I-NP O
52 of IN B-VP O
52 a DT B-NP O
52 fibroid JJ I-NP O
53 uterus NN I-NP O
53 , , O O
53 and CC O O
53 a DT B-NP O
53 history NN I-NP O
53 of IN B-VP O
53 recurrent NN B-NP O
53 miscarriages NNS I-NP O
53 In IN B-VP O
53 terms NNS B-NP O
53 of IN B-VP O
53 the DT B-NP O
54 fibroid JJ I-NP O
54 uterus NN I-NP O
54 , , O O
54 the DT B-NP O
54 patient NN I-NP O
54 did VBD B-VP O
54 report VB O O
54 pelvic NN B-NP O
54 pain NN I-NP O
54 in IN B-VP O
54 the DT B-NP O
55 outpatient NN I-NP O
55 setting VBG O O
55 Ultrasound NNP B-NP O
55 had VBD B-VP O
55 shown VBN O O
55 an DT B-NP O
55 8-10 JJ I-NP O
55 cm NN I-NP O
56 dominant JJ O O
56 posterior JJ O O
56 fibroid VBP O O
56 The DT B-NP O
56 patient NN I-NP O
56 occasionally RB O O
56 takes VBZ O O
57 oxycodone NN B-NP B-m
57 for IN B-VP O
57 fibroid JJ B-NP B-r
57 pain NN I-NP I-r
58 In IN B-VP O
58 terms NNS B-NP O
58 of IN B-VP O
58 the DT B-NP O
58 patient's NN I-NP O
58 recurrent NN I-NP O
58 miscarriages NNS I-NP O
58 , , O O
58 the DT B-NP O
58 patient NN I-NP O
58 had VBD B-VP O
58 fifteen JJ B-NP O
58 SABs NNP I-NP O
59 in IN B-VP O
59 the DT O O
59 past JJ O O
59 with IN B-VP O
59 over IN B-VP O
59 10 CD O O
59 dilatation NN B-NP O
59 and CC O O
59 evacuations NNS B-NP O
59 , , O O
59 including VBG O O
59 one CD O O
59 molar JJ B-NP O
60 pregnancy NN I-NP O
60 with IN B-VP O
60 subsequent JJ B-NP O
60 choriocarcinoma NN I-NP O
60 All DT B-NP O
60 losses NNS I-NP O
60 were VBD B-VP O
60 in IN B-VP O
60 the DT B-NP O
60 first JJ I-NP O
61 trimester NN I-NP O
61 , , O O
61 less JJR O O
61 than IN B-VP O
61 12 CD O O
61 weeks' JJ B-NP O
61 gestation NN I-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 had VBD B-VP O
61 been VBN O O
62 evaluated VBN O O
62 previously RB O O
62 for IN B-VP O
62 a DT B-NP O
62 thrombophilia NN I-NP O
62 workup NN I-NP O
62 , , O O
62 but CC O O
62 this DT O O
62 had VBD B-VP O
63 been VBN O O
63 negative JJ B-NP O
63 multiple JJ I-NP O
63 times NNS I-NP O
63 aside RB O O
63 from IN B-VP O
63 a DT B-NP O
63 MTHFR NNP I-NP O
63 gene NN I-NP O
63 mutation NN I-NP O
63 , , O O
64 which WDT O O
64 was VBD B-VP O
64 noted VBN O O
64 on IN B-VP O
64 this DT B-NP O
64 admission NN I-NP O
64 , , O O
64 and CC O O
64 it PRP O O
64 is VBZ O O
64 unclear JJ O O
64 whether IN B-VP O
64 this DT O O
65 has VBZ O O
65 been VBN O O
65 addressed VBN O O
65 previously RB O O
65 The DT B-NP O
65 patient NN I-NP O
65 had VBD B-VP O
65 previously RB O O
65 been VBN O O
66 told VBN O O
66 by IN B-VP O
66 a DT B-NP O
66 reproductive JJ I-NP O
66 endocrinologist NN I-NP O
66 , , O O
66 that IN B-VP O
66 she PRP O O
66 should MD O O
66 consider VB O O
67 adoption NN B-NP O
67 or CC O O
67 a DT B-NP O
67 gestational JJ I-NP O
67 carrier NN I-NP O
67 Chromosomes NNS I-NP O
67 on IN B-VP O
67 several JJ B-NP O
68 pathology NN I-NP O
68 specimens NNS I-NP O
68 from IN B-VP O
68 the DT B-NP O
68 previous JJ I-NP O
68 abortions NNS I-NP O
68 showed VBD B-VP O
69 aneuploidy IN B-VP O
70 The DT B-NP O
70 patient NN I-NP O
70 currently RB O O
70 denies VBZ O O
70 a DT B-NP O
70 history NN I-NP O
70 of IN B-VP O
70 sexually RB O O
71 transmitted VBN O O
71 infections NNS B-NP O
71 She PRP O O
71 has VBZ O O
71 a DT B-NP O
71 history NN I-NP O
71 of IN B-VP O
71 cervical JJ B-NP O
71 dysplasia NN I-NP O
71 , , O O
72 with IN B-VP O
72 a DT B-NP O
72 history NN I-NP O
72 of IN B-VP O
72 CIN NNP B-NP O
72 I PRP O O
72 and CC O O
72 CIN NNP B-NP O
72 II NNP I-NP O
72 in IN B-VP O
72 1990 CD O O
72 and CC O O
72 1992 CD O O
72 She PRP O O
73 underwent VBD B-VP O
73 a DT B-NP O
73 LEEP NNP I-NP O
73 in IN B-VP O
73 1992 CD O O
73 , , O O
73 which WDT O O
73 was VBD B-VP O
73 consistent JJ O O
73 with IN B-VP O
73 HSIL NNP B-NP O
73 All NNP I-NP O
74 subsequent VBD B-VP O
74 Pap NNP B-NP O
74 smears NNS I-NP O
74 were VBD B-VP O
74 either RB O O
74 within IN B-VP O
74 normal JJ B-NP O
74 limits NNS I-NP O
74 Last JJ B-NP O
74 Pap NNP I-NP O
75 smear VBD B-VP O
75 done VBN O O
75 in IN B-VP O
75 February NNP B-NP O
75 2006 CD O O
75 at IN B-VP O
75 Rexmo NNP B-NP O
75 Sha NNP I-NP O
75 Hospital NNP I-NP O
75 Of IN B-VP O
75 was VBD B-VP O
75 insufficient NN B-NP O
75 for IN B-VP O
76 analysis NN B-NP O
76 In IN B-VP O
76 terms NNS B-NP O
76 of IN B-VP O
76 the DT B-NP O
76 patient's JJ I-NP O
76 history NN I-NP O
76 of IN B-VP O
76 choriocarcinoma NN B-NP O
76 , , O O
76 the DT B-NP O
76 patient NN I-NP O
77 had VBD B-VP O
77 a DT B-NP O
77 molar JJ I-NP O
77 pregnancy NN I-NP O
77 , , O O
77 which WDT O O
77 then RB O O
77 developed VBD B-VP O
77 into IN B-VP O
77 a DT B-NP O
77 subsequent JJ I-NP O
77 choriocarcinoma NN I-NP B-r
77 choriocarcinoma NN I-NP B-r
77 choriocarcinoma NN I-NP B-r
78 For IN B-VP O
78 this DT O O
78 , , O O
78 the DT B-NP O
78 patient NN I-NP O
78 was VBD B-VP O
78 treated VBN O O
78 with IN B-VP O
78 methotrexate NN B-NP B-m
78 , , O O
78 actinomycin JJ B-NP B-m
78 D NNP I-NP I-m
78 and CC O O
78 Cytoxan NNP B-NP B-m
78 , , O O
79 then RB O O
79 VP-16 NNP B-NP B-m
79 , , O O
79 cisplatin NN B-NP B-m
79 and CC O O
79 bleomycin NN B-NP B-m
79 with IN B-VP O
79 presumed JJ B-NP O
79 cure NN I-NP O
80 PAST NNP I-NP O
80 SURGICAL NNP I-NP O
80 HISTORY: NNP I-NP O
80 Dilatation NNP I-NP O
80 and CC O O
80 evacuation NN B-NP O
80 x10 NN I-NP O
80 , , O O
81 hysteroscopy NN B-NP O
81 for IN B-VP O
81 infertility NN B-NP O
81 workup NN I-NP O
81 , , O O
81 and CC O O
81 LEEP NNP B-NP O
82 MEDICATIONS NNP I-NP O
82 ON NNP I-NP O
82 ADMISSION: NNP I-NP O
82 Humalog NNP I-NP B-m
82 Insulin NNP I-NP I-m
82 7 CD O B-do
82 units NNS B-NP I-do
82 twice RB O B-f
82 a DT B-NP I-f
82 day NN I-NP I-f
82 , , O O
83 Lantus NNP B-NP B-m
83 12 CD O B-do
83 units NNS B-NP I-do
83 in IN B-VP B-f
83 the DT B-NP I-f
83 evening NN I-NP I-f
83 , , O O
83 aspirin VBZ O B-m
83 81 CD O B-do
83 mg NN B-NP I-do
83 p.o JJ O B-mo
83 daily JJ O B-f
83 stopped VBD B-VP O
84 prior RB O O
84 to TO O O
84 pregnancy NN B-NP O
84 , , O O
84 history NN B-NP O
84 of IN B-VP O
84 lamivudine/Epivir NN B-NP B-m
84 use NN I-NP O
84 , , O O
84 150 CD O B-do
84 daily RB O B-f
85 stopped VBD B-VP O
85 prior RB O O
85 to TO O O
85 current JJ B-NP O
85 pregnancy NN I-NP O
86 ALLERGIES: NNP I-NP O
86 No NNP I-NP O
86 known VBN O O
86 drug NN B-NP O
86 allergies NNS I-NP O
87 SOCIAL NNP I-NP O
87 HISTORY: NNP I-NP O
87 Former NNP I-NP O
87 smoker NN I-NP O
87 , , O O
87 given VBN O O
87 up RP O O
87 smoking VBG O O
87 in IN B-VP O
87 2000 CD O O
87 after IN B-VP O
87 a DT B-NP O
88 myocardial JJ I-NP O
88 infarct NN I-NP O
88 No NNP I-NP O
88 history NN I-NP O
88 of IN B-VP O
88 alcohol NN B-NP O
88 abuse NN I-NP O
88 or CC O O
88 IV NNP B-NP O
88 drug NN I-NP O
88 use VBP O O
89 The DT B-NP O
89 patient NN I-NP O
89 lives VBZ O O
89 in IN B-VP O
89 Doreska NNP B-NP O
89 Dr NNP I-NP O
89 , , O O
89 Nah NNP B-NP O
89 Min NNP I-NP O
89 Knox NNP I-NP O
89 with IN B-VP O
89 her PRP$ O O
89 boyfriend NN B-NP O
89 , , O O
89 unemployed JJ B-NP O
90 FAMILY NNP I-NP O
90 HISTORY: NNP I-NP O
90 No NNP I-NP O
90 history NN I-NP O
90 of IN B-VP O
90 GYN NNP B-NP O
90 malignancies NNS I-NP O
90 , , O O
90 history NN B-NP O
90 of IN B-VP O
91 maternal JJ B-NP O
91 diabetes NNS I-NP O
91 , , O O
91 longstanding VBG O O
91 Father NNP B-NP O
91 with IN B-VP O
91 coronary JJ B-NP O
91 artery NN I-NP O
92 disease NN I-NP O
92 in IN B-VP O
92 his PRP$ O O
92 50s CD O O
93 HOSPITAL NNP B-NP O
93 COURSE: NNP I-NP O
93 The DT B-NP O
93 patient NN I-NP O
93 was VBD B-VP O
93 admitted VBN O O
93 for IN B-VP O
93 the DT B-NP O
93 primary JJ I-NP O
94 purpose NN I-NP O
94 of IN B-VP O
94 diabetic JJ B-NP O
94 control NN I-NP O
95 1 CD O O
95 Diabetes NNP B-NP O
95 mellitus VBD B-VP O
95 The DT B-NP O
95 patient NN I-NP O
95 had VBD B-VP O
95 reported VBN O O
95 poor JJ B-NP O
95 diabetic JJ I-NP O
96 control NN I-NP O
96 as IN B-VP O
96 an DT B-NP O
96 outpatient NN I-NP O
96 Therefore NN I-NP O
96 , , O O
96 her PRP$ O O
96 regimen NN B-NP O
96 was VBD B-VP O
96 continued VBN O O
96 , , O O
97 with IN B-VP O
97 the DT B-NP O
97 addition NN I-NP O
97 of IN B-VP O
97 a DT O O
97 sliding VBG O B-do
97 scale NN B-NP I-do
97 , , O O
97 in IN B-VP O
97 order NN B-NP O
97 to TO O O
97 determine VB O O
97 the DT B-NP O
98 additional JJ I-NP O
98 insulin NN I-NP B-m
98 needs NNS I-NP O
98 as IN B-VP O
98 an DT B-NP O
98 outpatient NN I-NP O
98 Over IN B-VP O
98 the DT B-NP O
98 course NN I-NP O
98 of IN B-VP O
99 the DT B-NP O
99 admission NN I-NP O
99 , , O O
99 the DT B-NP O
99 patient's NN I-NP O
99 Lantus NNP I-NP B-m
99 was VBD B-VP O
99 increased VBN O O
99 to TO O O
99 20 CD O B-do
99 units NNS B-NP I-do
99 at IN B-VP B-f
100 nighttime NN B-NP O
100 , , O O
100 and CC O O
100 she PRP O O
100 was VBD B-VP O
100 using VBG O O
100 8 CD O B-do
100 units NNS B-NP I-do
100 three CD O B-f
100 times NNS B-NP I-f
100 a DT B-NP I-f
100 day NN I-NP I-f
100 of IN B-VP O
100 insulin NN B-NP B-m
101 lispro NN I-NP O
101 , , O O
101 in IN B-VP O
101 addition NN B-NP O
101 to TO O O
101 a DT O O
101 lispro JJ O B-m
101 sliding VBG O B-do
101 scale NN B-NP I-do
101 With IN B-VP O
101 this DT B-NP O
102 regimen NNS I-NP O
102 , , O O
102 the DT B-NP O
102 fingerstick JJ I-NP O
102 glucose NN I-NP O
102 control NN I-NP O
102 improved VBN O O
102 , , O O
102 and CC O O
102 the DT B-NP O
103 fasting NN I-NP O
103 blood NN I-NP O
103 sugar NN I-NP O
103 on IN B-VP O
103 the DT B-NP O
103 day NN I-NP O
103 of IN B-VP O
103 discharge NN B-NP O
103 was VBD B-VP O
103 90 CD O O
103 On IN B-VP O
103 the DT B-NP O
103 day NN I-NP O
104 prior RB O O
104 to TO O O
104 discharge VB O O
104 , , O O
104 the DT B-NP O
104 patient NN I-NP O
104 had VBD B-VP O
104 blood NN B-NP O
104 sugars NNS I-NP O
104 in IN B-VP O
104 the DT B-NP O
104 range NN I-NP O
105 from IN B-VP O
105 93 CD O O
105 to TO O O
105 139 CD O O
105 An DT B-NP O
105 HbA1c NNP I-NP O
105 was VBD B-VP O
105 sent VBN O O
105 , , O O
105 which WDT O O
105 was VBD B-VP O
105 6.7 CD O O
105 , , O O
105 during IN B-VP O
105 this DT B-NP O
106 admission NN I-NP O
106 , , O O
106 the DT B-NP O
106 patient NN I-NP O
106 also RB O O
106 had VBD B-VP O
106 a DT B-NP O
106 Nutrition NN I-NP O
106 consult NN I-NP O
106 She PRP O O
106 will MD O O
106 be VB O O
107 followed VBN O O
107 in IN B-VP O
107 the DT B-NP O
107 High-Risk NNP I-NP O
107 Obstetric NNP I-NP O
107 and CC O O
107 Diabetic NNP B-NP O
107 Clinic NNP I-NP O
107 by IN B-VP O
107 Dr NNP B-NP O
108 Borguez NNP I-NP O
109 2 CD O O
109 Cardiology NNP B-NP O
109 The DT B-NP O
109 patient NN I-NP O
109 was VBD B-VP O
109 restarted VBN O O
109 on IN B-VP O
109 her PRP O O
109 aspirin NN B-NP B-m
109 , , O O
109 given VBN O O
110 her PRP$ O O
110 history NN B-NP O
110 of IN B-VP O
110 myocardial JJ B-NP B-r
110 infarct NN I-NP I-r
110 at IN B-VP O
110 a DT O O
110 very RB O O
110 early JJ B-NP O
110 age NN I-NP O
110 In IN B-VP O
111 addition NN B-NP O
111 , , O O
111 an DT B-NP O
111 echocardiogram NN I-NP O
111 was VBD B-VP O
111 obtained VBN O O
111 on IN B-VP O
111 the DT B-NP O
111 day NN I-NP O
111 after IN B-VP O
112 admission NN B-NP O
112 This DT O O
112 revealed VBD B-VP O
112 an DT B-NP O
112 ejection NN I-NP O
112 fraction NN I-NP O
112 of IN B-VP O
112 50% CD O O
112 as RB O O
112 well RB O O
112 as IN B-VP O
113 a DT B-NP O
113 large JJ I-NP O
113 left NN I-NP O
113 ventricular JJ B-NP O
113 thrombosis NN I-NP O
113 , , O O
113 which WDT O O
113 was VBD B-VP O
113 presumed VBN O O
113 to TO O O
113 be VB O O
113 a DT B-NP O
114 longstanding JJ I-NP O
114 Cardiology NNP I-NP O
114 was VBD B-VP O
114 consulted VBN O O
114 and CC O O
114 the DT B-NP O
114 impression NN I-NP O
114 was VBD B-VP O
115 that IN B-VP O
115 the DT B-NP O
115 thrombosis NN I-NP O
115 was VBD B-VP O
115 likely RB O O
115 a DT B-NP O
115 combination NN I-NP O
115 of IN B-VP O
115 her PRP$ O O
115 left JJ B-NP O
116 ventricular JJ I-NP O
116 hypokinesia NN I-NP O
116 related VBN O O
116 to TO O O
116 the DT B-NP O
116 previous JJ I-NP O
116 infarct NN I-NP O
116 , , O O
116 as RB O O
116 well RB O O
117 as IN B-VP O
117 her PRP$ O O
117 hypercoagulable JJ B-NP O
117 state NN I-NP O
117 Therefore NNP I-NP O
117 , , O O
117 their PRP$ O O
117 recommendation NN B-NP O
118 was VBD B-VP O
118 to TO O O
118 start VB O O
118 the DT B-NP O
118 patient NN I-NP O
118 on IN B-VP O
118 Lovenox NNP B-NP B-m
118 for IN B-VP B-du
118 the DT B-NP O
118 duration NN I-NP O
118 of IN B-VP O
118 this DT B-NP O
119 pregnancy NN I-NP O
119 , , O O
119 which WDT O O
119 adjusted VBD B-VP O
119 for IN B-VP O
119 her PRP$ O O
119 weight NN B-NP O
119 was VBD B-VP O
119 a DT B-NP O
119 dose NN I-NP O
119 of IN B-VP O
119 90 CD O B-do
119 mg JJ O I-do
120 daily RB O B-f
120 , , O O
120 followed VBN O O
120 by IN B-VP O
120 a DT B-NP O
120 transition NN I-NP O
120 to TO O O
120 Coumadin NNP B-NP B-m
120 postpartum NN I-NP O
120 , , O O
120 to TO O O
120 be VB O O
121 continued VBN O O
121 for IN B-VP B-du
121 likely JJ O I-du
121 long-term JJ O I-du
121 , , O I-du
121 possibly RB O I-du
121 lifelong JJ B-NP I-du
121 duration NN I-NP I-du
121 The DT B-NP O
122 Cardiology NNP I-NP O
122 Consult NNP I-NP O
122 Team NNP I-NP O
122 noted VBD B-VP O
122 that IN B-VP O
122 the DT B-NP O
122 MTHFR NNP I-NP O
122 mutation NN I-NP O
122 had VBD B-VP O
122 not RB O O
123 resulted VBN O O
123 in IN B-VP O
123 elevated JJ B-NP O
123 homocysteine NN I-NP O
123 levels NNS I-NP O
123 in IN B-VP O
123 the DT O O
123 past JJ O O
123 However RB O O
123 , , O O
124 they PRP O O
124 did VBD B-VP O
124 agree VB O O
124 that IN B-VP O
124 folate JJ B-NP B-m
124 supplementation NN I-NP I-m
124 at IN B-VP O
124 high JJ B-NP B-do
124 doses NNS I-NP I-do
124 was VBD B-VP O
125 indicated VBN O O
125 The DT B-NP O
125 patient NN I-NP O
125 will MD O O
125 be VB O O
125 continued VBN O O
125 on IN B-VP O
125 Lovenox NNP B-NP B-m
125 90 CD O B-do
125 mg JJ O I-do
125 daily RB O B-f
126 subcutaneously RB O B-mo
126 , , O O
126 and CC O O
126 aspirin RB O B-m
126 81 CD O B-do
126 mg NNS B-NP I-do
126 p.o JJ O B-mo
126 daily RB O B-f
126 as IN B-VP O
126 an DT B-NP O
126 outpatient NN I-NP O
127 She PRP O O
127 will MD O O
127 have VB O O
127 Cardiology NNP B-NP O
127 followup NN I-NP O
127 with IN B-VP O
127 Dr NNP B-NP O
127 Jasper NNP I-NP O
127 Erps NNP I-NP O
127 on IN B-VP O
128 11/27/07 CD O O
128 During IN B-VP O
128 the DT B-NP O
128 entire JJ I-NP O
128 admission NN I-NP O
128 , , O O
128 she PRP O O
128 was VBD B-VP O
128 hemodynamically RB O O
129 stable JJ O O
129 , , O O
129 in IN B-VP O
129 sinus NN B-NP O
129 rhythm NN I-NP O
129 , , O O
129 with IN B-VP O
129 no DT B-NP O
129 complaints NNS I-NP O
129 of IN B-VP O
129 chest NN B-NP O
129 pain NN I-NP O
129 , , O O
130 shortness NN B-NP O
130 of IN B-VP O
130 breath NN B-NP O
130 or CC O O
130 palpitations NNS B-NP O
131 3 CD O O
131 Hepatitis NNP B-NP O
131 B NNP I-NP O
131 The DT B-NP O
131 patient NN I-NP O
131 had VBD B-VP O
131 liver VBN O O
131 function NN B-NP O
131 tests NNS I-NP O
131 and CC O O
131 a DT B-NP O
132 hepatitis NN I-NP O
132 panel NN I-NP O
132 on IN B-VP O
132 this DT B-NP O
132 admission NN I-NP O
132 , , O O
132 given VBN O O
132 her PRP$ O O
132 history NN B-NP O
132 of IN B-VP O
132 active JJ B-NP O
133 disease NN I-NP O
133 diagnosed VBN O O
133 in IN B-VP O
133 2005 CD O O
133 , , O O
133 with IN B-VP O
133 a DT B-NP O
133 positive JJ I-NP O
133 hepatitis NN I-NP O
133 E NNP I-NP O
133 antigen NN I-NP O
134 On IN B-VP O
134 admission NN B-NP O
134 , , O O
134 the DT B-NP O
134 patient NN I-NP O
134 had VBD B-VP O
134 not RB O O
134 been VBN O O
134 on IN B-VP O
134 Epivir NNP B-NP B-m
134 , , O O
134 which WDT O O
134 had VBD B-VP O
134 been VBN O O
135 stopped VBN O O
135 prior RB O O
135 to TO O O
135 this DT B-NP O
135 current JJ I-NP O
135 pregnancy NN I-NP O
135 Liver NNP I-NP O
135 function NN I-NP O
135 tests NNS I-NP O
136 were VBD B-VP O
136 checked VBN O O
136 on IN B-VP O
136 this DT B-NP O
136 admission NN I-NP O
136 and CC O O
136 were VBD B-VP O
136 within IN B-VP O
136 normal JJ B-NP O
136 limits NNS I-NP O
136 In IN B-VP O
137 addition NN B-NP O
137 , , O O
137 serologies NNS B-NP O
137 were VBD B-VP O
137 checked VBN O O
137 and CC O O
137 the DT B-NP O
137 hepatitis NN I-NP O
137 E NNP I-NP O
137 antigen NN I-NP O
137 and CC O O
138 the DT B-NP O
138 E NNP I-NP O
138 antibody NN I-NP O
138 was VBD B-VP O
138 negative JJ B-NP O
138 Hepatitis NNP I-NP O
138 B NNP I-NP O
138 surface NN I-NP O
138 antigen NN I-NP O
138 and CC O O
138 hepatitis NN B-NP O
138 B NNP I-NP O
139 core NN I-NP O
139 antigen NN I-NP O
139 were VBD B-VP O
139 reactive JJ O O
139 At IN B-VP O
139 the DT B-NP O
139 time NN I-NP O
139 of IN B-VP O
139 this DT B-NP O
139 dictation NN I-NP O
139 , , O O
139 a DT B-NP O
140 hepatitis NN I-NP O
140 B NNP I-NP O
140 viral JJ B-NP O
140 load NN I-NP O
140 was VBD B-VP O
140 pending VBG O O
140 Given VBN O O
140 the DT B-NP O
140 patient's JJ I-NP O
140 history NN I-NP O
141 of IN B-VP O
141 hepatitis NN B-NP O
141 B NNP I-NP O
141 , , O O
141 an DT B-NP O
141 outpatient JJ I-NP O
141 appointment NN I-NP O
141 was VBD B-VP O
141 being VBG O O
141 arranged VBN O O
141 at IN B-VP O
142 the DT B-NP O
142 time NN I-NP O
142 of IN B-VP O
142 discharge NN B-NP O
142 , , O O
142 with IN B-VP O
142 Dr NNP B-NP O
142 Lavy NNP I-NP O
142 , , O O
142 from IN B-VP O
142 the DT B-NP O
142 Division NNP I-NP O
142 of IN B-VP O
143 Gastroenterology NNP B-NP O
143 at IN B-VP O
143 the DT B-NP O
143 Sasspan NNP I-NP O
143 Hospital NNP I-NP O
143 It PRP O O
143 was VBD B-VP O
144 decided VBN O O
144 that IN B-VP O
144 the DT B-NP O
144 patient NN I-NP O
144 should MD O O
144 not RB O O
144 take VB O O
144 any DT B-NP O
144 lamivudine NN I-NP B-m
144 until IN B-VP B-du
145 Gastroenterology NNP B-NP O
145 followup NN I-NP O
145 During IN B-VP O
145 the DT B-NP O
145 entire JJ I-NP O
145 hospital NN I-NP O
145 stay NN I-NP O
145 , , O O
145 the DT B-NP O
146 patient NN I-NP O
146 did VBD B-VP O
146 not RB O O
146 have VB O O
146 any DT B-NP O
146 GI NNP I-NP O
146 complaints NNS I-NP O
146 , , O O
146 was VBD B-VP O
146 tolerating VBG O O
146 a DT B-NP O
146 regular JJ I-NP O
147 diet NN I-NP O
147 , , O O
147 and CC O O
147 having VBG O O
147 normal JJ B-NP O
147 regular JJ I-NP O
147 bowel NN I-NP O
147 movements NNS I-NP O
148 4 CD O O
148 history NN B-NP O
148 of IN B-VP O
148 fibroids NNS B-NP O
148 , , O O
148 the DT B-NP O
148 patient NN I-NP O
148 was VBD B-VP O
148 noted VBN O O
148 again RB O O
148 to TO O O
148 have VB O O
148 an DT B-NP O
148 8-cm JJ I-NP O
148 fibroid NN I-NP O
149 on IN B-VP O
149 her PRP$ O O
149 ultrasound JJ O O
149 scan JJ O O
149 She PRP O O
149 required VBD B-VP O
149 rare JJ B-NP O
149 intermittent JJ I-NP B-do
149 doses NNS I-NP I-do
149 of IN B-VP O
150 oxycodone NN B-NP B-m
150 as IN B-VP O
150 required VBN O O
150 for IN B-VP O
150 pain NN B-NP B-r
150 , , O O
150 which WDT O O
150 was VBD B-VP O
150 presumed VBN O O
150 to TO O O
150 be VB O O
150 related VBN O O
151 to TO O O
151 her PRP$ O O
151 fibroid JJ O O
151 uterus JJ O O
152 5 CD O O
152 Prenatal NNP B-NP O
152 care NN I-NP O
152 The DT B-NP O
152 patient NN I-NP O
152 had VBD B-VP O
152 her PRP$ O O
152 first JJ B-NP O
152 trimester NN I-NP O
152 labs NN I-NP O
152 sent VBD B-VP O
153 on IN B-VP O
153 this DT B-NP O
153 admission NN I-NP O
153 GC NNP I-NP O
153 and CC O O
153 chlamydia VB O O
153 testing VBG O O
153 were VBD B-VP O
153 negative JJ B-NP O
154 Urine JJ I-NP O
154 culture NN I-NP O
154 was VBD B-VP O
154 negative JJ O O
154 The DT B-NP O
154 patient NN I-NP O
154 was VBD B-VP O
154 O NNP B-NP O
154 +ve NNP I-NP O
154 Given NNP I-NP O
154 the DT B-NP O
155 patient's JJ I-NP O
155 history NN I-NP O
155 of IN B-VP O
155 MTHFR NNP B-NP O
155 mutation NN I-NP O
155 and CC O O
155 the DT B-NP O
155 recurrent NN I-NP O
155 SABs NNP I-NP O
155 , , O O
155 the DT B-NP O
156 patient NN I-NP O
156 was VBD B-VP O
156 started VBN O O
156 on IN B-VP O
156 prenatal NN B-NP B-m
156 vitamins NNS I-NP I-m
156 , , O O
156 as RB O O
156 well RB O O
156 as IN B-VP O
156 high-dose JJ B-NP B-do
157 folic JJ I-NP B-m
157 acid NN I-NP I-m
157 , , O O
157 B12 NNP B-NP B-m
157 and CC O O
157 B6 NNP B-NP B-m
157 In IN B-VP O
157 view NN B-NP O
157 of IN B-VP O
157 the DT B-NP O
157 patient's JJ I-NP O
157 diabetic JJ I-NP O
158 history NN I-NP O
158 , , O O
158 and CC O O
158 a DT O O
158 transiently RB O O
158 elevated VBN O O
158 creatinine NN B-NP O
158 to TO O O
158 1.2 CD O O
158 on IN B-VP O
158 hospital JJ B-NP O
159 day NN I-NP O
159 2 CD O O
159 , , O O
159 which WDT O O
159 went VBD B-VP O
159 back RB O O
159 to TO O O
159 0.7 CD O O
159 on IN B-VP O
159 the DT B-NP O
159 day NN I-NP O
159 of IN B-VP O
159 discharge NN B-NP O
159 , , O O
159 the DT B-NP O
160 patient NN I-NP O
160 had VBD B-VP O
160 a DT B-NP O
160 24-hour JJ I-NP O
160 urine JJ I-NP O
160 collection NN I-NP O
160 sent VBD B-VP O
160 , , O O
160 this DT O O
160 returned VBD B-VP O
161 negative JJ O O
161 at IN B-VP O
161 92 CD O O
161 mg NNS B-NP O
161 per IN B-VP O
161 24 CD O O
161 hours NNS B-NP O
161 It PRP O O
161 was VBD B-VP O
161 noted VBN O O
161 that IN B-VP O
161 the DT B-NP O
161 patient NN I-NP O
162 had VBD B-VP O
162 an DT B-NP O
162 Ophthalmology NNP I-NP O
162 retinal JJ B-NP O
162 exam NN I-NP O
162 at IN B-VP O
162 an DT B-NP O
162 outside JJ I-NP O
162 hospital NN I-NP O
162 health NN I-NP O
163 center NN I-NP O
163 this DT B-NP O
163 year NN I-NP O
163 For IN B-VP O
163 the DT B-NP O
163 remainder NN I-NP O
163 of IN B-VP O
163 this DT B-NP O
163 pregnancy NN I-NP O
163 , , O O
163 it PRP O O
163 was VBD B-VP O
164 noted VBN O O
164 that IN B-VP O
164 the DT B-NP O
164 patient NN I-NP O
164 will MD O O
164 require VB O O
164 ultrasounds NNS B-NP O
164 at IN B-VP O
164 11 CD O O
164 and CC O O
164 17 CD O O
165 weeks NNS B-NP O
165 , , O O
165 as RB O O
165 well RB O O
165 as IN B-VP O
165 a DT B-NP O
165 fetal JJ I-NP O
165 echo NN I-NP O
165 , , O O
165 and CC O O
165 the DT B-NP O
165 recommended JJ I-NP O
165 testing NN I-NP O
165 for IN B-VP O
166 pre-gestational JJ B-NP O
166 diabetics NNS I-NP O
166 for IN B-VP O
166 the DT B-NP O
166 remainder NN I-NP O
166 of IN B-VP O
166 the DT B-NP O
166 pregnancy NN I-NP O
167 The DT B-NP O
167 patient NN I-NP O
167 was VBD B-VP O
167 discharged VBN O O
167 in IN B-VP O
167 a DT B-NP O
167 stable JJ I-NP O
167 condition NN I-NP O
167 , , O O
167 with IN B-VP O
167 followup JJ B-NP O
168 appointments NNS I-NP O
168 arranged VBN O O
168 for IN B-VP O
168 the DT B-NP O
168 various JJ I-NP O
168 specialties NNS I-NP O
169 DISPOSITION: NNP I-NP O
169 Home NNP I-NP O
169 without IN B-VP O
169 services NNS B-NP O
170 DISCHARGE NNP I-NP O
170 CONDITION: NNP I-NP O
170 Stable NNP I-NP O
171 DISCHARGE NNP I-NP O
171 MEDICATIONS: NNP I-NP O
172 1 CD O O
172 Aspirin NNP B-NP B-m
172 81 CD O B-do
172 mg NN B-NP I-do
172 p.o JJ O B-mo
172 daily JJ O B-f
173 2 CD O O
173 Lovenox NNP B-NP B-m
173 subcutaneously RB O B-mo
173 90 CD O B-do
173 mg JJ O I-do
173 daily RB O B-f
174 3 CD O O
174 Vitamin NNP B-NP B-m
174 B12 NNP I-NP I-m
174 100 CD O B-do
174 mcg NN B-NP I-do
174 p.o JJ O B-mo
174 daily JJ O B-f
175 4 CD O O
175 Folate NNP B-NP B-m
175 4 CD O B-do
175 mg NN B-NP I-do
175 p.o JJ O B-mo
175 daily JJ O B-f
176 5 CD O O
176 Prenatal JJ B-NP B-m
176 vitamins NNS I-NP I-m
176 one CD O B-do
176 tablet NN B-NP I-do
176 p.o VB O B-mo
176 daily JJ O B-f
177 6 CD O O
177 Lantus NNP B-NP B-m
177 20 CD O B-do
177 units NNS B-NP I-do
177 subcutaneously RB O B-mo
177 q.p.m RB O B-f
178 7 CD O O
178 Insulin NNP B-NP B-m
178 lispro VBD B-VP I-m
178 8 CD O B-do
178 units NNS B-NP I-do
178 subcutaneously RB O B-mo
178 AC NNP B-NP B-f
178 , , O O
178 as RB O O
178 well RB O O
178 as IN B-VP O
178 lispro JJ O B-m
179 sliding VBG O B-do
179 scale NN B-NP I-do
179 , , O O
179 in IN B-VP O
179 addition NN B-NP O
179 a DT B-NP O
179 AC NNP I-NP B-f
180 FOLLOW-UP NNP I-NP O
180 APPOINTMENTS: NNP I-NP O
181 1 CD O O
181 Special NNP B-NP O
181 OB NNP I-NP O
181 on IN B-VP O
181 10/4/07 CD O O
182 2 CD O O
182 Dr NNP B-NP O
182 Lantry NNP I-NP O
182 , , O O
182 Endocrinology NNP B-NP O
182 on IN B-VP O
182 10/4/07 CD O O
183 3 CD O O
183 Dr NNP B-NP O
183 Nolan NNP I-NP O
183 Conners NNP I-NP O
183 , , O O
183 Cardiology NNP B-NP O
183 , , O O
183 on IN B-VP O
183 11/27/07 CD O O
184 4 CD O O
184 Dr NNP B-NP O
184 Winscott NNP I-NP O
184 , , O O
184 Gastroenterology NNP B-NP O
184 , , O O
184 the DT B-NP O
184 patient NN I-NP O
184 will MD O O
184 receive VB O O
185 letter NN B-NP O
185 with IN B-VP O
185 the DT B-NP O
185 appointment NN I-NP O
185 from IN B-VP O
185 GI NNP B-NP O
185 Clinic NNP I-NP O
186 eScription NN I-NP O
186 document: VBD B-VP O
186 5-4895741 JJ B-NP O
186 CSSten NNP I-NP O
186 Tel NNP I-NP O
187 Dictated NNP I-NP O
187 By: NNP I-NP O
187 MAIOCCO NNP I-NP O
187 , , O O
187 DALLAS NNP B-NP O
188 Attending: NNP I-NP O
188 MARCOLINA NNP I-NP O
188 , , O O
188 EMMITT NNP B-NP O
189 Dictation NNP I-NP O
189 ID NNP I-NP O
189 8179861 CD O O
190 D: NNP B-NP O
190 10/30/07 CD O O
191 T: NNP B-NP O
191 10/30/07 CD O O
192 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #885288 VBZ O O
4 974383166 CD O O
4 OERH NNP B-NP O
4 24451935 CD O O
4 4700934 CD O O
4 5/2/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 COLONIC NNP I-NP O
4 POLYPS NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/10/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 9/22/2005 CD O O
7 ATTENDING: NNP B-NP O
7 POLAND NNP I-NP O
7 , , O O
7 BRODERICK NNP B-NP O
7 DEANGELO NNP I-NP O
7 MD NNP I-NP O
8 PRIMARY NNP I-NP O
8 CARE NNP I-NP O
8 PHYSICIAN: NNP I-NP O
8 Morton NNP I-NP O
8 Setter NNP I-NP O
8 , , O O
8 MD NNP B-NP O
9 PRINCIPAL NNP I-NP O
9 DIAGNOSIS: NNP I-NP O
9 Adenomatous NNP I-NP O
9 polyps NNS I-NP O
9 at IN B-VP O
9 the DT B-NP O
9 ileocecal JJ I-NP O
9 valve NN I-NP O
10 LIST NNP I-NP O
10 OF NNP I-NP O
10 PROBLEMS: NNP I-NP O
11 1 CD O O
11 Adenomatous NNP B-NP O
11 polyp NN I-NP O
11 at IN B-VP O
11 the DT B-NP O
11 ileocecal JJ I-NP O
11 valve NN I-NP O
12 2 CD O O
12 Past NNP B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 pulmonary JJ B-NP O
12 embolism NN I-NP O
13 3 CD O O
13 Diabetes NNP B-NP O
13 mellitus VBD B-VP O
14 4 CD O O
14 Vaginal NNP B-NP O
14 yeast NN I-NP O
14 infection NN I-NP O
15 HISTORY NNP I-NP O
15 OF NNP I-NP O
15 PRESENT NNP I-NP O
15 ILLNESS: NNP I-NP O
15 Ms NNP I-NP O
15 Wentz NNP I-NP O
15 is VBZ O O
15 a DT B-NP O
15 51-year-old JJ I-NP O
15 lady NN I-NP O
15 who WP O O
16 was VBD B-VP O
16 found VBN O O
16 to TO O O
16 have VB O O
16 an DT B-NP O
16 adenomatous JJ I-NP O
16 polyp NN I-NP O
16 at IN B-VP O
16 the DT B-NP O
16 ileocecal JJ I-NP O
16 valve NN I-NP O
16 , , O O
17 which WDT O O
17 was VBD B-VP O
17 not RB O O
17 amenable JJ O O
17 to TO O O
17 colonoscopy VB O O
17 resection NN B-NP O
17 The DT B-NP O
17 patient NN I-NP O
17 was VBD B-VP O
18 referred VBN O O
18 for IN B-VP O
18 colonoscopy NN B-NP O
18 after IN B-VP O
18 gastrointestinal JJ B-NP O
18 bleeding NN I-NP O
18 was VBD B-VP O
19 identified VBN O O
19 The DT B-NP O
19 patient NN I-NP O
19 does VBZ O O
19 have VB O O
19 a DT B-NP O
19 past JJ I-NP O
19 history NN I-NP O
19 of IN B-VP O
19 pulmonary JJ B-NP B-r
19 pulmonary JJ I-NP B-r
20 embolism NN I-NP O
20 that WDT O O
20 was VBD B-VP O
20 diagnosed VBN O O
20 in IN B-VP O
20 year NN B-NP O
20 2000 CD O O
20 that WDT O O
20 was VBD B-VP O
20 of IN B-VP O
20 unknown JJ B-NP O
21 origin NN I-NP O
21 and CC O O
21 has VBZ O O
21 since IN B-VP O
21 been VBN O O
21 on IN B-VP O
21 Coumadin NNP B-NP B-m
21 and CC O O
21 Coumadin NNP B-NP B-m
21 was VBD B-VP O
21 withheld VBN O O
21 a DT B-NP O
22 week NN I-NP O
22 before IN B-VP O
22 her PRP$ O O
22 operation NN B-NP O
22 , , O O
22 on IN B-VP O
22 6/30/05 CD O O
22 The DT B-NP O
22 patient NN I-NP O
22 was VBD B-VP O
22 on IN B-VP O
23 metformin NN B-NP B-m
23 for IN B-VP O
23 her PRP$ O B-r
23 diabetes NNS B-NP I-r
23 mellitus VBP O I-r
23 This DT B-NP B-m
23 medication NN I-NP I-m
23 was VBD B-VP O
23 also RB O O
24 withheld VBN O O
24 on IN B-VP O
24 the DT B-NP O
24 day NN I-NP O
24 of IN B-VP O
24 her PRP$ O O
24 operation NN B-NP O
25 PAST NNP I-NP O
25 MEDICAL NNP I-NP O
25 HISTORY: NNP I-NP O
26 1 CD O O
26 Pulmonary NNP B-NP O
26 embolism NN I-NP O
26 in IN B-VP O
26 2000 CD O O
27 2 CD O O
27 Diabetes NNPS B-NP O
27 mellitus` VBP O O
27 type JJ O O
27 2 CD O O
28 3 CD O O
28 Obesity NN B-NP O
29 4 CD O O
29 Hypercholesterolemia NNP B-NP O
30 5 CD O O
30 Probable NNP B-NP O
30 COPD NNP I-NP O
31 6 CD O O
31 Hypertension NNP B-NP O
32 7 CD O O
32 Moderate NNP B-NP O
32 obstructive JJ B-NP O
32 sleep NN I-NP O
32 apnea NN I-NP O
33 PAST NNP I-NP O
33 SURGICAL NNP I-NP O
33 HISTORY: NNP I-NP O
34 1 CD O O
34 Cholecystectomy NNP B-NP O
35 2 CD O O
35 Laparoscopic NNP B-NP O
35 tubal JJ B-NP O
35 ligation NN I-NP O
36 SOCIAL NNP I-NP O
36 HISTORY: NNP I-NP O
36 The DT B-NP O
36 patient NN I-NP O
36 has VBZ O O
36 a DT B-NP O
36 long JJ I-NP O
36 history NN I-NP O
36 of IN B-VP O
36 smoking VBG O O
36 She PRP O O
37 smoked VBD B-VP O
37 about IN B-VP O
37 35 CD O O
37 pack NN B-NP O
37 years NNS I-NP O
37 The DT B-NP O
37 patient NN I-NP O
37 quit NN I-NP O
37 five CD O O
37 months NNS B-NP O
37 ago RB O O
38 before IN B-VP O
38 her PRP$ O O
38 admission NN B-NP O
39 ALLERGIES: IN B-VP O
39 The DT B-NP O
39 patient NN I-NP O
39 is VBZ O O
39 allergic JJ O O
39 to TO O O
39 IV NNP B-NP O
39 erythromycin NN I-NP O
39 , , O O
39 which WDT O O
40 causes VBZ O O
40 rash NN B-NP O
41 MEDICATIONS: NNP I-NP O
42 1 CD O O
42 Lipitor NNP B-NP B-m
42 10 CD O B-do
42 mg NN B-NP I-do
42 once RB O B-f
42 a DT B-NP I-f
42 day NN I-NP I-f
43 2 CD O O
43 Metformin NNP B-NP B-m
43 Metformin NNP I-NP B-m
43 500 CD O B-do
43 mg NN B-NP I-do
43 in IN B-VP B-f
43 the DT B-NP I-f
43 morning NN I-NP I-f
43 , , O O
43 100 CD O B-do
43 mg NN B-NP I-do
43 in IN B-VP B-f
43 the DT B-NP I-f
43 afternoon NN I-NP I-f
44 3 CD O O
44 Coumadin NNP B-NP B-m
44 11 CD O B-do
44 mg NN B-NP I-do
45 4 CD O O
45 Tylenol NNP B-NP B-m
45 p.r.n NN I-NP B-f
45 for IN B-VP O
45 joint JJ B-NP B-r
45 pain NN I-NP I-r
46 REVIEW NNP I-NP O
46 OF NNP I-NP O
46 SYSTEMS: NNP I-NP O
46 Negative NNP I-NP O
46 for IN B-VP O
46 cardiac NN B-NP O
46 , , O O
46 pulmonary JJ O O
46 , , O O
46 GI NNP B-NP O
46 , , O O
46 and CC O O
46 GU NNP B-NP O
47 symptoms NNS I-NP O
48 PHYSICAL NNP I-NP O
48 EXAMINATION: NNP I-NP O
48 The DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 obese JJ O O
48 and CC O O
48 in IN B-VP O
48 no DT B-NP O
48 acute NN I-NP O
49 distress NN I-NP O
49 Lung NNP I-NP O
49 exam NN I-NP O
49 revealed VBD B-VP O
49 no DT B-NP O
49 wheezing NN I-NP O
49 or CC O O
49 rhonchi VB O O
49 Abdomen NNP B-NP O
50 was VBD B-VP O
50 soft JJ O O
50 , , O O
50 nondistended JJ O O
50 and CC O O
50 nontender JJ B-NP O
51 LABORATORY NNP I-NP O
51 DATA: NNP I-NP O
51 CBC NNP I-NP O
51 , , O O
51 white JJ B-NP O
51 blood NN I-NP O
51 cell NN I-NP O
51 count NN I-NP O
51 was VBD B-VP O
51 6.5 CD O O
51 , , O O
51 hematocrit NN B-NP O
52 was VBD B-VP O
52 30.7 CD O O
52 , , O O
52 platelet NN B-NP O
52 count NN I-NP O
52 was VBD B-VP O
52 310 CD O O
52 , , O O
52 000 CD O O
53 HOSPITAL NNP B-NP O
53 COURSE: NNP I-NP O
54 1 CD O O
54 Adenomatous NNP B-NP O
54 polyp NN I-NP O
54 at IN B-VP O
54 ileocecal JJ O O
54 valve VBP O O
54 The DT B-NP O
54 patient NN I-NP O
54 was VBD B-VP O
55 scheduled VBN O O
55 for IN B-VP O
55 a DT B-NP O
55 laparoscopic JJ I-NP O
55 ileocecectomy NN I-NP O
55 on IN B-VP O
55 6/30/05 CD O O
55 However RB O O
55 , , O O
56 the DT B-NP O
56 frozen JJ I-NP O
56 section NN I-NP O
56 revealed VBD B-VP O
56 an DT B-NP O
56 invasive JJ I-NP O
56 adenocarcinoma NN I-NP O
56 The DT B-NP O
57 procedure NN I-NP O
57 was VBD B-VP O
57 converted VBN O O
57 to TO O O
57 an DT B-NP O
57 open JJ I-NP O
57 right NN I-NP O
57 hemicolectomy NN I-NP O
57 along IN B-VP O
57 with IN B-VP O
58 umbilical JJ B-NP O
58 hernia NN I-NP O
58 repair NN I-NP O
58 Postoperative NNP I-NP O
58 course NN I-NP O
58 for IN B-VP O
58 the DT B-NP O
58 patient NN I-NP O
59 has VBZ O O
59 been VBN O O
59 rather RB O O
59 uneventful JJ O O
59 and CC O O
59 the DT B-NP O
59 pathology NN I-NP O
59 report NN I-NP O
59 revealed VBD B-VP O
59 that IN B-VP O
60 the DT B-NP O
60 tumor NN I-NP O
60 is VBZ O O
60 a DT B-NP O
60 stage NN I-NP O
60 T2 NNP I-NP O
60 , , O O
60 N0 NNP B-NP O
60 tumor NN I-NP O
60 with IN B-VP O
60 no DT B-NP O
60 lymph NN I-NP O
60 node RB O O
60 involvement JJ O O
61 2 CD O O
61 Past NNP B-NP O
61 history NN I-NP O
61 of IN B-VP O
61 pulmonary JJ B-NP O
61 embolism NN I-NP O
61 The DT B-NP O
61 patient's NN I-NP O
61 Coumadin NNP I-NP B-m
62 was VBD B-VP O
62 withheld VBN O O
62 a DT B-NP O
62 week NN I-NP O
62 before IN B-VP O
62 operation NN B-NP O
62 and CC O O
62 the DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
62 placed VBN O O
63 on IN B-VP O
63 heparin NN B-NP B-m
63 Her NNP I-NP O
63 Coumadin NNP I-NP B-m
63 was VBD B-VP O
63 restarted VBN O O
63 on IN B-VP O
63 7/3/05 CD O O
63 and CC O O
63 on IN B-VP O
63 her PRP$ O O
64 home NN B-NP O
64 dose NN I-NP O
64 of IN B-VP O
64 11 CD O B-do
64 mg NN B-NP I-do
64 Her NNP I-NP O
64 INR NNP I-NP O
64 steadily RB O O
64 increased VBD B-VP O
64 over IN B-VP O
64 the DT B-NP O
64 course NN I-NP O
65 of IN B-VP O
65 her PRP$ O O
65 hospital NN B-NP O
65 stay VB O O
65 up IN B-VP O
65 to TO O O
65 1.7 CD O O
65 at IN B-VP O
65 her PRP O O
65 discharge VBP O O
65 The DT B-NP O
65 patient NN I-NP O
66 will MD O O
66 follow VB O O
66 up RP O O
66 with IN B-VP O
66 her PRP$ O O
66 Coumadin NNP B-NP O
66 Clinic NNP I-NP O
66 and CC O O
66 as RB O O
66 well RB O O
66 as IN B-VP O
66 with IN B-VP O
66 PCP NNP B-NP O
67 to TO O O
67 monitor VB O O
67 her PRP$ O O
67 INR NNP B-NP O
67 after IN B-VP O
67 her PRP$ O O
67 discharge NN B-NP O
68 3 CD O O
68 Diabetes NNPS B-NP O
68 mellitus VBP O O
68 The DT B-NP O
68 patient NN I-NP O
68 has VBZ O O
68 diabetes VBN O B-r
68 mellitus NNS B-NP I-r
68 and CC O O
68 her PRP$ O O
69 metformin NN B-NP B-m
69 was VBD B-VP O
69 withheld VBN O O
69 on IN B-VP O
69 the DT B-NP O
69 day NN I-NP O
69 of IN B-VP O
69 her PRP$ O O
69 surgery NN B-NP O
69 During IN B-VP B-du
69 her PRP$ O O
70 hospital JJ B-NP O
70 course NN I-NP O
70 , , O O
70 she PRP O O
70 was VBD B-VP O
70 placed VBN O O
70 on IN B-VP O
70 Regular JJ B-NP B-m
70 Insulin NNP I-NP I-m
70 sliding VBG O B-do
70 scale NN B-NP I-do
71 Her NNP I-NP O
71 metformin NN I-NP B-m
71 was VBD B-VP O
71 restarted VBN O O
71 on IN B-VP O
71 11/16/05 CD O O
72 4 CD O O
72 Vaginal NNP B-NP O
72 yeast NN I-NP O
72 infection NN I-NP O
72 The DT B-NP O
72 patient NN I-NP O
72 complained VBD B-VP O
72 of IN B-VP O
72 white JJ B-NP B-r
73 creamy JJ I-NP O
73 discharge NN I-NP O
73 from IN B-VP O
73 her PRP$ O O
73 vagina NN B-NP O
73 on IN B-VP O
73 9/29/05 CD O O
73 and CC O O
73 miconazole JJ B-NP B-m
74 suppository NN I-NP O
74 was VBD B-VP O
74 prescribed VBN O O
74 for IN B-VP B-du
74 five CD O I-du
74 days NNS B-NP I-du
74 At IN B-VP O
74 the DT B-NP O
74 time NN I-NP O
74 of IN B-VP O
75 discharge NN B-NP O
75 , , O O
75 her PRP$ O O
75 discharge NN B-NP O
75 from IN B-VP O
75 her PRP$ O O
75 vagina NN B-NP O
75 has VBZ O O
75 resolved VBN O O
76 PHYSICAL NNP B-NP O
76 EXAM NNP I-NP O
76 AT NNP I-NP O
76 DISCHARGE: NNP I-NP O
76 The DT B-NP O
76 patient's JJ I-NP O
76 heart NN I-NP O
76 exam NN I-NP O
76 revealed VBD B-VP O
77 regular JJ B-NP O
77 rate NN I-NP O
77 and CC O O
77 rhythm NN B-NP O
77 , , O O
77 no DT B-NP O
77 murmurs NN I-NP O
77 and CC O O
77 lungs NNS B-NP O
77 were VBD B-VP O
77 clear JJ B-NP O
77 Her NNP I-NP O
78 abdomen NN I-NP O
78 was VBD B-VP O
78 obese JJ O O
78 , , O O
78 but CC O O
78 soft JJ O O
78 and CC O O
78 nontender NN B-NP O
78 with IN B-VP O
78 active JJ B-NP O
78 bowel NN I-NP O
79 sounds VBZ O O
79 Her PRP$ O O
79 wound NN B-NP O
79 was VBD B-VP O
79 clean JJ O O
79 , , O O
79 dry JJ O O
79 and CC O O
79 intact JJ B-NP O
79 Her NNP I-NP O
79 INR NNP I-NP O
79 was VBD B-VP O
79 1.7 CD O O
79 at IN B-VP O
80 discharge NN B-NP O
81 DISCHARGE NNP I-NP O
81 MEDICATIONS: NNP I-NP O
82 1 CD O O
82 DuoNeb NNP B-NP B-m
82 3/0.5 CD O B-do
82 mg NN B-NP I-do
82 q.6h NN I-NP B-f
83 2 CD O O
83 Coumadin NNP B-NP B-m
83 12 CD O B-do
83 mg NN B-NP I-do
83 p.o NN I-NP B-mo
83 nightly RB O B-f
84 3 CD O O
84 Lipitor NNP B-NP B-m
84 10 CD O B-do
84 mg NN B-NP I-do
84 p.o NN I-NP B-mo
84 once RB O B-f
84 a DT B-NP I-f
84 day NN I-NP I-f
85 4 CD O O
85 Metformin NNP B-NP B-m
85 Metformin NNP I-NP B-m
85 p.o NN I-NP B-mo
85 p.o NN I-NP B-mo
85 500 CD O B-do
85 mg NN B-NP I-do
85 in IN B-VP B-f
85 the DT B-NP I-f
85 morning NN I-NP I-f
85 , , O O
85 1000 CD O B-do
85 mg NN B-NP I-do
85 in IN B-VP B-f
85 the DT B-NP O
86 afternoon NN I-NP O
87 5 CD O O
87 Colace NNP B-NP B-m
87 100 CD O B-do
87 mg NN B-NP I-do
87 twice RB O B-f
87 a DT B-NP I-f
87 day NN I-NP I-f
87 p.o VBZ O B-mo
88 6 CD O O
88 Dilaudid NNP B-NP B-m
88 2-4 JJ B-NP B-do
88 mg NN I-NP I-do
88 q.3h NN I-NP B-f
88 p.o IN B-VP B-mo
89 The DT B-NP O
89 patient NN I-NP O
89 was VBD B-VP O
89 discharged VBN O O
89 in IN B-VP O
89 stable JJ B-NP O
89 condition NN I-NP O
89 She PRP O O
89 will MD O O
89 arrange VB O O
90 to TO O O
90 have VB O O
90 her PRP$ O O
90 INR NNP B-NP O
90 draw NN I-NP O
90 on IN B-VP O
90 1/1/05 CD O O
90 with IN B-VP O
90 follow-up JJ B-NP O
90 INRs NNP I-NP O
90 to TO O O
90 be VB O O
90 drain JJ O O
91 every DT O O
91 two CD O O
91 days NNS B-NP O
91 and CC O O
91 INR NNP B-NP O
91 will MD O O
91 be VB O O
91 followed VBN O O
91 by IN B-VP O
91 her PRP$ O O
91 primary JJ B-NP O
91 care NN I-NP O
92 physician NN I-NP O
92 , , O O
92 Dr NNP B-NP O
92 Afonso NNP I-NP O
92 The DT B-NP O
92 patient NN I-NP O
92 is VBZ O O
92 full JJ B-NP O
92 code NN I-NP O
93 eScription NN I-NP O
93 document: VBZ O O
93 2-6638086 JJ B-NP O
93 CS NNP I-NP O
94 Dictated NNP I-NP O
94 By: NNP I-NP O
94 MATARESE NNP I-NP O
94 , , O O
94 HARRISON NNP B-NP O
95 Attending: NNP I-NP O
95 WRIGHTS NNP I-NP O
95 , , O O
95 JAIME NNP B-NP O
95 JACINTO NNP I-NP O
96 Dictation NNP I-NP O
96 ID NNP I-NP O
96 1132181 CD O O
97 D: NNP B-NP O
97 11/28/05 CD O O
98 T: NNP B-NP O
98 11/28/05 CD O O
99 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #892793 VBZ O O
2 534206895 CD O O
2 TGMH NNP B-NP O
2 71107061 CD O O
2 633520 CD O O
2 11/3/2000 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ABD NNP I-NP O
2 PAIN NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/23/2000 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/28/2000 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 The DT B-NP O
4 patient NN I-NP O
4 is VBZ O O
4 a DT O O
4 33 CD O O
4 year-old JJ B-NP O
4 woman NN I-NP O
5 with IN B-VP O
5 diet JJ O O
5 controlled VBN O O
5 diabetes NNS B-NP O
6 mellitus NN I-NP O
6 , , O O
6 morbid NN B-NP O
6 obesity NN I-NP O
6 , , O O
6 who WP O O
6 presents VBZ O O
6 to TO O O
6 the DT B-NP O
6 emergency NN I-NP O
6 department NN I-NP O
7 with IN B-VP O
7 periumbilical JJ B-NP O
7 pain NN I-NP O
7 , , O O
7 radiating VBG O O
7 to TO O O
7 the DT B-NP O
7 right NN I-NP O
7 lower RBR O O
7 quadrant NN B-NP O
7 In IN B-VP O
8 her PRP$ O O
8 first JJ B-NP O
8 trip NN I-NP O
8 to TO O O
8 the DT B-NP O
8 emergency NN I-NP O
8 department NN I-NP O
8 her PRP$ O O
8 pain NN B-NP O
8 was VBD B-VP O
8 diffuse NN B-NP O
8 and CC O O
9 was VBD B-VP O
9 thought VBN O O
9 to TO O O
9 be VB O O
9 gastroenteritis NN B-NP O
9 After IN B-VP O
9 being VBG O O
9 sent VBD B-VP O
9 home NN B-NP O
9 , , O O
9 she PRP O O
9 had VBD B-VP O
10 an DT B-NP O
10 increase NN I-NP O
10 in IN B-VP O
10 pain NN B-NP O
10 and CC O O
10 vomiting NN B-NP O
10 and CC O O
10 was VBD B-VP O
10 unable JJ O O
10 to TO O O
10 tolerate VB O O
10 p.o NN B-NP O
10 On IN B-VP O
11 her PRP$ O O
11 second JJ B-NP O
11 trip NN I-NP O
11 one CD O O
11 day NN B-NP O
11 later RB O O
11 she PRP O O
11 was VBD B-VP O
11 vomiting VBG O O
11 with IN B-VP O
11 no DT B-NP O
11 fever NN I-NP O
11 but CC O O
12 chills NNS B-NP O
12 and CC O O
12 no DT B-NP O
12 flatus NN I-NP O
12 The DT B-NP O
12 decision NN I-NP O
12 was VBD B-VP O
12 made VBN O O
12 to TO O O
12 take VB O O
12 her PRP O O
12 to TO O O
12 the DT B-NP O
13 operating NN I-NP O
13 room NN I-NP O
13 to TO O O
13 explore VB O O
13 for IN B-VP O
13 appendicitis NN B-NP O
14 PAST NNP I-NP O
14 MEDICAL NNP I-NP O
14 HISTORY: NNP I-NP O
14 Non NNP I-NP O
14 Insulin NNP I-NP O
14 dependent NN I-NP O
14 diabetes VBZ O O
14 mellitus RBS O O
14 , , O O
15 diet JJ O O
15 controlled VBD B-VP O
16 PAST NNP B-NP O
16 SURGICAL NNP I-NP O
16 HISTORY: NNP I-NP O
16 None NNP I-NP O
17 MEDICATION: NNP I-NP O
17 None NNP I-NP O
18 ALLERGIES: NNP I-NP O
18 No NNP I-NP O
18 known VBN O O
18 drug NN B-NP O
18 allergies NNS I-NP O
19 PHYSICAL NNP I-NP O
19 EXAMINATION: NNP I-NP O
19 The DT B-NP O
19 patient NN I-NP O
19 was VBD B-VP O
19 a DT O O
19 morbidly RB O O
19 obese JJ B-NP O
19 woman NN I-NP O
19 in IN B-VP O
20 no DT B-NP O
20 acute NN I-NP O
20 distress NN I-NP O
20 She PRP O O
20 was VBD B-VP O
20 tachycardic JJ B-NP O
21 Chest NNP I-NP O
21 was VBD B-VP O
21 clear JJ B-NP O
21 Abdomen NNP I-NP O
21 was VBD B-VP O
21 soft JJ O O
21 with IN B-VP O
21 positive JJ B-NP O
21 bowel NN I-NP O
21 sounds NNS I-NP O
21 , , O O
22 tenderness NN B-NP O
22 in IN B-VP O
22 the DT B-NP O
22 right NN I-NP O
22 and CC O O
22 left VBD B-VP O
22 lower JJR B-NP O
22 quadrant NN I-NP O
22 with IN B-VP O
22 positive JJ B-NP O
22 psoas NN I-NP O
23 and CC O O
23 Rovsing's NNP B-NP O
23 sign NN I-NP O
23 Rectal NNP I-NP O
23 examination NN I-NP O
23 showed VBD B-VP O
23 normal JJ B-NP O
23 tone NN I-NP O
23 and CC O O
23 no DT B-NP O
24 stool NN I-NP O
24 Pelvic NNP I-NP O
24 examination NN I-NP O
24 showed VBD B-VP O
24 no DT B-NP O
24 cervical JJ I-NP O
24 motion NN I-NP O
24 tenderness NN I-NP O
25 LABORATORY: NNP I-NP O
25 Abdominal NNP I-NP O
25 CT NNP I-NP O
25 was VBD B-VP O
25 obtained VBN O O
25 which WDT O O
25 showed VBD B-VP O
25 5x5 CD O O
25 cm JJ B-NP O
25 cecal JJ I-NP O
26 thickening NN I-NP O
26 with IN B-VP O
26 extraluminal JJ B-NP O
26 air NN I-NP O
26 This DT O O
26 was VBD B-VP O
26 thought VBN O O
26 to TO O O
26 be VB O O
26 consistent JJ O O
26 with IN B-VP O
26 a DT B-NP O
27 perforated JJ I-NP O
27 appendicitis NN I-NP O
27 or CC O O
27 phlegmon NN B-NP O
27 CBC NNP I-NP O
27 showed VBD B-VP O
27 a DT B-NP O
27 white JJ I-NP O
27 blood NN I-NP O
28 count NN I-NP O
28 19 CD O O
28 , , O O
28 000 CD O O
28 Her NNP B-NP O
28 urine JJ B-NP O
28 HCG NNP I-NP O
28 was VBD B-VP O
28 negative JJ B-NP O
29 HOSPITAL NNP I-NP O
29 COURSE: NNP I-NP O
29 The DT B-NP O
29 patient NN I-NP O
29 was VBD B-VP O
29 taken VBN O O
29 to TO O O
29 the DT B-NP O
29 operating NN I-NP O
29 room NN I-NP O
29 on IN B-VP O
30 March NNP B-NP O
30 , , O O
30 by IN B-VP O
30 Dr NNP B-NP O
30 Jenovese NNP I-NP O
30 , , O O
30 who WP O O
30 initially RB O O
30 opened VBD B-VP O
30 the DT B-NP O
31 right JJ I-NP O
31 lower JJR I-NP O
31 quadrant NN I-NP O
31 to TO O O
31 explore VB O O
31 for IN B-VP O
31 appendicitis NN B-NP O
31 In IN B-VP O
31 exploring VBG O O
31 the DT B-NP O
32 abdomen NNS I-NP O
32 , , O O
32 purulent JJ B-NP O
32 material NN I-NP O
32 was VBD B-VP O
32 found VBN O O
32 in IN B-VP O
32 the DT B-NP O
32 right NN I-NP O
32 lower RBR O O
32 quadrant NN B-NP O
32 , , O O
33 and CC O O
33 the DT B-NP O
33 appendix NN I-NP O
33 was VBD B-VP O
33 not RB O O
33 able JJ O O
33 to TO O O
33 be VB O O
33 visualized VBN O O
33 The DT B-NP O
33 decision NN I-NP O
33 was VBD B-VP O
34 made VBN O O
34 to TO O O
34 open VB O O
34 the DT B-NP O
34 midline NN I-NP O
34 incision NN I-NP O
34 which WDT O O
34 was VBD B-VP O
34 done VBN O O
34 Details NNP B-NP O
34 of IN B-VP O
34 the DT B-NP O
35 operation NN I-NP O
35 may MD O O
35 be VB O O
35 found VBN O O
35 in IN B-VP O
35 Dr NNP B-NP O
35 Zinsli NNP I-NP O
35 's POS O O
35 operative JJ B-NP O
35 report NN I-NP O
35 By IN B-VP O
36 report NN B-NP O
36 , , O O
36 she PRP O O
36 had VBD B-VP O
36 gangrenous JJ B-NP O
36 portions NNS I-NP O
36 of IN B-VP O
36 the DT B-NP O
36 right JJ I-NP O
36 colon NN I-NP O
36 , , O O
37 necessitating VBG O O
37 a DT B-NP O
37 right JJ I-NP O
37 colectomy NN I-NP O
37 This DT O O
37 was VBD B-VP O
37 performed VBN O O
37 , , O O
37 and CC O O
37 she PRP O O
38 tolerated VBD B-VP O
38 the DT B-NP O
38 procedure NN I-NP O
38 well RB O O
38 and CC O O
38 was VBD B-VP O
38 transferred VBN O O
38 extubated VBN O O
38 in IN B-VP O
39 stable JJ B-NP O
39 condition NN I-NP O
39 to TO O O
39 the DT B-NP O
39 floor NN I-NP O
39 Her NNP I-NP O
39 immediate JJ B-NP O
39 postoperative JJ I-NP O
39 course NN I-NP O
40 was VBD B-VP O
40 complicated VBN O O
40 by IN B-VP O
40 supraventricular JJ B-NP B-r
40 supraventricular JJ I-NP B-r
40 tachycardia NN I-NP I-r
40 tachycardia NN I-NP I-r
40 to TO O O
40 a DT B-NP O
40 rate NN I-NP O
40 of IN B-VP O
40 200 CD O O
41 with IN B-VP O
41 hypotension NN B-NP O
41 , , O O
41 requiring VBG O O
41 beta NN B-NP B-m
41 blockade NN I-NP I-m
41 and CC O O
41 adenosine NN B-NP B-m
41 She PRP O O
41 was VBD B-VP O
42 transferred VBN O O
42 to TO O O
42 the DT B-NP O
42 Surgical NNP I-NP O
42 ICU NNP I-NP O
42 for IN B-VP O
42 further JJ B-NP O
42 management NN I-NP O
42 After IN B-VP O
42 the DT B-NP O
43 use NN I-NP O
43 of IN B-VP O
43 beta NN B-NP B-m
43 blockade NN I-NP I-m
43 and CC O O
43 adenosine NN B-NP B-m
43 , , O O
43 her PRP$ O O
43 arrhythmia NN B-NP B-r
43 arrhythmia NN I-NP B-r
43 resolved VBD B-VP O
43 This DT O O
44 was VBD B-VP O
44 found VBN O O
44 to TO O O
44 occur VB O O
44 with IN B-VP O
44 magnesium NN B-NP B-m
44 of IN B-VP O
44 1.5 CD O B-do
44 which WDT O O
44 was VBD B-VP O
44 repleted VBN O O
44 Per NNP B-NP O
45 recommendations NNS I-NP O
45 of IN B-VP O
45 the DT B-NP O
45 Cardiology NNP I-NP O
45 Service NNP I-NP O
45 , , O O
45 an DT B-NP O
45 echocardiogram NN I-NP O
45 was VBD B-VP O
46 obtained VBN O O
46 which WDT O O
46 was VBD B-VP O
46 normal JJ O O
46 , , O O
46 and CC O O
46 she PRP O O
46 ruled VBD B-VP O
46 out RP O O
46 for IN B-VP O
46 myocardial JJ B-NP O
47 infarction NN I-NP O
47 by IN B-VP O
47 serial JJ B-NP O
47 CKs NNP I-NP O
47 and CC O O
47 electrocardiograms VB O O
47 An DT B-NP O
47 NG NNP I-NP O
47 tube NN I-NP O
47 was VBD B-VP O
47 in IN B-VP O
48 place NN B-NP O
48 which WDT O O
48 was VBD B-VP O
48 continued VBN O O
48 on IN B-VP O
48 the DT B-NP O
48 first JJ I-NP O
48 postoperative JJ I-NP O
48 day NN I-NP O
48 , , O O
48 and CC O O
48 she PRP O O
49 was VBD B-VP O
49 kept VBN O O
49 on IN B-VP O
49 Zantac NNP B-NP B-m
49 She PRP O O
49 was VBD B-VP O
49 kept VBN O O
49 on IN B-VP O
49 ampicillin NN B-NP B-m
49 , , O O
49 levofloxacin NN B-NP B-m
49 and CC O O
50 Flagyl NNP B-NP B-m
50 A NNP I-NP O
50 central JJ B-NP O
50 line NN I-NP O
50 was VBD B-VP O
50 in IN B-VP O
50 place NN B-NP O
50 Over IN B-VP O
50 the DT B-NP O
50 next JJ I-NP O
50 few JJ I-NP O
51 postoperative JJ I-NP O
51 days NNS I-NP O
51 , , O O
51 as IN B-VP O
51 her PRP$ O O
51 NG NNP B-NP O
51 tube NN I-NP O
51 was VBD B-VP O
51 removed VBN O O
51 and CC O O
51 her PRP$ O O
51 diet JJ O O
51 slowly RB O O
52 advanced JJ O O
52 with IN B-VP O
52 sips NNS B-NP O
52 , , O O
52 she PRP O O
52 was VBD B-VP O
52 converted VBN O O
52 to TO O O
52 p.o VB O O
52 medication NN B-NP O
52 At IN B-VP O
52 one CD O O
53 point NN B-NP O
53 she PRP O O
53 developed VBD B-VP O
53 a DT B-NP O
53 second JJ I-NP O
53 episode NN I-NP O
53 of IN B-VP O
53 supraventricular JJ B-NP B-r
54 tachycardia NN I-NP O
54 and CC O O
54 was VBD B-VP O
54 thought VBN O O
54 to TO O O
54 be VB O O
54 either RB O O
54 atrial JJ B-NP O
54 fibrillation NN I-NP O
54 versus IN B-VP O
55 sinus JJ B-NP O
55 tachycardia NN I-NP O
55 This DT O O
55 did VBD B-VP O
55 not RB O O
55 respond VB O O
55 immediately RB O O
55 to TO O O
55 Lopressor NNP B-NP B-m
56 and CC O O
56 per IN B-VP O
56 Cardiology's NNP B-NP O
56 recommendations NNS I-NP O
56 , , O O
56 she PRP O O
56 was VBD B-VP O
56 changed VBN O O
56 to TO O O
56 diltiazem VB O B-m
57 followed VBN O O
57 by IN B-VP O
57 Diltiazem NNP B-NP B-m
57 drip NN I-NP I-m
57 When WRB O O
57 stabilized NN B-NP O
57 , , O O
57 her PRP$ O O
57 dose NN B-NP O
57 of IN B-VP O
57 Lopressor NNP B-NP B-m
58 was VBD B-VP O
58 increased VBN O O
58 , , O O
58 Diltiazem NNP B-NP B-m
58 stopped VBD B-VP O
58 and CC O O
58 she PRP O O
58 was VBD B-VP O
58 converted VBN O O
58 to TO O O
58 p.o VB O B-mo
59 Lopressor NNP B-NP B-m
59 50 CD O B-do
59 t.i.d NN B-NP B-f
59 which WDT O O
59 kept VBD B-VP O
59 her PRP O O
59 in IN B-VP O
59 sinus NN B-NP O
59 rhythm NN I-NP O
59 and CC O O
59 a DT B-NP O
59 stable JJ I-NP O
60 rate NN I-NP O
60 By IN B-VP O
60 the DT O O
60 third JJ O O
60 and CC O O
60 fourth JJ B-NP O
60 postoperative JJ I-NP O
60 day NN I-NP O
60 , , O O
60 she PRP O O
60 was VBD B-VP O
61 tolerating VBG O O
61 a DT B-NP O
61 regular JJ I-NP O
61 diet NN I-NP O
61 , , O O
61 passing VBG O O
61 flatus NN B-NP O
61 and CC O O
61 bowel NN B-NP O
61 movements NNS I-NP O
61 and CC O O
62 ambulating VBG O O
62 independently RB O O
62 She PRP O O
62 was VBD B-VP O
62 weaned VBN O O
62 off RP O O
62 her PRP$ O O
62 oxygen NN B-NP B-m
62 and CC O O
62 her PRP$ O O
63 central JJ B-NP O
63 line NN I-NP O
63 was VBD B-VP O
63 discontinued VBN O O
63 She PRP O O
63 was VBD B-VP O
63 stable JJ O O
63 for IN B-VP O
63 discharge NN B-NP O
64 The DT B-NP O
64 patient NN I-NP O
64 was VBD B-VP O
64 discharged VBN O O
64 to TO O O
64 home VB O O
64 on IN B-VP O
64 November NNP B-NP O
64 , , O O
64 2000 CD O O
64 At IN B-VP O
64 that DT B-NP O
64 time NN I-NP O
65 she PRP O O
65 will MD O O
65 have VB O O
65 completed VBN O O
65 a DT B-NP O
65 5-day JJ I-NP B-du
65 5-day JJ I-NP B-du
65 5-day JJ I-NP B-du
65 course NN I-NP I-du
65 course NN I-NP I-du
65 course NN I-NP I-du
65 of IN B-VP O
65 ampicillin NN B-NP B-m
65 , , O O
65 levofloxacin NN B-NP B-m
66 and CC O O
66 Flagyl NNP B-NP B-m
66 She PRP O O
66 is VBZ O O
66 tolerating VBG O O
66 a DT B-NP O
66 regular JJ I-NP O
66 diet NN I-NP O
66 , , O O
66 ambulating VBG O O
67 dependently RB O O
67 and CC O O
67 requiring VBG O O
67 minimal JJ B-NP B-do
67 amounts NNS I-NP I-do
67 of IN B-VP O
67 oral JJ B-NP B-mo
67 analgesics NNS I-NP B-m
67 She PRP O O
68 received VBD B-VP O
68 wet JJ O O
68 to TO O O
68 dry VB O O
68 dressing VBG O O
68 changes NNS B-NP O
68 b.i.d VBP O O
68 to TO O O
68 her PRP$ O O
68 wounds NNS B-NP O
68 , , O O
68 which WDT O O
69 will MD O O
69 need VB O O
69 to TO O O
69 be VB O O
69 continued VBN O O
69 as IN B-VP O
69 an DT B-NP O
69 outpatient NN I-NP O
69 by IN B-VP O
69 a DT B-NP O
69 visiting NN I-NP O
69 nurse JJ B-NP O
70 DISCHARGE NNP I-NP O
70 MEDICATION: NNP I-NP O
70 Lopressor NNP I-NP B-m
70 50 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 t.i.d NN I-NP B-f
70 , , O O
70 Percocet NNP B-NP B-m
70 1-2 JJ B-NP B-do
71 tabs NNS I-NP O
71 p.o JJ B-NP B-mo
71 q JJ I-NP B-f
71 3-4 JJ I-NP I-f
71 hours NNS I-NP I-f
71 p.r.n VBP O I-f
71 pain NN B-NP B-r
71 , , O O
71 Colace NNP B-NP B-m
71 100 CD O B-do
72 mg NN B-NP O
72 b.i.d NN I-NP B-f
72 while IN B-VP B-du
72 on IN B-VP I-du
72 Percocet NNP B-NP I-du
72 Percocet NNP I-NP B-m
73 FOLLOWUP: NNP I-NP O
73 The DT B-NP O
73 patient NN I-NP O
73 is VBZ O O
73 instructed VBN O O
73 to TO O O
73 followup VB O O
73 with IN B-VP O
73 Dr NNP B-NP O
73 Goan NNP I-NP O
74 in IN B-VP O
74 1-2 JJ B-NP O
74 weeks NNS I-NP O
74 and CC O O
74 should MD O O
74 call VB O O
74 his PRP$ O O
74 office NN B-NP O
74 for IN B-VP O
74 an DT B-NP O
75 appointment NN I-NP O
76 Dictated NNP I-NP O
76 By: NNP I-NP O
76 JOEL NNP I-NP O
76 J NNP I-NP O
76 MILLIMAKI NNP I-NP O
76 , , O O
76 M.D NNP B-NP O
76 HE10 NNP I-NP O
77 Attending: NNP I-NP O
77 HECTOR NNP I-NP O
77 TRIGGS NNP I-NP O
77 , , O O
77 M.D NNP B-NP O
77 XO20 NNP I-NP O
78 IQ143/0359 NNP I-NP O
79 Batch: NNP I-NP O
79 1984 CD O O
79 Index NNP B-NP O
79 No NNP I-NP O
79 JPNO1I8NZQ NNP I-NP O
79 D: NNP I-NP O
79 4/2 CD O O
80 T: NNP B-NP O
80 4/2 CD O O
81 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #893858 VBZ O O
4 646786895 CD O O
4 ICH NNP B-NP O
4 88612865 CD O O
4 620466 CD O O
4 5/8/1992 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/30/1992 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 8/3/1992 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 The DT B-NP O
7 patient NN I-NP O
7 is VBZ O O
7 a DT O O
7 37 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 woman NN I-NP O
8 with IN B-VP O
8 dilated VBN O O
8 cardiomyopathy NN B-NP O
8 admitted VBN O O
9 with IN B-VP O
9 positional JJ B-NP O
9 chest NN I-NP O
9 pain NN I-NP O
9 associated VBN O O
9 with IN B-VP O
9 viral JJ B-NP O
9 prodrome NN I-NP O
9 PAST NNP I-NP O
10 MEDICAL NNP I-NP O
10 HISTORY NNP I-NP O
10 revealed VBD B-VP O
10 the DT B-NP O
10 patient NN I-NP O
10 was VBD B-VP O
10 diagnosed VBN O O
10 with IN B-VP O
10 dilated JJ B-NP O
11 cardiomyopathy NN I-NP O
11 in IN B-VP O
11 10-89 CD O O
11 She PRP O O
11 was VBD B-VP O
11 worked VBN O O
11 up RP O O
11 at IN B-VP O
11 the DT B-NP O
11 Ingvid's NNP I-NP O
11 Health NNP I-NP O
11 Services NNPS I-NP O
11 with IN B-VP O
11 a DT B-NP O
11 conclusion NN I-NP O
11 of IN B-VP O
11 idiopathic JJ O O
11 dilated VBN O O
11 cardiomyopathy NN B-NP O
11 , , O O
12 work-up JJ O O
12 unavailable JJ O O
12 The DT B-NP O
12 patient NN I-NP O
12 was VBD B-VP O
12 discharged VBN O O
12 on IN B-VP O
12 Lasix NNP B-NP B-m
12 , , O O
12 digoxin NN B-NP B-m
13 and CC O O
13 an DT B-NP O
13 ACE NNP I-NP B-m
13 inhibitor NN I-NP I-m
13 In IN B-VP O
13 20 CD O O
13 of IN B-VP O
13 May NNP B-NP O
13 , , O O
13 the DT B-NP O
13 patient NN I-NP O
13 was VBD B-VP O
13 admitted VBN O O
13 to TO O O
13 Orecross NNP B-NP O
13 Medical NNP I-NP O
13 Center NNP I-NP O
13 after IN B-VP O
13 complaining VBG O O
13 of IN B-VP O
13 positional JJ B-NP O
13 chest NN I-NP O
13 pain NN I-NP O
13 , , O O
14 shortness NN B-NP O
14 of IN B-VP O
14 breath NN B-NP O
14 and CC O O
14 fatigue NN B-NP O
14 She PRP O O
14 was VBD B-VP O
14 diagnosed VBN O O
14 with IN B-VP O
14 dilated VBN O O
15 cardiomyopathy NN B-NP O
15 and CC O O
15 received VBD B-VP O
15 an DT B-NP O
15 echocardiogram NN I-NP O
15 , , O O
15 which WDT O O
15 revealed VBD B-VP O
15 large JJ B-NP O
16 ventricles NNS I-NP O
16 , , O O
16 2+ CD O O
16 mitral JJ B-NP O
16 regurgitation NN I-NP O
16 , , O O
16 3+ CD O O
16 tricuspid JJ B-NP O
16 regurgitation NN I-NP O
16 In IN B-VP O
17 7 CD O O
17 of IN B-VP O
17 July NNP B-NP O
17 , , O O
17 the DT B-NP O
17 patient NN I-NP O
17 underwent NN I-NP O
17 a DT B-NP O
17 bicycle NN I-NP O
17 exercise NN I-NP O
17 tolerance NN I-NP O
17 test NN I-NP O
17 and CC O O
18 endured VBD B-VP O
18 10 CD O O
18 minutes NNS B-NP O
18 and CC O O
18 16 CD O O
18 seconds NNS B-NP O
18 , , O O
18 limited VBN O O
18 by IN B-VP O
18 fatigue NN B-NP O
18 Peak NNP I-NP O
18 heart NN I-NP O
19 rate NN I-NP O
19 was VBD B-VP O
19 104 CD O O
19 , , O O
19 peak JJ B-NP O
19 blood NN I-NP O
19 pressure NN I-NP O
19 was VBD B-VP O
19 156/80 CD O O
19 , , O O
19 she PRP O O
19 had VBD B-VP O
19 a DT B-NP O
19 few JJ I-NP O
19 atrial JJ I-NP O
20 premature NN I-NP O
20 beats NNS I-NP O
20 and CC O O
20 no DT B-NP O
20 ischemic JJ I-NP O
20 ST-T JJ I-NP O
20 changes NNS I-NP O
20 Her PRP$ O O
20 oxygen NN B-NP O
20 uptake NN I-NP O
21 was VBD B-VP O
21 16.2 CD O O
21 milliliters NNS B-NP O
21 per IN B-VP O
21 kilogram NN B-NP O
21 per IN B-VP O
21 minute NN B-NP O
21 In IN B-VP O
21 4 CD O O
21 of IN B-VP O
21 October NNP B-NP O
21 , , O O
21 the DT B-NP O
21 patient NN I-NP O
22 underwent JJ B-NP O
22 right NN I-NP O
22 ventriculogram NN I-NP O
22 which WDT O O
22 showed VBD B-VP O
22 ejection NN B-NP O
22 fraction NN I-NP O
22 24% CD O O
23 and CC O O
23 global JJ B-NP O
23 hypokinesis NN I-NP O
23 On IN B-VP O
23 the DT B-NP O
23 day NN I-NP O
23 of IN B-VP O
23 admission NN B-NP O
23 , , O O
23 on IN B-VP O
23 28 CD O O
23 of IN B-VP O
23 May NNP B-NP O
23 , , O O
23 the DT B-NP O
24 patient NN I-NP O
24 complained VBD B-VP O
24 of IN B-VP O
24 4 CD O O
24 days NNS B-NP O
24 of IN B-VP O
24 diarrhea NN B-NP O
24 , , O O
24 nausea NN B-NP O
24 , , O O
24 vomiting VBG O O
24 and CC O O
25 malaise NN B-NP O
25 , , O O
25 followed VBN O O
25 by IN B-VP O
25 sharp JJ B-NP O
25 severe JJ I-NP O
25 chest NN I-NP O
25 pain NN I-NP O
25 in IN B-VP O
25 the DT B-NP O
25 mid NN I-NP O
25 chest NN I-NP O
25 below IN B-VP O
26 the DT B-NP O
26 left NN I-NP O
26 breast NN I-NP O
26 radiating VBG O O
26 to TO O O
26 the DT B-NP O
26 back NN I-NP O
26 , , O O
26 which WDT O O
26 was VBD B-VP O
26 relieved VBN O O
26 by IN B-VP O
26 lying VBG O O
27 on IN B-VP O
27 the DT B-NP O
27 left NN I-NP O
27 and CC O O
27 aggravated VBN O O
27 by IN B-VP O
27 leaning VBG O O
27 forward RB O O
27 or CC O O
27 lying VBG O O
27 on IN B-VP O
27 the DT B-NP O
28 right NN I-NP O
28 , , O O
28 also RB O O
28 worsened VBN O O
28 by IN B-VP O
28 deep JJ B-NP O
28 breathing NN I-NP O
28 and CC O O
28 cough NN B-NP O
28 , , O O
28 and CC O O
28 also RB O O
28 with IN B-VP O
29 ventral JJ B-NP O
29 palpation NN I-NP O
29 The DT B-NP O
29 patient NN I-NP O
29 claimed VBD B-VP O
29 that IN B-VP O
29 the DT B-NP O
29 pain NN I-NP O
29 had VBD B-VP O
29 never RB O O
30 gone VBN O O
30 away RB O O
30 in IN B-VP O
30 the DT O O
30 past JJ O O
30 12 CD O O
30 hours NNS B-NP O
30 , , O O
30 but CC O O
30 again RB O O
30 was VBD B-VP O
30 aggravated VBN O O
30 by IN B-VP O
30 certain JJ B-NP O
31 positions NNS I-NP O
31 PAST NNP I-NP O
31 MEDICAL NNP I-NP O
31 HISTORY NNP I-NP O
31 was VBD B-VP O
31 significant JJ O O
31 for IN B-VP O
32 cardiomyopathy NN B-NP O
32 , , O O
32 hypertension NN B-NP O
32 , , O O
32 gastritis NN B-NP O
32 , , O O
32 ex-intravenous JJ B-NP O
32 drug NN I-NP O
32 abuser NN I-NP O
33 for IN B-VP O
33 10 CD O O
33 years NNS B-NP O
33 , , O O
33 anemia NN B-NP O
33 , , O O
33 and CC O O
33 recent JJ B-NP O
33 crack NN I-NP O
33 cocaine NN I-NP O
33 use NN I-NP O
33 MEDICATIONS NNP I-NP O
33 ON NNP I-NP O
34 ADMISSION NNP I-NP O
34 included VBD B-VP O
34 Lasix NNP B-NP B-m
34 , , O O
34 Enalapril NNP B-NP B-m
34 and CC O O
34 digoxin NN B-NP B-m
34 ALLERGIES NNP I-NP O
34 were VBD B-VP O
34 no DT O O
35 known VBN O O
35 drug NN B-NP O
35 allergies NNS I-NP O
36 PHYSICAL NNP I-NP O
36 EXAMINATION: NNP I-NP O
36 The DT B-NP O
36 patient NN I-NP O
36 was VBD B-VP O
36 an DT B-NP O
36 obese JJ I-NP O
36 black JJ I-NP O
36 woman NN I-NP O
36 in IN B-VP O
36 no DT B-NP O
37 apparent JJ I-NP O
37 distress NN I-NP O
37 Blood NNP I-NP O
37 pressure NN I-NP O
37 was VBD B-VP O
38 162/100 CD O O
38 , , O O
38 heart NN B-NP O
38 rate NN I-NP O
38 90 CD O O
38 , , O O
38 respiratory NN B-NP O
38 rate NN I-NP O
38 24 CD O O
38 , , O O
38 oxygen NN B-NP O
38 saturation NN I-NP O
38 99% CD O O
38 , , O O
39 no DT B-NP O
39 pulsus NN I-NP O
39 Eyes NNS I-NP O
39 were VBD B-VP O
39 pupils NNS B-NP O
39 were VBD B-VP O
39 equal JJ O O
39 , , O O
39 round NN B-NP O
39 , , O O
39 reactive JJ O O
39 to TO O O
39 light JJ O O
39 , , O O
40 extraocular JJ B-NP O
40 movements NNS I-NP O
40 intact JJ O O
40 , , O O
40 muddy JJ B-NP O
40 sclera NN I-NP O
40 Neck NNP I-NP O
40 was VBD B-VP O
40 supple JJ O O
40 , , O O
41 jugular JJ B-NP O
41 venous JJ I-NP O
41 pressure NN I-NP O
41 was VBD B-VP O
41 8 CD O O
41 to TO O O
41 10 CD O O
41 centimeters NNS B-NP O
41 , , O O
41 carotids NNS B-NP O
41 were VBD B-VP O
41 2+ CD O O
42 bilaterally RB O O
42 Lungs NNS B-NP O
42 were VBD B-VP O
42 clear JJ O O
42 to TO O O
42 auscultation NN B-NP O
42 and CC O O
42 percussion NN B-NP O
43 except IN B-VP O
43 for IN B-VP O
43 a DT B-NP O
43 few JJ I-NP O
43 bibasilar JJ I-NP O
43 crackles NNS I-NP O
43 Heart NNP I-NP O
43 showed VBD B-VP O
43 normal JJ B-NP O
43 S1 NNP I-NP O
43 and CC O O
44 S2 NNP B-NP O
44 , , O O
44 no DT B-NP O
44 rubs NN I-NP O
44 , , O O
44 distant JJ B-NP O
44 heart NN I-NP O
44 sounds VBZ O O
44 , , O O
44 no DT B-NP O
44 murmurs NNS I-NP O
44 were VBD B-VP O
44 noted VBN O O
44 Abdomen NNP B-NP O
45 was VBD B-VP O
45 obese JJ O O
45 , , O O
45 soft JJ O O
45 , , O O
45 normal JJ B-NP O
45 bowel NN I-NP O
45 sounds NNS I-NP O
45 , , O O
45 she PRP O O
45 was VBD B-VP O
45 comfortable JJ O O
45 with IN B-VP O
45 deep JJ B-NP O
46 palpation NN I-NP O
46 diffusely RB O O
46 Extremities NNP B-NP O
46 showed VBD B-VP O
46 no DT B-NP O
46 edema NN I-NP O
46 Rectal NNP I-NP O
47 examination NN I-NP O
47 was VBD B-VP O
47 guaiac JJ B-NP O
47 negative JJ I-NP O
47 Neurologic NNP I-NP O
47 examination NN I-NP O
47 was VBD B-VP O
48 nonfocal JJ B-NP O
49 LABORATORY NNP I-NP O
49 EXAMINATION: NNP I-NP O
49 Sodium NNP I-NP O
49 was VBD B-VP O
49 137 CD O O
49 , , O O
49 potassium NN B-NP O
49 2.7 CD O O
49 , , O O
49 chloride RB O O
50 92 CD O O
50 , , O O
50 bicarbonate NN B-NP O
50 37 CD O O
50 , , O O
50 blood NN B-NP O
50 urea JJ B-NP O
50 nitrogen NN I-NP O
50 7 CD O O
50 , , O O
51 creatinine NN B-NP O
51 .9 NN I-NP O
51 , , O O
51 glucose JJ O O
51 159 CD O O
51 , , O O
51 AST NNP B-NP O
51 58 CD O O
51 , , O O
51 creatinine NN B-NP O
51 phosphokinase NN I-NP O
51 641 CD O O
51 , , O O
52 with IN B-VP O
52 23% CD O O
52 myocardial JJ B-NP O
52 bands NNS I-NP O
52 White NNP I-NP O
52 count NN I-NP O
52 was VBD B-VP O
52 4.6 CD O O
52 , , O O
52 hematocrit NN B-NP O
52 31.5 CD O O
52 , , O O
53 platelets NNS B-NP O
53 166 CD O O
53 , , O O
53 000 CD O O
53 , , O O
53 ESR NNP B-NP O
53 60 CD O O
53 , , O O
53 prothrombin JJ B-NP O
53 time NN I-NP O
53 11.3 CD O O
53 , , O O
53 partial JJ B-NP O
54 thromboplastin NN I-NP O
54 time NN I-NP O
54 18 CD O O
54 Chest NNP B-NP O
54 x-ray NN I-NP O
54 showed VBD B-VP O
54 a DT B-NP O
54 big JJ I-NP O
54 heart NN I-NP O
54 with IN B-VP O
54 mild JJ B-NP O
55 congestive JJ I-NP O
55 heart NN I-NP O
55 failure NN I-NP O
55 The DT B-NP O
55 electrocardiogram NN I-NP O
55 showed VBD B-VP O
55 T-wave NNP B-NP O
56 inversions NNS I-NP O
56 in IN B-VP O
56 I PRP O O
56 , , O O
56 II NNP B-NP O
56 , , O O
56 F NNP B-NP O
56 , , O O
56 L NNP B-NP O
56 , , O O
56 V2 NNP B-NP O
56 through IN B-VP O
56 V6 NNP B-NP O
56 , , O O
56 consistent NN B-NP O
56 with IN B-VP O
56 a DT O O
56 1990 CD O O
57 electrocardiogram NN B-NP O
57 done VBN O O
57 when WRB O O
57 she PRP O O
57 was VBD B-VP O
57 complaining VBG O O
57 of IN B-VP O
57 positional JJ B-NP O
57 chest NN I-NP O
58 pain NN I-NP O
58 similar JJ O O
58 to TO O O
58 the DT B-NP O
58 chest NN I-NP O
58 pain NN I-NP O
58 she PRP O O
58 is VBZ O O
58 having VBG O O
58 now RB O O
59 HOSPITAL NNP B-NP O
59 COURSE: NNP I-NP O
59 The DT B-NP O
59 patient NN I-NP O
59 was VBD B-VP O
59 admitted VBN O O
59 with IN B-VP O
59 the DT B-NP O
59 thought NN I-NP O
59 that IN B-VP O
60 her PRP$ O O
60 history NN B-NP O
60 was VBD B-VP O
60 consistent JJ O O
60 with IN B-VP O
60 pericarditis NN B-NP O
60 , , O O
60 but CC O O
61 was VBD B-VP O
61 also RB O O
61 worriesome JJ O O
61 for IN B-VP O
61 ischemia NN B-NP O
61 given VBN O O
61 her PRP$ O O
61 elevated JJ B-NP O
61 creatinine NN I-NP O
62 phosphokinase NN I-NP O
62 with IN B-VP O
62 myocardial JJ B-NP O
62 band NN I-NP O
62 fraction NN I-NP O
62 of IN B-VP O
62 23 CD O O
62 , , O O
62 and CC O O
62 her PRP$ O O
62 history NN B-NP O
63 of IN B-VP O
63 cocaine NN B-NP O
63 abuse IN B-VP O
63 Her NNP B-NP O
63 hospital NN I-NP O
63 course NN I-NP O
63 was VBD B-VP O
63 consistent JJ O O
63 with IN B-VP O
64 continuation NN B-NP O
64 of IN B-VP O
64 her PRP$ O O
64 pain NN B-NP B-r
64 through IN B-VP O
64 the DT B-NP O
64 first JJ I-NP O
64 day NN I-NP O
64 of IN B-VP O
64 hospitalization NN B-NP O
65 despite IN B-VP O
65 and CC O O
65 aggressive JJ B-NP O
65 anti-ischemic JJ I-NP B-m
65 regimen NNS I-NP I-m
65 It PRP O O
65 was VBD B-VP O
65 found VBN O O
65 that IN B-VP O
66 hermyocardial JJ B-NP O
66 band NN I-NP O
66 electrophoresis NN I-NP O
66 showed VBD B-VP O
66 no DT B-NP O
66 myocardial JJ I-NP O
66 band NN I-NP O
67 fraction NN I-NP O
67 detected VBN O O
67 , , O O
67 and CC O O
67 it PRP O O
67 was VBD B-VP O
67 decided VBN O O
67 that IN B-VP O
67 we PRP O O
67 would MD O O
67 shift VB O O
67 our PRP$ O O
68 therapy NN B-NP O
68 to TO O O
68 a DT O O
68 more RBR O O
68 anti-inflammatory JJ B-NP B-m
68 regimen NNS I-NP I-m
68 to TO O O
68 control VB O O
68 her PRP$ O B-r
69 pericarditis NN B-NP O
69 At IN B-VP O
69 that DT B-NP O
69 time NN I-NP O
69 , , O O
69 Indocin NNP B-NP B-m
69 was VBD B-VP O
69 started VBN O O
69 and CC O O
69 the DT B-NP B-r
69 chest NN I-NP I-r
69 pain NN I-NP I-r
70 resolved VBD B-VP O
70 With IN B-VP O
70 the DT B-NP O
70 resolution NN I-NP O
70 of IN B-VP O
70 her PRP$ O O
70 chest NN B-NP O
70 pain NN I-NP O
70 , , O O
70 the DT B-NP O
70 T-wave NNP I-NP O
71 inversions NNS I-NP O
71 corrected VBD B-VP O
71 The DT B-NP O
71 patient NN I-NP O
71 was VBD B-VP O
71 transerred VBN O O
71 to TO O O
71 the DT B-NP O
71 floor NN I-NP O
71 on IN B-VP O
72 Indocin NNP B-NP B-m
72 50 CD O B-do
72 milligrams NNS B-NP I-do
72 3 CD O B-f
72 times NNS B-NP I-f
72 a DT B-NP I-f
72 day NN I-NP I-f
72 , , O O
72 aspirin NN B-NP B-m
72 , , O O
72 Bactrim NNP B-NP B-m
72 , , O O
72 Enalapril NNP B-NP B-m
73 and CC O O
73 Carafate NNP B-NP B-m
73 and CC O O
73 remained VBD B-VP O
73 without IN B-VP O
73 chest JJS B-NP O
73 pain NN I-NP O
73 for IN B-VP O
73 the DT O O
73 next JJ O O
73 2 CD O O
73 days NNS B-NP O
74 She PRP O O
74 was VBD B-VP O
74 also RB O O
74 seen VBN O O
74 by IN B-VP O
74 the DT B-NP O
74 ACE NNP I-NP O
74 team NN I-NP O
74 in IN B-VP O
74 consultation NN B-NP O
74 about IN B-VP O
74 her PRP$ O O
74 drug NN B-NP O
75 and CC O O
75 alcohol NN B-NP O
75 problem NN I-NP O
75 , , O O
75 and CC O O
75 it PRP O O
75 was VBD B-VP O
75 decided VBN O O
75 that IN B-VP O
75 she PRP O O
75 would MD O O
75 be VB O O
76 discharged VBN O O
76 on IN B-VP O
76 28 CD O O
76 of IN B-VP O
76 September NNP B-NP O
76 , , O O
76 after IN B-VP O
76 arrangement NN B-NP O
76 for IN B-VP O
76 follow-up NN B-NP O
76 with IN B-VP O
76 the DT B-NP O
76 ACE NNP I-NP O
77 team NN I-NP O
78 DISPOSITION: NNP I-NP O
78 The DT B-NP O
78 patient NN I-NP O
78 was VBD B-VP O
78 discharged VBN O O
78 to TO O O
78 home NN B-NP O
78 MEDICATIONS NNP I-NP O
78 ON NNP I-NP O
79 DISCHARGE NNP I-NP O
79 included VBD B-VP O
79 aspirin NN B-NP B-m
79 , , O O
79 Indocin NNP B-NP B-m
79 50 CD O B-do
79 milligrams NNS B-NP I-do
79 by IN B-VP B-mo
80 mouth NN B-NP O
80 3 CD O B-f
80 times NNS B-NP I-f
80 a DT B-NP I-f
80 day NN I-NP I-f
80 , , O O
80 Enalapril NNP B-NP B-m
80 10 CD O B-do
80 milligrams NNS B-NP I-do
80 by IN B-VP B-mo
80 mouth JJ O I-mo
80 each DT B-NP B-f
80 day NN I-NP I-f
80 , , O O
81 Carafate NNP B-NP B-m
81 1 CD O B-do
81 gram NN B-NP I-do
81 by IN B-VP B-mo
81 mouth NN B-NP I-mo
81 4 CD O B-f
81 times NNS B-NP I-f
81 a DT B-NP I-f
81 day NN I-NP I-f
81 The DT B-NP O
81 patient NN I-NP O
81 is VBZ O O
81 to TO O O
82 FOLLOW-UP JJ O O
82 with IN B-VP O
82 Dr NNP B-NP O
82 Dewitt NNP I-NP O
82 A NNP I-NP O
82 Sisler NNP I-NP O
83 Dictated NNP I-NP O
83 By: NNP I-NP O
83 MIRELES NNP I-NP O
84 Attending: NNP I-NP O
84 BERNARDO NNP I-NP O
84 R NNP I-NP O
84 MOULD NNP I-NP O
84 , , O O
84 M.D NNP B-NP O
84 KR27 NNP I-NP O
84 AB563/1658 NNP I-NP O
85 Batch: NNP I-NP O
85 3411 CD O O
85 Index NNP B-NP O
85 No NNP I-NP O
85 UXU068574 NNP I-NP O
85 D: NNP I-NP O
85 7/22/92 CD O O
86 T: NNP B-NP O
86 6/1/92 CD O O
87 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #895892 VBZ O O
2 121670578 CD O O
2 SHAHC NNP B-NP O
2 33200811 CD O O
2 049559 CD O O
2 8/10/1998 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 PANCREATITIS NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/26/1998 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 7/12/1998 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 The DT B-NP O
4 patient NN I-NP O
4 is VBZ O O
4 a DT O O
4 65 CD O O
4 year NN B-NP O
4 old JJ B-NP O
5 African-American JJ I-NP O
5 female NN I-NP O
5 with IN B-VP O
5 a DT B-NP O
6 history NN I-NP O
6 of IN B-VP O
6 chronic JJ B-NP O
6 pancreatitis NN I-NP O
6 who WP O O
6 was VBD B-VP O
6 recently RB O O
6 admitted VBN O O
6 to TO O O
6 the DT B-NP O
7 Staho NNP I-NP O
7 Health NNP I-NP O
7 10 CD O O
7 of IN B-VP O
7 November NNP B-NP O
7 to TO O O
7 3 CD O O
7 of IN B-VP O
7 May NNP B-NP O
7 for IN B-VP O
7 her PRP$ O O
7 chronic JJ B-NP O
8 pancreatitis NN I-NP O
8 who WP O O
8 returned VBD B-VP O
8 on IN B-VP O
8 the DT O O
8 24 CD O O
8 of IN B-VP O
8 January NNP B-NP O
8 with IN B-VP O
8 recurrent JJ B-NP O
8 abdominal JJ I-NP O
8 pain NN I-NP O
9 and CC O O
9 symptoms NNS B-NP O
9 consistent JJ O O
9 with IN B-VP O
9 her PRP$ O O
9 chronic JJ B-NP O
9 pancreatitis NN I-NP O
9 Prior NNP I-NP O
10 studies NNS I-NP O
10 by IN B-VP O
10 abdominal JJ B-NP O
10 CT NNP I-NP O
10 scan NN I-NP O
10 had VBD B-VP O
10 showed VBN O O
10 findings NNS B-NP O
10 consistent JJ O O
10 with IN B-VP O
11 chronic JJ B-NP O
11 pancreatitis NN I-NP O
11 , , O O
11 such JJ O O
11 as IN B-VP O
11 multiple JJ B-NP O
11 calcifications NNS I-NP O
11 and CC O O
11 the DT B-NP O
12 setting NN I-NP O
12 of IN B-VP O
12 abdominal JJ B-NP O
12 pain NN I-NP O
12 , , O O
12 swelling VBG O O
12 and CC O O
12 peripancreatic JJ O O
12 increased VBN O O
13 attenuation NN B-NP O
13 Findings NNP I-NP O
13 consistent NN I-NP O
13 with IN B-VP O
13 acute JJ B-NP O
13 pancreatitis NN I-NP O
13 The DT B-NP O
14 patient NN I-NP O
14 was VBD B-VP O
14 admitted VBN O O
14 initially RB O O
14 to TO O O
14 the DT B-NP O
14 medical JJ I-NP O
14 service NN I-NP O
15 On IN B-VP O
15 admission NN B-NP O
15 , , O O
15 the DT B-NP O
15 patient NN I-NP O
15 had VBD B-VP O
15 a DT B-NP O
15 low JJ I-NP O
15 grade NN I-NP O
15 temperature NN I-NP O
15 of IN B-VP O
15 100.2 CD O O
15 , , O O
15 was VBD B-VP O
16 tachycardic JJ O O
16 with IN B-VP O
16 a DT B-NP O
16 heart NN I-NP O
16 rate NN I-NP O
16 of IN B-VP O
16 131 CD O O
16 , , O O
16 respiratory NN B-NP O
16 rate NN I-NP O
16 20 CD O O
16 , , O O
16 blood NN B-NP O
17 pressure NN I-NP O
17 132/80 CD O O
17 Her NNP B-NP O
17 exam NN I-NP O
17 was VBD B-VP O
17 remarkable JJ O O
17 for IN B-VP O
17 decreased JJ B-NP O
17 breath NN I-NP O
18 sounds NNS I-NP O
18 at IN B-VP O
18 the DT B-NP O
18 right JJ I-NP O
18 base NN I-NP O
18 and CC O O
18 a DT B-NP O
18 few JJ I-NP O
18 scattered JJ I-NP O
18 rhonchi NNS I-NP O
18 Cardiac NNP I-NP O
18 exam NN I-NP O
19 was VBD B-VP O
19 significant JJ O O
19 for IN B-VP O
19 tachycardia NN B-NP O
19 There EX O O
19 was VBD B-VP O
19 no DT B-NP O
19 murmurs NN I-NP O
19 , , O O
19 rubs NN B-NP O
19 or CC O O
20 gallops NNS B-NP O
20 appreciated VBN O O
20 Abdominal NNP B-NP O
20 exam NN I-NP O
20 was VBD B-VP O
20 significant JJ O O
20 for IN B-VP O
20 decreased JJ B-NP O
21 bowel NN I-NP O
21 sounds VBZ O O
21 She PRP O O
21 had VBD B-VP O
21 abdominal JJ B-NP O
21 tenderness NN I-NP O
21 in IN B-VP O
21 the DT B-NP O
21 midepigastric JJ I-NP O
22 region NN I-NP O
22 with IN B-VP O
22 guarding VBG O O
22 Rectal NNP B-NP O
22 exam NN I-NP O
22 was VBD B-VP O
22 guaiac JJ O O
22 negative JJ O O
22 in IN B-VP O
22 the DT B-NP O
23 emergency NN I-NP O
23 room NN I-NP O
24 LABORATORY NNP I-NP O
24 DATA: NNP I-NP O
24 Sodium NNP I-NP O
24 128 CD O O
24 , , O O
24 potassium NN B-NP O
24 4.1 CD O O
24 , , O O
24 chloride RB O O
24 95 CD O O
24 , , O O
25 bicarb NN B-NP O
25 26 CD O O
25 , , O O
25 BUN NNP B-NP O
25 23 CD O O
25 , , O O
25 creatinine NN B-NP O
25 0.8 CD O O
25 , , O O
25 glucose RB O O
25 433 CD O O
25 , , O O
26 WBC NNP B-NP O
26 17.8 CD O O
26 , , O O
26 hematocrit NN B-NP O
26 33 CD O O
26 , , O O
26 platelets NNS B-NP O
26 370 CD O O
26 Liver NNP B-NP O
26 function NN I-NP O
26 tests NNS I-NP O
26 had VBD B-VP O
27 an DT B-NP O
27 alk JJ I-NP O
27 level NN I-NP O
27 of IN B-VP O
27 434 CD O O
27 , , O O
27 T-bili NNP B-NP O
27 was VBD B-VP O
27 0.6 CD O O
27 , , O O
27 D-bili NNP B-NP O
27 was VBD B-VP O
27 0.2 CD O O
27 , , O O
27 lipase NN B-NP O
27 was VBD B-VP O
28 123 CD O O
28 , , O O
28 amylase NN B-NP O
28 was VBD B-VP O
28 37 CD O O
29 The DT B-NP O
29 patient NN I-NP O
29 had VBD B-VP O
29 an DT B-NP O
29 ultrasound NN I-NP O
29 in IN B-VP O
29 the DT B-NP O
29 Emergency NNP I-NP O
29 Department NNP I-NP O
29 which WDT O O
30 showed VBD B-VP O
30 no DT B-NP O
30 gallstones NNS I-NP O
30 Gallbladder NNP I-NP O
30 that WDT O O
30 was VBD B-VP O
30 mildly RB O O
30 distended VBD B-VP O
30 A NNP B-NP O
31 common JJ B-NP O
31 bile NN I-NP O
31 duct NN I-NP O
31 that WDT O O
31 was VBD B-VP O
31 dilated VBN O O
31 to TO O O
31 7 CD O O
31 mm NN B-NP O
31 as RB O O
31 well RB O O
31 as IN B-VP O
31 intrahepatic JJ B-NP O
32 duct NN I-NP O
32 dilatation NN I-NP O
32 In IN B-VP O
32 addition NN B-NP O
32 a DT O O
32 6 CD O O
32 cm NN B-NP O
32 cyst NN I-NP O
32 was VBD B-VP O
32 identified VBN O O
32 in IN B-VP O
32 the DT B-NP O
33 region NN I-NP O
33 of IN B-VP O
33 the DT B-NP O
33 pancreatic JJ I-NP O
33 head NN I-NP O
33 EKG NNP I-NP O
33 showed VBD B-VP O
33 her PRP$ O O
33 to TO O O
33 be VB O O
33 in IN B-VP O
33 sinus JJ B-NP O
34 tachycardia NN I-NP O
34 with IN B-VP O
34 the DT B-NP O
34 rate NN I-NP O
34 of IN B-VP O
34 122 CD O O
34 She PRP O O
34 had VBD B-VP O
34 a DT O O
34 left VBN O O
34 axis NN B-NP O
34 deviation NN I-NP O
34 in IN B-VP O
35 Qs NNP B-NP O
35 and CC O O
35 V1 NNP B-NP O
36 PAST NNP I-NP O
36 MEDICAL NNP I-NP O
36 HISTORY: NNP I-NP O
36 Significant NNP I-NP O
36 for IN B-VP O
36 pancreatitis NN B-NP O
36 , , O O
36 asthma NN B-NP O
36 , , O O
37 insulin NN B-NP O
37 dependent JJ O O
37 diabetes VBZ O O
37 mellitus NN B-NP O
37 , , O O
37 history NN B-NP O
38 of IN B-VP O
38 vascular JJ B-NP O
38 necrosis NN I-NP O
38 of IN B-VP O
38 both DT B-NP O
38 hips NNS I-NP O
38 , , O O
38 status NN B-NP O
38 post NN I-NP O
38 a DT B-NP O
38 total JJ I-NP O
38 hip NN I-NP O
39 replacement NN I-NP O
39 on IN B-VP O
39 the DT B-NP O
39 right NN I-NP O
39 as RB O O
39 well RB O O
39 as IN B-VP O
39 a DT B-NP O
39 total JJ I-NP O
39 hip NN I-NP O
39 replacement NN I-NP O
39 on IN B-VP O
39 the DT B-NP O
40 left NN I-NP O
40 She PRP O O
40 has VBZ O O
40 known VBN O O
40 coronary JJ B-NP O
40 artery NN I-NP O
40 disease NN I-NP O
40 , , O O
40 history NN B-NP O
40 of IN B-VP O
40 chronic JJ B-NP O
41 obstructive JJ I-NP O
41 pulmonary JJ I-NP O
41 disease NN I-NP O
41 , , O O
41 history NN B-NP O
41 of IN B-VP O
41 GI NNP B-NP O
41 bleed NN I-NP O
41 Status NNP I-NP O
41 post NN I-NP O
41 a DT B-NP O
42 Nissen NNP I-NP O
42 fundoplication NN I-NP O
42 with IN B-VP O
42 redo JJ B-NP O
42 Hypertension NNP I-NP O
42 Alpha NNP I-NP O
42 thalassemia JJ B-NP O
43 History NNP I-NP O
43 of IN B-VP O
43 congestive JJ B-NP O
43 heart NN I-NP O
43 failure NN I-NP O
43 Chronic NNP I-NP O
43 low NN I-NP O
43 back RB O O
43 pain NN B-NP O
44 secondary JJ O O
44 to TO O O
44 spinal JJ B-NP O
44 stenosis NN I-NP O
45 MEDICATIONS: NNP I-NP O
45 Metformin NNP I-NP B-m
45 , , O O
45 Atrovent NNP B-NP B-m
45 , , O O
45 Albuterol NNP B-NP B-m
45 , , O O
45 Flovent NNP B-NP B-m
45 , , O O
45 Elavil NNP B-NP B-m
45 , , O O
46 Cisapride NNP B-NP B-m
46 , , O O
46 Flexeril NNP B-NP B-m
46 , , O O
46 Axid NNP B-NP B-m
46 , , O O
46 NPH NNP B-NP B-m
46 insulin NN I-NP I-m
46 , , O O
46 Cardizem NNP B-NP B-m
46 CD NNP I-NP I-m
46 , , O O
47 lisinopril NN B-NP B-m
47 , , O O
47 Lasix NNP B-NP B-m
47 , , O O
47 magnesium NN B-NP B-m
47 oxide NN I-NP I-m
47 , , O O
47 Percocet NNP B-NP B-m
47 , , O O
47 Premarin NNP B-NP B-m
47 , , O O
47 Provera NNP B-NP B-m
47 , , O O
48 Prilosec NNP B-NP B-m
48 , , O O
48 Lipitor NNP B-NP B-m
48 , , O O
48 Tums NNP B-NP B-m
48 and CC O O
48 multi-vitamins NNS B-NP B-m
49 ALLERGIES: NNP I-NP O
49 Aspirin NNP I-NP O
49 causes VBZ O O
49 facial JJ B-NP O
49 swelling NN I-NP O
49 , , O O
49 palpitations NNS B-NP O
49 , , O O
50 reactive JJ B-NP O
50 airway NN I-NP O
50 disease NN I-NP O
50 Ibuprofen NNP I-NP O
50 causing VBG O O
50 GI NNP B-NP O
50 bleed NN I-NP O
51 meperidine NN I-NP O
51 causing VBG O O
51 itching NN B-NP O
51 , , O O
51 prednisone NN B-NP O
51 causing NN I-NP O
51 myalgias NN I-NP O
51 , , O O
52 arthralgias NN B-NP O
52 , , O O
52 osteoporosis NN B-NP O
52 Penicillin NNP I-NP O
52 causes VBZ O O
52 edema JJ B-NP O
52 Fophonomide NNP I-NP O
53 causes VBZ O O
53 itching VBG O O
53 Codeine NNP B-NP O
53 causes VBZ O O
53 itching VBG O O
53 Morphine NNP B-NP O
53 causes VBZ O O
53 itching VBG O O
54 SOCIAL NNP B-NP O
54 HISTORY: NNP I-NP O
54 She PRP O O
54 does VBZ O O
54 not RB O O
54 drink VB O O
54 or CC O O
54 use VB O O
54 tobacco NN B-NP O
54 She PRP O O
54 has VBZ O O
54 two CD O O
55 children NNS B-NP O
55 She PRP O O
55 lives VBZ O O
55 alone RB O O
56 After IN B-VP O
56 admission NN B-NP O
56 to TO O O
56 the DT B-NP O
56 medical JJ I-NP O
56 service NN I-NP O
56 , , O O
56 she PRP O O
56 was VBD B-VP O
56 seen VBN O O
56 by IN B-VP O
56 the DT B-NP O
57 surgical JJ I-NP O
57 service NN I-NP O
57 in IN B-VP O
57 consultation NN B-NP O
57 Based VBN O O
57 on IN B-VP O
57 clinical JJ B-NP O
57 findings NNS I-NP O
57 and CC O O
58 laboratory NN B-NP O
58 values NNS I-NP O
58 , , O O
58 a DT B-NP O
58 repeat NN I-NP O
58 abdominal JJ B-NP O
58 CT NNP I-NP O
58 study NN I-NP O
58 was VBD B-VP O
58 ordered VBN O O
58 with IN B-VP O
58 a DT B-NP O
59 plan NN I-NP O
59 for IN B-VP O
59 CT NNP B-NP O
59 guided VBD B-VP O
59 drainage NN B-NP O
59 to TO O O
59 rule VB O O
59 out RP O O
59 a DT B-NP O
59 pancreatic JJ I-NP O
59 abscess NN I-NP O
59 The DT B-NP O
60 CT NNP I-NP O
60 guided VBD B-VP O
60 aspirate NN B-NP O
60 appeared VBD B-VP O
60 purulent NN B-NP O
60 and CC O O
60 was VBD B-VP O
60 sent VBN O O
60 for IN B-VP O
60 gram NN B-NP O
60 and CC O O
61 cultures NNS B-NP O
61 Gram NNP I-NP O
61 stain NN I-NP O
61 was VBD B-VP O
61 positive JJ O O
61 for IN B-VP O
61 gram JJ B-NP O
61 negative JJ I-NP O
61 rods NNS I-NP O
61 and CC O O
61 gram JJ B-NP O
62 positive JJ I-NP O
62 cocci NN I-NP O
62 in IN B-VP O
62 pairs NNS B-NP O
62 actually RB O O
62 growing VBG O O
62 out RP O O
62 Strep NNP B-NP O
62 viridans NNS I-NP O
62 and CC O O
63 Klebsiella NNP B-NP O
64 While IN B-VP O
64 in IN B-VP O
64 the DT B-NP O
64 hospital NN I-NP O
64 , , O O
64 the DT B-NP O
64 patient NN I-NP O
64 also RB O O
64 developed VBD B-VP O
64 a DT B-NP B-r
64 urinary JJ I-NP O
64 tract NN I-NP O
65 infection NN I-NP O
65 with IN B-VP O
65 yeast NN B-NP O
65 , , O O
65 and CC O O
65 was VBD B-VP O
65 started VBN O O
65 on IN B-VP O
65 fluconazole NN B-NP B-m
65 This DT O O
65 too RB O O
65 , , O O
66 she PRP O O
66 will MD O O
66 be VB O O
66 discharged VBN O O
66 with IN B-VP O
66 , , O O
66 to TO O O
66 complete VB O O
66 a DT B-NP B-du
66 seven-day JJ I-NP I-du
66 course NN I-NP I-du
66 As NNP I-NP O
67 well RB O O
67 , , O O
67 the DT B-NP O
67 patient NN I-NP O
67 was VBD B-VP O
67 felt VBN O O
67 to TO O O
67 have VB O O
67 peptic JJ B-NP B-r
67 peptic JJ I-NP B-r
67 ulcer NN I-NP I-r
67 ulcer JJ B-NP I-r
67 disease NN I-NP I-r
67 disease NN I-NP I-r
67 , , O O
67 and CC O O
67 was VBD B-VP O
68 begun VBN O O
68 on IN B-VP O
68 H NNP B-NP O
68 pylori JJ B-NP O
68 therapy NN I-NP O
68 of IN B-VP O
68 Biaxin NNP B-NP B-m
68 and CC O O
68 bismuth NN B-NP B-m
68 , , O O
68 both DT O O
68 of IN B-VP O
68 which WDT O O
68 she PRP O O
69 will MD O O
69 be VB O O
69 discharged VBN O O
69 on IN B-VP O
69 to TO O O
69 complete VB O O
69 a DT O B-du
69 a DT B-NP B-du
69 seven-day JJ I-NP I-du
69 seven-day JJ I-NP I-du
69 course NN I-NP I-du
69 course NN I-NP I-du
69 At IN B-VP O
69 the DT B-NP O
69 time NN I-NP O
70 of IN B-VP O
70 discharge NN B-NP O
70 , , O O
70 the DT B-NP O
70 patient NN I-NP O
70 is VBZ O O
70 relatively RB O O
70 pain-free JJ O O
70 , , O O
70 tolerating VBG O O
70 a DT B-NP O
71 p.o NN I-NP O
71 diet NN I-NP O
71 , , O O
71 and CC O O
71 afebrile IN B-VP O
71 The DT B-NP O
71 plan NN I-NP O
71 is VBZ O O
71 to TO O O
71 discharge VB O O
71 her PRP O O
71 to TO O O
71 the DT B-NP O
72 Triadnockum NNP I-NP O
72 for IN B-VP O
72 rehabilitation NN B-NP O
72 on IN B-VP O
72 her PRP$ O O
72 usual JJ B-NP O
73 medications NNS I-NP O
73 , , O O
73 plus CC O O
73 the DT B-NP O
73 above-mentioned JJ I-NP O
73 antibiotics NNS I-NP B-m
73 She PRP O O
73 will MD O O
73 follow VB O O
74 up RP O O
74 in IN B-VP O
74 the DT B-NP O
74 Gug NNP I-NP O
74 University NNP I-NP O
74 in IN B-VP O
74 the DT O O
74 next JJ O O
74 one CD O O
74 to TO O O
74 two CD O O
74 weeks NNS B-NP O
74 , , O O
74 and CC O O
75 will MD O O
75 in IN B-VP O
75 addition NN B-NP O
75 be VB O O
75 followed VBN O O
75 by IN B-VP O
75 her PRP$ O O
75 primary JJ B-NP O
75 care NN I-NP O
75 physician NN I-NP O
75 , , O O
75 Dr NNP B-NP O
76 Lorenzo NNP I-NP O
77 Dictated NNP I-NP O
77 By: NNP I-NP O
77 COLEMAN NNP I-NP O
77 D NNP I-NP O
77 HONES NNP I-NP O
77 , , O O
77 M.D NNP B-NP O
77 AM50 NNP I-NP O
78 Attending: NNP I-NP O
78 STERLING NNP I-NP O
78 W NNP I-NP O
78 DONSON NNP I-NP O
78 , , O O
78 M.D NNP B-NP O
78 MS98 NNP I-NP O
79 XC841/6428 NNP I-NP O
80 Batch: NNP I-NP O
80 4574 CD O O
80 Index NNP B-NP O
80 No NNP I-NP O
80 MLULD48NDM NNP I-NP O
80 D: NNP I-NP O
80 1/15/98 CD O O
81 T: NNP B-NP O
81 1/15/98 CD O O
82 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #898277 VBZ O O
4 696082464 CD O O
4 WOMH NNP B-NP O
4 78090082 CD O O
4 896867 CD O O
4 4/25/1996 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/29/1996 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 9/18/1996 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 Pulmonary NNP I-NP O
7 edema NN I-NP O
8 This DT O O
8 is VBZ O O
8 a DT O O
8 51 CD O O
8 year-old JJ B-NP O
8 female NN I-NP O
8 with IN B-VP O
8 fibromyalgia NN B-NP O
8 , , O O
8 hypertension NN B-NP O
8 and CC O O
9 migraine NN B-NP O
9 headaches NNS I-NP O
9 She PRP O O
9 reports VBZ O O
9 two CD O O
9 months NNS B-NP O
9 of IN B-VP O
9 dyspnea NN B-NP O
9 at IN B-VP O
9 night NN B-NP O
9 , , O O
10 paroxysmal JJ B-NP O
10 nocturnal JJ I-NP O
10 dyspnea NN I-NP O
10 , , O O
10 and CC O O
10 orthopnea NN B-NP O
10 Over IN B-VP O
10 the DT O O
10 past JJ O O
10 two CD O O
11 weeks NNS B-NP O
11 prior RB O O
11 to TO O O
11 admission NN B-NP O
11 , , O O
11 the DT B-NP O
11 episodes NNS I-NP O
11 have VBP O O
11 been VBN O O
11 becoming VBG O O
11 worse RBR O O
12 On IN B-VP O
12 the DT B-NP O
12 day NN I-NP O
12 of IN B-VP O
12 admission NN B-NP O
12 , , O O
12 she PRP O O
12 had VBD B-VP O
12 an DT B-NP O
12 episode NN I-NP O
12 of IN B-VP O
12 severe JJ B-NP O
12 substernal JJ I-NP O
13 chest NN I-NP O
13 pressure NN I-NP O
13 associated VBN O O
13 with IN B-VP O
13 shortness NN B-NP O
13 of IN B-VP O
13 breath NN B-NP O
13 after IN B-VP O
13 carrying VBG O O
14 water NN B-NP O
14 bottles NNS I-NP O
14 from IN B-VP O
14 her PRP$ O O
14 car NN B-NP O
14 She PRP O O
14 presented VBD B-VP O
14 to TO O O
14 the DT B-NP O
14 Emergency NNP I-NP O
14 Room NNP I-NP O
15 for IN B-VP O
15 evaluation NN B-NP O
15 In IN B-VP O
15 the DT B-NP O
15 Emergency NNP I-NP O
15 Department NNP I-NP O
15 , , O O
15 V/Q NNP B-NP O
15 scan NN I-NP O
15 was VBD B-VP O
15 very RB O O
15 low JJ B-NP O
16 probability NN I-NP O
16 She PRP O O
16 had VBD B-VP O
16 lower JJR B-NP O
16 extremity NN I-NP O
16 noninvasive JJ B-NP O
16 studies NNS I-NP O
16 which WDT O O
17 were VBD B-VP O
17 also RB O O
17 unremarkable JJ B-NP O
18 PAST NNP I-NP O
18 MEDICAL NNP I-NP O
18 HISTORY: NNP I-NP O
18 Fibromyalgia NNP I-NP O
18 , , O O
18 hypertension NN B-NP O
18 , , O O
18 mild JJ B-NP O
18 asthma NN I-NP O
18 , , O O
19 osteoarthritis NN B-NP O
19 of IN B-VP O
19 the DT B-NP O
19 knee NN I-NP O
19 , , O O
19 migraines NNS B-NP O
19 , , O O
19 total JJ B-NP O
20 abdominal JJ I-NP O
20 hysterectomy NN I-NP O
20 , , O O
20 bilateral JJ B-NP O
20 salpingo-oophorectomy NN I-NP O
20 , , O O
20 chronic JJ B-NP O
21 fatigue NN I-NP O
21 syndrome NN I-NP O
21 , , O O
21 deep RB O O
21 venous JJ B-NP O
21 thrombosis NN I-NP O
21 in IN B-VP O
21 the DT B-NP O
21 right NN I-NP O
21 lower JJR B-NP O
22 extremity NN I-NP O
22 , , O O
22 history NN B-NP O
22 of IN B-VP O
22 gallstones NNS B-NP O
22 Medications NNS I-NP O
22 on IN B-VP O
22 admission NN B-NP O
23 included VBD B-VP O
23 Nortriptyline NNP B-NP B-m
23 , , O O
23 methyldopa NN B-NP B-m
23 , , O O
23 hydrochlorothiazide NN B-NP B-m
23 , , O O
23 Zantac NNP B-NP B-m
23 , , O O
24 estrogen NN B-NP B-m
24 , , O O
24 Advil NNP B-NP B-m
24 , , O O
24 ALternaGEL NNP B-NP B-m
25 SOCIAL NNP I-NP O
25 HISTORY: NNP I-NP O
25 She PRP O O
25 works VBZ O O
25 as IN B-VP O
25 a DT B-NP O
25 supervisor NN I-NP O
25 to TO O O
25 home NN B-NP O
25 health NN I-NP O
25 aides NNS I-NP O
26 FAMILY NNP I-NP O
26 HISTORY: NNP I-NP O
26 Notable NNP I-NP O
26 for IN B-VP O
26 coronary JJ B-NP O
26 artery NN I-NP O
26 disease NN I-NP O
27 REVIEW NNP I-NP O
27 OF NNP I-NP O
27 SYSTEMS: NNP I-NP O
27 The DT B-NP O
27 patient NN I-NP O
27 smokes VBZ O O
27 one CD O O
27 and CC O O
27 one-half JJ B-NP O
27 packs NNS I-NP O
27 per IN B-VP O
28 day NN B-NP O
28 for IN B-VP O
28 30 CD O O
28 years NNS B-NP O
29 PHYSICAL NNP I-NP O
29 EXAMINATION: NNP I-NP O
29 Temperature NNP I-NP O
29 97.4 CD O O
29 , , O O
29 respiratory NN B-NP O
29 rate NN I-NP O
29 22 CD O O
29 , , O O
30 heart NN B-NP O
30 rate NN I-NP O
30 100 CD O O
30 , , O O
30 blood NN B-NP O
30 pressure NN I-NP O
30 150/90 CD O O
31 HEENT: NNP B-NP O
31 Anicteric NNP I-NP O
31 LUNGS: NNP I-NP O
31 In IN B-VP O
31 the DT B-NP O
31 Emergency NNP I-NP O
31 Room NNP I-NP O
31 were VBD B-VP O
31 notable JJ O O
31 for IN B-VP O
32 bibasilar JJ B-NP O
32 crackles NNS I-NP O
32 about IN B-VP O
32 one-quarter NN B-NP O
32 of IN B-VP O
32 the DT B-NP O
32 way NN I-NP O
32 up RP O O
33 CARDIOVASCULAR: NNP B-NP O
33 Regular NNP I-NP O
33 rate NN I-NP O
33 and CC O O
33 rhythm NN B-NP O
33 II/VI NNP I-NP O
33 systolic JJ B-NP O
33 murmur NN I-NP O
34 No NNP I-NP O
34 rubs NN I-NP O
34 or CC O O
34 gallops NNS B-NP O
34 ABDOMEN: NNP I-NP O
34 Benign NNP I-NP O
34 RECTAL: NNP I-NP O
34 Guaiac NNP I-NP O
34 negative NN I-NP O
34 in IN B-VP O
35 the DT B-NP O
35 Emergency NNP I-NP O
35 Department NNP I-NP O
35 EXTREMITIES: NNP I-NP O
35 1+ CD O O
35 pedal NN B-NP O
35 edema NN I-NP O
36 bilaterally RB O O
36 , , O O
36 right RB O O
36 greater JJR O O
36 than IN B-VP O
36 left VBD B-VP O
36 NEUROLOGICAL: NNP B-NP O
36 Nonfocal NNP I-NP O
37 LABORATORY NNP I-NP O
37 DATA: NNP I-NP O
37 On IN B-VP O
37 admission NN B-NP O
37 , , O O
37 hematocrit NN B-NP O
37 41.6 CD O O
37 , , O O
37 BUN NNP B-NP O
37 13 CD O O
37 , , O O
37 creatinine NN B-NP O
38 0.6 CD O O
38 Chest NNP B-NP O
38 x-ray NN I-NP O
38 showed VBD B-VP O
38 mild JJ B-NP O
38 pulmonary JJ I-NP O
38 edema NN I-NP O
39 Electrocardiogram NNP I-NP O
39 showed VBD B-VP O
39 normal JJ B-NP O
39 sinus NN I-NP O
39 rhythm NN I-NP O
39 at IN B-VP O
39 91 CD O O
39 , , O O
39 no DT B-NP O
39 ischemic JJ I-NP O
40 changes NNS I-NP O
41 HOSPITAL NNP I-NP O
41 COURSE: NNP I-NP O
41 The DT B-NP O
41 patient NN I-NP O
41 was VBD B-VP O
41 admitted VBN O O
41 for IN B-VP O
41 rule NN B-NP O
41 out IN B-VP O
42 myocardial JJ B-NP O
42 infarction NN I-NP O
42 She PRP O O
42 had VBD B-VP O
42 serial JJ B-NP O
42 CPKs NNP I-NP O
42 which WDT O O
43 were VBD B-VP O
43 all DT O O
43 negative JJ O O
43 At IN B-VP O
43 that DT B-NP O
43 point NN I-NP O
43 , , O O
43 her PRP$ O O
43 monitor NN B-NP O
43 was VBD B-VP O
43 then RB O O
44 discontinued VBN O O
44 The DT B-NP O
44 patient's NN I-NP O
44 pulmonary JJ B-NP B-r
44 edema NN I-NP I-r
44 was VBD B-VP O
44 treated VBN O O
44 with IN B-VP O
44 two CD O B-du
45 doses NNS B-NP O
45 of IN B-VP O
45 intravenous JJ B-NP B-mo
45 Lasix NNP I-NP B-m
45 ( ( O O
45 20 CD O B-do
45 milligrams NNS B-NP I-do
45 each DT O O
45 ) ) O O
45 This DT O O
45 resulted VBN O O
45 in IN B-VP O
46 a DT B-NP O
46 moderate JJ I-NP O
46 diuresis NN I-NP O
46 and CC O O
46 resolution NN B-NP O
46 of IN B-VP O
46 her PRP$ O O
46 shortness NN B-NP O
46 of IN B-VP O
46 breath NN B-NP O
47 symptoms NNS I-NP O
47 She PRP O O
47 then RB O O
47 underwent VBD B-VP O
47 an DT B-NP O
47 exercise NN I-NP O
47 test NN I-NP O
47 This DT O O
47 was VBD B-VP O
47 done VBN O O
47 with IN B-VP O
48 arm NN B-NP O
48 ergometry NN I-NP O
48 ( ( O O
48 30 CD O O
48 watts NN B-NP O
48 ) ) O O
48 She PRP O O
48 went VBD B-VP O
48 ten JJ B-NP O
48 minutes NNS I-NP O
48 , , O O
48 stopped VBD B-VP O
48 secondary JJ O O
49 to TO O O
49 arm VB O O
49 fatigue NN B-NP O
49 Her NNP I-NP O
49 heart NN I-NP O
49 rate NN I-NP O
49 went VBD B-VP O
49 from IN B-VP O
49 100 CD O O
49 to TO O O
49 129 CD O O
49 , , O O
49 blood NN B-NP O
50 pressure NN I-NP O
50 went VBD B-VP O
50 from IN B-VP O
50 130 CD O O
50 systolic JJ O O
50 to TO O O
50 172 CD O O
50 Electrocardiogram NNP B-NP O
50 showed VBD B-VP O
51 no DT B-NP O
51 ischemic JJ I-NP O
51 changes NNS I-NP O
51 She PRP O O
51 had VBD B-VP O
51 no DT B-NP O
51 chest JJS I-NP O
51 pain NN I-NP O
51 or CC O O
51 chest VB O O
51 pressure NN B-NP O
51 with IN B-VP O
52 this DT O O
52 and CC O O
52 this DT O O
52 was VBD B-VP O
52 deemed VBN O O
52 a DT B-NP O
52 negative JJ I-NP O
52 test NN I-NP O
52 She PRP O O
52 then RB O O
52 underwent VBD B-VP O
52 an DT B-NP O
53 echocardiogram NN I-NP O
53 which WDT O O
53 showed VBD B-VP O
53 vigorous JJ B-NP O
53 systolic JJ I-NP O
53 function NN I-NP O
53 of IN B-VP O
53 86% CD O O
53 , , O O
53 no DT B-NP O
54 valvular JJ I-NP O
54 lesions NNS I-NP O
54 , , O O
54 no DT B-NP O
54 wall NN I-NP O
54 motion NN I-NP O
54 abnormalities NNS I-NP O
54 There EX O O
54 was VBD B-VP O
54 evidence NN B-NP O
55 of IN B-VP O
55 thickening VBG O O
55 in IN B-VP O
55 her PRP$ O O
55 ventricular JJ B-NP O
55 walls NNS I-NP O
56 Given VBN O O
56 the DT B-NP O
56 fact NN I-NP O
56 that IN B-VP O
56 the DT B-NP O
56 patient NN I-NP O
56 had VBD B-VP O
56 an DT O B-r
56 elevated VBN O I-r
56 diastolic JJ B-NP I-r
56 pressure NN I-NP I-r
57 and CC O O
57 did VBD B-VP O
57 show VB O O
57 some DT B-NP O
57 early JJ I-NP O
57 evidence NN I-NP O
57 of IN B-VP O
57 thickening VBG O O
57 in IN B-VP O
57 her PRP$ O O
57 ventricular JJ B-NP O
58 walls NNS I-NP O
58 , , O O
58 the DT B-NP O
58 decision NN I-NP O
58 was VBD B-VP O
58 then RB O O
58 made VBN O O
58 to TO O O
58 begin VB O O
58 her PRP$ O O
58 on IN B-VP O
58 a DT B-NP O
58 calcium NN I-NP B-m
58 channel NN I-NP O
59 blocker NN I-NP O
59 Verapamil NNP I-NP B-m
59 240 CD O B-do
59 milligrams NNS B-NP I-do
59 p.o VBP O B-mo
59 q.d NN B-NP B-f
59 was VBD B-VP O
59 initiated VBN O O
59 and CC O O
59 the DT B-NP O
60 patient NN I-NP O
60 tolerated VBD B-VP O
60 this DT O O
60 prior JJ O O
60 to TO O O
60 discharge VB O O
60 This DT O O
60 was VBD B-VP O
60 added VBN O O
60 in IN B-VP O
61 addition NN B-NP O
61 to TO O O
61 all DT O O
61 her PRP$ O O
61 usual JJ B-NP O
61 medications NNS I-NP O
61 She PRP O O
61 was VBD B-VP O
61 discharged VBN O O
61 to TO O O
61 home NN B-NP O
62 in IN B-VP O
62 good JJ B-NP O
62 condition NN I-NP O
63 DISCHARGE NNP I-NP O
63 MEDICATIONS: NNP I-NP O
63 Verapamil NNP I-NP B-m
63 SR NNP I-NP I-m
63 240 CD O B-do
63 milligrams NNS B-NP I-do
63 p.o VBP O B-mo
63 q.d.; JJ B-NP B-f
64 Zantac NNP I-NP B-m
64 300 CD O B-do
64 milligrams NNS B-NP I-do
64 q.d.; VBP O B-f
64 estrogen RB O B-m
64 1.25 CD O B-do
65 milligrams NNS B-NP O
65 q.d.; VBP O B-f
65 Advil NNP B-NP B-m
65 800 CD O B-do
65 milligrams NNS B-NP I-do
65 p.o VBP O B-mo
65 b.i.d JJ B-NP B-f
65 p.r.n.; NN I-NP I-f
66 hydrochlorothiazide NN I-NP B-m
66 25 CD O B-do
66 milligrams NNS B-NP I-do
66 p.o VBP O B-mo
66 q.d.; JJ B-NP B-f
66 methyldopa NN I-NP B-m
66 250 CD O B-do
67 milligrams NNS B-NP O
67 q.d.; VBP O B-f
67 Nortriptyline NNP B-NP B-m
67 125 CD O B-do
67 milligrams NNS B-NP I-do
67 p.o VBP O B-mo
67 q.h.s PDT O B-f
68 The DT B-NP O
68 patient NN I-NP O
68 has VBZ O O
68 scheduled VBN O O
68 an DT B-NP O
68 appointment NN I-NP O
68 to TO O O
68 see VB O O
68 a DT B-NP O
68 new JJ I-NP O
68 primary JJ I-NP O
69 physician NN I-NP O
69 , , O O
69 Dr NNP B-NP O
69 Kenneth NNP I-NP O
69 Finneran NNP I-NP O
69 at IN B-VP O
69 Dowsna NNP B-NP O
69 Medical NNP I-NP O
69 Center NNP I-NP O
69 She PRP O O
70 states VBZ O O
70 that IN B-VP O
70 appointment NN B-NP O
70 is VBZ O O
70 scheduled VBN O O
70 for IN B-VP O
70 May NNP B-NP O
70 , , O O
70 1996 CD O O
71 Dictated NNP B-NP O
71 By: NNP I-NP O
71 HOUSTON NNP I-NP O
71 N NNP I-NP O
71 MONSALVE NNP I-NP O
71 , , O O
71 M.D NNP B-NP O
71 HE93 NNP I-NP O
72 Attending: NNP I-NP O
72 ARCHIE NNP I-NP O
72 J NNP I-NP O
72 SOLINAS NNP I-NP O
72 , , O O
72 M.D NNP B-NP O
72 YO28 NNP I-NP O
72 SY476/6632 NNP I-NP O
73 Batch: NNP I-NP O
73 0874 CD O O
73 Index NNP B-NP O
73 No NNP I-NP O
73 Z5HYF120UB NNP I-NP O
73 D: NNP I-NP O
73 11/28/96 CD O O
74 T: NNP B-NP O
74 11/28/96 CD O O
75 CC: NNP B-NP O
75 1 CD O O
75 ELTON NNP B-NP O
75 D NNP I-NP O
75 LEHNER NNP I-NP O
75 , , O O
75 M.D NNP B-NP O
75 HM16 NNP I-NP O
76 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #898807 VBZ O O
2 199067318 CD O O
2 LCSMC NNP B-NP O
2 97187933 CD O O
2 8546667 CD O O
2 10/4/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 hereditary JJ B-NP O
2 angioedema NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/6/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/17/2005 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 BRUNSCHEEN NNP I-NP O
5 , , O O
5 GARTH NNP B-NP O
5 H NNP I-NP O
5 657-64-55-6 JJ B-NP O
6 Co NNP I-NP O
6 Room: NNP I-NP O
6 Jack NNP I-NP O
6 , , O O
6 Texas NNP B-NP O
6 78463 CD O O
7 Service: NNP B-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 8/5/05 CD O O
8 AT NNP B-NP O
8 12:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 FLEMISTER NNP I-NP O
11 , , O O
11 RUEBEN NNP B-NP O
11 RANDELL NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ACETYLSALICYLIC NNP I-NP B-m
16 ACID NNP I-NP I-m
16 81 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 VIT NNP I-NP B-m
17 C NNP I-NP I-m
17 ( ( O I-m
17 ASCORBIC NNP B-NP I-m
17 ACID NNP I-NP I-m
17 ) ) O I-m
17 500 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 BID NNP I-NP B-f
18 ATENOLOL NNP I-NP B-m
18 75 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
18 HOLD NNP I-NP O
18 IF: NNP I-NP O
18 sbp&lt;100 NN I-NP O
18 , , O O
18 hr&lt;60 NN B-NP O
19 DIGOXIN NNP I-NP B-m
19 0.125 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QOD NNP I-NP O
19 Instructions: NNP I-NP O
19 Sun NNP I-NP O
19 , , O O
19 Tues NNP B-NP O
19 , , O O
19 Thurs NNP B-NP O
20 Override NNP I-NP O
20 Notice: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 5/6/05 CD O O
20 by IN B-VP O
21 LEEMING NNP B-NP O
21 , , O O
21 ARMANDO NNP B-NP O
21 R NNP I-NP O
21 , , O O
21 M.D NNP B-NP O
22 on IN B-VP O
22 order NN B-NP O
22 for IN B-VP O
22 SYNTHROID NNP B-NP B-m
22 PO NNP I-NP B-mo
22 ( ( O O
22 ref JJ O O
22 # # O O
22 66804792 CD O O
22 ) ) O O
23 POTENTIALLY NNP B-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 DIGOXIN NNP I-NP B-m
23 &amp; NNP I-NP O
23 LEVOTHYROXINE NNP I-NP B-m
24 SODIUM NNP I-NP O
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 will MD O O
24 monitor VB O O
25 DIGOXIN NNP B-NP B-m
25 0.1875 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QOD NNP I-NP O
25 Instructions: NNP I-NP O
25 On IN B-VP O
25 M NNP B-NP O
25 , , O O
25 W NNP B-NP O
25 , , O O
25 F NNP B-NP O
25 , , O O
25 Sat NNP B-NP O
26 Alert NNP I-NP O
26 overridden: NNP I-NP O
26 Override NNP I-NP O
26 added VBD B-VP O
26 on IN B-VP O
26 5/6/05 CD O O
26 by IN B-VP O
27 BRUNFIELD NNP B-NP O
27 , , O O
27 BEAU NNP B-NP O
27 M NNP I-NP O
27 , , O O
27 M.D NNP B-NP O
28 POTENTIALLY NNP I-NP O
28 SERIOUS NNP I-NP O
28 INTERACTION: NNP I-NP O
28 LEVOTHYROXINE NNP I-NP B-m
28 SODIUM NNP I-NP I-m
28 &amp; NNP I-NP O
29 DIGOXIN NNP I-NP B-m
29 Reason NNP I-NP O
29 for IN B-VP O
29 override: NN B-NP O
29 will MD O O
29 monitor VB O O
30 COLACE NNP B-NP B-m
30 ( ( O I-m
30 DOCUSATE NNP B-NP I-m
30 SODIUM NNP I-NP I-m
30 ) ) O I-m
30 100 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 BID NNP I-NP B-f
30 PRN NNP I-NP I-f
30 Constipation NNP I-NP B-r
31 PEPCID NNP I-NP B-m
31 ( ( O I-m
31 FAMOTIDINE NNP B-NP I-m
31 ) ) O I-m
31 20 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 Instructions: NNP I-NP O
32 therapeutic JJ B-NP O
32 interchange NN I-NP O
33 LASIX NNP I-NP B-m
33 ( ( O I-m
33 FUROSEMIDE NNP B-NP I-m
33 ) ) O I-m
33 20 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
34 Alert NNP I-NP O
34 overridden: NNP I-NP O
34 Override NNP I-NP O
34 added VBD B-VP O
34 on IN B-VP O
34 5/6/05 CD O O
34 by IN B-VP O
35 HOEPPNER NNP B-NP O
35 , , O O
35 ARCHIE NNP B-NP O
35 D NNP I-NP O
35 , , O O
35 M.D NNP B-NP O
36 on IN B-VP O
36 order NN B-NP O
36 for IN B-VP O
36 LASIX NNP B-NP B-m
36 PO NNP I-NP B-mo
36 ( ( O O
36 ref JJ O O
36 # # O O
36 91042032 CD O O
36 ) ) O O
37 Pt NNP B-NP O
37 has VBZ O O
37 a DT B-NP O
37 POSSIBLE NNP I-NP O
37 allergy NN I-NP O
37 to TO O O
37 Sulfa; NNP B-NP O
37 reaction NN I-NP O
37 is VBZ O O
37 RASH NNP B-NP O
38 Reason NNP I-NP O
38 for IN B-VP O
38 override: NN B-NP O
38 tolerates NNS I-NP O
38 at IN B-VP O
38 home NN B-NP O
39 SYNTHROID NNP I-NP B-m
39 ( ( O I-m
39 LEVOTHYROXINE NNP B-NP I-m
39 SODIUM NNP I-NP I-m
39 ) ) O I-m
39 50 CD O B-do
39 MCG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 QD NNP I-NP B-f
40 Override NNP I-NP O
40 Notice: NNP I-NP O
40 Override NNP I-NP O
40 added VBD B-VP O
40 on IN B-VP O
40 5/6/05 CD O O
40 by IN B-VP O
41 FELVER NNP B-NP O
41 , , O O
41 BERNARDO NNP B-NP O
41 T NNP I-NP O
41 , , O O
41 M.D NNP B-NP O
42 on IN B-VP O
42 order NN B-NP O
42 for IN B-VP O
42 DIGOXIN NNP B-NP B-m
42 PO NNP I-NP B-mo
42 ( ( O O
42 ref JJ O O
42 # # O O
42 41989730 CD O O
42 ) ) O O
43 POTENTIALLY NNP B-NP O
43 SERIOUS NNP I-NP O
43 INTERACTION: NNP I-NP O
43 LEVOTHYROXINE NNP I-NP B-m
43 SODIUM NNP I-NP I-m
43 &amp; NNP I-NP O
44 DIGOXIN NNP I-NP B-m
44 Reason NNP I-NP O
44 for IN B-VP O
44 override: NN B-NP O
44 will MD O O
44 monitor VB O O
45 Previous JJ O O
45 override IN B-VP O
45 information: JJ B-NP O
46 Override NNP I-NP O
46 added VBD B-VP O
46 on IN B-VP O
46 5/6/05 CD O O
46 by IN B-VP O
46 SAAR NNP B-NP O
46 , , O O
46 HERSCHEL NNP B-NP O
46 S NNP I-NP O
46 , , O O
46 M.D NNP B-NP O
47 POTENTIALLY NNP I-NP O
47 SERIOUS NNP I-NP O
47 INTERACTION: NNP I-NP O
47 DIGOXIN NNP I-NP B-m
47 &amp; NNP I-NP O
47 LEVOTHYROXINE NNP I-NP B-m
48 SODIUM NNP I-NP O
48 Reason NNP I-NP O
48 for IN B-VP O
48 override: NN B-NP O
48 will MD O O
48 monitor VB O O
49 SENNA NNP B-NP B-m
49 TABLETS NNP I-NP I-m
49 2 CD O B-do
49 TAB NNP B-NP I-do
49 PO NNP I-NP B-mo
49 BID NNP I-NP B-f
49 PRN NNP I-NP I-f
49 Constipation NNP I-NP B-r
50 STANOZOLOL NNP I-NP B-m
50 4 CD O B-do
50 MG NNP B-NP I-do
50 PO NNP I-NP B-mo
50 QD NNP I-NP B-f
50 Starting NNP I-NP I-f
50 IN NNP I-NP I-f
50 AM NNP I-NP I-f
50 ( ( O O
50 1/10 CD O O
50 ) ) O O
51 VIT NNP B-NP B-m
51 E NNP I-NP I-m
51 ( ( O I-m
51 TOCOPHEROL-DL-ALPHA NNP B-NP I-m
51 ) ) O I-m
51 400 CD O B-do
51 UNITS NNP B-NP I-do
51 PO NNP I-NP B-mo
51 QD NNP I-NP B-f
52 KEFLEX NNP I-NP B-m
52 ( ( O I-m
52 CEPHALEXIN NNP B-NP I-m
52 ) ) O I-m
52 500 CD O B-do
52 MG NNP B-NP I-do
52 PO NNP I-NP B-mo
52 QID NNP I-NP B-f
52 X NNP I-NP B-du
52 28 CD O I-du
52 doses NNS B-NP I-du
53 Starting VBG O O
53 Today NNP B-NP O
53 ( ( O O
53 1/6 CD O O
53 ) ) O O
54 Alert NNP B-NP O
54 overridden: NNP I-NP O
54 Override NNP I-NP O
54 added VBD B-VP O
54 on IN B-VP O
54 5/6/05 CD O O
54 by IN B-VP O
55 MCWELLS NNP B-NP O
55 , , O O
55 COURTNEY NNP B-NP O
55 M NNP I-NP O
55 , , O O
55 M.D NNP B-NP O
56 on IN B-VP O
56 order NN B-NP O
56 for IN B-VP O
56 KEFLEX NNP B-NP B-m
56 PO NNP I-NP B-mo
56 ( ( O O
56 ref JJ O O
56 # # O O
56 63524947 CD O O
56 ) ) O O
57 Pt NNP B-NP O
57 has VBZ O O
57 a DT B-NP O
57 POSSIBLE NNP I-NP O
57 allergy NN I-NP O
57 to TO O O
57 Penicillins; NNP B-NP O
57 reaction NN I-NP O
57 is VBZ O O
58 RASH NNP B-NP O
58 Reason NNP I-NP O
58 for IN B-VP O
58 override: NN B-NP O
58 patient NN I-NP O
58 has VBZ O O
58 tolerated VBN O O
58 in IN B-VP O
58 past JJ B-NP O
58 ok JJ I-NP O
59 RHINOCORT NNP I-NP B-m
59 ( ( O I-m
59 BUDESONIDE NNP B-NP I-m
59 NASAL NNP I-NP I-m
59 INHALER NNP I-NP I-m
59 ) ) O I-m
59 2 CD O B-do
59 SPRAY NNP B-NP I-do
59 NA NNP I-NP B-mo
59 BID NNP I-NP B-f
60 ALLEGRA NNP I-NP B-m
60 ( ( O I-m
60 FEXOFENADINE NNP B-NP I-m
60 HCL NNP I-NP I-m
60 ) ) O I-m
60 60 CD O B-do
60 MG NNP B-NP I-do
60 PO NNP I-NP B-mo
60 BID NNP I-NP B-f
61 Food/Drug NNP I-NP O
61 Interaction NNP I-NP O
61 Instruction NNP I-NP O
62 Avoid NNP I-NP O
62 grapefruit NN I-NP O
62 unless IN B-VP O
62 MD NNP B-NP O
62 instructs NNS I-NP O
62 otherwise RB O O
63 DIET: NNP B-NP O
63 House NNP I-NP O
63 / VBD B-VP O
63 Low NNP B-NP O
63 chol/low NN I-NP O
63 sat VBD B-VP O
63 fat JJ B-NP O
64 ACTIVITY: NNP I-NP O
64 Resume NNP I-NP O
64 regular JJ B-NP O
64 exercise NN I-NP O
65 FOLLOW NNP I-NP O
65 UP NNP I-NP O
65 APPOINTMENT( NNP I-NP O
65 S NNP I-NP O
65 ): NNP I-NP O
66 Dr NNP I-NP O
66 Morrell NNP I-NP O
66 1-2 JJ B-NP O
66 weeks NNS I-NP O
66 , , O O
67 Dr NNP B-NP O
67 Guadagnolo NNP I-NP O
67 or CC O O
67 Dr NNP B-NP O
67 Yoes NNP I-NP O
67 1-2 JJ B-NP O
67 weeks NNS I-NP O
67 , , O O
68 ALLERGY: NNP B-NP O
68 IV NNP I-NP O
68 Contrast NNP I-NP O
68 , , O O
68 Sulfa NNP B-NP O
68 , , O O
68 Penicillins NNP B-NP O
68 , , O O
68 QUINIDINE NNP B-NP O
68 SULFATE NNP I-NP O
68 , , O O
69 LEVOFLOXACIN NNP B-NP O
69 , , O O
69 LISINOPRIL NNP B-NP O
69 , , O O
69 NITROFURANTOIN NNP B-NP O
69 , , O O
69 STANAZOL NNP B-NP O
69 , , O O
70 PROCAINE NNP B-NP O
70 HCL NNP I-NP O
70 , , O O
70 Dairy NNP B-NP O
70 Products NNPS I-NP O
70 , , O O
70 WHEAT/GLUTEN NNP B-NP O
70 , , O O
71 NITROFURANTOIN NNP B-NP O
71 MACROCRYSTAL NNP I-NP O
72 ADMIT NNP I-NP O
72 DIAGNOSIS: NNP I-NP O
73 hereditary JJ B-NP O
73 angioedema NN I-NP O
74 PRINCIPAL NNP I-NP O
74 DISCHARGE NNP I-NP O
74 DIAGNOSIS NNP I-NP O
74 ;Responsible JJ O O
74 After IN B-VP O
74 Study NNP B-NP O
74 for IN B-VP O
74 Causing NNP B-NP O
74 Admission NNP I-NP O
74 ) ) O O
75 hereditary VBP O O
75 angioedema IN B-VP O
76 OTHER NNP B-NP O
76 DIAGNOSIS;Conditions NNP I-NP O
76 , , O O
76 Infections NNP B-NP O
76 , , O O
76 Complications NNP B-NP O
76 , , O O
76 affecting VBG O O
76 Treatment/Stay NNP B-NP O
77 HEREDITARY NNP I-NP B-r
77 HEREDITARY NNP I-NP B-r
77 ANGIOEDEMA NNP I-NP I-r
77 ANGIOEDEMA NNP I-NP I-r
77 AFIB NNP I-NP I-r
77 AFIB NNP I-NP I-r
77 - : O O
77 lodose JJ B-NP O
77 Coum/ASA NNP I-NP B-m
77 HYPOTHY NNP I-NP O
78 H/O NNP I-NP O
78 SUBDURAL NNP I-NP O
78 ON NNP I-NP O
78 COUM NNP I-NP B-m
78 S/P NNP I-NP O
78 APPY NNP I-NP O
78 , , O O
78 TAH NNP B-NP O
78 tracheostomies VBZ O O
78 x $ O O
79 3 CD O O
79 multiple JJ B-NP O
79 intubations NNS I-NP O
79 DVT NNP I-NP O
79 , , O O
79 ivc JJ B-NP O
79 filter NN I-NP O
79 in IN B-VP O
79 place NN B-NP O
79 GERD NNP I-NP O
79 polycythemia NN I-NP O
80 OPERATIONS NNP I-NP O
80 AND NNP I-NP O
80 PROCEDURES: NNP I-NP O
81 none NN I-NP O
82 OTHER NNP I-NP O
82 TREATMENTS/PROCEDURES NNP I-NP O
82 ( ( O O
82 NOT NNP B-NP O
82 IN NNP I-NP O
82 O.R NNP I-NP O
82 ) ) O O
83 none NN B-NP O
84 BRIEF NNP I-NP O
84 RESUME NNP I-NP O
84 OF NNP I-NP O
84 HOSPITAL NNP I-NP O
84 COURSE: NNP I-NP O
85 83 CD O O
85 yo NN B-NP O
85 F NNP I-NP O
85 with IN B-VP O
85 hereditary JJ B-NP O
85 angioedema NN I-NP O
85 presents NNS I-NP O
85 with IN B-VP O
86 abdominal JJ B-NP O
86 pain NN I-NP O
86 Pt NNP I-NP O
86 had VBD B-VP O
86 URI NNP B-NP O
86 one CD O O
86 week NN B-NP O
86 ago RB O O
86 , , O O
86 which WDT O O
86 resolved VBD B-VP O
86 , , O O
86 but CC O O
86 then RB O O
87 woke VBD B-VP O
87 up RP O O
87 on IN B-VP O
87 day NN B-NP O
87 of IN B-VP O
87 admission NN B-NP O
87 with IN B-VP O
87 severe JJ B-NP O
87 abd NN I-NP O
87 pain NN I-NP O
87 Pt NNP I-NP O
87 has VBZ O O
87 had VBN O O
87 multiple JJ B-NP O
88 admits NNS I-NP O
88 in IN B-VP O
88 past NN B-NP O
88 for IN B-VP O
88 GI NNP B-NP O
88 sx VBD B-VP O
88 2/2 CD O O
88 hereditary JJ B-NP O
88 angioedema NN I-NP O
88 , , O O
89 and CC O O
89 pain NN B-NP B-r
89 on IN B-VP O
89 day NN B-NP O
89 of IN B-VP O
89 admit NN B-NP O
89 same JJ O O
89 as IN B-VP O
89 these DT B-NP O
89 episodes NNS I-NP O
90 Was VBD B-VP O
90 not RB O O
90 relieved VBN O O
90 by IN B-VP O
90 stanazolol NN B-NP B-m
90 Also RB O O
90 had VBD B-VP O
91 diarrhea NNS B-NP O
91 , , O O
91 N/V NNP B-NP O
91 , , O O
91 sweats NNS B-NP O
91 and CC O O
91 decreased VBN O O
91 POs NNP B-NP O
91 Admitted NNP I-NP O
91 for IN B-VP O
92 FFP NNP B-NP O
92 rx NN I-NP O
92 , , O O
92 which WDT O O
92 usually RB O O
92 resolves VBZ O O
92 her PRP O O
93 sx JJ B-NP O
93 Baseline NNP I-NP O
93 PE: NNP I-NP O
93 98.1 CD O O
93 85 CD O O
93 94/80 CD O O
93 20 CD O O
93 94% CD O O
94 RA NNP B-NP O
94 Very NNP I-NP O
94 distended VBD B-VP O
94 , , O O
94 tender NN B-NP O
94 abdomen NNS I-NP O
94 and CC O O
94 decreased VBD B-VP O
95 bowel NN B-NP O
95 sounds NNS I-NP O
96 Impression: NNP I-NP O
96 Hereditary NNP I-NP O
96 angioedema NN I-NP O
96 flare NN I-NP O
96 with IN B-VP O
96 GI NNP B-NP O
96 manifestations NNS I-NP O
97 HOSPITAL NNP I-NP O
97 COURSE: NNP I-NP O
97 ALLERGY: NNP I-NP O
97 The DT B-NP O
97 patient NN I-NP O
97 received VBD B-VP O
97 6 CD O O
97 units NNS B-NP O
97 FFP NNP I-NP O
97 with IN B-VP O
98 premedication NN B-NP O
98 with IN B-VP O
98 IV NNP B-NP B-mo
98 Benadryl NNP I-NP B-m
98 on IN B-VP O
98 the DT B-NP O
98 first JJ I-NP O
98 night NN I-NP O
98 of IN B-VP O
98 her PRP$ O O
99 hospitalization NN B-NP O
99 She PRP O O
99 was VBD B-VP O
99 also RB O O
99 given VBN O O
99 Stanazolol NNP B-NP B-m
99 Stanazolol NNP I-NP B-m
99 4 CD O B-do
99 4 CD O B-do
99 mg NN B-NP I-do
99 mg NN I-NP I-do
99 q4h NN I-NP B-f
99 overnight NN I-NP B-du
99 , , O O
99 wh NN B-NP O
100 ich NN I-NP O
100 was VBD B-VP O
100 changed VBN O O
100 to TO O O
100 bid VB O B-f
100 on IN B-VP O
100 the DT B-NP O
100 second JJ I-NP O
100 hospital NN I-NP O
100 day NN I-NP O
100 She PRP O O
100 was VBD B-VP O
100 continued VBN O O
101 on IN B-VP O
101 her PRP$ O O
101 outpatient NN B-NP O
101 dose NN I-NP O
101 of IN B-VP O
101 rhinocort NN B-NP B-m
101 and CC O O
101 allegra NN B-NP B-m
101 PAIN: NNP I-NP O
101 The DT B-NP B-r
102 patient's NN I-NP O
102 pain NN I-NP O
102 was VBD B-VP O
102 controlled VBN O O
102 with IN B-VP O
102 Dilaudid NNP B-NP B-m
102 CV: NNP I-NP O
102 The DT B-NP O
102 patient NN I-NP O
102 was VBD B-VP O
102 c JJ O O
103 ontinued VBN O O
103 on IN B-VP O
103 her PRP$ O O
103 home NN B-NP O
103 cardiac NN I-NP B-m
103 meds NNS I-NP I-m
103 , , O O
103 no DT B-NP O
103 changes NNS I-NP O
103 ENDO: VBP O O
103 The DT B-NP O
103 patient NN I-NP O
103 was VBD B-VP O
104 continued VBN O O
104 on IN B-VP O
104 her PRP$ O O
104 home NN B-NP B-do
104 dose NN I-NP I-do
104 of IN B-VP O
104 synthroid NN B-NP B-m
104 for IN B-VP O
104 hypothyroid NN B-NP B-r
104 GI: NNP I-NP O
104 The DT B-NP O
105 patient NN I-NP O
105 was VBD B-VP O
105 maintained VBN O O
105 on IN B-VP O
105 Zantac NNP B-NP B-m
105 and CC O O
105 Stanazolol NNP B-NP B-m
105 PPX: NNP I-NP O
105 Lovenox NNP I-NP B-m
105 FULL NNP I-NP O
106 CODE NNP I-NP O
107 The DT B-NP O
107 patient NN I-NP O
107 was VBD B-VP O
107 discharged VBN O O
107 with IN B-VP O
107 instructions NNS B-NP O
107 to TO O O
107 follow VB O O
107 up RP O O
107 with IN B-VP O
107 allergy JJ B-NP O
108 ADDITIONAL NNP I-NP O
108 COMMENTS: NNP I-NP O
108 Please NNP I-NP O
108 call VB O O
108 your PRP$ O O
108 doctor NN B-NP O
108 right RB O O
108 away RB O O
108 if IN B-VP O
108 you PRP O O
108 develop VBP O O
108 fevers NNS B-NP O
108 , , O O
108 worsening VBG O O
108 of IN B-VP O
109 your PRP$ O O
109 abdominal JJ B-NP O
109 pain NN I-NP O
109 , , O O
109 or CC O O
109 other JJ O O
109 concerning VBG O O
109 symptoms NNS B-NP O
110 Please NNP I-NP O
110 call VB O O
110 Dr NNP B-NP O
110 Zaspel NNP I-NP O
110 and CC O O
110 Dr NNP B-NP O
110 Muskopf NNP I-NP O
110 's POS O O
110 offices NNS B-NP O
110 tomorrow NN I-NP O
110 to TO O O
110 make VB O O
110 follow JJ B-NP O
110 u JJ I-NP O
111 p NN I-NP O
111 appointments NNS I-NP O
111 for IN B-VP O
111 1-2 JJ B-NP O
111 weeks NNS I-NP O
112 DISCHARGE NNP I-NP O
112 CONDITION: NNP I-NP O
112 Stable NNP I-NP O
113 TO NNP I-NP O
113 DO/PLAN: NNP I-NP O
114 No NNP I-NP O
114 dictated VBD B-VP O
114 summary JJ B-NP O
115 ENTERED NNP I-NP O
115 BY: NNP I-NP O
115 WINGENTER NNP I-NP O
115 , , O O
115 DARIO NNP B-NP O
115 B NNP I-NP O
115 , , O O
115 M.D NNP B-NP O
115 ( ( O O
115 XB735 NNP B-NP O
115 ) ) O O
115 8/5/05 CD O O
115 @ $ O O
115 09 CD O O
116 ****** JJ B-NP O
116 END NN I-NP O
116 OF NNP I-NP O
116 DISCHARGE NNP I-NP O
116 ORDERS NNP I-NP O
116 ****** NNP I-NP O
117 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #901540 VBZ O O
2 029231694 CD O O
2 GH NNP B-NP O
2 84870418 CD O O
2 7244648 CD O O
2 10/6/2003 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 10/6/2003 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
4 ATTENDING: NNP I-NP O
4 RANDELL NNP I-NP O
4 SOUPHOM NNP I-NP O
4 M.D NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
6 Dilated NNP I-NP O
6 cardiomyopathy JJ B-NP O
7 SECONDARY NNP I-NP O
7 DIAGNOSES: NNP I-NP O
8 Right NNP I-NP O
8 foot NN I-NP O
8 osteomylitis NN I-NP O
8 , , O O
8 left VBD B-VP O
8 calf JJ B-NP O
8 ulcer NN I-NP O
8 , , O O
8 hypertension NN B-NP O
8 , , O O
9 peripheral JJ B-NP O
9 vascular JJ I-NP O
9 disease NN I-NP O
9 , , O O
9 nonsustained VBD B-VP O
9 VT NNP B-NP O
9 , , O O
9 gout NN B-NP O
9 , , O O
9 occipital JJ B-NP O
10 CVA NNP I-NP O
10 , , O O
10 atrial JJ B-NP O
10 fibrillation NN I-NP O
10 , , O O
10 left VBD B-VP O
10 vocal JJ B-NP O
10 cord NN I-NP O
10 paralysis NN I-NP O
10 , , O O
10 and CC O O
10 renal JJ B-NP O
11 failure NN I-NP O
12 HISTORY NNP I-NP O
12 OF NNP I-NP O
12 PRESENT NNP I-NP O
12 ILLNESS: NNP I-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 is VBZ O O
13 a DT B-NP O
13 54-year-old JJ I-NP O
13 man NN I-NP O
13 with IN B-VP O
13 nonischemic JJ O O
13 dilated VBN O O
14 cardiomyopathy NN B-NP O
14 who WP O O
14 presents VBZ O O
14 with IN B-VP O
14 weight JJ B-NP O
14 gain NN I-NP O
14 , , O O
14 weakness NN B-NP O
14 , , O O
14 and CC O O
15 azotemia VBZ O O
15 The DT B-NP O
15 patient NN I-NP O
15 has VBZ O O
15 known VBN O O
15 cardiomyopathy JJ B-NP O
15 thought NN I-NP O
15 to TO O O
15 be VB O O
16 secondary JJ O O
16 to TO O O
16 alcohol VB O O
16 with IN B-VP O
16 incomplete JJ B-NP O
16 cardiology NN I-NP O
16 follow VBP O O
16 up RP O O
17 Cardiac NNP B-NP O
17 catheterization NN I-NP O
17 performed VBD B-VP O
17 in IN B-VP O
17 1998 CD O O
17 showed VBD B-VP O
17 a DT B-NP O
17 right JJ I-NP O
17 atrial JJ I-NP O
18 pressure NN I-NP O
18 of IN B-VP O
18 16 CD O O
18 , , O O
18 PA NNP B-NP O
18 pressure NN I-NP O
18 49 CD O O
18 of IN B-VP O
18 28 CD O O
18 , , O O
18 pulmonary JJ B-NP O
18 capillary JJ I-NP O
18 wedge NN I-NP O
19 pressure NN I-NP O
19 of IN B-VP O
19 26 CD O O
19 , , O O
19 cardiac JJ B-NP O
19 output NN I-NP O
19 of IN B-VP O
19 4 CD O O
19 , , O O
19 cardiac JJ B-NP O
19 stress NN I-NP O
19 done VBN O O
19 in IN B-VP O
19 2002 CD O O
19 , , O O
20 he PRP O O
20 lasted VBD B-VP O
20 5 CD O O
20 minutes NNS B-NP O
20 30 CD O O
20 seconds NNS B-NP O
20 did VBD B-VP O
20 not RB O O
20 read VB O O
20 anaerobic JJ B-NP O
20 threshold NN I-NP O
21 with IN B-VP O
21 a DT B-NP O
21 ZO2 NNP I-NP O
21 of IN B-VP O
21 11.1 CD O O
21 The DT B-NP O
21 patient NN I-NP O
21 was VBD B-VP O
21 admitted VBN O O
21 in IN B-VP O
21 February NNP B-NP O
21 2003 CD O O
21 with IN B-VP O
22 decompensated JJ B-NP O
22 heart NN I-NP O
22 failure NN I-NP O
22 An DT B-NP O
22 echo NN I-NP O
22 showed VBD B-VP O
22 LV NNP B-NP O
22 EDD NNP I-NP O
22 of IN B-VP O
22 65 CD O O
22 and CC O O
23 ejection JJ B-NP O
23 fraction NN I-NP O
23 of IN B-VP O
23 25% CD O O
23 with IN B-VP O
23 moderate JJ B-NP B-r
23 moderate JJ I-NP B-r
23 moderate JJ I-NP B-r
23 MR NNP I-NP I-r
23 MR NNP I-NP I-r
23 MR NNP I-NP I-r
23 and CC O O
23 severe RB O B-r
23 severe JJ B-NP B-r
23 severe JJ I-NP B-r
23 TR NNP I-NP I-r
23 TR NNP I-NP I-r
23 TR NNP I-NP I-r
23 treated VBD B-VP O
24 with IN B-VP O
24 dobutamine JJ B-NP B-m
24 dobutamine NN I-NP B-m
24 , , O O
24 seretide JJ B-NP B-m
24 seretide NN I-NP B-m
24 , , O O
24 and CC O O
24 diuretics NNS B-NP B-m
24 diuretics NNS I-NP B-m
24 with IN B-VP O
24 good JJ B-NP O
24 effect NN I-NP O
25 Course NNP I-NP O
25 complicated VBN O O
25 by IN B-VP O
25 left JJ B-NP O
25 leg NN I-NP O
25 cellulitis NN I-NP O
25 and CC O O
25 worsening VBG O O
25 renal JJ B-NP O
26 functioning NN I-NP O
26 on IN B-VP O
26 ACE NNP B-NP B-m
26 inhibitor NN I-NP I-m
26 Two CD O O
26 weeks NNS B-NP O
26 prior RB O O
26 to TO O O
26 presentation NN B-NP O
26 , , O O
27 the DT B-NP O
27 patient NN I-NP O
27 was VBD B-VP O
27 seen VBN O O
27 in IN B-VP O
27 clinic JJ O O
27 with IN B-VP O
27 fluid JJ B-NP B-r
27 retention NN I-NP I-r
27 , , O O
27 diuretics NNS B-NP B-m
28 were VBD B-VP O
28 increased VBN O O
28 , , O O
28 then RB O O
28 had VBD B-VP O
28 worsening VBG O O
28 renal JJ B-NP O
28 function NN I-NP O
28 , , O O
28 so IN B-VP O
28 diuretics NNS B-NP B-m
29 was VBD B-VP O
29 held VBN O O
29 and CC O O
29 now RB O O
29 presented VBN O O
29 with IN B-VP O
29 fatigue NN B-NP O
29 , , O O
29 leg NN B-NP O
29 edema NN I-NP O
29 , , O O
29 and CC O O
29 draining VBG O O
30 foot NN B-NP O
30 wound NN I-NP O
31 PAST NNP I-NP O
31 MEDICAL NNP I-NP O
31 HISTORY: NNP I-NP O
32 Hypertension NNP I-NP O
32 , , O O
32 diabetes VBZ O O
32 , , O O
32 peripheral JJ B-NP O
32 vasculare NN I-NP O
32 disease NN I-NP O
32 , , O O
32 status NN B-NP O
32 post NN I-NP O
33 transmetatarsal NN I-NP O
33 amputations NNS I-NP O
33 , , O O
33 osteomyelitis NN B-NP O
33 , , O O
33 and CC O O
33 VT NNP B-NP O
33 The DT B-NP O
33 patient NN I-NP O
34 declined VBD B-VP O
34 ICD NNP B-NP O
34 , , O O
34 gout NN B-NP O
34 , , O O
34 occipital JJ B-NP O
34 CVA NNP I-NP O
34 , , O O
34 and CC O O
34 atrial JJ B-NP O
34 fibrillation NN I-NP O
35 MEDICATIONS NNP I-NP O
35 ON NNP I-NP O
35 ADMISSION: NNP I-NP O
36 Digoxin NNP I-NP B-m
36 0.125 CD O B-do
36 mg NN B-NP I-do
36 q.o.d NN I-NP B-f
36 , , O O
36 Imdur NNP B-NP B-m
36 30 CD O B-do
36 mg NN B-NP I-do
36 q.d NN I-NP B-f
36 , , O O
36 hydralazine VBP O B-m
36 25 CD O B-do
36 mg NN B-NP I-do
37 t.i.d NN I-NP B-f
37 , , O O
37 torsemide NN B-NP B-m
37 was VBD B-VP O
37 being VBG O O
37 held VBN O O
37 , , O O
37 Coumadin NNP B-NP B-m
37 1 CD O B-do
37 mg NN B-NP I-do
37 q.d NN I-NP B-f
37 , , O O
37 carvedilol VBP O B-m
38 3.125 CD O B-do
38 mg NN B-NP I-do
38 b.i.d NN I-NP B-f
38 , , O O
38 allopurinol RB O B-m
38 100 CD O B-do
38 mg NN B-NP I-do
38 q.d NN I-NP B-f
38 , , O O
38 Glucophage NNP B-NP B-m
38 , , O O
38 and CC O O
39 glyburide JJ B-NP B-m
40 FAMILY NNP I-NP O
40 HISTORY: NNP I-NP O
41 Father NNP I-NP O
41 with IN B-VP O
41 coronary JJ B-NP O
41 artery NN I-NP O
41 disease NN I-NP O
41 in IN B-VP O
41 80s CD O O
42 SOCIAL NNP B-NP O
42 HISTORY: NNP I-NP O
43 He PRP O O
43 currently RB O O
43 lives VBZ O O
43 with IN B-VP O
43 a DT B-NP O
43 roommate NN I-NP O
43 Family NNP I-NP O
43 is VBZ O O
43 somewhat RB O O
43 strange JJ O O
43 , , O O
44 although IN B-VP O
44 recently RB O O
44 more RBR O O
44 involved JJ O O
44 with IN B-VP O
44 the DT B-NP O
44 patient NN I-NP O
44 No NNP I-NP O
44 tobacco NN I-NP O
44 use NN I-NP O
45 and CC O O
45 moderate JJ B-NP O
45 alcohol NN I-NP O
45 consumption NN I-NP O
45 per IN B-VP O
45 patient NN B-NP O
46 ALLERGIES: NNP I-NP O
47 No NNP I-NP O
47 known VBN O O
47 drug NN B-NP O
47 allergies NNS I-NP O
48 PHYSICAL NNP I-NP O
48 EXAMINATION: NNP I-NP O
49 A NNP I-NP O
49 tired JJ B-NP O
49 older JJR I-NP O
49 man NN I-NP O
49 lying VBG O O
49 at IN B-VP O
49 30 CD O O
49 degrees NNS B-NP O
49 with IN B-VP O
49 profound JJ B-NP O
49 fatigue NN I-NP O
50 Blood NNP I-NP O
50 pressure NN I-NP O
50 84/60 CD O O
50 , , O O
50 pulse RB O O
50 100 CD O O
50 and CC O O
50 regular JJ O O
50 , , O O
50 weight VBD B-VP O
50 102.4 CD O O
50 kg NN B-NP O
50 , , O O
50 and CC O O
51 temperature NN B-NP O
51 99.4 CD O O
51 Mild NNP B-NP O
51 pallor NN I-NP O
51 No NNP I-NP O
51 scleral JJ B-NP O
51 icterus NN I-NP O
51 JVP NNP I-NP O
51 to TO O O
51 the DT B-NP O
52 angle NN I-NP O
52 of IN B-VP O
52 jaw NN B-NP O
52 Coarse NNP I-NP O
52 breath NN I-NP O
52 sounds VBZ O O
52 bilaterally RB O O
52 without IN B-VP O
52 wheeze NN B-NP O
53 Cardiac NNP I-NP O
53 irregular NN I-NP O
53 and CC O O
53 soft JJ B-NP O
53 systolic JJ I-NP O
53 murmur NN I-NP O
53 at IN B-VP O
53 the DT B-NP O
53 left JJ I-NP O
53 sternal JJ I-NP O
54 border NN I-NP O
54 No NNP I-NP O
54 S3 NNP I-NP O
54 , , O O
54 gallop NN B-NP O
54 , , O O
54 or CC O O
54 rub VB O O
54 Abdomen NNP B-NP O
54 reveals NNS I-NP O
54 decreased VBD B-VP O
54 bowel NN B-NP O
55 sounds NNS I-NP O
55 Liver NNP I-NP O
55 - : O O
55 four CD O O
55 fingerbreadths NNS B-NP O
55 below RB O O
55 right JJ B-NP O
55 costal NN I-NP O
55 margin NN I-NP O
55 , , O O
56 nonpulsatile IN B-VP O
56 No DT B-NP O
56 guarding NN I-NP O
56 or CC O O
56 rebound NN B-NP O
56 Extremities: NNP I-NP O
56 Warm NNP I-NP O
56 with IN B-VP O
56 3+ CD O O
57 edema NN B-NP O
57 to TO O O
57 thighs VB O O
58 LABORATORY NNP B-NP O
58 DATA NNP I-NP O
58 ON NNP I-NP O
58 ADMISSION: NNP I-NP O
59 Sodium NNP I-NP O
59 129 CD O O
59 , , O O
59 potassium NN B-NP O
59 4.2 CD O O
59 , , O O
59 BUN NNP B-NP O
59 133 CD O O
59 , , O O
59 creatinine NN B-NP O
59 1.2 CD O O
59 , , O O
59 hematocrit NN B-NP O
60 31.9 CD O O
60 , , O O
60 white JJ B-NP O
60 blood NN I-NP O
60 cell NN I-NP O
60 count NN I-NP O
60 15.8 CD O O
60 with IN B-VP O
60 89% CD O O
60 polys NNS B-NP O
60 , , O O
60 8 CD O O
60 bands NNS B-NP O
60 , , O O
60 and CC O O
61 INR NNP B-NP O
61 4.6 CD O O
61 , , O O
61 albumin RB O O
61 2.7 CD O O
61 and CC O O
61 total JJ B-NP O
61 bilirubin NN I-NP O
61 3.4 CD O O
61 , , O O
61 and CC O O
61 normal JJ B-NP O
62 transaminases NNS I-NP O
62 ECG NNP I-NP O
62 showed VBD B-VP O
62 atrial JJ B-NP O
62 fibrillation NN I-NP O
62 at IN B-VP O
62 90 CD O O
62 per IN B-VP O
62 minute NN B-NP O
62 , , O O
63 low JJ B-NP O
63 voltage NN I-NP O
63 , , O O
63 poor JJ B-NP O
63 R-wave JJ I-NP O
63 progression NN I-NP O
63 with IN B-VP O
63 QRS NNP B-NP O
63 widening NN I-NP O
63 , , O O
63 and CC O O
64 nonspecific JJ B-NP O
64 T-wave NNP I-NP O
64 abnormality NN I-NP O
65 HOSPITAL NNP I-NP O
65 COURSE: NNP I-NP O
66 The DT B-NP O
66 patient NN I-NP O
66 was VBD B-VP O
66 admitted VBN O O
66 to TO O O
66 Cardiology NNP B-NP O
66 Service NNP I-NP O
66 for IN B-VP O
66 continued JJ B-NP O
67 management NN I-NP O
67 of IN B-VP O
67 his PRP$ O O
67 volume NN B-NP O
67 overload NN I-NP O
67 , , O O
67 dilated VBN O O
67 cardiomyopathy NN B-NP O
67 , , O O
67 and CC O O
68 lower JJR B-NP O
68 extremity NN I-NP O
68 infections NNS I-NP O
68 This DT B-NP O
68 hospital NN I-NP O
68 course NN I-NP O
68 will MD O O
68 be VB O O
69 summarized VBN O O
69 briefly NN B-NP O
69 by IN B-VP O
69 dates NNS B-NP O
70 1 CD O O
70 On IN B-VP O
70 4/13/03 CD O O
70 , , O O
70 the DT B-NP O
70 patient NN I-NP O
70 was VBD B-VP O
70 found VBN O O
70 to TO O O
70 have VB O O
70 progression NN B-NP O
70 of IN B-VP O
70 his PRP$ O O
71 right NN B-NP O
71 lower RBR O O
71 extremity NN B-NP O
71 infection NN I-NP O
71 and CC O O
71 was VBD B-VP O
71 taken VBN O O
71 to TO O O
71 the DT B-NP O
71 OR NNP I-NP O
71 for IN B-VP O
72 debridement JJ O O
73 2 CD O O
73 On IN B-VP O
73 2/19/03 CD O O
73 , , O O
73 Diuril NNP B-NP B-m
73 was VBD B-VP O
73 added VBN O O
73 to TO O O
73 his PRP$ O O
73 regimen NNS B-NP O
73 and CC O O
73 his PRP$ O O
74 creatinine NN B-NP O
74 was VBD B-VP O
74 noted VBN O O
74 to TO O O
74 increase VB O O
74 from IN B-VP O
74 2.6 CD O O
74 to TO O O
74 3.6 CD O O
74 and CC O O
74 diuretics NNS B-NP B-m
75 were VBD B-VP O
75 subsequently RB O O
75 held VBN O O
76 3 CD O O
76 On IN B-VP O
76 11/30/03 CD O O
76 , , O O
76 the DT B-NP O
76 patient NN I-NP O
76 retuned VBD B-VP O
76 to TO O O
76 the DT B-NP O
76 OR NNP I-NP O
76 for IN B-VP O
76 revision NN B-NP O
76 of IN B-VP O
77 right NN B-NP O
77 wound NN I-NP O
77 infection NN I-NP O
77 and CC O O
77 underwent VB O O
77 a DT B-NP O
77 further JJ I-NP O
77 transmetatarsal NN I-NP O
78 amputation NN I-NP O
79 4 CD O O
79 On IN B-VP O
79 4/12/03 CD O O
79 , , O O
79 the DT B-NP O
79 patient NN I-NP O
79 noted VBD B-VP O
79 nausea NN B-NP O
79 , , O O
79 fatigue NN B-NP O
79 , , O O
79 and CC O O
79 malaise VB O O
80 coincident NN B-NP O
80 with IN B-VP O
80 20-beat JJ B-NP O
80 run NN I-NP O
80 of IN B-VP O
80 VT NNP B-NP O
80 followed VBN O O
80 by IN B-VP O
80 syncope NN B-NP O
80 in IN B-VP O
80 the DT B-NP O
81 stetting NN I-NP O
81 of IN B-VP O
81 dobutamine NN B-NP B-m
81 The DT B-NP O
81 VT NNP I-NP O
81 terminated VBD B-VP O
81 spontaneously RB O O
81 The DT B-NP O
82 patient NN I-NP O
82 was VBD B-VP O
82 loaded VBN O O
82 on IN B-VP O
82 amiodarone NN B-NP B-m
82 , , O O
82 unfortunately RB O O
82 still RB O O
82 required VBN O O
83 low JJ B-NP B-do
83 dose JJ I-NP I-do
83 dobutamine NN I-NP B-m
83 to TO O O
83 maintain VB O O
83 his PRP$ O O
83 cardiac JJ B-NP B-r
83 output NN I-NP I-r
84 5 CD O O
84 On IN B-VP O
84 3/15/03 CD O O
84 , , O O
84 the DT B-NP O
84 patient NN I-NP O
84 returned VBD B-VP O
84 to TO O O
84 the DT B-NP O
84 OR NNP I-NP O
84 for IN B-VP O
84 debridement NN B-NP O
85 and CC O O
85 was VBD B-VP O
85 noted VBN O O
85 to TO O O
85 be VB O O
85 hypotensive JJ O O
85 with IN B-VP O
85 baseline JJ B-NP O
85 systolic JJ I-NP O
85 blood NN I-NP O
86 pressures NNS I-NP O
86 of IN B-VP O
86 80s CD O O
86 going VBG O O
86 to TO O O
86 60s CD O O
86 over IN B-VP O
86 palp NN B-NP O
86 with IN B-VP O
86 decrease NN B-NP O
86 urine NN I-NP O
87 output NN I-NP O
87 He PRP O O
87 was VBD B-VP O
87 transferred VBN O O
87 to TO O O
87 the DT B-NP O
87 CCU NNP I-NP O
87 briefly NN I-NP O
87 and CC O O
87 did VBD B-VP O
87 well RB O O
87 on IN B-VP O
88 ionotropes NNS B-NP B-m
88 and CC O O
88 diuretics NNS B-NP B-m
88 He PRP O O
88 was VBD B-VP O
88 transferred VBN O O
88 back RB O O
88 to TO O O
88 the DT B-NP O
88 floor NN I-NP O
89 and CC O O
89 continued VBD B-VP O
89 to TO O O
89 have VB O O
89 decrease NN B-NP O
89 urine JJ B-NP O
89 output NN I-NP O
89 on IN B-VP O
89 maximal JJ B-NP B-do
89 diuretic JJ I-NP B-m
90 doses NNS I-NP O
90 and CC O O
90 ionotropes VBZ O B-m
91 6 CD O O
91 On IN B-VP O
91 6/8/03 CD O O
91 , , O O
91 the DT B-NP O
91 renal JJ I-NP O
91 surgery NN I-NP O
91 recommended VBD B-VP O
91 that IN B-VP O
91 the DT B-NP O
91 dobutamine NN I-NP B-m
92 be VB O O
92 stopped VBN O O
92 in IN B-VP O
92 order NN B-NP O
92 to TO O O
92 enhance VB O B-r
92 renal JJ B-NP I-r
92 perfusion NN I-NP I-r
92 and CC O O
92 Lasix NNP B-NP B-m
92 Lasix NNP I-NP B-m
92 be VB O O
93 increased VBN O O
93 to TO O O
93 80 CD O B-do
93 mg NNS B-NP I-do
93 per IN B-VP B-f
93 hour NN B-NP I-f
93 The DT B-NP O
93 patient NN I-NP O
93 promptly RB O O
93 developed VBD B-VP O
94 cardiogenic JJ B-NP O
94 shock NN I-NP O
94 with IN B-VP O
94 discontinuation NN B-NP O
94 of IN B-VP O
94 dobutamine NN B-NP B-m
94 and CC O O
94 was VBD B-VP O
95 again RB O O
95 transferred VBN O O
95 to TO O O
95 the DT B-NP O
95 CCU NNP I-NP O
95 with IN B-VP O
95 systolic JJ B-NP O
95 blood NN I-NP O
95 pressures NNS I-NP O
95 in IN B-VP O
95 the DT B-NP O
96 60s NNS I-NP O
96 He PRP O O
96 was VBD B-VP O
96 ashen RB O O
96 and CC O O
96 cold VB O O
96 Subsequently RB O O
96 , , O O
96 he PRP O O
96 has VBZ O O
96 required VBN O O
97 dobutamine NN B-NP B-m
97 between IN B-VP B-do
97 1 CD O I-do
97 and CC O I-do
97 2.5 CD O I-do
97 mcg/kg/minute NN B-NP I-do
97 to TO O O
97 maintain VB O O
97 his PRP$ O O
98 cardiac JJ B-NP B-r
98 output NN I-NP I-r
98 as RB O O
98 well RB O O
98 as IN B-VP O
98 CVVH NNP B-NP O
98 for IN B-VP O
98 volume NN B-NP O
98 management NN I-NP O
98 He PRP O O
98 has VBZ O O
99 tolerated VBN O O
99 the DT B-NP O
99 FL NNP I-NP O
99 rates NNS I-NP O
99 between IN B-VP O
99 15 CD O O
99 and CC O O
99 200 CD O O
100 7 CD O O
100 On IN B-VP O
100 7/0/03 CD O O
100 , , O O
100 the DT B-NP O
100 patient NN I-NP O
100 noted VBD B-VP O
100 hoarseness JJ B-NP O
100 Otolaryngology NNP I-NP O
101 evaluation NN I-NP O
101 demonstrated VBD B-VP O
101 paralyzed JJ B-NP O
101 left JJ I-NP O
101 vocal JJ I-NP O
101 cords NNS I-NP O
101 thought VBN O O
101 to TO O O
101 be VB O O
102 secondary JJ O O
102 to TO O O
102 left VB O O
102 atrial JJ B-NP O
102 enlargement NN I-NP O
102 or CC O O
102 potentially RB O O
102 the DT B-NP O
102 placement NN I-NP O
103 of IN B-VP O
103 a DT B-NP O
103 left JJ I-NP O
103 IJ NNP I-NP O
103 catheter NN I-NP O
104 8 CD O O
104 On IN B-VP O
104 2/11/03 CD O O
104 , , O O
104 a DT B-NP O
104 tunneled JJ I-NP O
104 catheter NN I-NP O
104 was VBD B-VP O
104 placed VBN O O
104 for IN B-VP O
104 hemodialysis NN B-NP O
105 and CC O O
105 CVVH NNP B-NP O
105 access NN I-NP O
105 with IN B-VP O
105 plan NN B-NP O
105 initiation NN I-NP O
105 of IN B-VP O
105 hemodialysis NN B-NP O
106 9 CD O O
106 On IN B-VP O
106 11/26/03 CD O O
106 , , O O
106 he PRP O O
106 had VBD B-VP O
106 first JJ B-NP O
106 course NN I-NP O
106 of IN B-VP O
106 hemodialysis NN B-NP O
106 and CC O O
106 he PRP O O
107 tolerated VBD B-VP O
107 this DT B-NP O
107 procedure NN I-NP O
107 well RB O O
107 A NNP B-NP O
107 PICC NNP I-NP O
107 line NN I-NP O
107 was VBD B-VP O
107 placed VBN O O
107 The DT B-NP O
108 patient NN I-NP O
108 was VBD B-VP O
108 given VBN O O
108 a DT B-NP O
108 pneumococcal JJ I-NP O
108 vaccine NN I-NP O
109 10 CD O O
109 Cardiovascular: NNP B-NP O
110 a DT B-NP O
110 Pump: NNP I-NP O
110 The DT B-NP O
110 patient NN I-NP O
110 with IN B-VP O
110 advanced JJ O O
110 dilated VBN O O
110 cardiomyopathy NN B-NP O
110 with IN B-VP O
111 poor JJ B-NP O
111 overall JJ I-NP O
111 prognosis NN I-NP O
111 , , O O
111 was VBD B-VP O
111 admitted VBN O O
111 for IN B-VP O
111 aggressive JJ B-NP O
111 diuresis NN I-NP O
111 in IN B-VP O
112 order NN B-NP O
112 to TO O O
112 improve VB O O
112 his PRP$ O O
112 position NN B-NP O
112 on IN B-VP O
112 the DT B-NP O
112 ?? NNP I-NP O
112 ?? NNP I-NP O
112 curve NN I-NP O
112 This DT O O
112 was VBD B-VP O
113 performed VBN O O
113 by IN B-VP O
113 CVVH NNP B-NP O
113 and CC O O
113 is VBZ O O
113 now RB O O
113 being VBG O O
113 transitioned VBN O O
113 to TO O O
113 hemodialysis NN B-NP O
114 He PRP O O
114 has VBZ O O
114 beyond IN B-VP O
114 less RBR O O
114 invasive JJ B-NP O
114 measures NNS I-NP O
114 such JJ O O
114 as IN B-VP O
114 digoxin NN B-NP B-m
114 and CC O O
114 ACE NNP B-NP B-m
115 inhibitors NNS I-NP O
115 , , O O
115 and CC O O
115 he PRP O O
115 is VBZ O O
115 now RB O O
115 dobutamine JJ B-NP B-m
115 dependent NN I-NP O
116 b NN I-NP O
116 Ischemia: NNP I-NP O
116 The DT B-NP O
116 patient NN I-NP O
116 without IN B-VP O
116 any DT B-NP O
116 history NN I-NP O
116 of IN B-VP O
116 ischemic JJ B-NP O
116 heart NN I-NP O
117 disease NN I-NP O
117 and CC O O
117 no DT B-NP O
117 symptoms NNS I-NP O
117 suggestive CD O O
117 of IN B-VP O
117 any DT B-NP O
117 incorporate JJ I-NP O
117 lesions NNS I-NP O
118 c VBP O O
118 Rhythm: NNP B-NP O
118 Chronic NNP I-NP B-r
118 AF NNP I-NP I-r
118 and CC O O
118 occasional JJ B-NP B-r
118 ectopy NN I-NP I-r
118 and CC O O
118 VT NNP B-NP B-r
118 on IN B-VP O
119 dobutamine NN B-NP B-m
119 dobutamine NN I-NP B-m
119 dobutamine NN I-NP B-m
119 , , O O
119 currently RB O O
119 loaded VBN O O
119 on IN B-VP O
119 amiodarone NN B-NP B-m
119 without IN B-VP O
119 any DT B-NP O
119 further JJ I-NP O
120 events NNS I-NP O
121 11 CD O O
121 Infectious NNP B-NP O
121 Disease: NNP I-NP O
121 The DT B-NP O
121 patient NN I-NP O
121 with IN B-VP O
121 chronic JJ B-NP O
121 osteomylitis NN I-NP O
121 , , O O
122 currently RB O O
122 in IN B-VP O
122 a DT B-NP O
122 six-week JJ I-NP B-du
122 six-week JJ I-NP B-du
122 six-week JJ I-NP B-du
122 six-week JJ I-NP B-du
122 course NN I-NP I-du
122 course NN I-NP I-du
122 course NN I-NP I-du
122 course NN I-NP I-du
122 of IN B-VP O
122 ceftazidime NN B-NP B-m
122 , , O O
122 vancomycin NN B-NP B-m
122 , , O O
123 Flagyl NNP B-NP B-m
123 , , O O
123 and CC O O
123 Diflucan NNP B-NP B-m
123 for IN B-VP O
123 complicated VBN O B-r
123 complicated VBN O B-r
123 complicated VBN O B-r
123 complicated JJ B-NP B-r
123 osteomyelitis NN I-NP I-r
123 osteomyelitis NN I-NP I-r
123 osteomyelitis NN I-NP I-r
123 osteomyelitis NN I-NP I-r
123 , , O O
123 end NN B-NP O
123 date NN I-NP O
123 is VBZ O O
124 on IN B-VP O
124 2/30/03 CD O O
124 He PRP O O
124 was VBD B-VP O
124 given VBN O O
124 pneumococcal JJ B-NP O
124 vaccine NN I-NP O
124 He PRP O O
124 is VBZ O O
125 up-to-date JJ O O
125 on IN B-VP O
125 his PRP$ O O
125 flu NN B-NP O
125 vaccine NN I-NP O
126 12 CD O O
126 Renal: NNP B-NP O
126 The DT B-NP O
126 patient NN I-NP O
126 has VBZ O O
126 had VBN O O
126 progressive JJ B-NP O
126 renal JJ I-NP O
126 failure NN I-NP O
126 likely JJ O O
127 secondary JJ O O
127 to TO O O
127 low JJ B-NP O
127 flow NN I-NP O
127 to TO O O
127 the DT B-NP O
127 kidneys NN I-NP O
127 This DT O O
127 has VBZ O O
127 been VBN O O
127 exacerbated VBN O O
128 by IN B-VP O
128 ACE NNP B-NP B-m
128 inhibitors NNS I-NP I-m
128 in IN B-VP O
128 the DT B-NP O
128 past NN I-NP O
128 In IN B-VP O
128 addition NN B-NP O
128 , , O O
128 increasing VBG O O
128 doses NNS B-NP O
128 of IN B-VP O
129 diuretics NNS B-NP B-m
129 have VBP O O
129 been VBN O O
129 ineffective JJ O O
129 that IN B-VP O
129 the DT B-NP O
129 patient NN I-NP O
129 is VBZ O O
129 able JJ O O
129 to TO O O
130 obtain VB O O
130 increased JJ B-NP O
130 amounts NNS I-NP O
130 of IN B-VP O
130 cardiac JJ B-NP O
130 output NN I-NP O
130 As IN B-VP O
130 he PRP O O
130 comes VBZ O O
130 on IN B-VP O
131 strongly RB O O
131 through IN B-VP O
131 , , O O
131 he PRP O O
131 may MD O O
131 regain VB O O
131 some DT B-NP O
131 renal JJ I-NP O
131 function NN I-NP O
131 , , O O
131 however RB O O
131 , , O O
131 it PRP O O
132 is VBZ O O
132 predicted VBN O O
132 that IN B-VP O
132 he PRP O O
132 will MD O O
132 require VB O O
132 hemodialysis NN B-NP O
132 for IN B-VP O
132 remainder NN B-NP O
132 of IN B-VP O
133 the DT B-NP O
133 life NN I-NP O
133 He PRP O O
133 has VBZ O O
133 tolerated VBN O O
133 this DT B-NP O
133 A NNP I-NP O
133 tunneled VBD B-VP O
133 catheter NN B-NP O
133 was VBD B-VP O
133 placed VBN O O
134 for IN B-VP O
134 access NN B-NP O
134 on IN B-VP O
134 9/2/03 CD O O
135 13 CD O O
135 Vascular: NNP B-NP O
135 The DT B-NP O
135 patient NN I-NP O
135 with IN B-VP O
135 peripheral JJ B-NP O
135 vascular JJ I-NP O
135 disease NN I-NP O
135 now RB O O
136 status NN B-NP O
136 post NN I-NP O
136 transmetatarsal NN I-NP O
136 amputation NN I-NP O
136 He PRP O O
136 remains VBZ O O
136 with IN B-VP O
136 a DT B-NP O
136 open JJ I-NP O
137 wound NN I-NP O
137 in IN B-VP O
137 his PRP$ O O
137 left JJ B-NP O
137 foot NN I-NP O
137 and CC O O
137 a DT B-NP O
137 calf NN I-NP O
137 ulcer IN B-VP O
137 The DT B-NP O
137 patient NN I-NP O
137 is VBZ O O
137 planned VBN O O
138 to TO O O
138 be VB O O
138 evaluated VBN O O
138 by IN B-VP O
138 Plastic NNP B-NP O
138 Surgery NNP I-NP O
138 prior RB O O
138 to TO O O
138 discharge VB O O
138 for IN B-VP O
138 final JJ B-NP O
139 plans NNS I-NP O
139 whether IN B-VP O
139 a DT B-NP O
139 flap NN I-NP O
139 or CC O O
139 healing NN B-NP O
139 by IN B-VP O
139 secondary JJ B-NP O
139 retention NN I-NP O
140 14 CD O O
140 Psychiatry: NNP B-NP O
140 The DT B-NP O
140 patient NN I-NP O
140 is VBZ O O
140 depressed VBN O O
140 with IN B-VP O
140 frequent JJ B-NP O
140 periods NNS I-NP O
141 of IN B-VP O
141 anxiety NN B-NP O
141 , , O O
141 exceedingly RB O O
141 fearful JJ O O
141 of IN B-VP O
141 dying VBG O O
141 , , O O
141 and CC O O
141 unable JJ O O
141 to TO O O
141 sleep VB O O
142 with IN B-VP O
142 light JJ O O
142 off RP O O
142 or CC O O
142 with IN B-VP O
142 drapes NNS B-NP O
142 pole JJ O O
142 secondary JJ O O
142 to TO O O
142 believe VB O O
142 that IN B-VP O
142 if IN B-VP O
143 he PRP O O
143 falls VBZ O O
143 asleep RB O O
143 , , O O
143 he PRP O O
143 will MD O O
143 no RB O O
143 longer RB O O
143 wake VB O O
143 up RP O O
143 He PRP O O
143 was VBD B-VP O
143 seen VBN O O
143 by IN B-VP O
144 Psychiatry NNP B-NP O
144 , , O O
144 who WP O O
144 suggested VBD B-VP O
144 starting VBG O O
144 low JJ B-NP B-do
144 dose NN I-NP I-do
144 of IN B-VP O
144 Zyprexa NNP B-NP B-m
144 in IN B-VP B-f
144 the DT B-NP O
145 evening NN I-NP O
145 This DT O O
145 has VBZ O O
145 greatly RB O O
145 improved VBN O O
145 his PRP$ O O
145 mood NN B-NP O
145 and CC O O
145 he PRP O O
145 is VBZ O O
145 doing VBG O O
145 well RB O O
146 from IN B-VP O
146 this DT B-NP O
146 regard NN I-NP O
147 15 CD O O
147 Endocrine: NNP B-NP O
147 The DT B-NP O
147 patient NN I-NP O
147 failed VBD B-VP O
147 a DT B-NP O
147 course NN I-NP O
147 of IN B-VP O
147 stimulation NN B-NP O
147 test NN I-NP O
148 and CC O O
148 was VBD B-VP O
148 started VBN O O
148 on IN B-VP O
148 hydrocortisone NN B-NP B-m
148 hydrocortisone NN I-NP B-m
148 When WRB O O
148 this DT O O
148 was VBD B-VP O
148 tapered VBN O O
148 down RB O O
148 , , O O
149 he PRP O O
149 had VBD B-VP O
149 some DT B-NP O
149 periods NNS I-NP O
149 of IN B-VP O
149 hypotension NN B-NP B-r
149 and CC O O
149 this DT O O
149 was VBD B-VP O
149 increased VBN O O
149 again RB O O
150 He PRP O O
150 remains VBZ O O
150 on IN B-VP O
150 maintenance NN B-NP B-do
150 maintenance NN I-NP B-do
150 doses VBZ O I-do
150 doses NNS B-NP I-do
150 of IN B-VP O
150 hydrocortisone NN B-NP B-m
150 hydrocortisone NN I-NP B-m
150 Etiology NNP I-NP O
150 of IN B-VP O
151 his PRP$ O O
151 adrenal JJ B-NP O
151 insufficieny NN I-NP O
151 is VBZ O O
151 unclear JJ O O
151 Additionally RB O O
151 , , O O
151 the DT B-NP O
151 patient NN I-NP O
152 has VBZ O O
152 diabetes VBN O B-r
152 diabetes NNS B-NP B-r
152 diabetes VBZ O B-r
152 diabetes NNS B-NP B-r
152 He PRP O O
152 was VBD B-VP O
152 on IN B-VP O
152 oral JJ B-NP B-mo
152 hypoglycemic NN I-NP B-m
152 as IN B-VP O
152 an DT B-NP O
152 outpatient NN I-NP O
152 , , O O
153 however RB O O
153 , , O O
153 now RB O O
153 this DT B-NP O
153 renal JJ I-NP O
153 function NN I-NP O
153 , , O O
153 he PRP O O
153 has VBZ O O
153 been VBN O O
153 transitioned VBN O O
153 over IN B-VP O
154 to TO O O
154 insulin VB O B-m
154 with IN B-VP O
154 his PRP$ O O
154 standing VBG O B-do
154 doses NNS B-NP I-do
154 of IN B-VP O
154 Lantus NNP B-NP B-m
154 with IN B-VP O
154 a DT O O
154 lispro JJ O B-m
155 sliding VBG O B-do
155 scale JJ O I-do
156 16 CD O O
156 FEN: NNP B-NP O
156 The DT B-NP O
156 patient NN I-NP O
156 was VBD B-VP O
156 started VBN O O
156 on IN B-VP O
156 TPN NNP B-NP B-m
156 for IN B-VP O
156 quite RB O B-r
156 severe JJ B-NP O
157 malnutrition NN I-NP O
157 He PRP O O
157 now RB O O
157 has VBZ O O
157 increasing VBG O O
157 albumin RP O O
157 with IN B-VP O
157 increased JJ B-NP O
158 appetite NN I-NP O
158 , , O O
158 and CC O O
158 he PRP O O
158 is VBZ O O
158 tolerating VBG O O
158 more RBR O O
158 food NN B-NP O
158 He PRP O O
158 has VBZ O O
158 been VBN O O
158 placed VBN O O
158 on IN B-VP O
159 nectar NN B-NP O
159 thick NN I-NP O
159 liquids NNS I-NP O
159 for IN B-VP O
159 secondary JJ O O
159 to TO O O
159 left VB O O
159 vocal JJ B-NP O
159 cord NN I-NP O
159 paralysis NN I-NP O
160 and CC O O
160 visualized JJ B-NP O
160 aspiration NN I-NP O
160 on IN B-VP O
160 barium NN B-NP O
160 swallow NN I-NP O
160 by IN B-VP O
160 ENT NNP B-NP O
161 DISPOSITION: NNP I-NP O
162 The DT B-NP O
162 patient NN I-NP O
162 currently RB O O
162 is VBZ O O
162 stable JJ B-NP O
163 PLAN: NNP I-NP O
164 At IN B-VP O
164 this DT B-NP O
164 point NN I-NP O
164 , , O O
164 would MD O O
164 be VB O O
164 discharge VBN O O
164 with IN B-VP O
164 home NN B-NP O
164 dobutamine NN I-NP B-m
164 and CC O O
165 frequent JJ O O
165 and CC O O
165 careful JJ O O
165 follow VB O O
165 up RP O O
165 by IN B-VP O
165 his PRP$ O O
165 primary JJ B-NP O
165 cardiologist NN I-NP O
165 Dr NNP I-NP O
166 Mongiovi NNP I-NP O
167 eScription NN I-NP O
167 document: VBD B-VP O
167 9-3711468 CD O O
167 EMS NNP B-NP O
168 Dictated NNP I-NP O
168 By: NNP I-NP O
168 KAEDING NNP I-NP O
168 , , O O
168 DAMIAN NNP B-NP O
169 Attending: NNP I-NP O
169 ROTHBERG NNP I-NP O
169 , , O O
169 CLETUS NNP B-NP O
170 Dictation NNP I-NP O
170 ID NNP I-NP O
170 4865660 CD O O
171 D: NNP B-NP O
171 11/26/03 CD O O
172 T: NNP B-NP O
172 8/4/03 CD O O
173 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #903921 VBZ O O
2 390336468 CD O O
2 BMH NNP B-NP O
2 27343781 CD O O
2 4801760 CD O O
2 1/9/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CELLULITIS NNP I-NP O
2 RIGHT NNP I-NP O
2 FOOT NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/4/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 7/5/2006 CD O O
4 ATTENDING: NNP B-NP O
4 GLANDEN NNP I-NP O
4 , , O O
4 MODESTO NNP B-NP O
4 HAL NNP I-NP O
4 MD NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Chronic NNP I-NP O
5 peripheral JJ B-NP O
5 vascular JJ I-NP O
5 disease NN I-NP O
6 complicated VBN O O
6 by IN B-VP O
6 atheroemboli NN B-NP O
6 , , O O
6 status NN B-NP O
6 post NN I-NP O
6 cardiac JJ B-NP O
6 catheterization NN I-NP O
7 PROCEDURES: NNP I-NP O
8 1 CD O O
8 10/30/2006 CD O O
8 , , O O
8 aortogram RB O O
8 bilateral JJ B-NP O
8 lower JJR I-NP O
8 extremity NN I-NP O
8 runoff NN I-NP O
8 Dr NNP I-NP O
9 Zumstein NNP I-NP O
10 2 CD O O
10 0/25/2006 CD O O
10 left VBD B-VP O
10 femoral JJ O O
10 to TO O O
10 dorsalis VB O O
10 pedis JJ B-NP O
10 bypass NN I-NP O
10 graft NN I-NP O
10 , , O O
10 Dr NNP B-NP O
11 Saltzberg NNP I-NP O
12 HISTORY NNP I-NP O
12 OF NNP I-NP O
12 PRESENT NNP I-NP O
12 ILLNESS: NNP I-NP O
12 This DT O O
12 is VBZ O O
12 a DT B-NP O
12 75-year-old JJ I-NP O
12 former JJ I-NP O
12 smoker NN I-NP O
13 with IN B-VP O
13 hypertension NN B-NP O
13 , , O O
13 diabetes VBZ O O
13 , , O O
13 end-stage JJ B-NP O
13 renal JJ I-NP O
13 disease NN I-NP O
13 on IN B-VP O
14 hemodialysis NN B-NP O
14 , , O O
14 CAD NNP B-NP O
14 status NN I-NP O
14 post NN I-NP O
14 coronary JJ B-NP O
14 catheterization NN I-NP O
14 in IN B-VP O
14 March NNP B-NP O
15 2006 CD O O
15 and CC O O
15 March NNP B-NP O
15 2006 CD O O
15 who WP O O
15 presented VBD B-VP O
15 in IN B-VP O
15 clinic NN B-NP O
15 with IN B-VP O
15 progressively RB O O
16 worsening VBG O O
16 bilateral JJ B-NP O
16 foot NN I-NP O
16 pain NN I-NP O
16 , , O O
16 foot NN B-NP O
16 mottling NN I-NP O
16 and CC O O
16 new JJ B-NP O
16 ulcerations NNS I-NP O
17 Concern NNP I-NP O
17 for IN B-VP O
17 atheroembolization NN B-NP O
17 was VBD B-VP O
17 raised VBN O O
17 following VBG O O
17 cardiac JJ B-NP O
18 catheterization NN I-NP O
18 In IN B-VP O
18 followup NN B-NP O
18 , , O O
18 the DT B-NP O
18 patient NN I-NP O
18 appeared VBD B-VP O
18 to TO O O
18 have VB O O
19 persistent JJ B-NP O
19 ulcerations NNS I-NP O
19 as RB O O
19 well RB O O
19 as IN B-VP O
19 erythema NN B-NP O
19 Pedal NNP I-NP O
19 signals NNS I-NP O
19 by IN B-VP O
20 Doppler NNP B-NP O
20 , , O O
20 however RB O O
20 , , O O
20 were VBD B-VP O
20 present JJ O O
20 She PRP O O
20 was VBD B-VP O
20 admitted VBN O O
20 from IN B-VP O
20 clinic NN B-NP O
20 for IN B-VP O
21 cellulitis NN B-NP O
21 and CC O O
21 further JJ B-NP O
21 evaluation NN I-NP O
21 of IN B-VP O
21 her PRP$ O O
21 vascular JJ B-NP O
21 anatomy NN I-NP O
21 At IN B-VP O
22 the DT B-NP O
22 time NN I-NP O
22 of IN B-VP O
22 admission NN B-NP O
22 , , O O
22 she PRP O O
22 denied VBD B-VP O
22 chest NN B-NP O
22 pain NN I-NP O
22 , , O O
22 shortness NN B-NP O
22 of IN B-VP O
22 breath NN B-NP O
23 or CC O O
23 fever NN B-NP O
23 , , O O
23 chills VBZ O O
23 She PRP O O
23 described VBD B-VP O
23 the DT B-NP O
23 pain NN I-NP O
23 as IN B-VP O
23 burning NN B-NP O
23 in IN B-VP O
23 both DT O O
23 her PRP$ O O
24 feet NNS B-NP O
24 with IN B-VP O
24 some DT B-NP O
24 relief NN I-NP O
24 obtained VBN O O
24 when WRB O O
24 dangling VBG O O
24 the DT B-NP O
24 feet NNS I-NP O
24 off IN B-VP O
24 the DT B-NP O
25 bed NN I-NP O
26 PAST NNP I-NP O
26 MEDICAL NNP I-NP O
26 HISTORY: NNP I-NP O
27 1 CD O O
27 End-stage JJ B-NP O
27 renal JJ I-NP O
27 disease NN I-NP O
27 on IN B-VP O
27 hemodialysis NN B-NP O
27 Monday NNP I-NP O
27 , , O O
27 Wednesday NNP B-NP O
27 , , O O
28 Friday NNP B-NP O
29 a DT O O
29 7/6/2004 CD O O
29 , , O O
29 status NN B-NP O
29 post NN I-NP O
29 left VBD B-VP O
29 radiocephalic JJ B-NP O
29 AV NNP I-NP O
29 fistula NN I-NP O
29 by IN B-VP O
29 Dr NNP B-NP O
30 Mcbroom NNP I-NP O
31 b NN I-NP O
31 2/1/2005 CD O O
31 , , O O
31 status NN B-NP O
31 post NN I-NP O
31 left VBD B-VP O
31 AV NNP B-NP O
31 fistula VBZ O O
31 cephalic JJ B-NP O
32 transposition NN I-NP O
32 by IN B-VP O
32 Dr NNP B-NP O
32 Roskovensky NNP I-NP O
33 c VBD B-VP O
33 11/28/2006 CD O O
33 , , O O
33 status NN B-NP O
33 post NN I-NP O
33 left VBD B-VP O
33 AVF NNP B-NP O
33 revision NN I-NP O
33 by IN B-VP O
33 Dr NNP B-NP O
33 Espinel NNP I-NP O
34 d VBZ O O
34 6/21/2006 CD O O
34 , , O O
34 status NN B-NP O
34 post NN I-NP O
34 right RB O O
34 IJ NNP B-NP O
34 tunneled VBD B-VP O
34 hemodialysis NN B-NP O
35 catheter NN I-NP O
36 2 CD O O
36 CAD NNP B-NP O
37 a DT B-NP O
37 History NNP I-NP O
37 of IN B-VP O
37 non-ST JJ B-NP O
37 elevation NN I-NP O
37 MI NNP I-NP O
38 b NN I-NP O
38 status NN I-NP O
38 post NN I-NP O
38 catheterization NN I-NP O
38 on IN B-VP O
38 11/28/2006 CD O O
38 with IN B-VP O
38 80% CD O O
38 proximal JJ B-NP O
39 LAD NNP I-NP O
39 stenosis NN I-NP O
39 status NN I-NP O
39 post NN I-NP O
39 drug-eluting JJ B-NP O
39 stent NN I-NP O
39 of IN B-VP O
39 the DT B-NP O
39 LAD NNP I-NP O
40 c NN I-NP O
40 Status NNP I-NP O
40 post NN I-NP O
40 catheterization NN I-NP O
40 0/12/2006 CD O O
40 with IN B-VP O
40 left VBN O O
40 circumflex NN B-NP O
41 and CC O O
41 right JJ B-NP O
41 coronary JJ I-NP O
41 artery NN I-NP O
41 disease NN I-NP O
41 , , O O
41 noncritical JJ O O
42 3 CD O O
42 CHF NNP B-NP O
42 with IN B-VP O
42 diastolic JJ B-NP O
42 dysfunction NN I-NP O
43 a DT O O
43 3/7/2006 CD O O
43 , , O O
43 Echo NNP B-NP O
43 showing VBG O O
43 concentric JJ O O
43 left VBD B-VP O
43 ventricular JJ B-NP O
44 hypertrophy NN I-NP O
44 , , O O
44 EF NNP B-NP O
44 of IN B-VP O
44 45-50% CD O O
44 which WDT O O
44 was VBD B-VP O
44 reduced VBN O O
44 from IN B-VP O
44 2004 CD O O
44 Septal NNP B-NP O
45 and CC O O
45 inferior JJ B-NP O
45 wall NN I-NP O
45 hypokinesis NN I-NP O
45 , , O O
45 mild JJ O O
45 left VBD B-VP O
45 atrial JJ B-NP O
45 enlargement NN I-NP O
45 , , O O
46 moderate VB O O
46 to TO O O
46 severe VB O O
46 MR NNP B-NP O
46 , , O O
46 mild JJ B-NP O
46 TR NNP I-NP O
47 4 CD O O
47 COPD NNP B-NP O
47 , , O O
47 on IN B-VP O
47 intermittent JJ B-NP O
47 home NN I-NP O
47 oxygen NN I-NP O
48 5 CD O O
48 Obstructive JJ B-NP O
48 sleep NN I-NP O
48 apnea NN I-NP O
49 6 CD O O
49 Diabetes NNP B-NP O
49 mellitus VBD B-VP O
50 7 CD O O
50 Hypertension NNP B-NP O
51 8 CD O O
51 Dyslipidemia NNP B-NP O
52 9 CD O O
52 Gout NNP B-NP O
53 10 CD O O
53 GERD NNP B-NP O
54 11 CD O O
54 History NNP B-NP O
54 of IN B-VP O
54 right JJ B-NP O
54 pleural JJ I-NP O
54 effusion NN I-NP O
55 MEDICATIONS NNP I-NP O
55 ON NNP I-NP O
55 ADMISSION: NNP I-NP O
56 1 CD O O
56 Aspirin NNP B-NP B-m
56 325 CD O B-do
56 mg NN B-NP I-do
56 p.o JJ O B-mo
56 daily JJ O B-f
57 2 CD O O
57 Plavix NNP B-NP B-m
57 75 CD O B-do
57 mg NN B-NP I-do
57 p.o JJ O B-mo
57 daily JJ O B-f
58 3 CD O O
58 Cardizem NNP B-NP B-m
58 60 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 t.i.d VBD B-VP B-f
59 4 CD O O
59 Lipitor NNP B-NP B-m
59 80 CD O B-do
59 mg VBD B-VP I-do
59 daily RB O B-f
60 5 CD O O
60 Atrovent JJ O B-m
60 2 CD O B-do
60 puffs NNS B-NP I-do
60 four CD O B-f
60 times NNS B-NP I-f
60 a DT B-NP I-f
60 day NN I-NP I-f
61 6 CD O O
61 Albuterol NNP B-NP B-m
61 2 CD O B-do
61 puffs NNS B-NP I-do
61 b.i.d VBD B-VP B-f
62 7 CD O O
62 Renagel NNP B-NP B-m
62 806 CD O B-do
62 mg NN B-NP I-do
62 p.o NN I-NP B-mo
62 every DT B-NP B-f
62 meal NN I-NP I-f
63 8 CD O O
63 Allopurinol NNP B-NP B-m
63 100 CD O B-do
63 mg NN B-NP I-do
63 p.o JJ O B-mo
63 daily JJ O B-f
64 9 CD O O
64 Zaroxylyn NNP B-NP B-m
64 2.5 CD O B-do
64 mg NN B-NP I-do
64 p.o JJ B-NP B-mo
64 daily JJ I-NP B-f
64 p.r.n NN I-NP I-f
64 overload NN I-NP B-r
65 10 CD O O
65 Lantus NNP B-NP B-m
65 10 CD O B-do
65 units NNS B-NP I-do
65 subcutaneous JJ O B-mo
65 nightly RB O B-f
66 11 CD O O
66 Regular JJ B-NP B-m
66 insulin NN I-NP I-m
66 sliding VBG O B-do
66 scale JJ O I-do
67 12 CD O O
67 Valium NNP B-NP B-m
67 5 CD O B-do
67 mg NN B-NP I-do
67 p.o NN I-NP B-mo
67 b.i.d NN I-NP B-f
67 p.r.n NN I-NP I-f
68 13 CD O O
68 Isordil NNP B-NP B-m
68 40 CD O B-do
68 mg NN B-NP I-do
68 p.o NN I-NP B-mo
68 t.i.d VBD B-VP B-f
69 14 CD O O
69 Hydralazine NNP B-NP B-m
69 20 CD O B-do
69 mg NN B-NP I-do
69 p.o NN I-NP B-mo
69 t.i.d VBD B-VP B-f
70 15 CD O O
70 Lopressor NNP B-NP B-m
70 75 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 t.i.d VBD B-VP B-f
71 16 CD O O
71 Zantac NNP B-NP B-m
71 150 CD O B-do
71 mg NN B-NP I-do
71 p.o NN I-NP B-mo
71 b.i.d VBD B-VP B-f
72 17 CD O O
72 Aciphex NNP B-NP B-m
72 20 CD O B-do
72 mg NN B-NP I-do
72 p.o JJ O B-mo
72 daily JJ O B-f
73 18 CD O O
73 Neurontin NNP B-NP B-m
73 300 CD O B-do
73 mg NN B-NP I-do
73 p.o VBD B-VP B-mo
73 post-dialysis NN B-NP O
74 19 CD O O
74 Metamucil NNP B-NP B-m
75 20 CD O O
75 Nitroglycerine NNP B-NP B-m
75 p.r.n NN I-NP B-f
76 21 CD O O
76 Procrit NNP B-NP B-m
76 40 CD O B-do
76 , , O I-do
76 000 CD O I-do
76 units NNS B-NP I-do
76 subcutaneously RB O B-mo
76 every DT B-NP B-f
76 week NN I-NP I-f
77 22 CD O O
77 Lilly NNP B-NP B-m
77 Lilly NNP I-NP B-m
77 insulin JJ B-NP I-m
77 insulin NN I-NP I-m
77 pen JJ B-NP I-m
77 pen NN I-NP I-m
77 , , O O
77 unknown JJ B-NP O
77 dosage NN I-NP O
77 20 CD O B-do
77 units NNS B-NP I-do
77 every DT B-NP B-f
77 morning NN I-NP I-f
77 and CC O O
78 10 CD O B-do
78 units NNS B-NP I-do
78 every DT B-NP B-f
78 evening NN I-NP I-f
79 23 CD O O
79 Loperamide NNP B-NP B-m
79 2 CD O B-do
79 tabs NNS B-NP I-do
79 p.o RB O B-mo
79 four CD O B-f
79 times NNS B-NP I-f
79 a DT B-NP I-f
79 day NN I-NP I-f
80 24 CD O O
80 Ambien NNP B-NP B-m
80 10 CD O B-do
80 mg NN B-NP I-do
80 p.o NN I-NP B-mo
80 nightly RB O B-f
80 p.r.n VBZ O I-f
81 ALLERGIES: NNP B-NP O
82 1 CD O O
82 Penicillin NNP B-NP O
82 causing VBG O O
82 tongue NN B-NP O
82 swelling VBG O O
83 2 CD O O
83 Morphine NNP B-NP O
83 causing VBG O O
83 mental JJ B-NP O
83 status NN I-NP O
83 changes NNS I-NP O
84 3 CD O O
84 Codeine NNP B-NP O
84 causing VBG O O
84 mental JJ B-NP O
84 status NN I-NP O
84 change NN I-NP O
85 4 CD O O
85 Dilaudid NNP B-NP O
85 causing VBG O O
85 mental JJ B-NP O
85 status NN I-NP O
85 change NN I-NP O
85 , , O O
85 added VBD B-VP O
85 on IN B-VP O
85 this DT B-NP O
86 admission NN I-NP O
87 SOCIAL NNP I-NP O
87 HISTORY: NNP I-NP O
88 1 CD O O
88 Tobacco NNP B-NP O
88 , , O O
88 80-pack-year JJ B-NP O
88 history NN I-NP O
88 , , O O
88 quit NN B-NP O
88 in IN B-VP O
88 1990 CD O O
89 2 CD O O
89 No DT B-NP O
89 alcohol NN I-NP O
90 PHYSICAL NNP I-NP O
90 EXAMINATION NNP I-NP O
90 ON NNP I-NP O
90 ADMISSION: NNP I-NP O
90 Notable NNP I-NP O
90 for IN B-VP O
90 temperature NN B-NP O
90 of IN B-VP O
91 99.2 CD O O
91 , , O O
91 heart NN B-NP O
91 rate NN I-NP O
91 of IN B-VP O
91 121 CD O O
91 in IN B-VP O
91 sinus JJ B-NP O
91 tachycardia NN I-NP O
91 , , O O
91 blood NN B-NP O
91 pressure NN I-NP O
92 116/60 CD O O
92 , , O O
92 saturating VBG O O
92 98% CD O O
92 on IN B-VP O
92 room NN B-NP O
92 air NN I-NP O
92 She PRP O O
92 was VBD B-VP O
92 noted VBN O O
92 to TO O O
92 have VB O O
92 a DT O O
92 2/6 CD O O
93 systolic JJ B-NP O
93 murmur NN I-NP O
93 at IN B-VP O
93 the DT B-NP O
93 apex JJ I-NP O
93 Lungs NNS I-NP O
93 were VBD B-VP O
93 clear JJ O O
93 bilaterally RB O O
94 Pulse NNP B-NP O
94 exam NN I-NP O
94 showed VBD B-VP O
94 no DT B-NP O
94 palpable JJ I-NP O
94 femoral JJ I-NP O
94 pulses NNS I-NP O
94 and CC O O
94 biphasic JJ B-NP O
95 dopplerable JJ I-NP O
95 pulses NNS I-NP O
95 bilaterally RB O O
95 , , O O
95 DP NNP B-NP O
95 and CC O O
95 PT NNP B-NP O
95 Extremities NNP I-NP O
95 showed VBD B-VP O
96 bilateral JJ B-NP O
96 mottling NN I-NP O
96 of IN B-VP O
96 all DT B-NP O
96 toes NNS I-NP O
96 and CC O O
96 an DT O O
96 open JJ O O
96 0.5 CD O O
96 cm JJ B-NP O
96 ulceration NN I-NP O
96 at IN B-VP O
97 the DT B-NP O
97 base NN I-NP O
97 of IN B-VP O
97 the DT B-NP O
97 left JJ I-NP O
97 fourth JJ I-NP O
97 toe NN I-NP O
97 All DT B-NP O
97 toes NNS I-NP O
97 are VBP O O
97 exquisitely RB O O
97 tender NN B-NP O
98 to TO O O
98 palpation NN B-NP O
98 Sensation NNP I-NP O
98 is VBZ O O
98 decreased VBN O O
98 but CC O O
98 equal JJ O O
98 bilaterally RB O O
99 HOSPITAL NNP B-NP O
99 COURSE: NNP I-NP O
99 This DT B-NP O
99 75-year-old JJ I-NP O
99 female JJ I-NP O
99 vasculopath NN I-NP O
99 was VBD B-VP O
100 admitted VBN O O
100 for IN B-VP O
100 further JJ B-NP O
100 evaluation NN I-NP O
100 of IN B-VP O
100 her PRP$ O O
100 peripheral JJ B-NP O
100 vascular JJ I-NP O
101 disease NN I-NP O
101 which WDT O O
101 was VBD B-VP O
101 suspected VBN O O
101 to TO O O
101 be VB O O
101 contributing VBG O O
101 to TO O O
101 her PRP$ O O
101 new JJ B-NP O
102 ulcerations NNS I-NP O
102 and CC O O
102 progressively RB O O
102 worsening VBG O O
102 wrist NN B-NP O
102 pain NN I-NP O
102 as IN B-VP O
102 an DT O O
103 exacerbating VBG O O
103 factor NN B-NP O
103 to TO O O
103 likely JJ B-NP O
103 atheroembolic JJ I-NP O
103 phenomenon NN I-NP O
103 , , O O
103 status NN B-NP O
104 post NN I-NP O
104 coronary JJ B-NP O
104 catheterizations NNS I-NP O
104 earlier RBR O O
104 in IN B-VP O
104 the DT B-NP O
104 year NN I-NP O
104 She PRP O O
104 was VBD B-VP O
105 placed VBN O O
105 on IN B-VP O
105 broad-spectrum JJ B-NP O
105 antibiotics NNS I-NP B-m
105 and CC O O
105 plan NN B-NP O
105 was VBD B-VP O
105 made VBN O O
105 for IN B-VP O
105 an DT B-NP O
105 MRA NNP I-NP O
106 to TO O O
106 evaluate VB O O
106 her PRP$ O O
106 anatomy NN B-NP O
106 Unfortunately RB O O
106 , , O O
106 the DT B-NP O
106 patient NN I-NP O
106 was VBD B-VP O
106 unable JJ O O
107 to TO O O
107 tolerate VB O O
107 the DT B-NP O
107 MR NNP I-NP O
107 and CC O O
107 did VBD B-VP O
107 experience VB O O
107 some DT B-NP O
107 mental JJ I-NP O
107 status NN I-NP O
107 changes NNS I-NP O
108 that WDT O O
108 prevented VBD B-VP O
108 further RBR O O
108 noninvasive JJ B-NP O
108 imaging NN I-NP O
108 , , O O
108 when WRB O O
108 she PRP O O
108 received VBD B-VP O
109 some DT O O
109 narcotic JJ O B-m
109 following VBG O O
109 her PRP$ O O
109 hemodialysis NN B-NP O
109 round NN I-NP O
109 Over IN B-VP O
109 the DT B-NP O
109 ensuing JJ I-NP O
110 days NNS I-NP O
110 she PRP O O
110 required VBD B-VP O
110 rather RB O O
110 significant JJ B-NP B-do
110 significant JJ I-NP B-do
110 doses NNS I-NP I-do
110 doses NNS I-NP I-do
110 of IN B-VP O
110 Zyprexa NNP B-NP B-m
110 Zyprexa NNP I-NP B-m
110 and CC O O
110 Haldol NNP B-NP B-m
110 Haldol NNP I-NP B-m
111 to TO O O
111 contain VB O O
111 agitation NN B-NP B-r
111 agitation NN I-NP B-r
111 and CC O O
111 delirium NN B-NP B-r
111 delirium NN I-NP B-r
111 , , O O
111 as IN B-VP O
111 the DT B-NP O
111 patient NN I-NP O
111 would MD O O
111 also RB O O
111 get VB O O
112 physical JJ O O
112 and CC O O
112 violent JJ O O
112 This DT O O
112 appeared VBD B-VP O
112 to TO O O
112 sedate VB O O
112 her PRP$ O O
112 sufficiently RB O O
113 and CC O O
113 over IN B-VP O
113 the DT B-NP O
113 following JJ I-NP O
113 days NNS I-NP O
113 , , O O
113 she PRP O O
113 did VBD B-VP O
113 manage VB O O
113 to TO O O
113 calm VB O O
113 significantly RB O O
114 and CC O O
114 returned VBD B-VP O
114 to TO O O
114 her PRP$ O O
114 baseline NN B-NP O
114 mental NN I-NP O
114 status NN I-NP O
114 She PRP O O
114 did VBD B-VP O
114 appear VB O O
114 very RB O O
115 emotionally RB O O
115 labile JJ O O
115 throughout IN B-VP O
115 the DT B-NP O
115 rest NN I-NP O
115 of IN B-VP O
115 her PRP$ O O
115 stay NN B-NP O
115 and CC O O
115 incredibly RB O O
116 remorseful VB O O
116 for IN B-VP O
116 previous JJ B-NP O
116 events NNS I-NP O
116 On IN B-VP O
116 10/30/2006 CD O O
116 , , O O
116 she PRP O O
116 was VBD B-VP O
116 offered VBN O O
117 an DT B-NP O
117 angiogram NN I-NP O
117 to TO O O
117 delineate VB O O
117 aortic JJ O O
117 and CC O O
117 bilateral JJ B-NP O
117 lower JJR I-NP O
117 extremity NN I-NP O
118 runoff NN I-NP O
118 anatomy IN B-VP O
118 She PRP O O
118 did VBD B-VP O
118 tolerate VB O O
118 this DT B-NP O
118 well NN I-NP O
118 under IN B-VP O
118 simple JJ B-NP O
118 IV NNP I-NP O
119 conscious JJ B-NP O
119 sedation NN I-NP O
119 This DT O O
119 showed VBD B-VP O
119 chronic JJ B-NP O
119 disease NN I-NP O
119 with IN B-VP O
120 collateralization NN B-NP O
120 and CC O O
120 very RB O O
120 poor JJ B-NP O
120 inflow NN I-NP O
120 to TO O O
120 the DT B-NP O
120 bilateral JJ I-NP O
120 feet NNS I-NP O
120 with IN B-VP O
121 essentially RB O O
121 one CD O O
121 vessel NN B-NP O
121 run VB O O
121 off RP O O
121 on IN B-VP O
121 either DT B-NP O
121 side NN I-NP O
121 After IN B-VP O
121 extensive JJ B-NP O
122 discussions NNS I-NP O
122 with IN B-VP O
122 the DT B-NP O
122 patient NN I-NP O
122 and CC O O
122 the DT B-NP O
122 patient's JJ I-NP O
122 family NN I-NP O
122 , , O O
122 the DT B-NP O
123 patient NN I-NP O
123 did VBD B-VP O
123 agree VB O O
123 to TO O O
123 a DT O O
123 left JJ O O
123 femoral JJ O O
123 to TO O O
123 dorsalis VB O O
123 pedis JJ B-NP O
123 bypass NN I-NP O
124 graft NN I-NP O
124 which WDT O O
124 was VBD B-VP O
124 performed VBN O O
124 on IN B-VP O
124 0/25/2006 CD O O
124 without IN B-VP O
124 complication NN B-NP O
125 Please NNP I-NP O
125 see VB O O
125 the DT B-NP O
125 operative JJ I-NP O
125 note NN I-NP O
125 for IN B-VP O
125 further JJ B-NP O
125 details NNS I-NP O
125 The DT B-NP O
125 patient NN I-NP O
126 did VBD B-VP O
126 tolerate VB O O
126 the DT B-NP O
126 procedure NN I-NP O
126 well RB O O
126 By IN B-VP O
126 time NN B-NP O
126 of IN B-VP O
126 discharge NN B-NP O
126 , , O O
126 she PRP O O
126 was VBD B-VP O
127 tolerating VBG O O
127 a DT B-NP O
127 regular JJ I-NP O
127 diet NN I-NP O
127 and CC O O
127 ambulating VBG O O
127 at IN B-VP O
127 baseline NN B-NP O
127 with IN B-VP O
127 her PRP$ O O
128 rolling VBG O O
128 walker NN B-NP O
128 The DT B-NP O
128 pain NN I-NP O
128 was VBD B-VP O
128 well RB O O
128 controlled VBN O O
128 with IN B-VP O
128 minimal JJ B-NP O
129 analgesics NNS I-NP O
129 that WDT O O
129 were VBD B-VP O
129 not RB O O
129 narcotic JJ O O
129 based VBN O O
129 Cardiology NNP B-NP O
129 was VBD B-VP O
130 consulted VBN O O
130 during IN B-VP O
130 this DT B-NP O
130 time NN I-NP O
130 to TO O O
130 optimize VB O O
130 her PRP$ O O
130 prior JJ O O
130 to TO O O
130 the DT B-NP O
130 OR NNP I-NP O
130 Her NNP I-NP O
131 primary JJ B-NP O
131 cardiologist NN I-NP O
131 , , O O
131 Dr NNP B-NP O
131 Fugle NNP I-NP O
131 did VBD B-VP O
131 make VB O O
131 some DT B-NP O
131 recommendations NNS I-NP O
132 including VBG O O
132 an DT B-NP O
132 echocardiogram NN I-NP O
132 that WDT O O
132 showed VBD B-VP O
132 preserved VBN O O
132 ejection NN B-NP O
133 fraction NN I-NP O
133 and CC O O
133 no DT B-NP O
133 wall NN I-NP O
133 motion NN I-NP O
133 abnormalities VBZ O O
133 Her NNP B-NP O
133 beta NN I-NP B-m
133 blockade NN I-NP I-m
133 was VBD B-VP O
134 titrated VBN O B-do
134 up RP O I-do
134 and CC O O
134 she PRP O O
134 was VBD B-VP O
134 instructed VBN O O
134 to TO O O
134 follow VB O O
134 up RP O O
134 with IN B-VP O
134 cardiology NN B-NP O
135 She PRP O O
135 did VBD B-VP O
135 tolerate VB O O
135 hemodialysis NN B-NP O
135 throughout IN B-VP O
135 this DT B-NP O
135 time NN I-NP O
135 without IN B-VP O
135 undue JJ B-NP O
136 difficulty NN I-NP O
136 She PRP O O
136 did VBD B-VP O
136 on IN B-VP O
136 one CD O O
136 occasion NN B-NP O
136 experience NN I-NP O
136 dyspnea NN I-NP O
136 following VBG O O
137 hemodialysis NN B-NP O
137 that WDT O O
137 resolved VBD B-VP O
137 of IN B-VP O
137 its PRP$ O O
137 own JJ B-NP O
137 accord NN I-NP O
137 , , O O
137 no DT B-NP O
137 cardiac JJ I-NP O
137 events NNS I-NP O
138 or CC O O
138 in IN B-VP O
138 evidence NN B-NP O
138 by IN B-VP O
138 EKG NNP B-NP O
138 or CC O O
138 by IN B-VP O
138 following VBG O O
138 cardiac JJ B-NP O
138 enzymes NNS I-NP O
138 As IN B-VP O
138 the DT B-NP O
139 patient NN I-NP O
139 was VBD B-VP O
139 in IN B-VP O
139 stable JJ B-NP O
139 condition NN I-NP O
139 and CC O O
139 back RB O O
139 to TO O O
139 her PRP$ O O
139 baseline JJ B-NP O
139 level NN I-NP O
139 of IN B-VP O
140 activity NN B-NP O
140 with IN B-VP O
140 very RB O O
140 strong JJ B-NP O
140 support NN I-NP O
140 at IN B-VP O
140 home NN B-NP O
140 , , O O
140 she PRP O O
140 was VBD B-VP O
140 discharged VBN O O
140 to TO O O
141 home NN B-NP O
141 with IN B-VP O
141 services NNS B-NP O
141 for IN B-VP O
141 wound NN B-NP O
141 checks NNS I-NP O
141 and CC O O
141 home NN B-NP O
141 safety NN I-NP O
141 evaluation NN I-NP O
142 She PRP O O
142 was VBD B-VP O
142 instructed VBN O O
142 to TO O O
142 follow VB O O
142 up RP O O
142 with IN B-VP O
142 Dr NNP B-NP O
142 Sedlachek NNP I-NP O
142 in IN B-VP O
142 one CD O O
142 to TO O O
142 two CD O O
143 weeks NNS B-NP O
144 DISCHARGE NNP I-NP O
144 INSTRUCTIONS: NNP I-NP O
145 1 CD O O
145 Touchdown NNP B-NP O
145 weightbearing VBG O O
145 on IN B-VP O
145 the DT B-NP O
145 left NN I-NP O
145 heel VBZ O O
145 The DT B-NP O
145 patient NN I-NP O
145 should MD O O
146 not RB O O
146 keep VB O O
146 legs NNS B-NP O
146 in IN B-VP O
146 dependent JJ B-NP O
146 position NN I-NP O
146 for IN B-VP O
146 more JJR O O
146 than IN B-VP O
146 10 CD O O
146 minutes NNS B-NP O
146 at IN B-VP O
146 a DT B-NP O
147 time NN I-NP O
147 She PRP O O
147 was VBD B-VP O
147 to TO O O
147 use VB O O
147 the DT B-NP O
147 walker NN I-NP O
147 and CC O O
147 a DT B-NP O
147 cane NN I-NP O
147 as IN B-VP O
147 instructed VBN O O
147 by IN B-VP O
148 physical JJ B-NP O
148 therapy NN I-NP O
149 2 CD O O
149 Legs NNP B-NP O
149 are VBP O O
149 to TO O O
149 be VB O O
149 elevated VBN O O
149 as RB O O
149 much JJ O O
149 as IN B-VP O
149 possible JJ O O
149 while IN B-VP O
149 sitting VBG O O
149 or CC O O
150 lying VBG O O
150 down RP O O
151 3 CD O O
151 All DT B-NP O
151 home NN I-NP B-m
151 medications NNS I-NP I-m
151 were VBD B-VP O
151 to TO O O
151 be VB O O
151 resumed VBN O O
151 except IN B-VP O
151 for IN B-VP O
151 Lopressor NNP B-NP B-m
151 , , O O
152 the DT B-NP O
152 dose NN I-NP O
152 of IN B-VP O
152 which WDT O O
152 had VBD B-VP O
152 been VBN O O
152 changed VBN O O
152 by IN B-VP O
152 Dr NNP B-NP O
152 Huggins NNP I-NP O
152 to TO O O
152 50 CD O B-do
152 mg NNS B-NP I-do
152 p.o JJ O B-mo
152 t.i.d VBP O B-f
153 4 CD O O
153 VNA NNP B-NP O
153 was VBD B-VP O
153 ordered VBN O O
153 to TO O O
153 assist VB O O
153 with IN B-VP O
153 wound NN B-NP B-r
153 care NN I-NP I-r
153 including VBG O O
153 Betadine NNP B-NP B-m
154 paint NN I-NP O
154 to TO O O
154 incisions NNS B-NP B-mo
154 daily RB O B-f
155 5 CD O O
155 Showering VBG O O
155 only RB O O
155 , , O O
155 no DT B-NP O
155 bathing NN I-NP O
155 or CC O O
155 immersion NN B-NP O
155 in IN B-VP O
155 water NN B-NP O
155 for IN B-VP O
156 prolonged JJ B-NP O
156 periods NNS I-NP O
156 of IN B-VP O
156 time NN B-NP O
157 6 CD O O
157 Follow-up JJ B-NP O
157 visit NN I-NP O
157 to TO O O
157 be VB O O
157 scheduled VBN O O
157 with IN B-VP O
157 Dr NNP B-NP O
157 Amorose NNP I-NP O
157 in IN B-VP O
157 one CD O O
157 to TO O O
157 two CD O O
158 weeks NNS B-NP O
158 and CC O O
158 Dr NNP B-NP O
158 Morici NNP I-NP O
158 primary JJ B-NP O
158 care NN I-NP O
158 physician NN I-NP O
158 in IN B-VP O
158 one CD O O
158 week NN B-NP O
159 DISCHARGE NNP I-NP O
159 MEDICATIONS: NNP I-NP O
160 1 CD O O
160 Tylenol NNP B-NP B-m
160 325 CD O B-do
160 mg NN B-NP I-do
160 p.o NN I-NP B-mo
160 every DT O B-f
160 four CD O I-f
160 hours NNS B-NP I-f
160 p.r.n VBP O I-f
160 pain VBP O B-r
161 2 CD O O
161 Albuterol NNP B-NP B-m
161 inhaler NN I-NP I-m
161 2 CD O B-do
161 puffs NNS B-NP I-do
161 b.i.d VBD B-VP B-f
162 3 CD O O
162 Allopurinol NNP B-NP B-m
162 100 CD O B-do
162 mg NN B-NP I-do
162 p.o JJ O B-mo
162 daily JJ O B-f
163 4 CD O O
163 Aspirin NNP B-NP B-m
163 325 CD O B-do
163 mg NN B-NP I-do
163 p.o JJ O B-mo
163 daily JJ O B-f
164 5 CD O O
164 Calcitriol NNP B-NP B-m
164 Calcitriol NNP I-NP B-m
164 1.5 CD O B-do
164 1.5 CD O B-do
164 mcg NN B-NP I-do
164 mcg NN I-NP I-do
164 p.o NN I-NP B-mo
164 p.o NN I-NP B-mo
164 every DT O B-f
164 every DT B-NP B-f
164 Monday NNP I-NP I-f
164 Monday NNP I-NP I-f
164 and CC O I-f
164 every DT B-NP I-f
164 Friday NNP I-NP I-f
165 6 CD O O
165 Plavix NNP B-NP B-m
165 75 CD O B-do
165 mg NN B-NP I-do
165 p.o JJ O B-mo
165 daily JJ O B-f
166 7 CD O O
166 Darbepoetin NNP B-NP B-m
166 alfa NN I-NP I-m
166 100 CD O B-do
166 mcg NN B-NP I-do
166 subcutaneous JJ O B-mo
166 every DT B-NP B-f
166 week NN I-NP I-f
167 8 CD O O
167 Ferrous JJ B-NP B-m
167 sulfate NN I-NP I-m
167 325 CD O B-do
167 mg NN B-NP I-do
167 p.o NN I-NP B-mo
167 t.i.d VBD B-VP B-f
168 9 CD O O
168 Prozac NNP B-NP B-m
168 40 CD O B-do
168 mg NN B-NP I-do
168 p.o JJ O B-mo
168 daily JJ O B-f
169 10 CD O O
169 Neurontin NNP B-NP B-m
169 300 CD O B-do
169 mg NN B-NP I-do
169 p.o VBD B-VP B-mo
169 post-dialysis NN B-NP O
170 11 CD O O
170 Motrin NNP B-NP B-m
170 400 CD O B-do
170 mg NN B-NP I-do
170 p.o NN I-NP B-mo
170 every DT O B-f
170 eight CD O I-f
170 hours NNS B-NP I-f
170 p.r.n VBP O I-f
170 pain VBP O B-r
171 12 CD O O
171 Lantus NNP B-NP B-m
171 10 CD O B-do
171 units NNS B-NP I-do
171 subcutaneous JJ O B-mo
171 nightly RB O B-f
172 13 CD O O
172 Insulin NNP B-NP B-m
172 regular JJ O I-m
172 sliding VBG O B-do
172 scale NN B-NP I-do
172 See NNP I-NP O
172 discharge NN I-NP O
172 order NN I-NP O
172 for IN B-VP O
173 scale NN B-NP O
174 14 CD O O
174 Atrovent NNP B-NP B-m
174 2 CD O B-do
174 puffs NNS B-NP I-do
174 four CD O B-f
174 times NNS B-NP I-f
174 a DT B-NP I-f
174 day NN I-NP I-f
175 15 CD O O
175 Lopressor NNP B-NP B-m
175 50 CD O B-do
175 mg NN B-NP I-do
175 p.o NN I-NP B-mo
175 t.i.d NN I-NP B-f
175 Do NNP I-NP O
175 not RB O O
175 take VB O O
175 with IN B-VP O
176 lightheadedness NN B-NP O
176 or CC O O
176 dizziness NN B-NP O
177 16 CD O O
177 Metamucil NNP B-NP B-m
177 1 CD O B-do
177 packet NN B-NP I-do
177 p.o JJ O B-mo
177 daily JJ O B-f
178 17 CD O O
178 Sevelamer NNP B-NP B-m
178 800 CD O B-do
178 mg NN B-NP I-do
178 p.o NN I-NP B-mo
178 t.i.d VBD B-VP B-f
179 18 CD O O
179 Lipitor NNP B-NP B-m
179 80 CD O B-do
179 mg NN B-NP I-do
179 p.o NN I-NP B-mo
179 nightly RB O B-f
180 eScription JJ O O
180 document: IN B-VP O
180 5-4188453 JJ B-NP O
180 HFFocus NNP I-NP O
181 Dictated NNP I-NP O
181 By: NNP I-NP O
181 BODE NNP I-NP O
181 , , O O
181 NED NNP B-NP O
182 Attending: NNP I-NP O
182 STENT NNP I-NP O
182 , , O O
182 PABLO NNP B-NP O
182 JARRED NNP I-NP O
183 Dictation NNP I-NP O
183 ID NNP I-NP O
183 5557264 CD O O
184 D: NNP B-NP O
184 5/1/06 CD O O
185 T: NNP B-NP O
185 5/1/06 CD O O
186 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #904835 VBZ O O
4 546608017 CD O O
4 HH NNP B-NP O
4 85716261 CD O O
4 546508 CD O O
4 0/3/1999 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 STROKE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/3/1999 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 0/30/1999 CD O O
7 CHIEF NNP B-NP O
7 COMPLAINT: NNP I-NP O
7 This DT B-NP O
7 patient NN I-NP O
7 presented VBD B-VP O
7 with IN B-VP O
7 an DT B-NP O
7 acute JJ I-NP O
7 stroke NN I-NP O
7 and CC O O
8 was VBD B-VP O
8 brought VBN O O
8 in IN B-VP O
8 by IN B-VP O
8 her PRP$ O O
8 daughter JJ B-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 Sixty-six NNP I-NP O
9 year NN I-NP O
9 old JJ B-NP O
9 obese JJ I-NP O
9 African JJ I-NP O
10 American NNP I-NP O
10 woman NN I-NP O
10 of IN B-VP O
10 previous JJ B-NP O
10 CVA NNP I-NP O
10 of IN B-VP O
11 unclear JJ B-NP O
11 etiology NN I-NP O
11 and CC O O
11 unclear JJ B-NP O
11 clinical JJ I-NP O
11 sequelae NN I-NP O
11 She PRP O O
11 was VBD B-VP O
11 driving VBG O O
11 as IN B-VP O
12 a DT B-NP O
12 passenger NN I-NP O
12 in IN B-VP O
12 a DT B-NP O
12 car NN I-NP O
12 around RB O O
12 11:00 CD O O
12 o'clock NN B-NP O
12 in IN B-VP O
12 the DT B-NP O
12 morning NN I-NP O
12 and CC O O
13 experienced VBD B-VP O
13 a DT B-NP O
13 sudden JJ I-NP O
13 speech NN I-NP O
13 arrest NN I-NP O
13 which WDT O O
13 was VBD B-VP O
13 witnessed VBN O O
13 by IN B-VP O
13 her PRP$ O O
14 daughter-in-law NN B-NP O
14 She PRP O O
14 has VBZ O O
14 also RB O O
14 difficulty NN B-NP O
14 moving VBG O O
14 her PRP$ O O
14 right JJ B-NP O
14 arm NN I-NP O
14 and CC O O
15 she PRP O O
15 had VBD B-VP O
15 some DT B-NP O
15 tearing NN I-NP O
15 of IN B-VP O
15 her PRP$ O O
15 left JJ B-NP O
15 eye NN I-NP O
15 as RB O O
15 well RB O O
15 as IN B-VP O
15 a DT B-NP O
15 skewed JJ I-NP O
15 look NN I-NP O
15 on IN B-VP O
16 her PRP$ O O
16 face NN B-NP O
16 By IN B-VP O
16 11:40 CD O O
16 a.m NNS B-NP O
16 , , O O
16 the DT B-NP O
16 ambulance NN I-NP O
16 had VBD B-VP O
16 arrived VBN O O
16 and CC O O
16 she PRP O O
16 was VBD B-VP O
17 admitted VBN O O
17 to TO O O
17 the DT B-NP O
17 Koote NNP I-NP O
17 Hospital NNP I-NP O
17 emergency NN I-NP O
17 department NN I-NP O
18 where WRB O O
18 the DT B-NP O
18 protocol NN I-NP O
18 for IN B-VP O
18 acute JJ B-NP O
18 stroke NN I-NP O
18 was VBD B-VP O
18 instituted VBN O O
18 The DT B-NP O
18 patient NN I-NP O
19 had VBD B-VP O
19 a DT B-NP O
19 CTA NNP I-NP O
19 done VBN O O
19 which WDT O O
19 showed VBD B-VP O
19 questionable JJ B-NP O
19 luminal JJ I-NP O
19 narrowing NN I-NP O
19 of IN B-VP O
19 the DT O O
20 distal JJ O O
20 left VBD B-VP O
20 middle JJ B-NP O
20 cerebral JJ I-NP O
20 artery NN I-NP O
20 CT NNP I-NP O
20 scan NN I-NP O
20 was VBD B-VP O
20 normal JJ O O
20 and CC O O
20 the DT B-NP O
21 patient NN I-NP O
21 was VBD B-VP O
21 given VBN O O
21 intravenous JJ B-NP B-mo
21 TPA NNP I-NP B-m
21 at IN B-VP O
21 1323 CD O O
21 p.m NN B-NP O
21 She PRP O O
21 was VBD B-VP O
21 given VBN O O
21 a DT O O
21 9 CD O B-do
21 9 CD O B-do
22 mg NN B-NP O
22 bolus NN I-NP B-m
22 bolus JJ O B-m
22 bolus CC O B-m
22 dose JJ O O
22 over IN B-VP B-du
22 two CD O I-du
22 two CD O B-du
22 minutes NNS B-NP I-du
22 minutes NNS I-NP I-du
22 and CC O O
22 81 CD O B-do
22 mg NN B-NP I-do
22 given VBN O O
22 over IN B-VP O
22 the DT B-NP B-du
22 following JJ I-NP O
23 hour NN I-NP O
23 She PRP O O
23 was VBD B-VP O
23 transferred VBN O O
23 to TO O O
23 the DT B-NP O
23 neuro JJ I-NP O
23 intensive JJ I-NP O
23 care NN I-NP O
23 unit NN I-NP O
23 of IN B-VP O
24 Ham NNP B-NP O
24 Tertnough NNP I-NP O
24 Memorial NNP I-NP O
24 Hospital NNP I-NP O
25 PAST NNP I-NP O
25 MEDICAL NNP I-NP O
25 HISTORY; NNP I-NP O
25 Diet NNP I-NP O
25 controlled VBD B-VP O
25 diabetes NNS B-NP O
25 , , O O
25 obesity NN B-NP O
25 , , O O
26 hypertension NN B-NP O
26 as IN B-VP O
26 per IN B-VP O
26 the DT B-NP O
26 Rinn NNP I-NP O
26 Maield NNP I-NP O
26 Pinessi NNP I-NP O
26 Hospital NNP I-NP O
26 internal JJ B-NP O
27 medicine NN I-NP O
27 associate NN I-NP O
27 records NNS I-NP O
27 She PRP O O
27 also RB O O
27 has VBZ O O
27 history NN B-NP O
27 of IN B-VP O
27 ulcerative JJ B-NP O
28 colitis NN I-NP O
28 and CC O O
28 is VBZ O O
28 on IN B-VP O
28 treatment NN B-NP O
28 She PRP O O
28 is VBZ O O
28 status NN B-NP O
28 post NN I-NP O
28 MI NNP I-NP O
28 in IN B-VP O
28 1988 CD O O
28 and CC O O
29 there EX O O
29 is VBZ O O
29 question NN B-NP O
29 of IN B-VP O
29 an DT B-NP O
29 old JJ I-NP O
29 stroke NN I-NP O
29 in IN B-VP O
29 the DT B-NP O
29 past NN I-NP O
29 There EX O O
29 is VBZ O O
29 also RB O O
30 question NN B-NP O
30 of IN B-VP O
30 asthma JJ B-NP O
31 MEDICATIONS: NNP I-NP O
31 Currently NNP I-NP O
31 is VBZ O O
31 aspirin JJ O B-m
31 325 CD O B-do
31 mg NN B-NP I-do
31 and CC O O
31 Asacol NNP B-NP B-m
31 although IN B-VP O
31 she PRP O O
32 wasn't VBZ O O
32 sure JJ O O
32 of IN B-VP O
32 the DT B-NP O
32 dose JJ I-NP O
33 SOCIAL NNP I-NP O
33 HISTORY: NNP I-NP O
33 Nonsmoker NNP I-NP O
33 , , O O
33 married VBD B-VP O
33 with IN B-VP O
33 several JJ B-NP O
33 children NNS I-NP O
33 At IN B-VP O
34 baseline NN B-NP O
34 , , O O
34 she PRP O O
34 is VBZ O O
34 wheelchair JJ O O
34 dependent JJ O O
34 due JJ O O
34 to TO O O
35 chronic JJ B-NP O
35 hip NN I-NP O
35 and CC O O
35 back RB O O
35 pain NN B-NP O
35 although IN B-VP O
35 she PRP O O
35 ambulates VBZ O O
35 at IN B-VP O
35 home NN B-NP O
36 REVIEW NNP I-NP O
36 OF NNP I-NP O
36 SYSTEMS: NNP I-NP O
36 Revealed NNP I-NP O
36 chronic JJ B-NP O
36 mild NN I-NP O
36 shortness NN I-NP O
36 of IN B-VP O
36 breath NN B-NP O
37 FAMILY NNP I-NP O
37 HISTORY: NNP I-NP O
37 There EX O O
37 was VBD B-VP O
37 no DT B-NP O
37 significant JJ I-NP O
37 other JJ I-NP O
37 family NN I-NP O
37 history NN I-NP O
38 PHYSICAL NNP I-NP O
38 EXAMINATION; NNP I-NP O
38 Blood NNP I-NP O
38 pressure NN I-NP O
38 is VBZ O O
38 138/76 CD O O
38 , , O O
38 heart NN B-NP O
38 rate NN I-NP O
38 was VBD B-VP O
38 80 CD O O
39 and CC O O
39 paced VBD B-VP O
39 She PRP O O
39 was VBD B-VP O
39 an DT B-NP O
39 obese JJ I-NP O
39 lady NN I-NP O
39 lying VBG O O
39 on IN B-VP O
40 her PRP O O
40 back RB O O
40 HEAD NNP B-NP O
40 AND NNP I-NP O
40 NECK: NNP I-NP O
40 Revealed VBD B-VP O
40 no DT B-NP O
40 evidence NN I-NP O
40 of IN B-VP O
40 trauma NN B-NP O
40 There EX O O
41 were VBD B-VP O
41 no DT B-NP O
41 bruits NNS I-NP O
41 in IN B-VP O
41 the DT B-NP O
41 neck NN I-NP O
41 CHEST: NNP I-NP O
41 Clear NNP I-NP O
41 There EX O O
41 were VBD B-VP O
41 bilateral JJ B-NP O
42 wheezes NNS I-NP O
42 ABDOMEN: NNP I-NP O
42 Soft NNP I-NP O
42 , , O O
42 non-tender JJ B-NP O
42 EXTREMITIES: NNP I-NP O
42 Normal NNP I-NP O
42 , , O O
42 obese JJ O O
43 with IN B-VP O
43 no DT B-NP O
43 edema NN I-NP O
43 NEURO: NNP I-NP O
43 The DT B-NP O
43 patient NN I-NP O
43 is VBZ O O
43 awake JJ O O
43 and CC O O
43 alert JJ O O
43 , , O O
43 looking VBG O O
44 around IN B-VP O
44 She PRP O O
44 was VBD B-VP O
44 mute JJ O O
44 however RB O O
44 She PRP O O
44 was VBD B-VP O
44 able JJ O O
44 to TO O O
44 follow VB O O
44 one CD O O
44 step NN B-NP O
45 commands VBZ O O
45 She PRP O O
45 had VBD B-VP O
45 a DT B-NP O
45 question NN I-NP O
45 of IN B-VP O
45 a DT B-NP O
45 right JJ I-NP O
45 field NN I-NP O
45 compromise NN I-NP O
46 difficulty NN I-NP O
46 crossing VBG O O
46 the DT B-NP O
46 midline NN I-NP O
46 She PRP O O
46 had VBD B-VP O
46 a DT B-NP O
46 right JJ I-NP O
46 upper JJ I-NP O
46 motor NN I-NP O
47 neuron IN B-VP O
47 seventh JJ B-NP O
47 weakness NN I-NP O
47 with IN B-VP O
47 decreased JJ B-NP O
47 power NN I-NP O
47 on IN B-VP O
47 the DT B-NP O
47 right JJ I-NP O
47 side NN I-NP O
47 of IN B-VP O
48 the DT B-NP O
48 face NN I-NP O
48 She PRP O O
48 had VBD B-VP O
48 flaccid VBN O O
48 right JJ B-NP O
48 arm NN I-NP O
48 Her PRP$ O O
48 right JJ B-NP O
48 leg NN I-NP O
48 had VBD B-VP O
48 some DT B-NP O
48 power NN I-NP O
49 with IN B-VP O
49 flexion NN B-NP O
49 at IN B-VP O
49 the DT B-NP O
49 knee NN I-NP O
49 but CC O O
49 was VBD B-VP O
49 generally RB O O
49 weak JJ O O
49 She PRP O O
49 had VBD B-VP O
49 optimum JJ B-NP O
50 coordination NN I-NP O
50 and CC O O
50 absent NN B-NP O
50 pinprick NN I-NP O
50 and CC O O
50 proprioception NN B-NP O
50 on IN B-VP O
50 the DT B-NP O
50 right JJ I-NP O
51 All NNP I-NP O
51 of IN B-VP O
51 this DT O O
51 was VBD B-VP O
51 documented VBN O O
51 at IN B-VP O
51 12:30 CD O O
51 a.m NN B-NP O
51 By IN B-VP O
51 14;30 CD O O
51 a.m NNS B-NP O
51 , , O O
51 after IN B-VP O
51 the DT B-NP O
52 patient NN I-NP O
52 was VBD B-VP O
52 given VBN O O
52 intravenous JJ B-NP B-mo
52 TPA NNP I-NP B-m
52 , , O O
52 the DT B-NP O
52 patient's NN I-NP O
52 language NN I-NP O
52 had VBD B-VP O
53 returned VBN O O
53 completely RB O O
53 to TO O O
53 normal JJ O O
53 She PRP O O
53 had VBD B-VP O
53 normal JJ B-NP O
53 speech NN I-NP O
53 including VBG O O
54 comprehension NN B-NP O
54 and CC O O
54 naming VBG O O
54 Her PRP$ O O
54 ability NN B-NP O
54 to TO O O
54 distinguish VB O O
54 left VBN O O
54 from IN B-VP O
55 right NN B-NP O
55 was VBD B-VP O
55 intact JJ B-NP O
55 Her NNP I-NP O
55 repetition NN I-NP O
55 was VBD B-VP O
55 intact JJ B-NP O
55 SHe NNP I-NP O
55 had VBD B-VP O
55 full JJ B-NP O
55 range NN I-NP O
55 of IN B-VP O
56 movement NN B-NP O
56 of IN B-VP O
56 the DT B-NP O
56 eyes NNS I-NP O
56 with IN B-VP O
56 full JJ B-NP O
56 fields NNS I-NP O
56 of IN B-VP O
56 confrontation NN B-NP O
56 She PRP O O
56 had VBD B-VP O
56 a DT B-NP O
57 mild JJ I-NP O
57 right JJ I-NP O
57 arm NN I-NP O
57 drift NN I-NP O
57 on IN B-VP O
57 the DT B-NP O
57 right JJ I-NP O
57 side NN I-NP O
57 but CC O O
57 her PRP$ O O
57 strength NN B-NP O
57 was VBD B-VP O
57 4+/5 CD O O
58 distally RB O O
58 and CC O O
58 proximally RB O O
58 There EX O O
58 was VBD B-VP O
58 normal JJ B-NP O
58 power NN I-NP O
58 in IN B-VP O
58 the DT B-NP O
58 right NN I-NP O
58 lower JJR B-NP O
59 lobe NN I-NP O
59 and CC O O
59 the DT B-NP O
59 plantars NNS I-NP O
59 were VBD B-VP O
59 normal JJ O O
59 There EX O O
59 was VBD B-VP O
59 no DT B-NP O
59 increase NN I-NP O
59 in IN B-VP O
60 reflexes NNS B-NP O
60 The DT B-NP O
60 patient NN I-NP O
60 was VBD B-VP O
60 transferred VBN O O
60 to TO O O
60 the DT B-NP O
60 intensive JJ I-NP O
60 care NN I-NP O
60 unit NN I-NP O
61 for IN B-VP O
61 the DT B-NP O
61 neurological JJ I-NP O
61 service NN I-NP O
61 of IN B-VP O
61 Teaspell NNP B-NP O
61 Diee NNP I-NP O
61 Hospital NNP I-NP O
62 HOSPITAL NNP I-NP O
62 COURSE: NNP I-NP O
62 Blood NNP I-NP O
62 pressure NN I-NP O
62 monitoring NN I-NP O
62 was VBD B-VP O
62 instituted VBN O O
62 per IN B-VP O
63 protocol NN B-NP O
63 , , O O
63 nasal JJ B-NP B-mo
63 oxygen NN I-NP B-m
63 was VBD B-VP O
63 given VBN O O
63 and CC O O
63 no DT B-NP O
63 antiplatelet NN I-NP O
64 therapy NN I-NP O
64 was VBD B-VP O
64 given VBN O O
64 for IN B-VP B-du
64 24 CD O I-du
64 hours NNS B-NP I-du
64 Head NNP I-NP O
64 of IN B-VP O
64 bed NN B-NP O
64 was VBD B-VP O
64 raised VBN O O
64 to TO O O
64 30 CD O O
65 degrees NNS B-NP O
65 Head NNP I-NP O
65 CT NNP I-NP O
65 was VBD B-VP O
65 repeated VBN O O
65 the DT O O
65 following VBG O O
65 morning NN B-NP O
65 , , O O
65 the DT B-NP O
65 results NNS I-NP O
66 of IN B-VP O
66 which WDT O O
66 show VBP O O
66 that IN B-VP O
66 there EX O O
66 is VBZ O O
66 slight JJ B-NP O
66 left JJ I-NP O
66 basal NN I-NP O
66 ganglion NN I-NP O
66 internal JJ B-NP O
67 capsule NN I-NP O
67 , , O O
67 acute NN B-NP O
67 and CC O O
67 subacute NN B-NP O
67 infarct NN I-NP O
67 in IN B-VP O
67 the DT B-NP O
67 left NN I-NP O
67 middle JJ B-NP O
67 cerebral JJ I-NP O
68 artery NN I-NP O
68 distribution NN I-NP O
68 which WDT O O
68 was VBD B-VP O
68 evolving VBG O O
68 from IN B-VP O
68 the DT B-NP O
68 previous JJ I-NP O
68 study NN I-NP O
69 THere NNP I-NP O
69 was VBD B-VP O
69 no DT B-NP O
69 evidence NN I-NP O
69 of IN B-VP O
69 intracranial JJ B-NP O
69 hemorrhage NN I-NP O
69 The DT B-NP O
69 patient NN I-NP O
69 had VBD B-VP O
70 further JJ B-NP O
70 investigations NNS I-NP O
70 to TO O O
70 look VB O O
70 for IN B-VP O
70 a DT B-NP O
70 cause NN I-NP O
70 of IN B-VP O
70 this DT B-NP O
70 presumed JJ I-NP O
70 embolic JJ I-NP O
71 stroke NN I-NP O
71 She PRP O O
71 had VBD B-VP O
71 an DT B-NP O
71 echocardiogram NN I-NP O
71 done VBN O O
71 which WDT O O
71 showed VBD B-VP O
71 the DT B-NP O
71 aortic JJ I-NP O
72 root NN I-NP O
72 at IN B-VP O
72 3.5 CD O O
72 cm NN B-NP O
72 , , O O
72 the DT B-NP O
72 atrium NN I-NP O
72 at IN B-VP O
72 3.2 CD O O
72 which WDT O O
72 is VBZ O O
72 slightly RB O O
72 dilated VBN O O
72 There EX O O
73 was VBD B-VP O
73 normal JJ B-NP O
73 ventricular JJ I-NP O
73 size NN I-NP O
73 and CC O O
73 overall JJ O O
73 preserved VBN O O
73 systolic JJ B-NP O
74 function NN I-NP O
74 , , O O
74 trace NN B-NP O
74 aortic JJ B-NP O
74 insufficiency NN I-NP O
74 , , O O
74 1+ CD O O
74 tricuspid JJ B-NP O
74 regurgitation NN I-NP O
74 , , O O
75 trace NN B-NP O
75 mitral JJ B-NP O
75 regurgitation NN I-NP O
75 Holter NNP I-NP O
75 monitor NN I-NP O
75 was VBD B-VP O
75 done VBN O O
75 which WDT O O
75 showed VBD B-VP O
76 persistent JJ B-NP O
76 atrial JJ I-NP O
76 flutter NN I-NP O
76 The DT B-NP O
76 patient NN I-NP O
76 was VBD B-VP O
76 coumadinized VBN O O
76 and CC O O
76 some DT B-NP O
77 discussion NN I-NP O
77 pertaining VBG O O
77 to TO O O
77 cardioversion NN B-NP O
77 was VBD B-VP O
77 entertained VBN O O
77 by IN B-VP O
77 the DT B-NP O
78 electrophysiology NN I-NP O
78 service NN I-NP O
78 However RB O O
78 , , O O
78 this DT O O
78 was VBD B-VP O
78 not RB O O
78 done VBN O O
78 as IN B-VP O
78 an DT B-NP O
79 inpatient NN I-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 continued VBD B-VP O
79 to TO O O
79 do VB O O
79 remarkably RB O O
79 well RB O O
79 after IN B-VP O
79 her PRP$ O O
80 intravenous JJ B-NP B-mo
80 thrombolysis NN I-NP B-m
80 over IN B-VP B-du
80 the DT B-NP I-du
80 next JJ I-NP I-du
80 couple NN I-NP I-du
80 of IN B-VP I-du
80 days NNS B-NP I-du
80 She PRP O O
80 had VBD B-VP O
81 persistent JJ B-NP O
81 drift NN I-NP O
81 on IN B-VP O
81 the DT B-NP O
81 right NN I-NP O
81 arm; NN I-NP O
81 however RB O O
81 , , O O
81 her PRP O O
81 speech NN B-NP O
81 remained VBD B-VP O
82 completely RB O O
82 normal JJ B-NP O
82 SHe NNP I-NP O
82 was VBD B-VP O
82 reviewed VBN O O
82 by IN B-VP O
82 the DT B-NP O
82 chronic JJ I-NP O
82 pain NN I-NP O
82 service NN I-NP O
82 on IN B-VP O
83 several JJ B-NP O
83 occasions NNS I-NP O
83 for IN B-VP O
83 chronic JJ B-NP O
83 back NN I-NP O
83 and CC O O
83 leg NN B-NP O
83 pain NN I-NP O
83 She PRP O O
83 reached VBD B-VP O
84 normal JJ B-NP O
84 levels NNS I-NP O
84 of IN B-VP O
84 Coumadin NNP B-NP B-m
84 within IN B-VP O
84 several JJ B-NP B-du
84 days NNS I-NP I-du
84 and CC O O
84 was VBD B-VP O
84 discharged VBN O O
85 without IN B-VP O
85 rehabilitation NN B-NP O
85 She PRP O O
85 will MD O O
85 be VB O O
85 followed VBN O O
85 by IN B-VP O
85 the DT B-NP O
85 cardiac JJ I-NP O
86 service NN I-NP O
86 and CC O O
86 a DT B-NP O
86 plan NN I-NP O
86 for IN B-VP O
86 complete JJ B-NP O
86 cardioversion NN I-NP O
86 was VBD B-VP O
86 instituted VBN O O
86 within IN B-VP O
87 one CD O O
87 month NN B-NP O
87 The DT B-NP O
87 patient NN I-NP O
87 went VBD B-VP O
87 home NN B-NP O
87 on IN B-VP O
87 Coumadin NNP B-NP B-m
87 She PRP O O
87 was VBD B-VP O
87 finally RB O O
88 discharged VBN O O
88 on IN B-VP O
88 0/21/99 CD O O
89 Dictated NNP B-NP O
89 By: NNP I-NP O
89 HAROLD NNP I-NP O
89 ULLMANN NNP I-NP O
89 , , O O
89 M.D NNP B-NP O
89 HQ91 NNP I-NP O
90 Attending: NNP I-NP O
90 IAN NNP I-NP O
90 M NNP I-NP O
90 LAJEUNESSE NNP I-NP O
90 , , O O
90 M.D NNP B-NP O
90 IX83 NNP I-NP O
90 RO255/5843 NNP I-NP O
91 Batch: NNP I-NP O
91 74024 CD O O
91 Index NNP B-NP O
91 No NNP I-NP O
91 B7NM1543EG NNP I-NP O
91 D: NNP I-NP O
91 6/6/99 CD O O
92 T: NNP B-NP O
92 6/6/99 CD O O
93 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #910475 VBZ O O
2 138430825 CD O O
2 OHAHC NNP B-NP O
2 06084114 CD O O
2 488437 CD O O
2 10/29/1995 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 7/6/1995 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/20/1995 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 1 CD O O
4 CHEST NNP B-NP O
4 PAIN NNP I-NP O
4 , , O O
4 FOR NNP B-NP O
4 RULE NNP I-NP O
4 OUT NNP I-NP O
4 MYOCARDIAL NNP I-NP O
5 INFARCTION NNP I-NP O
6 SECONDARY NNP I-NP O
6 DIAGNOSES: NNP I-NP O
6 2 CD O O
6 INSULIN NNP B-NP O
6 DEPENDENT NNP I-NP O
6 DIABETES NNP I-NP O
7 3 CD O O
7 CHRONIC NNP B-NP O
7 ATRIAL NNP I-NP O
7 FIBRILLATION NNP I-NP O
8 4 CD O O
8 HYPERTENSION NNP B-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 The DT B-NP O
9 patient NN I-NP O
9 is VBZ O O
9 a DT O O
9 60 CD O O
9 year NN B-NP O
9 old JJ O O
9 , , O O
9 Spanish JJ O O
10 speaking VBG O O
10 woman NN B-NP O
10 with IN B-VP O
10 multiple JJ B-NP O
10 cardiac JJ I-NP O
11 risk NN I-NP O
11 factors NNS I-NP O
11 who WP O O
11 presented VBD B-VP O
11 complaining NN B-NP O
11 of IN B-VP O
11 unstable JJ B-NP O
11 chest NN I-NP O
11 pain NN I-NP O
11 The DT B-NP O
12 patient's NN I-NP O
12 cardiac JJ B-NP O
12 risk NN I-NP O
12 factors NNS I-NP O
12 include VBP O O
12 adult JJ B-NP O
12 onset NN I-NP O
12 diabetes NNS I-NP O
12 , , O O
13 hypertension NN B-NP O
13 , , O O
13 hypercholesterolemia NN B-NP O
13 , , O O
13 a DT B-NP O
13 positive JJ I-NP O
13 family NN I-NP O
13 history NN I-NP O
13 , , O O
14 previous JJ B-NP O
14 history NN I-NP O
14 of IN B-VP O
14 smoking NN B-NP O
14 as RB O O
14 well RB O O
14 as IN B-VP O
14 postmenopausal NN B-NP O
14 state NN I-NP O
15 secondary JJ O O
15 to TO O O
15 hysterectomy VB O O
15 21 CD O O
15 years NNS B-NP O
15 ago RB O O
15 and CC O O
15 not RB O O
15 on IN B-VP O
15 estrogen NN B-NP O
16 replacement NN I-NP O
16 therapy IN B-VP O
16 The DT B-NP O
16 patient NN I-NP O
16 has VBZ O O
16 a DT O O
16 two CD O O
16 to TO O O
16 three CD O O
16 year NN B-NP O
16 history NN I-NP O
17 of IN B-VP O
17 exertional JJ B-NP O
17 angina NN I-NP O
17 Of IN B-VP O
17 note NN B-NP O
17 , , O O
17 approximately RB O O
17 one CD O O
17 year NN B-NP O
17 ago IN B-VP O
17 she PRP O O
18 began VBD B-VP O
18 to TO O O
18 have VB O O
18 substernal JJ B-NP O
18 chest NN I-NP O
18 pain NN I-NP O
18 at IN B-VP O
18 rest NN B-NP O
18 The DT B-NP O
18 patient NN I-NP O
18 states VBZ O O
19 that IN B-VP O
19 currently RB O O
19 she PRP O O
19 is VBZ O O
19 having VBG O O
19 approximately RB O O
19 three CD O O
19 episodes NNS B-NP O
19 a DT B-NP O
19 day NN I-NP O
19 on IN B-VP O
20 average NN B-NP O
20 She PRP O O
20 describes VBZ O O
20 these DT O O
20 as IN B-VP O
20 substernal JJ B-NP O
20 chest NN I-NP O
20 pressure NN I-NP O
20 which WDT O O
21 radiates VBZ O O
21 to TO O O
21 her PRP$ O O
21 bilateral JJ B-NP O
21 arms NNS I-NP O
21 as RB O O
21 well RB O O
21 as IN B-VP O
21 her PRP$ O O
21 jaw NN B-NP O
21 She PRP O O
21 denies VBZ O O
21 any DT B-NP O
22 associated JJ I-NP O
22 shortness NN I-NP O
22 of IN B-VP O
22 breath NN B-NP O
22 but CC O O
22 does VBZ O O
22 occasionally RB O O
22 note VB O O
23 diaphoresis NN B-NP O
23 She PRP O O
23 denies VBZ O O
23 any DT B-NP O
23 nausea NN I-NP O
23 or CC O O
23 vomiting NN B-NP O
23 or CC O O
23 palpitations NNS B-NP O
24 In IN B-VP O
24 July NNP B-NP O
24 of IN B-VP O
24 1994 CD O O
24 the DT B-NP O
24 patient NN I-NP O
24 underwent VBD B-VP O
24 an DT B-NP O
24 echocardiogram NN I-NP O
24 which WDT O O
25 showed VBD B-VP O
25 a DT B-NP O
25 left JJ I-NP O
25 atrial JJ I-NP O
25 size NN I-NP O
25 of IN B-VP O
25 4.0 CD O O
25 cm NN B-NP O
25 and CC O O
25 ejection NN B-NP O
25 fraction NN I-NP O
25 of IN B-VP O
26 approximately RB O O
26 60% CD O O
26 with IN B-VP O
26 mild JJ O O
26 left VBD B-VP O
26 ventricular JJ B-NP O
26 hypertrophy NN I-NP O
26 and CC O O
26 mild JJ B-NP O
27 tricuspid JJ I-NP O
27 regurgitation NN I-NP O
27 Since IN B-VP O
27 this DT B-NP O
27 time NN I-NP O
27 she PRP O O
27 has VBZ O O
27 been VBN O O
27 followed VBN O O
27 by IN B-VP O
28 Dr NNP B-NP O
28 Maximo NNP I-NP O
28 Bryum NNP I-NP O
28 in IN B-VP O
28 C&O NNP B-NP O
28 MEDICAL NNP I-NP O
28 CENTER NNP I-NP O
28 Clinic NNP I-NP O
28 who WP O O
28 initiated VBD B-VP O
28 an DT B-NP O
28 antianginal JJ I-NP B-m
28 regimen NNS I-NP I-m
29 which WDT O O
29 resulted VBD B-VP O
29 in IN B-VP O
29 decreased JJ B-NP O
29 frequency NN I-NP O
29 of IN B-VP O
29 her PRP$ O O
29 symptoms NNS B-NP O
29 Of IN B-VP O
29 note VBP O O
29 the DT B-NP O
30 patient NN I-NP O
30 recently RB O O
30 stopped VBD B-VP O
30 taking VBG O O
30 Aspirin NNP B-NP B-m
30 Her NNP I-NP O
30 symptoms NNS I-NP O
30 then RB O O
31 recurred VBD B-VP O
31 On IN B-VP O
31 the DT O O
31 27 CD O O
31 of IN B-VP O
31 January NNP B-NP O
31 , , O O
31 1995 CD O O
31 the DT B-NP O
31 patient NN I-NP O
31 underwent NN I-NP O
31 a DT B-NP O
32 Dobutamine NNP I-NP B-m
32 MIBBE NNP I-NP O
32 on IN B-VP O
32 which WDT O O
32 she PRP O O
32 went VBD B-VP O
32 6 CD O O
32 minutes NNS B-NP O
32 and CC O O
32 48 CD O O
32 seconds NNS B-NP O
33 reaching VBG O O
33 a DT B-NP O
33 maximal JJ I-NP O
33 heart NN I-NP O
33 rate NN I-NP O
33 of IN B-VP O
33 154 CD O O
33 , , O O
33 a DT B-NP O
33 blood NN I-NP O
33 pressure NN I-NP O
33 of IN B-VP O
33 172/82 CD O O
34 The DT B-NP O
34 test NN I-NP O
34 showed VBD B-VP O
34 2 CD O O
34 mm NNS B-NP O
34 ST NNP I-NP O
34 depressions NNS I-NP O
34 diffusely RB O O
34 The DT B-NP O
34 MIBBE NNP I-NP O
34 showed VBD B-VP O
35 moderate JJ O O
35 to TO O O
35 severe VB O O
35 reversible JJ O O
35 anterior JJ O O
35 and CC O O
35 anteroseptal JJ B-NP O
35 wall NN I-NP O
36 ischemia NN I-NP O
36 Of IN B-VP O
36 note NN B-NP O
36 , , O O
36 on IN B-VP O
36 the DT B-NP O
36 morning NN I-NP O
36 of IN B-VP O
36 admission NN B-NP O
36 the DT B-NP O
36 patient NN I-NP O
36 was VBD B-VP O
37 seen VBN O O
37 by IN B-VP O
37 her PRP$ O O
37 VNA NNP B-NP O
37 During IN B-VP O
37 her PRP$ O O
37 VNA's NNP B-NP O
37 visit NN I-NP O
37 the DT B-NP O
37 patient NN I-NP O
37 began VBD B-VP O
37 to TO O O
37 have VB O O
38 her PRP$ O B-r
38 typical JJ B-NP I-r
38 anginal JJ I-NP I-r
38 symptoms NNS I-NP I-r
38 with IN B-VP O
38 radiation NN B-NP O
38 to TO O O
38 her PRP$ O O
38 arms NNS B-NP O
38 and CC O O
38 jaw NN B-NP O
38 as RB O O
39 well RB O O
39 as IN B-VP O
39 shortness NN B-NP B-r
39 of IN B-VP I-r
39 breath NN B-NP I-r
39 She PRP O O
39 denied VBD B-VP O
39 any DT B-NP O
39 diaphoresis NN I-NP O
39 or CC O O
39 nausea VB O O
40 The DT B-NP O
40 patient NN I-NP O
40 was VBD B-VP O
40 given VBN O O
40 three CD O B-do
40 three CD O B-do
40 three CD O B-do
40 sublingual JJ B-NP B-mo
40 sublingual JJ I-NP B-mo
40 sublingual JJ I-NP B-mo
40 Nitroglycerins NNP I-NP B-m
40 Nitroglycerins NNP I-NP B-m
40 Nitroglycerins NNP I-NP B-m
40 after IN B-VP O
40 her PRP$ O O
41 primary JJ B-NP O
41 M.D NNP I-NP O
41 was VBD B-VP O
41 called VBN O O
41 and CC O O
41 her PRP$ O B-r
41 pain NN B-NP I-r
41 resolved VBD B-VP O
41 after IN B-VP O
41 approximately RB O O
42 15 CD O O
42 minutes NNS B-NP O
42 PAST NNP I-NP O
42 MEDICAL NNP I-NP O
42 HISTORY: NNP I-NP O
42 Remarkable NNP I-NP O
42 for IN B-VP O
42 a DT O O
42 10 CD O O
42 year NN B-NP O
43 history NN I-NP O
43 of IN B-VP O
43 Insulin NNP B-NP O
43 dependent NN I-NP O
43 diabetes VBZ O O
43 with IN B-VP O
43 complications NNS B-NP O
43 including VBG O O
44 neuropathy JJ O O
44 and CC O O
44 retinopathy JJ B-NP O
44 Chronic NNP I-NP O
44 atrial JJ B-NP O
44 fibrillation NN I-NP O
44 included VBD B-VP O
44 a DT B-NP O
45 normal JJ I-NP O
45 TSH NNP I-NP O
45 Hypertension NNP I-NP O
45 Degenerative NNP I-NP O
45 joint JJ B-NP O
45 disease NN I-NP O
46 Gastroesophageal NNP I-NP O
46 reflux NN I-NP O
46 Status NNP I-NP O
46 post NN I-NP O
46 hysterectomy NN I-NP O
46 approximately RB O O
46 21 CD O O
47 years NNS B-NP O
47 ago RB O O
47 MEDICATIONS NNP B-NP O
47 ON NNP I-NP O
47 ADMISSION: NNP I-NP O
47 Atenolol NNP I-NP B-m
47 50 CD O B-do
47 mg NN B-NP I-do
47 p.o NN I-NP B-mo
47 q.d NN I-NP B-f
47 , , O O
48 Axid NNP B-NP B-m
48 150 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 b.i.d NN I-NP B-f
48 , , O O
48 Enteric NNP B-NP B-m
48 Coated NNP I-NP I-m
48 Aspirin NNP I-NP I-m
48 325 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 q.d NN I-NP B-f
49 which WDT O O
49 the DT B-NP O
49 patient NN I-NP O
49 recently RB O O
49 stopped VBD B-VP O
49 , , O O
49 Coumadin NNP B-NP B-m
49 10 CD O B-do
49 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 q.h.s NN I-NP B-f
49 , , O O
50 Diltiazem NNP B-NP B-m
50 240 CD O B-do
50 mg NN B-NP I-do
50 p.o NN I-NP B-mo
50 q.d NN I-NP B-f
50 , , O O
50 Lisinopril NNP B-NP B-m
50 10 CD O B-do
50 mg NN B-NP I-do
50 p.o NN I-NP B-mo
50 q.d NN I-NP B-f
50 , , O O
50 Lopipd NNP B-NP B-m
50 600 CD O B-do
51 mg NN B-NP O
51 p.o NN I-NP B-mo
51 q.d NN I-NP B-f
51 , , O O
51 Lasix NNP B-NP B-m
51 40 CD O B-do
51 mg NN B-NP I-do
51 p.o NN I-NP B-mo
51 q.d NN I-NP B-f
51 , , O O
51 Insulin NNP B-NP B-m
51 Insulin NNP I-NP B-m
51 , , O I-m
51 , , O I-m
51 NPH NNP B-NP I-m
51 NPH NNP I-NP I-m
51 , , O O
51 75 CD O B-do
51 units NNS B-NP I-do
51 sub-q JJ B-NP B-mo
52 q.a.m NN I-NP B-f
52 , , O O
52 50 CD O B-do
52 units NNS B-NP I-do
52 q.p.m RB O B-f
52 , , O O
52 Insulin NNP B-NP B-m
52 Regular NNP I-NP I-m
52 25 CD O B-do
52 units NNS B-NP I-do
52 sub-q JJ B-NP B-mo
52 q.a.m NN I-NP B-f
53 ALLERGIES: NNP I-NP O
53 The DT B-NP O
53 patient NN I-NP O
53 has VBZ O O
53 no DT O O
53 known VBN O O
53 drug NN B-NP O
53 allergies NNS I-NP O
54 PHYSICAL NNP I-NP O
54 EXAMINATION: NNP I-NP O
54 Her NNP I-NP O
54 heart NN I-NP O
54 rate NN I-NP O
54 was VBD B-VP O
54 58 CD O O
54 , , O O
54 blood NN B-NP O
54 pressure NN I-NP O
55 141/73 CD O O
55 , , O O
55 O-2 NNP B-NP O
55 saturation NN I-NP O
55 97% CD O O
55 on IN B-VP O
55 2 CD O O
55 liters NNS B-NP O
55 , , O O
56 respiratory NN B-NP O
56 rate NN I-NP O
56 16 CD O O
56 and CC O O
56 unlabored JJ B-NP O
56 HEENT NNP I-NP O
56 exam NN I-NP O
56 showed VBD B-VP O
56 pupils NNS B-NP O
56 equal JJ B-NP O
57 round NN I-NP O
57 and CC O O
57 reactive JJ O O
57 to TO O O
57 light JJ B-NP O
57 Extraocular JJ I-NP O
57 movements NNS I-NP O
57 were VBD B-VP O
57 intact JJ B-NP O
58 Oropharynx NNP I-NP O
58 was VBD B-VP O
58 clear JJ B-NP O
58 Mucous JJ I-NP O
58 membranes NNS I-NP O
58 were VBD B-VP O
58 moist JJ B-NP O
58 Neck NNP I-NP O
58 was VBD B-VP O
59 supple JJ O O
59 with IN B-VP O
59 full JJ B-NP O
59 range NN I-NP O
59 of IN B-VP O
59 motion NN B-NP O
59 Jugular NNP I-NP O
59 venous JJ B-NP O
59 pressure NN I-NP O
59 was VBD B-VP O
60 difficult JJ O O
60 to TO O O
60 assess VB O O
60 secondary JJ O O
60 to TO O O
60 increased VBN O O
60 soft JJ B-NP O
60 tissue NN I-NP O
60 around IN B-VP O
60 the DT B-NP O
61 neck NN I-NP O
61 Carotids NNP I-NP O
61 were VBD B-VP O
61 2+ CD O O
61 and CC O O
61 without IN B-VP O
61 bruits NNS B-NP O
61 Cardiac NNP I-NP O
61 exam NN I-NP O
61 showed VBD B-VP O
61 an DT B-NP O
62 irregularly JJ I-NP O
62 irregular JJ I-NP O
62 rate NN I-NP O
62 and CC O O
62 rhythm NN B-NP O
62 , , O O
62 a DT O O
62 normal JJ O O
62 S-1 JJ O O
62 and CC O O
62 S-2 NNP B-NP O
62 , , O O
62 a DT B-NP O
62 I/VI NNP I-NP O
63 systolic JJ B-NP O
63 ejection NN I-NP O
63 murmur NN I-NP O
63 noted VBD B-VP O
63 at IN B-VP O
63 the DT B-NP O
63 left JJ I-NP O
63 upper JJ I-NP O
63 sternal JJ I-NP O
63 border NN I-NP O
64 Lungs NNS I-NP O
64 were VBD B-VP O
64 clear JJ O O
64 to TO O O
64 auscultation NN B-NP O
64 and CC O O
64 percussion NN B-NP O
64 Abdomen NNP I-NP O
64 was VBD B-VP O
64 soft JJ O O
64 , , O O
65 nontender NN B-NP O
65 , , O O
65 obese JJ O O
65 with IN B-VP O
65 active JJ B-NP O
65 bowel NN I-NP O
65 sounds VBZ O O
65 Extremities NNS B-NP O
65 showed VBD B-VP O
65 a DT B-NP O
66 right JJ I-NP O
66 shin NN I-NP O
66 scar NN I-NP O
66 which WDT O O
66 was VBD B-VP O
66 healing VBG O O
66 well RB O O
66 There EX O O
66 was VBD B-VP O
66 no DT B-NP O
66 clubbing NN I-NP O
66 or CC O O
67 cyanosis NN B-NP O
67 , , O O
67 no DT B-NP O
67 evidence NN I-NP O
67 of IN B-VP O
67 any DT B-NP O
67 femoral JJ I-NP O
67 bruits NNS I-NP O
67 Rectal NNP I-NP O
67 examination NN I-NP O
68 was VBD B-VP O
68 guaiac JJ O O
68 negative JJ O O
68 On IN B-VP O
68 neurologic JJ B-NP O
68 examination NN I-NP O
68 the DT B-NP O
68 patient NN I-NP O
68 was VBD B-VP O
69 alert JJ O O
69 and CC O O
69 oriented VBD B-VP O
69 x $ O O
69 2 CD O O
69 Cranial JJ B-NP O
69 nerves NNS I-NP O
69 II-XII NNP I-NP O
69 were VBD B-VP O
69 intact JJ B-NP O
70 Strength NNP I-NP O
70 was VBD B-VP O
70 5/5 CD O O
70 bilaterally RB O O
70 There EX O O
70 was VBD B-VP O
70 decreased VBN O O
70 sensation NN B-NP O
70 to TO O O
71 light JJ B-NP O
71 touch NN I-NP O
71 bilaterally RB O O
71 in IN B-VP O
71 the DT B-NP O
71 lower JJR I-NP O
71 extremities NNS I-NP O
72 LABORATORY NNP I-NP O
72 DATA: NNP I-NP O
72 On IN B-VP O
72 admission NN B-NP O
72 Sodium NNP I-NP O
72 134 CD O O
72 , , O O
72 Potassium NNP B-NP O
72 4.7 CD O O
72 , , O O
72 Chloride NNP B-NP O
73 96 CD O O
73 , , O O
73 Bicarb NNP B-NP O
73 22 CD O O
73 , , O O
73 BUN NNP B-NP O
73 28 CD O O
73 , , O O
73 Creatinine NNP B-NP O
73 1.3 CD O O
73 , , O O
73 Blood NNP B-NP O
74 Glucose NNP I-NP O
74 472 CD O O
74 , , O O
74 Digoxin NNP B-NP O
74 level VBZ O O
74 1.0 CD O O
74 PT NNP B-NP O
74 14.5 CD O O
74 , , O O
74 PTT NNP B-NP O
74 26 CD O O
74 Urinalysis NNP B-NP O
74 was VBD B-VP O
75 negative JJ B-NP O
75 EKG NNP I-NP O
75 showed VBD B-VP O
75 atrial JJ B-NP O
75 fibrillation NN I-NP O
75 at IN B-VP O
75 a DT B-NP O
75 rate NN I-NP O
75 of IN B-VP O
75 60 CD O O
75 with IN B-VP O
75 a DT B-NP O
76 normal JJ I-NP O
76 axis NN I-NP O
76 T NNP I-NP O
76 wave VBP O O
76 inversions NNS B-NP O
76 were VBD B-VP O
76 noted VBN O O
76 in IN B-VP O
76 both DT B-NP O
76 leads NNS I-NP O
76 3 CD O O
76 and CC O O
76 F NNP B-NP O
77 and CC O O
77 Q NNP B-NP O
77 waves NNS I-NP O
77 were VBD B-VP O
77 noted VBN O O
77 in IN B-VP O
77 V-1 NNP B-NP O
77 through IN B-VP O
77 V-3 NNP B-NP O
77 Chest NNP I-NP O
77 x-ray NN I-NP O
77 showed VBD B-VP O
77 no DT B-NP O
78 evidence NN I-NP O
78 of IN B-VP O
78 infiltrates NNS B-NP O
78 or CC O O
78 effusions NNS B-NP O
78 There EX O O
78 was VBD B-VP O
78 borderline NN B-NP O
79 cardiomegaly NN I-NP O
80 HOSPITAL NNP I-NP O
80 COURSE: NNP I-NP O
80 The DT B-NP O
80 patient NN I-NP O
80 was VBD B-VP O
80 admitted VBN O O
80 to TO O O
80 Medicine NNP B-NP O
80 Team NNP I-NP O
80 Voone NNP I-NP O
80 Parkway NNP I-NP O
80 , , O O
80 Ainggo NNP B-NP O
80 Ra NNP I-NP O
80 I PRP O O
80 , , O O
80 Alaska $ O O
80 89772 CD O O
81 She PRP O O
81 was VBD B-VP O
81 ruled VBN O O
81 out RP O O
81 for IN B-VP O
81 myocardial JJ B-NP O
81 infarction NN I-NP O
81 with IN B-VP O
82 serial JJ B-NP O
82 CK NNP I-NP O
82 , , O O
82 MB NNP B-NP O
82 and CC O O
82 EKG's NNP B-NP O
82 Heparin NNP I-NP B-m
82 was VBD B-VP O
82 initially RB O O
82 started VBN O O
82 given VBN O O
82 the DT B-NP O
83 possibility NN I-NP O
83 that IN B-VP O
83 this DT O O
83 was VBD B-VP O
83 unstable JJ O B-r
83 angina IN B-VP I-r
83 The DT B-NP O
83 Cardiology NNP I-NP O
83 Team NNP I-NP O
83 was VBD B-VP O
84 consulted VBN O O
84 for IN B-VP O
84 recommendations NNS B-NP O
84 on IN B-VP O
84 possible JJ B-NP O
84 cardiac JJ I-NP O
84 catheterization NN I-NP O
85 On IN B-VP O
85 further JJ B-NP O
85 review NN I-NP O
85 of IN B-VP O
85 her PRP$ O O
85 history NN B-NP O
85 the DT B-NP O
85 Cardiology NNP I-NP O
85 Team NNP I-NP O
85 decided VBD B-VP O
85 to TO O O
86 schedule VB O O
86 a DT B-NP O
86 cardiac JJ I-NP O
86 catheterization NN I-NP O
86 This DT O O
86 was VBD B-VP O
86 performed VBN O O
86 on IN B-VP O
86 the DT O O
86 4 CD O O
86 of IN B-VP O
86 June NNP B-NP O
86 and CC O O
86 showed VBD B-VP O
86 mildly RB O O
86 elevated VBN O O
86 right RB O O
86 sided JJ B-NP O
86 pressure NN I-NP O
86 including VBG O O
86 a DT B-NP O
87 right JJ I-NP O
87 atrial JJ I-NP O
87 pressure NN I-NP O
87 of IN B-VP O
87 15 CD O O
87 , , O O
87 an DT B-NP O
87 RV NNP I-NP O
87 pressure NN I-NP O
87 of IN B-VP O
87 50/16 CD O O
87 with IN B-VP O
87 a DT B-NP O
87 mean JJ I-NP O
87 PA NNP I-NP O
88 pressure NN I-NP O
88 of IN B-VP O
88 32 CD O O
88 , , O O
88 pulmonary JJ B-NP O
88 capillary JJ I-NP O
88 wedge NN I-NP O
88 of IN B-VP O
88 22 CD O O
88 The DT B-NP O
88 coronary JJ I-NP O
89 arteries NNS I-NP O
89 were VBD B-VP O
89 noted VBN O O
89 to TO O O
89 be VB O O
89 normal JJ O O
89 and CC O O
89 left VBD B-VP O
89 ventricular JJ B-NP O
89 function NN I-NP O
89 was VBD B-VP O
90 also RB O O
90 assessed VBN O O
90 as IN B-VP O
90 normal JJ O O
90 The DT B-NP O
90 patient NN I-NP O
90 tolerated VBD B-VP O
90 this DT B-NP O
90 procedure NN I-NP O
90 well RB O O
91 and CC O O
91 without IN B-VP O
91 complications NNS B-NP O
91 Given VBP O O
91 the DT B-NP O
91 confluence NN I-NP O
91 of IN B-VP O
91 her PRP$ O O
91 data NNS B-NP O
91 , , O O
91 two CD O O
92 possible JJ B-NP O
92 explanations NNS I-NP O
92 were VBD B-VP O
92 postulated VBN O O
92 including VBG O O
92 either CC O O
92 syndrome JJ B-NP O
92 X NN I-NP O
93 or CC O O
93 small JJ B-NP O
93 vessel NN I-NP O
93 disease NN I-NP O
93 , , O O
93 not RB O O
93 noted VBN O O
93 on IN B-VP O
93 cardiac JJ B-NP O
93 catheterization NN I-NP O
93 The DT B-NP O
94 patient NN I-NP O
94 remained VBD B-VP O
94 stable JJ O O
94 , , O O
94 status NN B-NP O
94 post NN I-NP O
94 cardiac JJ B-NP O
94 catheterization NN I-NP O
94 and CC O O
95 was VBD B-VP O
95 prepared VBN O O
95 for IN B-VP O
95 discharge NN B-NP O
95 Also RB O O
95 during IN B-VP O
95 her PRP$ O O
95 hospital JJ B-NP O
95 course NN I-NP O
95 the DT B-NP O
96 patient's JJ I-NP O
96 Insulin NNP I-NP B-m
96 dosages NNS I-NP O
96 were VBD B-VP O
96 adjusted VBN O O
96 in IN B-VP O
96 the DT B-NP O
96 manner NN I-NP O
96 to TO O O
96 keep VB O O
96 her PRP$ O B-r
97 blood NN B-NP O
97 sugars NNS I-NP O
97 in IN B-VP O
97 the DT O O
97 approximately RB O O
97 200 CD O O
97 range NN B-NP O
98 DISPOSITION: NNP I-NP O
98 MEDICATIONS NNP I-NP O
98 ON NNP I-NP O
98 DISCHARGE: NNP I-NP O
98 Enteric NNP I-NP B-m
98 Coated NNP I-NP I-m
98 Aspirin NNP I-NP I-m
98 325 CD O B-do
99 mg NN B-NP O
99 p.o NN I-NP B-mo
99 q.d.; NN I-NP B-f
99 Lasix NNP I-NP B-m
99 40 CD O B-do
99 mg NN B-NP I-do
99 p.o NN I-NP B-mo
99 q.d.; NN I-NP B-f
99 Lopid NNP I-NP B-m
99 600 CD O B-do
99 mg NN B-NP I-do
100 p.o NN I-NP B-mo
100 q.d.; JJ B-NP B-f
100 Insulin NNP I-NP B-m
100 Insulin NNP I-NP B-m
100 NPH NNP I-NP I-m
100 NPH NNP I-NP I-m
100 100 CD O B-do
100 units NNS B-NP I-do
100 sub-q JJ B-NP B-mo
100 q.a.m NN I-NP B-f
100 , , O O
100 70 CD O B-do
100 units NNS B-NP I-do
100 sub-q JJ B-NP B-mo
101 q.h.s NN I-NP B-f
101 , , O O
101 Insulin NNP B-NP B-m
101 Regular NNP I-NP I-m
101 25 CD O B-do
101 units NNS B-NP I-do
101 sub-q JJ B-NP B-mo
101 q.a.m.; JJ I-NP B-f
101 Lisinopril NNP I-NP B-m
101 10 CD O B-do
101 mg NN B-NP I-do
102 p.o NN I-NP B-mo
102 q.d.; NN I-NP B-f
102 Nitroglycerin NNP I-NP B-m
102 1/150th CD O I-m
102 one CD O B-do
102 tablet NN B-NP I-do
102 sublingual JJ B-NP B-mo
102 q NN I-NP B-f
102 5 CD O O
102 minutes NNS B-NP O
103 x VBP O O
103 3 CD O O
103 p.r.n JJ B-NP O
103 chest NN I-NP B-r
103 pain; NN I-NP I-r
103 Omeprazole NNP I-NP B-m
103 20 CD O B-do
103 mg NN B-NP I-do
103 p.o NN I-NP B-mo
103 q.d.; NN I-NP B-f
103 Coumadin NNP I-NP B-m
103 10 CD O B-do
103 mg NN B-NP I-do
104 p.o NN I-NP B-mo
104 q.h.s.; NN I-NP B-f
104 Diltiazem NNP I-NP B-m
104 CD NN I-NP I-m
104 240 CD O B-do
104 mg NN B-NP I-do
104 p.o NN I-NP B-mo
104 q.d JJ B-NP B-f
104 FOLLOW-UP NNP I-NP O
104 CARE: NNP I-NP O
104 The DT B-NP O
105 patient NN I-NP O
105 will MD O O
105 follow-up VB O O
105 with IN B-VP O
105 her PRP$ O O
105 primary JJ B-NP O
105 M.D NNP I-NP O
105 , , O O
105 Dr NNP B-NP O
105 Jarvis NNP I-NP O
105 Needy NNP I-NP O
105 in IN B-VP O
106 the DT B-NP O
106 RINGBURG NNP I-NP O
106 RITA'S NNP I-NP O
106 PROPRES NNP I-NP O
106 MEMORIAL NNP I-NP O
106 HOSPITAL NNP I-NP O
106 Clinic NNP I-NP O
107 Dictated NNP I-NP O
107 By: NNP I-NP O
107 DARRON NNP I-NP O
107 MCCLARIN NNP I-NP O
107 , , O O
107 M.D NNP B-NP O
107 BV80 NNP I-NP O
108 Attending: NNP I-NP O
108 IGNACIO NNP I-NP O
108 W NNP I-NP O
108 DITTER NNP I-NP O
108 , , O O
108 M.D NNP B-NP O
108 OC31 NNP I-NP O
109 CQ254/6623 NNP I-NP O
110 Batch: NNP I-NP O
110 7060 CD O O
110 Index NNP B-NP O
110 No NNP I-NP O
110 F5QNED61F1 NNP I-NP O
110 D: NNP I-NP O
110 11/10/95 CD O O
111 T: NNP B-NP O
111 2/12/95 CD O O
112 CC: NNP B-NP O
112 1 CD O O
112 CLARENCE NNP B-NP O
112 L NNP I-NP O
112 BRABANT NNP I-NP O
112 , , O O
112 M.D NNP B-NP O
112 EZ23 NNP I-NP O
113 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #912444 VBZ O O
2 992808716 CD O O
2 IMC NNP B-NP O
2 44368736 CD O O
2 638469 CD O O
2 4/17/1996 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/5/1996 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/18/1996 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 Ms NNP I-NP O
4 Hora NNP I-NP O
4 is VBZ O O
4 a DT O O
4 45 CD O O
4 year NN B-NP O
4 old JJ B-NP O
4 woman NN I-NP O
5 with IN B-VP O
5 hypertensive JJ B-NP O
5 disease NN I-NP O
5 , , O O
5 as RB O O
5 well RB O O
5 as IN B-VP O
6 diabetes NNS B-NP O
6 , , O O
6 who WP O O
6 presents VBZ O O
6 with IN B-VP O
6 sustained JJ B-NP O
6 chest NN I-NP O
6 pain NN I-NP O
6 and CC O O
6 shortness NN B-NP O
6 of IN B-VP O
7 breath NN B-NP O
7 The DT B-NP O
7 patient NN I-NP O
7 has VBZ O O
7 long RB O O
7 standing JJ B-NP O
7 obesity NN I-NP O
7 with IN B-VP O
7 moderate JJ O O
7 to TO O O
8 severe VB O O
8 hypertension NN B-NP O
8 which WDT O O
8 has VBZ O O
8 been VBN O O
8 fairly RB O O
8 well RB O O
8 controlled VBN O O
8 and CC O O
9 poorly RB O O
9 controlled VBN O O
9 diabetes NNS B-NP O
9 , , O O
9 as RB O O
9 well RB O O
9 as IN B-VP O
9 atypical JJ B-NP O
9 chest NN I-NP O
9 pain NN I-NP O
9 and CC O O
10 asthma NN B-NP O
10 Over IN B-VP O
10 the DT O O
10 last JJ O O
10 four CD O O
10 days NNS B-NP O
10 she PRP O O
10 has VBZ O O
10 had VBD B-VP O
10 increased VBN O O
10 episodes NNS B-NP O
10 of IN B-VP O
11 rather RB O O
11 persistent JJ B-NP O
11 chest JJS I-NP O
11 discomfort NN I-NP O
11 , , O O
11 shortness NN B-NP O
11 of IN B-VP O
11 breath NN B-NP O
11 She PRP O O
12 generally RB O O
12 describes VBZ O O
12 it PRP O O
12 in IN B-VP O
12 her PRP$ O O
12 anterior JJ B-NP O
12 chest NN I-NP O
12 wall NN I-NP O
12 as IN B-VP O
12 pressure NN B-NP O
12 , , O O
12 but CC O O
13 there EX O O
13 is VBZ O O
13 also RB O O
13 some DT B-NP O
13 sharp JJ I-NP O
13 qualities NNS I-NP O
13 as IN B-VP O
13 well RB O O
13 The DT B-NP O
13 patient NN I-NP O
13 has VBZ O O
13 also RB O O
14 noted VBN O O
14 increasing VBG O O
14 shortness NN B-NP O
14 of IN B-VP O
14 breath NN B-NP O
14 and CC O O
14 dyspnea NN B-NP O
14 without IN B-VP O
14 subjective JJ B-NP O
15 wheezing NN I-NP O
15 and CC O O
15 there EX O O
15 has VBZ O O
15 been VBN O O
15 an DT B-NP O
15 increase NN I-NP O
15 in IN B-VP O
15 her PRP$ O O
15 orthopnea NN B-NP O
15 The DT B-NP O
16 patient NN I-NP O
16 is VBZ O O
16 unsure JJ O O
16 of IN B-VP O
16 whether IN B-VP O
16 her PRP$ O O
16 shortness NN B-NP O
16 of IN B-VP O
16 breath NN B-NP O
16 correlates NNS I-NP O
17 with IN B-VP O
17 her PRP$ O O
17 chest NN B-NP O
17 pressure NN I-NP O
17 Previous NNP I-NP O
17 evaluation NN I-NP O
17 has VBZ O O
17 included VBN O O
17 several JJ B-NP O
18 negative JJ I-NP O
18 exercise NN I-NP O
18 tolerance NN I-NP O
18 tests NNS I-NP O
18 , , O O
18 but CC O O
18 there RB O O
18 was VBD B-VP O
18 in IN B-VP O
18 1981 CD O O
18 an DT B-NP O
19 exercise NN I-NP O
19 tolerance NN I-NP O
19 test NN I-NP O
19 with IN B-VP O
19 Thallium NN B-NP O
19 that WDT O O
19 showed VBD B-VP O
19 a DT B-NP O
19 fixed JJ I-NP O
19 anterior JJ I-NP O
20 profusion NN I-NP O
20 defect NN I-NP O
20 and CC O O
20 an DT B-NP O
20 EKG NNP I-NP O
20 has VBZ O O
20 chronic JJ B-NP O
20 anterolateral JJ I-NP O
20 Q NNP I-NP O
20 wave NN I-NP O
20 to TO O O
21 poor JJ B-NP O
21 R NNP I-NP O
21 wave NN I-NP O
21 progression NN I-NP O
21 An DT B-NP O
21 echo NN I-NP O
21 in IN B-VP O
21 1991 CD O O
21 showed VBD B-VP O
21 LVH NNP B-NP O
21 with IN B-VP O
21 no DT B-NP O
22 regional JJ I-NP O
22 wall NN I-NP O
22 motion NN I-NP O
22 abnormalities VBZ O O
22 The DT B-NP O
22 patient NN I-NP O
22 was VBD B-VP O
22 admitted VBN O O
22 for IN B-VP O
23 rule NN B-NP O
23 out IN B-VP O
23 MI NNP B-NP O
23 three CD O O
23 months NNS B-NP O
23 prior RB O O
23 to TO O O
23 this DT B-NP O
23 admission NN I-NP O
24 PAST NNP I-NP O
24 MEDICAL NNP I-NP O
24 HISTORY: NNP I-NP O
24 1 CD O O
24 Asthma NNP B-NP O
24 2 CD O O
24 Hypertension NNP B-NP O
24 3 CD O O
24 Diabetes NNP B-NP O
25 mellitus VBD B-VP O
25 4 CD O O
25 Obesity NNP B-NP O
25 5 CD O O
25 Sleep NNP B-NP O
25 apnea NN I-NP O
26 6 CD O O
26 Peptic JJ B-NP O
26 ulcer JJ I-NP O
26 disease NN I-NP O
27 ALLERGIES: NNP I-NP O
27 The DT B-NP O
27 patient NN I-NP O
27 has VBZ O O
27 an DT B-NP O
27 allergy NN I-NP O
27 to TO O O
27 Codeine NNP B-NP O
27 which WDT O O
27 produces VBZ O O
28 nausea NN B-NP O
29 CARDIAC NNP I-NP O
29 RISK NNP I-NP O
29 FACTORS: NNP I-NP O
29 1 CD O O
29 Diabetes NNP B-NP O
29 mellitus VBD B-VP O
29 2 CD O O
29 Hypertension NNP B-NP O
30 3 CD O O
30 Family NNP B-NP O
30 history NN I-NP O
30 of IN B-VP O
30 CAD NNP B-NP O
30 4 CD O O
30 No NNP B-NP O
30 tobacco NN I-NP O
31 5 CD O O
31 No NNP B-NP O
31 hypercholesterolemia NN I-NP O
32 PAST NNP I-NP O
32 SURGICAL NNP I-NP O
32 HISTORY: NNP I-NP O
32 Notable NNP I-NP O
32 for: VBD B-VP O
32 1 CD O O
32 Hysterectomy NNP B-NP O
32 vaginally RB O O
33 2 CD O O
33 Status NNP B-NP O
33 post NN I-NP O
33 an DT B-NP O
33 umbilical JJ I-NP O
33 hernia NN I-NP O
33 repair NN I-NP O
34 ADMISSION NNP I-NP O
34 MEDICATIONS: NNP I-NP O
34 Azmacort NNP I-NP B-m
34 , , O O
34 Proventil NNP B-NP B-m
34 , , O O
34 Tagamet NNP B-NP B-m
34 , , O O
34 Cardizem NNP B-NP B-m
34 300 CD O B-do
35 q.day NN B-NP B-f
35 , , O O
35 insulin JJ B-NP B-m
35 insulin NN I-NP B-m
35 NPH NNP I-NP I-m
35 NPH NNP I-NP I-m
35 40 CD O B-do
35 units NNS B-NP I-do
35 q.AM RB O B-f
35 and CC O O
35 55 CD O B-do
36 units NNS B-NP O
36 q.PM RB O B-f
36 , , O O
36 aspirin NN B-NP B-m
36 , , O O
36 Motrin NNP B-NP B-m
36 , , O O
36 Maxide NNP B-NP B-m
36 1 CD O B-do
36 per IN B-VP B-f
36 day NN B-NP I-f
36 , , O O
36 Lisinopril NNP B-NP B-m
36 20 CD O B-do
36 mg NN B-NP I-do
37 p.o NN I-NP B-mo
37 q.day JJ B-NP B-f
38 PHYSICAL NNP I-NP O
38 EXAMINATION: NNP I-NP O
38 The DT B-NP O
38 patient NN I-NP O
38 was VBD B-VP O
38 afebrile RB O O
38 , , O O
38 heart NN B-NP O
38 rate NN I-NP O
38 100 CD O O
38 , , O O
39 respiratory NN B-NP O
39 rate NN I-NP O
39 20 CD O O
39 , , O O
39 blood NN B-NP O
39 pressure NN I-NP O
39 was VBD B-VP O
40 140/80 CD O O
40 , , O O
40 oxygen NN B-NP O
40 saturation NN I-NP O
40 was VBD B-VP O
40 99% CD O O
40 on IN B-VP O
40 2 CD O O
40 liters NNS B-NP O
40 She PRP O O
40 was VBD B-VP O
40 an DT B-NP O
40 obese JJ I-NP O
41 black JJ I-NP O
41 female NN I-NP O
41 lying NN I-NP O
41 in IN B-VP O
41 the DT B-NP O
41 bed NN I-NP O
41 at IN B-VP O
41 45 CD O O
41 degrees NNS B-NP O
41 with IN B-VP O
41 nasal JJ B-NP O
41 cannula NN I-NP O
41 in IN B-VP O
42 no DT B-NP O
42 acute NN I-NP O
42 distress NN I-NP O
42 Her PRP$ O O
42 head NN B-NP O
42 was VBD B-VP O
42 normocephalic JJ B-NP O
42 atraumatic JJ I-NP O
42 Pupils NNS I-NP O
43 were VBD B-VP O
43 equal JJ O O
43 and CC O O
43 round NN B-NP O
43 to TO O O
43 light NN B-NP O
43 and CC O O
43 accommodation NN B-NP O
43 Her NNP I-NP O
43 extraocular NN I-NP O
44 movements NNS I-NP O
44 were VBD B-VP O
44 full JJ B-NP O
44 Cranial JJ I-NP O
44 nerves NNS I-NP O
44 were VBD B-VP O
44 intact JJ O O
44 There EX O O
44 were VBD B-VP O
44 no DT B-NP O
45 oral JJ I-NP O
45 lesions NNS I-NP O
45 There EX O O
45 was VBD B-VP O
45 minimal JJ B-NP O
45 jugular JJ I-NP O
45 venous JJ I-NP O
45 distention NN I-NP O
45 Chest NNP I-NP O
46 was VBD B-VP O
46 clear JJ B-NP O
46 Heart NNP I-NP O
46 was VBD B-VP O
46 regular JJ B-NP O
46 rate NN I-NP O
46 and CC O O
46 rhythm NN B-NP O
46 with IN B-VP O
46 no DT B-NP O
46 murmurs NNS I-NP O
46 , , O O
47 rubs NNS B-NP O
47 , , O O
47 or CC O O
47 gallops NNS B-NP O
47 There EX O O
47 was VBD B-VP O
47 no DT B-NP O
47 CVA NNP I-NP O
47 tenderness NN I-NP O
47 There EX O O
47 was VBD B-VP O
47 some DT B-NP O
48 chest JJS I-NP O
48 wall NN I-NP O
48 tenderness NN I-NP O
48 on IN B-VP O
48 the DT O O
48 left VBN O O
48 The DT B-NP O
48 abdomen NNS I-NP O
48 was VBD B-VP O
48 obese JJ O O
48 and CC O O
49 non-tender JJ O O
49 , , O O
49 with IN B-VP O
49 bowel NN B-NP O
49 sounds NNS I-NP O
49 present JJ O O
49 There EX O O
49 was VBD B-VP O
49 no DT B-NP O
49 cyanosis NN I-NP O
49 , , O O
50 clubbing VBG O O
50 , , O O
50 or CC O O
50 edema VB O O
50 There EX O O
50 was VBD B-VP O
50 no DT B-NP O
50 proprioceptive JJ I-NP O
50 defects NNS I-NP O
51 LABORATORY NNP I-NP O
51 DATA: NNP I-NP O
51 Laboratories NNPS I-NP O
51 on IN B-VP O
51 admission NN B-NP O
51 showed VBD B-VP O
51 her PRP O O
51 to TO O O
51 have VB O O
51 a DT B-NP O
52 potassium NN I-NP O
52 of IN B-VP O
52 3.7 CD O O
52 , , O O
52 BUN NNP B-NP O
52 and CC O O
52 creatinine NN B-NP O
52 of IN B-VP O
52 11/1.2 CD O O
52 , , O O
53 creatinine JJ B-NP O
53 kinase NN I-NP O
53 of IN B-VP O
53 148 CD O O
53 , , O O
53 troponin NN B-NP O
53 of IN B-VP O
53 0.0 CD O O
53 Chest NNP B-NP O
53 x-ray NN I-NP O
53 was VBD B-VP O
53 clear JJ O O
54 with IN B-VP O
54 no DT B-NP O
54 evidence NN I-NP O
54 of IN B-VP O
54 left JJ B-NP O
54 ventricular JJ I-NP O
54 failure NN I-NP O
54 EKG NNP I-NP O
54 showed VBD B-VP O
54 normal JJ B-NP O
55 sinus NN I-NP O
55 rhythm NN I-NP O
55 at IN B-VP O
55 90 CD O O
55 with IN B-VP O
55 Q NNP B-NP O
55 waves/poor NN I-NP O
55 R NNP I-NP O
55 wave VBP O O
55 progression NN B-NP O
55 in IN B-VP O
55 I PRP O O
55 , , O O
55 III NNP B-NP O
55 , , O O
56 IV NNP B-NP O
56 , , O O
56 which WDT O O
56 was VBD B-VP O
56 no DT B-NP O
56 acute JJ I-NP O
56 change NN I-NP O
56 from IN B-VP O
56 the DT O O
56 most RBS O O
56 recent JJ B-NP O
56 EKG NNP I-NP O
57 HOSPITAL NNP I-NP O
57 COURSE: NNP I-NP O
57 The DT B-NP O
57 patient NN I-NP O
57 was VBD B-VP O
57 admitted VBN O O
57 and CC O O
57 ruled VBN O O
57 out RP O O
57 for IN B-VP O
57 a DT B-NP O
58 myocardial JJ I-NP O
58 infarction NN I-NP O
58 with IN B-VP O
58 serial JJ B-NP O
58 CPK NNP I-NP O
58 , , O O
58 as RB O O
58 well RB O O
58 as IN B-VP O
59 serial JJ B-NP O
59 troponin NN I-NP O
59 , , O O
59 both DT O O
59 of IN B-VP O
59 which WDT O O
59 showed VBD B-VP O
59 0.0 CD O O
59 The DT B-NP O
59 patient NN I-NP O
59 also RB O O
60 underwent VBD B-VP O
60 a DT B-NP O
60 VQ NNP I-NP O
60 scan JJ O O
60 given VBN O O
60 her PRP$ O O
60 sedentary JJ B-NP O
60 life NN I-NP O
60 style NN I-NP O
60 to TO O O
60 rule VB O O
60 out RP O O
61 pulmonary JJ B-NP O
61 embolus NN I-NP O
61 , , O O
61 and CC O O
61 in IN B-VP O
61 fact NN B-NP O
61 it PRP O O
61 was VBD B-VP O
61 very RB O O
61 low JJ B-NP O
61 probability NN I-NP O
61 The DT B-NP O
62 patient NN I-NP O
62 at IN B-VP O
62 that DT B-NP O
62 point NN I-NP O
62 was VBD B-VP O
62 managed VBN O O
62 by IN B-VP O
62 the DT B-NP O
62 addition NN I-NP O
62 of IN B-VP O
62 a DT B-NP O
63 gastrointestinal JJ I-NP O
63 regimen NN I-NP O
63 of IN B-VP O
63 Prilosec NNP B-NP B-m
63 and CC O O
63 Cisapride NNP B-NP B-m
63 as IN B-VP O
63 she PRP O O
63 had VBD B-VP O
64 complained VBN O O
64 of IN B-VP O
64 some DT B-NP O
64 worsening NN I-NP O
64 of IN B-VP O
64 her PRP$ O B-r
64 her PRP$ O B-r
64 chest NN B-NP I-r
64 chest NN I-NP I-r
64 pressure NN I-NP I-r
64 pressure NN I-NP I-r
64 when WRB O O
64 she PRP O O
64 laid VBD B-VP O
65 back RB O O
65 flat JJ O O
65 and CC O O
65 some DT B-NP O
65 sour JJ I-NP O
65 taste NN I-NP O
65 in IN B-VP O
65 her PRP$ O O
65 mouth NN B-NP O
65 The DT B-NP O
65 patient NN I-NP O
65 reported VBD B-VP O
66 that IN B-VP O
66 this DT B-NP O
66 combination NN I-NP O
66 of IN B-VP O
66 medications NNS B-NP O
66 made VBD B-VP O
66 her PRP$ O O
66 feel NN B-NP O
66 somewhat RB O O
66 better VBD B-VP O
67 The DT B-NP O
67 patient NN I-NP O
67 finally RB O O
67 underwent VBD B-VP O
67 an DT B-NP O
67 exercise NN I-NP O
67 tolerance NN I-NP O
67 test NN I-NP O
67 with IN B-VP O
67 MIBI NNP B-NP O
68 1/9/96 CD O O
68 She PRP O O
68 went VBD B-VP O
68 5 CD O O
68 minutes NNS B-NP O
68 and CC O O
68 0 CD O O
68 seconds NNS B-NP O
68 on IN B-VP O
68 a DT B-NP O
68 Bruce NNP I-NP O
68 protocol NN I-NP O
68 , , O O
69 stopped VBD B-VP O
69 secondary JJ O O
69 to TO O O
69 chest VB O O
69 pain NN B-NP O
69 Her NNP I-NP O
69 peak JJ B-NP O
69 heart NN I-NP O
69 rate NN I-NP O
69 was VBD B-VP O
69 140 CD O O
69 , , O O
70 which WDT O O
70 is VBZ O O
70 85% CD O O
70 of IN B-VP O
70 predicted VBN O O
70 Her NNP B-NP O
70 systolic JJ B-NP O
70 maximum NN I-NP O
70 was VBD B-VP O
70 120 CD O O
70 The DT B-NP O
71 chest NN I-NP O
71 pressure NN I-NP O
71 was VBD B-VP O
71 similar JJ O O
71 to TO O O
71 that DT O O
71 on IN B-VP O
71 admission NN B-NP O
71 and CC O O
71 it PRP O O
71 was VBD B-VP O
71 somewhat RB O O
72 atypical JJ O O
72 and CC O O
72 ill JJ O O
72 defined VBD B-VP O
72 The DT B-NP O
72 patient NN I-NP O
72 then RB O O
72 had VBD B-VP O
72 MIBI NNP B-NP O
72 images NNS I-NP O
72 which WDT O O
73 showed VBD B-VP O
73 a DT B-NP O
73 borderline NN I-NP O
73 to TO O O
73 minimal VB O O
73 anterior JJ B-NP O
73 reversible JJ I-NP O
73 defect NN I-NP O
73 , , O O
73 but CC O O
73 that DT O O
74 was VBD B-VP O
74 as IN B-VP O
74 said VBD B-VP O
74 borderline IN B-VP O
74 The DT B-NP O
74 patient NN I-NP O
74 was VBD B-VP O
74 deemed VBN O O
74 suitable JJ O O
74 for IN B-VP O
75 discharge NN B-NP O
75 after IN B-VP O
75 conversation NN B-NP O
75 with IN B-VP O
75 Dr NNP B-NP O
75 Dubin NNP I-NP O
75 of IN B-VP O
75 the DT B-NP O
75 Cardiology NNP I-NP O
76 Service NNP I-NP O
76 , , O O
76 and CC O O
76 the DT B-NP O
76 patient NN I-NP O
76 will MD O O
76 be VB O O
76 following VBG O O
76 up RP O O
76 with IN B-VP O
76 her PRP$ O O
76 primary JJ B-NP O
76 care NN I-NP O
77 doctor NN I-NP O
77 The DT B-NP O
77 medication NN I-NP O
77 changes NNS I-NP O
77 will MD O O
77 be VB O O
77 the DT B-NP O
77 addition NN I-NP O
77 of IN B-VP O
77 Prilosec NNP B-NP B-m
78 and CC O O
78 Cisapride NNP B-NP B-m
78 in IN B-VP O
78 the DT B-NP O
78 place NN I-NP O
78 of IN B-VP O
78 Axid NNP B-NP O
78 AND CC O O
78 the DT B-NP O
78 addition NN I-NP O
78 of IN B-VP O
78 isordil NN B-NP B-m
78 10mg CD O B-do
78 po NN B-NP B-mo
78 tid NN I-NP B-f
79 DISCHARGE NNP I-NP O
79 MEDICATIONS: NNP I-NP O
79 Proventil NNP I-NP B-m
79 2 CD O B-do
79 puffs NNS B-NP I-do
79 inhaler JJ B-NP B-mo
79 q.i.d NN I-NP B-f
79 , , O O
79 enteric RB O B-m
80 coated VBD B-VP O
80 aspirin JJ O O
80 325 CD O B-do
80 mg NN B-NP I-do
80 p.o NN I-NP B-mo
80 q.day NN I-NP B-f
80 , , O O
80 NPH NNP B-NP B-m
80 NPH NNP I-NP B-m
80 40 CD O B-do
81 units NNS B-NP O
81 q.AM RB O B-f
81 and CC O O
81 55 CD O B-do
81 units NNS B-NP I-do
81 subcu JJ B-NP B-mo
81 q.PM NN I-NP B-f
81 , , O O
81 Lisinopril NNP B-NP B-m
81 20 CD O B-do
81 mg NN B-NP I-do
81 p.o NN I-NP B-mo
81 q.day NN I-NP B-f
81 , , O O
82 Maxide NNP B-NP B-m
82 1 CD O B-do
82 tablet NN B-NP I-do
82 p.o NN I-NP B-mo
82 q.day NN I-NP B-f
82 , , O O
82 nitroglycerin RB O B-m
82 1/150 CD O I-m
82 1 CD O B-do
82 tablet NN B-NP I-do
82 sublingual JJ B-NP B-mo
83 q.5 NN I-NP B-f
83 minutes NNS I-NP I-f
83 times NNS I-NP I-f
83 three CD O I-f
83 p.r.n NN B-NP I-f
83 chest NN I-NP B-r
83 pain NN I-NP I-r
83 , , O O
83 Prilosec NNP B-NP B-m
83 20 CD O B-do
83 mg NN B-NP I-do
83 p.o NN I-NP B-mo
84 q.day NN I-NP B-f
84 , , O O
84 Azmacort NNP B-NP B-m
84 4 CD O B-do
84 puffs NNS B-NP I-do
84 inhaler JJ B-NP B-mo
84 b.i.d NN I-NP B-f
84 , , O O
84 Cardizem NNP B-NP B-m
84 CD NNP I-NP I-m
84 300 CD O B-do
84 mg NN B-NP I-do
84 p.o NN I-NP B-mo
85 q.day NN I-NP B-f
85 , , O O
85 Cisapride NNP B-NP B-m
85 10 CD O B-do
85 mg NN B-NP I-do
85 p.o NN I-NP B-mo
85 q.i.d NN I-NP B-f
85 , , O O
85 and CC O O
85 isordil RB O B-m
85 10 CD O B-do
85 mg NNS B-NP I-do
85 po JJ O B-mo
85 tid RB O B-f
86 Dictated NNP B-NP O
86 By: NNP I-NP O
86 SHELTON NNP I-NP O
86 BUEL NNP I-NP O
86 , , O O
86 M.D NNP B-NP O
86 RV15 NNP I-NP O
87 Attending: NNP I-NP O
87 JAMEY NNP I-NP O
87 L NNP I-NP O
87 GOLOMBECKI NNP I-NP O
87 , , O O
87 M.D NNP B-NP O
87 DH5 NNP I-NP O
88 NT789/8157 NNP I-NP O
89 Batch: NNP I-NP O
89 93753 CD O O
89 Index NNP B-NP O
89 No NNP I-NP O
89 B3HMCL54Z3 NNP I-NP O
89 D: NNP I-NP O
89 0/9/96 CD O O
90 T: NNP B-NP O
90 4/25/96 CD O O
91 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #915973 VBZ O O
4 741191636 CD O O
4 LWMMC NNP B-NP O
4 76526432 CD O O
4 5688336 CD O O
4 2/4/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 DEHYDRATION NNP I-NP O
4 , , O O
4 NEUTROPENIC NNP B-NP O
4 , , O O
4 LUNG NNP B-NP O
4 CANCER NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/19/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/18/2005 CD O O
7 ATTENDING: NNP B-NP O
7 LAFUENTE NNP I-NP O
7 , , O O
7 NATHANIAL NNP B-NP O
7 ROOSEVELT NNP I-NP O
7 MD NNP I-NP O
8 PRINCIPAL NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
8 Urosepsis NNP I-NP O
9 LIST NNP I-NP O
9 OF NNP I-NP O
9 PROBLEMS NNP I-NP O
9 AND NNP I-NP O
9 DIAGNOSES: NNP I-NP O
9 Diabetes NNP I-NP O
9 , , O O
9 obesity NN B-NP O
9 , , O O
9 severe JJ B-NP O
9 COPD NNP I-NP O
9 , , O O
10 obstructive JJ B-NP O
10 sleep NN I-NP O
10 apnea NN I-NP O
10 , , O O
10 hypercholesterolemia NN B-NP O
10 , , O O
10 anemia NN B-NP O
10 , , O O
10 colonic JJ B-NP O
11 polyps NNS I-NP O
11 , , O O
11 uterine JJ B-NP O
11 fibroids NNS I-NP O
11 , , O O
11 gastrointestinal JJ O O
11 bled VBD B-VP O
11 , , O O
11 neutropenic JJ B-NP O
12 enteritis NN I-NP O
12 , , O O
12 nonsmall DT B-NP O
12 cell NN I-NP O
12 lung NN I-NP O
12 cancer NN I-NP O
12 , , O O
12 chronic JJ B-NP O
12 renal JJ I-NP O
13 insufficiency NN I-NP O
13 , , O O
13 status NN B-NP O
13 post NN I-NP O
13 appendectomy NN I-NP O
13 , , O O
13 gout NN B-NP O
13 , , O O
13 and CC O O
14 osteoarthritis JJ B-NP O
15 BRIEF NNP I-NP O
15 HISTORY NNP I-NP O
15 OF NNP I-NP O
15 PRESENT NNP I-NP O
15 ILLNESS: NNP I-NP O
15 For IN B-VP O
15 further JJ B-NP O
15 details NNS I-NP O
15 please VB O O
15 see VB O O
16 the DT B-NP O
16 chart NN I-NP O
16 The DT B-NP O
16 patient NN I-NP O
16 is VBZ O O
16 a DT B-NP O
16 64-year-old JJ I-NP O
16 female NN I-NP O
16 with IN B-VP O
16 multiple JJ B-NP O
17 medical JJ I-NP O
17 problems NNS I-NP O
17 including VBG O O
17 severe JJ B-NP B-r
17 COPD NNP I-NP I-r
17 , , O O
17 ( ( O O
17 on IN B-VP O
17 home NN B-NP B-m
17 O2 NNP I-NP I-m
17 2 CD O B-do
17 liters NNS B-NP I-do
18 baseline VBP O O
18 sat VBN O O
18 below IN B-VP O
18 90s CD O O
18 ) ) O O
18 , , O O
18 nonsmall RB O B-r
18 cell NN B-NP I-r
18 lung NN I-NP I-r
18 cancer NN I-NP I-r
18 , , O O
18 diagnosed VBN O O
18 in IN B-VP O
19 1999 CD O O
19 status NN B-NP O
19 post NN I-NP O
19 multiple JJ B-NP O
19 chemotherapy NN I-NP B-m
19 regimens NNS I-NP I-m
19 , , O O
19 most JJS O O
19 recently RB O O
20 ALIMTA NNP B-NP B-m
20 from IN B-VP B-du
20 1/29/2005 CD O I-du
20 to TO O I-du
20 09 CD O I-du
20 , , O O
20 diabetes NNS B-NP O
20 , , O O
20 obesity NN B-NP O
20 , , O O
20 and CC O O
21 chronic JJ B-NP O
21 renal JJ I-NP O
21 insufficiency NN I-NP O
21 , , O O
21 who WP O O
21 was VBD B-VP O
21 admitted VBN O O
21 to TO O O
21 MICU NNP B-NP O
21 on IN B-VP O
22 2/19/2005 CD O O
22 for IN B-VP O
22 neutropenia NN B-NP O
22 , , O O
22 nausea NN B-NP O
22 , , O O
22 vomiting VBG O O
22 , , O O
22 abdominal JJ B-NP O
22 pain NN I-NP O
22 , , O O
23 shortness NN B-NP O
23 of IN B-VP O
23 breath NN B-NP O
23 , , O O
23 requiring VBG O O
23 intubation NN B-NP O
23 , , O O
23 hypertension NN B-NP O
23 , , O O
23 prerenal JJ B-NP O
24 azotemia NN I-NP O
24 with IN B-VP O
24 a DT B-NP O
24 creatinine NN I-NP O
24 of IN B-VP O
24 2.9; CD O O
24 all DT O O
24 of IN B-VP O
24 which WDT O O
24 are VBP O O
24 believed VBN O O
24 to TO O O
25 be VB O O
25 secondary JJ O O
25 to TO O O
25 sepsis VB O O
26 MEDICATIONS NNP B-NP O
26 ON NNP I-NP O
26 ADMISSION: NNP I-NP O
26 Included NNP I-NP O
26 Avapro NNP I-NP B-m
26 , , O O
26 Lipitor NNP B-NP B-m
26 , , O O
26 Decadron NNP B-NP B-m
26 , , O O
27 ranitidine NN B-NP B-m
27 , , O O
27 Humalog NNP B-NP B-m
27 , , O O
27 allopurinol NN B-NP B-m
27 , , O O
27 Alimta NNP B-NP B-m
27 , , O O
27 Flonase NNP B-NP B-m
27 , , O O
27 vitamin NN B-NP B-m
27 D NNP I-NP I-m
27 , , O O
28 B12 NNP B-NP B-m
28 , , O O
28 and CC O O
28 Colace NNP B-NP B-m
29 ALLERGIES: NNP I-NP O
29 Bactrim NNP I-NP O
29 , , O O
29 resulting VBG O O
29 in IN B-VP O
29 acute JJ B-NP O
29 renal JJ I-NP O
29 failure NN I-NP O
29 and CC O O
30 hyperkalemic NN B-NP O
30 , , O O
30 and CC O O
30 penicillin NN B-NP O
30 resulting VBG O O
30 in IN B-VP O
30 anaphylaxis JJ B-NP O
31 SOCIAL NNP I-NP O
31 HISTORY: NNP I-NP O
31 Pertinent NNP I-NP O
31 for IN B-VP O
31 the DT B-NP O
31 fact NN I-NP O
31 that IN B-VP O
31 she PRP O O
31 lives VBZ O O
31 at IN B-VP O
31 home NN B-NP O
32 She PRP O O
32 has VBZ O O
32 a DT B-NP O
32 remote JJ I-NP O
32 history NN I-NP O
32 of IN B-VP O
32 smoking NN B-NP O
32 , , O O
32 quit VBP O O
32 15 CD O O
32 years NNS B-NP O
32 ago RB O O
32 , , O O
32 and CC O O
33 denies VBZ O O
33 alcohol VBP O O
34 FAMILY NNP B-NP O
34 HISTORY: NNP I-NP O
34 Pertinent NNP I-NP O
34 for IN B-VP O
34 hypertension NN B-NP O
34 , , O O
34 stroke NN B-NP O
34 , , O O
34 thyroid JJ B-NP O
35 cancer NN I-NP O
35 , , O O
35 and CC O O
35 cervical JJ B-NP O
35 cancer NN I-NP O
36 FINDINGS NNP I-NP O
36 ON NNP I-NP O
36 ADMISSION NNP I-NP O
36 PHYSICAL NNP I-NP O
36 EXAMINATION: NNP I-NP O
36 Shows VBZ O O
36 a DT B-NP O
36 temperature NN I-NP O
37 of IN B-VP O
37 98.9 CD O O
37 pulse NN B-NP O
37 of IN B-VP O
37 116 CD O O
37 , , O O
37 and CC O O
37 blood NN B-NP O
37 pressure NN I-NP O
37 84/47 CD O O
37 , , O O
37 and CC O O
37 96% CD O O
37 on IN B-VP O
38 ventilation NN B-NP O
38 General NNP I-NP O
38 exam: NN I-NP O
38 She PRP O O
38 is VBZ O O
38 an DT B-NP O
38 obese JJ I-NP O
38 female NN I-NP O
38 , , O O
38 intubated VBN O O
39 and CC O O
39 awake VB O O
39 , , O O
39 motioning VBG O O
39 to TO O O
39 take VB O O
39 her PRP$ O O
39 tube NN B-NP O
39 out IN B-VP O
39 Skin NNP B-NP O
39 exam NN I-NP O
39 showed VBD B-VP O
40 scattered JJ B-NP O
40 group NN I-NP O
40 petechial JJ B-NP O
40 areas NNS I-NP O
40 over IN B-VP O
40 the DT B-NP O
40 torso NN I-NP O
40 , , O O
40 abdomen NNS B-NP O
40 , , O O
40 and CC O O
41 under IN B-VP O
41 the DT B-NP O
41 right JJ I-NP O
41 breast NN I-NP O
41 HEENT NNP I-NP O
41 Exam NNP I-NP O
41 shows VBZ O O
41 pupils NNS B-NP O
41 equal JJ O O
41 , , O O
41 round NN B-NP O
41 , , O O
42 and CC O O
42 reactive JJ O O
42 and CC O O
42 anicteric JJ O O
42 , , O O
42 with IN B-VP O
42 a DT B-NP O
42 normal JJ I-NP O
42 JVP NNP I-NP O
42 Pulmonary NNP I-NP O
42 exam NN I-NP O
43 shows NNS I-NP O
43 decreased VBD B-VP O
43 mildly RB O O
43 decreased VBN O O
43 breath NN B-NP O
43 sounds NNS I-NP O
43 at IN B-VP O
43 the DT B-NP O
43 right JJ I-NP O
43 base NN I-NP O
44 No NNP I-NP O
44 crackles NNS I-NP O
44 , , O O
44 increase NN B-NP O
44 in IN B-VP O
44 expiratory JJ B-NP O
44 phase NN I-NP O
44 , , O O
44 few JJ O O
44 scattered VBD B-VP O
44 rales NNS B-NP O
45 Cardiac NNP I-NP O
45 exam NN I-NP O
45 shows VBZ O O
45 tachycardia JJ O O
45 otherwise RB O O
45 regular JJ O O
45 rhythm VB O O
45 A DT O O
45 2/6 CD O O
46 systolic JJ B-NP O
46 murmur NN I-NP O
46 across IN B-VP O
46 precordium NN B-NP O
46 Abdomen NNP I-NP O
46 is VBZ O O
46 soft JJ O O
46 , , O O
46 obese JJ O O
46 , , O O
47 positive JJ B-NP O
47 bowel NN I-NP O
47 sounds NNS I-NP O
47 , , O O
47 nontender NN B-NP O
47 , , O O
47 and CC O O
47 nondistended VBD B-VP O
47 with IN B-VP O
47 chronic JJ B-NP O
48 skin NN I-NP O
48 changes NNS I-NP O
48 below IN B-VP O
48 the DT B-NP O
48 pannus NN I-NP O
48 Extremities NNP I-NP O
48 show VBP O O
48 trace NN B-NP O
48 to TO O O
48 1+ CD O O
49 edema NN B-NP O
49 to TO O O
49 the DT B-NP O
49 shins NNS I-NP O
49 , , O O
49 with IN B-VP O
49 2+ CD O O
49 dorsalis NNS B-NP O
49 pedis JJ B-NP O
49 pulses NNS I-NP O
49 bilaterally RB O O
50 Neurologic NNP B-NP O
50 , , O O
50 the DT B-NP O
50 patient NN I-NP O
50 is VBZ O O
50 awake; JJ O O
50 however RB O O
50 , , O O
50 the DT B-NP O
50 exam NN I-NP O
50 is VBZ O O
50 otherwise RB O O
51 difficult JJ O O
51 to TO O O
51 perform VB O O
51 secondary JJ O O
51 to TO O O
51 the DT B-NP O
51 patient NN I-NP O
51 being VBG O O
51 intubated VBN O O
52 PERTINENT NNP B-NP O
52 LABS NNP I-NP O
52 ON NNP I-NP O
52 ADMISSION: NNP I-NP O
52 Show NNP I-NP O
52 a DT B-NP O
52 white JJ I-NP O
52 count NN I-NP O
52 of IN B-VP O
52 0.74 CD O O
52 with IN B-VP O
52 46% CD O O
53 polys NNS B-NP O
53 and CC O O
53 6% CD O O
53 bands NNS B-NP O
53 , , O O
53 resulting VBG O O
53 in IN B-VP O
53 an DT B-NP O
53 absolute JJ I-NP O
53 neutrophil NN I-NP O
53 count NN I-NP O
53 of IN B-VP O
54 340 CD O O
54 , , O O
54 a DT B-NP O
54 hematocrit NN I-NP O
54 of IN B-VP O
54 26.2 CD O O
54 , , O O
54 and CC O O
54 platelets NNS B-NP O
54 of IN B-VP O
54 37 CD O O
54 Creatinine NNP B-NP O
54 of IN B-VP O
55 3.1 CD O O
55 , , O O
55 a DT B-NP O
55 PTT NNP I-NP O
55 of IN B-VP O
55 83.5 CD O O
55 and CC O O
55 INR NNP B-NP O
55 of IN B-VP O
55 1.4 CD O O
55 , , O O
55 and CC O O
55 lactic JJ B-NP O
55 acid NN I-NP O
55 of IN B-VP O
55 1.4 CD O O
56 Chest NNP B-NP O
56 x-ray NN I-NP O
56 on IN B-VP O
56 admission NN B-NP O
56 shows NNS I-NP O
56 right RB O O
56 infrahilar JJ B-NP O
56 mass NN I-NP O
56 , , O O
56 bibasilar JJ B-NP O
57 opacities NNS I-NP O
57 , , O O
57 with IN B-VP O
57 chronic JJ B-NP O
57 alveolar JJ I-NP O
57 disease NN I-NP O
57 versus IN B-VP O
57 new JJ B-NP O
57 fusions NNS I-NP O
57 , , O O
57 I PRP O O
58 cannot VBP O O
58 rule VB O O
58 out RP O O
58 infiltrate JJ B-NP O
58 Abdominal NNP I-NP O
58 CT NNP I-NP O
58 shows VBZ O O
58 small JJ B-NP O
58 bowel NN I-NP O
58 wall NN I-NP O
59 thickening NN I-NP O
59 and CC O O
59 left-sided JJ B-NP O
59 atelectasis NN I-NP O
59 versus NN I-NP O
59 pneumonia NN I-NP O
60 PROCEDURES: NNP I-NP O
60 Status NNP I-NP O
60 post NN I-NP O
60 intubation NN I-NP O
60 and CC O O
60 extubation NN B-NP O
61 HOSPITAL NNP I-NP O
61 COURSE NNP I-NP O
61 BY NNP I-NP O
61 PROBLEMS: NNP I-NP O
62 1 CD O O
62 Infectious NNP B-NP O
62 disease: NN I-NP O
62 Ms NNP I-NP O
62 Dozois NNP I-NP O
62 was VBD B-VP O
62 admitted VBN O O
62 with IN B-VP O
62 fever NN B-NP O
62 and CC O O
63 hypertension NN B-NP O
63 , , O O
63 and CC O O
63 I PRP O O
63 was VBD B-VP O
63 concerned VBN O O
63 for IN B-VP O
63 sepsis NN B-NP O
63 , , O O
63 I PRP O O
63 initially RB O O
63 thought VBD B-VP O
64 nosocomial JJ B-NP O
64 pneumonia NN I-NP O
64 versus NN I-NP O
64 GI NNP I-NP O
64 as IN B-VP O
64 the DT B-NP O
64 primary JJ I-NP O
64 source NN I-NP O
64 She PRP O O
65 required VBD B-VP O
65 intubation NN B-NP O
65 and CC O O
65 pressors NNS B-NP O
65 , , O O
65 and CC O O
65 was VBD B-VP O
65 started VBN O O
65 on IN B-VP O
65 vancomycin NN B-NP B-m
65 , , O O
66 Levaquin NNP B-NP B-m
66 , , O O
66 and CC O O
66 aztreonam RB O B-m
66 along IN B-VP O
66 with IN B-VP O
66 Flagyl NNP B-NP B-m
66 empirically RB O O
66 Her PRP$ O O
66 urine NN B-NP O
67 grew VBD B-VP O
67 Enterococcus NNP B-NP O
67 and CC O O
67 she PRP O O
67 was VBD B-VP O
67 changed VBN O O
67 to TO O O
67 Levaquin NNP B-NP B-m
67 Levaquin NNP I-NP B-m
67 only RB O O
67 on IN B-VP O
68 10/25/2005 CD O O
68 to TO O O
68 treat VB O O
68 an DT B-NP B-r
68 enterococcal JJ I-NP I-r
68 UTI NNP I-NP I-r
68 and CC O O
68 possible JJ B-NP B-r
68 nosocomial JJ I-NP O
69 pneumonia NN I-NP O
69 An DT B-NP O
69 abdominal JJ I-NP O
69 CT NNP I-NP O
69 was VBD B-VP O
69 obtained VBN O O
69 , , O O
69 which WDT O O
69 shows VBZ O O
69 small JJ B-NP O
69 bowel NN I-NP O
70 wall NN I-NP O
70 thickening NN I-NP O
70 and CC O O
70 injection NN B-NP O
70 of IN B-VP O
70 the DT B-NP O
70 SMA NNP I-NP O
70 territory NN I-NP O
70 concerning VBG O O
70 for IN B-VP O
71 a DT B-NP B-r
71 neutropenic JJ I-NP I-r
71 enteritis NN I-NP I-r
71 Surgery NNP I-NP O
71 was VBD B-VP O
71 consulted VBN O O
71 and CC O O
71 she PRP O O
71 was VBD B-VP O
72 managed VBN O O
72 conservatively RB O O
72 with IN B-VP O
72 antibiotics NNS B-NP B-m
72 initially RB O O
72 and CC O O
72 then RB O O
72 with IN B-VP O
73 bowel NN B-NP O
73 rest NN I-NP O
73 She PRP O O
73 is VBZ O O
73 no RB O O
73 longer JJR O O
73 neutropenic JJ O O
73 and CC O O
73 was VBD B-VP O
73 off RB O O
73 Neupogen NNP B-NP B-m
74 over IN B-VP O
74 a DT B-NP O
74 week NN I-NP O
74 prior RB O O
74 to TO O O
74 discharge VB O O
74 She PRP O O
74 was VBD B-VP O
74 afebrile RB O O
74 over IN B-VP O
74 the DT B-NP O
74 last JJ I-NP O
75 week NN I-NP O
75 and CC O O
75 will MD O O
75 stay VB O O
75 and CC O O
75 finish VB O O
75 the DT B-NP O
75 14-day JJ I-NP B-du
75 course NN I-NP I-du
75 of IN B-VP O
75 Levaquin NNP B-NP B-m
75 for IN B-VP O
76 UTI NNP B-NP B-r
77 2 CD O O
77 GI: NNP B-NP O
77 Ms NNP I-NP O
77 Lorts NNP I-NP O
77 was VBD B-VP O
77 treated VBN O O
77 with IN B-VP O
77 bowel NN B-NP O
77 rest NN I-NP O
77 for IN B-VP O
77 her PRP$ O O
77 neutropenic JJ B-NP O
78 enteritis NN I-NP O
78 and CC O O
78 once RB O O
78 she PRP O O
78 was VBD B-VP O
78 no RB O O
78 longer JJR O O
78 neutropenic JJ O O
78 without IN B-VP O
79 abdominal JJ B-NP O
79 pain NN I-NP O
79 , , O O
79 she PRP O O
79 was VBD B-VP O
79 started VBN O O
79 on IN B-VP O
79 clear JJ B-NP O
79 liquid NN I-NP O
79 diet NN I-NP O
79 However RB O O
79 , , O O
80 she PRP O O
80 developed VBD B-VP O
80 intermittent JJ B-NP O
80 GI NNP I-NP O
80 bleed NN I-NP O
80 , , O O
80 secondary JJ O O
80 to TO O O
80 likely JJ B-NP O
81 sloughing NN I-NP O
81 of IN B-VP O
81 her PRP$ O O
81 mucosa NN B-NP O
81 status NN I-NP O
81 post NN I-NP O
81 neutropenic JJ B-NP O
81 enteritis NN I-NP O
81 GI NNP I-NP O
82 was VBD B-VP O
82 consulted VBN O O
82 and CC O O
82 she PRP O O
82 was VBD B-VP O
82 again RB O O
82 placed VBN O O
82 on IN B-VP O
82 bowel NN B-NP O
82 rest NN I-NP O
82 Though IN B-VP O
82 , , O O
83 she PRP O O
83 has VBZ O O
83 a DT B-NP O
83 history NN I-NP O
83 of IN B-VP O
83 colonic JJ B-NP O
83 polyps NNS I-NP O
83 , , O O
83 GI NNP B-NP O
83 also RB O O
83 felt VBD B-VP O
83 that IN B-VP O
83 the DT B-NP O
84 culprit NN I-NP O
84 of IN B-VP O
84 her PRP$ O O
84 GI NNP B-NP O
84 bleed NN I-NP O
84 is VBZ O O
84 mucosal JJ O O
84 sloughing VBG O O
84 as RB O O
84 well RB O O
84 She PRP O O
85 continued VBD B-VP O
85 to TO O O
85 have VB O O
85 intermittent JJ B-NP O
85 episodes NNS I-NP O
85 of IN B-VP O
85 bloody NN B-NP O
85 diarrhea NN I-NP O
86 whenever WRB O O
86 she PRP O O
86 was VBD B-VP O
86 re VBG O O
86 challenged VBN O O
86 with IN B-VP O
86 p.o JJ O O
86 intake VB O O
86 Her PRP$ O O
86 C-diff NNP B-NP O
86 is VBZ O O
87 negative JJ B-NP O
87 Colonoscopy NNP I-NP O
87 was VBD B-VP O
87 deferred VBN O O
87 secondary JJ O O
87 to TO O O
88 thrombocytopenia VB O O
88 She PRP O O
88 required JJ B-NP O
88 multiple JJ I-NP B-do
88 red JJ I-NP B-m
88 blood NN I-NP I-m
88 transfusions NNS I-NP I-m
89 to TO O O
89 maintain VB O O
89 her PRP$ O B-r
89 hematocrit NN B-NP I-r
89 greater JJR O O
89 than IN B-VP O
89 26 CD O O
89 , , O O
89 though IN B-VP O
89 she PRP O O
89 was VBD B-VP O
89 never RB O O
90 hemodynamically RB O O
90 unstable JJ B-NP O
90 Finally NNP I-NP O
90 , , O O
90 after IN B-VP O
90 given VBN O O
90 sustained VBD B-VP O
90 bowel JJ B-NP O
91 rest NN I-NP O
91 , , O O
91 her PRP$ O O
91 blood NN B-NP O
91 stools NNS I-NP O
91 resolved VBD B-VP O
91 , , O O
91 and CC O O
91 she PRP O O
91 was VBD B-VP O
91 able JJ O O
91 to TO O O
91 tolerate VB O O
92 oral JJ B-NP O
92 contrast NN I-NP O
92 and CC O O
92 an DT B-NP O
92 abdominal JJ I-NP O
92 CT NNP I-NP O
92 on IN B-VP O
92 6/30/2005 CD O O
92 showed VBD B-VP O
92 no DT B-NP O
92 small JJ I-NP O
93 bowel NN I-NP O
93 wall NN I-NP O
93 thickening NN I-NP O
93 or CC O O
93 any DT B-NP O
93 other JJ I-NP O
93 intraabdominal JJ I-NP O
93 process NN I-NP O
93 causing VBG O O
94 her PRP$ O O
94 symptoms NNS B-NP O
94 Her PRP$ O O
94 diet NN B-NP O
94 was VBD B-VP O
94 advanced VBN O O
94 , , O O
94 and CC O O
94 she PRP O O
94 was VBD B-VP O
94 tolerating VBG O O
95 regular JJ B-NP O
95 diet NN I-NP O
95 at IN B-VP O
95 the DT B-NP O
95 time NN I-NP O
95 of IN B-VP O
95 discharge NN B-NP O
95 without IN B-VP O
95 problems NNS B-NP O
96 3 CD O O
96 COPD: NNP B-NP O
96 On IN B-VP O
96 home NN B-NP O
96 O2 NNP I-NP O
96 , , O O
96 typically RB O O
96 requiring VBG O O
96 2 CD O O
96 liters NNS B-NP O
96 with IN B-VP O
96 baseline NN B-NP O
97 sat VBD B-VP O
97 over IN B-VP O
97 90s CD O O
97 Ms NNP B-NP O
97 Shubrick NNP I-NP O
97 was VBD B-VP O
97 intubated VBN O O
97 on IN B-VP O
97 admission NN B-NP O
97 for IN B-VP O
97 increased JJ B-NP O
98 shortness NN I-NP O
98 of IN B-VP O
98 breath NN B-NP O
98 and CC O O
98 hypoxia NN B-NP O
98 She PRP O O
98 was VBD B-VP O
98 extubated VBN O O
98 the DT B-NP O
98 following JJ I-NP O
99 day NN I-NP O
99 on IN B-VP O
99 4/16/2005 CD O O
99 She PRP O O
99 requires VBZ O O
99 BiPAP NNP B-NP O
99 nightly RB O O
99 , , O O
99 now RB O O
99 stable JJ O O
99 on IN B-VP O
99 2 CD O O
100 to TO O O
100 4 CD O O
100 liters NNS B-NP O
100 nasal JJ B-NP O
100 cannula NN I-NP O
100 during IN B-VP O
100 the DT B-NP O
100 day NN I-NP O
101 4 CD O O
101 Heme: NNP B-NP O
101 On IN B-VP O
101 chemotherapy NN B-NP B-m
101 induced VBN O O
101 anemia IN B-VP B-r
101 with IN B-VP O
101 hematocrit JJ B-NP O
101 drop NN I-NP O
101 on IN B-VP O
102 admission NN B-NP O
102 to TO O O
102 21 CD O O
102 from IN B-VP O
102 the DT B-NP O
102 baseline NN I-NP O
102 of IN B-VP O
102 around IN B-VP O
102 26 CD O O
102 She PRP O O
102 responded VBD B-VP O
103 well RB O O
103 initially RB O O
103 to TO O O
103 three CD O B-do
103 units NNS B-NP I-do
103 of IN B-VP O
103 packed JJ B-NP B-m
103 red JJ I-NP I-m
103 blood NN I-NP I-m
103 cells NNS I-NP I-m
103 over IN B-VP O
104 7/28/2005 CD O O
104 and CC O O
104 09 CD O O
104 However RB O O
104 , , O O
104 in IN B-VP O
104 the DT B-NP O
104 setting NN I-NP O
104 of IN B-VP O
104 her PRP$ O O
104 GI NNP B-NP O
105 bleed NN I-NP O
105 from IN B-VP O
105 a DT O O
105 sloughing VBG O O
105 mucosa NN B-NP O
105 secondary JJ O O
105 to TO O O
105 resolving VBG O O
105 neutropenic JJ B-NP O
106 enteritis NN I-NP O
106 and CC O O
106 recent JJ B-NP O
106 chemo NN I-NP B-m
106 , , O O
106 she PRP O O
106 required VBD B-VP O
106 multiple RB O B-do
106 further JJ B-NP O
106 RBC NNP I-NP B-m
107 transfusions NNS I-NP O
107 to TO O O
107 keep VB O O
107 her PRP$ O O
107 hematocrit NN B-NP B-r
107 greater JJR O O
107 than IN B-VP O
107 30 CD O O
107 She PRP O O
107 was VBD B-VP O
108 also RB O O
108 thrombocytopenic JJ O O
108 , , O O
108 status NN B-NP O
108 post NN I-NP O
108 chemo NN I-NP O
108 and CC O O
108 required VBN O O
108 multiple JJ B-NP B-do
109 platelet NN I-NP B-m
109 transfusions NNS I-NP I-m
109 to TO O O
109 keep VB O O
109 her PRP$ O O
109 platelets NNS B-NP O
109 greater JJR O O
109 than IN B-VP O
109 30 CD O O
109 , , O O
109 000 CD O O
110 Hematology NNP B-NP O
110 was VBD B-VP O
110 consulted VBN O O
110 secondary JJ O O
110 to TO O O
110 suboptimal VB O O
110 busted JJ B-NP O
110 platelet NN I-NP O
111 levels NNS I-NP O
111 status NN I-NP O
111 post NN I-NP O
111 transfusions NNS I-NP O
111 , , O O
111 which WDT O O
111 was VBD B-VP O
111 felt VBN O O
111 to TO O O
111 be VB O O
111 secondary JJ O O
112 to TO O O
112 poor JJ B-NP O
112 marrow NN I-NP O
112 response NN I-NP O
112 in IN B-VP O
112 the DT B-NP O
112 setting NN I-NP O
112 of IN B-VP O
112 recent JJ B-NP O
112 chemo NN I-NP B-m
112 ( ( O O
112 workup NN B-NP O
113 was VBD B-VP O
113 negative JJ O O
113 for IN B-VP O
113 other JJ B-NP O
113 possible JJ I-NP O
113 causes NNS I-NP O
113 refractory JJ B-NP O
114 thrombocytopenia NN I-NP O
114 , , O O
114 nystatin NN B-NP B-m
114 , , O O
114 allopurinol NN B-NP B-m
114 , , O O
114 were VBD B-VP O
114 held VBN O O
114 given VBN O O
114 possible JJ B-NP O
115 worsening NN I-NP O
115 of IN B-VP O
115 her PRP$ O O
115 thrombocytopenia NN B-NP B-r
115 thrombocytopenia NN I-NP B-r
115 ) ) O O
115 On IN B-VP O
115 discharge NN B-NP O
115 her PRP$ O O
115 hematocrit NN B-NP O
116 and CC O O
116 platelets NNS B-NP O
116 were VBD B-VP O
116 stable JJ O O
116 respectively RB O O
116 at IN B-VP O
116 29.8 CD O O
116 and CC O O
116 46 CD O O
116 , , O O
116 000 CD O O
116 and CC O O
116 she PRP O O
117 had VBD B-VP O
117 not RB O O
117 required VBN O O
117 a DT B-NP O
117 transfusion NN I-NP O
117 in IN B-VP O
117 greater JJR O O
117 than IN B-VP O
117 24 CD O O
117 hours NNS B-NP O
117 prior RB O O
117 to TO O O
118 discharge VB O O
119 5 CD O O
119 Acute NNP B-NP O
119 on IN B-VP O
119 chronic JJ B-NP O
119 renal JJ I-NP O
119 failure: NN I-NP O
119 The DT B-NP O
119 patient's NN I-NP O
119 baseline NN I-NP O
120 creatine NN I-NP O
120 is VBZ O O
120 1.7; CD O O
120 however RB O O
120 , , O O
120 on IN B-VP O
120 admission NN B-NP O
120 it PRP O O
120 was VBD B-VP O
120 noted VBN O O
120 to TO O O
120 be VB O O
120 3 CD O O
120 , , O O
121 likely RB O O
121 secondary JJ O O
121 to TO O O
121 hypovolemia VB O O
121 from IN B-VP O
121 vomiting VBG O O
121 and CC O O
121 diarrhea NN B-NP O
121 ( ( O O
121 FENa NNP B-NP O
122 was VBD B-VP O
122 0.22% CD O O
122 ) ) O O
122 Her PRP$ O O
122 creatinine NN B-NP O
122 is VBZ O O
122 now RB O O
122 back RB O O
122 to TO O O
122 baseline VB O O
122 with IN B-VP O
123 hydration NN B-NP O
123 Her NNP I-NP O
123 creatinine NN I-NP O
123 was VBD B-VP O
123 1.1 CD O O
123 prior RB O O
123 to TO O O
123 discharge VB O O
124 6 CD O O
124 Nonsmall NNP B-NP O
124 cell NN I-NP O
124 lung NN I-NP O
124 cancer: VBP O O
124 The DT B-NP O
124 patient NN I-NP O
124 is VBZ O O
124 on IN B-VP O
124 Alimta NNP B-NP B-m
124 started VBD B-VP O
125 for IN B-VP O
125 her PRP$ O B-r
125 neutropenia NN B-NP I-r
125 , , O O
125 which WDT O O
125 has VBZ O O
125 since IN B-VP O
125 resolved VBN O O
125 She PRP O O
125 will MD O O
125 follow VB O O
126 with IN B-VP O
126 her PRP O O
126 oncologist JJ B-NP O
126 Dr NNP I-NP O
126 Ervin NNP I-NP O
126 Tonrey NNP I-NP O
126 for IN B-VP O
126 further JJ B-NP O
126 therapy NN I-NP O
127 7 CD O O
127 Endocrine: NNP B-NP O
127 Because IN B-VP O
127 of IN B-VP O
127 her PRP$ O O
127 insulin-dependent JJ B-NP O
127 diabetes NNS I-NP O
127 , , O O
127 the DT B-NP O
128 patient NN I-NP O
128 was VBD B-VP O
128 placed VBN O O
128 on IN B-VP O
128 portland NN B-NP O
128 protocol NN I-NP O
128 while IN B-VP O
128 on IN B-VP O
128 the DT B-NP O
128 stress NN I-NP O
128 dose JJ B-NP O
129 Steroids NNP I-NP B-m
129 were VBD B-VP O
129 discontinued VBN O O
129 on IN B-VP O
129 10/25/2005 CD O O
129 and CC O O
129 she PRP O O
129 passed VBD B-VP O
129 a DT B-NP O
130 cortisol JJ I-NP B-m
130 stimulation NN I-NP O
130 test NN I-NP O
130 on IN B-VP O
130 10/25/2005 CD O O
130 as RB O O
130 well RB O O
130 She PRP O O
130 was VBD B-VP O
130 changed VBN O O
131 to TO O O
131 standing VBG O O
131 insulin NN B-NP B-m
131 on IN B-VP O
131 10/25/2005 CD O O
131 and CC O O
131 her PRP$ O O
131 Lantus NN B-NP B-m
131 was VBD B-VP O
131 up RB O B-do
131 titrated VBN O I-do
132 along IN B-VP O
132 with IN B-VP O
132 sliding VBG O B-do
132 scale JJ B-NP I-do
132 insulin NN I-NP B-m
132 to TO O O
132 maintain VB O O
132 blood NN B-NP B-r
132 blood NN I-NP B-r
132 blood NN I-NP B-r
132 sugars NNS I-NP I-r
132 sugars VBZ O I-r
132 sugars NNS B-NP I-r
132 in IN B-VP O
132 the DT O O
133 80s CD O O
133 to TO O O
133 120s CD O O
133 She PRP O O
133 will MD O O
133 return VB O O
133 home NN B-NP O
133 on IN B-VP O
133 her PRP$ O O
133 home NN B-NP B-m
133 regimen NNS I-NP I-m
134 8 CD O O
134 FEN: NNP B-NP O
134 TPN NNP I-NP B-m
134 was VBD B-VP O
134 started VBN O O
134 on IN B-VP O
134 4/21/2005 CD O O
134 , , O O
134 given VBN O O
134 her PRP$ O B-r
134 bowel NN B-NP I-r
134 rest NN I-NP I-r
134 for IN B-VP O
135 possible JJ B-NP O
135 neutropenic JJ I-NP O
135 enteritis NN I-NP O
135 She PRP O O
135 restarted VBD B-VP O
135 p.o JJ B-NP O
135 intake NN I-NP O
135 on IN B-VP O
136 9/2/2005 CD O O
136 and CC O O
136 tolerated VBD B-VP O
136 advancement NN B-NP O
136 to TO O O
136 diabetic JJ B-NP O
136 diet NN I-NP O
136 , , O O
136 and CC O O
136 she PRP O O
137 was VBD B-VP O
137 weaned VBN O O
137 off RP O O
137 her PRP$ O O
137 TPN NNP B-NP B-m
137 prior NN I-NP O
137 to TO O O
137 discharge VB O O
138 CONSULTANTS: NNP B-NP O
138 General NNP I-NP O
138 Surgery NNP I-NP O
138 , , O O
138 Hematology NNP B-NP O
138 , , O O
138 and CC O O
138 Gastroenterology NNP B-NP O
139 PHYSICAL NNP I-NP O
139 EXAMINATION NNP I-NP O
139 AT NNP I-NP O
139 DISCHARGE: NNP I-NP O
139 Vital NNP I-NP O
139 signs: VBD B-VP O
139 T NNP B-NP O
139 max NN I-NP O
139 98 CD O O
139 , , O O
139 blood NN B-NP O
140 pressure NN I-NP O
140 120/60 CD O O
140 , , O O
140 pulse RB O O
140 88 CD O O
140 , , O O
140 and CC O O
140 respirations NNS B-NP O
140 20 CD O O
140 sating VBG O O
140 at IN B-VP O
140 95% CD O O
140 on IN B-VP O
141 3.5 CD O B-do
141 liters NNS B-NP I-do
141 of IN B-VP O
141 oxygen NN B-NP B-m
141 General NNP I-NP O
141 exam NN I-NP O
141 shows VBZ O O
141 an DT B-NP O
141 obese JJ I-NP O
141 female NN I-NP O
141 resting NN I-NP O
142 and CC O O
142 in IN B-VP O
142 no DT B-NP O
142 acute NN I-NP O
142 distress NN I-NP O
142 Nasal NNP I-NP O
142 cannula NN I-NP O
142 in IN B-VP O
142 place NN B-NP O
142 HEENT NNP I-NP O
142 Exam NNP I-NP O
143 was VBD B-VP O
143 normocephalic JJ O O
143 , , O O
143 atraumatic JJ B-NP O
143 Pulmonary NNP I-NP O
143 exam NN I-NP O
143 showed VBD B-VP O
143 decreased JJ B-NP O
144 air NN I-NP O
144 entry NN I-NP O
144 , , O O
144 decreased VBN O O
144 breath NN B-NP O
144 sounds NNS I-NP O
144 , , O O
144 but CC O O
144 otherwise RB O O
144 no DT B-NP O
144 obvious JJ I-NP O
145 wheezes NNS I-NP O
145 or CC O O
145 rhonchi VB O O
145 Cardiovascular JJ B-NP O
145 exam NN I-NP O
145 shows NNS I-NP O
145 regular JJ B-NP O
145 rate NN I-NP O
145 and CC O O
146 rhythm NN B-NP O
146 , , O O
146 no DT B-NP O
146 murmurs NN I-NP O
146 , , O O
146 rubs NN B-NP O
146 , , O O
146 or CC O O
146 gallops NNS B-NP O
146 , , O O
146 but CC O O
146 decreased VBD B-VP O
146 heart NN B-NP O
146 sounds VBZ O O
147 Abdominal NNP B-NP O
147 exam NN I-NP O
147 shows VBZ O O
147 an DT B-NP O
147 obese JJ I-NP O
147 abdomen NNS I-NP O
147 , , O O
147 nontender NN B-NP O
147 , , O O
147 nondistended VBD B-VP O
147 , , O O
148 positive JJ B-NP O
148 bowel NN I-NP O
148 sounds VBZ O O
148 Extremities NNP B-NP O
148 show VBP O O
148 1 CD O O
148 to TO O O
148 2+ CD O O
148 edema NNS B-NP O
149 bilaterally RB O O
149 to TO O O
149 the DT B-NP O
149 knee NN I-NP O
149 Skin NNP I-NP O
149 exam NN I-NP O
149 shows VBZ O O
149 a DT B-NP O
149 area NN I-NP O
149 where WRB O O
149 left VBD B-VP O
150 internal JJ B-NP O
150 jugular JJ I-NP O
150 line NN I-NP O
150 was VBD B-VP O
150 removed VBN O O
150 and CC O O
150 the DT B-NP O
150 site NN I-NP O
150 is VBZ O O
150 intact JJ O O
150 and CC O O
151 dressed JJ B-NP O
151 Improved NNP I-NP O
151 erythema NN I-NP O
151 in IN B-VP O
151 her PRP$ O O
151 intertriginous JJ B-NP O
151 areas NNS I-NP O
152 Neurologic NNP I-NP O
152 exam NN I-NP O
152 shows VBZ O O
152 the DT B-NP O
152 patient NN I-NP O
152 is VBZ O O
152 alert JJ O O
152 and CC O O
152 oriented JJ B-NP O
152 x3 NN I-NP O
153 without IN B-VP O
153 any DT B-NP O
153 focal JJ I-NP O
153 neurologic NN I-NP O
153 deficits VBZ O O
154 The DT B-NP O
154 patient NN I-NP O
154 was VBD B-VP O
154 discharged VBN O O
154 in IN B-VP O
154 stable JJ B-NP O
154 condition NN I-NP O
154 and CC O O
154 she PRP O O
154 will MD O O
155 follow VB O O
155 up RP O O
155 with IN B-VP O
155 Dr NNP B-NP O
155 Marco NNP I-NP O
155 Derosset NNP I-NP O
155 in IN B-VP O
155 one CD O O
155 week NN B-NP O
156 The DT B-NP O
156 patient NN I-NP O
156 is VBZ O O
156 full JJ B-NP O
156 code NN I-NP O
157 DISCHARGE NNP I-NP O
157 MEDICATIONS: NNP I-NP O
157 Tylenol NNP I-NP B-m
157 Tylenol NNP I-NP B-m
157 Tylenol NNP I-NP B-m
157 650 CD O B-do
157 650 CD O B-do
157 650 CD O B-do
157 to TO O I-do
157 to TO O I-do
157 to TO O I-do
157 1000 CD O I-do
157 1000 CD O I-do
157 1000 CD O I-do
157 mg NN B-NP I-do
157 mg NN I-NP I-do
157 mg NN I-NP I-do
157 p.o NN I-NP B-mo
157 p.o NN I-NP B-mo
157 p.o NN I-NP B-mo
157 q NN I-NP B-f
157 q NN I-NP B-f
157 q VBD B-VP B-f
157 6h CD O I-f
157 6h CD O I-f
157 6h CD O I-f
157 p.r.n NN B-NP I-f
157 p.r.n NN I-NP I-f
157 p.r.n NN I-NP I-f
158 pain NN I-NP B-r
158 , , O O
158 headache NN B-NP B-r
158 , , O O
158 if IN B-VP O
158 fever NN B-NP B-r
158 is VBZ O O
158 greater JJR O O
158 than IN B-VP O
158 101 CD O O
158 , , O O
158 Peridex NNP B-NP B-m
158 mouth VBD B-VP I-m
158 wash JJ O I-m
159 10 CD O B-do
159 mL NN B-NP I-do
159 twice RB O B-f
159 a DT B-NP I-f
159 day NN I-NP I-f
159 , , O O
159 nystatin RB O B-m
159 mouth JJ B-NP I-m
159 wash NN I-NP I-m
159 10 CD O B-do
159 mL NN B-NP I-do
159 swish NN I-NP B-mo
159 and CC O I-mo
159 swallow VB O I-mo
159 4 CD O B-f
160 x JJ B-NP O
160 day NN I-NP O
160 as IN B-VP O
160 needed VBN O O
160 , , O O
160 oxycodone PRP O B-m
160 5 CD O B-do
160 mg NN B-NP I-do
160 p.o NN I-NP B-mo
160 q VBD B-VP B-f
160 6h CD O I-f
160 p.r.n NN B-NP I-f
160 pain NN I-NP B-r
160 , , O O
161 simethicone NN B-NP B-m
161 80 CD O B-do
161 mg NN B-NP I-do
161 p.o NN I-NP B-mo
161 q.i.d NN I-NP B-f
161 p.r.n NN I-NP I-f
161 gaseousness NN I-NP B-r
161 , , O O
161 trazodone NN B-NP B-m
161 25 CD O B-do
161 mg NN B-NP I-do
162 p.o NN I-NP B-mo
162 at IN B-VP B-f
162 bedtime NN B-NP I-f
162 , , O O
162 miconazole JJ B-NP B-m
162 nitrate NN I-NP I-m
162 2% CD O I-m
162 powder NN B-NP I-m
162 topical JJ B-NP B-mo
162 b.i.d NN I-NP B-f
162 to TO O O
163 areas NNS B-NP O
163 between IN B-VP O
163 skin NN B-NP O
163 folds NNS I-NP O
163 including VBG O O
163 under IN B-VP O
163 the DT B-NP O
163 right JJ I-NP O
163 breast NN I-NP O
163 , , O O
163 Nexium NNP B-NP B-m
164 20 CD O B-do
164 mg NN B-NP I-do
164 p.o JJ O B-mo
164 daily RB O B-f
164 , , O O
164 Lantus NNP B-NP B-m
164 30 CD O B-do
164 mg NN B-NP I-do
164 subcutaneous JJ O B-mo
164 daily RB O B-f
164 , , O O
164 DuoNeb NNP B-NP B-m
164 3/0.5 CD O B-do
165 mg NN B-NP O
165 Nebs NNP I-NP B-mo
165 q VBZ O B-f
165 3 CD O I-f
165 h NN B-NP I-f
165 p.r.n NN I-NP I-f
165 shortness NN I-NP B-r
165 of IN B-VP I-r
165 breath NN B-NP I-r
165 , , O O
165 aspart RB O B-m
165 4 CD O B-do
165 units NNS B-NP I-do
165 before IN B-VP B-f
166 each DT B-NP O
166 meal NN I-NP O
166 subcutaneously RB O B-mo
166 , , O O
166 folate VB O B-m
166 3 CD O B-do
166 mg NNS B-NP I-do
166 p.o JJ O B-mo
166 daily RB O B-f
166 , , O O
166 Avapro NNP B-NP B-m
166 150 CD O B-do
166 mg NN B-NP I-do
167 p.o JJ O B-mo
167 daily RB O B-f
167 , , O O
167 meclizine PRP O B-m
167 25 CD O B-do
167 mg NN B-NP I-do
167 p.o NN I-NP B-mo
167 t.i.d NN I-NP B-f
167 , , O O
167 Combivent NNP B-NP B-m
167 2 CD O B-do
167 puffs NNS B-NP I-do
168 inhaled VBD B-VP B-mo
168 q.i.d NN B-NP B-f
168 , , O O
168 vitamin NN B-NP B-m
168 D NNP I-NP I-m
168 125 CD O I-m
168 0.25 CD O B-do
168 mcg NNS B-NP I-do
168 p.o JJ B-NP B-mo
168 daily JJ I-NP B-f
169 eScription NN I-NP O
169 document: VBZ O O
169 5-0185679 JJ B-NP O
169 AFFocus NNP I-NP O
170 Dictated NNP I-NP O
170 By: NNP I-NP O
170 SPAHN NNP I-NP O
170 , , O O
170 LELAND NNP B-NP O
171 Attending: NNP I-NP O
171 SCHEURING NNP I-NP O
171 , , O O
171 WILLY NNP B-NP O
171 LYMAN NNP I-NP O
172 Dictation NNP I-NP O
172 ID NNP I-NP O
172 2453716 CD O O
173 D: NNP B-NP O
173 6/13/05 CD O O
174 T: NNP B-NP O
174 10/30/05 CD O O
175 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #916765 VBZ O O
4 970021603 CD O O
4 ALEH NNP B-NP O
4 38063617 CD O O
4 188368 CD O O
4 11/10/1997 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 AORTIC NNP I-NP O
4 VALVE NNP I-NP O
4 DISEASE NNP I-NP O
4 , , O O
4 MITRAL NNP B-NP O
4 VALVE NNP I-NP O
4 DISEASE NNP I-NP O
4 , , O O
4 CORONARY NNP B-NP O
4 ARTERY NNP I-NP O
4 DISEASE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/10/1997 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/10/1997 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 Mr NNP I-NP O
7 Vendetti NNP I-NP O
7 is VBZ O O
7 a DT O O
7 61 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 man NN I-NP O
7 who WP O O
8 was VBD B-VP O
8 admitted VBN O O
8 to TO O O
8 the DT B-NP O
8 cardiac JJ I-NP O
8 surgical JJ I-NP O
9 service NN I-NP O
9 on IN B-VP O
9 0/14/97 CD O O
9 for IN B-VP O
9 aortic JJ B-NP O
9 valve NN I-NP O
9 replacement NN I-NP O
9 , , O O
9 mitral JJ O O
9 valve FW O O
10 replacement NN B-NP O
10 He PRP O O
10 had VBD B-VP O
10 an DT B-NP O
10 echocardiogram NN I-NP O
10 at IN B-VP O
10 an DT B-NP O
10 outside JJ I-NP O
10 hospital NN I-NP O
10 that WDT O O
11 demonstrated VBD B-VP O
11 a DT B-NP O
11 dilated JJ I-NP O
11 left NN I-NP O
11 ventricle NN I-NP O
11 and CC O O
11 an DT B-NP O
11 ejection NN I-NP O
11 fraction NN I-NP O
11 of IN B-VP O
12 55% CD O O
12 with IN B-VP O
12 moderate JJ B-NP O
12 aortic JJ I-NP O
12 stenosis NN I-NP O
12 with IN B-VP O
12 moderate JJ O O
12 to TO O O
12 severe VB O O
12 aortic JJ B-NP O
13 insufficiency NN I-NP O
13 with IN B-VP O
13 a DT B-NP O
13 peak JJ I-NP O
13 gradient NN I-NP O
13 of IN B-VP O
13 35 CD O O
13 millimeters NNS B-NP O
13 of IN B-VP O
13 mercury NN B-NP O
13 , , O O
14 mild NN B-NP O
14 to TO O O
14 moderate VB O O
14 mitral JJ B-NP O
14 stenosis NN I-NP O
14 and CC O O
14 moderate JJ B-NP O
14 mitral JJ I-NP O
14 insufficiency NN I-NP O
15 with IN B-VP O
15 a DT B-NP O
15 mitral JJ I-NP O
15 valve JJ I-NP O
15 area NN I-NP O
15 of IN B-VP O
15 1.1 CD O O
15 cm NN B-NP O
15 squared VBD B-VP O
15 He PRP O O
15 has VBZ O O
15 had VBD B-VP O
15 a DT B-NP O
15 history NN I-NP O
16 of IN B-VP O
16 rheumatic JJ B-NP O
16 heart NN I-NP O
16 disease VB O O
16 His PRP$ O O
16 cardiac JJ B-NP O
16 catheterization NN I-NP O
16 on IN B-VP O
17 4/21/97 CD O O
17 demonstrated VBD B-VP O
17 a DT O O
17 95% CD O O
17 proximal JJ B-NP O
17 right JJ I-NP O
17 coronary JJ I-NP O
17 artery NN I-NP O
17 lesion NN I-NP O
18 and CC O O
18 an DT B-NP O
18 ejection NN I-NP O
18 fraction NN I-NP O
18 of IN B-VP O
18 50% CD O O
19 PAST NNP B-NP O
19 MEDICAL NNP I-NP O
19 HISTORY: NNP I-NP O
19 Included NNP I-NP O
19 rheumatic JJ B-NP O
19 heart NN I-NP O
19 disease NN I-NP O
19 and CC O O
20 hypertension NN B-NP O
21 PAST NNP I-NP O
21 SURGICAL NNP I-NP O
21 HISTORY: NNP I-NP O
21 Is VBZ O O
21 none JJ B-NP O
22 SOCIAL NNP I-NP O
22 HISTORY: NNP I-NP O
22 Former NNP I-NP O
22 smoker; VBD B-VP O
22 twenty NN B-NP O
22 pack NN I-NP O
22 year NN I-NP O
22 history NN I-NP O
23 MEDICATIONS: NNP I-NP O
23 On IN B-VP O
23 admission NN B-NP O
23 are VBP O O
23 Toprol NNP B-NP B-m
23 XL NNP I-NP I-m
23 50 CD O B-do
23 once RB O B-f
23 a DT B-NP I-f
23 day NN I-NP I-f
23 , , O O
23 aspirin NN B-NP B-m
24 once RB O B-f
24 a DT B-NP I-f
24 day NN I-NP I-f
24 , , O O
24 sublingual JJ B-NP B-mo
24 nitroglycerin NN I-NP B-m
24 and CC O O
24 Zocor NNP B-NP B-m
24 50 CD O B-do
25 once RB O B-f
25 a DT B-NP I-f
25 day NN I-NP I-f
26 ALLERGIES: NNP I-NP O
26 No NNP I-NP O
26 known VBN O O
26 drug NN B-NP O
26 allergies NNS I-NP O
27 PHYSICAL NNP I-NP O
27 EXAM: NNP I-NP O
27 Unremarkable NNP I-NP O
27 except IN B-VP O
27 for IN B-VP O
27 a DT O O
27 3/6 CD O O
27 diastolic JJ B-NP O
27 murmur NN I-NP O
27 at IN B-VP O
28 the DT B-NP O
28 apex NN I-NP O
28 and CC O O
28 a DT O O
28 3 CD O O
28 to TO O O
28 4/6 CD O O
28 systolic JJ B-NP O
28 murmur NN I-NP O
28 at IN B-VP O
28 the DT O O
29 lower JJR O O
29 left VBD B-VP O
29 sternal JJ B-NP O
29 border NN I-NP O
30 LABORATORY: NNP I-NP O
30 Were NNP I-NP O
30 all DT O O
30 normal JJ O O
30 , , O O
30 within IN B-VP O
30 normal JJ B-NP O
30 limits NNS I-NP O
31 HOSPITAL NNP I-NP O
31 COURSE: NNP I-NP O
31 He PRP O O
31 went VBD B-VP O
31 to TO O O
31 the DT B-NP O
31 operating NN I-NP O
31 room NN I-NP O
31 on IN B-VP O
31 5/16/97 CD O O
31 where WRB O O
32 he PRP O O
32 had VBD B-VP O
32 a DT B-NP O
32 mitral JJ I-NP O
32 valve NN I-NP O
32 replacement NN I-NP O
32 with IN B-VP O
32 a DT B-NP O
32 #31 JJ I-NP O
32 St NNP I-NP O
33 Jude NNP I-NP O
33 mechanical JJ B-NP O
33 prosthesis NN I-NP O
33 and CC O O
33 an DT B-NP O
33 aortic JJ I-NP O
33 valve NN I-NP O
33 replacement NN I-NP O
33 with IN B-VP O
33 a DT B-NP O
34 #25 JJ I-NP O
34 St NNP I-NP O
34 Jude NNP I-NP O
34 mechanical JJ B-NP O
34 prosthesis NN I-NP O
34 and CC O O
34 a DT B-NP O
34 right JJ I-NP O
34 internal JJ I-NP O
34 mammary JJ I-NP O
35 artery NN I-NP O
35 bypass NN I-NP O
35 grafting VBG O O
35 to TO O O
35 the DT B-NP O
35 right JJ I-NP O
35 coronary JJ I-NP O
35 artery NN I-NP O
35 He PRP O O
35 had VBD B-VP O
35 no DT B-NP O
36 complications NNS I-NP O
37 He PRP O O
37 is VBZ O O
37 being VBG O O
37 discharged VBN O O
37 on IN B-VP O
37 postop JJ B-NP O
37 day NN I-NP O
37 four CD O O
37 without IN B-VP O
37 complications NNS B-NP O
38 He PRP O O
38 will MD O O
38 be VB O O
38 discharged VBN O O
38 on IN B-VP O
38 Lopressor NNP B-NP B-m
38 50 CD O B-do
38 mg NN B-NP I-do
38 twice RB O B-f
38 a DT B-NP I-f
38 day NN I-NP I-f
38 , , O O
38 Lasix NNP B-NP B-m
38 40 CD O B-do
38 mg NN B-NP I-do
39 once RB O B-f
39 a DT B-NP I-f
39 day NN I-NP I-f
39 for IN B-VP B-du
39 two CD O I-du
39 days NNS B-NP I-du
39 with IN B-VP O
39 potassium NN B-NP B-m
39 , , O O
39 K-Dur NNP B-NP B-m
39 tabs VBZ O I-m
39 10 CD O B-do
39 mEq NN B-NP I-do
39 once RB O B-f
39 a DT B-NP O
40 day NN I-NP O
40 for IN B-VP B-du
40 two CD O I-du
40 days NNS B-NP I-du
40 with IN B-VP O
40 Lasix NNP B-NP B-m
40 , , O O
40 Coumadin NNP B-NP B-m
40 5 CD O B-do
40 mg NN B-NP I-do
40 one CD O I-do
40 tab NN B-NP I-do
40 once RB O B-f
40 a DT B-NP I-f
40 day NN I-NP I-f
40 or CC O O
40 as IN B-VP O
41 directed VBN O O
41 The DT B-NP O
41 Coumadin NNP I-NP B-m
41 has VBZ O O
41 been VBN O O
41 restarted VBN O O
41 for IN B-VP O
41 right JJ B-NP B-r
41 leg NN I-NP I-r
41 DVT NNP I-NP I-r
41 that WDT O O
42 was VBD B-VP O
42 discovered VBN O O
42 post NN B-NP O
42 cardiac JJ B-NP O
42 catheterization NN I-NP O
42 and CC O O
42 is VBZ O O
42 to TO O O
42 be VB O O
42 continued VBN O O
43 for IN B-VP B-du
43 a DT B-NP I-du
43 total NN I-NP I-du
43 of IN B-VP I-du
43 three CD O I-du
43 months NNS B-NP I-du
43 Percocet NNP I-NP B-m
43 is VBZ O O
43 one CD O B-do
43 tab NN B-NP I-do
43 q.4h NN I-NP B-f
43 prn NN I-NP I-f
43 for IN B-VP O
44 pain NN B-NP B-r
44 and CC O O
44 he PRP O O
44 is VBZ O O
44 being VBG O O
44 discharged VBN O O
44 to TO O O
44 the DT B-NP O
44 care NN I-NP O
44 of IN B-VP O
44 Dr NNP B-NP O
44 Sterling NNP I-NP O
44 Goodson NNP I-NP O
45 Dictated NNP I-NP O
45 By: NNP I-NP O
45 CLIFFORD NNP I-NP O
45 GASCOIGNE NNP I-NP O
45 , , O O
45 P.A NNP B-NP O
46 Attending: NNP I-NP O
46 LUIS NNP I-NP O
46 O NNP I-NP O
46 HEMPE NNP I-NP O
46 , , O O
46 M.D NNP B-NP O
46 OQ0 NNP I-NP O
46 GF827/5167 NNP I-NP O
47 Batch: NNP I-NP O
47 14692 CD O O
47 Index NNP B-NP O
47 No NNP I-NP O
47 A7KPYH929V NNP I-NP O
47 D: NNP I-NP O
47 10/22/97 CD O O
48 T: NNP B-NP O
48 9/15/97 CD O O
49 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #916948 VBZ O O
4 976430219 CD O O
4 TMMC NNP B-NP O
4 90625216 CD O O
4 905629 CD O O
4 9/15/2002 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 ATRIAL NNP I-NP O
4 FIBRILLATION NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/23/2002 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/12/2002 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 CONGESTIVE NNP I-NP O
7 HEART NNP I-NP O
7 FAILURE NNP I-NP O
8 SIGNIFICANT NNP I-NP O
8 PROBLEMS: NNP I-NP O
8 1 CD O O
8 CONGESTIVE NNP B-NP O
8 HEART NNP I-NP O
8 FAILURE NNP I-NP O
9 2 CD O O
9 ATRIAL NNP B-NP O
9 FIBRILLATION NNP I-NP O
10 3 CD O O
10 URINARY NNP B-NP O
10 TRACT NNP I-NP O
10 INFECTION NNP I-NP O
11 4 CD O O
11 DIABETES NNP B-NP O
11 MELLITUS NNP I-NP O
12 HISTORY NNP I-NP O
12 OF NNP I-NP O
12 PRESENT NNP I-NP O
12 ILLNESS: NNP I-NP O
12 The DT B-NP O
12 patient NN I-NP O
12 is VBZ O O
12 a DT B-NP O
12 70-year-old JJ I-NP O
12 woman NN I-NP O
12 who WP O O
13 was VBD B-VP O
13 followed VBN O O
13 in IN B-VP O
13 cardiology NN B-NP O
13 by IN B-VP O
14 Dr NNP B-NP O
14 Pikula NNP I-NP O
14 who WP O O
14 has VBZ O O
14 presumed VBN O O
14 diastolic JJ B-NP O
14 dysfunction NN I-NP O
14 , , O O
14 who WP O O
14 was VBD B-VP O
14 in IN B-VP O
14 her PRP$ O O
15 usual JJ B-NP O
15 state NN I-NP O
15 of IN B-VP O
15 health NN B-NP O
15 until IN B-VP O
15 5/12 CD O O
15 , , O O
15 when WRB O O
15 she PRP O O
15 was VBD B-VP O
15 admitted VBN O O
15 to TO O O
15 the DT B-NP O
15 Dobubay NNP I-NP O
15 Naicent NNP I-NP O
15 University NNP I-NP O
15 Of IN B-VP O
15 Medical NNP B-NP O
15 Center NNP I-NP O
15 with IN B-VP O
15 a DT B-NP O
15 flare NN I-NP O
15 of IN B-VP O
15 Crohn's NNP B-NP O
15 ileitis NN I-NP O
16 At IN B-VP O
16 the DT B-NP O
16 time NN I-NP O
16 of IN B-VP O
16 her PRP$ O O
16 discharge NN B-NP O
16 , , O O
16 she PRP O O
16 was VBD B-VP O
16 not RB O O
16 restarted VBN O O
16 on IN B-VP O
16 her PRP$ O O
16 Lasix NNP B-NP O
17 and CC O O
17 subsequently RB O O
17 developed VBD B-VP O
17 fluid JJ B-NP O
17 retention NN I-NP O
17 with IN B-VP O
17 gradual JJ B-NP O
17 worsening NN I-NP O
17 , , O O
18 shortness NN B-NP O
18 of IN B-VP O
18 breath NN B-NP O
18 and CC O O
18 lower JJR B-NP O
18 extremity NN I-NP O
18 edema VBP O O
18 The DT B-NP O
18 patient NN I-NP O
18 noted VBD B-VP O
18 a DT O O
19 20 CD O O
19 lb NN B-NP O
19 weight VBD B-VP O
19 gain NN B-NP O
19 during IN B-VP O
19 this DT B-NP O
19 period NN I-NP O
19 , , O O
19 as RB O O
19 well RB O O
19 as IN B-VP O
19 increasing VBG O O
20 orthopnea NN B-NP O
20 and CC O O
20 increasing VBG O O
20 dyspnea NN B-NP O
20 on IN B-VP O
20 exertion NN B-NP O
20 when WRB O O
20 getting VBG O O
20 dressed VBN O O
21 or CC O O
21 doing VBG O O
21 any DT B-NP O
21 different JJ I-NP O
21 movements NNS I-NP O
21 She PRP O O
21 was VBD B-VP O
21 seen VBN O O
21 in IN B-VP O
21 cardiology NN B-NP O
22 clinic NN I-NP O
22 on IN B-VP O
22 4/7/02 CD O O
22 and CC O O
22 found VBD B-VP O
22 to TO O O
22 be VB O O
22 in IN B-VP O
22 much JJ B-NP O
22 worse JJR I-NP O
22 congestive JJ I-NP O
22 heart NN I-NP O
23 failure NN I-NP O
23 with IN B-VP O
23 new JJ B-NP O
23 atrial JJ I-NP O
23 fibrillation NN I-NP O
23 She PRP O O
23 was VBD B-VP O
23 transferred VBN O O
23 then RB O O
23 to TO O O
24 the DT B-NP O
24 emergency NN I-NP O
24 department NN I-NP O
24 here RB O O
24 at IN B-VP O
24 the DT B-NP O
24 Peresvillee NNP I-NP O
24 Nawvine NNP I-NP O
24 University NNP I-NP O
24 Of IN B-VP O
24 Hospitals NNP B-NP O
24 And CC O O
24 Clinics NNP B-NP O
25 Her NNP I-NP O
25 most RBS O O
25 recent JJ B-NP O
25 echocardiogram NN I-NP O
25 on IN B-VP O
25 11/18/01 CD O O
25 revealed VBD B-VP O
25 mild NN B-NP O
25 to TO O O
26 moderate VB O O
26 left JJ B-NP O
26 ventricular JJ I-NP O
26 hypertrophy NN I-NP O
26 without IN B-VP O
26 any DT B-NP O
26 regional JJ I-NP O
26 wall NN I-NP O
27 motion NN I-NP O
27 abnormalities VBZ O O
27 Her NNP B-NP O
27 systolic JJ B-NP O
27 ejection NN I-NP O
27 fraction NN I-NP O
27 was VBD B-VP O
27 estimated VBN O O
28 to TO O O
28 be VB O O
28 60% CD O O
28 suggesting VBG O O
28 a DT B-NP O
28 diagnosis NN I-NP O
28 of IN B-VP O
28 diastolic JJ B-NP O
28 dysfunction NN I-NP O
28 and CC O O
28 heart NN B-NP O
29 failure NN I-NP O
29 She PRP O O
29 was VBD B-VP O
29 admitted VBN O O
29 with IN B-VP O
29 volume NN B-NP O
29 overload NN I-NP O
29 for IN B-VP O
29 diuresis NN B-NP O
30 REVIEW NNP I-NP O
30 OF NNP I-NP O
30 SYSTEMS: NNP I-NP O
30 The DT B-NP O
30 review NN I-NP O
30 of IN B-VP O
30 symptoms NNS B-NP O
30 was VBD B-VP O
30 notable JJ O O
30 for IN B-VP O
30 chest JJS B-NP O
31 tightness NN I-NP O
31 with IN B-VP O
31 occasional JJ B-NP O
31 palpitations NNS I-NP O
31 She PRP O O
32 experienced VBD B-VP O
32 no DT B-NP O
32 dizziness NN I-NP O
32 , , O O
32 no DT B-NP O
32 syncope NN I-NP O
32 and CC O O
32 no DT B-NP O
32 recent JJ I-NP O
32 diarrhea NN I-NP O
32 , , O O
32 no DT B-NP O
33 abdominal JJ I-NP O
33 pain NN I-NP O
33 , , O O
33 no DT B-NP O
33 nausea NN I-NP O
33 or CC O O
33 vomiting VBG O O
33 She PRP O O
33 did VBD B-VP O
33 report VB O O
33 chronic NN B-NP O
34 arthritis IN B-VP O
35 PAST NNP B-NP O
35 MEDICAL NNP I-NP O
35 HISTORY: NNP I-NP O
35 ( ( O O
35 1 CD O O
35 ) ) O O
35 Significant NN B-NP O
35 for IN B-VP O
35 congestive JJ B-NP O
35 heart NN I-NP O
35 failure NN I-NP O
36 due JJ O O
36 to TO O O
36 diastolic JJ B-NP O
36 dysfunction NN I-NP O
36 , , O O
36 ( ( O O
36 2 CD O O
36 ) ) O O
36 Crohn's NNP B-NP O
37 colitis NN I-NP O
37 diagnosed VBD B-VP O
37 in IN B-VP O
37 1963 CD O O
37 , , O O
37 ( ( O O
37 3 CD O O
37 ) ) O O
37 Right NNP B-NP O
37 breast NN I-NP O
37 carcinoma NN I-NP O
37 stage NN I-NP O
37 II NNP I-NP O
38 previously RB O O
38 treated VBD B-VP O
38 , , O O
38 not RB O O
38 currently RB O O
38 active JJ O O
38 , , O O
38 ( ( O O
38 4 CD O O
38 ) ) O O
38 Diabetes NNPS B-NP O
38 mellitus NN I-NP O
38 , , O O
39 ( ( O O
39 5 CD O O
39 ) ) O O
39 Obstructive CD O O
39 sleep JJ B-NP O
39 apnea NN I-NP O
39 , , O O
39 ( ( O O
39 6 CD O O
39 ) ) O O
39 Gastroesophageal NNP B-NP O
39 reflux NN I-NP O
39 disease NN I-NP O
39 , , O O
40 ( ( O O
40 7 CD O O
40 ) ) O O
40 Hypercholesterolemia NN B-NP O
40 , , O O
40 ( ( O O
40 8 CD O O
40 ) ) O O
40 Osteoarthritis NNP B-NP O
41 SOCIAL NNP I-NP O
41 HISTORY: NNP I-NP O
41 The DT B-NP O
41 patient NN I-NP O
41 is VBZ O O
41 a DT B-NP O
41 prior JJ I-NP O
41 tobacco NN I-NP O
41 smoker NN I-NP O
41 , , O O
41 having VBG O O
42 smoked VBN O O
42 two CD O O
42 packs NNS B-NP O
42 per IN B-VP O
42 day NN B-NP O
42 for IN B-VP O
42 38 CD O O
42 years NNS B-NP O
42 , , O O
42 but CC O O
42 has VBZ O O
43 quit VBN O O
43 She PRP O O
43 does VBZ O O
43 not RB O O
43 drink VB O O
43 alcohol NN B-NP O
43 and CC O O
43 does VBZ O O
43 not RB O O
43 use VB O O
43 any DT B-NP O
43 recreational JJ I-NP O
44 drugs NNS I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 lives VBZ O O
44 in IN B-VP O
44 Di NNP B-NP O
44 with IN B-VP O
44 a DT B-NP O
44 friend NN I-NP O
44 and CC O O
44 is VBZ O O
44 a DT B-NP O
44 retired JJ I-NP O
45 x-ray JJ I-NP O
45 technician JJ I-NP O
46 FAMILY NNP I-NP O
46 HISTORY: NNP I-NP O
46 Noncontributory NNP I-NP O
47 ALLERGIES: NNP I-NP O
47 The DT B-NP O
47 patient's NN I-NP O
47 medical JJ B-NP O
47 allergies NNS I-NP O
47 include VBP O O
47 penicillin NN B-NP O
47 , , O O
48 which WDT O O
48 causes VBZ O O
48 a DT B-NP O
48 rash NN I-NP O
48 , , O O
48 Demerol NNP B-NP O
48 and CC O O
48 Dilaudid NNP B-NP O
48 causing VBG O O
49 nausea NN B-NP O
49 , , O O
49 and CC O O
49 Macrodantin NNP B-NP O
50 PHYSICAL NNP I-NP O
50 EXAMINATION: NNP I-NP O
50 VITAL NNP I-NP O
50 SIGNS: NNP I-NP O
50 Included VBD B-VP O
50 a DT B-NP O
50 temperature NN I-NP O
50 of IN B-VP O
50 97 CD O O
50 , , O O
51 heart NN B-NP O
51 rate NN I-NP O
51 76 CD O O
51 , , O O
51 blood NN B-NP O
51 pressure NN I-NP O
51 90/60 CD O O
51 , , O O
52 respiratory NN B-NP O
52 rate NN I-NP O
52 28 CD O O
52 , , O O
52 and CC O O
52 a DT B-NP O
52 saturation NN I-NP O
52 of IN B-VP O
52 97% CD O O
52 on IN B-VP O
52 room NN B-NP O
52 air NN I-NP O
52 The DT B-NP O
53 patient NN I-NP O
53 was VBD B-VP O
53 noted VBN O O
53 to TO O O
53 be VB O O
53 in IN B-VP O
53 atrial JJ B-NP O
53 fibrillation NN I-NP O
53 GENERAL: NNP I-NP O
53 Physical NNP I-NP O
54 examination NN I-NP O
54 showed VBD B-VP O
54 that IN B-VP O
54 the DT B-NP O
54 patient NN I-NP O
54 was VBD B-VP O
54 alert JJ O O
54 and CC O O
54 oriented JJ B-NP O
54 x3 NN I-NP O
54 , , O O
54 in IN B-VP O
55 no DT B-NP O
55 acute NN I-NP O
55 distress NN I-NP O
55 , , O O
55 having VBG O O
55 shortness NN B-NP O
55 of IN B-VP O
55 breath NN B-NP O
55 while IN B-VP O
55 sitting VBG O O
55 up RP O O
55 in IN B-VP O
56 bed NN B-NP O
56 HEENT: NNP I-NP O
56 Normocephalic NNP I-NP O
56 , , O O
56 atraumatic JJ O O
56 , , O O
56 pupils JJ O O
56 equal JJ O O
56 , , O O
56 round NN B-NP O
56 , , O O
56 and CC O O
57 reactive JJ O O
57 , , O O
57 extraocular JJ B-NP O
57 movements NNS I-NP O
57 were VBD B-VP O
57 intact JJ B-NP O
57 NECK: NNP I-NP O
57 Showed NNP I-NP O
57 jugular JJ B-NP O
58 venous JJ I-NP O
58 distention NN I-NP O
58 to TO O O
58 at IN B-VP O
58 least JJS O O
58 20 CD O O
58 cm NN B-NP O
58 CHEST: NNP I-NP O
58 Showed NNP I-NP O
58 crackles VBZ O O
59 posteriorly RB O O
59 approximately RB O O
59 half NN B-NP O
59 of IN B-VP O
59 the DT B-NP O
59 way NN I-NP O
59 up RP O O
59 CARDIOVASCULAR: NNP B-NP O
60 Showed NNP I-NP O
60 an DT B-NP O
60 irregular JJ I-NP O
60 rhythm NN I-NP O
60 and CC O O
60 a DT B-NP O
60 systolic JJ I-NP O
60 ejection NN I-NP O
60 murmur FW O O
61 consistent NN B-NP O
61 with IN B-VP O
61 the DT B-NP O
61 prior JJ I-NP O
61 diagnosis NN I-NP O
61 of IN B-VP O
61 aortic JJ B-NP O
61 stenosis NN I-NP O
61 ABDOMEN: NNP I-NP O
62 Showed NNP I-NP O
62 profound IN B-VP O
62 obesity NN B-NP O
62 EXTREMITIES: NNP I-NP O
62 Showed NNP I-NP O
62 significant JJ O O
62 pitting VBG O O
63 edema NN B-NP O
63 bilaterally RB O O
63 over IN B-VP O
63 the DT B-NP O
63 calves NNS I-NP O
64 LABORATORY NNP I-NP O
64 DATA: NNP I-NP O
64 Showed VBD B-VP O
64 a DT B-NP O
64 white JJ I-NP O
64 blood NN I-NP O
64 cell NN I-NP O
64 count NN I-NP O
64 of IN B-VP O
64 7 CD O O
64 , , O O
64 hematocrit NN B-NP O
65 31 CD O O
65 , , O O
65 platelets NNS B-NP O
65 of IN B-VP O
65 148 CD O O
65 Sodium NNP B-NP O
65 was VBD B-VP O
65 142 CD O O
65 , , O O
65 potassium NN B-NP O
66 3.9 CD O O
66 , , O O
66 BUN NNP B-NP O
66 56 CD O O
66 , , O O
66 creatinine NN B-NP O
66 1.3 CD O O
66 , , O O
66 with IN B-VP O
66 a DT B-NP O
66 glucose NN I-NP O
66 of IN B-VP O
66 75 CD O O
66 Liver NNP B-NP O
66 function NN I-NP O
67 tests NNS I-NP O
67 were VBD B-VP O
67 normal JJ B-NP O
67 CK NNP I-NP O
67 was VBD B-VP O
67 44 CD O O
67 and CC O O
67 troponin NN B-NP O
67 was VBD B-VP O
67 0.02 CD O O
67 A NNP B-NP O
67 chest NN I-NP O
67 x-ray NN I-NP O
68 showed VBD B-VP O
68 mild JJ B-NP O
68 pulmonary JJ I-NP O
68 vascular JJ I-NP O
68 congestion NN I-NP O
68 without IN B-VP O
68 any DT B-NP O
68 evidence NN I-NP O
68 of IN B-VP O
69 infiltrates NNS B-NP O
69 EKG NNP I-NP O
69 showed VBD B-VP O
69 atrial JJ B-NP O
69 fibrillation NN I-NP O
69 at IN B-VP O
69 a DT B-NP O
69 rate NN I-NP O
69 of IN B-VP O
69 72 CD O O
69 , , O O
70 otherwise RB O O
70 no DT B-NP O
70 abnormalities NNS I-NP O
70 beside VBP O O
70 some DT B-NP O
70 nonspecific JJ I-NP O
70 ST-T JJ I-NP O
70 wave NN I-NP O
71 changes NNS I-NP O
71 Urinalysis NNP I-NP O
71 showed VBD B-VP O
71 evidence NN B-NP O
71 of IN B-VP O
71 an DT B-NP O
71 urinary JJ I-NP O
71 tract NN I-NP O
71 infection NN I-NP O
72 with IN B-VP O
72 20-30 JJ B-NP O
72 white JJ I-NP O
72 blood NN I-NP O
72 cells NNS I-NP O
72 and CC O O
72 was VBD B-VP O
72 leukocyte JJ B-NP O
72 esterase NN I-NP O
72 positive JJ B-NP O
73 Urine NNP I-NP O
73 culture NN I-NP O
73 was VBD B-VP O
73 sent VBN O O
73 at IN B-VP O
73 that DT B-NP O
73 time NN I-NP O
74 HOSPITAL NNP I-NP O
74 COURSE: NNP I-NP O
74 1 CD O O
74 Congestive NNP B-NP B-r
74 Congestive NNP I-NP B-r
74 heart NN I-NP I-r
74 heart NN I-NP I-r
74 failure NN I-NP I-r
74 failure NN I-NP I-r
74 - : O O
74 The DT B-NP O
74 patient NN I-NP O
74 was VBD B-VP O
75 started VBN O O
75 on IN B-VP O
75 IV NNP B-NP B-mo
75 Lasix NNP I-NP B-m
75 along IN B-VP O
75 with IN B-VP O
75 Zaroxolyn NNP B-NP B-m
75 and CC O O
76 responded VBD B-VP O
76 with IN B-VP O
76 a DT B-NP O
76 brisk JJ I-NP O
76 diuresis NN I-NP O
76 over IN B-VP O
76 the DT B-NP O
76 course NN I-NP O
76 of IN B-VP O
76 the DT B-NP O
76 admission NN I-NP O
77 The DT B-NP O
77 patient's NN I-NP O
77 weight NN I-NP O
77 declined VBN O O
77 by IN B-VP O
77 approximately RB O O
77 5.2 CD O O
77 kg VBD B-VP O
77 It PRP O O
77 was VBD B-VP O
78 estimated VBN O O
78 that IN B-VP O
78 the DT B-NP O
78 total JJ I-NP O
78 volume NN I-NP O
78 of IN B-VP O
78 fluid NN B-NP O
78 removed VBN O O
78 was VBD B-VP O
78 approximately RB O O
79 15 CD O O
79 liters NNS B-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 was VBD B-VP O
79 reported VBN O O
79 great JJ B-NP O
79 improvement NN I-NP O
79 in IN B-VP O
79 her PRP$ O O
80 symptoms NNS B-NP O
80 , , O O
80 was VBD B-VP O
80 able JJ O O
80 to TO O O
80 ambulate VB O O
80 without IN B-VP O
80 requiring VBG O O
80 supplemental JJ B-NP O
81 oxygen NN I-NP O
81 The DT B-NP O
81 patient NN I-NP O
81 was VBD B-VP O
81 switched VBN O O
81 to TO O O
81 oral JJ B-NP B-mo
81 Lasix NNP I-NP B-m
81 and CC O O
81 continued VBD B-VP O
81 her PRP O B-r
82 diuresis NN B-NP O
82 The DT B-NP O
82 day NN I-NP O
82 prior RB O O
82 to TO O O
82 discharge VB O O
82 , , O O
82 the DT B-NP O
82 patient NN I-NP O
82 was VBD B-VP O
82 switched VBN O O
82 to TO O O
83 oral JJ B-NP B-mo
83 torsemide NN I-NP B-m
83 , , O O
83 and CC O O
83 she PRP O O
83 will MD O O
83 be VB O O
83 discharged VBN O O
83 on IN B-VP O
83 that DT B-NP B-m
83 medication NN I-NP I-m
84 2 CD O O
84 Atrial NNP B-NP O
84 fibrillation NN I-NP O
84 - : O O
84 The DT B-NP O
84 patient NN I-NP O
84 was VBD B-VP O
84 noted VBN O O
84 to TO O O
84 have VB O O
84 new JJ O O
84 onset VBN O O
85 of IN B-VP O
85 atrial JJ B-NP O
85 fibrillation NN I-NP O
85 while IN B-VP O
85 being VBG O O
85 seen VBN O O
85 in IN B-VP O
85 cardiology NN B-NP O
85 clinic NN I-NP O
85 on IN B-VP O
86 4/7/02 CD O O
86 Since IN B-VP O
86 it PRP O O
86 was VBD B-VP O
86 not RB O O
86 known VBN O O
86 how WRB O O
86 long JJ O O
86 the DT B-NP O
86 atrial JJ I-NP O
86 fibrillation NN I-NP O
87 had VBD B-VP O
87 been VBN O O
87 going VBG O O
87 on IN B-VP O
87 , , O O
87 a DT B-NP O
87 decision NN I-NP O
87 was VBD B-VP O
87 made VBN O O
87 to TO O O
87 anticoagulate VB O O
87 the DT B-NP O
88 patient NN I-NP O
88 She PRP O O
88 was VBD B-VP O
88 initially RB O O
88 started VBN O O
88 on IN B-VP O
88 intravenous JJ B-NP B-mo
88 unfractionated JJ I-NP O
89 heparin NN I-NP B-m
89 while IN B-VP O
89 starting VBG O O
89 anticoagulation NN B-NP B-r
89 with IN B-VP O
89 Coumadin NNP B-NP B-m
89 The DT B-NP O
89 patient NN I-NP O
90 reached VBD B-VP O
90 a DT B-NP O
90 therapeutic JJ I-NP O
90 INR NNP I-NP O
90 of IN B-VP O
90 2.5 CD O O
90 within IN B-VP O
90 approximately RB O O
90 4-5 JJ B-NP O
90 days NNS I-NP O
90 and CC O O
91 the DT B-NP O
91 IV NNP I-NP B-mo
91 heparin NN I-NP B-m
91 was VBD B-VP O
91 discontinued VBN O O
91 At IN B-VP O
91 the DT B-NP O
91 time NN I-NP O
91 of IN B-VP O
91 discharge NN B-NP O
91 , , O O
91 the DT B-NP O
92 patient NN I-NP O
92 INR NNP I-NP O
92 was VBD B-VP O
92 3.2 CD O O
92 She PRP O O
92 will MD O O
92 have VB O O
92 INR NNP B-NP O
92 follow VB O O
92 up RP O O
92 through IN B-VP O
92 her PRP$ O O
93 primary JJ B-NP O
93 cardiologist NN I-NP O
93 , , O O
93 Dr NNP B-NP O
93 Janousek NNP I-NP O
93 Currently NNP I-NP O
93 , , O O
93 the DT B-NP O
93 decision NN I-NP O
93 to TO O O
94 cardiovert VB O O
94 the DT B-NP O
94 patient NN I-NP O
94 is VBZ O O
94 left VBN O O
94 in IN B-VP O
94 the DT B-NP O
94 hands NNS I-NP O
94 of IN B-VP O
94 her PRP$ O O
94 outpatient JJ B-NP O
95 cardiologist NN I-NP O
96 3 CD O O
96 Urinary NNP B-NP O
96 tract NN I-NP O
96 infection NN I-NP O
96 - : O O
96 The DT B-NP O
96 patient's JJ I-NP O
96 initial JJ I-NP O
96 urinalysis NN I-NP O
97 indicated VBD B-VP O
97 a DT B-NP B-r
97 bacterial JJ I-NP I-r
97 urinary JJ I-NP I-r
97 tract NN I-NP I-r
97 infection NN I-NP I-r
97 Subsequent NNP I-NP O
97 urine NN I-NP O
98 culture NN I-NP O
98 grew VBD B-VP O
98 out RP O O
98 E NNP B-NP O
98 coli NNS I-NP O
98 , , O O
98 which WDT O O
98 was VBD B-VP O
98 subsequently RB O O
98 determined VBN O O
98 to TO O O
98 be VB O O
99 resistant JJ O O
99 to TO O O
99 levofloxacin VB O B-m
99 Initially NNP B-NP O
99 , , O O
99 the DT B-NP O
99 patient NN I-NP O
99 had VBD B-VP O
99 been VBN O O
99 started VBN O O
100 on IN B-VP O
100 IV NNP B-NP B-mo
100 levofloxacin NN I-NP B-m
100 , , O O
100 which WDT O O
100 was VBD B-VP O
100 subsequently RB O O
100 changed VBN O O
100 to TO O O
100 p.o VB O B-mo
101 cefixime VB O B-m
101 The DT B-NP O
101 patient NN I-NP O
101 completed VBD B-VP O
101 a DT B-NP B-du
101 five-day JJ I-NP I-du
101 course NN I-NP I-du
101 of IN B-VP O
101 p.o JJ B-NP B-mo
101 cefixime NN I-NP B-m
102 while IN B-VP O
102 here RB O O
102 in IN B-VP O
102 the DT B-NP O
102 hospital NN I-NP O
102 and CC O O
102 was VBD B-VP O
102 discharged VBN O O
102 on IN B-VP O
102 that DT B-NP B-m
102 medicine NN I-NP I-m
102 to TO O O
103 complete VB O O
103 a DT B-NP B-du
103 10-day JJ I-NP I-du
103 course NN I-NP I-du
103 Of IN B-VP O
103 note NN B-NP O
103 , , O O
103 the DT B-NP O
103 initial JJ I-NP O
103 symptoms NNS I-NP O
103 the DT B-NP O
104 patient NN I-NP O
104 had VBD B-VP O
104 including VBG O O
104 hematuria NN B-NP O
104 , , O O
104 resolved VBN O O
104 by IN B-VP O
104 the DT B-NP O
104 time NN I-NP O
104 of IN B-VP O
104 discharge NN B-NP O
105 4 CD O O
105 Diabetes NNPS B-NP B-r
105 mellitus SYM O I-r
105 - : O O
105 The DT B-NP O
105 patient NN I-NP O
105 has VBZ O O
105 a DT B-NP O
105 long JJ I-NP O
105 history NN I-NP O
105 of IN B-VP O
105 diabetes NNS B-NP O
106 requiring VBG O O
106 insulin NN B-NP B-m
106 treatment NN I-NP O
106 She PRP O O
106 is VBZ O O
106 followed VBN O O
106 by IN B-VP O
106 endocrinologist NN B-NP O
106 at IN B-VP O
107 the DT B-NP O
107 Kingnix NNP I-NP O
107 Lowemar NNP I-NP O
107 W.kell NNP I-NP O
107 Medical NNP I-NP O
107 Center NNP I-NP O
107 During IN B-VP I-du
107 this DT B-NP I-du
107 hospitalization NN I-NP O
107 , , O O
107 her PRP$ O B-r
108 blood NN B-NP O
108 sugars NNS I-NP O
108 were VBD B-VP O
108 maintained VBN O O
108 with IN B-VP O
108 insulin NN B-NP B-m
108 subcutaneous JJ B-NP B-mo
108 injections NNS I-NP I-mo
109 The DT B-NP O
109 patient NN I-NP O
109 is VBZ O O
109 to TO O O
109 continue VB O O
109 the DT B-NP O
109 management NN I-NP O
109 of IN B-VP O
109 her PRP$ O O
109 diabetes NNS B-NP O
109 per IN B-VP O
109 her PRP$ O O
110 endocrinologist NN B-NP O
111 DISCHARGE NNP I-NP O
111 MEDICATIONS: NNP I-NP O
111 ( ( O O
111 1 CD O O
111 ) ) O O
111 Vitamin NNP B-NP B-m
111 C NNP I-NP I-m
111 500 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 q.d NN I-NP B-f
111 , , O O
111 ( ( O O
111 2 CD O O
111 ) ) O O
111 ferrous JJ B-NP B-m
112 sulfate NN I-NP O
112 300 CD O B-do
112 mg NN B-NP I-do
112 p.o NN I-NP B-mo
112 q.d NN I-NP B-f
112 , , O O
112 ( ( O O
112 3 CD O O
112 ) ) O O
112 insulin NN B-NP B-m
112 Lente NNP I-NP I-m
113 subcutaneous JJ O B-mo
113 30 CD O B-do
113 U NNP B-NP I-do
113 q.h.s NN I-NP B-f
113 , , O O
113 ( ( O O
113 4 CD O O
113 ) ) O O
113 insulin NN B-NP B-m
113 Regular NNP I-NP I-m
113 subcutaneous JJ O B-mo
113 30 CD O B-do
113 U NNP B-NP I-do
114 q.h.s NN I-NP B-f
114 , , O O
114 ( ( O O
114 5 CD O O
114 ) ) O O
114 Synthroid NNP B-NP B-m
114 200 CD O B-do
114 mcg NN B-NP I-do
114 p.o NN I-NP B-mo
114 q.d NN I-NP B-f
114 , , O O
114 ( ( O O
114 6 CD O O
114 ) ) O O
114 Zaroxolyn VBD B-VP B-m
114 5 CD O B-do
114 mg NN B-NP I-do
114 p.o NN I-NP B-mo
115 q.a.m NN I-NP B-f
115 , , O O
115 ( ( O O
115 7 CD O O
115 ) ) O O
115 tamoxifen NN B-NP B-m
115 20 CD O B-do
115 mg NN B-NP I-do
115 p.o NN I-NP B-mo
115 q.h.s NN I-NP B-f
115 , , O O
115 ( ( O O
115 8 CD O O
115 ) ) O O
115 Vitamin NNP B-NP B-m
115 E NNP I-NP I-m
115 400 CD O B-do
115 U NNP B-NP I-do
115 p.o NN I-NP B-mo
116 q.d NN I-NP B-f
116 , , O O
116 ( ( O O
116 9 CD O O
116 ) ) O O
116 Coumadin NNP B-NP B-m
116 5 CD O B-do
116 mg NN B-NP I-do
116 p.o NN I-NP B-mo
116 q.h.s NN I-NP B-f
116 , , O O
116 ( ( O O
116 10 CD O O
116 ) ) O O
116 multivitamins VBZ O B-m
116 1 CD O B-do
116 tablet NN B-NP I-do
117 p.o NN I-NP B-mo
117 q.d NN I-NP B-f
117 , , O O
117 ( ( O O
117 11 CD O O
117 ) ) O O
117 Zocor NNP B-NP B-m
117 40 CD O B-do
117 mg NN B-NP I-do
117 p.o NN I-NP B-mo
117 q.h.s NN I-NP B-f
117 , , O O
117 ( ( O O
117 12 CD O O
117 ) ) O O
117 insulin NN B-NP B-m
117 70/30 CD O I-m
117 35 CD O B-do
117 U NNP B-NP I-do
118 subcu NN I-NP B-mo
118 q.a.m NN I-NP B-f
118 , , O O
118 ( ( O O
118 13 CD O O
118 ) ) O O
118 Neurontin NNP B-NP B-m
118 Neurontin NNP I-NP B-m
118 Neurontin NNP I-NP B-m
118 300 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
118 q.a.m NN I-NP B-f
118 , , O O
118 100 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
118 at IN B-VP B-f
119 2:00 CD O O
119 p.m NN B-NP O
119 , , O O
119 300 CD O B-do
119 mg NN B-NP I-do
119 p.o NN I-NP B-mo
119 q.h.s NN I-NP B-f
119 , , O O
119 ( ( O O
119 14 CD O O
119 ) ) O O
119 Serevent NN B-NP B-m
119 inhaled VBD B-VP B-mo
119 1 CD O B-do
119 puff NN B-NP I-do
119 b.i.d NN I-NP B-f
119 , , O O
120 ( ( O O
120 15 CD O O
120 ) ) O O
120 torsemide RB O B-m
120 100 CD O B-do
120 p.o NN B-NP B-mo
120 q.a.m NN I-NP B-f
120 , , O O
120 ( ( O O
120 16 CD O O
120 ) ) O O
120 Trusopt $ O B-m
120 1 CD O B-do
120 drop NN B-NP I-do
120 b.i.d NN I-NP B-f
120 , , O O
121 ( ( O O
121 17 CD O O
121 ) ) O O
121 Flonase NNP B-NP B-m
121 nasal JJ B-NP B-mo
121 1-2 JJ I-NP B-do
121 sprays NNS I-NP I-do
121 b.i.d NN I-NP B-f
121 , , O O
121 ( ( O O
121 18 CD O O
121 ) ) O O
121 Xalatan VBD B-VP B-m
121 1 CD O B-do
121 drop NN B-NP I-do
121 ocular NN I-NP B-mo
122 q.h.s NN I-NP B-f
122 , , O O
122 ( ( O O
122 19 CD O O
122 ) ) O O
122 Pulmicort NNP B-NP B-m
122 inhaled VBD B-VP B-mo
122 1 CD O B-do
122 puff NN B-NP I-do
122 b.i.d NN I-NP B-f
122 , , O O
122 ( ( O O
122 20 CD O O
122 ) ) O O
122 Celebrex NNP B-NP B-m
122 100 CD O B-do
122 mg NN B-NP I-do
123 p.o NN I-NP B-mo
123 b.i.d NN I-NP B-f
123 , , O O
123 ( ( O O
123 21 CD O O
123 ) ) O O
123 Avandia NNP B-NP B-m
123 4 CD O B-do
123 mg NN B-NP I-do
123 p.o NN I-NP B-mo
123 q.d NN I-NP B-f
123 , , O O
123 ( ( O O
123 22 CD O O
123 ) ) O O
123 Hyzaar $ O B-m
123 12.5 CD O I-m
123 mg/50 NN B-NP I-m
123 mg NN I-NP I-m
124 1 CD O B-do
124 tablet NN B-NP I-do
124 p.o NN I-NP B-mo
124 q.d NN I-NP B-f
124 , , O O
124 ( ( O O
124 23 CD O O
124 ) ) O O
124 Nexium NN B-NP B-m
124 20 CD O B-do
124 mg NN B-NP I-do
124 p.o NN I-NP B-mo
124 q.d NN I-NP B-f
124 , , O O
124 ( ( O O
124 24 CD O O
124 ) ) O O
124 potassium NN B-NP B-m
125 chloride NN I-NP O
125 20 CD O B-do
125 mEq NN B-NP I-do
125 p.o NN I-NP B-mo
125 b.i.d NN I-NP B-f
125 , , O O
125 ( ( O O
125 25 CD O O
125 ) ) O O
125 Suprax NNP B-NP B-m
125 400 CD O B-do
125 mg NN B-NP I-do
125 p.o NN I-NP B-mo
125 q.d NN I-NP B-f
125 x4 NNP I-NP B-du
125 days NNS I-NP I-du
125 , , O O
126 ( ( O O
126 26 CD O O
126 ) ) O O
126 albuterol NN B-NP B-m
126 inhaled VBD B-VP B-mo
126 2 CD O B-do
126 puffs NNS B-NP I-do
126 q.i.d JJ B-NP B-f
126 p.r.n NN I-NP I-f
126 wheezing NN I-NP B-r
126 , , O O
127 ( ( O O
127 27 CD O O
127 ) ) O O
127 miconazole NN B-NP B-m
127 2% CD O I-m
127 powder NN B-NP I-m
127 applied VBN O O
127 topically RB O B-mo
127 on IN B-VP O
127 skin NN B-NP O
127 b.i.d NN I-NP B-f
127 for IN B-VP O
128 itching VBG O B-r
129 CONDITION NNP B-NP O
129 ON NNP I-NP O
129 DISCHARGE: NNP I-NP O
129 The DT B-NP O
129 patient NN I-NP O
129 is VBZ O O
129 stable JJ O O
129 upon IN B-VP O
129 discharge NN B-NP O
130 DISCHARGE NNP I-NP O
130 DISPOSITION: NNP I-NP O
130 The DT B-NP O
130 patient NN I-NP O
130 is VBZ O O
130 discharged VBN O O
130 to TO O O
130 home NN B-NP O
130 with IN B-VP O
130 the DT O O
131 following VBG O O
131 services: NN B-NP O
131 ( ( O O
131 1 CD O O
131 ) ) O O
131 Visiting VBG O O
131 nurse NN B-NP O
131 on IN B-VP O
132 Wednesday NNP B-NP O
132 , , O O
132 2/11/02 CD O O
132 , , O O
132 who WP O O
132 will MD O O
132 send VB O O
132 blood NN B-NP O
132 for IN B-VP O
132 INR NNP B-NP O
132 and CC O O
132 a DT O O
132 basic JJ O O
133 metabolic JJ O O
133 seven CD O O
133 panel NN B-NP O
133 to TO O O
133 be VB O O
133 sent VBN O O
133 to TO O O
133 Dr NNP B-NP O
133 Silsbee NNP I-NP O
133 , , O O
133 her PRP$ O O
133 primary JJ B-NP O
134 cardiologist NN I-NP O
134 ( ( O O
134 2 CD O O
134 ) ) O O
134 The DT B-NP O
134 patient NN I-NP O
134 has VBZ O O
134 an DT B-NP O
134 appointment NN I-NP O
134 scheduled VBN O O
134 with IN B-VP O
135 Dr NNP B-NP O
135 Sedgwick NNP I-NP O
135 on IN B-VP O
135 0/10/02 CD O O
135 at IN B-VP O
135 4:00 CD O O
135 p.m NN B-NP O
135 , , O O
135 which WDT O O
135 is VBZ O O
135 already RB O O
135 scheduled VBN O O
136 Dictated NNP B-NP O
136 By: NNP I-NP O
136 HUGH NNP I-NP O
136 WRAIGHT NNP I-NP O
136 , , O O
136 M.D NNP B-NP O
136 MT68 NNP I-NP O
137 Attending: NNP I-NP O
137 ROMAN NNP I-NP O
137 B NNP I-NP O
137 ZAPANTA NNP I-NP O
137 , , O O
137 M.D NNP B-NP O
137 WX5 NNP I-NP O
137 GO317/880453 NNP I-NP O
138 Batch: NNP I-NP O
138 73154 CD O O
138 Index NNP B-NP O
138 No NNP I-NP O
138 UWORGB5W18 NNP I-NP O
138 D: NNP I-NP O
138 11/29/02 CD O O
139 T: NNP B-NP O
139 11/29/02 CD O O
140 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #918321 VBZ O O
4 094005161 CD O O
4 WGH NNP B-NP O
4 94426176 CD O O
4 066618 CD O O
4 11/2/1991 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/16/1991 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/13/1991 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 CORONARY NNP I-NP O
7 ARTERY NNP I-NP O
7 DISEASE NNP I-NP O
8 HYPERTENSION NNP I-NP O
9 HYPERCHOLESTEROLEMIA NNP I-NP O
10 PROCEDURES: NNP I-NP O
10 CORONARY NNP I-NP O
10 ARTERY NNP I-NP O
10 BYPASS NNP I-NP O
10 GRAFTING NNP I-NP O
10 TIMES NNP I-NP O
10 THREE NNP I-NP O
11 WITH NNP I-NP O
11 RIGHT NNP I-NP O
11 CORONARY NNP I-NP O
11 ARTERY NNP I-NP O
11 AND NNP I-NP O
11 LEFT NNP I-NP O
11 ANTERIOR NNP I-NP O
12 DESCENDING NNP I-NP O
12 ARTERY NNP I-NP O
12 ENDARTERECTOMY NNP I-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 is VBZ O O
13 a DT B-NP O
13 37-year-old JJ I-NP O
14 gentleman NN I-NP O
14 with IN B-VP O
14 known JJ B-NP O
14 coronary JJ I-NP O
14 artery NN I-NP O
15 disease NN I-NP O
15 admitted VBD B-VP O
15 for IN B-VP O
15 pre-coronary JJ B-NP O
15 artery NN I-NP O
15 bypass NN I-NP O
15 grafting VBG O O
16 evaluation NN B-NP O
16 The DT B-NP O
16 patient's JJ I-NP O
16 cardiac JJ I-NP O
16 history NN I-NP O
16 dates NNS I-NP O
16 back RB O O
16 to TO O O
16 the DT B-NP O
16 fall NN I-NP O
17 of IN B-VP O
17 1989 CD O O
17 when WRB O O
17 the DT B-NP O
17 patient NN I-NP O
17 began VBD B-VP O
17 to TO O O
17 experience VB O O
17 exertional JJ O O
17 angina IN B-VP O
18 The DT B-NP O
18 patient NN I-NP O
18 has VBZ O O
18 been VBN O O
18 followed VBN O O
18 for IN B-VP O
18 his PRP$ O O
18 angina NN B-NP O
18 since IN B-VP O
18 that DT B-NP O
18 time NN I-NP O
19 Currently NNP I-NP O
19 , , O O
19 the DT B-NP O
19 patient NN I-NP O
19 experiences VBZ O O
19 angina RB O O
19 at IN B-VP O
19 the DT B-NP O
19 end NN I-NP O
19 of IN B-VP O
19 most JJS B-NP O
19 work NN I-NP O
20 days NNS I-NP O
20 In IN B-VP O
20 light NN B-NP O
20 of IN B-VP O
20 his PRP$ O O
20 young JJ B-NP O
20 age NN I-NP O
20 , , O O
20 he PRP O O
20 was VBD B-VP O
20 referred VBN O O
20 for IN B-VP O
20 cardiac JJ B-NP O
21 catheterization NN I-NP O
21 and CC O O
21 probable JJ B-NP O
21 coronary JJ I-NP O
21 artery NN I-NP O
21 bypass NN I-NP O
21 grafting VBG O O
22 HOSPITAL NNP B-NP O
22 COURSE: NNP I-NP O
22 The DT B-NP O
22 patient JJ I-NP O
22 underwent JJ I-NP O
22 cardiac JJ I-NP O
22 catheterization NN I-NP O
23 on IN B-VP O
23 8/10/91 CD O O
23 This DT O O
23 showed VBD B-VP O
23 severe JJ B-NP O
23 triple JJ I-NP O
23 vessel NN I-NP O
24 disease NN I-NP O
24 with IN B-VP O
24 an DT O O
24 essentially RB O O
24 normal JJ B-NP O
24 left JJ I-NP O
24 ventricle NN I-NP O
24 Thus NNP I-NP O
24 , , O O
24 the DT B-NP O
25 patient NN I-NP O
25 was VBD B-VP O
25 taken VBN O O
25 to TO O O
25 the DT B-NP O
25 Operating NN I-NP O
25 Room NNP I-NP O
25 on IN B-VP O
25 8/26/91 CD O O
25 Under IN B-VP O
25 general JJ B-NP O
26 endotracheal NN I-NP O
26 anesthesia NN I-NP O
26 , , O O
26 the DT B-NP O
26 patient JJ I-NP O
26 underwent JJ I-NP O
26 coronary JJ I-NP O
26 artery NN I-NP O
27 bypass NN I-NP O
27 grafting VBG O O
27 times NNS B-NP O
27 three CD O O
27 with IN B-VP O
27 bilateral JJ B-NP O
27 internal JJ I-NP O
27 mammary JJ I-NP O
28 arteries NNS I-NP O
28 The DT B-NP O
28 left JJ I-NP O
28 internal JJ I-NP O
28 mammary NN I-NP O
28 was VBD B-VP O
28 taken VBN O O
28 to TO O O
28 the DT O O
28 left VBN O O
28 anterior JJ B-NP O
29 descending NN I-NP O
29 and CC O O
29 the DT B-NP O
29 right JJ I-NP O
29 internal JJ I-NP O
29 mammary JJ I-NP O
29 artery NN I-NP O
29 was VBD B-VP O
29 taken VBN O O
29 to TO O O
29 the DT B-NP O
30 right JJ I-NP O
30 coronary JJ I-NP O
30 artery NN I-NP O
30 The DT B-NP O
30 saphenous JJ I-NP O
30 vein NN I-NP O
30 graft NN I-NP O
30 was VBD B-VP O
30 taken VBN O O
30 to TO O O
30 the DT B-NP O
31 first JJ I-NP O
31 obtuse NN I-NP O
31 marginal JJ B-NP O
31 branch NN I-NP O
31 The DT B-NP O
31 patient NN I-NP O
31 was VBD B-VP O
31 found VBN O O
31 to TO O O
31 have VB O O
32 extremely RB O O
32 pronounced JJ B-NP O
32 atherosclerosis NN I-NP O
32 of IN B-VP O
32 his PRP$ O O
32 coronary JJ B-NP O
32 arteries NNS I-NP O
33 There EX O O
33 were VBD B-VP O
33 no DT B-NP O
33 apparent JJ I-NP O
33 complications NNS I-NP O
33 and CC O O
33 the DT B-NP O
33 patient NN I-NP O
33 was VBD B-VP O
33 taken VBN O O
33 to TO O O
34 the DT B-NP O
34 Intensive NNP I-NP O
34 Care NNP I-NP O
34 Unit NNP I-NP O
34 in IN B-VP O
34 stable JJ B-NP O
34 condition NN I-NP O
34 Postoperatively RB O O
34 , , O O
34 the DT B-NP O
35 patient NN I-NP O
35 had VBD B-VP O
35 an DT O O
35 entirely RB O O
35 smooth JJ B-NP O
35 postoperative JJ I-NP O
35 course NN I-NP O
35 He PRP O O
35 was VBD B-VP O
36 maintained VBN O O
36 on IN B-VP O
36 low JJ B-NP B-m
36 molecular JJ I-NP I-m
36 weight NN I-NP I-m
36 Dextran NNP I-NP I-m
36 for IN B-VP B-du
36 48 CD O I-du
36 hours NNS B-NP I-du
36 for IN B-VP O
36 his PRP$ O B-r
37 endarterectomy NN B-NP O
37 The DT B-NP O
37 patient NN I-NP O
37 was VBD B-VP O
37 started VBN O O
37 on IN B-VP O
37 enteric JJ B-NP B-m
37 enteric NN I-NP B-m
37 coated VBD B-VP I-m
37 coated JJ B-NP I-m
37 aspirin NN I-NP I-m
37 aspirin NN I-NP I-m
38 on IN B-VP O
38 the DT B-NP O
38 first JJ I-NP O
38 day NN I-NP O
38 of IN B-VP O
38 his PRP$ O O
38 operation NN B-NP O
38 The DT B-NP O
38 patient NN I-NP O
38 was VBD B-VP O
38 extubated VBN O O
38 and CC O O
39 all DT O O
39 his PRP$ O O
39 chest NN B-NP O
39 tubes NNS I-NP O
39 and CC O O
39 mediastinal JJ B-NP O
39 tubes NNS I-NP O
39 were VBD B-VP O
39 removed VBN O O
39 The DT B-NP O
40 patient NN I-NP O
40 diuresed VBD B-VP O
40 very RB O O
40 well RB O O
40 and CC O O
40 was VBD B-VP O
40 started VBN O O
40 on IN B-VP O
40 beta NN B-NP B-m
40 blockers NNS I-NP I-m
40 The DT B-NP O
41 patient NN I-NP O
41 remained VBD B-VP O
41 in IN B-VP O
41 normal JJ B-NP O
41 sinus NN I-NP O
41 rhythm NN I-NP O
41 and CC O O
41 sinus JJ B-NP O
41 tachycardia NN I-NP O
41 for IN B-VP O
42 the DT B-NP O
42 entire JJ I-NP O
42 postoperative JJ I-NP O
42 course NN I-NP O
43 DISPOSITION: NNP I-NP O
43 The DT B-NP O
43 patient NN I-NP O
43 was VBD B-VP O
43 discharged VBN O O
43 home NN B-NP O
43 in IN B-VP O
43 stable JJ B-NP O
43 condition NN I-NP O
44 MEDICATIONS: NNP I-NP O
44 On IN B-VP O
44 discharge NN B-NP O
44 included VBD B-VP O
44 Tenormin NNP B-NP B-m
44 , , O O
44 75 CD O B-do
44 mg NN B-NP I-do
45 po NN I-NP B-mo
45 q NN I-NP B-f
45 day; NN I-NP I-f
45 enteric NN I-NP B-m
45 coated VBD B-VP I-m
45 aspirin RB O I-m
45 , , O O
45 one CD O B-do
45 po NN B-NP B-mo
45 q NN I-NP B-f
45 day; NN I-NP I-f
45 Carafate NNP I-NP B-m
45 , , O O
45 1 CD O B-do
45 gram NN B-NP I-do
45 po NN I-NP B-mo
46 q.i.d.; NN I-NP B-f
46 iron NN I-NP B-m
46 sulfate NN I-NP I-m
46 , , O O
46 325 CD O B-do
46 mg NN B-NP I-do
46 po NN I-NP B-mo
46 q NN I-NP B-f
46 day; NN I-NP I-f
46 Percocet NNP I-NP B-m
46 and CC O O
46 Colace NNP B-NP B-m
47 UI094/9465 NNP I-NP O
48 DORIAN NNP I-NP O
48 L NNP I-NP O
48 DUNAY NNP I-NP O
48 , , O O
48 M.D NNP B-NP O
48 DF5 NNP I-NP O
48 D: NNP I-NP O
48 5/9/91 CD O O
49 Batch: NNP B-NP O
49 5818 CD O O
49 Report: NNP B-NP O
49 M8839A4 NNP I-NP O
49 T: NNP I-NP O
49 7/19/91 CD O O
50 Dictated NNP B-NP O
50 By: NNP I-NP O
50 REED NNP I-NP O
50 KIZZIE NNP I-NP O
50 , , O O
50 M.D NNP B-NP O
50 VS71 NNP I-NP O
51 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #919745 VBZ O O
2 144441147 CD O O
2 PVNMH NNP B-NP O
2 55286769 CD O O
2 8657724 CD O O
2 1/30/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Left NNP I-NP O
2 globus NN I-NP O
2 pallidus NN I-NP O
2 hemorrhage NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/30/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/18/2005 CD O O
4 ****** NNP B-NP O
4 INCOMPLETE NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 MOLANO NNP I-NP O
5 , , O O
5 PALMER NNP B-NP O
5 296-21-40-4 CD O O
6 Ton NNP B-NP O
6 Blo NNP I-NP O
6 Day NNP I-NP O
7 Service: NNP I-NP O
7 NEU NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 0/18/05 CD O O
8 AT NNP B-NP O
8 03:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 SNF/rehab NNP I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 SLEIGHT NNP I-NP O
11 , , O O
11 SAMUEL NNP B-NP O
11 ORVAL NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 Incomplete NNP I-NP O
14 Discharge NNP I-NP O
15 DISPOSITION: NNP I-NP O
15 Rehabilitation NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 COLACE NNP I-NP B-m
17 ( ( O I-m
17 DOCUSATE NNP B-NP I-m
17 SODIUM NNP I-NP I-m
17 ) ) O I-m
17 100 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 BID NNP I-NP B-f
18 LASIX NNP I-NP B-m
18 ( ( O I-m
18 FUROSEMIDE NNP B-NP I-m
18 ) ) O I-m
18 20 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 HYDRALAZINE NNP I-NP B-m
19 HCL NNP I-NP I-m
19 10 CD O B-do
19 MG NNP B-NP I-do
19 IV NNP I-NP B-mo
19 Q6H NNP I-NP B-f
19 PRN NNP I-NP I-f
19 Other:SBP&gt;160mmHg NNP I-NP O
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 INSULIN NNP I-NP B-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 REGULAR NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
20 HUMAN NNP I-NP I-m
21 Sliding VBG O B-do
21 Sliding VBG O B-do
21 Sliding VBG O B-do
21 Scale NNP B-NP I-do
21 Scale NNP I-NP I-do
21 Scale NNP I-NP I-do
21 ( ( O B-mo
21 ( ( O B-mo
21 subcutaneously RB O I-mo
21 subcutaneously RB O I-mo
21 ) ) O I-mo
21 ) ) O I-mo
21 SC NNP B-NP I-mo
21 SC NNP I-NP I-mo
21 qAC NN I-NP B-f
21 , , O O
21 qHS RB O B-f
21 qHS JJ O B-f
22 If IN B-VP O
22 BS NNP B-NP O
22 is VBZ O O
22 less JJR O O
22 than IN B-VP O
22 125 CD O O
22 , , O O
22 then RB O O
22 give VB O O
22 0 CD O B-do
22 units NNS B-NP I-do
22 subcutaneously RB O B-mo
23 If IN B-VP O
23 BS NNP B-NP O
23 is VBZ O O
23 125-150 JJ O O
23 , , O O
23 then RB O O
23 give VB O O
23 2 CD O B-do
23 units NNS B-NP I-do
23 subcutaneously RB O B-mo
24 If IN B-VP O
24 BS NNP B-NP O
24 is VBZ O O
24 151-200 CD O O
24 , , O O
24 then RB O O
24 give VB O O
24 3 CD O B-do
24 units NNS B-NP I-do
24 subcutaneously RB O B-mo
25 If IN B-VP O
25 BS NNP B-NP O
25 is VBZ O O
25 201-250 JJ O O
25 , , O O
25 then RB O O
25 give VB O O
25 4 CD O B-do
25 units NNS B-NP I-do
25 subcutaneously RB O B-mo
26 If IN B-VP O
26 BS NNP B-NP O
26 is VBZ O O
26 251-300 JJ O O
26 , , O O
26 then RB O O
26 give VB O O
26 6 CD O B-do
26 units NNS B-NP I-do
26 subcutaneously RB O B-mo
27 If IN B-VP O
27 BS NNP B-NP O
27 is VBZ O O
27 301-350 JJ O O
27 , , O O
27 then RB O O
27 give VB O O
27 8 CD O B-do
27 units NNS B-NP I-do
27 subcutaneously RB O B-mo
28 If IN B-VP O
28 BS NNP B-NP O
28 is VBZ O O
28 351-400 CD O O
28 , , O O
28 then RB O O
28 give VB O O
28 10 CD O B-do
28 units NNS B-NP I-do
28 subcutaneously RB O B-mo
28 and CC O O
29 call VB O O
29 HO NNP B-NP O
29 Call NNP I-NP O
29 HO NNP I-NP O
29 if IN B-VP O
29 BS NNP B-NP O
29 is VBZ O O
29 greater JJR O O
29 than IN B-VP O
29 400 CD O O
30 LISINOPRIL NNP B-NP B-m
30 20 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 QD NNP I-NP B-f
31 MAGNESIUM NNP I-NP B-m
31 GLUCONATE NNP I-NP I-m
31 500 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 BID NNP I-NP B-f
32 MILK NNP I-NP B-m
32 OF NNP I-NP I-m
32 MAGNESIA NNP I-NP I-m
32 ( ( O I-m
32 MAGNESIUM NNP B-NP I-m
32 HYDROXIDE NNP I-NP I-m
32 ) ) O I-m
33 30 CD O B-do
33 MILLILITERS NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
33 PRN NNP I-NP I-f
33 Constipation NNP I-NP B-r
34 METOPROLOL NNP I-NP B-m
34 TARTRATE NNP I-NP I-m
34 25 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 TID NNP I-NP B-f
34 Starting NNP I-NP O
34 IN NNP I-NP O
34 PM NNP I-NP O
34 on IN B-VP O
34 0/17 CD O O
35 Food/Drug NNP B-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
36 Take NNP I-NP O
36 consistently RB O O
36 with IN B-VP O
36 meals NNS B-NP O
36 or CC O O
36 on IN B-VP O
36 empty JJ B-NP O
36 stomach NN I-NP O
37 XALATAN NNP I-NP B-m
37 ( ( O I-m
37 LATANOPROST NNP B-NP I-m
37 ) ) O I-m
37 1 CD O B-do
37 DROP NNP B-NP I-do
37 OU NNP I-NP B-mo
37 QPM NNP I-NP B-f
38 Number NNP I-NP B-du
38 of IN B-VP I-du
38 Doses NNP B-NP I-du
38 Required NNP I-NP I-du
38 ( ( O I-du
38 approximate JJ B-NP I-du
38 ): NN I-NP I-du
38 10 CD O I-du
39 FLOMAX NNP B-NP B-m
39 ( ( O I-m
39 TAMSULOSIN NNP B-NP I-m
39 ) ) O I-m
39 0.4 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 QD NNP I-NP B-f
40 NEXIUM NNP I-NP B-m
40 ( ( O I-m
40 ESOMEPRAZOLE NNP B-NP I-m
40 ) ) O I-m
40 20 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 DIET: NNP I-NP O
41 House NNP I-NP O
41 / VBD B-VP O
41 Low NNP B-NP O
41 chol/low NN I-NP O
41 sat VBD B-VP O
41 fat JJ B-NP O
42 ACTIVITY: NNP I-NP O
42 Walking NNP I-NP O
42 as IN B-VP O
42 tolerated VBN O O
43 FOLLOW NNP B-NP O
43 UP NNP I-NP O
43 APPOINTMENT( NNP I-NP O
43 S NNP I-NP O
43 ): NNP I-NP O
44 Marshall NNP I-NP O
44 Dewilde NNP I-NP O
44 ( ( O O
44 PCP NNP B-NP O
44 ) ) O O
44 Next NNP B-NP O
44 Available NNP I-NP O
44 , , O O
45 Willie NNP B-NP O
45 Milbrath NNP I-NP O
45 ( ( O O
45 Neurology NNP B-NP O
45 ) ) O O
45 358-579-5885 CD O O
45 Next NNP B-NP O
45 Available NNP I-NP O
45 , , O O
46 ALLERGY: NNP B-NP O
46 NKA NNP I-NP O
47 ADMIT NNP I-NP O
47 DIAGNOSIS: NNP I-NP O
48 Left NNP I-NP O
48 globus NN I-NP O
48 pallidus NN I-NP O
48 hemorrhage NN I-NP O
49 PRINCIPAL NNP I-NP O
49 DISCHARGE NNP I-NP O
49 DIAGNOSIS NNP I-NP O
49 ;Responsible JJ O O
49 After IN B-VP O
49 Study NNP B-NP O
49 for IN B-VP O
49 Causing NNP B-NP O
49 Admission NNP I-NP O
49 ) ) O O
50 Left VBD B-VP O
50 globus JJ B-NP O
50 pallidus NN I-NP O
50 hemorrhage NN I-NP O
51 OTHER NNP I-NP O
51 DIAGNOSIS;Conditions NNP I-NP O
51 , , O O
51 Infections NNP B-NP O
51 , , O O
51 Complications NNP B-NP O
51 , , O O
51 affecting VBG O O
51 Treatment/Stay NNP B-NP O
52 aortic JJ B-NP O
52 stenosis NN I-NP O
52 heart NN I-NP O
52 block NN I-NP O
52 w/ppm VBD B-VP O
52 atrial JJ B-NP O
52 fibrillation NN I-NP O
52 diabetes VBZ O O
52 gout IN B-VP O
52 CAD NNP B-NP O
53 BPH NNP I-NP O
53 gout NN I-NP O
54 OPERATIONS NNP I-NP O
54 AND NNP I-NP O
54 PROCEDURES: NNP I-NP O
55 OTHER NNP I-NP O
55 TREATMENTS/PROCEDURES NNP I-NP O
55 ( ( O O
55 NOT NNP B-NP O
55 IN NNP I-NP O
55 O.R NNP I-NP O
55 ) ) O O
56 CT NNP B-NP O
56 scan NN I-NP O
56 of IN B-VP O
56 brain NN B-NP O
57 CXR NNP I-NP O
58 EKG NNP I-NP O
59 BRIEF NNP I-NP O
59 RESUME NNP I-NP O
59 OF NNP I-NP O
59 HOSPITAL NNP I-NP O
59 COURSE: NNP I-NP O
60 HPI: NNP I-NP O
61 82 CD O O
61 yo NN B-NP O
61 RHM NNP I-NP O
61 with IN B-VP O
61 h/o NN B-NP O
61 HTN NNP I-NP O
61 , , O O
61 DM-2 NNP B-NP O
61 , , O O
61 CAD NNP B-NP O
61 and CC O O
61 AVR NNP B-NP O
61 ( ( O O
61 on IN B-VP O
61 coumadin NN B-NP B-m
61 until IN B-VP B-du
61 3/29 CD O I-du
61 ) ) O O
62 was VBD B-VP O
62 last JJ O O
62 seen VBN O O
62 normal JJ O O
62 when WRB O O
62 went VBD B-VP O
62 to TO O O
62 nap VB O O
62 this DT B-NP O
62 afternoon NN I-NP O
62 at IN B-VP O
62 12:45pm CD O O
62 At IN B-VP O
63 2:30pm CD O O
63 he PRP O O
63 woke VBD B-VP O
63 up RP O O
63 somewhat RB O O
63 confused JJ O O
63 with IN B-VP O
63 slurred JJ B-NP O
63 speech NN I-NP O
63 , , O O
63 mild JJ B-NP O
63 RUE NNP I-NP O
64 weakness NN I-NP O
64 Initial NNP I-NP O
64 vitals NNS I-NP O
64 148/80 CD O O
64 , , O O
64 p-62 JJ B-NP O
64 sent NN I-NP O
64 to TO O O
64 FH NNP B-NP O
64 where WRB O O
64 coags NN B-NP O
64 and CC O O
65 platelets NNS B-NP O
65 WNL NNP I-NP O
65 , , O O
65 head NN B-NP O
65 CT NNP I-NP O
65 showed VBD B-VP O
65 right JJ B-NP O
65 thalamic NNS I-NP O
65 bleed VBD B-VP O
65 with IN B-VP O
65 3rd CD O O
65 ventricle NN B-NP O
66 extension NN I-NP O
67 Received NNP I-NP O
67 Mannitol NNP I-NP B-m
67 -&gt; NNP I-NP O
67 referred VBD B-VP O
67 to TO O O
67 WTSMC NNP B-NP O
67 ER NNP I-NP O
67 for IN B-VP O
67 further JJ B-NP O
67 w/u NN I-NP O
68 PMH: NNP I-NP O
69 Aortic NNP I-NP O
69 valve NN I-NP O
69 stenosis NN I-NP O
69 -s/p NNP I-NP O
69 AVR NNP I-NP O
69 + NNP I-NP O
69 CABG NNP I-NP O
69 , , O O
69 with IN B-VP O
69 #25 JJ B-NP O
69 CE-MAGNA NNP I-NP O
69 PERICARDIAL NNP I-NP O
70 BIOPROSTHESIS NNP I-NP O
71 AVB NNP I-NP O
71 s/p NN I-NP O
71 Pacemaker NNP I-NP O
71 placement NN I-NP O
71 ( ( O O
71 and CC O O
71 a-fib JJ B-NP O
71 focus NN I-NP O
71 ablation NN I-NP O
71 ) ) O O
72 DM-2 NNP B-NP O
72 complicated VBN O O
72 by IN B-VP O
72 neuropathy JJ O O
72 and CC O O
72 nephropathy JJ B-NP O
73 Gout NNP I-NP O
74 Glaucoma NNP I-NP O
75 CHF: NNP I-NP O
75 last JJ B-NP O
75 EF: NNP I-NP O
75 55% CD O O
76 S/P NNP B-NP O
76 right RB O O
76 3rd CD O O
76 toe NN B-NP O
76 amp NN I-NP O
76 and CC O O
76 s/p NN B-NP O
76 left VBD B-VP O
76 2nd CD O O
76 tow NN B-NP O
76 amp NN I-NP O
77 MEDS: NNP I-NP O
78 BRIMONIDINE NNP I-NP B-m
78 0.2% CD O I-m
78 BID NNP B-NP B-f
79 LASIX NNP I-NP B-m
79 20 CD O B-do
79 PO NNP B-NP B-mo
79 QD NNP I-NP B-f
80 XALATAN NNP I-NP B-m
80 0.005 CD O B-do
80 OU NNP B-NP B-mo
80 QHS NNP I-NP B-f
81 GLIPIZIDE NNP I-NP B-m
81 10MG CD O B-do
81 PO NNP B-NP B-mo
81 QD NNP I-NP B-f
82 NEXIUM NNP I-NP B-m
82 20MG CD O B-do
82 PO NNP B-NP B-mo
82 QD NNP I-NP B-f
83 FLOMAX NNP I-NP B-m
83 0.4 CD O B-do
83 QD NNP B-NP B-f
84 ZOCOR NNP I-NP B-m
84 20MG CD O B-do
84 QD NNP B-NP B-f
85 METOPROLOL NNP I-NP B-m
85 50MG CD O B-do
85 QD NNP B-NP B-f
86 METFORMIN NNP I-NP B-m
86 1000MG CD O B-do
86 BID NNP B-NP B-f
87 LISINOPRIL NNP I-NP B-m
87 10MG CD O B-do
87 QD NNP B-NP B-f
88 NIFEREX NNP I-NP B-m
88 150 CD O B-do
88 BID NNP B-NP B-f
89 ASA NNP I-NP B-m
89 81 CD O B-do
89 PO NNP B-NP B-mo
89 QD NNP I-NP B-f
90 Coumadin: NNP I-NP B-m
90 by IN B-VP O
90 report NN B-NP O
90 held VBD B-VP O
90 since IN B-VP O
90 3/29 CD O O
90 , , O O
90 for IN B-VP O
90 unclear JJ B-NP O
90 reason NN I-NP O
91 ALL: NNP I-NP O
92 Sulfa NNP I-NP O
92 , , O O
92 amoxicillin NN B-NP O
92 , , O O
92 azithro: JJ B-NP O
92 unclear JJ I-NP O
92 reactions NNS I-NP O
93 SH: NNP I-NP O
94 Lives VBZ O O
94 with IN B-VP O
94 his PRP$ O O
94 wife NN B-NP O
94 , , O O
94 retired VBN O O
94 from IN B-VP O
94 a DT B-NP O
94 phone NN I-NP O
94 company NN I-NP O
94 Remote NNP I-NP O
94 ( ( O O
94 45y CD O O
94 ago RB O O
94 ) ) O O
95 history NN B-NP O
95 of IN B-VP O
95 smoking NN B-NP O
95 , , O O
95 raer NN B-NP O
95 etoh NN I-NP O
96 ROS: NNP I-NP O
96 denied VBD B-VP O
96 diplopia NN B-NP O
96 , , O O
96 numbness NN B-NP O
96 of IN B-VP O
96 face NN B-NP O
96 , , O O
96 vertigo/tinnitus NN B-NP O
96 , , O O
96 dysphagia NN B-NP O
96 or CC O O
97 dysarthria NN B-NP O
97 ( ( O O
97 prior JJ O O
97 to TO O O
97 this DT B-NP O
97 event NN I-NP O
97 ) ) O O
97 , , O O
97 HA NNP B-NP O
97 F/C/N/V NNP I-NP O
97 , , O O
97 CP/pressure NNP B-NP O
97 , , O O
97 heartburn NN B-NP O
97 , , O O
98 constipation NN B-NP O
98 , , O O
98 diarrhea NN B-NP O
98 , , O O
98 dysuria NN B-NP O
98 , , O O
98 rashes NNS B-NP O
98 , , O O
98 joint JJ B-NP O
98 aches NNS I-NP O
98 Reports NNPS I-NP O
98 occasional JJ B-NP O
99 SOB NNP I-NP O
99 even RB O O
99 in IN B-VP O
99 mild JJ B-NP O
99 effort NN I-NP O
100 EXAM NNP I-NP O
101 VS: NNP I-NP O
101 T: NNP I-NP O
101 afebrile IN B-VP O
101 BP: NNP B-NP O
101 145/64 CD O O
101 P: NNP B-NP O
101 60 CD O O
101 RR: NNP B-NP O
101 18 CD O O
101 O2 NNP B-NP O
101 sat: VBD B-VP O
101 97%r.a CD O O
102 General: NNP B-NP O
102 WNWD NNP I-NP O
102 , , O O
102 NAD NNP B-NP O
103 HEENT: NNP I-NP O
103 Anicteric NNP I-NP O
103 , , O O
103 MMM NNP B-NP O
103 without IN B-VP O
103 lesions NNS B-NP O
103 , , O O
103 OP NNP B-NP O
103 clear JJ B-NP O
104 Neck: NNP I-NP O
104 Supple NNP I-NP O
104 , , O O
104 No NNP B-NP O
104 LAD NNP I-NP O
105 CV: NNP I-NP O
105 s1s2 NN I-NP O
105 paced VBD B-VP O
105 , , O O
105 pronounce NN B-NP O
105 S2 NNP I-NP O
105 , , O O
105 3/6 CD O O
105 systolic JJ B-NP O
105 murmur NN I-NP O
105 , , O O
105 2/6 CD O O
106 diastolic JJ B-NP O
107 Resp: NNP I-NP O
107 CTAB NNP I-NP O
108 Abd: NNP I-NP O
108 +BS NNP I-NP O
108 Soft/NT/ND NNP I-NP O
109 Ext: NNP I-NP O
109 No NNP I-NP O
109 C/C/E NNP I-NP O
109 , , O O
109 s/p NN B-NP O
109 above IN B-VP O
109 amputation NN B-NP O
110 MS: NNP I-NP O
110 Awake NNP I-NP O
110 and CC O O
110 alert NN B-NP O
110 , , O O
110 oriented VBN O O
110 to TO O O
110 date NN B-NP O
110 , , O O
110 place NN B-NP O
110 and CC O O
110 self NN B-NP O
111 Attention: NNP I-NP O
111 DOW NNP I-NP O
111 backwards NNS I-NP O
112 Memory: NNP I-NP O
112 registration NN I-NP O
112 3/3 CD O O
112 , , O O
112 recall NN B-NP O
112 2/3 CD O O
112 at IN B-VP O
112 5 CD O O
112 min NNS B-NP O
112 3/3 CD O O
112 with IN B-VP O
113 prompting VBG O O
114 Language: NNP B-NP O
114 fluent NN I-NP O
114 , , O O
114 +comprehension NN B-NP O
114 , , O O
114 +repetition NN B-NP O
114 , , O O
114 +naming VBG O O
114 intact JJ O O
114 , , O O
115 Nondominant: NNP B-NP O
115 no DT B-NP O
115 neglect NN I-NP O
115 to TO O O
115 DSS NNP B-NP O
115 , , O O
115 able JJ O O
115 to TO O O
115 salute/brush VB O O
115 teeth NNS B-NP O
115 , , O O
116 CN: NNP B-NP O
116 II NNP I-NP O
116 , , O O
116 III NNP B-NP O
116 - : O O
116 pupils VBZ O O
116 3 CD O O
116 ` `` O O
116 2 CD O O
116 bilaterally RB O O
116 , , O O
116 VFF NNP B-NP O
116 by IN B-VP O
116 confrontation; NN B-NP O
117 III NNP I-NP O
117 , , O O
117 IV NNP B-NP O
117 , , O O
117 VI NNP B-NP O
117 - : O O
117 EOMI NNP B-NP O
117 , , O O
117 no DT B-NP O
117 ptosis NN I-NP O
117 , , O O
117 no DT B-NP O
117 nystagmus; JJ I-NP O
118 V- NNP I-NP O
118 sensation NN I-NP O
118 intact NN I-NP O
118 to TO O O
118 LT/PP NNP B-NP O
118 , , O O
118 corneal NN B-NP O
118 reflex JJ B-NP O
118 intact; NN I-NP O
119 VII NNP I-NP O
119 - : O O
119 mild NN B-NP O
119 right JJ B-NP O
119 facial JJ I-NP O
119 weakness NN I-NP O
120 VIII NNP I-NP O
120 - : O O
120 hears NNS B-NP O
120 finger VBP O O
120 rub VB O O
121 IX NNP B-NP O
121 , , O O
121 X NNP B-NP O
121 - : O O
121 voice NN B-NP O
121 dysarthric NN I-NP O
121 , , O O
121 palate NN B-NP O
121 elevates NNS I-NP O
121 symmetrically RB O O
121 , , O O
121 gag JJ B-NP O
121 intact; NN I-NP O
122 XI NNP I-NP O
122 - : O O
122 SCM/Trapezii NN B-NP O
122 5/5 CD O O
122 B NNP B-NP O
123 XII NNP I-NP O
123 - : O O
123 tongue NN B-NP O
123 protrudes NNS I-NP O
123 midline VBP O O
124 Motor: NNP B-NP O
124 Right NNP I-NP O
124 pronator NN I-NP O
124 drift NN I-NP O
124 No NNP I-NP O
124 asterixis NN I-NP O
124 nl RB O O
124 bulk NN B-NP O
124 and CC O O
124 tone NN B-NP O
124 , , O O
124 no DT B-NP O
125 tremor NN I-NP O
125 , , O O
125 rigidity NN B-NP O
125 or CC O O
125 bradykinesia NN B-NP O
126 Strength: NNP I-NP O
127 ShFl NNP I-NP O
127 ElFl NNP I-NP O
127 ElEx NNP I-NP O
127 WrFl NNP I-NP O
127 WrEx NNP I-NP O
127 FgSp NNP I-NP O
127 HpFl NNP I-NP O
127 KnEx NNP I-NP O
127 KnFl NNP I-NP O
127 Dors NNP I-NP O
127 Plan NNP I-NP O
128 R NNP I-NP O
128 4 CD O O
128 4+ CD O O
128 4+ CD O O
128 5 CD O O
128 4+ CD O O
128 5 CD O O
128 5 CD O O
128 5 CD O O
128 5 CD O O
128 5 CD O O
128 5 CD O O
129 L NNP B-NP O
129 5 CD O O
129 5 CD O O
129 5 CD O O
129 5 CD O O
129 5 CD O O
129 5 CD O O
129 5 CD O O
129 5 CD O O
129 5 CD O O
129 5 CD O O
129 5 CD O O
130 DTRs:Bi NNP B-NP O
130 ( ( O O
130 C56 NNP B-NP O
130 )BR NNP I-NP O
130 ( ( O O
130 C6 NNP B-NP O
130 )Tri NNP I-NP O
130 ( ( O O
130 C7 NNP B-NP O
130 )Pa NNP I-NP O
130 ( ( O O
130 L34 NNP B-NP O
130 )Ac NNP I-NP O
130 ( ( O O
130 S12 NNP B-NP O
130 )Plantar NNP I-NP O
131 L2 NNP I-NP O
131 2 CD O O
131 2 CD O O
131 1 CD O O
131 0 CD O O
131 amputated VBD B-VP O
132 R1 NNP B-NP O
132 1 CD O O
132 1 CD O O
132 1 CD O O
132 0 CD O O
132 up RB O O
133 Sensory: NNP B-NP O
133 significant JJ O O
133 for IN B-VP O
133 decreased JJ B-NP O
133 LT NNP I-NP O
133 , , O O
133 temperature NN B-NP O
133 , , O O
133 vibration NN B-NP O
134 distally RB O O
134 up IN B-VP O
134 to TO O O
134 knees NNS B-NP O
135 Coord: NNP I-NP O
135 finger NN I-NP O
135 tap NN I-NP O
135 rapid JJ B-NP O
135 &amp; NNP I-NP O
135 symm NN I-NP O
135 , , O O
135 FNF NNP B-NP O
135 &amp; NNP I-NP O
135 finger NN I-NP O
135 follow VB O O
135 intact JJ O O
135 ( ( O O
135 for IN B-VP O
136 weakness NN B-NP O
136 ) ) O O
136 foot NN B-NP O
136 tap NN I-NP O
136 rapid JJ B-NP O
136 &amp; NNP I-NP O
136 symm NN I-NP O
137 Gait: NNP I-NP O
137 deferred VBD B-VP O
138 LABS: NNP B-NP O
139 SODIUM NNP I-NP O
139 141 CD O O
139 ( ( O O
139 136-142 JJ O O
139 ) ) O O
140 mmol/L NN B-NP O
141 POTASSIUM $ O O
141 4.7 CD O O
141 ( ( O O
141 3.5-5.0 CD O O
141 ) ) O O
142 mmol/L NN B-NP O
143 CHLORIDE NNP I-NP O
143 103 CD O O
143 ( ( O O
143 98-108 CD O O
143 ) ) O O
144 mmol/L NN B-NP O
145 TOTAL NNP I-NP O
145 CO2 NNP I-NP O
145 29 CD O O
145 ( ( O O
145 23-32 JJ O O
145 ) ) O O
146 mmol/L FW O O
147 ANION NNP B-NP O
147 GAP NNP I-NP O
147 9 CD O O
147 ( ( O O
147 3-15 CD O O
147 ) ) O O
148 mmol/L NN B-NP O
149 CK NNP I-NP O
149 33 CD O O
149 * NNP B-NP O
149 ( ( O O
149 41-266 JJ O O
149 ) ) O O
150 U/L NNP B-NP O
151 CKMB NNP I-NP O
151 QUANT NNP I-NP O
151 1.7 CD O O
151 # # O O
151 ( ( O O
151 0.0-5.0 JJ O O
151 ) ) O O
152 ng/mL FW O O
153 CALCIUM $ O O
153 9.0 CD O O
153 ( ( O O
153 8.8-10.5 CD O O
153 ) ) O O
154 mg/dL NN B-NP O
155 MAGNESIUM NNP I-NP O
155 1.6 CD O O
155 * NNP B-NP O
155 ( ( O O
155 1.8-2.5 JJ O O
155 ) ) O O
156 mg/dL VBZ O O
157 cTn-I JJ B-NP O
157 See NNP I-NP O
157 Result NNP I-NP O
157 Below NNP I-NP O
157 ( ( O O
157 0.00-0.10 JJ O O
157 ) ) O O
158 ng/mL VBP O O
159 GLUCOSE $ O O
159 130 CD O O
159 * NNP B-NP O
159 ( ( O O
159 54-118 JJ O O
159 ) ) O O
160 mg/dL FW O O
161 UREA NNP B-NP O
161 N NNP I-NP O
161 20 CD O O
161 ( ( O O
161 9-25 CD O O
161 ) ) O O
162 mg/dL NN B-NP O
163 CREATININE NNP I-NP O
163 0.9 CD O O
163 ( ( O O
163 0.7-1.3 NN B-NP O
163 ) ) O O
164 mg/dL NN B-NP O
165 eGFR $ O O
165 86 CD O O
166 WBC NNP B-NP O
166 7.83 CD O O
166 ( ( O O
166 4-10 JJ O O
166 ) ) O O
167 K/uL NNP B-NP O
168 RBC NNP I-NP O
168 4.15 CD O O
168 * NNP B-NP O
168 ( ( O O
168 4.5-6.4 JJ O O
168 ) ) O O
169 M/uL NNP B-NP O
170 HGB NNP I-NP O
170 11.9 CD O O
170 * NNP B-NP O
170 ( ( O O
170 13.5-18.0 JJ O O
170 ) ) O O
171 g/dL NN B-NP O
172 HCT $ O O
172 35.5 CD O O
172 *# NNP B-NP O
172 ( ( O O
172 40-54 JJ O O
172 ) ) O O
173 % NN B-NP O
174 MCV NNP I-NP O
174 85.6 CD O O
174 # # O O
174 ( ( O O
174 80-95 JJ O O
174 ) ) O O
175 um3 JJ B-NP O
176 MCH NNP I-NP O
176 28.7 CD O O
176 ( ( O O
176 27-32 JJ O O
176 ) ) O O
177 uug JJ B-NP O
178 MCHC NNP I-NP O
178 33.6 CD O O
178 ( ( O O
178 32-36 CD O O
178 ) ) O O
179 g/dL NN B-NP O
180 RDW $ O O
180 13.9 CD O O
180 ( ( O O
180 10-14.5 JJ O O
180 ) ) O O
181 PLT NNP B-NP O
181 215 CD O O
181 # # O O
181 ( ( O O
181 150-450 JJ O O
181 ) ) O O
182 K/uL NNP B-NP O
183 LYMP NNP I-NP O
183 % NN I-NP O
183 24.2 CD O O
183 ( ( O O
183 18-41 JJ O O
183 ) ) O O
184 MONO NNP B-NP O
184 % NN I-NP O
184 6.7 CD O O
184 ( ( O O
184 2.5-8.5 JJ O O
184 ) ) O O
185 NEUT NNP B-NP O
185 % NN I-NP O
185 65.9 CD O O
185 ( ( O O
185 48-76 JJ O O
185 ) ) O O
186 EOS NNP B-NP O
186 % NN I-NP O
186 2.6 CD O O
186 ( ( O O
186 0-5 NN B-NP O
186 ) ) O O
187 BASO NNP B-NP O
187 % NN I-NP O
187 0.6 CD O O
187 ( ( O O
187 0-1.5 NN B-NP O
187 ) ) O O
188 LYMP NNP B-NP O
188 # # O O
188 1.89 CD O O
188 ( ( O O
188 0.8-4.1 NN B-NP O
188 ) ) O O
189 K/uL NNP B-NP O
190 MONO NNP I-NP O
190 # # O O
190 0.52 CD O O
190 ( ( O O
190 .10-0.8 JJ O O
190 ) ) O O
191 K/uL NNP B-NP O
192 NEUT NNP I-NP O
192 # # O O
192 5.16 CD O O
192 ( ( O O
192 1.9-7.6 JJ O O
192 ) ) O O
193 K/uL NNP B-NP O
194 EOS NNP I-NP O
194 # # O O
194 0.21 CD O O
194 ( ( O O
194 0-0.5 NN B-NP O
194 ) ) O O
195 K/uL NNP B-NP O
196 BASO NNP I-NP O
196 # # O O
196 0.04 CD O O
196 ( ( O O
196 0.00-0.15 NN B-NP O
196 ) ) O O
197 K/uL NNP B-NP O
198 PT NNP I-NP O
198 14.3 CD O O
198 # # O O
198 ( ( O O
198 11.8-14.6 JJ O O
198 ) ) O O
199 sec NN B-NP O
200 PTT NNP I-NP O
200 29.2 CD O O
200 # # O O
200 ( ( O O
200 23.8-36.6 JJ O O
200 ) ) O O
201 sec NN B-NP O
202 PT( NNP I-NP O
202 INR NNP I-NP O
202 ) ) O O
202 1.1 CD O O
202 ( ( O O
202 0.9-1.1 NN B-NP O
202 ) ) O O
203 CT NNP B-NP O
203 I-: NNP I-NP O
204 Small NNP I-NP O
204 left VBD B-VP O
204 putamminal JJ B-NP O
204 bleed NN I-NP O
204 extending VBG O O
204 above IN B-VP O
204 l-thalamus NN B-NP O
204 Small NNP I-NP O
204 amount NN I-NP O
204 of IN B-VP O
205 blood NN B-NP O
205 in IN B-VP O
205 left JJ B-NP O
205 occipital JJ I-NP O
205 horn NN I-NP O
205 Stable NNP I-NP O
205 compared VBN O O
205 to TO O O
205 CT NNP B-NP O
205 at IN B-VP O
205 SMC NNP B-NP O
206 A/P: NNP I-NP O
207 82 CD O O
207 yo NN B-NP O
207 RHM NNP I-NP O
207 with IN B-VP O
207 h/o NN B-NP O
207 HTN NNP I-NP O
207 , , O O
207 DM-2 NNP B-NP O
207 , , O O
207 CAD NNP B-NP O
207 and CC O O
207 AVR NNP B-NP O
207 ( ( O O
207 on IN B-VP O
207 coumadin NN B-NP B-m
207 until IN B-VP B-du
207 3/29 CD O I-du
207 ) ) O O
208 was VBD B-VP O
208 last JJ O O
208 seen VBN O O
208 normal JJ O O
208 when WRB O O
208 went VBD B-VP O
208 to TO O O
208 nap VB O O
208 this DT B-NP O
208 afternoon NN I-NP O
208 at IN B-VP O
208 12:45pm CD O O
208 At IN B-VP O
209 2:30pm CD O O
209 woke VBD B-VP O
209 up RB O O
209 dysarthric JJ O O
209 , , O O
209 mild JJ B-NP O
209 RUE NNP I-NP O
209 weakness NN I-NP O
209 His PRP$ O O
209 wife NN B-NP O
209 noticed VBD B-VP O
209 slowing VBG O O
210 and CC O O
210 confusion NN B-NP O
210 Head NNP I-NP O
210 CT NNP I-NP O
210 at IN B-VP O
210 BMC NNP B-NP O
210 ( ( O O
210 repeated VBN O O
210 here RB O O
210 ) ) O O
210 showed VBD B-VP O
210 small JJ O O
210 left VBD B-VP O
210 BG NNP B-NP O
210 bleed NN I-NP O
210 , , O O
211 extending VBG O O
211 to TO O O
211 left JJ O O
211 lateral JJ O O
211 ( ( O O
211 occipital JJ B-NP O
211 horn NN I-NP O
211 ) ) O O
211 Given NNP B-NP O
211 location NN I-NP O
211 , , O O
211 most RBS O O
211 likely JJ B-NP O
212 hypertensive JJ I-NP O
212 bleed NN I-NP O
212 Cannot NNP I-NP O
212 rule NN I-NP O
212 out IN B-VP O
212 underlying VBG O O
212 small JJ B-NP O
212 stroke NN I-NP O
212 Given NNP I-NP O
212 h/o NN I-NP O
213 AVR NNP I-NP O
213 will MD O O
213 r/o VB O O
213 endocarditis NN B-NP O
213 as RB O O
213 well RB O O
213 Plan NNP B-NP O
214 1 CD O O
214 admit NN B-NP O
214 to TO O O
214 NICU NNP B-NP O
214 When WRB O O
214 transfer NN B-NP O
214 to TO O O
214 the DT B-NP O
214 floor NN I-NP O
214 TAGH NNP I-NP O
215 2 CD O O
215 BP NNP B-NP O
215 control NN I-NP O
215 with IN B-VP O
215 home NN B-NP O
215 regimen NNS I-NP O
215 keep VB O O
215 SBP&lt;140 NNP B-NP O
216 3 CD O O
216 Hold NNP B-NP O
216 ASA NNP I-NP B-m
216 Continue NNP I-NP O
216 holding VBG O O
216 coumadin NN B-NP B-m
216 , , O O
216 clarify VB O O
216 indication NN B-NP O
216 in IN B-VP O
217 the DT B-NP O
217 future NN I-NP O
218 4 CD O O
218 Hold NNP B-NP O
218 metformin NN I-NP B-m
218 for IN B-VP O
218 now RB O O
218 ( ( O O
218 in IN B-VP O
218 case NN B-NP O
218 needs NNS I-NP O
218 CT/A NNP I-NP O
218 ) ) O O
218 , , O O
218 add JJ B-NP O
218 insulin NN I-NP B-m
219 sliding VBG O B-do
219 scale JJ B-NP I-do
220 Brief NNP I-NP O
220 Hospital NNP I-NP O
220 Course: NNP I-NP O
221 The DT B-NP O
221 hemorrhage NN I-NP O
221 was VBD B-VP O
221 stable JJ O O
221 on IN B-VP O
221 follow-up JJ B-NP O
221 imaging NN I-NP O
221 INR NNP I-NP O
221 was VBD B-VP O
221 1.1 CD O O
222 Neurologic NNP B-NP O
222 exam NN I-NP O
222 was VBD B-VP O
222 stable JJ O O
222 , , O O
222 with IN B-VP O
222 persistent JJ B-NP O
222 dysarthria NNS I-NP O
222 , , O O
222 right JJ B-NP O
222 pronator NN I-NP O
223 drift NN I-NP O
223 , , O O
223 and CC O O
223 mild VB O O
223 right JJ B-NP O
223 leg NN I-NP O
223 weakness NN I-NP O
223 Patient NNP I-NP O
223 evaluated VBN O O
223 by IN B-VP O
223 PT/OT NNP B-NP O
223 and CC O O
224 deemed VBN O O
224 appropriate JJ B-NP O
224 candidate NN I-NP O
224 for IN B-VP O
224 acute JJ B-NP O
224 rehab NN I-NP O
225 Cardiovascular: NNP I-NP O
225 Continued VBD B-VP O
225 to TO O O
225 be VB O O
225 in IN B-VP O
225 atrial JJ B-NP O
225 fibrillation NN I-NP O
225 Pacemaker NNP I-NP O
225 was VBD B-VP O
226 firing VBG O O
226 , , O O
226 but CC O O
226 on IN B-VP O
226 4/27 CD O O
226 pm NN B-NP O
226 had VBD B-VP O
226 an DT B-NP O
226 episode NN I-NP O
226 of IN B-VP O
226 hr NN B-NP O
226 30's CD O O
226 x NNP B-NP O
226 few JJ B-NP O
226 seconds NNS I-NP O
226 , , O O
226 and CC O O
226 for IN B-VP O
227 rest NN B-NP O
227 of IN B-VP O
227 night NN B-NP O
227 hr NN I-NP O
227 40's CD O O
227 - : O O
227 50's CD O O
227 EKG NNP B-NP O
227 unchanged JJ O O
227 from IN B-VP O
227 admission NN B-NP O
227 - : O O
227 atrial JJ B-NP O
228 fibrillation NN I-NP O
228 , , O O
228 left VBD B-VP O
228 anterior JJ B-NP O
228 fascicular JJ I-NP O
228 block NN I-NP O
228 , , O O
228 some DT B-NP O
228 pvc's NN I-NP O
228 Consulted VBD B-VP O
229 PH NNP B-NP O
229 Cardiology NNP I-NP O
229 , , O O
229 who WP O O
229 analyzed VBD B-VP O
229 the DT B-NP O
229 telemetry NN I-NP O
229 and CC O O
229 found VBD B-VP O
229 that IN B-VP O
229 bradycardic JJ B-NP O
230 readings NNS I-NP O
230 were VBD B-VP O
230 artifactual JJ O O
230 There EX O O
230 was VBD B-VP O
230 no DT B-NP O
230 EKG NNP I-NP O
230 obtained VBD B-VP O
230 during IN B-VP O
230 bradycardia NN B-NP O
231 and CC O O
231 no DT B-NP O
231 documented JJ I-NP O
231 physical JJ I-NP O
231 exam NN I-NP O
231 findings NNS I-NP O
231 to TO O O
231 suggest VB O O
231 bradycardia NN B-NP O
232 Cardiology NNP I-NP O
232 felt VBD B-VP O
232 there EX O O
232 was VBD B-VP O
232 no DT B-NP O
232 other JJ I-NP O
232 evidence NN I-NP O
232 of IN B-VP O
232 pacer NN B-NP O
232 malfunction NN I-NP O
233 ADDITIONAL NNP I-NP O
233 COMMENTS: NNP I-NP O
234 DISCHARGE NNP I-NP O
234 CONDITION: NNP I-NP O
234 Fair NNP I-NP O
235 TO NNP I-NP O
235 DO/PLAN: NNP I-NP O
236 Follow NNP I-NP O
236 up RP O O
236 with IN B-VP O
236 outpatient JJ B-NP O
236 cardiologist NN I-NP O
236 , , O O
236 neurologist NN B-NP O
236 , , O O
236 and CC O O
236 PCP NNP B-NP O
237 No NNP I-NP O
237 dictated VBD B-VP O
237 summary JJ B-NP O
238 ENTERED NNP I-NP O
238 BY: NNP I-NP O
238 MCCOLGAN NNP I-NP O
238 , , O O
238 SAM NNP B-NP O
238 F NNP I-NP O
238 , , O O
238 M.D NNP B-NP O
238 ( ( O O
238 IW52 NNP B-NP O
238 ) ) O O
238 0/18/05 CD O O
238 @ $ O O
238 12 CD O O
239 ****** JJ B-NP O
239 END NN I-NP O
239 OF NNP I-NP O
239 DISCHARGE NNP I-NP O
239 ORDERS NNP I-NP O
239 ****** NNP I-NP O
240 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #920102 VBZ O O
4 590629022 CD O O
4 SMC NNP B-NP O
4 89867333 CD O O
4 3190948 CD O O
4 11/27/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CARDIAC NNP I-NP O
4 ISCHEMIA NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/6/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/10/2005 CD O O
7 ATTENDING: NNP B-NP O
7 DUSTY NNP I-NP O
7 GREGER NNP I-NP O
7 MD NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 Mr NNP I-NP O
8 Laborn NNP I-NP O
8 is VBZ O O
8 a DT B-NP O
8 54-year-old JJ I-NP O
8 male NN I-NP O
8 with IN B-VP O
9 no DT B-NP O
9 significant JJ I-NP O
9 past JJ I-NP O
9 medical JJ I-NP O
9 history NN I-NP O
9 , , O O
9 who WP O O
9 presented VBD B-VP O
9 to TO O O
9 his PRP$ O O
10 cardiologist NN B-NP O
10 with IN B-VP O
10 complaints NNS B-NP O
10 of IN B-VP O
10 chest JJ B-NP O
10 pressure NN I-NP O
10 while IN B-VP O
10 he PRP O O
10 was VBD B-VP O
11 working VBG O O
11 out RP O O
11 This DT O O
11 was VBD B-VP O
11 approximately RB O O
11 one CD O O
11 month NN B-NP O
11 prior RB O O
11 to TO O O
12 admission NN B-NP O
12 Since IN B-VP O
12 this DT B-NP O
12 time NN I-NP O
12 , , O O
12 he PRP O O
12 has VBZ O O
12 been VBN O O
12 having VBG O O
12 similar JJ B-NP O
12 episodes NNS I-NP O
13 of IN B-VP O
13 chest JJS B-NP O
13 discomfort NN I-NP O
13 while IN B-VP O
13 working VBG O O
13 out RP O O
13 Stress NNP B-NP O
13 test NN I-NP O
13 was VBD B-VP O
13 positive JJ O O
14 for IN B-VP O
14 anterior JJ B-NP O
14 lateral JJ I-NP O
14 ischemic JJ I-NP O
14 changes NNS I-NP O
14 , , O O
14 which WDT O O
14 was VBD B-VP O
14 followed VBN O O
14 by IN B-VP O
15 cardiac JJ B-NP O
15 catheterization NN I-NP O
15 showing VBG O O
15 diffuse NN B-NP O
15 LAD NNP I-NP O
15 disease VBZ O O
15 The DT B-NP O
15 patient NN I-NP O
16 was VBD B-VP O
16 referred VBN O O
16 to TO O O
16 Dr NNP B-NP O
16 Pillon NNP I-NP O
16 for IN B-VP O
16 coronary JJ B-NP O
16 revascularization NN I-NP O
17 PAST NNP I-NP O
17 MEDICAL NNP I-NP O
17 HISTORY: NNP I-NP O
17 Hypertension NNP I-NP O
17 , , O O
17 diabetes VBZ O O
17 mellitus NN B-NP O
17 , , O O
18 hyperlipidemia NN B-NP O
18 , , O O
18 COPD NNP B-NP O
18 , , O O
18 asthma VBZ O O
19 SOCIAL NNP B-NP O
19 HISTORY: NNP I-NP O
19 No NNP I-NP O
19 history NN I-NP O
19 of IN B-VP O
19 tobacco NN B-NP O
19 use NN I-NP O
20 ALLERGIES: NNP I-NP O
20 No NNP I-NP O
20 known VBN O O
20 drug NN B-NP O
20 allergies NNS I-NP O
21 PREOPERATIVE NNP I-NP O
21 MEDICATIONS: NNP I-NP O
21 Lisinopril NNP I-NP B-m
21 20 CD O B-do
21 mg NN B-NP I-do
21 p.o JJ O B-mo
21 daily RB O B-f
21 , , O O
22 atorvastatin VBD B-VP B-m
22 40 CD O B-do
22 mg NNS B-NP I-do
22 p.o JJ O B-mo
22 daily RB O B-f
22 , , O O
22 Xanax NNP B-NP B-m
22 dose VBP O O
22 unknown JJ B-NP O
23 PHYSICAL NNP I-NP O
23 EXAMINATION: NNP I-NP O
23 Vital NNP I-NP O
23 signs: VBD B-VP O
23 Temperature NNP B-NP O
23 97.7 CD O O
23 , , O O
23 heart NN B-NP O
23 rate NN I-NP O
24 70 CD O O
24 , , O O
24 blood NN B-NP O
24 pressure NN I-NP O
24 in IN B-VP O
24 the DT B-NP O
24 right JJ I-NP O
24 arm NN I-NP O
24 160/100 CD O O
24 , , O O
24 blood NN B-NP O
24 pressure NN I-NP O
24 in IN B-VP O
25 the DT B-NP O
25 left JJ I-NP O
25 arm NN I-NP O
25 150/100 CD O O
25 HEENT: NNP B-NP O
25 Dentition NNP I-NP O
25 without IN B-VP O
25 evidence NN B-NP O
25 of IN B-VP O
26 infection NN B-NP O
26 No NNP I-NP O
26 carotid NN I-NP O
26 bruit NN I-NP O
26 Chest: NNP I-NP O
26 No NNP I-NP O
26 incisions NNS I-NP O
27 Cardiovascular: NNP I-NP O
27 Regular NNP I-NP O
27 rate NN I-NP O
27 and CC O O
27 rhythm NN B-NP O
27 without IN B-VP O
27 murmur JJ B-NP O
28 Peripheral NNP I-NP O
28 pulses NNS I-NP O
28 are VBP O O
28 all DT O O
28 2+ CD O O
28 include VBP O O
28 the DT B-NP O
28 carotid NN I-NP O
28 , , O O
28 radial JJ O O
28 , , O O
29 femoral JJ O O
29 , , O O
29 dorsalis JJ B-NP O
29 pedis NN I-NP O
29 , , O O
29 posterior JJ B-NP O
29 tibial JJ I-NP O
29 Respiratory: NNP I-NP O
29 Breath NNP I-NP O
30 sounds VBZ O O
30 clear JJ O O
30 bilaterally RB O O
30 Extremities: NNP B-NP O
30 Without IN B-VP O
30 scarring VBG O O
30 , , O O
31 varicosities NNS B-NP O
31 or CC O O
31 edema VB O O
31 Neuro: NNP B-NP O
31 Alert NNP I-NP O
31 and CC O O
31 oriented VBN O O
31 with IN B-VP O
31 no DT B-NP O
31 focal JJ I-NP O
32 deficits NNS I-NP O
33 PREOPERATIVE NNP I-NP O
33 LABS: NNP I-NP O
33 Sodium NNP I-NP O
33 141 CD O O
33 , , O O
33 potassium NN B-NP O
33 3.7 CD O O
33 , , O O
33 chloride RB O O
33 102 CD O O
33 , , O O
34 carbon NN B-NP O
34 dioxide NN I-NP O
34 32 CD O O
34 , , O O
34 BUN NNP B-NP O
34 17 CD O O
34 , , O O
34 creatinine NN B-NP O
34 1.2 CD O O
34 , , O O
34 glucose RB O O
34 95 CD O O
34 , , O O
34 magnesium NN B-NP O
35 2.1 CD O O
35 , , O O
35 white JJ B-NP O
35 blood NN I-NP O
35 cells NNS I-NP O
35 7.37 CD O O
35 , , O O
35 hematocrit NN B-NP O
35 46.8 CD O O
35 , , O O
35 hemoglobin NN B-NP O
35 16.2 CD O O
35 , , O O
36 platelets NNS B-NP O
36 174 CD O O
36 , , O O
36 000 CD O O
36 , , O O
36 PT NNP B-NP O
36 13.7 CD O O
36 , , O O
36 INR NNP B-NP O
36 1 CD O O
36 , , O O
36 PTT NNP B-NP O
36 28.1 CD O O
37 CARDIAC NNP B-NP O
37 CATHETERIZATION NNP I-NP O
37 DATA: NNP I-NP O
37 On IN B-VP O
37 2/1/05 CD O O
37 coronary JJ B-NP O
37 anatomy NN I-NP O
37 95% CD O O
38 osteal NN B-NP O
38 LAD NNP I-NP O
38 , , O O
38 90% CD O O
38 proximal JJ B-NP O
38 LAD NNP I-NP O
38 , , O O
38 70% CD O O
38 LAD NNP B-NP O
38 left VBD B-VP O
38 dominant JJ B-NP O
38 circulation NN I-NP O
39 ECG NNP I-NP O
39 on IN B-VP O
39 2/1/05 CD O O
39 was VBD B-VP O
39 normal JJ B-NP O
39 sinus JJ I-NP O
39 rhythm NN I-NP O
39 at IN B-VP O
39 61 CD O O
39 Chest NNP B-NP O
39 x-ray NN I-NP O
39 on IN B-VP O
40 2/1/05 CD O O
40 was VBD B-VP O
40 read VBN O O
40 as IN B-VP O
40 normal JJ B-NP O
41 HOSPITAL NNP I-NP O
41 COURSE: NNP I-NP O
41 Date NNP I-NP O
41 of IN B-VP O
41 surgery NN B-NP O
41 0/8/05 CD O O
42 PREOPERATIVE NNP B-NP O
42 DIAGNOSIS: NNP I-NP O
42 Coronary NNP I-NP O
42 artery NN I-NP O
42 disease NN I-NP O
43 POSTOPERATIVE NNP I-NP O
43 DIAGNOSIS: NNP I-NP O
43 Coronary NNP I-NP O
43 artery NN I-NP O
43 disease NN I-NP O
44 PROCEDURE: NNP I-NP O
44 CABG NNP I-NP O
44 x2 NNP I-NP O
44 with IN B-VP O
44 a DT B-NP O
44 LIMA NNP I-NP O
44 to TO O O
44 the DT B-NP O
44 LAD NNP I-NP O
44 , , O O
44 SVG1 NNP B-NP O
44 to TO O O
44 the DT B-NP O
44 D1 NNP I-NP O
44 Bypass NNP I-NP O
45 time NN I-NP O
45 was VBD B-VP O
45 60 CD O O
45 minutes NNS B-NP O
45 Crossclamp NNP I-NP O
45 time NN I-NP O
45 was VBD B-VP O
45 41 CD O O
45 minutes NNS B-NP O
45 One CD O O
46 Ventricular NNP B-NP O
46 wire NN I-NP O
46 , , O O
46 two CD O O
46 pericardial JJ B-NP O
46 tubes NNS I-NP O
46 , , O O
46 and CC O O
46 one CD O O
46 left VBD B-VP O
46 pleural JJ B-NP O
47 tube NNS I-NP O
47 were VBD B-VP O
47 placed VBN O O
48 FINDINGS: NNP B-NP O
48 Unable JJ O O
48 to TO O O
48 perform VB O O
48 off RP O O
48 pump NN B-NP O
48 CABG NNP I-NP O
48 due JJ O O
48 to TO O O
48 the DT B-NP O
48 difficult JJ I-NP O
49 position NN I-NP O
49 of IN B-VP O
49 the DT B-NP O
49 D1 NNP I-NP O
49 target NN I-NP O
49 After IN B-VP O
49 the DT B-NP O
49 operation NN I-NP O
49 , , O O
49 the DT B-NP O
49 patient NN I-NP O
49 was VBD B-VP O
50 transferred VBN O O
50 to TO O O
50 the DT B-NP O
50 cardiac JJ I-NP O
50 intensive JJ I-NP O
50 care NN I-NP O
50 unit NN I-NP O
50 under IN B-VP O
50 stable JJ B-NP O
51 condition NN I-NP O
51 His PRP$ O O
51 course NN B-NP O
51 was VBD B-VP O
51 uncomplicated VBN O O
51 in IN B-VP O
51 the DT B-NP O
51 cardiac JJ I-NP O
51 intensive JJ I-NP O
52 care NN I-NP O
52 unit NN I-NP O
52 He PRP O O
52 was VBD B-VP O
52 transferred VBN O O
52 to TO O O
52 the DT B-NP O
52 cardiac JJ I-NP O
52 step-down JJ I-NP O
52 unit NN I-NP O
53 All NNP I-NP O
53 epicardial JJ B-NP O
53 pacing NN I-NP O
53 wires NNS I-NP O
53 and CC O O
53 chest JJS B-NP O
53 tubes NNS I-NP O
53 were VBD B-VP O
53 removed VBN O O
53 without IN B-VP O
54 complication NN B-NP O
54 He PRP O O
54 was VBD B-VP O
54 weaned VBN O O
54 from IN B-VP O
54 his PRP$ O O
54 oxygen NN B-NP B-m
54 requirement NN I-NP O
54 and CC O O
55 diuresed VBD B-VP O
55 to TO O O
55 below IN B-VP O
55 his PRP$ O O
55 preoperative JJ B-NP O
55 weight NN I-NP O
56 DISCHARGE NNP I-NP O
56 MEDICATIONS: NNP I-NP O
56 He PRP O O
56 will MD O O
56 be VB O O
56 discharged VBN O O
56 home NN B-NP O
56 on IN B-VP O
57 postoperative JJ B-NP O
57 day NN I-NP O
57 #4 NNP I-NP O
57 in IN B-VP O
57 stable JJ B-NP O
57 condition NN I-NP O
57 on IN B-VP O
57 the DT B-NP B-m
57 following JJ I-NP O
58 medications NNS I-NP O
58 Aspirin VBP O B-m
58 325 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 q JJ B-NP B-f
58 day NN I-NP I-f
58 , , O O
58 Niferex NNP B-NP B-m
58 150 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
59 b.i.d NN I-NP B-f
59 , , O O
59 oxycodone RB O B-m
59 5 CD O B-do
59 mg NNS B-NP I-do
59 p.o JJ B-NP B-mo
59 q.6h JJ I-NP B-f
59 p.r.n NN I-NP I-f
59 pain NN I-NP B-r
59 , , O O
59 Toprol NNP B-NP B-m
59 XL NNP I-NP I-m
59 100 CD O B-do
59 mg NN B-NP I-do
60 p.o NN I-NP B-mo
60 q JJ B-NP B-f
60 day NN I-NP I-f
60 , , O O
60 Flovent NNP B-NP B-m
60 44 CD O B-do
60 mcg NN B-NP I-do
60 inhaler NN I-NP B-mo
60 b.i.d NN I-NP B-f
60 , , O O
60 Lipitor NNP B-NP B-m
60 40 CD O B-do
60 mg NN B-NP I-do
60 p.o JJ B-NP B-mo
61 daily JJ I-NP B-f
62 PLAN: NNP I-NP O
62 Mr NNP I-NP O
62 Gariety NNP I-NP O
62 is VBZ O O
62 to TO O O
62 follow-up JJ O O
62 with IN B-VP O
62 Dr NNP B-NP O
62 Delawyer NNP I-NP O
62 cardiac JJ B-NP O
62 surgeon NN I-NP O
63 in IN B-VP O
63 six CD O O
63 weeks NNS B-NP O
63 and CC O O
63 Dr NNP B-NP O
63 Eggleston NNP I-NP O
63 , , O O
63 cardiologist NN B-NP O
63 in IN B-VP O
63 two CD O O
63 weeks NNS B-NP O
64 eScription NN I-NP O
64 document: IN B-VP O
64 4-2047447 JJ B-NP O
64 JSSten NNP I-NP O
64 Tel NNP I-NP O
65 Dictated NNP I-NP O
65 By: NNP I-NP O
65 WISENER NNP I-NP O
65 , , O O
65 WILMER NNP B-NP O
66 Attending: NNP I-NP O
66 SHARON NNP I-NP O
66 , , O O
66 HUNG NNP B-NP O
67 Dictation NNP I-NP O
67 ID NNP I-NP O
67 7131983 CD O O
68 D: NNP B-NP O
68 7/28/05 CD O O
69 T: NNP B-NP O
69 7/28/05 CD O O
70 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #920361 VBZ O O
2 697378455 CD O O
2 HTRH NNP B-NP O
2 74497426 CD O O
2 665281 CD O O
2 4/12/1997 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 BRONCHITIS NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/23/1997 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 11/13/1997 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 Bronchitis NNP I-NP O
5 PAST NNP I-NP O
5 MEDICAL NNP I-NP O
5 HISTORY: NNP I-NP O
5 1 CD O O
5 ) ) O O
5 Hypertension NNP B-NP O
5 2 CD O O
5 ) ) O O
5 History NN B-NP O
5 of IN B-VP O
6 cerebrovascular JJ B-NP O
6 accident NN I-NP O
6 in IN B-VP O
6 1983 CD O O
6 with IN B-VP O
6 left VBN O O
7 sided JJ B-NP O
7 involvement NN I-NP O
7 3 CD O O
7 ) ) O O
7 History NN B-NP O
7 of IN B-VP O
7 congestive JJ B-NP O
7 heart NN I-NP O
7 failure NN I-NP O
7 4 CD O O
7 ) ) O O
8 Insulin NNP B-NP O
8 dependent JJ B-NP O
8 diabetes NNS I-NP O
8 mellitus VBP O O
8 5 CD O O
8 ) ) O O
8 Arthritis $ O O
8 6 CD O O
8 ) ) O O
9 Cataracts VBZ O O
9 7 CD O O
9 ) ) O O
9 Total JJ B-NP O
9 abdominal JJ I-NP O
9 hysterectomy NN I-NP O
9 8 CD O O
9 ) ) O O
9 History NN B-NP O
9 of IN B-VP O
9 sinus NN B-NP O
10 problems NNS I-NP O
10 9 CD O O
10 ) ) O O
10 Stable JJ B-NP O
10 angina JJ I-NP O
11 HISTORY NNP I-NP O
11 OF NNP I-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
11 The DT B-NP O
11 patient NN I-NP O
11 is VBZ O O
11 a DT B-NP O
11 69 JJ I-NP O
11 year-old JJ I-NP O
11 woman NN I-NP O
11 with IN B-VP O
12 past JJ B-NP O
12 hospitalizations NNS I-NP O
12 for IN B-VP O
12 congestive JJ B-NP O
13 heart NN I-NP O
13 failure NN I-NP O
13 ( ( O O
13 last JJ B-NP O
13 March NNP I-NP O
13 , , O O
13 1996 CD O O
13 ) ) O O
13 and CC O O
13 hypertension NN B-NP O
13 , , O O
13 who WP O O
13 3-4 JJ B-NP O
13 weeks NNS I-NP O
14 prior RB O O
14 to TO O O
14 admission NN B-NP O
14 had VBD B-VP O
14 been VBN O O
14 having VBG O O
14 increasing VBG O O
14 cough NN B-NP O
14 Initially NNP I-NP O
14 she PRP O O
15 thought VBD B-VP O
15 it PRP O O
15 was VBD B-VP O
15 because IN B-VP O
15 of IN B-VP O
15 allergies NNS B-NP O
15 , , O O
15 but CC O O
15 it PRP O O
15 progressed VBD B-VP O
15 and CC O O
15 over IN B-VP O
15 the DT B-NP O
16 3-4 JJ I-NP O
16 days NNS I-NP O
16 prior RB O O
16 to TO O O
16 admission VB O O
16 she PRP O O
16 had VBD B-VP O
16 increasing VBG O O
16 cough JJ B-NP O
16 productive NN I-NP O
16 of IN B-VP O
17 yellow JJ B-NP O
17 sputum NN I-NP O
17 Over IN B-VP O
17 the DT O O
17 three CD O O
17 days NNS B-NP O
17 prior RB O O
17 to TO O O
17 admission VB O O
17 the DT B-NP O
17 patient NN I-NP O
18 felt VBD B-VP O
18 feverish JJ O O
18 , , O O
18 chills NNS B-NP O
18 , , O O
18 shortness NN B-NP O
18 of IN B-VP O
18 breath NN B-NP O
18 and CC O O
18 wheezing VBG O O
18 She PRP O O
18 had VBD B-VP O
18 a DT B-NP O
19 fever NN I-NP O
19 to TO O O
19 101 CD O O
19 on IN B-VP O
19 the DT B-NP O
19 day NN I-NP O
19 prior RB O O
19 to TO O O
19 admission VB O O
19 She PRP O O
19 denied VBD B-VP O
19 ill JJ B-NP O
20 contacts NNS I-NP O
20 or CC O O
20 recent JJ B-NP O
20 travel NN I-NP O
20 Her PRP$ O O
20 last JJ B-NP O
20 pneumonia JJ I-NP O
20 vaccine NN I-NP O
20 was VBD B-VP O
20 in IN B-VP O
20 July NNP B-NP O
21 of IN B-VP O
21 1997 CD O O
21 She PRP O O
21 has VBZ O O
21 stable JJ O O
21 three CD O O
21 pillow JJ B-NP O
21 orthopnea NN I-NP O
21 She PRP O O
21 has VBZ O O
21 no DT B-NP O
21 PND NNP I-NP O
21 , , O O
22 recent JJ B-NP O
22 leg NN I-NP O
22 swelling VBG O O
22 She PRP O O
22 has VBZ O O
22 no DT B-NP O
22 recent JJ I-NP O
22 increase NN I-NP O
22 in IN B-VP O
22 frequency NN B-NP O
22 in IN B-VP O
23 angina NN B-NP O
23 and CC O O
23 no DT B-NP O
23 recent JJ I-NP O
23 weight NN I-NP O
23 gain NN I-NP O
23 or CC O O
23 increase VB O O
23 in IN B-VP O
23 abdominal JJ B-NP O
23 girth NN I-NP O
24 She PRP O O
24 describes VBZ O O
24 increasing VBG O O
24 shortness NN B-NP O
24 of IN B-VP O
24 breath NN B-NP O
24 when WRB O O
24 lying VBG O O
24 on IN B-VP O
24 her PRP$ O O
24 left JJ B-NP O
25 side NN I-NP O
25 which WDT O O
25 is VBZ O O
25 relieved VBN O O
25 by IN B-VP O
25 sleeping VBG O O
25 on IN B-VP O
25 her PRP O O
25 right JJ B-NP O
25 side NN I-NP O
25 Her NNP I-NP O
25 most RBS O O
26 recent JJ B-NP O
26 echocardiogram NN I-NP O
26 in IN B-VP O
26 March NNP B-NP O
26 of IN B-VP O
26 1996 CD O O
26 showed VBD B-VP O
26 an DT B-NP O
26 ejection NN I-NP O
27 fraction NN I-NP O
27 of IN B-VP O
27 40% CD O O
27 with IN B-VP O
27 1 CD O O
27 plus CC O O
27 mitral JJ B-NP O
27 regurgitation NN I-NP O
27 She PRP O O
27 had VBD B-VP O
27 a DT B-NP O
28 Persantine NNP I-NP B-m
28 MIBI NNP I-NP O
28 in IN B-VP O
28 March NNP B-NP O
28 of IN B-VP O
28 1996 CD O O
28 , , O O
28 on IN B-VP O
28 which WDT O O
28 she PRP O O
28 had VBD B-VP O
28 no DT O O
28 fixed VBN O O
28 or CC O O
29 reversible JJ B-NP O
29 ischemia NN I-NP O
29 The DT B-NP O
29 patient NN I-NP O
29 presented VBD B-VP O
29 to TO O O
29 the DT B-NP O
29 Mashard NNP I-NP O
29 Medical NNP I-NP O
29 Center NNP I-NP O
29 in IN B-VP O
29 the DT B-NP O
29 emergency NN I-NP O
29 room NN I-NP O
29 on IN B-VP O
29 the DT B-NP O
29 day NN I-NP O
29 of IN B-VP O
29 admission NN B-NP O
29 and CC O O
29 she PRP O O
29 was VBD B-VP O
30 afebrile JJ B-NP O
31 PAST NNP I-NP O
31 MEDICAL NNP I-NP O
31 HISTORY: NNP I-NP O
31 1 CD O O
31 ) ) O O
31 Hypertension NNP B-NP O
31 2 CD O O
31 ) ) O O
31 Status NNP B-NP O
31 post NN I-NP O
32 cerebrovascular JJ B-NP O
32 accident NN I-NP O
32 in IN B-VP O
32 1983 CD O O
32 with IN B-VP O
32 left VBN O O
33 sided JJ B-NP O
33 involvement NN I-NP O
33 but CC O O
33 no DT B-NP O
33 residual JJ I-NP O
33 symptoms NNS I-NP O
33 3 CD O O
33 ) ) O O
33 History NN B-NP O
33 of IN B-VP O
34 congestive JJ B-NP O
34 heart NN I-NP O
34 failure: NN I-NP O
34 Echocardiogram NNP I-NP O
34 - : O O
34 March NNP B-NP O
34 of IN B-VP O
34 1996 CD O O
35 revealing VBG O O
35 1+ CD O O
35 mitral JJ B-NP O
35 regurge NN I-NP O
35 , , O O
35 1+ CD O O
35 tricuspid JJ B-NP O
35 regurge NN I-NP O
35 , , O O
35 normal JJ O O
35 left VBD B-VP O
36 ventricular JJ B-NP O
36 size NN I-NP O
36 with IN B-VP O
36 mild JJ B-NP O
36 decrease NN I-NP O
36 in IN B-VP O
36 systolic JJ B-NP O
36 function NN I-NP O
36 , , O O
36 mild JJ O O
36 left VBD B-VP O
37 ventricular JJ B-NP O
37 hypertrophy NN I-NP O
37 with IN B-VP O
37 ejection NN B-NP O
37 fraction NN I-NP O
37 of IN B-VP O
37 40% CD O O
37 , , O O
37 inferior JJ B-NP O
38 wall NN I-NP O
38 with IN B-VP O
38 slight JJ B-NP O
38 hypokinesis NN I-NP O
38 and CC O O
38 apex NN B-NP O
38 mildly RB O O
38 abnormal JJ O O
38 , , O O
38 with IN B-VP O
39 bi-atrial JJ O O
39 enlargement JJ O O
39 4 CD O O
39 ) ) O O
39 Persantine NNP B-NP B-m
39 MIBI NNP I-NP O
39 in IN B-VP O
39 March NNP B-NP O
39 of IN B-VP O
39 1996 CD O O
39 with IN B-VP O
40 maximum JJ B-NP O
40 heart NN I-NP O
40 rate NN I-NP O
40 of IN B-VP O
40 89 CD O O
40 , , O O
40 maximum JJ B-NP O
40 blood NN I-NP O
40 pressure NN I-NP O
40 180/120 CD O O
40 with IN B-VP O
40 no DT O O
41 fixed JJ O O
41 or CC O O
41 reversible JJ B-NP O
41 perfusion NN I-NP O
41 abnormalities NNS I-NP O
41 Catheterization NNP I-NP O
41 in IN B-VP O
42 May NNP B-NP O
42 of IN B-VP O
42 1992 CD O O
42 showed VBD B-VP O
42 normal JJ B-NP O
42 coronaries NNS I-NP O
42 5 CD O O
42 ) ) O O
42 Insulin NNP B-NP O
42 dependent JJ B-NP O
43 diabetes NNS I-NP O
43 mellitus VBP O O
43 - : O O
43 hemoglobin NN B-NP O
43 A1C NNP I-NP O
43 of IN B-VP O
43 7.6 CD O O
43 in IN B-VP O
43 March NNP B-NP O
43 of IN B-VP O
43 1997 CD O O
43 6 CD O O
43 ) ) O O
44 Arthritis $ O O
44 7 CD O O
44 ) ) O O
44 Cataracts NNPS B-NP O
44 - : O O
44 status NN B-NP O
44 post NN I-NP O
44 right RB O O
44 sided VBD B-VP O
44 cataract JJ B-NP O
45 surgery NN I-NP O
45 in IN B-VP O
45 1993 CD O O
45 8 CD O O
45 ) ) O O
45 Total JJ B-NP O
45 abdominal JJ I-NP O
45 hysterectomy NN I-NP O
45 9 CD O O
45 ) ) O O
45 History NN B-NP O
45 of IN B-VP O
46 sinus NN B-NP O
46 problems NNS I-NP O
46 10 CD O O
46 ) ) O O
46 Stable JJ O O
46 angina SYM O O
46 - : O O
46 "chest JJS B-NP B-r
46 heaviness" NN I-NP I-r
46 after IN B-VP O
47 climbing VBG O O
47 one CD O O
47 flight NN B-NP O
47 of IN B-VP O
47 stairs NNS B-NP O
47 , , O O
47 relieved VBN O O
47 by IN B-VP O
47 rest NN B-NP O
47 and CC O O
47 one CD O B-do
47 sublingual JJ B-NP B-mo
48 nitroglycerin NN I-NP B-m
49 MEDICATIONS NNP I-NP O
49 ON NNP I-NP O
49 ADMISSION: NNP I-NP O
49 1 CD O O
49 ) ) O O
49 Lasix FW O B-m
49 40 CD O B-do
49 mg NNS B-NP I-do
49 per IN B-VP B-f
49 day NN B-NP I-f
49 2 CD O O
49 ) ) O O
49 Insulin NNP B-NP B-m
49 Insulin NNP I-NP B-m
50 70/30 CD O O
50 28 CD O B-do
50 units NNS B-NP I-do
50 q JJ B-NP B-f
50 a.m NN I-NP I-f
50 and CC O O
50 5 CD O B-do
50 units NNS B-NP I-do
50 q RB O B-f
50 p.m RB O I-f
51 3 CD O O
51 ) ) O O
51 Verapamil NNP B-NP B-m
51 SR NNP I-NP I-m
51 120 CD O B-do
51 mg NN B-NP I-do
51 PO NNP I-NP B-mo
51 b.i.d VBZ O B-f
51 4 CD O O
51 ) ) O O
51 Enteric NNP B-NP B-m
51 coated VBD B-VP I-m
51 aspirin RB O I-m
51 325 CD O B-do
51 mg NNS B-NP I-do
52 q JJ B-NP B-f
52 day NN I-NP I-f
52 5 CD O O
52 ) ) O O
52 KCL NNP B-NP B-m
52 10 CD O B-do
52 mEq NN B-NP I-do
52 PO NNP I-NP B-mo
52 q NNP I-NP B-f
52 day NN I-NP I-f
52 6 CD O O
52 ) ) O O
52 Premarin VBD B-VP B-m
52 0.625 CD O B-do
52 mg NN B-NP I-do
52 PO NNP I-NP B-mo
52 q NNP I-NP B-f
52 day NN I-NP I-f
53 7 CD O O
53 ) ) O O
53 Zestril VBD B-VP B-m
53 20 CD O B-do
53 mg NN B-NP I-do
53 b.i.d NN I-NP B-f
53 8 CD O O
53 ) ) O O
53 Atenolol NNP B-NP B-m
53 , , O O
53 recently RB O O
53 discontinued VBD B-VP O
53 9 CD O O
53 ) ) O O
54 Tofranil $ O B-m
54 75 CD O B-do
54 mg NN B-NP I-do
54 PO NNP I-NP B-mo
54 q NN I-NP B-f
54 HS NNP I-NP I-f
55 No NNP I-NP O
55 known VBN O O
55 drug NN B-NP O
55 allergies NNS I-NP O
56 FAMILY NNP I-NP O
56 HISTORY: NNP I-NP O
56 Mother NNP I-NP O
56 died VBD B-VP O
56 at IN B-VP O
56 age NN B-NP O
56 82 CD O O
56 from IN B-VP O
56 kidney NN B-NP O
56 failure NN I-NP O
56 No NNP I-NP O
57 history NN I-NP O
57 of IN B-VP O
57 diabetes NNS B-NP O
57 , , O O
57 coronary JJ B-NP O
57 artery NN I-NP O
57 disease NN I-NP O
57 or CC O O
58 hypertension NN B-NP O
58 in IN B-VP O
58 the DT B-NP O
58 family NN I-NP O
59 SOCIAL NNP I-NP O
59 HISTORY: NNP I-NP O
59 The DT B-NP O
59 patient NN I-NP O
59 lives VBZ O O
59 with IN B-VP O
59 her PRP O O
59 two CD O O
59 grandchildren NN B-NP O
59 and CC O O
60 her PRP$ O O
60 daughter NN B-NP O
60 She PRP O O
60 does VBZ O O
60 not RB O O
60 use VB O O
60 tobacco NN B-NP O
60 and CC O O
60 does VBZ O O
61 not RB O O
61 drink VB O O
61 alcohol IN B-VP O
61 She PRP O O
61 is VBZ O O
61 originally RB O O
61 from IN B-VP O
61 Sco NNP B-NP O
61 Oale NNP I-NP O
61 Fran NNP I-NP O
61 where WRB O O
61 the DT B-NP O
61 rest NN I-NP O
62 of IN B-VP O
62 her PRP$ O O
62 family NN B-NP O
62 currently RB O O
62 lives VBZ O O
62 She PRP O O
62 left VBD B-VP O
62 there EX O O
62 several JJ B-NP O
62 months NNS I-NP O
62 ago RB O O
63 PHYSICAL NNP B-NP O
63 EXAM: NNP I-NP O
63 The DT B-NP O
63 patient NN I-NP O
63 was VBD B-VP O
63 a DT B-NP O
63 pleasant JJ I-NP O
63 woman NN I-NP O
63 lying VBG O O
63 comfortably RB O O
64 in IN B-VP O
64 bed NN B-NP O
64 in IN B-VP O
64 no DT B-NP O
64 apparent JJ I-NP O
64 distress NN I-NP O
64 Her PRP$ O O
64 temperature NN B-NP O
64 was VBD B-VP O
64 98.4 CD O O
64 , , O O
64 pulse RB O O
65 106 CD O O
65 , , O O
65 blood NN B-NP O
65 pressure NN I-NP O
65 150/70 CD O O
65 , , O O
65 respiratory NN B-NP O
65 rate NN I-NP O
65 20 CD O O
65 , , O O
65 saturation NN B-NP O
65 95% CD O O
65 on IN B-VP O
66 room NN B-NP O
66 air NN I-NP O
66 HEENT: NNP I-NP O
66 Surgical NNP I-NP O
66 right NN I-NP O
66 pupil NN I-NP O
66 , , O O
66 anicteric JJ B-NP O
66 sclera NN I-NP O
66 , , O O
66 no DT B-NP O
66 nasal JJ I-NP O
67 discharge NN I-NP O
67 , , O O
67 moist NN B-NP O
67 oropharynx NN I-NP O
67 Neck: NNP I-NP O
67 Supple NNP I-NP O
67 No NNP I-NP O
67 jugular NN I-NP O
67 venous JJ B-NP O
68 distention NN I-NP O
68 and CC O O
68 no DT B-NP O
68 lymphadenopathy NN I-NP O
68 , , O O
68 full JJ B-NP O
68 range NN I-NP O
68 of IN B-VP O
68 motion NN B-NP O
68 Lungs: NNP I-NP O
69 Diffusely NNP I-NP O
69 rigorous JJ O O
69 , , O O
69 no DT B-NP O
69 crackles NNS I-NP O
69 or CC O O
69 wheezes VBZ O O
69 bilaterally RB O O
70 Cardiovascular: NNP B-NP O
70 Distant NNP I-NP O
70 heart NN I-NP O
70 sounds VBZ O O
70 S1 NNP B-NP O
70 and CC O O
70 S2 NNP B-NP O
70 , , O O
70 no DT B-NP O
70 S3 NNP I-NP O
70 and CC O O
70 no DT B-NP O
70 S4 NNP I-NP O
70 , , O O
71 no DT B-NP O
71 murmurs NNS I-NP O
71 Abdomen: NNP I-NP O
71 Normal NNP I-NP O
71 active JJ B-NP O
71 bowel NN I-NP O
71 sounds VBZ O O
71 Soft JJ O O
71 , , O O
72 non-tender JJ O O
72 , , O O
72 non-distended JJ O O
72 and CC O O
72 no DT B-NP O
72 hepatosplenomegaly NN I-NP O
72 Extremities: NNP I-NP O
73 No NNP I-NP O
73 edema NN I-NP O
73 Dorsalis NNP I-NP O
73 pedis NN I-NP O
73 pulses VBZ O O
73 2+ CD O O
73 bilaterally RB O O
73 Neurological: NNP B-NP O
74 Mild NNP I-NP O
74 decreased VBD B-VP O
74 sensation NN B-NP O
74 left VBD B-VP O
74 side NN B-NP O
74 of IN B-VP O
74 face NN B-NP O
74 , , O O
74 otherwise RB O O
74 cranial JJ B-NP O
75 nerves NNS I-NP O
75 III-XII NNP I-NP O
75 are VBP O O
75 grossly RB O O
75 intact JJ B-NP O
75 Reflexes NNP I-NP O
75 in IN B-VP O
75 upper JJ B-NP O
75 extremities NNS I-NP O
76 were VBD B-VP O
76 1 CD O O
76 plus CC O O
76 , , O O
76 no DT B-NP O
76 reflexes NNS I-NP O
76 elicited VBN O O
76 in IN B-VP O
76 lower JJR B-NP O
76 extremities NNS I-NP O
77 LABORATORY NNP I-NP O
77 DATA: NNP I-NP O
77 White NNP I-NP O
77 blood NN I-NP O
77 cell NN I-NP O
77 count NN I-NP O
77 9.3 CD O O
77 , , O O
77 hematocrit NN B-NP O
77 43 CD O O
77 , , O O
78 platelet NN B-NP O
78 count NN I-NP O
78 312 CD O O
78 BUN NNP B-NP O
78 20 CD O O
78 , , O O
78 creatinine NN B-NP O
78 1.4 CD O O
78 , , O O
79 glucose RB O O
79 377 CD O O
79 , , O O
79 LDH NNP B-NP O
79 220 CD O O
79 Sputum NNP B-NP O
79 revealed VBD B-VP O
79 4+ CD O O
79 polys NN B-NP O
79 , , O O
79 4+ CD O O
79 epithelial JJ B-NP O
80 cells NNS I-NP O
80 , , O O
80 gram JJ O O
80 negative JJ O O
80 and CC O O
80 gram JJ B-NP O
80 positive JJ I-NP O
80 cocci NN I-NP O
80 Chest NNP I-NP O
80 x-ray NN I-NP O
80 revealed VBD B-VP O
81 no DT B-NP O
81 evidence NN I-NP O
81 of IN B-VP O
81 congestive JJ B-NP O
81 heart NN I-NP O
81 failure NN I-NP O
81 and CC O O
81 no DT B-NP O
81 infiltrates NNS I-NP O
82 HOSPITAL NNP I-NP O
82 COURSE: NNP I-NP O
82 This DT O O
82 is VBZ O O
82 a DT B-NP O
82 69 JJ I-NP O
82 year-old JJ I-NP O
82 woman NN I-NP O
82 with IN B-VP O
82 a DT B-NP O
82 history NN I-NP O
82 of IN B-VP O
83 congestive JJ B-NP O
83 heart NN I-NP O
83 failure NN I-NP O
83 and CC O O
83 hypertension NN B-NP O
83 who WP O O
84 presented VBD B-VP O
84 with IN B-VP O
84 a DT B-NP O
84 productive JJ I-NP O
84 cough NN I-NP O
84 which WDT O O
84 was VBD B-VP O
84 worsening VBG O O
84 over IN B-VP O
84 the DT B-NP O
84 past JJ I-NP O
85 3-4 JJ I-NP O
85 days NNS I-NP O
85 and CC O O
85 fever NN B-NP O
85 to TO O O
85 101 CD O O
85 with IN B-VP O
85 chills NNS B-NP O
85 and CC O O
85 shakes NNS B-NP O
85 and CC O O
85 increasing VBG O O
86 shortness NN B-NP O
86 of IN B-VP O
86 breath NN B-NP O
86 She PRP O O
86 was VBD B-VP O
86 afebrile JJ O O
86 however RB O O
86 at IN B-VP O
86 the DT B-NP O
86 time NN I-NP O
86 of IN B-VP O
87 admission NN B-NP O
87 Her NNP I-NP O
87 exam NN I-NP O
87 was VBD B-VP O
87 remarkable JJ O O
87 for IN B-VP O
87 diffuse NN B-NP O
87 rhonchi NN I-NP O
87 and CC O O
88 moderate JJ B-NP O
88 jugular NN I-NP O
88 venous JJ B-NP O
88 distention NN I-NP O
88 She PRP O O
88 had VBD B-VP O
88 a DT B-NP O
88 white JJ I-NP O
88 blood NN I-NP O
88 cell NN I-NP O
89 count NN I-NP O
89 of IN B-VP O
89 9.3 CD O O
89 with IN B-VP O
89 54% CD O O
89 polys NNS B-NP O
89 and CC O O
89 9.6 CD O O
89 % NN B-NP O
89 eosinophils JJ B-NP O
89 Blood NNP I-NP O
89 glucose NN I-NP O
90 of IN B-VP O
90 377 CD O O
90 and CC O O
90 a DT B-NP O
90 chest JJ I-NP O
90 x-ray NN I-NP O
90 without IN B-VP O
90 evidence NN B-NP O
90 of IN B-VP O
90 congestive JJ B-NP O
90 heart NN I-NP O
91 failure NN I-NP O
91 or CC O O
91 infiltrate NN B-NP O
91 She PRP O O
91 was VBD B-VP O
91 treated VBN O O
91 in IN B-VP O
91 the DT B-NP O
91 emergency NN I-NP O
91 room NN I-NP O
91 with IN B-VP O
92 Albuterol NNP B-NP B-m
92 nebulizer NN I-NP I-m
92 and CC O O
92 plans NNS B-NP O
92 were VBD B-VP O
92 to TO O O
92 discharge VB O O
92 her PRP$ O O
92 to TO O O
92 home NN B-NP O
92 , , O O
93 however RB O O
93 , , O O
93 her PRP O O
93 saturations NNS B-NP O
93 dropped VBD B-VP O
93 to TO O O
93 89% CD O O
93 on IN B-VP O
93 room NN B-NP O
93 air NN I-NP O
93 with IN B-VP O
93 exercise NN B-NP O
94 in IN B-VP O
94 the DT B-NP O
94 emergency NN I-NP O
94 room NN I-NP O
94 and CC O O
94 was VBD B-VP O
94 admitted VBN O O
94 for IN B-VP O
94 further JJ B-NP O
94 observation NN I-NP O
95 She PRP O O
95 was VBD B-VP O
95 started VBN O O
95 on IN B-VP O
95 intravenous JJ B-NP B-mo
95 intravenous JJ I-NP B-mo
95 Cefuroxime NNP I-NP B-m
95 Cefuroxime NNP I-NP B-m
95 , , O O
95 and CC O O
95 initially RB O O
95 improved VBN O O
96 with IN B-VP O
96 decrease NN B-NP O
96 in IN B-VP O
96 cough NN B-NP B-r
96 and CC O O
96 shortness NN B-NP B-r
96 of IN B-VP I-r
96 breath NN B-NP I-r
96 however RB O O
96 , , O O
96 the DT B-NP O
96 patient NN I-NP O
97 continued VBD B-VP O
97 to TO O O
97 desat VB O O
97 with IN B-VP O
97 exercise NN B-NP O
97 A NNP I-NP O
97 repeat NN I-NP O
97 chest NN I-NP O
97 x-ray NN I-NP O
97 was VBD B-VP O
98 performed VBN O O
98 which WDT O O
98 showed VBD B-VP O
98 no DT B-NP O
98 change NN I-NP O
98 when WRB O O
98 compared VBN O O
98 to TO O O
98 the DT B-NP O
98 admission NN I-NP O
99 film NN I-NP O
99 Her NNP I-NP O
99 sputum NN I-NP O
99 culture NN I-NP O
99 grew VBD B-VP O
99 out RP O O
99 Pen-sensitive JJ B-NP B-r
99 E-coli NN I-NP I-r
99 and CC O O
99 she PRP O O
99 was VBD B-VP O
100 continued VBN O O
100 on IN B-VP O
100 her PRP$ O O
100 intravenous JJ O B-mo
100 and CC O O
100 then RB O O
100 PO NNP B-NP B-mo
100 antibiotics NNS I-NP B-m
100 antibiotics NNS I-NP B-m
100 She PRP O O
101 continued VBD B-VP O
101 to TO O O
101 desat VB O O
101 with IN B-VP O
101 exercise NN B-NP O
101 , , O O
101 however RB O O
101 , , O O
101 and CC O O
101 her PRP$ O O
101 cough NN B-NP O
101 persisted VBN O O
102 although IN B-VP O
102 she PRP O O
102 remained VBD B-VP O
102 afebrile JJ O O
102 with IN B-VP O
102 a DT O O
102 slightly RB O O
102 elevated VBN O O
102 white JJ B-NP O
102 count NN I-NP O
103 and CC O O
103 moderate JJ O O
103 peripheral JJ O O
103 eosinophilia FW O O
103 Her PRP$ O O
103 chest NN B-NP O
103 exam NN I-NP O
103 remained VBD B-VP O
104 rancorous JJ O O
104 and CC O O
104 the DT B-NP O
104 reason NN I-NP O
104 for IN B-VP O
104 this DT O O
104 remained JJ O O
104 unclear JJ O O
104 Given VBN O O
104 the DT B-NP O
105 finding NN I-NP O
105 of IN B-VP O
105 E-coli NNP B-NP O
105 in IN B-VP O
105 the DT B-NP O
105 sputum NN I-NP O
105 sample NN I-NP O
105 , , O O
105 in IN B-VP O
105 addition NN B-NP O
105 to TO O O
105 the DT O O
105 elevated VBN O O
106 eosinophilia NN B-NP O
106 and CC O O
106 lack NN B-NP O
106 of IN B-VP O
106 finding VBG O O
106 on IN B-VP O
106 chest JJS O O
106 x-ray JJ O O
106 despite IN B-VP O
106 significant JJ B-NP O
107 findings NNS I-NP O
107 on IN B-VP O
107 chest NN B-NP O
107 exam NN I-NP O
107 , , O O
107 the DT B-NP O
107 possibility NN I-NP O
107 of IN B-VP O
107 a DT B-NP O
107 worm NN I-NP O
107 or CC O O
107 parasitic JJ B-NP O
108 disease NN I-NP O
108 was VBD B-VP O
108 raised VBN O O
108 The DT B-NP O
108 patient NN I-NP O
108 is VBZ O O
108 from IN B-VP O
108 Pa NNP B-NP O
108 but CC O O
108 had VBD B-VP O
108 not RB O O
108 been VBN O O
109 there RB O O
109 in IN B-VP O
109 8 CD O O
109 years NNS B-NP O
109 She PRP O O
109 did VBD B-VP O
109 have VB O O
109 a DT B-NP O
109 history NN I-NP O
109 of IN B-VP O
109 diarrhea NN B-NP O
109 for IN B-VP O
109 several JJ B-NP O
110 weeks NNS I-NP O
110 a DT B-NP O
110 few JJ I-NP O
110 months NNS I-NP O
110 prior RB O O
110 to TO O O
110 this DT B-NP O
110 admission NN I-NP O
110 Stool NNP I-NP O
110 specimen NNS I-NP O
110 was VBD B-VP O
111 sent VBN O O
111 but CC O O
111 was VBD B-VP O
111 rejected VBN O O
111 by IN B-VP O
111 the DT B-NP O
111 laboratory NN I-NP O
111 and CC O O
111 the DT B-NP O
111 patient NN I-NP O
111 was VBD B-VP O
111 unable JJ O O
112 to TO O O
112 produce VB O O
112 another DT B-NP O
112 stool NN I-NP O
112 specimen NNS I-NP O
112 before IN B-VP O
112 discharge NN B-NP O
112 The DT B-NP O
112 patient NN I-NP O
113 was VBD B-VP O
113 discharged VBN O O
113 to TO O O
113 home NN B-NP O
113 with IN B-VP O
113 Albuterol NNP B-NP B-m
113 inhaler NN I-NP I-m
113 and CC O O
113 instructions NNS B-NP O
113 to TO O O
114 follow VB O O
114 up RP O O
114 with IN B-VP O
114 her PRP$ O O
114 primary JJ B-NP O
114 physician NN I-NP O
114 In IN B-VP O
114 addition NN B-NP O
114 , , O O
114 plans NNS B-NP O
114 were VBD B-VP O
114 made VBN O O
115 for IN B-VP O
115 her PRP$ O O
115 to TO O O
115 have VB O O
115 PFTs NNP B-NP O
115 done VBN O O
115 as IN B-VP O
115 an DT B-NP O
115 outpatient NN I-NP O
115 and CC O O
115 plan NN B-NP O
115 for IN B-VP O
115 chest NN B-NP O
115 CT NN I-NP O
115 if IN B-VP O
116 her PRP$ O O
116 symptoms NNS B-NP O
116 continued VBN O O
116 without IN B-VP O
116 other JJ B-NP O
116 etiology NN I-NP O
116 being VBG O O
116 discovered VBN O O
117 MEDICATIONS NNP B-NP O
117 ON NNP I-NP O
117 DISCHARGE: NNP I-NP O
117 1 CD O O
117 ) ) O O
117 Enteric NNP B-NP B-m
117 coated VBD B-VP I-m
117 aspirin RB O I-m
117 325 CD O B-do
117 mg NNS B-NP I-do
117 po JJ B-NP B-mo
118 q JJ I-NP B-f
118 day NN I-NP I-f
118 2 CD O O
118 ) ) O O
118 Cefuroxime NNP B-NP B-m
118 500 CD O B-do
118 mg NN B-NP I-do
118 PO NNP I-NP B-mo
118 b.i.d VBZ O B-f
119 3 CD O O
119 ) ) O O
119 Premarin VBD B-VP B-m
119 0.625 CD O B-do
119 mg NN B-NP I-do
119 PO NNP I-NP B-mo
119 q NNP I-NP B-f
119 day NN I-NP I-f
119 4 CD O O
119 ) ) O O
119 Lasix FW O B-m
119 40 CD O B-do
119 mg NN B-NP I-do
119 PO NNP I-NP B-mo
119 q NNP I-NP B-f
119 day NN I-NP I-f
119 5 CD O O
119 ) ) O O
120 Tofranil $ O B-m
120 75 CD O B-do
120 mg NN B-NP I-do
120 PO NNP I-NP B-mo
120 q NN I-NP B-f
120 HS NNP I-NP I-f
120 6 CD O O
120 ) ) O O
120 Zestril VBD B-VP B-m
120 20 CD O B-do
120 mg NN B-NP I-do
120 PO NNP I-NP B-mo
120 b.i.d VBZ O B-f
120 7 CD O O
120 ) ) O O
120 Verapamil NNP B-NP B-m
121 SR NNP I-NP O
121 120 CD O B-do
121 mg NN B-NP I-do
121 PO NNP I-NP B-mo
121 b.i.d VBZ O B-f
121 8 CD O O
121 ) ) O O
121 Insulin NNP B-NP B-m
121 Insulin NNP I-NP B-m
121 70/30 CD O I-m
121 70/30 CD O I-m
121 28 CD O B-do
121 units NNS B-NP I-do
121 q JJ B-NP B-f
121 a.m NN I-NP I-f
121 and CC O O
121 5 CD O B-do
121 units NNS B-NP I-do
122 q RB O B-f
122 p.m VBP O I-f
122 subcue JJ O B-mo
122 9 CD O O
122 ) ) O O
122 Potassium NN B-NP B-m
122 slow JJ B-NP I-m
122 release NN I-NP I-m
122 10 CD O B-do
122 mEq NN B-NP I-do
122 PO NNP I-NP B-mo
122 q NNP I-NP B-f
122 day NN I-NP I-f
122 10 CD O O
122 ) ) O O
123 Albuterol NNP B-NP B-m
123 inhaler NN I-NP I-m
123 two CD O B-do
123 puffs NNS B-NP I-do
123 inhaled VBD B-VP B-mo
123 q.i.d JJ B-NP B-f
124 DISPOSITION: NNP I-NP O
124 At IN B-VP O
124 the DT B-NP O
124 time NN I-NP O
124 of IN B-VP O
124 discharge NN B-NP O
124 the DT B-NP O
124 patient's NN I-NP O
124 saturation NN I-NP O
124 was VBD B-VP O
125 92 CD O O
125 to TO O O
125 93% CD O O
125 on IN B-VP O
125 room NN B-NP O
125 air NN I-NP O
125 and CC O O
125 dropping VBG O O
125 slightly RB O O
125 to TO O O
125 90 CD O O
125 to TO O O
126 91% CD O O
126 with IN B-VP O
126 exercise NN B-NP O
126 , , O O
126 however RB O O
126 she PRP O O
126 was VBD B-VP O
126 tolerating VBG O O
126 this DT B-NP O
126 well NN I-NP O
126 and CC O O
126 was VBD B-VP O
127 getting VBG O O
127 relief NN B-NP O
127 from IN B-VP O
127 her PRP$ O O
127 Albuterol NNP B-NP B-m
127 inhaler NN I-NP I-m
127 She PRP O O
127 was VBD B-VP O
127 to TO O O
127 finish VB O O
127 a DT B-NP O
128 full JJ I-NP O
128 ten JJ I-NP B-du
128 day NN I-NP I-du
128 course NN I-NP I-du
128 of IN B-VP O
128 antibiotics NNS B-NP B-m
128 for IN B-VP O
128 presumed JJ B-NP B-r
128 bronchitis NN I-NP I-r
128 and CC O O
128 to TO O O
129 follow VB O O
129 up RP O O
129 with IN B-VP O
129 her PRP$ O O
129 primary JJ B-NP O
129 physician NN I-NP O
129 in IN B-VP O
129 clinic NN B-NP O
129 for IN B-VP O
129 further JJ B-NP O
130 evaluation NN I-NP O
130 including VBG O O
130 PFTs NNP B-NP O
130 and CC O O
130 possible JJ B-NP O
130 chest NN I-NP O
130 CT NNP I-NP O
130 if IN B-VP O
130 symptoms NNS B-NP O
130 did VBD B-VP O
130 not RB O O
131 abate VB O O
132 Dictated NNP B-NP O
132 By: NNP I-NP O
132 RICKEY NNP I-NP O
132 HAWS NNP I-NP O
132 , , O O
132 M.D NNP B-NP O
132 ZW08 NNP I-NP O
133 Attending: NNP I-NP O
133 ANDREA NNP I-NP O
133 E NNP I-NP O
133 LEETH NNP I-NP O
133 , , O O
133 M.D NNP B-NP O
133 KO9 NNP I-NP O
134 TG420/6864 NNP I-NP O
135 Batch: NNP I-NP O
135 52134 CD O O
135 Index NNP B-NP O
135 No NNP I-NP O
135 DXRA899I31 NNP I-NP O
135 D: NNP I-NP O
135 10/6/97 CD O O
136 T: NNP B-NP O
136 2/30/97 CD O O
137 CC: NNP B-NP O
137 1 CD O O
137 CLEVELAND NNP B-NP O
137 MAYR NNP I-NP O
137 , , O O
137 M.D NNP B-NP O
137 ZW08 NNP I-NP O
138 2 CD O O
138 FRANKLIN NNP B-NP O
138 H NNP I-NP O
138 KUKAHIKO NNP I-NP O
138 , , O O
138 M.D NNP B-NP O
138 KO9 NNP I-NP O
139 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #921741 VBZ O O
4 024934655 CD O O
4 GTMHO NNP B-NP O
4 75482269 CD O O
4 7544011 CD O O
4 11/4/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 , , O O
4 CARDIOMYOPATHY NNP B-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/4/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/19/2004 CD O O
7 ATTENDING: NNP B-NP O
7 MILFORD NNP I-NP O
7 WIZWER NNP I-NP O
7 M.D NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
9 This DT O O
9 is VBZ O O
9 a DT B-NP O
9 36-year-old JJ I-NP O
9 man NN I-NP O
9 with IN B-VP O
9 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 a DT B-NP O
9 familial JJ I-NP O
10 cardiomyopathy NN I-NP O
10 , , O O
10 ejection NN B-NP O
10 fraction NN I-NP O
10 estimated VBN O O
10 at IN B-VP O
10 around IN B-VP O
10 15% CD O O
10 with IN B-VP O
11 marked VBN O O
11 left NN B-NP O
11 and CC O O
11 right JJ B-NP O
11 chamber NN I-NP O
11 enlargement NN I-NP O
11 , , O O
11 severe JJ B-NP O
11 mitral JJ I-NP O
12 regurgitation NN I-NP O
12 , , O O
12 tricuspid JJ B-NP O
12 regurgitation NN I-NP O
12 , , O O
12 and CC O O
12 PA NNP B-NP O
12 pressures NNS I-NP O
12 of IN B-VP O
12 51 CD O O
13 plus CC O O
13 right JJ B-NP O
13 atrium NN I-NP O
13 , , O O
13 as IN B-VP O
13 per IN B-VP O
13 an DT B-NP O
13 echo NN I-NP O
13 in IN B-VP O
13 2003 CD O O
13 He PRP O O
13 was VBD B-VP O
13 also RB O O
13 status NN B-NP O
14 post NN I-NP O
14 ICD NNP I-NP O
14 placement NN I-NP O
14 in IN B-VP O
14 2001 CD O O
14 At IN B-VP O
14 baseline NN B-NP O
14 , , O O
14 he PRP O O
14 has VBZ O O
14 a DT O O
14 one CD O O
14 staircase NN B-NP O
15 exercise NN I-NP O
15 tolerance NN I-NP O
15 before IN B-VP O
15 becoming VBG O O
15 short JJ O O
15 of IN B-VP O
15 breath NN B-NP O
15 He PRP O O
15 also RB O O
16 admits VBZ O O
16 that IN B-VP O
16 he PRP O O
16 has VBZ O O
16 been VBN O O
16 having VBG O O
16 increasing VBG O O
16 orthopnea NN B-NP O
16 and CC O O
17 paroxysmal JJ B-NP O
17 nocturnal JJ I-NP O
17 dyspnea NN I-NP O
17 He PRP O O
17 denies VBZ O O
17 , , O O
17 chest JJS B-NP O
17 pain NN I-NP O
17 , , O O
18 palpitations NNS B-NP O
18 , , O O
18 or CC O O
18 peripheral JJ B-NP O
18 edema NN I-NP O
18 He PRP O O
18 also RB O O
18 has VBZ O O
18 a DT B-NP O
18 history NN I-NP O
18 of IN B-VP O
19 dietary JJ B-NP O
19 fluid NNS I-NP O
19 intake NN I-NP O
19 and CC O O
19 medications NNS B-NP O
19 noncompliance RB O O
19 leading VBG O O
19 to TO O O
20 heart NN B-NP O
20 failure NN I-NP O
20 exacerbations NNS I-NP O
20 Currently RB O O
20 , , O O
20 he PRP O O
20 states VBZ O O
20 that IN B-VP O
20 he PRP O O
20 has VBZ O O
21 been VBN O O
21 eating VBG O O
21 "salty NN B-NP O
21 foods NNS I-NP O
21 , , O O
21 " NN B-NP O
21 and CC O O
21 has VBZ O O
21 been VBN O O
21 drinking VBG O O
21 a DT B-NP O
21 lot NN I-NP O
21 of IN B-VP O
21 extra JJ B-NP O
22 fluids NNS I-NP O
22 because IN B-VP O
22 he PRP O O
22 has VBZ O O
22 been VBN O O
22 feeling VBG O O
22 dry JJ O O
22 and CC O O
22 is VBZ O O
22 not RB O O
22 always RB O O
22 taking VBG O O
23 his PRP$ O O
23 medications NNS B-NP O
23 Consequently RB O O
23 , , O O
23 he PRP O O
23 has VBZ O O
23 noticed VBN O O
23 a DT B-NP O
23 worsening NN I-NP O
23 in IN B-VP O
23 his PRP$ O O
24 exercise NN B-NP O
24 tolerance NN I-NP O
24 , , O O
24 worsening VBG O O
24 orthopnea NN B-NP O
24 , , O O
24 and CC O O
24 most JJS O O
24 notably RB O O
24 an DT B-NP O
25 increase NN I-NP O
25 in IN B-VP O
25 abdominal JJ B-NP O
25 girth NN I-NP O
25 Because IN B-VP O
25 of IN B-VP O
25 these DT B-NP O
25 symptoms NNS I-NP O
26 consistent VBP O O
26 with IN B-VP O
26 decompensated JJ B-NP O
26 heart NN I-NP O
26 failure NN I-NP O
26 , , O O
26 his PRP$ O O
26 physicians NNS B-NP O
27 suggested VBD B-VP O
27 that IN B-VP O
27 he PRP O O
27 be VB O O
27 admitted VBN O O
27 to TO O O
27 the DT B-NP O
27 hospital NN I-NP O
27 for IN B-VP O
27 management NN B-NP O
27 of IN B-VP O
28 his PRP$ O O
28 decompensated JJ B-NP O
28 heart NN I-NP O
28 failure NN I-NP O
28 Of IN B-VP O
28 note NN B-NP O
28 , , O O
28 he PRP O O
28 has VBZ O O
28 been VBN O O
28 previously RB O O
29 on IN B-VP O
29 a DT B-NP O
29 transplant JJ I-NP O
29 list NN I-NP O
29 , , O O
29 but CC O O
29 has VBZ O O
29 been VBN O O
29 delisted VBN O O
29 given VBN O O
29 his PRP$ O O
30 noncompliance NN B-NP O
30 and CC O O
30 continuation NN B-NP O
30 of IN B-VP O
30 tobacco NN B-NP O
30 use NN I-NP O
31 PAST NNP I-NP O
31 MEDICAL NNP I-NP O
31 HISTORY: NNP I-NP O
32 In IN B-VP O
32 addition NN B-NP O
32 to TO O O
32 the DT B-NP O
32 cardiomyopathy NN I-NP O
32 is VBZ O O
32 chronic JJ B-NP O
32 renal JJ I-NP O
32 insufficiency NN I-NP O
33 with IN B-VP O
33 the DT B-NP O
33 creatinine NN I-NP O
33 ranging VBG O O
33 from IN B-VP O
33 1.2 CD O O
33 to TO O O
33 3.5 CD O O
33 at IN B-VP O
33 times NNS B-NP O
34 MEDICATIONS NNP I-NP O
34 ON NNP I-NP O
34 ADMISSION: NNP I-NP O
35 Aldactone NNP I-NP B-m
35 25 CD O B-do
35 mg NN B-NP I-do
35 once RB O B-f
35 a DT B-NP I-f
35 day NN I-NP I-f
35 , , O O
35 K-Dur NNP B-NP B-m
35 40 CD O B-do
35 mEq NN B-NP I-do
35 once RB O B-f
35 a DT B-NP I-f
35 day NN I-NP I-f
35 , , O O
35 lisinopril VBZ O B-m
36 2.5 CD O B-do
36 mg NN B-NP I-do
36 once RB O B-f
36 a DT B-NP I-f
36 day NN I-NP I-f
36 , , O O
36 Isordil NNP B-NP B-m
36 20 CD O B-do
36 mg NN B-NP I-do
36 three CD O B-f
36 times NNS B-NP I-f
36 a DT B-NP I-f
36 day NN I-NP I-f
36 , , O O
36 digoxin NN B-NP B-m
36 0.125 CD O B-do
37 once RB O B-f
37 a DT B-NP I-f
37 day NN I-NP I-f
37 , , O O
37 torsemide RB O B-m
37 200 CD O B-do
37 mg NN B-NP I-do
37 twice RB O B-f
37 , , O O
37 and CC O O
37 metolazone NN B-NP B-m
37 p.r.n NN I-NP B-f
37 for IN B-VP O
38 volume NN B-NP B-r
38 overload NN I-NP I-r
39 SOCIAL NNP I-NP O
39 HISTORY: NNP I-NP O
40 As NNP I-NP O
40 mentioned VBD B-VP O
40 , , O O
40 he PRP O O
40 is VBZ O O
40 smoking VBG O O
40 one-half JJ O O
40 per IN B-VP O
40 day NN B-NP O
40 of IN B-VP O
40 cigarettes NNS B-NP O
40 , , O O
41 occasional JJ B-NP O
41 alcohol NN I-NP O
41 use NN I-NP O
41 , , O O
41 no DT B-NP O
41 IV NNP I-NP O
41 drug NN I-NP O
41 use NN I-NP O
42 FAMILY NNP I-NP O
42 HISTORY: NNP I-NP O
43 His PRP$ O O
43 mother NN B-NP O
43 , , O O
43 his PRP$ O O
43 brother NN B-NP O
43 , , O O
43 and CC O O
43 his PRP$ O O
43 cousin NN B-NP O
43 and CC O O
43 nephew RB O O
43 all DT O O
43 have VBP O O
43 the DT B-NP O
44 familial JJ I-NP O
44 cardiomyopathy JJ I-NP O
45 PHYSICAL NNP I-NP O
45 EXAMINATION: NNP I-NP O
46 On IN B-VP O
46 the DT B-NP O
46 day NN I-NP O
46 of IN B-VP O
46 admission NN B-NP O
46 , , O O
46 he PRP O O
46 presented VBD B-VP O
46 with IN B-VP O
46 the DT B-NP O
46 JVP NNP I-NP O
46 in IN B-VP O
46 the DT O O
46 18 CD O O
46 to TO O O
47 20 CD O O
47 range NN B-NP O
47 on IN B-VP O
47 the DT B-NP O
47 physical JJ I-NP O
47 examination NN I-NP O
47 with IN B-VP O
47 positive JJ B-NP O
47 HJR NNP I-NP O
47 His PRP$ O O
48 cardiac NN B-NP O
48 exam NN I-NP O
48 had VBD B-VP O
48 a DT B-NP O
48 positive JJ I-NP O
48 S3 NNP I-NP O
48 of IN B-VP O
48 laterally RB O O
48 displaced VBN O O
48 PMI NNP B-NP O
48 with IN B-VP O
49 the DT B-NP O
49 right JJ I-NP O
49 ventricular NN I-NP O
49 heave NN I-NP O
49 He PRP O O
49 also RB O O
49 had VBD B-VP O
49 a DT O O
49 2/6 CD O O
49 systolic JJ O O
49 murmur FW O O
50 His PRP$ O O
50 abdomen NNS B-NP O
50 was VBD B-VP O
50 distended VBN O O
50 , , O O
50 nontender NN B-NP O
50 , , O O
50 but CC O O
50 likely RB O O
50 with IN B-VP O
50 ascites NNS B-NP O
50 and CC O O
51 palpable JJ B-NP O
51 liver NN I-NP O
51 edge VB O O
51 His PRP$ O O
51 extremities NNS B-NP O
51 were VBD B-VP O
51 warm JJ O O
51 without IN B-VP O
51 edema JJ B-NP O
52 HOSPITAL NNP I-NP O
52 COURSE: NNP I-NP O
53 From IN B-VP O
53 the DT B-NP O
53 cardiac JJ I-NP O
53 standpoint NN I-NP O
53 , , O O
53 we PRP O O
53 initially RB O O
53 attempted VBD B-VP O
53 to TO O O
53 diurese VB O O
54 him PRP O O
54 IV NNP B-NP B-mo
54 torsemide RB O B-m
54 200 CD O B-do
54 mg NN B-NP I-do
54 b.i.d NN I-NP B-f
54 However RB O O
54 , , O O
54 he PRP O O
54 did VBD B-VP O
54 not RB O O
54 respond VB O O
54 well RB O O
55 enough RB O O
55 to TO O O
55 this DT B-NP O
55 regimen NNS I-NP O
55 , , O O
55 and CC O O
55 therefore RB O O
55 we PRP O O
55 started VBD B-VP O
55 drip NN B-NP B-mo
55 with IN B-VP O
56 Zaroxolyn NNP B-NP B-m
56 p.r.n NN I-NP B-f
56 We PRP O O
56 also RB O O
56 stopped VBD B-VP O
56 his PRP$ O O
56 Isordil NNP B-NP B-m
56 and CC O O
56 ACE NNP B-NP B-m
56 inhibitor VBP O I-m
57 early RB O O
57 on IN B-VP O
57 because IN B-VP O
57 of IN B-VP O
57 blood NN B-NP B-r
57 pressures NNS I-NP I-r
57 in IN B-VP O
57 the DT O O
57 80s CD O O
57 On IN B-VP O
57 admission NN B-NP O
57 , , O O
58 his PRP$ O O
58 creatinine NN B-NP O
58 was VBD B-VP O
58 2.0 CD O O
58 and CC O O
58 on IN B-VP O
58 the DT B-NP O
58 next JJ I-NP O
58 day NN I-NP O
58 of IN B-VP O
58 admission NN B-NP O
58 , , O O
58 it PRP O O
58 was VBD B-VP O
59 2.2 CD O O
59 with IN B-VP O
59 low JJ B-NP O
59 blood NN I-NP O
59 pressures NNS I-NP O
59 , , O O
59 at IN B-VP O
59 which WDT O O
59 point NN B-NP O
59 , , O O
59 we PRP O O
59 decided VBD B-VP O
59 to TO O O
59 start VB O O
60 a DT B-NP O
60 low-dose JJ I-NP O
60 dopamine NN I-NP B-m
60 drips NNS I-NP B-mo
60 at IN B-VP O
60 2 CD O O
60 mcg NNS B-NP O
60 per IN B-VP B-f
60 hour NN B-NP I-f
60 However RB O O
60 , , O O
60 his PRP$ O O
60 urine JJ B-NP O
61 output NN I-NP O
61 was VBD B-VP O
61 only RB O O
61 about RB O O
61 500 CD O O
61 cc NNS B-NP O
61 negative JJ O O
61 , , O O
61 so IN B-VP O
61 we PRP O O
61 further VBP O O
61 increased VBD B-VP O
62 the DT B-NP O
62 Lasix NNP I-NP B-m
62 Lasix NNP I-NP B-m
62 drip NN I-NP I-m
62 drip NN I-NP I-m
62 from IN B-VP O
62 10 CD O B-do
62 10 CD O B-do
62 mg NN B-NP I-do
62 mg VBD B-VP I-do
62 an DT B-NP B-f
62 hour NN I-NP I-f
62 to TO O O
62 20 CD O O
62 mg NNS B-NP O
62 an DT B-NP B-du
62 hour NN I-NP I-du
62 after IN B-VP O
62 200 CD O B-do
62 mg NN B-NP I-do
63 IV NNP I-NP B-mo
63 Lasix NNP I-NP B-m
63 bolus NN I-NP I-m
63 On IN B-VP O
63 this DT B-NP O
63 combination NN I-NP O
63 of IN B-VP O
63 the DT B-NP O
63 Lasix NNP I-NP B-m
63 drip NN I-NP I-m
63 at IN B-VP O
63 20 CD O B-do
63 an DT B-NP B-f
64 hour NN I-NP O
64 and CC O O
64 dopamine NN B-NP B-m
64 at IN B-VP O
64 2 CD O B-do
64 mcg NNS B-NP I-do
64 per IN B-VP B-f
64 hour NN B-NP I-f
64 , , O O
64 he PRP O O
64 began VBD B-VP O
64 to TO O O
64 have VB O O
64 very RB O O
64 good JJ O O
65 and CC O O
65 effective JJ B-NP O
65 urine NN I-NP O
65 output NN I-NP O
65 at IN B-VP O
65 approximately RB O O
65 2-3 JJ B-NP O
65 liters NNS I-NP O
65 per IN B-VP O
65 day NN B-NP O
65 , , O O
66 negative JJ O O
66 , , O O
66 also RB O O
66 reflected VBN O O
66 in IN B-VP O
66 his PRP$ O O
66 total JJ B-NP O
66 weight NN I-NP O
66 , , O O
66 and CC O O
66 came VBD B-VP O
66 in IN B-VP O
66 with IN B-VP O
67 admission NN B-NP O
67 weight NN I-NP O
67 of IN B-VP O
67 around IN B-VP O
67 90 CD O O
67 kg NNS B-NP O
67 On IN B-VP O
67 each DT B-NP O
67 day NN I-NP O
67 , , O O
67 he PRP O O
67 diuresed VBD B-VP O
67 about IN B-VP O
68 an DT B-NP O
68 half NN I-NP O
68 to TO O O
68 kilo VB O O
68 off RP O O
68 until IN B-VP O
68 the DT B-NP O
68 day NN I-NP O
68 of IN B-VP O
68 discharge NN B-NP O
68 , , O O
68 at IN B-VP O
68 which WDT O O
68 point NN B-NP O
68 , , O O
69 he PRP O O
69 was VBD B-VP O
69 less JJR O O
69 than IN B-VP O
69 86 CD O O
69 kg NN B-NP O
69 We PRP O O
69 monitored VBD B-VP O
69 strict JJ B-NP O
69 I's NNP I-NP O
69 and CC O O
69 O's NNP B-NP O
69 , , O O
69 checked VBD B-VP O
70 daily JJ B-NP O
70 weight NN I-NP O
70 During IN B-VP O
70 the DT B-NP O
70 course NN I-NP O
70 of IN B-VP O
70 his PRP$ O O
70 diuresis NN B-NP O
70 , , O O
70 his PRP$ O O
70 sodium NN B-NP O
71 levels NNS I-NP O
71 were VBD B-VP O
71 decreasing VBG O O
71 mostly RB O O
71 secondary JJ O O
71 to TO O O
71 the DT B-NP O
71 patient NN I-NP O
71 drinking VBG O O
71 a DT B-NP O
72 lot NN I-NP O
72 of IN B-VP O
72 free JJ B-NP O
72 water NN I-NP O
72 The DT B-NP O
72 combination NN I-NP O
72 of IN B-VP O
72 free JJ B-NP O
72 water NN I-NP O
72 intake NN I-NP O
72 in IN B-VP O
72 the DT B-NP O
73 setting NN I-NP O
73 of IN B-VP O
73 natriuresis NN B-NP O
73 resulted VBN O O
73 in IN B-VP O
73 further JJ B-NP O
73 worsening NN I-NP O
73 of IN B-VP O
73 his PRP$ O O
74 hyponatremia NN B-NP O
74 from IN B-VP O
74 an DT B-NP O
74 admission NN I-NP O
74 sodium NN I-NP O
74 of IN B-VP O
74 128 CD O O
74 to TO O O
74 124 CD O O
74 , , O O
74 eventually RB O O
75 to TO O O
75 122 CD O O
75 We PRP O O
75 strictly RB O O
75 reinforce VBP O O
75 the DT B-NP O
75 need NN I-NP O
75 to TO O O
75 limit VB O O
75 his PRP$ O O
75 fluid NN B-NP O
75 intake NN I-NP O
76 to TO O O
76 less JJR O O
76 than IN B-VP O
76 2 CD O O
76 liters NNS B-NP O
76 per IN B-VP O
76 day NN B-NP O
76 , , O O
76 and CC O O
76 at IN B-VP O
76 that DT B-NP O
76 point NN I-NP O
76 , , O O
76 his PRP$ O O
76 sodium NN B-NP O
77 levels NNS I-NP O
77 than IN B-VP O
77 rebounded VBD B-VP O
77 to TO O O
77 124 CD O O
77 and CC O O
77 also RB O O
77 128 CD O O
77 on IN B-VP O
77 the DT B-NP O
77 day NN I-NP O
77 of IN B-VP O
78 discharge NN B-NP O
78 We PRP O O
78 monitored VBD B-VP O
78 the DT B-NP O
78 b.i.d NN I-NP O
78 lytes VBZ O O
78 Eventually RB O O
78 , , O O
78 his PRP$ O O
78 blood NN B-NP O
79 pressures NNS I-NP O
79 remained VBD B-VP O
79 stable JJ O O
79 His PRP$ O O
79 JVP NNP B-NP O
79 decreased VBD B-VP O
79 from IN B-VP O
79 18 CD O O
79 to TO O O
79 20 CD O O
79 on IN B-VP O
80 admission NN B-NP O
80 to TO O O
80 about RB O O
80 10 CD O O
80 to TO O O
80 12 CD O O
80 and CC O O
80 continued VBD B-VP O
80 to TO O O
80 have VB O O
80 good JJ B-NP O
80 urine NN I-NP O
81 output NN I-NP O
81 , , O O
81 thus RB O O
81 we PRP O O
81 weaned VBD B-VP O
81 off RP O O
81 the DT B-NP O
81 dopamine NN I-NP B-m
81 , , O O
81 but CC O O
81 continued VBD B-VP O
81 the DT B-NP O
81 Lasix NNP I-NP B-m
82 drip NN I-NP O
82 for IN B-VP B-du
82 one CD O I-du
82 more JJR B-NP I-du
82 day NN I-NP I-du
82 We PRP O O
82 then RB O O
82 discontinued VBD B-VP O
82 the DT B-NP O
82 Lasix NNP I-NP B-m
82 drip NN I-NP B-mo
82 and CC O O
83 transitioned VBD B-VP O
83 him PRP O O
83 back RB O O
83 over IN B-VP O
83 to TO O O
83 torsemide VB O B-m
83 200 CD O B-do
83 b.i.d NN B-NP B-f
83 p.o NN I-NP B-mo
83 , , O O
83 which WDT O O
84 was VBD B-VP O
84 his PRP$ O O
84 home NN B-NP O
84 regimen NNS I-NP O
84 and CC O O
84 watch VBP O O
84 him PRP O O
84 for IN B-VP O
84 another DT O O
84 24 CD O O
84 hours NNS B-NP O
84 He PRP O O
85 continued VBD B-VP O
85 to TO O O
85 diurese VB O O
85 at IN B-VP O
85 this DT B-NP O
85 dose NN I-NP O
85 , , O O
85 but CC O O
85 then RB O O
85 on IN B-VP O
85 the DT B-NP O
85 day NN I-NP O
85 of IN B-VP O
86 discharge NN B-NP O
86 , , O O
86 his PRP$ O O
86 I's NNP B-NP O
86 and CC O O
86 O's NNP B-NP O
86 were VBD B-VP O
86 finally RB O O
86 about IN B-VP O
86 500 CD O O
86 cc NNS B-NP O
86 negative JJ O O
86 , , O O
87 which WDT O O
87 is VBZ O O
87 a DT B-NP O
87 change NN I-NP O
87 from IN B-VP O
87 about IN B-VP O
87 1 CD O O
87 to TO O O
87 2 CD O O
87 liters NNS B-NP O
87 negative JJ O O
87 per IN B-VP O
87 day NN B-NP O
87 His PRP$ O O
88 JVP NNP B-NP O
88 was VBD B-VP O
88 about RB O O
88 9 CD O O
88 to TO O O
88 10 CD O O
88 and CC O O
88 his PRP$ O O
88 creatinine NN B-NP O
88 was VBD B-VP O
88 stable JJ O O
88 at IN B-VP O
88 1.7 CD O O
88 We PRP O O
89 re-added VBD B-VP O
89 his PRP$ O O
89 Isordil NN B-NP B-m
89 at IN B-VP O
89 10 CD O B-do
89 mg NNS B-NP I-do
89 t.i.d NN I-NP B-f
89 for IN B-VP B-du
89 the DT O I-du
89 last JJ O I-du
89 24 CD O I-du
89 hours NNS B-NP I-du
89 and CC O O
90 his PRP$ O O
90 blood NN B-NP B-r
90 pressures NNS I-NP I-r
90 were VBD B-VP O
90 stable JJ O O
90 in IN B-VP O
90 the DT O O
90 90s CD O O
90 Given NNP B-NP O
90 his PRP$ O B-r
90 potassium NN B-NP B-m
90 potassium NN I-NP I-r
90 , , O O
91 which WDT O O
91 was VBD B-VP O
91 always RB O O
91 borderline JJ O O
91 low JJ O O
91 in IN B-VP O
91 the DT O O
91 33 CD O O
91 or CC O O
91 35 CD O O
91 range NN B-NP O
91 , , O O
91 we PRP O O
91 decided VBD B-VP O
92 to TO O O
92 increase VB O O
92 his PRP$ O O
92 Aldactone NNP B-NP B-m
92 Aldactone NNP I-NP B-m
92 dose VBD B-VP O
92 to TO O O
92 25 CD O B-do
92 mg NN B-NP I-do
92 b.i.d NN I-NP B-f
92 , , O O
92 but CC O O
92 given VBN O O
92 his PRP$ O O
93 underlying JJ B-NP O
93 renal JJ I-NP O
93 insufficiency NN I-NP O
93 , , O O
93 we PRP O O
93 have VBP O O
93 decreased VBN O O
93 his PRP$ O O
93 standing VBG O O
94 K-Dur NNP B-NP B-m
94 K-Dur NNP I-NP B-m
94 from IN B-VP O
94 40 CD O B-do
94 mEq NNS B-NP I-do
94 a DT B-NP B-f
94 day NN I-NP I-f
94 to TO O O
94 20 CD O B-do
94 mEq NNS B-NP I-do
94 a DT B-NP B-f
94 day NN I-NP I-f
94 An DT B-NP O
94 echo NN I-NP O
94 was VBD B-VP O
94 done VBN O O
94 , , O O
94 which WDT O O
95 showed VBD B-VP O
95 an DT B-NP O
95 ejection NN I-NP O
95 fraction NN I-NP O
95 of IN B-VP O
95 20% CD O O
95 and CC O O
95 4+ CD O O
95 MR NNP B-NP O
95 They PRP O O
95 did VBD B-VP O
95 not RB O O
96 comment VB O O
96 on IN B-VP O
96 the DT B-NP O
96 synchrony NN I-NP O
96 on IN B-VP O
96 the DT B-NP O
96 preliminary JJ I-NP O
96 report NN I-NP O
96 However RB O O
96 , , O O
96 he PRP O O
97 is VBZ O O
97 a DT B-NP O
97 candidate NN I-NP O
97 for IN B-VP O
97 Bi-V NNP B-NP O
97 pacing VBG O O
97 given VBN O O
97 his PRP$ O O
97 mildly RB O O
97 widened VBD B-VP O
97 QRS NNP B-NP O
98 complex JJ B-NP O
98 stage NN I-NP O
98 III NNP I-NP O
98 heart NN I-NP O
98 failure NN I-NP O
98 and CC O O
98 having VBG O O
98 been VBN O O
98 on IN B-VP O
98 a DT O O
98 very RB O O
98 good JJ B-NP O
99 heart NN I-NP O
99 failure NN I-NP O
99 regimen VBZ O O
99 up RP O O
99 until IN B-VP O
99 this DT B-NP O
99 point NN I-NP O
100 DISCHARGE NNP I-NP O
100 MEDICATIONS: NNP I-NP O
101 At IN B-VP O
101 discharge NN B-NP O
101 , , O O
101 his PRP$ O O
101 medical JJ B-NP O
101 regimen NNS I-NP O
101 consisted VBN O O
101 of IN B-VP O
101 digoxin NN B-NP B-m
101 0.125 CD O B-do
101 mg NN B-NP I-do
102 once RB O B-f
102 a DT B-NP I-f
102 day NN I-NP I-f
102 , , O O
102 torsemide RB O B-m
102 200 CD O B-do
102 mg NN B-NP I-do
102 b.i.d NN I-NP B-f
102 , , O O
102 Aldactone NNP B-NP B-m
102 25 CD O B-do
102 mg NN B-NP I-do
102 b.i.d NN I-NP B-f
102 , , O O
103 Isordil NNP B-NP B-m
103 10 CD O B-do
103 mg NN B-NP I-do
103 t.i.d NN I-NP B-f
103 , , O O
103 and CC O O
103 K-Dur NNP B-NP B-m
103 20 CD O B-do
103 mEq NN B-NP I-do
103 We PRP O O
103 also RB O O
103 added VBD B-VP O
103 folate JJ O B-m
103 5 CD O B-do
104 mg NN B-NP O
104 to TO O O
104 his PRP$ O O
104 regimen NNS B-NP O
104 because IN B-VP O
104 he PRP O O
104 had VBD B-VP O
104 an DT B-NP O
104 elevated JJ I-NP B-r
104 homocystine NN I-NP I-r
104 level NN I-NP O
105 He PRP O O
105 also RB O O
105 takes VBZ O O
105 Ambien NNP B-NP B-m
105 at IN B-VP B-f
105 night NN B-NP I-f
105 p.r.n NN I-NP I-f
105 for IN B-VP O
105 insomnia NN B-NP B-r
106 DISPOSITION: NNP I-NP O
107 He PRP O O
107 is VBZ O O
107 being VBG O O
107 discharged VBN O O
107 to TO O O
107 home NN B-NP O
107 with IN B-VP O
107 plan NN B-NP O
107 to TO O O
107 follow VB O O
107 up RP O O
107 with IN B-VP O
107 Dr NNP B-NP O
108 Grassi NNP I-NP O
108 in IN B-VP O
108 her PRP$ O O
108 Thyroid NNP B-NP O
108 Clinic NNP I-NP O
108 on IN B-VP O
108 2/11/05 CD O O
108 He PRP O O
108 has VBZ O O
108 been VBN O O
108 again RB O O
108 urged VBN O O
109 to TO O O
109 stop VB O O
109 smoking NN B-NP O
109 and CC O O
109 to TO O O
109 be VB O O
109 complaint NN B-NP O
109 with IN B-VP O
109 his PRP$ O O
109 regimen NNS B-NP O
109 because IN B-VP O
109 he PRP O O
110 is VBZ O O
110 a DT B-NP O
110 good JJ I-NP O
110 heart NN I-NP O
110 transplant NN I-NP O
110 candidate NN I-NP O
110 and CC O O
110 for IN B-VP O
110 the DT B-NP O
110 current JJ I-NP O
110 time NN I-NP O
110 , , O O
110 he PRP O O
111 is VBZ O O
111 not RB O O
111 listed VBN O O
111 given VBN O O
111 the DT B-NP O
111 aforementioned JJ I-NP O
111 reasons NNS I-NP O
111 Overall NNP I-NP O
111 , , O O
111 Mr NNP B-NP O
112 Plagmann NNP I-NP O
112 states VBZ O O
112 that IN B-VP O
112 his PRP$ O O
112 symptoms NNS B-NP O
112 have VBP O O
112 drastically RB O O
112 improved VBN O O
112 He PRP O O
113 no RB O O
113 longer RBR O O
113 has VBZ O O
113 orthopnea NN B-NP O
113 He PRP O O
113 is VBZ O O
113 able JJ O O
113 to TO O O
113 exert VB O O
113 himself PRP O O
113 much RB O O
113 more RBR O O
114 without IN B-VP O
114 symptoms NNS B-NP O
114 of IN B-VP O
114 shortness NN B-NP O
114 of IN B-VP O
114 breath NN B-NP O
114 or CC O O
114 lightheadedness NN B-NP O
114 , , O O
114 and CC O O
115 he PRP O O
115 is VBZ O O
115 eager JJ O O
115 to TO O O
115 go VB O O
115 home NN B-NP O
116 eScription NN I-NP O
116 document: VBD B-VP O
116 3-1999936 JJ B-NP O
116 EMSSten NNP I-NP O
116 Tel NNP I-NP O
117 Dictated NNP I-NP O
117 By: NNP I-NP O
117 BURK NNP I-NP O
117 , , O O
117 MARIANO NNP B-NP O
118 Attending: NNP I-NP O
118 MIRICLE NNP I-NP O
118 , , O O
118 BRENDAN NNP B-NP O
119 Dictation NNP I-NP O
119 ID NNP I-NP O
119 9252376 CD O O
120 D: NNP B-NP O
120 9/28/04 CD O O
121 T: NNP B-NP O
121 9/28/04 CD O O
122 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #922618 VBZ O O
4 399346117 CD O O
4 RH NNP B-NP O
4 54171890 CD O O
4 497574 CD O O
4 5/24/1991 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/12/1991 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/21/1991 CD O O
7 DISCHARGE NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 CHOLECYSTITIS NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 is VBZ O O
8 a DT O O
8 65 CD O O
8 year NN B-NP O
8 old JJ B-NP O
8 female NN I-NP O
9 who WP O O
9 presented VBD B-VP O
9 with IN B-VP O
9 the DT B-NP O
9 sudden JJ I-NP O
9 onset NN I-NP O
9 of IN B-VP O
10 right JJ B-NP O
10 upper JJ I-NP O
10 quadrant NN I-NP O
10 and CC O O
10 epigastric JJ B-NP O
10 abdominal JJ I-NP O
10 pain NN I-NP O
10 The DT B-NP O
10 pain NN I-NP O
10 had VBD B-VP O
11 awoken VBN O O
11 her PRP$ O O
11 from IN B-VP O
11 sleep NN B-NP O
11 and CC O O
11 radiated VBD B-VP O
11 to TO O O
11 her PRP$ O O
11 right NN B-NP O
11 back RB O O
11 She PRP O O
11 had VBD B-VP O
11 an DT O O
12 ultrasound JJ O O
12 two CD O O
12 years NNS B-NP O
12 prior RB O O
12 to TO O O
12 admission NN B-NP O
12 which WDT O O
12 showed VBD B-VP O
12 sludge NN B-NP O
12 in IN B-VP O
12 her PRP$ O O
13 gallbladder NN B-NP O
13 with IN B-VP O
13 no DT B-NP O
13 other JJ I-NP O
13 abnormalities NNS I-NP O
13 noted VBD B-VP O
13 She PRP O O
13 had VBD B-VP O
13 one CD O O
14 episode NN B-NP O
14 of IN B-VP O
14 bilious JJ O O
14 vomiting VBG O O
14 with IN B-VP O
14 nausea NN B-NP O
14 prior RB O O
14 to TO O O
14 presentation VB O O
15 Patient NNP B-NP O
15 had VBD B-VP O
15 been VBN O O
15 given VBN O O
15 some DT B-NP O
15 Demerol NNP I-NP B-m
15 with IN B-VP O
15 some DT B-NP O
15 relief NN I-NP O
15 but CC O O
15 she PRP O O
15 had VBD B-VP O
16 persistent JJ B-NP O
16 pain NN I-NP O
16 The DT B-NP O
16 last JJ I-NP O
16 bowel NN I-NP O
16 movement NN I-NP O
16 was VBD B-VP O
16 the DT B-NP O
16 day NN I-NP O
16 prior RB O O
16 to TO O O
17 admission NN B-NP O
17 and CC O O
17 she PRP O O
17 had VBD B-VP O
17 an DT B-NP O
17 ultrasound NN I-NP O
17 on IN B-VP O
17 the DT B-NP O
17 night NN I-NP O
17 of IN B-VP O
17 admission NN B-NP O
17 which WDT O O
18 showed VBD B-VP O
18 multiple IN B-VP O
18 small JJ B-NP O
18 stones NNS I-NP O
18 and CC O O
18 a DT B-NP O
18 gallbladder NN I-NP O
18 with IN B-VP O
18 sludge NN B-NP O
18 and CC O O
19 thickening NN B-NP O
19 of IN B-VP O
19 the DT B-NP O
19 gallbladder NN I-NP O
19 wall NN I-NP O
19 HIDA NNP I-NP O
19 scan NN I-NP O
19 showed VBD B-VP O
19 no DT B-NP O
19 filling NN I-NP O
19 of IN B-VP O
20 the DT B-NP O
20 gallbladder NN I-NP O
20 consistent NN I-NP O
20 with IN B-VP O
20 cholecystitis NN B-NP O
20 PAST NNP I-NP O
20 MEDICAL NNP I-NP O
21 HISTORY: NNP I-NP O
21 Significant NNP I-NP O
21 for IN B-VP O
21 hypertension NN B-NP O
21 and CC O O
21 morbid NN B-NP O
21 obesity NN I-NP O
21 CURRENT NNP I-NP O
22 MEDICATIONS: NNP I-NP O
22 Vistaril NNP I-NP B-m
22 , , O O
22 Premarin NNP B-NP B-m
22 , , O O
22 and CC O O
22 Clinoril NNP B-NP B-m
23 PHYSICAL NNP I-NP O
23 EXAMINATION: NNP I-NP O
23 On IN B-VP O
23 admission NN B-NP O
23 , , O O
23 the DT B-NP O
23 patient NN I-NP O
23 was VBD B-VP O
23 an DT B-NP O
24 uncomfortable JJ I-NP O
24 obese JJ I-NP O
24 white JJ I-NP O
24 female NN I-NP O
24 in IN B-VP O
24 moderate JJ B-NP O
25 distress NN I-NP O
25 Vital NNP I-NP O
25 signs NNS I-NP O
25 were VBD B-VP O
25 stable JJ O O
25 and CC O O
25 her PRP$ O O
25 temperature NN B-NP O
25 was VBD B-VP O
25 98.6 CD O O
26 SKIN: NNP B-NP O
26 Normal NNP I-NP O
26 HEENT: NNP I-NP O
26 Normocephalic NNP I-NP O
26 and CC O O
26 atraumatic JJ B-NP O
26 CHEST: NNP I-NP O
27 Clear NNP I-NP O
27 bilaterally RB O O
27 CARDIAC: NNP B-NP O
27 Regular NNP I-NP O
27 rate NN I-NP O
27 and CC O O
27 rhythm NN B-NP O
27 with IN B-VP O
27 normal JJ B-NP O
28 Sl NNP I-NP O
28 and CC O O
28 S2 NNP B-NP O
28 with IN B-VP O
28 a DT B-NP O
28 grade NN I-NP O
28 II/VI NNP I-NP O
28 systolic JJ B-NP O
28 ejection NN I-NP O
28 murmur NN I-NP O
28 ABDOMEN: NNP I-NP O
29 Soft NNP I-NP O
29 , , O O
29 non-tender NN B-NP O
29 , , O O
29 and CC O O
29 non-distended JJ B-NP O
29 except NN I-NP O
29 for IN B-VP O
29 in IN B-VP O
29 the DT B-NP O
29 right JJ I-NP O
29 upper NN I-NP O
30 quadrant NN I-NP O
30 where WRB O O
30 she PRP O O
30 had VBD B-VP O
30 right JJ B-NP O
30 upper JJ I-NP O
30 quadrant NN I-NP O
30 pain NN I-NP O
30 and CC O O
30 a DT B-NP O
30 positive JJ I-NP O
31 Murphy's NNP I-NP O
31 but CC O O
31 no DT B-NP O
31 peritoneal JJ I-NP O
31 signs NNS I-NP O
32 LABORATORY NNP I-NP O
32 EXAMINATION: NNP I-NP O
32 Significant NNP I-NP O
32 for IN B-VP O
32 a DT B-NP O
32 white JJ I-NP O
32 count NN I-NP O
32 of IN B-VP O
32 7.2 CD O O
32 , , O O
33 hematocrit NN B-NP O
33 of IN B-VP O
33 40.5 CD O O
33 , , O O
33 and CC O O
33 a DT B-NP O
33 normal JJ I-NP O
33 set NN I-NP O
33 of IN B-VP O
34 liver JJ B-NP O
34 function NN I-NP O
34 tests NNS I-NP O
34 with IN B-VP O
34 an DT B-NP O
34 amylase NN I-NP O
34 of IN B-VP O
34 63 CD O O
35 HOSPITAL NNP B-NP O
35 COURSE: NNP I-NP O
35 The DT B-NP O
35 patient NN I-NP O
35 was VBD B-VP O
35 admitted VBN O O
35 to TO O O
35 the DT B-NP O
35 Teeleah NNP I-NP O
35 Valley NNP I-NP O
35 Medical NNP I-NP O
35 Center NNP I-NP O
35 , , O O
35 given VBN O O
35 triple RB O O
35 intravenous JJ B-NP B-mo
35 antibiotics NNS I-NP B-m
35 , , O O
36 kept VBD B-VP O
36 NPO NNP B-NP O
36 , , O O
36 and CC O O
36 placed VBD B-VP O
36 on IN B-VP O
36 intravenous JJ B-NP B-mo
36 hydration NN I-NP B-m
36 On IN B-VP O
36 10 CD O O
36 of IN B-VP O
36 May NNP B-NP O
36 , , O O
36 she PRP O O
37 was VBD B-VP O
37 taken VBN O O
37 to TO O O
37 the DT B-NP O
37 Operating NN I-NP O
37 Room NN I-NP O
37 where WRB O O
37 she PRP O O
37 underwent VBD B-VP O
37 an DT B-NP O
38 esophagogastroduodenoscopy NN I-NP O
38 , , O O
38 a DT B-NP O
38 cholecystectomy NN I-NP O
38 with IN B-VP O
38 an DT B-NP O
39 intraoperative JJ I-NP O
39 cholangiogram NN I-NP O
39 , , O O
39 and CC O O
39 common JJ B-NP O
39 bile NN I-NP O
39 duct NN I-NP O
39 exploration NN I-NP O
39 with IN B-VP O
40 T-Tube NNP B-NP O
40 placement NN I-NP O
40 by IN B-VP O
40 Dr NNP B-NP O
40 Karsh NNP I-NP O
40 , , O O
40 Dr NNP B-NP O
40 Karty NNP I-NP O
40 , , O O
40 and CC O O
40 Dr NNP B-NP O
40 Noorani NNP I-NP O
41 Intraoperatively NNP I-NP O
41 , , O O
41 she PRP O O
41 was VBD B-VP O
41 found VBN O O
41 to TO O O
41 have VB O O
41 a DT B-NP O
41 large JJ I-NP O
41 inflamed JJ I-NP O
42 gallbladder NN I-NP O
42 with IN B-VP O
42 multiple JJ B-NP O
42 small JJ I-NP O
42 cholesterol NN I-NP O
42 stones NNS I-NP O
42 in IN B-VP O
42 her PRP$ O O
43 gallbladder NN B-NP O
43 and CC O O
43 two CD O O
43 stones NNS B-NP O
43 in IN B-VP O
43 her PRP$ O O
43 common JJ B-NP O
43 duct NN I-NP O
43 Intraoperatively RB O O
43 , , O O
44 she PRP O O
44 was VBD B-VP O
44 noted VBN O O
44 to TO O O
44 have VB O O
44 a DT B-NP O
44 short JJ I-NP O
44 run NN I-NP O
44 of IN B-VP O
44 an DT B-NP O
44 abnormal JJ I-NP O
44 rhythm NN I-NP O
44 with IN B-VP O
44 a DT B-NP O
44 rate NN I-NP O
45 in IN B-VP O
45 the DT B-NP O
45 seventies NNS I-NP O
45 which WDT O O
45 quickly RB O O
45 resolved VBD B-VP O
45 Post-operatively RB O O
45 , , O O
45 she PRP O O
46 continued VBD B-VP O
46 to TO O O
46 remain VB O O
46 stable JJ O O
46 and CC O O
46 was VBD B-VP O
46 transferred VBN O O
46 to TO O O
46 the DT B-NP O
46 Recovery NNP I-NP O
46 Room NNP I-NP O
47 and CC O O
47 eventually RB O O
47 back RB O O
47 to TO O O
47 the DT B-NP O
47 floor NN I-NP O
47 She PRP O O
47 was VBD B-VP O
47 ruled VBN O O
47 out RP O O
47 for IN B-VP O
47 myocardial JJ B-NP O
48 infarction NN I-NP O
48 On IN B-VP O
48 0/30/9l CD O O
48 , , O O
48 she PRP O O
48 was VBD B-VP O
48 doing VBG O O
48 well RB O O
48 , , O O
48 had VBD B-VP O
48 been VBN O O
48 started VBN O O
48 on IN B-VP O
49 sips NNS B-NP O
49 of IN B-VP O
49 clear JJ B-NP O
49 fluids NNS I-NP O
49 , , O O
49 and CC O O
49 was VBD B-VP O
49 up RB O O
49 out IN B-VP O
49 of IN B-VP O
49 bed NN B-NP O
49 voiding VBG O O
49 on IN B-VP O
49 her PRP$ O O
49 own JJ O O
49 By IN B-VP O
50 10/19/9l CD O O
50 , , O O
50 she PRP O O
50 was VBD B-VP O
50 tolerating VBG O O
50 a DT B-NP O
50 regular JJ I-NP O
50 diet NN I-NP O
50 Her PRP$ O O
50 wound NN B-NP O
50 showed VBD B-VP O
50 some DT B-NP O
51 erythema NN I-NP O
51 but CC O O
51 continued VBD B-VP O
51 to TO O O
51 heal VB O O
51 well RB O O
51 On IN B-VP O
51 1/12/9l CD O O
51 , , O O
51 she PRP O O
51 had VBD B-VP O
51 a DT B-NP O
51 normal JJ I-NP O
52 T-Tube JJ I-NP O
52 cholangiogram NN I-NP O
52 and CC O O
52 was VBD B-VP O
52 clamped VBN O O
53 DISPOSITION: NNP B-NP O
53 She PRP O O
53 remained VBD B-VP O
53 afebrile JJ O O
53 with IN B-VP O
53 no DT B-NP O
53 abdominal JJ I-NP O
53 tenderness NN I-NP O
54 and CC O O
54 is VBZ O O
54 discharged VBN O O
54 to TO O O
54 home VB O O
54 on IN B-VP O
54 1/9/9l CD O O
54 to TO O O
54 be VB O O
54 followed VBN O O
55 up RP O O
55 by IN B-VP O
55 Dr NNP B-NP O
55 Tendick NNP I-NP O
55 in IN B-VP O
55 Clinic NNP B-NP O
56 BT272/5455 NNP I-NP O
57 RICKIE NNP I-NP O
57 S NNP I-NP O
57 SANGH NNP I-NP O
57 , , O O
57 M.D NNP B-NP O
57 NQ6 NNP I-NP O
57 D: NNP I-NP O
57 11/1/91 CD O O
58 Batch: NNP B-NP O
58 9763 CD O O
58 Report: NNP B-NP O
58 N6056S64 NNP I-NP O
58 T: NNP I-NP O
58 3/5/91 CD O O
59 Dictated NNP B-NP O
59 By: NNP I-NP O
59 ELISHA NNP I-NP O
59 H NNP I-NP O
59 DOLFAY NNP I-NP O
59 , , O O
59 M.D NNP B-NP O
59 BI41 NNP I-NP O
60 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #924060 VBZ O O
2 666197546 CD O O
2 TRH NNP B-NP O
2 10577072 CD O O
2 8354947 CD O O
2 1/18/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Right NNP I-NP O
2 Shoulder NNP I-NP O
2 Pain NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/18/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/18/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 NESSPOR NNP I-NP O
5 , , O O
5 JEROME NNP B-NP O
5 171-12-68-8 CD O O
6 Hend NNP B-NP O
7 Service: NNP I-NP O
7 ORT NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 11/0/06 CD O O
8 AT NNP B-NP O
8 11:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 SZUFAT NNP I-NP O
11 , , O O
11 JERRELL NNP B-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 COLACE NNP I-NP B-m
16 ( ( O I-m
16 DOCUSATE NNP B-NP I-m
16 SODIUM NNP I-NP I-m
16 ) ) O I-m
16 100 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 BID NNP I-NP B-f
17 NEXIUM NNP I-NP B-m
17 ( ( O I-m
17 ESOMEPRAZOLE NNP B-NP I-m
17 ) ) O I-m
17 40 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 BID NNP I-NP B-f
18 DILAUDID NNP I-NP B-m
18 ( ( O I-m
18 HYDROMORPHONE NNP B-NP I-m
18 HCL NNP I-NP I-m
18 ) ) O I-m
18 2-6 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 Q4H NNP I-NP B-f
18 PRN NNP I-NP I-f
18 Pain NNP I-NP B-r
19 ATROVENT NNP I-NP B-m
19 HFA NNP I-NP I-m
19 INHALER NNP I-NP I-m
19 ( ( O I-m
19 IPRATROPIUM NNP B-NP I-m
19 INHALER NNP I-NP I-m
19 ) ) O I-m
20 2 CD O B-do
20 PUFF NNP B-NP I-do
20 INH NNP I-NP B-mo
20 QID NNP I-NP B-f
20 PRN NNP I-NP I-f
20 Shortness NNP I-NP B-r
20 of IN B-VP I-r
20 Breath NNP B-NP I-r
21 Food/Drug NNP I-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Contraindicated NNP I-NP O
22 in IN B-VP O
22 Patients NNP B-NP O
22 with IN B-VP O
22 Peanut NNP B-NP O
22 , , O O
22 Soya NNP B-NP O
22 or CC O O
22 Soyabean NNP B-NP O
23 Allergy NNP I-NP O
24 LOPRESSOR NNP I-NP B-m
24 ( ( O I-m
24 METOPROLOL NNP B-NP I-m
24 TARTRATE NNP I-NP I-m
24 ) ) O I-m
24 12.5 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 BID NNP I-NP B-f
25 HOLD NNP I-NP O
25 IF: NNP I-NP O
25 SBP&lt;110 NNP I-NP O
25 , , O O
25 HR&lt;60 NNP B-NP O
25 Food/Drug NNP I-NP O
25 Interaction NNP I-NP O
25 Instruction NNP I-NP O
26 Take NNP I-NP O
26 consistently RB O O
26 with IN B-VP O
26 meals NNS B-NP O
26 or CC O O
26 on IN B-VP O
26 empty JJ B-NP O
26 stomach NN I-NP O
27 MS NNP I-NP B-m
27 CONTIN NNP I-NP I-m
27 ( ( O I-m
27 MORPHINE NNP B-NP I-m
27 CONTROLLED NNP I-NP I-m
27 RELEASE NNP I-NP I-m
27 ) ) O I-m
27 45 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QAM NNP I-NP B-f
28 MS NNP I-NP B-m
28 CONTIN NNP I-NP I-m
28 ( ( O I-m
28 MORPHINE NNP B-NP I-m
28 CONTROLLED NNP I-NP I-m
28 RELEASE NNP I-NP I-m
28 ) ) O I-m
28 30 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QPM NNP I-NP B-f
29 SIMVASTATIN NNP I-NP B-m
29 80 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 DAILY NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 Avoid NNP I-NP O
31 grapefruit NN I-NP O
31 unless IN B-VP O
31 MD NNP B-NP O
31 instructs NNS I-NP O
31 otherwise RB O O
32 TERAZOSIN NNP B-NP B-m
32 HCL NNP I-NP I-m
32 10 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 DAILY NNP I-NP B-f
33 Number NNP I-NP B-du
33 of IN B-VP I-du
33 Doses NNP B-NP I-du
33 Required NNP I-NP I-du
33 ( ( O I-du
33 approximate JJ B-NP I-du
33 ): NN I-NP I-du
33 3 CD O I-du
34 DIET: NNP B-NP O
34 No NNP I-NP O
34 Restrictions NNP I-NP O
35 RETURN NNP I-NP O
35 TO NNP I-NP O
35 WORK: NNP I-NP O
35 After IN B-VP O
35 Appt NNP B-NP O
35 with IN B-VP O
35 local JJ B-NP O
35 physician NN I-NP O
36 FOLLOW NNP I-NP O
36 UP NNP I-NP O
36 APPOINTMENT( NNP I-NP O
36 S NNP I-NP O
36 ): NNP I-NP O
37 Dr NNP I-NP O
37 Hally NNP I-NP O
37 3/18/06 CD O O
37 scheduled VBN O O
37 , , O O
38 ALLERGY: NNP B-NP O
38 IV NNP I-NP O
38 Contrast NNP I-NP O
38 , , O O
38 Tape NNP B-NP O
39 ADMIT NNP I-NP O
39 DIAGNOSIS: NNP I-NP O
40 Right NNP I-NP O
40 Shoulder NNP I-NP O
40 Pain NNP I-NP O
40 ?Infection NN I-NP O
41 PRINCIPAL NNP I-NP O
41 DISCHARGE NNP I-NP O
41 DIAGNOSIS NNP I-NP O
41 ;Responsible JJ O O
41 After IN B-VP O
41 Study NNP B-NP O
41 for IN B-VP O
41 Causing NNP B-NP O
41 Admission NNP I-NP O
41 ) ) O O
42 Right NNP B-NP O
42 Shoulder NNP I-NP O
42 Pain NNP I-NP O
43 OTHER NNP I-NP O
43 DIAGNOSIS;Conditions NNP I-NP O
43 , , O O
43 Infections NNP B-NP O
43 , , O O
43 Complications NNP B-NP O
43 , , O O
43 affecting VBG O O
43 Treatment/Stay NNP B-NP O
44 asthma JJ B-NP O
45 OPERATIONS NNP I-NP O
45 AND NNP I-NP O
45 PROCEDURES: NNP I-NP O
46 8/18/2006 CD O O
46 : : O O
46 CT NN B-NP O
46 guided VBD B-VP O
46 aspiration NN B-NP O
46 of IN B-VP O
46 R NNP B-NP O
46 shoulder NN I-NP O
46 joint NN I-NP O
46 fluid NN I-NP O
47 OTHER NNP I-NP O
47 TREATMENTS/PROCEDURES NNP I-NP O
47 ( ( O O
47 NOT NNP B-NP O
47 IN NNP I-NP O
47 O.R NNP I-NP O
47 ) ) O O
48 Pain NNP B-NP O
48 Control NNP I-NP O
49 BRIEF NNP I-NP O
49 RESUME NNP I-NP O
49 OF NNP I-NP O
49 HOSPITAL NNP I-NP O
49 COURSE: NNP I-NP O
50 Mr NNP I-NP O
50 Notari NNP I-NP O
50 was VBD B-VP O
50 admitted VBN O O
50 to TO O O
50 the DT B-NP O
50 Orthopaedic NNP I-NP O
50 Hand NNP I-NP O
50 Service NNP I-NP O
50 on IN B-VP O
50 1/18/2006 CD O O
51 w/ NN B-NP O
51 a DT B-NP O
51 history NN I-NP O
51 of IN B-VP O
51 increased JJ B-NP O
51 R NNP I-NP O
51 shoulder NN I-NP O
51 pain NN I-NP O
51 following VBG O O
51 a DT B-NP O
51 cellulitis NN I-NP O
51 of IN B-VP O
52 the DT B-NP O
52 right JJ I-NP O
52 hand NN I-NP O
52 An DT B-NP O
52 ESR NNP I-NP O
52 was VBD B-VP O
52 checked VBN O O
52 on IN B-VP O
52 admission NN B-NP O
52 and CC O O
52 was VBD B-VP O
52 slightly RB O O
53 elevated VBN O O
53 at IN B-VP O
53 18 CD O O
53 He PRP O O
53 was VBD B-VP O
53 afebrile JJ O O
53 and CC O O
53 non-toxic JJ O O
53 , , O O
53 therefore RB O O
53 was VBD B-VP O
53 not RB O O
53 started VBN O O
54 on IN B-VP O
54 antibiotics NNS B-NP O
54 Dilaudid NNP I-NP B-m
54 was VBD B-VP O
54 added VBN O O
54 to TO O O
54 his PRP$ O O
54 pain NN B-NP O
54 regimen NNS I-NP O
54 for IN B-VP O
54 his PRP$ O B-r
54 increased JJ B-NP O
55 discomfort NN I-NP O
56 On IN B-VP O
56 9/25/2006 CD O O
56 a DT B-NP O
56 CT NNP I-NP O
56 guided VBD B-VP O
56 R NNP B-NP O
56 shoulder NN I-NP O
56 joint NN I-NP O
56 fluid NN I-NP O
56 aspiration NN I-NP O
56 was VBD B-VP O
56 performed VBN O O
57 by IN B-VP O
57 Radiology NNP B-NP O
57 Analysis NNP I-NP O
57 of IN B-VP O
57 this DT B-NP O
57 fluid NN I-NP O
57 was VBD B-VP O
57 not RB O O
57 consistant JJ O O
57 with IN B-VP O
57 joint JJ B-NP O
58 infection NN I-NP O
59 He PRP O O
59 received VBD B-VP O
59 Lovenox NNP B-NP B-m
59 for IN B-VP O
59 DVT NNP B-NP B-r
59 prophylaxis NN I-NP I-r
59 during IN B-VP B-du
59 his PRP$ O I-du
59 admission NN B-NP I-du
59 On IN B-VP O
59 HD#4 NNP B-NP O
59 he PRP O O
60 was VBD B-VP O
60 awake RB O O
60 , , O O
60 alert NN B-NP O
60 , , O O
60 appropriate JJ O O
60 and CC O O
60 afebrile JJ O O
60 with IN B-VP O
60 stable JJ B-NP O
60 vitals NNS I-NP O
60 signs NNS I-NP O
60 His PRP$ O B-r
61 pain NN B-NP O
61 was VBD B-VP O
61 well RB O O
61 controlled VBN O O
61 on IN B-VP O
61 oral JJ B-NP B-m
61 medications NNS I-NP I-m
61 He PRP O O
61 was VBD B-VP O
61 discharged VBN O O
61 to TO O O
61 home NN B-NP O
62 and CC O O
62 instructed VBD B-VP O
62 to TO O O
62 follow VB O O
62 up RP O O
62 with IN B-VP O
62 Dr NNP B-NP O
62 Rumler NNP I-NP O
62 at IN B-VP O
62 his PRP$ O O
62 previously RB O O
62 scheduled VBN O O
63 appointment NN B-NP O
63 on IN B-VP O
63 4/13/2006 CD O O
63 His PRP$ O O
63 final JJ B-NP O
63 joint NN I-NP O
63 fluid NN I-NP O
63 cultures NNS I-NP O
63 were VBD B-VP O
63 pending VBG O O
63 at IN B-VP O
64 the DT B-NP O
64 time NN I-NP O
64 of IN B-VP O
64 discharge NN B-NP O
64 , , O O
64 he PRP O O
64 will MD O O
64 be VB O O
64 contacted VBN O O
64 at IN B-VP O
64 home NN B-NP O
64 if IN B-VP O
64 these DT O O
64 turn VBP O O
65 positivie JJ B-NP O
66 ADDITIONAL NNP I-NP O
66 COMMENTS: NNP I-NP O
66 1 CD O O
66 Do NNP B-NP O
66 pendulum NN I-NP O
66 range NN I-NP O
66 of IN B-VP O
66 motion NN B-NP O
66 exercises VBZ O O
66 regularly RB O O
66 This DT O O
66 is VBZ O O
66 very RB O O
67 important JJ O O
67 in IN B-VP O
67 maintaining VBG O O
67 full JJ B-NP O
67 range NN I-NP O
67 of IN B-VP O
67 motion NN B-NP O
67 You PRP O O
67 should MD O O
67 not RB O O
67 add VB O O
67 any DT B-NP O
68 additional JJ I-NP O
68 exercises NNS I-NP O
68 until IN B-VP O
68 cleared VBN O O
68 to TO O O
68 do VB O O
68 so RB O O
68 by IN B-VP O
68 Dr NNP B-NP O
68 Stupka NNP I-NP O
69 2 CD O O
69 You PRP O O
69 have VBP O O
69 been VBN O O
69 given VBN O O
69 a DT B-NP O
69 prescription NN I-NP O
69 for IN B-VP O
69 a DT O O
69 narcotic JJ O B-m
69 for IN B-VP O
69 pain NN B-NP B-r
69 control NN I-NP I-r
69 Do NNP I-NP O
70 not RB O O
70 drive VB O O
70 a DT B-NP O
70 motor NN I-NP O
70 vehicle NN I-NP O
70 , , O O
70 drink VB O O
70 any DT B-NP O
70 alcohol NN I-NP O
70 or CC O O
70 operate VB O O
70 machinery NN B-NP O
70 while IN B-VP O
71 taking VBG O O
71 this DT B-NP B-m
71 medication NN I-NP I-m
71 As IN B-VP O
71 your PRP$ O O
71 pain NN B-NP O
71 allows NNS I-NP O
71 , , O O
71 you PRP O O
71 should MD O O
71 reduce VB O O
71 the DT B-NP O
71 amount NN I-NP O
72 of IN B-VP O
72 this DT B-NP B-m
72 medication NN I-NP I-m
72 accordingly RB O O
72 Narcotic NNP B-NP B-m
72 pain NN I-NP I-m
72 medications NNS I-NP I-m
72 can MD O O
72 cause VB O O
73 constipation NN B-NP B-r
73 constipation NN I-NP B-r
73 , , O O
73 so IN B-VP O
73 you PRP O O
73 should MD O O
73 drink VB O O
73 plenty NN B-NP O
73 of IN B-VP O
73 water NN B-NP O
73 and CC O O
73 take VB O O
73 a DT B-NP O
73 stool NN I-NP B-m
74 softener NN I-NP O
74 ( ( O O
74 Colace NNP B-NP O
74 ) ) O O
74 to TO O O
74 help VB O O
74 prevent VB O O
74 this DT B-NP O
74 side NN I-NP O
74 effect NN I-NP O
75 3 CD O O
75 Call NNP B-NP O
75 Dr NNP I-NP O
75 Camelo NNP I-NP O
75 at IN B-VP O
75 the DT B-NP O
75 number NN I-NP O
75 above IN B-VP O
75 , , O O
75 or CC O O
75 your PRP$ O O
75 Primary JJ B-NP O
75 Care NNP I-NP O
75 Physician NNP I-NP O
75 , , O O
75 or CC O O
76 go VB O O
76 to TO O O
76 a DT B-NP O
76 local JJ I-NP O
76 emergency NN I-NP O
76 room NN I-NP O
76 if IN B-VP O
76 you PRP O O
76 develop VBP O O
76 fevers/chills NNS B-NP O
76 , , O O
76 redness NN B-NP O
76 around IN B-VP O
77 your PRP$ O O
77 incision NN B-NP O
77 that DT O O
77 is VBZ O O
77 warm JJ O O
77 to TO O O
77 the DT B-NP O
77 touch NN I-NP O
77 , , O O
77 pus-like JJ B-NP O
77 drainage NN I-NP O
77 from IN B-VP O
77 the DT B-NP O
78 wound NN I-NP O
78 , , O O
78 loss NN B-NP O
78 of IN B-VP O
78 function NN B-NP O
78 ( ( O O
78 either CC O O
78 strength NN B-NP O
78 or CC O O
78 sensation NN B-NP O
78 ) ) O O
78 in IN B-VP O
78 your PRP$ O O
78 hand NN B-NP O
78 , , O O
79 return NN B-NP O
79 to TO O O
79 your PRP$ O O
79 original JJ B-NP O
79 symptoms NNS I-NP O
79 , , O O
79 chest JJS B-NP O
79 pain NN I-NP O
79 , , O O
79 shortness NN B-NP O
79 of IN B-VP O
79 breath NN B-NP O
79 or CC O O
79 any DT B-NP O
80 other JJ I-NP O
80 concerning NN I-NP O
80 symptoms NNS I-NP O
81 4 CD O O
81 You PRP O O
81 may MD O O
81 not RB O O
81 drive VB O O
81 a DT B-NP O
81 car NN I-NP O
81 until IN B-VP O
81 cleared VBN O O
81 to TO O O
81 do VB O O
81 so RB O O
81 by IN B-VP O
81 Dr NNP B-NP O
81 Boys NNP I-NP O
82 5 CD O O
82 Resume NNP B-NP O
82 home NN I-NP B-m
82 medications NNS I-NP I-m
82 unless IN B-VP O
82 specifically RB O O
82 instructed VBN O O
82 otherwise RB O O
83 DISCHARGE NNP B-NP O
83 CONDITION: NNP I-NP O
83 Stable NNP I-NP O
84 TO NNP I-NP O
84 DO/PLAN: NNP I-NP O
85 No NNP I-NP O
85 dictated VBD B-VP O
85 summary JJ B-NP O
86 ENTERED NNP I-NP O
86 BY: NNP I-NP O
86 GRDINA NNP I-NP O
86 , , O O
86 EDDY NNP B-NP O
86 R NNP I-NP O
86 , , O O
86 M.D NNP B-NP O
86 ( ( O O
86 ZL34 NNP B-NP O
86 ) ) O O
86 11/0/06 CD O O
86 @ $ O O
86 09 CD O O
87 ****** JJ B-NP O
87 END NN I-NP O
87 OF NNP I-NP O
87 DISCHARGE NNP I-NP O
87 ORDERS NNP I-NP O
87 ****** NNP I-NP O
88 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #937042 VBZ O O
4 774927831 CD O O
4 LCH NNP B-NP O
4 62092282 CD O O
4 8782800 CD O O
4 0/12/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHEST NNP I-NP O
4 PAIN NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/12/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/12/2007 CD O O
7 ATTENDING: NNP B-NP O
7 PAAVOLA NNP I-NP O
7 , , O O
7 OMAR NNP B-NP O
7 MD NNP I-NP O
8 ADMITTING NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
8 Coronary NNP I-NP O
8 artery NN I-NP O
8 disease NN I-NP O
9 BRIEF NNP I-NP O
9 HISTORY: NNP I-NP O
9 The DT B-NP O
9 patient NN I-NP O
9 is VBZ O O
9 an DT B-NP O
9 81-year-old JJ I-NP O
9 Italian-speaking JJ I-NP O
10 gentleman NN I-NP O
10 with IN B-VP O
10 a DT B-NP O
10 past JJ I-NP O
10 medical JJ I-NP O
10 history NN I-NP O
10 significant JJ O O
10 for IN B-VP O
10 diabetes NNS B-NP O
10 , , O O
11 hypertension NN B-NP O
11 , , O O
11 and CC O O
11 COPD NNP B-NP O
11 who WP O O
11 was VBD B-VP O
11 admitted VBN O O
11 to TO O O
11 an DT B-NP O
11 outside JJ I-NP O
11 hospital NN I-NP O
12 with IN B-VP O
12 rise NN B-NP O
12 in IN B-VP O
12 his PRP$ O O
12 chest NN B-NP O
12 pain NN I-NP O
12 At IN B-VP O
12 that DT B-NP O
12 time NN I-NP O
12 , , O O
12 there EX O O
12 were VBD B-VP O
12 no DT B-NP O
12 EKG NNP I-NP O
13 changes NNS I-NP O
13 and CC O O
13 the DT B-NP O
13 chest JJS I-NP O
13 CT NNP I-NP O
13 PE NNP I-NP O
13 protocol NN I-NP O
13 was VBD B-VP O
13 reportedly RB O O
13 negative JJ B-NP O
14 Several JJ I-NP O
14 hours NNS I-NP O
14 later RB O O
14 , , O O
14 the DT B-NP O
14 patient NN I-NP O
14 developed VBD B-VP O
14 left-sided JJ B-NP O
14 chest NN I-NP O
14 pain NN I-NP O
15 with IN B-VP O
15 ST NNP B-NP O
15 elevations NNS I-NP O
15 in IN B-VP O
15 V2 NNP B-NP O
15 , , O O
15 V4 NNP B-NP O
15 and CC O O
15 enzyme JJ B-NP O
15 leak NN I-NP O
15 On IN B-VP O
16 11/5/06 CD O O
16 , , O O
16 the DT B-NP O
16 patient NN I-NP O
16 was VBD B-VP O
16 transferred VBN O O
16 to TO O O
16 M NNP B-NP O
16 Valley NNP I-NP O
16 Medical NNP I-NP O
16 Center NNP I-NP O
16 where WRB O O
16 he PRP O O
16 underwent VBD B-VP O
16 a DT B-NP O
16 cardiac JJ I-NP O
16 catheterization NN I-NP O
16 , , O O
16 which WDT O O
17 revealed VBD B-VP O
17 three-vessel JJ B-NP O
17 disease NN I-NP O
18 PAST NNP I-NP O
18 MEDICAL NNP I-NP O
18 HISTORY: NNP I-NP O
19 1 CD O O
19 Hypertension NNP B-NP O
20 2 CD O O
20 Diabetes VBZ O O
21 3 CD O O
21 Hyperglyceridemia NNP B-NP O
22 4 CD O O
22 COPD NNP B-NP O
23 5 CD O O
23 BPH NNP B-NP O
24 6 CD O O
24 Seizures NNP B-NP O
25 7 CD O O
25 Blindness NNP B-NP O
25 in IN B-VP O
25 the DT B-NP O
25 right NN I-NP O
25 eye NN I-NP O
26 PAST NNP I-NP O
26 SURGICAL NNP I-NP O
26 HISTORY: NNP I-NP O
27 1 CD O O
27 Bilateral NNP B-NP O
27 knee NN I-NP O
27 replacement NN I-NP O
28 2 CD O O
28 Right NNP B-NP O
28 knee NN I-NP O
28 re-operated JJ O O
28 for IN B-VP O
28 infection NN B-NP O
29 3 CD O O
29 Bilateral NNP B-NP O
29 inguinal JJ B-NP O
29 hernia NN I-NP O
29 repair NN I-NP O
30 4 CD O O
30 Right NNP B-NP O
30 eye NN I-NP O
30 enucleation NN I-NP O
31 FAMILY NNP I-NP O
31 HISTORY: NNP I-NP O
31 No NNP I-NP O
31 family NN I-NP O
31 history NN I-NP O
31 of IN B-VP O
31 coronary JJ B-NP O
31 artery NN I-NP O
31 disease NN I-NP O
32 SOCIAL NNP I-NP O
32 HISTORY: NNP I-NP O
32 Italian JJ B-NP O
32 speaking NN I-NP O
32 , , O O
32 lives VBZ O O
32 at IN B-VP O
32 home NN B-NP O
32 , , O O
32 is VBZ O O
32 accompanied VBN O O
33 with IN B-VP O
33 his PRP$ O O
33 son NN B-NP O
33 The DT B-NP O
33 patient NN I-NP O
33 is VBZ O O
33 a DT B-NP O
33 retired JJ I-NP O
33 farm NN I-NP O
33 worker NN I-NP O
34 ALLERGIES: NNP I-NP O
34 The DT B-NP O
34 patient NN I-NP O
34 is VBZ O O
34 allergic JJ O O
34 to TO O O
34 Ciprofloxacin NNP B-NP O
34 , , O O
34 Ceftin NNP B-NP O
34 , , O O
34 and CC O O
35 Singulair NNP B-NP O
36 ADMISSION NNP I-NP O
36 MEDICATIONS: NNP I-NP O
37 1 CD O O
37 Lopressor NNP B-NP B-m
37 25 CD O B-do
37 orally RB O B-mo
37 every DT O B-f
37 6 CD O I-f
37 hours NNS B-NP I-f
38 2 CD O O
38 Diltiazem NNP B-NP B-m
38 125 CD O B-do
38 mg NNS B-NP I-do
38 orally RB O B-mo
38 daily RB O B-f
39 3 CD O O
39 Aspirin NNP B-NP B-m
39 325 CD O B-do
39 mg NNS B-NP I-do
39 orally RB O B-mo
39 daily RB O B-f
40 4 CD O O
40 Furosemide NNP B-NP B-m
40 20 CD O B-do
40 mg NNS B-NP I-do
40 orally RB O B-mo
40 daily RB O B-f
41 5 CD O O
41 Methylprednisolone NNP B-NP B-m
41 30 CD O B-do
41 mg NN B-NP I-do
41 IV NNP I-NP B-mo
41 every DT O B-f
41 8 CD O I-f
41 hours NNS B-NP I-f
42 6 CD O O
42 Atorvastatin NNP B-NP B-m
42 80 CD O B-do
42 mg NNS B-NP I-do
42 orally RB O B-mo
42 daily RB O B-f
43 7 CD O O
43 Allopurinol NNP B-NP B-m
43 100 CD O B-do
43 mg NNS B-NP I-do
43 orally RB O B-mo
43 daily RB O B-f
44 8 CD O O
44 Ativan NNP B-NP B-m
44 0.5 CD O B-do
44 mg NN B-NP I-do
44 orally RB O B-mo
44 at IN B-VP B-f
44 bedtime RB O I-f
45 9 CD O O
45 Nexium NNP B-NP B-m
45 20 CD O B-do
45 mg NNS B-NP I-do
45 orally RB O B-mo
45 daily RB O B-f
46 10 CD O O
46 Proscar NNP B-NP B-m
46 5 CD O B-do
46 mg NN B-NP I-do
46 orally RB O B-mo
46 every DT B-NP B-f
46 night NN I-NP I-f
47 PHYSICAL NNP I-NP O
47 EXAMINATION NNP I-NP O
47 ON NNP I-NP O
47 ADMISSION: NNP I-NP O
47 Vital NNP I-NP O
47 signs NNS I-NP O
47 were VBD B-VP O
47 as IN B-VP O
47 follows VBZ O O
48 Temperature NNP B-NP O
48 97.1 CD O O
48 , , O O
48 heart NN B-NP O
48 rate NN I-NP O
48 73 CD O O
48 , , O O
48 blood NN B-NP O
48 pressure NN I-NP O
48 on IN B-VP O
48 the DT B-NP O
48 right JJ I-NP O
48 arm NN I-NP O
49 108/59 CD O O
49 , , O O
49 and CC O O
49 oxygen NN B-NP O
49 saturation NN I-NP O
49 98% CD O O
49 HEENT NNP B-NP O
49 , , O O
49 PERRLA NNP B-NP O
49 , , O O
49 dentition NN B-NP O
50 without IN B-VP O
50 evidence NN B-NP O
50 of IN B-VP O
50 infection NN B-NP O
50 , , O O
50 no DT B-NP O
50 carotid NN I-NP O
50 bruits VBZ O O
50 On IN B-VP O
50 chest JJS B-NP O
51 examination NN I-NP O
51 , , O O
51 no DT B-NP O
51 incisions NNS I-NP O
51 Cardiovascular NNP I-NP O
51 , , O O
51 regular JJ B-NP O
51 rate NN I-NP O
51 and CC O O
52 rhythm NN B-NP O
52 without IN B-VP O
52 murmurs NNS B-NP O
52 Respiratory NNP I-NP O
52 , , O O
52 breath NN B-NP O
52 sounds NNS I-NP O
52 are VBP O O
52 clear JJ O O
53 bilaterally RB O O
53 On IN B-VP O
53 abdominal JJ B-NP O
53 exam NN I-NP O
53 , , O O
53 bilateral JJ B-NP O
53 inguinal JJ I-NP O
53 hernia NN I-NP O
54 incisions NNS I-NP O
54 and CC O O
54 enlarged VBD B-VP O
54 right JJ B-NP O
54 groin NN I-NP O
54 hematoma NN I-NP O
54 from IN B-VP O
54 previous JJ B-NP O
54 cardiac JJ I-NP O
55 catheterization NN I-NP O
55 On IN B-VP O
55 extremities NNS B-NP O
55 , , O O
55 bilateral JJ B-NP O
55 lower JJR I-NP O
55 extremity NN I-NP O
56 varicosities NNS I-NP O
56 Neuro NNP I-NP O
56 exam NN I-NP O
56 , , O O
56 the DT B-NP O
56 patient NN I-NP O
56 was VBD B-VP O
56 alert JJ O O
56 and CC O O
56 oriented VBN O O
57 without IN B-VP O
57 focal JJ B-NP O
57 deficits NNS I-NP O
58 Cardiac NNP I-NP O
58 catheterization NN I-NP O
58 performed VBD B-VP O
58 at IN B-VP O
58 An DT O O
59 on IN B-VP O
59 10/28/06 CD O O
59 revealed VBD B-VP O
59 30% CD O O
59 mid NN B-NP O
59 RCA NNP I-NP O
59 occlusion NN I-NP O
59 , , O O
59 40% CD O O
59 distal JJ B-NP O
59 RCA NNP I-NP O
59 , , O O
59 90% CD O O
60 ostial JJ B-NP O
60 OM1 NNP I-NP O
60 , , O O
60 90% CD O O
60 mid NN B-NP O
60 CX NNP I-NP O
60 , , O O
60 80% CD O O
60 proximal JJ B-NP O
60 LAD NNP I-NP O
60 , , O O
60 99% CD O O
60 mid NN B-NP O
60 LAD NNP I-NP O
60 , , O O
60 and CC O O
60 60% CD O O
61 mid NN B-NP O
61 LM NNP I-NP O
61 EKG NNP I-NP O
61 on IN B-VP O
61 2/5/06 CD O O
61 showed VBD B-VP O
61 a DT B-NP O
61 normal JJ I-NP O
61 sinus NN I-NP O
61 rhythm NN I-NP O
61 at IN B-VP O
61 76 CD O O
61 and CC O O
62 an DT B-NP O
62 incomplete JJ I-NP O
62 right JJ I-NP O
62 bundle-branch NN I-NP O
62 block NN I-NP O
62 A NNP I-NP O
62 chest NN I-NP O
62 x-ray NN I-NP O
62 on IN B-VP O
63 10/28/06 CD O O
63 was VBD B-VP O
63 consistent JJ O O
63 with IN B-VP O
63 congestive JJ B-NP O
63 heart NN I-NP O
63 failure NN I-NP O
64 HOSPITAL NNP I-NP O
64 COURSE: NNP I-NP O
64 The DT B-NP O
64 patient's JJ I-NP O
64 hospital NN I-NP O
64 course NN I-NP O
64 is VBZ O O
64 as IN B-VP O
64 follows VBZ O O
64 by IN B-VP O
65 systems NNS B-NP O
66 1 CD O O
66 Neurologic: NNP B-NP O
66 Agitation NNP I-NP O
66 and CC O O
66 delirium NN B-NP O
66 In IN B-VP O
66 the DT B-NP O
66 immediate JJ I-NP O
67 postoperative JJ I-NP O
67 period NN I-NP O
67 , , O O
67 the DT B-NP O
67 patient NN I-NP O
67 was VBD B-VP O
67 on IN B-VP O
67 alcohol NN B-NP B-m
67 drip NN I-NP B-mo
67 , , O O
67 given VBN O O
67 a DT B-NP O
68 preop JJ I-NP O
68 history NN I-NP O
68 of IN B-VP O
68 alcohol NN B-NP B-r
68 use IN B-VP I-r
68 The DT B-NP O
68 patient's NN I-NP O
68 neurologic JJ B-NP O
68 status NN I-NP O
69 improved VBN O O
69 with IN B-VP O
69 the DT B-NP O
69 patient NN I-NP O
69 being VBG O O
69 more JJR B-NP O
69 alert NN I-NP O
69 during IN B-VP O
69 the DT B-NP O
69 day NN I-NP O
69 , , O O
70 particularly RB O O
70 with IN B-VP O
70 family NN B-NP O
70 members NNS I-NP O
70 present JJ B-NP O
70 Haldol NNP I-NP B-m
70 was VBD B-VP O
70 used VBN O O
70 p.r.n NN B-NP B-f
71 for IN B-VP O
71 agitation NN B-NP B-r
71 during IN B-VP B-du
71 the DT B-NP I-du
71 hospital JJ I-NP I-du
71 course NN I-NP I-du
72 2 CD O O
72 Cardiovascular: NNP B-NP O
72 On IN B-VP O
72 11/5/06 CD O O
72 , , O O
72 the DT B-NP O
72 patient NN I-NP O
72 was VBD B-VP O
72 taken VBN O O
72 to TO O O
72 the DT B-NP O
73 operating NN I-NP O
73 room NN I-NP O
73 and CC O O
73 underwent JJ B-NP O
73 coronary JJ I-NP O
73 artery NN I-NP O
73 bypass NN I-NP O
73 grafting VBG O O
73 x1 NN B-NP O
74 with IN B-VP O
74 LIMA NNP B-NP O
74 to TO O O
74 LAD NNP B-NP O
74 , , O O
74 with IN B-VP O
74 incomplete JJ B-NP O
74 revascularization NN I-NP O
74 due JJ O O
74 to TO O O
75 inadequate VB O O
75 conduit NN B-NP O
75 The DT B-NP O
75 patient NN I-NP O
75 tolerated VBD B-VP O
75 the DT B-NP O
75 procedure NN I-NP O
75 well NN I-NP O
75 and CC O O
76 after IN B-VP O
76 a DT B-NP O
76 period NN I-NP O
76 of IN B-VP O
76 observation NN B-NP O
76 , , O O
76 was VBD B-VP O
76 transferred VBN O O
76 to TO O O
76 the DT B-NP O
76 Cardiac NNP I-NP O
77 Surgery NNP I-NP O
77 Intensive NNP I-NP O
77 Care NNP I-NP O
77 Unit NNP I-NP O
77 Subsequently NNP I-NP O
77 , , O O
77 during IN B-VP O
77 the DT B-NP O
77 hospital NN I-NP O
78 stay NN I-NP O
78 , , O O
78 the DT B-NP O
78 patient NN I-NP O
78 was VBD B-VP O
78 started VBN O O
78 on IN B-VP O
78 beta-blockers NNS B-NP B-m
78 and CC O O
78 statins NNS B-NP B-m
79 Later NNP I-NP O
79 during IN B-VP O
79 the DT B-NP O
79 hospital NN I-NP O
79 stay NN I-NP O
79 , , O O
79 the DT B-NP O
79 patient NN I-NP O
79 became VBD B-VP O
79 hypotensive JJ B-NP B-r
79 hypotensive NN I-NP B-r
79 , , O O
79 requiring VBG O O
80 fluid NN B-NP B-m
80 resuscitation NN I-NP O
80 and CC O O
80 vasopressor NN B-NP B-m
80 administration NN I-NP O
81 3 CD O O
81 Respiratory: NNP B-NP O
81 The DT B-NP O
81 patient NN I-NP O
81 was VBD B-VP O
81 extubated VBN O O
81 on IN B-VP O
81 postoperative JJ B-NP O
81 day NN I-NP O
82 two CD O O
82 , , O O
82 but CC O O
82 he PRP O O
82 was VBD B-VP O
82 reintubated VBN O O
82 for IN B-VP O
82 acute JJ B-NP O
82 respiratory NN I-NP O
82 failure NN I-NP O
82 later RBR O O
82 during IN B-VP O
82 the DT B-NP O
82 day NN I-NP O
83 with IN B-VP O
83 subsequent JJ B-NP O
83 re-extubation NN I-NP O
83 on IN B-VP O
83 1/14/07 CD O O
83 During IN B-VP O
83 the DT B-NP O
83 hospital NN I-NP O
83 stay NN I-NP O
83 , , O O
84 the DT B-NP O
84 patient NN I-NP O
84 had VBD B-VP O
84 two CD O O
84 additional JJ B-NP O
84 re-intubations NNS I-NP O
84 for IN B-VP O
84 acute JJ B-NP O
84 respiratory JJ I-NP O
84 failure NN I-NP O
85 events NNS I-NP O
85 , , O O
85 one CD O O
85 on IN B-VP O
85 0/7/07 CD O O
85 followed VBN O O
85 by IN B-VP O
85 extubation NN B-NP O
85 on IN B-VP O
85 the DT B-NP O
85 next JJ I-NP O
85 day NN I-NP O
85 , , O O
85 on IN B-VP O
85 0/14/07 CD O O
85 and CC O O
86 the DT B-NP O
86 second JJ I-NP O
86 one NN I-NP O
86 on IN B-VP O
86 9/26/07 CD O O
86 followed VBN O O
86 by IN B-VP O
86 extubation NN B-NP O
86 on IN B-VP O
86 6/24/07 CD O O
87 4 CD O O
87 GI: NNP B-NP O
87 It PRP O O
87 was VBD B-VP O
87 characterized VBN O O
87 by IN B-VP O
87 nutrition NN B-NP O
87 deficiency NN I-NP O
87 , , O O
87 although IN B-VP O
88 the DT B-NP O
88 patient NN I-NP O
88 was VBD B-VP O
88 able JJ O O
88 to TO O O
88 tolerate VB O O
88 soft JJ B-NP O
88 mechanical JJ I-NP O
88 diet NN I-NP O
88 , , O O
88 the DT B-NP O
88 intake NN I-NP O
89 was VBD B-VP O
89 limited VBN O O
89 The DT B-NP O
89 puff NN I-NP O
89 tubes NNS I-NP O
89 were VBD B-VP O
89 placed VBN O O
89 multiple JJ B-NP O
89 times NNS I-NP O
89 for IN B-VP O
90 additional JJ B-NP O
90 nutrition NN I-NP O
90 , , O O
90 but CC O O
90 were VBD B-VP O
90 frequently RB O O
90 removed VBN O O
90 by IN B-VP O
90 the DT B-NP O
90 patient NN I-NP O
90 , , O O
91 given VBN O O
91 the DT B-NP O
91 delirium NN I-NP O
91 and CC O O
91 agitation NN B-NP O
92 5 CD O O
92 Renal: NNP B-NP O
92 The DT B-NP O
92 patient NN I-NP O
92 had VBD B-VP O
92 good JJ B-NP O
92 urine NN I-NP O
92 output NN I-NP O
92 and CC O O
92 the DT B-NP O
92 electrolyte NN I-NP O
93 and CC O O
93 creatinine NN B-NP O
93 levels NNS I-NP O
93 were VBD B-VP O
93 closely RB O O
93 monitored JJ O O
94 6 CD O O
94 Endocrine: NNP B-NP O
94 Tight NNP I-NP B-r
94 glycemic FW O I-r
94 control NN B-NP I-r
94 was VBD B-VP O
94 maintained VBN O O
94 with IN B-VP O
95 Portland NNP B-NP O
95 protocol NN I-NP O
95 in IN B-VP O
95 the DT B-NP O
95 immediate JJ I-NP O
95 postop JJ I-NP O
95 period NN I-NP O
95 and CC O O
95 subsequently RB O O
96 with IN B-VP O
96 subcu JJ B-NP B-mo
96 insulin NN I-NP B-m
96 The DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 also RB O O
96 on IN B-VP O
96 prednisone NN B-NP B-m
96 prednisone NN I-NP B-m
96 with IN B-VP O
96 the DT B-NP O
97 preop NN I-NP O
97 indications NNS I-NP O
97 for IN B-VP O
97 COPD NNP B-NP B-r
97 and CC O O
97 given VBN O O
97 his PRP$ O B-r
97 postop JJ B-NP O
97 frequent JJ I-NP O
98 bronchospastic JJ I-NP O
98 events NNS I-NP O
99 7 CD O O
99 Hematologic: NNP B-NP O
99 The DT B-NP O
99 patient NN I-NP O
99 was VBD B-VP O
99 started VBN O O
99 on IN B-VP O
99 aspirin NN B-NP B-m
99 and CC O O
99 also RB O O
99 on IN B-VP O
100 Plavix NNP B-NP B-m
100 , , O O
100 given VBN O O
100 the DT B-NP O
100 incomplete JJ I-NP B-r
100 incomplete JJ I-NP B-r
100 coronary JJ I-NP I-r
100 coronary JJ I-NP I-r
100 vascularization NN I-NP I-r
100 vascularization NN I-NP I-r
101 Hematocrit NNP I-NP O
101 and CC O O
101 platelets NNS B-NP O
101 were VBD B-VP O
101 stable JJ O O
102 8 CD O O
102 Infectious JJ B-NP O
102 disease: NN I-NP O
102 The DT B-NP O
102 course NN I-NP O
102 was VBD B-VP O
102 complicated VBN O O
102 by: IN B-VP O
102 A NNP B-NP O
102 ) ) O O
103 Sternal NNP B-NP O
103 wound NN I-NP O
103 infection NN I-NP O
103 for IN B-VP O
103 which WDT O O
103 the DT B-NP O
103 patient NN I-NP O
103 underwent JJ B-NP O
104 pericardial JJ I-NP O
104 strip NN I-NP O
104 advancement NN I-NP O
104 on IN B-VP O
104 0/7/07 CD O O
104 and CC O O
104 omental JJ B-NP O
104 flap NN I-NP O
104 and CC O O
105 wound JJ B-NP O
105 closure NN I-NP O
105 on IN B-VP O
105 10/13/07 CD O O
105 The DT B-NP O
105 wound NN I-NP O
105 was VBD B-VP O
105 reopened VBN O O
105 at IN B-VP O
105 the DT B-NP O
105 bedside NN I-NP O
106 on IN B-VP O
106 10/30/07 CD O O
106 by IN B-VP O
106 Plastic NN B-NP O
106 Surgery NNP I-NP O
106 due JJ O O
106 to TO O O
106 increased VBN O O
106 drainage NN B-NP O
106 and CC O O
106 a DT B-NP O
107 VAC NNP I-NP O
107 sponge NN I-NP O
107 was VBD B-VP O
107 placed VBN O O
107 Wound IN B-VP O
107 cultures NNS B-NP O
107 were VBD B-VP O
107 sent VBN O O
107 and CC O O
107 appropriate JJ B-NP O
108 antibiotic JJ I-NP B-m
108 treatment NN I-NP O
108 was VBD B-VP O
108 instituted VBN O O
108 B NNP B-NP O
108 ) ) O O
108 Pneumonias NNP B-NP B-r
108 Treated NNP I-NP O
109 initially RB O O
109 empirically RB O O
109 and CC O O
109 subsequently RB O O
109 with IN B-VP O
109 specific JJ B-NP O
109 antibiotics NNS I-NP B-m
110 after IN B-VP O
110 culture NN B-NP O
110 results NNS I-NP O
110 became VBD B-VP O
110 available JJ B-NP O
110 C NNP I-NP O
110 ) ) O O
110 Fever NNP B-NP O
110 , , O O
110 later RB O O
110 in IN B-VP O
110 the DT B-NP O
111 hospital NN I-NP O
111 course NN I-NP O
111 , , O O
111 the DT B-NP O
111 patient NN I-NP O
111 experienced VBD B-VP O
111 fever RB O O
111 without IN B-VP O
112 leukocytosis NN B-NP O
112 despite IN B-VP O
112 negative JJ B-NP O
112 cultures NNS I-NP O
112 Throughout IN B-VP O
112 the DT B-NP O
112 hospital NN I-NP O
113 course NN I-NP O
113 , , O O
113 Infectious NNP B-NP O
113 Disease NNP I-NP O
113 Service NNP I-NP O
113 and CC O O
113 Pulmonary NNP B-NP O
113 Service NNP I-NP O
113 were VBD B-VP O
114 consulted VBN O O
114 and CC O O
114 they PRP O O
114 followed VBD B-VP O
114 the DT B-NP O
114 patient NN I-NP O
114 continuously RB O O
115 9 CD O O
115 Other: NNP B-NP O
115 Incidental NNP I-NP O
115 radiologic VBD B-VP O
115 finding NN B-NP O
115 of IN B-VP O
115 a DT B-NP O
115 renal JJ I-NP O
115 mass NN I-NP O
116 consistent NN I-NP O
116 with IN B-VP O
116 renal JJ B-NP O
116 cell NN I-NP O
116 carcinoma NN I-NP O
116 Urology NNP I-NP O
116 Service NNP I-NP O
116 was VBD B-VP O
117 consulted VBN O O
117 and CC O O
117 the DT B-NP O
117 recommendations NNS I-NP O
117 were VBD B-VP O
117 made VBN O O
117 for IN B-VP O
117 no DT B-NP O
117 intervention NN I-NP O
118 at IN B-VP O
118 this DT B-NP O
118 time NN I-NP O
119 After IN B-VP O
119 excessive JJ B-NP O
119 discussion NN I-NP O
119 with IN B-VP O
119 the DT O O
119 very RB O O
119 supportive JJ B-NP O
119 patient's NNS I-NP O
119 family NN I-NP O
119 with IN B-VP O
120 regards NNS B-NP O
120 to TO O O
120 the DT B-NP O
120 patient's NN I-NP O
120 prognosis NN I-NP O
120 , , O O
120 family NN B-NP O
120 decision NN I-NP O
120 was VBD B-VP O
120 made VBN O O
120 to TO O O
120 withdraw VB O O
121 medical JJ B-NP O
121 care NN I-NP O
121 and CC O O
121 discharge VB O O
121 the DT B-NP O
121 patient NN I-NP O
121 to TO O O
121 home NN B-NP O
121 with IN B-VP O
121 hospice NN B-NP O
121 services NNS I-NP O
121 Thus RB O O
121 , , O O
121 on IN B-VP O
122 9/26/07 CD O O
122 , , O O
122 the DT B-NP O
122 patient NN I-NP O
122 was VBD B-VP O
122 discharged VBN O O
122 to TO O O
122 home NN B-NP O
122 after IN B-VP O
122 hospice NN B-NP O
122 services NNS I-NP O
122 were VBD B-VP O
123 arranged VBN O O
124 MEDICATIONS NNP B-NP O
124 AT NNP I-NP O
124 DISCHARGE: NNP I-NP O
124 Were NNP I-NP O
124 the DT O O
124 following VBG O O
125 1 CD O O
125 Tylenol NNP B-NP B-m
125 suppository NN I-NP I-m
125 650 CD O B-do
125 mg NN B-NP I-do
125 every DT O B-f
125 6 CD O I-f
125 hours NNS B-NP I-f
126 2 CD O O
126 Toradol NNP B-NP B-m
126 orally RB O B-mo
126 10 CD O B-do
126 mg NN B-NP I-do
126 every DT O B-f
126 4 CD O I-f
126 hours NNS B-NP I-f
126 as IN B-VP I-f
126 needed VBN O I-f
126 for IN B-VP O
126 pain NN B-NP B-r
127 3 CD O O
127 Haldol NNP B-NP B-m
127 liquid VBD B-VP I-m
127 1 CD O B-do
127 to TO O I-do
127 3 CD O I-do
127 mg NNS B-NP I-do
127 orally RB O B-mo
127 every DT O B-f
127 4 CD O I-f
127 hours NNS B-NP I-f
127 as IN B-VP I-f
127 needed VBN O I-f
127 for IN B-VP O
128 agitation NN B-NP B-r
129 4 CD O O
129 Nexium NN B-NP B-m
129 20 CD O B-do
129 mg NN B-NP I-do
129 everyday JJ O B-f
130 5 CD O O
130 Morphine NNP B-NP B-m
130 Morphine NNP I-NP B-m
130 liquid NN I-NP I-m
130 liquid VBD B-VP I-m
130 5 CD O B-do
130 5 CD O B-do
130 to TO O I-do
130 to TO O I-do
130 20 CD O I-do
130 20 CD O I-do
130 mg NN B-NP I-do
130 mg NN I-NP I-do
130 orally RB O B-mo
130 orally RB O B-mo
130 every DT O B-f
130 every DT O B-f
130 2 CD O I-f
130 2 CD O I-f
130 hours NNS B-NP I-f
130 hours NNS I-NP I-f
130 as IN B-VP I-f
130 as IN B-VP I-f
130 needed VBN O I-f
130 needed VBN O I-f
130 for IN B-VP O
131 pain NN B-NP B-r
131 and CC O O
131 for IN B-VP O
131 shortness NN B-NP B-r
131 of IN B-VP I-r
131 breath NN B-NP I-r
132 Support NNP I-NP O
132 for IN B-VP O
132 the DT B-NP O
132 patient's JJ I-NP O
132 family NN I-NP O
132 was VBD B-VP O
132 provided VBN O O
132 throughout IN B-VP O
132 the DT B-NP O
133 hospital NN I-NP O
133 course NN I-NP O
133 , , O O
133 and CC O O
133 the DT B-NP O
133 patient's JJ I-NP O
133 family NN I-NP O
133 was VBD B-VP O
133 instructed VBN O O
133 to TO O O
133 call VB O O
134 house NN B-NP O
134 officer NN I-NP O
134 on IN B-VP O
134 call NN B-NP O
134 if IN B-VP O
134 any DT B-NP O
134 question NN I-NP O
134 might MD O O
134 arise VB O O
135 eScription NN B-NP O
135 document: IN B-VP O
135 9-8603383 CD O O
135 CSSten NNP B-NP O
135 Tel NNP I-NP O
136 Dictated NNP I-NP O
136 By: NNP I-NP O
136 SPAHN NNP I-NP O
136 , , O O
136 NEWTON NNP B-NP O
137 Attending: NNP I-NP O
137 MUDRICK NNP I-NP O
137 , , O O
137 JAMEY NNP B-NP O
138 Dictation NNP I-NP O
138 ID NNP I-NP O
138 2086227 CD O O
139 D: NNP B-NP O
139 2/5/07 CD O O
140 T: NNP B-NP O
140 2/5/07 CD O O
141 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #939003 VBZ O O
4 979128258 CD O O
4 DAMC NNP B-NP O
4 19635378 CD O O
4 745862 CD O O
4 10/15/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 sob NN I-NP O
4 of IN B-VP O
4 unknown JJ B-NP O
4 etiology NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/15/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/16/2001 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 DIOMEDE NNP I-NP O
8 , , O O
8 DAVID NNP B-NP O
8 572-07-61-6 CD O O
9 U NNP B-NP O
9 Ertna NNP I-NP O
9 Leigh NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 6/2/01 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 CONER NNP I-NP O
14 , , O O
14 LEN NNP B-NP O
14 DOMINGO NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ECASA NNP I-NP B-m
19 ( ( O I-m
19 ASPIRIN NNP B-NP I-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 ) ) O I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 ATENOLOL NNP I-NP B-m
20 50 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
20 Food/Drug NNP I-NP O
20 Interaction NNP I-NP O
20 Instruction NNP I-NP O
21 Take NNP I-NP O
21 consistently RB O O
21 with IN B-VP O
21 meals NNS B-NP O
21 or CC O O
21 on IN B-VP O
21 empty JJ B-NP O
21 stomach NN I-NP O
22 KLONOPIN NNP I-NP B-m
22 ( ( O I-m
22 CLONAZEPAM NNP B-NP I-m
22 ) ) O I-m
22 1 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 TID NNP I-NP B-f
23 Override NNP I-NP O
23 Notice: NNP I-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 4/20/01 CD O O
23 by IN B-VP O
24 FRIEDRICHS NNP B-NP O
24 , , O O
24 ERIK NNP B-NP O
24 JIM NNP I-NP O
24 , , O O
24 M.D NNP B-NP O
25 on IN B-VP O
25 order NN B-NP O
25 for IN B-VP O
25 AZITHROMYCIN NNP B-NP B-m
25 PO NNP I-NP B-mo
25 ( ( O O
25 ref JJ O O
25 # # O O
25 63922816 CD O O
25 ) ) O O
26 POTENTIALLY NNP B-NP O
26 SERIOUS NNP I-NP O
26 INTERACTION: NNP I-NP O
26 CLONAZEPAM NNP I-NP B-m
26 &amp; NNP I-NP O
26 AZITHROMYCIN NNP I-NP B-m
27 Reason NNP I-NP O
27 for IN B-VP O
27 override: NN B-NP O
27 monitor NN I-NP O
27 Previous NNP I-NP O
27 override IN B-VP O
27 information: JJ B-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 4/20/01 CD O O
28 by IN B-VP O
28 RESSEGUIE NNP B-NP O
28 , , O O
28 COLUMBUS NNP B-NP O
28 DARELL NNP I-NP O
28 , , O O
28 M.D NNP B-NP O
29 on IN B-VP O
29 order NN B-NP O
29 for IN B-VP O
29 AZITHROMYCIN NNP B-NP B-m
29 PO NNP I-NP B-mo
29 ( ( O O
29 ref JJ O O
29 # # O O
29 78776952 CD O O
29 ) ) O O
30 POTENTIALLY NNP B-NP O
30 SERIOUS NNP I-NP O
30 INTERACTION: NNP I-NP O
30 CLONAZEPAM NNP I-NP B-m
30 &amp; NNP I-NP O
30 AZITHROMYCIN NNP I-NP B-m
31 Reason NNP I-NP O
31 for IN B-VP O
31 override: NN B-NP O
31 monitor NN I-NP O
32 COLACE NNP I-NP B-m
32 ( ( O I-m
32 DOCUSATE NNP B-NP I-m
32 SODIUM NNP I-NP I-m
32 ) ) O I-m
32 100 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
33 PROZAC NNP I-NP B-m
33 ( ( O I-m
33 FLUOXETINE NNP B-NP I-m
33 HCL NNP I-NP I-m
33 ) ) O I-m
33 20 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
34 ZESTRIL NNP I-NP B-m
34 ( ( O I-m
34 LISINOPRIL NNP B-NP I-m
34 ) ) O I-m
34 10 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QD NNP I-NP B-f
35 NIFEREX-150 NNP I-NP B-m
35 150 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 BID NNP I-NP B-f
36 PERCOCET NNP I-NP B-m
36 1 CD O B-do
36 TAB NNP B-NP I-do
36 PO NNP I-NP B-mo
36 Q6H NNP I-NP O
36 X NNP I-NP B-du
36 7 CD O I-du
36 Days NNPS B-NP I-du
36 Starting VBG O O
36 Today NNP B-NP O
36 ( ( O O
36 6/1 CD O O
36 ) ) O O
37 PRN NNP B-NP O
37 pain VBP O B-r
38 AZITHROMYCIN NNP B-NP B-m
38 250 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 QD NNP I-NP B-f
38 X NNP I-NP B-du
38 4 CD O I-du
38 Days NNPS B-NP I-du
38 Starting VBG O O
38 IN NNP B-NP O
38 AM NNP I-NP O
38 ( ( O O
38 6/1 CD O O
38 ) ) O O
39 Food/Drug NNP B-NP O
39 Interaction NNP I-NP O
39 Instruction NNP I-NP O
39 Take NNP I-NP O
39 with IN B-VP O
39 food NN B-NP O
40 Alert NNP I-NP O
40 overridden: NNP I-NP O
40 Override NNP I-NP O
40 added VBD B-VP O
40 on IN B-VP O
40 4/20/01 CD O O
40 by IN B-VP O
41 HUNZIKER NNP B-NP O
41 , , O O
41 BARTON NNP B-NP O
41 ELDON NNP I-NP O
41 , , O O
41 M.D NNP B-NP O
42 POTENTIALLY NNP I-NP O
42 SERIOUS NNP I-NP O
42 INTERACTION: NNP I-NP O
42 CLONAZEPAM NNP I-NP B-m
42 &amp; NNP I-NP O
42 AZITHROMYCIN NNP I-NP B-m
43 POTENTIALLY NNP I-NP O
43 SERIOUS NNP I-NP O
43 INTERACTION: NNP I-NP O
43 CLONAZEPAM NNP I-NP B-m
43 &amp; NNP I-NP O
43 AZITHROMYCIN NNP I-NP B-m
44 Reason NNP I-NP O
44 for IN B-VP O
44 override: NN B-NP O
44 monitor NN I-NP O
45 PRILOSEC NNP I-NP B-m
45 ( ( O I-m
45 OMEPRAZOLE NNP B-NP I-m
45 ) ) O I-m
45 20 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 QD NNP I-NP B-f
46 ALBUTEROL NNP I-NP B-m
46 INHALER NNP I-NP I-m
46 2 CD O B-do
46 PUFF NNP B-NP I-do
46 INH NNP I-NP B-mo
46 QID NNP I-NP B-f
47 ATROVENT NNP I-NP B-m
47 INHALER NNP I-NP I-m
47 ( ( O I-m
47 IPRATROPIUM NNP B-NP I-m
47 INHALER NNP I-NP I-m
47 ) ) O I-m
47 2 CD O B-do
47 PUFF NNP B-NP I-do
47 INH NNP I-NP B-mo
47 QID NNP I-NP B-f
48 PREDNISONE NNP I-NP B-m
48 PREDNISONE NNP I-NP B-m
48 PREDNISONE NNP I-NP B-m
48 PREDNISONE NNP I-NP B-m
48 PREDNISONE NNP I-NP B-m
48 PREDNISONE NNP I-NP B-m
48 PREDNISONE NNP I-NP B-m
48 Taper NNP I-NP O
48 PO NNP I-NP B-mo
48 PO NNP I-NP B-mo
48 PO NNP I-NP B-mo
48 PO NNP I-NP B-mo
48 PO NNP I-NP B-mo
48 PO NNP I-NP B-mo
48 PO NNP I-NP B-mo
49 Give NNP I-NP O
49 60 CD O B-do
49 mg NN B-NP I-do
49 QD NNP I-NP B-f
49 X NNP I-NP B-du
49 2 CD O I-du
49 day( NN B-NP I-du
49 s NN I-NP I-du
49 ) ) O I-du
49 ( ( O O
49 0/22/01-09 JJ O O
49 ) ) O O
49 , , O O
49 then RB O O
49 ---done CD O O
50 Give NNP B-NP O
50 50 CD O B-do
50 mg NN B-NP I-do
50 QD NNP I-NP B-f
50 X NNP I-NP B-du
50 2 CD O I-du
50 day( NN B-NP I-du
50 s NN I-NP I-du
50 ) ) O I-du
50 ( ( O O
50 2/26/01-09 JJ O O
50 ) ) O O
50 , , O O
50 then RB O O
50 ---done CD O O
51 Give NNP B-NP O
51 40 CD O B-do
51 mg NN B-NP I-do
51 QD NNP I-NP B-f
51 X NNP I-NP B-du
51 2 CD O I-du
51 day( NN B-NP I-du
51 s NN I-NP I-du
51 ) ) O I-du
51 ( ( O O
51 9/28/01-09 CD O O
51 ) ) O O
51 , , O O
51 then RB O O
51 ---done CD O O
52 Give NNP B-NP O
52 30 CD O B-do
52 mg NN B-NP I-do
52 QD NNP I-NP B-f
52 X NNP I-NP B-du
52 2 CD O I-du
52 day( NN B-NP I-du
52 s NN I-NP I-du
52 ) ) O I-du
52 ( ( O O
52 4/0/01-09 JJ O O
52 ) ) O O
52 , , O O
52 then RB O O
52 ---done CD O O
53 Give NNP B-NP O
53 20 CD O B-do
53 mg NN B-NP I-do
53 QD NNP I-NP B-f
53 X NNP I-NP B-du
53 2 CD O I-du
53 day( NN B-NP I-du
53 s NN I-NP I-du
53 ) ) O I-du
53 ( ( O O
53 8/26/01-09 JJ O O
53 ) ) O O
53 , , O O
53 then RB O O
53 ---done CD O O
54 Give NNP B-NP O
54 10 CD O B-do
54 mg NN B-NP I-do
54 QD NNP I-NP B-f
54 X NNP I-NP B-du
54 2 CD O I-du
54 day( NN B-NP I-du
54 s NN I-NP I-du
54 ) ) O I-du
54 ( ( O O
54 2/20/01-10 JJ O O
54 ) ) O O
54 , , O O
54 then RB O O
54 ---done CD O O
55 Give NNP B-NP O
55 5 CD O B-do
55 mg NN B-NP I-do
55 QD NNP I-NP B-f
55 X NNP I-NP B-du
55 2 CD O I-du
55 day( NN B-NP I-du
55 s NN I-NP I-du
55 ) ) O I-du
55 ( ( O O
55 3/6/01-10 JJ O O
55 ) ) O O
55 , , O O
55 then RB O O
55 ---done CD O O
56 DIET: NNP B-NP O
56 House NNP I-NP O
56 / VBD B-VP O
56 Low NNP B-NP O
56 chol/low NN I-NP O
56 sat VBD B-VP O
56 fat JJ B-NP O
57 RETURN NNP I-NP O
57 TO NNP I-NP O
57 WORK: NNP I-NP O
57 After IN B-VP O
57 Appt NNP B-NP O
57 with IN B-VP O
57 local JJ B-NP O
57 physician JJ I-NP O
58 No NNP I-NP O
58 Known NNP I-NP O
58 Allergies NNP I-NP O
59 ADMIT NNP I-NP O
59 DIAGNOSIS: NNP I-NP O
60 sob NN I-NP O
61 PRINCIPAL NNP I-NP O
61 DISCHARGE NNP I-NP O
61 DIAGNOSIS NNP I-NP O
61 ;Responsible JJ O O
61 After IN B-VP O
61 Study NNP B-NP O
61 for IN B-VP O
61 Causing NNP B-NP O
61 Admission NNP I-NP O
61 ) ) O O
62 sob NN B-NP O
62 of IN B-VP O
62 unknown JJ B-NP O
62 etiology NN I-NP O
63 OTHER NNP I-NP O
63 DIAGNOSIS;Conditions NNP I-NP O
63 , , O O
63 Infections NNP B-NP O
63 , , O O
63 Complications NNP B-NP O
63 , , O O
63 affecting VBG O O
63 Treatment/Stay NNP B-NP O
64 Borderline NNP I-NP O
64 HTN NNP I-NP O
64 Anxiety NNP I-NP O
64 D/O NNP I-NP O
64 PPD NNP I-NP O
64 + NNP I-NP O
64 s/p VBD B-VP O
64 INH NNP B-NP O
64 G5P4TAB1 NNP I-NP O
65 morbid NN I-NP O
65 obesity NN I-NP O
65 ( ( O O
65 obesity NN B-NP O
65 ) ) O O
65 obstructive JJ B-NP O
65 sleep NN I-NP O
65 apnea NN I-NP O
65 ( ( O O
65 sleep JJ B-NP O
65 apnea NN I-NP O
65 ) ) O O
66 psoriasis NN B-NP O
66 ( ( O O
66 psoriasis NN B-NP O
66 ) ) O O
67 OPERATIONS NNP B-NP O
67 AND NNP I-NP O
67 PROCEDURES: NNP I-NP O
68 none NN I-NP O
69 OTHER NNP I-NP O
69 TREATMENTS/PROCEDURES NNP I-NP O
69 ( ( O O
69 NOT NNP B-NP O
69 IN NNP I-NP O
69 O.R NNP I-NP O
69 ) ) O O
70 none NN B-NP O
71 BRIEF NNP I-NP O
71 RESUME NNP I-NP O
71 OF NNP I-NP O
71 HOSPITAL NNP I-NP O
71 COURSE: NNP I-NP O
72 37 CD O O
72 yo NN B-NP O
72 multiple JJ B-NP O
72 admissions NNS I-NP O
72 for IN B-VP O
72 atypical JJ B-NP O
72 chest NN I-NP O
72 pain NN I-NP O
72 , , O O
73 morbid NN B-NP O
73 obesity NN I-NP O
73 , , O O
73 restrictive JJ B-NP O
73 lung NN I-NP O
73 dz NN I-NP O
73 by IN B-VP O
73 PFTs NNP B-NP O
73 , , O O
73 sleep JJ B-NP O
73 apnea NN I-NP O
73 , , O O
73 borderline NN B-NP O
74 HTN NNP I-NP O
74 Had NNP I-NP O
74 cath NN I-NP O
74 last JJ B-NP O
74 admission NN I-NP O
74 and CC O O
74 showed VBD B-VP O
74 clean JJ B-NP O
74 coronaries NNS I-NP O
74 Now RB O O
74 comes VBZ O O
74 in IN B-VP O
75 complaining VBG O O
75 of IN B-VP O
75 SOB NNP B-NP O
75 and CC O O
75 "asthma NNP B-NP O
75 attack" NN I-NP O
75 and CC O O
75 anxiety NN B-NP B-r
75 Responded NNP I-NP O
75 well RB O O
75 to TO O O
76 Nebs NNP B-NP O
76 and CC O O
76 Ativan NNP B-NP B-m
76 in IN B-VP O
76 ED NNP B-NP O
76 Will NNP I-NP O
76 d/c VB O O
76 to TO O O
76 complete VB O O
76 course NN B-NP O
76 of IN B-VP O
76 Macrolide NNP B-NP B-m
76 antibio RB O O
77 tic JJ O O
77 to TO O O
77 cover VB O O
77 atypicals NNS B-NP O
77 for IN B-VP O
77 tracheobronchitis NN B-NP B-r
77 at IN B-VP O
77 home NN B-NP O
78 ADDITIONAL NNP I-NP O
78 COMMENTS: NNP I-NP O
79 DISCHARGE NNP I-NP O
79 CONDITION: NNP I-NP O
79 Stable NNP I-NP O
80 TO NNP I-NP O
80 DO/PLAN: NNP I-NP O
81 No NNP I-NP O
81 dictated VBD B-VP O
81 summary JJ B-NP O
82 ENTERED NNP I-NP O
82 BY: NNP I-NP O
82 JAY NNP I-NP O
82 , , O O
82 LAMAR NNP B-NP O
82 KRIS NNP I-NP O
82 , , O O
82 M.D NNP B-NP O
82 ( ( O O
82 TD84 NNP B-NP O
82 ) ) O O
82 6/2/01 CD O O
82 @ $ O O
82 10:58 CD O O
82 AM NNP B-NP O
83 ****** JJ B-NP O
83 END NN I-NP O
83 OF NNP I-NP O
83 DISCHARGE NNP I-NP O
83 ORDERS NNP I-NP O
83 ****** NNP I-NP O
84 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #939531 VBZ O O
2 214850753 CD O O
2 RVHC NNP B-NP O
2 17622865 CD O O
2 943010 CD O O
2 7/21/1995 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Unsigned VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/15/1995 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/29/1995 CD O O
4 PRELIMINARY NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 CORONARY NNP I-NP O
4 ARTERY NNP I-NP O
4 DISEASE NNP I-NP O
5 HISTORY NNP I-NP O
5 OF NNP I-NP O
5 PRESENT NNP I-NP O
5 ILLNESS: NNP I-NP O
5 The DT B-NP O
5 patient NN I-NP O
5 is VBZ O O
5 a DT B-NP O
5 62-year-old JJ I-NP O
6 white JJ I-NP O
6 male NN I-NP O
6 status NN I-NP O
6 post NN I-NP O
6 anterior RB O O
6 wall JJ B-NP O
7 myocardial JJ I-NP O
7 infarction NN I-NP O
7 , , O O
7 status NN B-NP O
7 post NN I-NP O
7 TPA NNP I-NP O
7 who WP O O
7 presented VBD B-VP O
7 with IN B-VP O
8 post-infarct JJ B-NP O
8 angina NNS I-NP O
8 and CC O O
8 three-vessel JJ B-NP O
8 disease NN I-NP O
8 by IN B-VP O
8 catheterization NN B-NP O
9 The DT B-NP O
9 patient's NN I-NP O
9 cardiac JJ B-NP O
9 risk NN I-NP O
9 factors NNS I-NP O
9 include VBP O O
9 diabetes NNS B-NP O
9 , , O O
9 hypertension NN B-NP O
9 , , O O
10 and CC O O
10 positive JJ B-NP O
10 family NN I-NP O
10 history NN I-NP O
10 The DT B-NP O
10 patient NN I-NP O
10 denies VBZ O O
10 cigarettes VBZ O O
10 The DT B-NP O
11 patient NN I-NP O
11 is VBZ O O
11 a DT O O
11 very RB O O
11 noncooperative JJ B-NP O
11 historian NN I-NP O
12 PAST NNP I-NP O
12 MEDICAL NNP I-NP O
12 HISTORY: NNP I-NP O
12 The DT B-NP O
12 patient's NN I-NP O
12 past JJ B-NP O
12 medical JJ I-NP O
12 history NN I-NP O
12 is VBZ O O
13 significant JJ O O
13 for IN B-VP O
13 diabetes NNS B-NP B-r
13 of IN B-VP O
13 20 CD O O
13 years NNS B-NP O
14 without IN B-VP O
14 neurological JJ O O
14 or CC O O
14 retinopathy JJ O O
14 treated VBN O O
14 with IN B-VP O
14 oral JJ B-NP B-mo
15 hypoglycemics NNS I-NP B-m
15 The DT B-NP O
15 patient NN I-NP O
15 has VBZ O O
15 long-standing JJ B-NP O
15 hypotension NN I-NP O
15 of IN B-VP O
15 30 CD O O
15 to TO O O
16 40 CD O O
16 years NNS B-NP O
16 The DT B-NP O
16 patient NN I-NP O
16 , , O O
16 in IN B-VP O
16 1985 CD O O
16 , , O O
16 had VBD B-VP O
16 a DT B-NP O
16 percutaneous JJ I-NP O
16 transluminal JJ I-NP O
17 coronary JJ I-NP O
17 angioplasty NN I-NP O
17 at IN B-VP O
17 the DT B-NP O
17 Ribush NNP I-NP O
17 Bassta NNP I-NP O
17 Syark NNP I-NP O
17 Hospital NNP I-NP O
17 and CC O O
17 has VBZ O O
18 had VBN O O
18 rule NN B-NP O
18 outs NNS I-NP O
18 since IN B-VP O
18 for IN B-VP O
18 myocardial JJ B-NP O
18 infarction NN I-NP O
18 with IN B-VP O
18 the DT O O
18 last JJ O O
18 one CD O O
19 approximately RB O O
19 in IN B-VP O
19 1990 CD O O
19 at IN B-VP O
19 Dormro NNP B-NP O
19 General NNP I-NP O
19 Hospital NNP I-NP O
19 The DT B-NP O
20 patient NN I-NP O
20 , , O O
20 however RB O O
20 , , O O
20 has VBZ O O
20 been VBN O O
20 able JJ O O
20 to TO O O
20 work VB O O
20 and CC O O
20 climb VB O O
20 stairs NNS B-NP O
20 and CC O O
20 walk VBP O O
21 about IN B-VP O
21 a DT B-NP O
21 mile NN I-NP O
21 without IN B-VP O
21 difficulty NN B-NP O
21 Several JJ B-NP O
21 days NNS I-NP O
21 to TO O O
21 admission NN B-NP O
21 , , O O
21 the DT B-NP O
22 patient NN I-NP O
22 reports NNS I-NP O
22 pain NN I-NP O
22 and CC O O
22 ache NN B-NP O
22 over IN B-VP O
22 the DT B-NP O
22 lower JJR I-NP O
22 back NN I-NP O
22 and CC O O
22 flanks NNS B-NP O
22 as RB O O
23 well RB O O
23 as IN B-VP O
23 substernal JJ B-NP O
23 chest NN I-NP O
23 pain NN I-NP O
23 with IN B-VP O
23 radiation NN B-NP O
23 to TO O O
23 the DT B-NP O
23 upper JJ I-NP O
23 left NN I-NP O
23 arm VBZ O O
24 The DT B-NP O
24 patient NN I-NP O
24 is VBZ O O
24 unable JJ O O
24 to TO O O
24 describe VB O O
24 any DT B-NP O
24 further JJ I-NP O
24 symptoms NNS I-NP O
24 The DT B-NP O
25 patient NN I-NP O
25 denied VBD B-VP O
25 nausea NN B-NP O
25 or CC O O
25 vomiting NN B-NP O
25 but CC O O
25 says VBZ O O
25 he PRP O O
25 was VBD B-VP O
25 diaphoretic JJ O O
25 The DT B-NP O
26 patient NN I-NP O
26 took VBD B-VP O
26 four CD O B-do
26 to TO O I-do
26 five CD O I-do
26 Nitroglycerins NNS B-NP B-m
26 without IN B-VP O
26 relief NN B-NP O
26 The DT B-NP O
27 patient NN I-NP O
27 subsequently RB O O
27 was VBD B-VP O
27 admitted VBN O O
27 to TO O O
27 Agrit NNP B-NP O
27 Medical NNP I-NP O
27 Center NNP I-NP O
27 and CC O O
27 had VBD B-VP O
27 at IN B-VP O
28 least JJS O O
28 3 CD O O
28 hours NNS B-NP O
28 of IN B-VP O
28 pain NN B-NP O
28 at IN B-VP O
28 Pari NNP B-NP O
28 The DT B-NP O
28 patient NN I-NP O
28 was VBD B-VP O
28 ruled VBN O O
29 in IN B-VP O
29 for IN B-VP O
29 anterior JJ B-NP O
29 wall NN I-NP O
29 myocardial JJ B-NP O
29 infarction NN I-NP O
29 with IN B-VP O
29 ST NNP B-NP O
29 elevations NNS I-NP O
29 4 CD O O
29 to TO O O
30 5 CD O O
30 mm NNS B-NP O
30 in IN B-VP O
30 V1 NNP B-NP O
30 Blood NNP I-NP O
30 pressure NN I-NP O
30 was VBD B-VP O
30 152/95 CD O O
30 The DT B-NP O
30 patient NN I-NP O
30 received VBD B-VP O
31 front-loaded JJ B-NP B-m
31 TPA NNP I-NP I-m
31 , , O O
31 Heparin NNP B-NP B-m
31 , , O O
31 Aspirin NNP B-NP B-m
31 , , O O
31 Morphine NNP B-NP B-m
31 sulfate NN I-NP I-m
31 and CC O O
32 Nifedipine NNP B-NP B-m
32 At IN B-VP O
32 1:00 CD O O
32 a.m NN B-NP O
32 , , O O
32 the DT B-NP O
32 patient NN I-NP O
32 had VBD B-VP O
32 recurrent JJ B-NP O
32 chest NN I-NP O
32 pain NN I-NP O
33 with IN B-VP O
33 elevations NNS B-NP O
33 in IN B-VP O
33 V1 NNP B-NP O
33 through IN B-VP O
33 6 CD O O
33 , , O O
33 Lead NNP B-NP O
33 , , O O
33 1 CD O O
33 , , O O
33 AVL NNP B-NP O
33 and CC O O
33 the DT B-NP O
33 patient NN I-NP O
33 was VBD B-VP O
34 subsequently RB O O
34 transferred VBN O O
34 to TO O O
34 the DT B-NP O
34 Pepor NNP I-NP O
34 El NNP I-NP O
34 Medical NNP I-NP O
34 Center NNP I-NP O
34 Of IN B-VP O
34 At IN B-VP O
35 the DT B-NP O
35 Hitchter NNP I-NP O
35 University NNP I-NP O
35 Medical NNP I-NP O
35 Center NNP I-NP O
35 , , O O
35 the DT B-NP O
35 patient NN I-NP O
35 was VBD B-VP O
35 cathed VBN O O
35 and CC O O
35 had VBD B-VP O
36 100% CD O O
36 stenotic JJ B-NP O
36 mid NN I-NP O
36 left VBD B-VP O
36 anterior JJ B-NP O
36 descending NN I-NP O
36 , , O O
36 90% CD O O
36 ulcerated JJ O O
36 obtuse IN B-VP O
37 marginal JJ B-NP O
37 first JJ I-NP O
37 branch NN I-NP O
37 , , O O
37 60 CD O O
37 to TO O O
37 70% CD O O
37 stenotic JJ O O
37 right RB O O
37 coronary JJ B-NP O
37 artery NN I-NP O
37 and CC O O
38 anterior JJ B-NP O
38 apical JJ I-NP O
38 aneurysm NN I-NP O
38 was VBD B-VP O
38 noted VBN O O
38 The DT B-NP O
38 patient NN I-NP O
38 was VBD B-VP O
38 placed VBN O O
38 on IN B-VP O
38 an DT B-NP O
39 intra-aortic JJ I-NP O
39 balloon NN I-NP O
39 pump NN I-NP O
39 in IN B-VP O
39 preparation NN B-NP O
39 for IN B-VP O
39 coronary JJ B-NP O
39 artery NN I-NP O
39 bypass NN I-NP O
40 surgery NN I-NP O
41 PAST NNP I-NP O
41 MEDICAL NNP I-NP O
41 HISTORY: NNP I-NP O
41 The DT B-NP O
41 patient's NN I-NP O
41 past JJ B-NP O
41 medical JJ I-NP O
41 history NN I-NP O
41 is VBZ O O
42 inclusive JJ O O
42 of IN B-VP O
42 status NN B-NP O
42 post NN I-NP O
42 percutaneous JJ B-NP O
43 transluminal JJ I-NP O
43 coronary NN I-NP O
43 angioplasty NN I-NP O
43 in IN B-VP O
43 '85 NN B-NP O
43 at IN B-VP O
43 Ason NNP B-NP O
43 Medical NNP I-NP O
43 Center NNP I-NP O
43 , , O O
43 coronary JJ B-NP O
43 artery NN I-NP O
43 disease NN I-NP O
43 , , O O
43 diabetes VBZ O O
43 , , O O
43 hypertension NN B-NP O
43 and CC O O
44 ruptured VBD B-VP O
44 appendectomy RB O O
44 25 CD O O
44 years NNS B-NP O
44 prior RB O O
44 to TO O O
44 admission NN B-NP O
45 MEDICATIONS NNP I-NP O
45 ON NNP I-NP O
45 ADMISSION: NNP I-NP O
45 The DT B-NP O
45 patient NN I-NP O
45 was VBD B-VP O
45 admitted VBN O O
45 on IN B-VP O
45 the DT B-NP O
46 following JJ I-NP O
46 medications: NN I-NP O
46 Diltiazem NNP I-NP B-m
46 60 CD O B-do
47 t.i.d NN B-NP B-f
47 , , O O
47 Glyburide NNP B-NP B-m
47 , , O O
47 Lisinopril NNP B-NP B-m
47 20 CD O B-do
47 PO NNP B-NP B-mo
47 q.day NN I-NP B-f
48 ALLERGIES: NNP I-NP O
48 The DT B-NP O
48 patient NN I-NP O
48 has VBZ O O
48 no DT O O
48 known VBN O O
48 drug NN B-NP O
49 allergies NNS I-NP O
50 PHYSICAL NNP I-NP O
50 EXAMINATION: NNP I-NP O
50 On IN B-VP O
50 physical JJ B-NP O
50 examination NN I-NP O
50 , , O O
50 the DT B-NP O
51 patient's NN I-NP O
51 temperature NN I-NP O
51 is VBZ O O
51 98.1 CD O O
51 , , O O
51 heart NN B-NP O
52 rate NN I-NP O
52 66 CD O O
52 , , O O
52 sinus VBD B-VP O
52 137/57 CD O O
52 , , O O
52 saturating VBG O O
52 at IN B-VP O
52 97% CD O O
52 and CC O O
52 100% CD O O
52 face NN B-NP O
52 mask NN I-NP O
52 who WP O O
52 is VBZ O O
53 in IN B-VP O
53 no DT B-NP O
53 acute NN I-NP O
53 distress NN I-NP O
53 lying VBG O O
53 in IN B-VP O
53 bed NN B-NP O
53 with IN B-VP O
53 an DT B-NP O
53 intra-aortic JJ I-NP O
53 balloon NN I-NP O
54 pump NN I-NP O
54 HEENT: NNP I-NP O
54 Pupils NNP I-NP O
54 are VBP O O
54 equal JJ O O
54 and CC O O
54 reactive JJ O O
54 to TO O O
54 light JJ O O
54 and CC O O
55 accommodation NN B-NP O
55 Intraocular NNP I-NP O
55 muscles NNS I-NP O
55 intact JJ B-NP O
55 Oropharynx NNP I-NP O
55 clear JJ B-NP O
56 Neck: NNP I-NP O
56 Jugular NNP I-NP O
56 venous JJ B-NP O
56 pressure NN I-NP O
56 was VBD B-VP O
56 about IN B-VP O
56 8 CD O O
56 cm NN B-NP O
56 There EX O O
56 was VBD B-VP O
56 no DT B-NP O
57 hepatojugular JJ I-NP O
57 reflux NN I-NP O
57 No NNP I-NP O
57 thyromegaly NN I-NP O
57 No NNP I-NP O
57 lymphadenopathy JJ B-NP O
58 Carotids NNP I-NP O
58 were VBD B-VP O
58 2+ CD O O
58 without IN B-VP O
58 bruits NNS B-NP O
58 Heart: NNP I-NP O
58 A NNP I-NP O
58 balloon NN I-NP O
58 pump NN I-NP O
58 was VBD B-VP O
58 in IN B-VP O
59 place NN B-NP O
59 Regular JJ B-NP O
59 rate NN I-NP O
59 and CC O O
59 rhythm NN B-NP O
59 Normal NNP I-NP O
59 S1 NNP I-NP O
59 , , O O
59 S2 NNP B-NP O
59 No NNP I-NP O
59 murmurs NN I-NP O
60 appreciated VBD B-VP O
60 Abdomen NNP B-NP O
60 was VBD B-VP O
60 soft JJ O O
60 , , O O
60 nontender NN B-NP O
60 , , O O
60 nondistended VBD B-VP O
60 with IN B-VP O
61 positive JJ B-NP O
61 bowel NN I-NP O
61 sounds VBZ O O
61 Extremities: NNP B-NP O
61 No NNP I-NP O
61 clubbing NN I-NP O
61 , , O O
61 cyanosis NN B-NP O
61 or CC O O
62 edema VB O O
62 The DT B-NP O
62 patient NN I-NP O
62 had VBD B-VP O
62 2+ CD O O
62 dorsalis NNS B-NP O
62 and CC O O
62 posterior JJ B-NP O
62 tibial JJ I-NP O
62 pulses NNS I-NP O
63 bilaterally RB O O
63 and CC O O
63 on IN B-VP O
63 the DT B-NP O
63 right JJ I-NP O
63 femoral JJ I-NP O
63 artery NN I-NP O
63 had VBD B-VP O
63 a DT B-NP O
63 right JJ I-NP O
64 intra-aortic JJ I-NP O
64 balloon NN I-NP O
64 pump NN I-NP O
64 in IN B-VP O
64 place NN B-NP O
64 There EX O O
64 were VBD B-VP O
64 no DT B-NP O
64 varices NNS I-NP O
64 noted VBD B-VP O
65 HOSPITAL NNP B-NP O
65 COURSE: NNP I-NP O
65 The DT B-NP O
65 patient NN I-NP O
65 went VBD B-VP O
65 to TO O O
65 the DT B-NP O
65 Operating NN I-NP O
66 Room NNP I-NP O
66 on IN B-VP O
66 11/23 CD O O
66 , , O O
66 had VBD B-VP O
66 a DT B-NP O
66 coronary JJ I-NP O
66 artery NN I-NP O
67 bypass NN I-NP O
67 graft NN I-NP O
67 x NNP I-NP O
67 three CD O O
67 with IN B-VP O
67 a DT B-NP O
67 saphenous JJ I-NP O
67 vein NN I-NP O
67 graft NN I-NP O
67 to TO O O
67 the DT B-NP O
67 LAD NNP I-NP O
67 , , O O
67 first JJ B-NP O
68 branch NN I-NP O
68 of IN B-VP O
68 the DT B-NP O
68 obtuse NN I-NP O
68 marginal JJ O O
68 and CC O O
68 the DT B-NP O
68 posterior JJ I-NP O
68 descending NN I-NP O
68 artery IN B-VP O
69 The DT B-NP O
69 patient NN I-NP O
69 tolerated VBD B-VP O
69 the DT B-NP O
69 procedure NN I-NP O
69 well RB O O
69 and CC O O
69 was VBD B-VP O
69 transferred VBN O O
69 to TO O O
69 the DT B-NP O
70 Cardiac NNP I-NP O
70 Surgery NNP I-NP O
70 Unit NNP I-NP O
70 in IN B-VP O
70 stable JJ B-NP O
70 condition NN I-NP O
70 On IN B-VP O
70 postoperative JJ B-NP O
70 day NN I-NP O
70 #1 NNP I-NP O
70 , , O O
71 the DT O O
71 patient JJ O O
71 self-extubated JJ O O
71 himself PRP O O
71 and CC O O
71 resultantly RB O O
71 had VBD B-VP O
71 an DT B-NP O
71 adequate JJ I-NP O
72 arterial JJ I-NP O
72 blood NN I-NP O
72 gas NN I-NP O
72 , , O O
72 thus RB O O
72 not RB O O
72 requiring VBG O O
72 emergent JJ B-NP O
72 intubation NN I-NP O
72 The DT B-NP O
73 patient's JJ I-NP O
73 intra-aortic JJ I-NP O
73 balloon NN I-NP O
73 pump NN I-NP O
73 was VBD B-VP O
73 subsequently RB O O
73 removed VBN O O
74 without IN B-VP O
74 further JJ B-NP O
74 incident NN I-NP O
74 , , O O
74 and CC O O
74 the DT B-NP O
74 patient NN I-NP O
74 was VBD B-VP O
74 subsequently RB O O
75 transferred VBN O O
75 to TO O O
75 the DT B-NP O
75 floor NN I-NP O
75 in IN B-VP O
75 stable JJ B-NP O
75 condition NN I-NP O
75 On IN B-VP O
75 postoperative JJ B-NP O
75 day NN I-NP O
76 #3 NNP I-NP O
76 , , O O
76 the DT B-NP O
76 patient NN I-NP O
76 had VBD B-VP O
76 atrial JJ B-NP O
76 fibrillation NN I-NP O
76 which WDT O O
76 was VBD B-VP O
76 treated VBN O O
76 and CC O O
77 controlled VBN O O
77 pharmacologically RB O O
77 , , O O
77 and CC O O
77 also RB O O
77 the DT B-NP O
77 patient NN I-NP O
77 was VBD B-VP O
77 treated VBN O O
77 with IN B-VP O
78 prophylactic JJ B-NP B-r
78 anticoagulation NN I-NP I-r
78 with IN B-VP O
78 Coumadin NNP B-NP B-m
78 The DT B-NP O
78 remainder NN I-NP O
78 of IN B-VP O
78 the DT B-NP O
79 hospital NN I-NP O
79 stay NN I-NP O
79 , , O O
79 the DT B-NP O
79 patient NN I-NP O
79 remained VBD B-VP O
79 afebrile JJ O O
79 , , O O
79 tolerated VBD B-VP O
79 his PRP$ O O
79 diet NN B-NP O
79 , , O O
80 was VBD B-VP O
80 ambulatory JJ O O
80 , , O O
80 had VBD B-VP O
80 his PRP$ O O
80 chest NN B-NP O
80 tube NN I-NP O
80 and CC O O
80 cordis NN B-NP O
80 and CC O O
80 Foley NNP B-NP O
80 catheters NNS I-NP O
81 removed VBD B-VP O
81 On IN B-VP O
81 postoperative JJ B-NP O
81 day NN I-NP O
81 #6 NNP I-NP O
81 , , O O
81 the DT B-NP O
81 patient NN I-NP O
81 converted VBD B-VP O
81 to TO O O
81 sinus VB O O
82 rhythm NN B-NP O
82 , , O O
82 and CC O O
82 the DT B-NP O
82 patient NN I-NP O
82 had VBD B-VP O
82 planned VBN O O
82 discharge NN B-NP O
82 for IN B-VP O
82 24 CD O O
82 hours NNS B-NP O
82 after IN B-VP O
83 that DT O O
83 which WDT O O
83 would MD O O
83 have VB O O
83 been VBN O O
83 on IN B-VP O
83 6/10 CD O O
83 However RB O O
83 , , O O
83 the DT B-NP O
83 patient NN I-NP O
84 requested VBD B-VP O
84 to TO O O
84 be VB O O
84 discharged VBN O O
84 to TO O O
84 home VB O O
84 The DT B-NP O
84 condition NN I-NP O
84 was VBD B-VP O
84 discussed VBN O O
85 with IN B-VP O
85 the DT B-NP O
85 patient NN I-NP O
85 and CC O O
85 the DT B-NP O
85 patient's NN I-NP O
85 wife NN I-NP O
85 which WDT O O
85 required VBD B-VP O
85 continued JJ B-NP O
86 observation NN I-NP O
86 until IN B-VP O
86 the DT B-NP O
86 morning NN I-NP O
86 for IN B-VP O
86 removal NN B-NP O
86 of IN B-VP O
86 epicardial JJ B-NP O
86 wires NNS I-NP O
87 However RB O O
87 , , O O
87 the DT B-NP O
87 patient NN I-NP O
87 refused VBD B-VP O
87 to TO O O
87 stay VB O O
87 He PRP O O
87 experienced VBD B-VP O
87 a DT B-NP O
87 desire NN I-NP O
87 to TO O O
88 go VB O O
88 home NN B-NP O
88 stating NN I-NP O
88 that IN B-VP O
88 he PRP O O
88 does VBZ O O
88 not RB O O
88 like IN B-VP O
88 the DT B-NP O
88 food NN I-NP O
88 here RB O O
88 and CC O O
88 is VBZ O O
88 unable JJ O O
89 to TO O O
89 sleep VB O O
89 and CC O O
89 does VBZ O O
89 not RB O O
89 want VB O O
89 further RBR O O
89 medical JJ B-NP O
89 intervention NN I-NP O
89 The DT B-NP O
89 risks NNS I-NP O
90 of IN B-VP O
90 the DT B-NP O
90 discharge NN I-NP O
90 including VBG O O
90 rhythm NN B-NP O
90 , , O O
90 abnormalities NNS B-NP O
90 and CC O O
90 complications NNS B-NP O
91 related VBN O O
91 to TO O O
91 pacing VBG O O
91 wires NNS B-NP O
91 were VBD B-VP O
91 reviewed VBN O O
91 with IN B-VP O
91 the DT B-NP O
91 patient NN I-NP O
91 and CC O O
91 his PRP$ O O
92 wife NN B-NP O
93 DISPOSITION: NNP I-NP O
93 Despite IN B-VP O
93 understanding VBG O O
93 potential JJ B-NP O
93 risks NNS I-NP O
94 for IN B-VP O
94 discharge NN B-NP O
94 , , O O
94 the DT B-NP O
94 patient NN I-NP O
94 expressed VBD B-VP O
95 desire NN B-NP O
95 for IN B-VP O
95 leaving VBG O O
95 against IN B-VP O
95 medical JJ B-NP O
95 advice NN I-NP O
95 The DT B-NP O
95 above JJ I-NP O
95 condition NN I-NP O
95 was VBD B-VP O
96 discussed VBN O O
96 with IN B-VP O
96 Dr NNP B-NP O
96 Poore NNP I-NP O
96 , , O O
96 the DT O O
96 attending VBG O O
96 surgeon NN B-NP O
96 The DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
97 subsequently RB O O
97 found VBN O O
97 to TO O O
97 have VB O O
97 left VBN O O
97 the DT B-NP O
97 hospital NN I-NP O
97 by IN B-VP O
97 taxi NN B-NP O
97 with IN B-VP O
97 IV NNP B-NP O
98 Heplocks NNP I-NP O
98 , , O O
98 wires NNS B-NP O
98 and CC O O
98 Telemetry NNP B-NP O
98 intact VBP O O
98 The DT B-NP O
98 patient NN I-NP O
98 was VBD B-VP O
98 called VBN O O
98 at IN B-VP O
99 home NN B-NP O
99 , , O O
99 and CC O O
99 condition NN B-NP O
99 of IN B-VP O
99 his PRP$ O O
99 discharge NN B-NP O
99 and CC O O
99 recommendations NNS B-NP O
99 were VBD B-VP O
99 given VBN O O
100 which WDT O O
100 were VBD B-VP O
100 to TO O O
100 return VB O O
100 to TO O O
100 the DT B-NP O
100 hospital NN I-NP O
100 to TO O O
100 have VB O O
100 IV's NNP B-NP O
100 , , O O
100 wires NNS B-NP O
100 and CC O O
101 Telemetry NNP B-NP O
101 removed VBD B-VP O
101 The DT B-NP O
101 patient NN I-NP O
101 refused VBD B-VP O
101 , , O O
101 however RB O O
101 He PRP O O
101 refused VBD B-VP O
101 to TO O O
102 have VB O O
102 the DT B-NP O
102 Visiting NNP I-NP O
102 Nurse NNP I-NP O
102 Association NNP I-NP O
102 to TO O O
102 come VB O O
102 in IN B-VP O
102 to TO O O
102 remove VB O O
102 his PRP$ O O
102 IV's NNP B-NP O
103 The DT B-NP O
103 patient NN I-NP O
103 was VBD B-VP O
103 encouraged VBN O O
103 to TO O O
103 return VB O O
103 for IN B-VP O
103 clipping NN B-NP O
103 of IN B-VP O
103 the DT B-NP O
103 epicardial JJ I-NP O
104 pacing NN I-NP O
104 wires; NN I-NP O
104 however RB O O
104 , , O O
104 he PRP O O
104 refused VBD B-VP O
104 The DT B-NP O
104 patient's JJ I-NP O
104 wife NN I-NP O
104 was VBD B-VP O
104 sent VBN O O
105 with IN B-VP O
105 prescriptions NNS B-NP O
105 and CC O O
105 risk NN B-NP O
105 management NN I-NP O
105 was VBD B-VP O
105 also RB O O
105 informed VBN O O
105 The DT B-NP O
106 patient NN I-NP O
106 was VBD B-VP O
106 requested VBN O O
106 to TO O O
106 return VB O O
106 today NN B-NP O
106 , , O O
106 the DT O O
106 7 CD O O
106 of IN B-VP O
106 August NNP B-NP O
106 , , O O
106 to TO O O
106 have VB O O
107 pacing NN B-NP O
107 wires NNS I-NP O
107 and CC O O
107 Telemetry NNP B-NP O
107 removed VBD B-VP O
107 as RB O O
107 well RB O O
107 as IN B-VP O
107 IV's NNP B-NP O
107 The DT B-NP O
107 patient NN I-NP O
108 returned VBD B-VP O
108 for IN B-VP O
108 an DT B-NP O
108 hour NN I-NP O
108 , , O O
108 had VBD B-VP O
108 pacing NN B-NP O
108 wires NNS I-NP O
108 removed VBD B-VP O
108 and CC O O
108 Telemetry NNP B-NP O
108 box NN I-NP O
109 also RB O O
109 removed VBD B-VP O
109 The DT B-NP O
109 patient NN I-NP O
109 just RB O O
109 left VBN O O
109 on IN B-VP O
109 his PRP$ O O
109 own JJ B-NP O
109 accord NN I-NP O
109 The DT B-NP O
110 patient NN I-NP O
110 requested VBD B-VP O
110 to TO O O
110 follow-up JJ O O
110 with IN B-VP O
110 Dr NNP B-NP O
110 Schoening NNP I-NP O
110 in IN B-VP O
110 6 CD O O
110 weeks NNS B-NP O
110 and CC O O
110 his PRP$ O O
111 cardiologist NN B-NP O
111 in IN B-VP O
111 2 CD O O
111 weeks NNS B-NP O
112 Dictated VBN O O
112 By: NNP B-NP O
112 MYLES NNP I-NP O
112 VELASQUEZ NNP I-NP O
112 , , O O
112 M.D NNP B-NP O
112 TV19 NNP I-NP O
113 Attending: NNP I-NP O
113 ARTHUR NNP I-NP O
113 G NNP I-NP O
113 SHEFFIELD NNP I-NP O
113 , , O O
113 M.D NNP B-NP O
113 EN0 NNP I-NP O
114 VA550/1873 NNP I-NP O
115 Batch: NNP I-NP O
115 0923 CD O O
115 Index NNP B-NP O
115 No NNP I-NP O
115 Z3WLE779PM NNP I-NP O
115 D: NNP I-NP O
115 3/28/95 CD O O
116 T: NNP B-NP O
116 3/28/95 CD O O
117 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #940794 VBZ O O
4 750216362 CD O O
4 TMH NNP B-NP O
4 21370582 CD O O
4 6716015 CD O O
4 2/27/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Non NNP I-NP O
4 cardiac JJ B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/21/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/11/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 LANTON NNP I-NP O
8 , , O O
8 ORVAL NNP B-NP O
8 313-51-70-4 CD O O
9 Bufft NNP B-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 9/11/06 CD O O
11 AT NNP B-NP O
11 05:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 BECKETT NNP I-NP O
14 , , O O
14 COLIN NNP B-NP O
14 WALLY NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Rehabilitation NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACEBUTOLOL NNP I-NP B-m
19 HCL NNP I-NP I-m
19 400 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
19 Starting NNP I-NP O
19 IN NNP I-NP O
19 AM NNP I-NP O
19 ( ( O O
19 8/10 CD O O
19 ) ) O O
20 Food/Drug NNP B-NP O
20 Interaction NNP I-NP O
20 Instruction NNP I-NP O
21 Take NNP I-NP O
21 consistently RB O O
21 with IN B-VP O
21 meals NNS B-NP O
21 or CC O O
21 on IN B-VP O
21 empty JJ B-NP O
21 stomach NN I-NP O
22 ALLOPURINOL NNP I-NP B-m
22 100 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 DAILY NNP I-NP B-f
23 VITAMIN NNP I-NP B-m
23 C NNP I-NP I-m
23 ( ( O I-m
23 ASCORBIC NNP B-NP I-m
23 ACID NNP I-NP I-m
23 ) ) O I-m
23 500 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 CALCIUM NNP I-NP B-m
24 CARBONATE NNP I-NP I-m
24 ( ( O I-m
24 500 CD O I-m
24 MG NNP B-NP I-m
24 ELEMENTAL NNP I-NP I-m
24 CA++ NNP I-NP I-m
24 ) ) O I-m
24 500 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 BID NNP I-NP B-f
25 CIPROFLOXACIN NNP I-NP B-m
25 250 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 Q12H NNP I-NP B-f
25 X NNP I-NP B-du
25 4 CD O I-du
25 doses NNS B-NP I-du
26 Starting VBG O O
26 Today NNP B-NP O
26 ( ( O O
26 5/28 CD O O
26 ) ) O O
26 Food/Drug NNP B-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 Administer NNP I-NP O
27 iron NN I-NP B-m
27 products NNS I-NP I-m
27 a DT B-NP O
27 minimum NN I-NP O
27 of IN B-VP O
27 2 CD O O
27 hours NNS B-NP O
27 before IN B-VP O
27 or CC O O
28 after IN B-VP O
28 a DT B-NP O
28 levofloxacin NN I-NP B-m
28 or CC O O
28 ciprofloxacin NN B-NP B-m
28 dose VBP O O
28 dose JJ O O
29 If IN B-VP O
29 on IN B-VP O
29 tube NN B-NP O
29 feeds NNS I-NP O
29 , , O O
29 please VB O O
29 cycle NN B-NP O
29 ( ( O O
29 hold VB O O
29 1 CD O O
29 hr NN B-NP O
29 before IN B-VP O
29 to TO O O
29 2 CD O O
29 hr NNS B-NP O
30 after IN B-VP O
30 ) ) O O
30 Take VBP O O
30 2 CD O O
30 hours NNS B-NP O
30 before IN B-VP O
30 or CC O O
30 2 CD O O
30 hours NNS B-NP O
30 after IN B-VP O
30 dairy NN B-NP O
30 products NNS I-NP O
31 DIGOXIN NNP I-NP B-m
31 0.125 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 DAILY NNP I-NP B-f
32 COLACE NNP I-NP B-m
32 ( ( O I-m
32 DOCUSATE NNP B-NP I-m
32 SODIUM NNP I-NP I-m
32 ) ) O I-m
